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Abstract 
 
Mathematical models are frequently used to assess the cost-effectiveness of Public Health 
interventions to improve allocation of scarce resources. Public Health interventions tend to operate 
within dynamically complex systems and require broader considerations than clinical interventions. 
Inappropriately simple models and lack of justification may lead to poor validity and credibility, 
resulting in suboptimal allocation of resources. A conceptual modelling framework is a methodology 
that guides modellers through the development of a model structure. This research aims to answer 
the question; ‘What might a conceptual modelling framework for Public Health economic evaluation 
comprise and what could its potential be to improve model quality?’ Such a framework does not 
currently exist. 
 
The framework was informed by: (a) two literature reviews of the key challenges in Public Health 
economic modelling and existing conceptual modelling frameworks; (b) qualitative research to 
understand the experiences of modellers when developing Public Health economic models and their 
views about using a conceptual modelling framework; and (c) piloting a draft version of the 
framework within a diabetes prevention project. Evaluation was via theory-based analysis and a 
focus group of modellers. 
 
The conceptual modelling framework comprises four key principles of good practice and a proposed 
methodology. The principles are; (1) a systems approach to Public Health modelling should be taken; 
(2) developing a thorough documented understanding of the problem is imperative prior to and 
alongside developing and justifying the model structure; (3) strong communication with 
stakeholders and members of the team throughout model development is essential; and (4) a 
systematic consideration of the determinants of health is central to identifying all key impacts of the 
interventions within Public Health economic modelling. The conceptual modelling framework is 
described within the thesis.  
 
Evaluation suggested that the framework, which could be used for good practice, reference and 
education, could improve model quality if disseminated in an accessible form. Future research 
recommendations include use within different case studies followed by further evaluation and 
development of methods for modelling individual and social behaviour drawing upon Sociology, 
Psychology and Public Health. 
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Chapter 1: Why a formal conceptual modelling 
framework might have the potential to improve the 
quality of Public Health economic model structures 
 
1.1 Chapter outline 
The research question addressed within this thesis is ‘What might a conceptual modelling 
framework for Public Health economic evaluation comprise and what could its potential be to 
improve model quality?’, where ‘quality’ is defined as part of the research. There is no agreed 
definition of a conceptual modelling framework,1 which is also developed as part of the research; 
however the preliminary definition is taken to be ‘a set of principles and methods which facilitate 
the development of a qualitative description of a quantitative model.’ Section 1.2 describes the 
study aim and objectives and Section 1.3 explains the rationale for the research. Section 1.4 
describes my academic and philosophical position and Section 1.5 sets out the approach taken 
within the research. Section 1.6 outlines the structure of the thesis.  
 
1.2 Aim and objectives of the study 
The aim of this thesis is to develop a conceptual modelling framework which has the potential to 
improve the quality of Public Health economic model structures. The objectives are: 
 To identify and explore key challenges within Public Health economic evaluation by 
reviewing what other researchers have exposed within the literature. 
 To specify the way in which existing conceptual modelling frameworks might help within 
Public Health economic evaluation by exploring the literature across a broad range of 
disciplines. 
 To provide an analysis of modellers’ views about the way in which Public Health economic 
models are currently developed and the benefits and barriers of conceptual modelling 
frameworks.   
 To assess critically the use of the draft conceptual modelling framework within a case study 
assessing the cost-effectiveness of interventions for diabetes screening and prevention. 
 To produce a conceptual modelling framework document that can be used by modellers to 
help them develop Public Health economic model structures. 
 To evaluate the framework via focus group analysis and theory-based evaluation. 
 To make recommendations around future research and use of the conceptual modelling 
framework developed. 
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1.3 Rationale for the thesis 
In order to describe the rationale for the thesis, background information about health economic 
modelling, methods for dealing with uncertainty, the discipline of public health and conceptual 
modelling, is required. These are each described below. 
 
1.3.1 Health economic modelling 
Worldwide there are insufficient resources to meet the demand for healthcare.2  This means that 
decisions are required about which healthcare resources should be funded and which should not. In 
many countries including the UK, rather than making ad hoc decisions based upon non-explicit and 
selective information, a rational and coherent framework is used for making these decisions, with an 
aim of maximising the health gains of society according to the available budget.3  Health economic 
evaluation attempts to provide such a framework by comparing the differences in costs and 
outcomes between alternative options in order to help decision makers make choices between 
competing priorities.2  Health economic evaluation is now well established within the UK and 
worldwide.3  
 
Types of economic evaluation 
The predominant type of economic evaluation within applied healthcare research is cost-
effectiveness analysis.3  The origin of cost-effectiveness analysis is said to be within Operational 
Research where a unidimensional health-related objective function is maximised within a set of 
budget constraints by identifying and valuing all healthcare interventions.3  However, due to the 
large number of permutations of healthcare interventions and settings, and the continuously 
changing nature of healthcare, this theoretical approach is not practically possible. As such, simple 
decision rules have been developed for comparing two or more alternatives for a specific population 
within a particular setting. This approach involves employing a threshold to represent the estimated 
opportunity cost (the monetary value of the health foregone) of healthcare interventions displaced 
by new, more costly interventions to assess whether the benefit of the new intervention is greater 
than the interventions being displaced, assuming a fixed budget constraint.4  The outcome measure 
most commonly employed within cost-effectiveness analysis is the incremental quality-adjusted life 
year (QALY) gained.3;4  Cost-effectiveness analysis is the recommended approach for economic 
evaluation by the UK National Institute for Health and Care Excellence (NICE). Within England and 
Wales, the generally accepted threshold for a healthcare intervention to be considered to be cost-
effective is £20,000 - £30,000 per incremental QALY gained.5  
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Cost-benefit analysis is an alternative approach, which requires both resource use and consequences 
of an intervention to be expressed in monetary amounts. This is usually estimated by valuing the 
willingness to pay of individuals for a health gain or for avoiding a disbenefit.3  This can be assessed 
via a survey, known as contingent valuation, or it can be estimated based on trade-offs which have 
previously been made between outcomes and money.6   Under Kaldor-Hicks criterion, interventions 
must result in sufficient benefits such that the people who benefit could in theory compensate the 
people who lose out and as a result of this compensation no individuals are made worse off (taking 
into account both costs and outcomes).3  Whilst a cost-effectiveness analysis in economics is 
associated with extra-welfarism which aims to maximise health by choosing all medical procedures 
which are more cost-effective than a certain threshold, cost-benefit analysis is grounded within 
welfarism which aims to maximise overall welfare subject to a budget constraint.3  This means that 
healthcare interventions would be compared with all other goods. Given the scope of Public Health 
interventions and associated outcomes, a cost-benefit analysis may be considered theoretically 
superior,7  however there are practical issues associated with monetary valuation of outcomes.  
 
Another form of economic evaluation is cost-consequence analysis, where relevant costs and 
outcomes in multiple dimensions are presented separately rather than being combined.2  
 
Mathematical models 
Very commonly, mathematical models are used as a vehicle for undertaking economic evaluation.2  
This is because trials, particularly of Public Health interventions, would require large sample sizes 
and a long follow up period in order to be able to fully capture the costs and outcomes of the 
interventions. Mathematical models use mathematics to represent the parts of the real world and 
the relationships between those parts that are perceived to be of interest to those individuals who 
are assessing a particular problem.8  This means that the level of abstraction is dependent upon the 
purpose of the model. Mathematical models can be used for economic evaluation to estimate the 
differences between the costs and outcomes of alternative interventions by simplifying complex 
realities, synthesising evidence from a wide range of sources and extrapolating short term data over 
the long term. Within these models, judgements about what is relevant for inclusion within the 
model and how relationships within the model should be represented are required. A model in 
health economic evaluation usually includes information about the relevant disease natural 
histories, current service pathways, the resources required and the health outcomes of the affected 
individuals. Models are intended to be simplifications of reality and we usually have imperfect data 
upon which to develop the model. This means that there are always uncertainties associated with 
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the model structure and inputs, and hence with the model results. It is important fully to describe 
the level of uncertainty within the model results so that decision makers can understand the risk of 
making an inefficient and possibly irreversible decision. In addition, a description of which aspects of 
a problem are uncertain helps decision makers to consider where areas of further research may be 
of most value in reducing decision uncertainty.3  
 
1.3.2 Methods for dealing with uncertainty 
Uncertainty within a health economic model can be classified into parameter uncertainty, 
methodological uncertainty and structural uncertainty.9;10  
 
Parameter uncertainty 
The conventional approach for addressing parameter uncertainty is via the use of probabilistic 
sensitivity analysis (PSA) which involves the characterisation of uncertainty surrounding all model 
parameters using appropriate statistical probability distributions.11 This uncertainty is most 
commonly propagated through the model using Monte Carlo simulation over a large number of 
samples to assess the likelihood that a given policy option is optimal.11  However, current 
approaches to PSA do not account for methodological or structural uncertainty.12  
 
Methodological uncertainty 
Methodological uncertainty relates to methodological choices such as the perspective of the 
analysis, the discount rate and the valuation of health outcomes. NICE, which produces Public Health 
guidance within England and Wales, uses a Reference Case in order to standardise decisions around 
modelling methodology.5  This reflects the broad technical value judgements of the decision making 
body. Key features of the Reference Case for Public Health economic evaluation are that: a cost-
effectiveness analysis should be undertaken as the primary analysis (cost-utility where possible), 
with a cost consequence or cost-benefit analysis as a secondary analysis; costs should be based upon 
a public sector perspective; outcomes should include all health effects on individuals; a QALY has the 
same weight irrespective of the characteristics of the population; all costs and health effects should 
be discounted by an annual rate of 3.5%; and the comparator should be interventions routinely used 
in the public sector, including those regarded as best practice.5 
  
Structural uncertainty 
Structural uncertainty relates to whether all relevant processes are represented in the model, that 
is, what is included and excluded and how the relationships between inputs and outputs are 
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captured.13  In mathematical terms, given a function f(p1,p2,…pn) + ε, where pi is a parameter and ε is 
an error term, structural uncertainty relates to which pis to include within the model and the 
specification of the function ‘f’.10  Examples of structural uncertainty are which diseases should be 
included within the model, how to represent the disease natural history, which service pathways are 
relevant and how to model the relationships between intermediate outcomes and long term 
outcomes. Decisions about model structure are to some extent dependent upon the availability of 
evidence. If the model structure is inadequate then the PSA may provide misleading results in terms 
of the estimated mean result and/or the extent of the uncertainty around the results. Despite this, 
structural uncertainty has received the least attention in terms of methods development.12 
 
Methods for dealing with structural uncertainty 
Uncertainty around the most appropriate model structure may be dealt with retrospectively 
following model implementation by expressing the impact of uncertainties upon the model results 
and/or prospectively by considering the process through which decisions are made around the 
conceptualisation, structuring and implementation of the model.14  The former of these aims to 
characterise uncertainty, whilst the latter aims to reduce uncertainty and understand where areas of 
uncertainty remain. Since in principle most structural uncertainties are fully or partially reducible, 
prospective methods are likely to be useful to decrease the probability of making an inefficient 
policy decision. The approach most commonly employed for handling structural uncertainty within 
health economic evaluation is scenario analysis, which involves assessing the impact of alternative 
structural assumptions upon the model results in turn. However, scenario analysis does not capture 
the combined uncertainty within the model results. Moreover, there are no formal methods for 
choosing the initial model structures or which structures to vary within the scenario analysis.  
 
Recent methodological attention on structural uncertainty has focussed on variants of model 
averaging approaches, either at the whole model level or at the individual structural assumption 
level.10;12;15  This approach essentially reduces to a process of converting structural uncertainty into 
parametric uncertainty by building alternative structures into the model and ascribing elicited 
probabilities to each structure so that standard approaches to analysing probabilistic uncertainty can 
then be used.11  Resource and time constraints mean that it is not practical, or necessarily helpful, to 
ensure that all possible model structures (which may each require a number of different parameters 
to be specified) are implemented and ascribed appropriate probabilities. As for scenario analysis, 
currently there are no methods for determining a set of plausible model structures to incorporate 
within the analysis. 
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Strong et al. have recently developed a discrepancy approach; an alternative method which helps 
the modeller decide which structural assumptions are important during implementation of the 
quantitative model.16  It does this by comparing intermediate model outcomes with available data 
and applying some discrepancy term to describe the error. However, this approach is in its infancy 
and the process of capturing structural choices as discrepancies is poorly understood.  
 
Importantly, a fundamental flaw with all of the existing approaches for handling structural 
uncertainty is that there are no prospective methods for choosing and justifying appropriate model 
structures for the analyses.17  Within this thesis it is argued that in order to handle structural 
uncertainty appropriately, prospective methods for understanding the decision problem and 
choosing appropriate model structures should be developed. 
 
In 2010 within a study of avoiding and identifying errors in Health Technology Assessment (HTA), 
Chilcott et al. found that there were no formal methods for developing the model structure of health 
economic evaluations which were systematic or transparent.17  Two conceptual modelling 
frameworks have been developed since 2010 when this research began: (1) by Kaltenthaler et al. 
(which I was involved in developing); and (2) by a working group of the International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR).14;18  This highlights the timely nature of this 
work. Both of these frameworks were developed for the economic modelling of clinical interventions 
and thus the structural development of Public Health economic models continues to be based upon 
ad hoc methods which are highly dependent upon the modeller and the stakeholders, as well as the 
decision problem.  
 
1.3.3 Public health  
Public Health has been defined as ‘the science and art of preventing disease, prolonging life and 
promoting health through the organised efforts and informed choices of society, organisations, 
public and private, communities and individuals’.19;20 More specifically, according to Green and 
Hiatt,21 in order to prevent morbidity and early mortality by influencing behaviour and by protecting 
others from harmful behaviours, the objectives of the discipline of public health are to: 
a) Identify, measure, monitor, and anticipate community health needs; 
b) Formulate, promote and enforce essential health policies; 
c) Organise and ensure high quality, cost-effective public health and health care services; 
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d) Reduce health disparities and ensure access to healthcare for all by improving the health of 
the poor and disadvantaged; 
e) Promote and protect a healthy environment; 
f) Disseminate health information and mobilise communities to take appropriate action; 
g) Plan and prepare for natural and man-made disasters; 
h) Reduce interpersonal violence and aggressive war; 
i) Conduct research and evaluate health promoting / disease preventing strategies; 
j) Develop new methodologies for research and evaluation; 
k) Train and ensure a competent public health workforce.  
Within Public Health, it is known that certain changes in diet or lifestyle will impact upon disease 
incidence; however much less is known about why people behave the way that they do and how to 
change the public’s behaviour, and little is known about maintaining modified behaviour.21;22  
 
Social structure  
Social structure is the result of billions of individual actions (human agency) which create patterns of 
behaviour.23  However, society is more than the sum of the individual actions of the people within it, 
because there is inevitable interaction between the actions of individuals with each other, and with 
their social structure. The exact nature of this interaction is debated; however most sociologists 
agree that this relationship is complex and that, to some extent, people’s behaviour will affect their 
social structure and at the same time their social structure will affect their behaviour.24  Thus society 
is an entity in itself, which constrains and organises human behaviour without the conscious intent 
of the individual.24-26  Different mechanisms act upon disease at the social level to the individual 
level.27  At the social level, health is affected by the influences of social patterning, whilst at the 
individual level, behaviour and biology are causally linked to disease. It would therefore be 
insufficient for Public Health interventions to aim to modify individual behaviour, without 
consideration of the social structure, or to ignore the interaction between the individual and social 
level when assessing the effectiveness and cost-effectiveness of the interventions. The factors of 
social structure that impact upon health are known as the social determinants of health. 
 
The determinants of health 
The determinants of health have been classified in many different ways, but they tend to include 
individual, community and population level influence upon health. Perhaps the most well known is 
that of Dahlgren and Whitehead, shown in Figure 1.1,28 reproduced with permission.  
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Figure 1.1: Determinants of health 
 
 
 
 
 
 
 
 
 
Within Figure 1.1, the age, sex and constitutional (i.e. hereditary) factors in the centre are generally 
predetermined; however the remainder of the factors within the diagram are potentially modifiable. 
Other classifications of the determinants of health are briefly reviewed within Chapter 3.  
 
Health inequalities and inequities 
Health inequalities are differences between the health of groups of individuals, which may be 
unrelated to policy,29 whilst health inequities are defined by the WHO as ‘unfair and avoidable or 
remediable differences in health among population groups defined socially, economically, 
demographically, or geographically’.30  It has been shown in the UK and in many other countries that 
there is a correlation between socioeconomic status and health, known as the social gradient.31;32  
This is the case for almost every disease.33  The social gradient has become steeper over the last 
forty years.34  This is because people with a higher socioeconomic status tend to benefit more from 
Public Health interventions than people with a lower socioeconomic status, thus improving average 
health across the population generally steepens this gradient.32  It is therefore important that Public 
Health aims to tackle the challenges posed by the social gradient.32;35  The relationship between 
socioeconomic status and health is complex and debated amongst social epidemiologists, involving 
material, psychosocial, behavioural and biological factors. Very little is known about how 
socioeconomic status directly influences biological factors.36 Some researchers take a psychosocial 
perspective, suggesting that the perception of lower socioeconomic status causes stress which 
impacts upon health,37 whilst others take a materialist position whereby lack of resources impacts 
upon health directly and psychosocial factors play a smaller role.38 Other theories try to integrate 
these factors with behavioural and/or biological factors.35;39   
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The life course 
It is important to understand the impact of time and timing upon the relationships between the 
determinants of health and the impacts of Public Health interventions when measuring and 
estimating outcomes. Complex behaviour generally takes time to modify and behaviours may be 
reinforced over the lifetime of the individual (i.e. a positive feedback loop may occur where an 
intervention leads to behaviour modification and the result of this leads to further similar behaviour 
modification) if the intervention is targeted at an appropriate time in a person’s life course.40  The 
concept of feedback loops within Public Health systems are explored in more detail within Chapters 
2 and 3.  Kelly et al. suggest that interventions may be most effective at specific points in the life 
course.40  Within the NICE behaviour change guidance, examples provided of this are leaving school, 
entering the workforce, becoming a parent, becoming unemployed, retirement and bereavement.22  
This life course approach aims to understand how the social determinants of health impact on all 
stages of life from child development to adulthood.40 
 
Complexity of Public Health systems 
Public Health is generally associated with greater complexity than systems within which clinical 
interventions operate; thus my research focuses upon Public Health economic evaluation. Within 
assessments of clinical interventions, it is generally the disease and the impact of the intervention 
upon that disease which needs to be understood. Within Public Health economic evaluation, in 
addition to this, it may also be necessary to understand the relationship between the determinants 
of health / health inequities and behaviour and how that is affected by the intervention (as 
discussed above). As a result, the scope of the system involved may not be easily defined. The causal 
relationships associated with many Public Health interventions are shown in Figure 1.2 below and an 
example of the complexity of a Public Health system is demonstrated within the Foresight obesity 
map,41 reproduced with permission in Figure 1.3. Further discussion of the complexity of Public 
Health systems and the implications of this for modelling is provided within Chapters 2 and 3.  
 
Current approach to Public Health economic model development 
Guidelines and checklists for good modelling practice have been developed for health economic 
models.42;43  These allow modellers to review a model and check what has been done, but they do 
not describe criteria by which to judge each requirement or describe how models might be 
developed. For example, Phillips et al. suggest that ‘all structural assumptions should be transparent 
and justified. They should be reasonable in the light of the needs and purposes of the decision-
maker.’42  The aim of the checklist is not to describe how to develop structural assumptions, nor are 
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the criteria for the assumptions being ‘reasonable’ defined. Similarly, the NICE Public Health 
methods guide describes what to present, but does not provide methods for choosing model 
structures. Assumptions about the appropriateness of approaches for modelling clinical 
interventions may not always be questioned for economic modelling of Public Health interventions. 
Therefore, not only is there a limited understanding of the complexity of Public Health for which no 
formal methods for developing the model structures currently exist, but there may also be a lack of 
awareness for some modellers that the assessment of many Public Health interventions is a different 
type of problem which requires new ways of thinking for developing the model structure. A 
framework for developing Public Health economic model structures may help to guide modellers.  
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Figure 1.2: Causality for Public Health interventions   
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Figure 1.3: Foresight obesity map41 
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Choices with permission from Government 
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1.3.4 Conceptual modelling 
Conceptual modelling is broadly the abstraction of reality at an appropriate level of simplification for 
the problem;44  however there is currently no single agreed more comprehensive definition. This is 
explored further within Chapter 4.  
 
Current practice 
In 2010, a qualitative research study was published by Chilcott et al. about avoiding and identifying 
errors within health technology assessment models. One of the major findings was the large amount 
of variability within the model development process between modellers, particularly in conceptual 
modelling.17  Conceptualising the problem (in some form) is an inevitable a priori process in order to 
develop a mathematical model; however within the Chilcott study some modellers suggested that 
they did not make a distinction between conceptualisation and implementation of the quantitative 
model, and of those that did, the process and level of documentation varied.17 By undertaking 
conceptualisation and implementation in parallel, there is no basis for justifying the structure of the 
final model.14  Modellers within that study suggested that written documentation may consist of the 
proposed model structure, assumptions, a diagram or sketch of the model design and/or clinical / 
disease pathways, memos, representative mock-ups to illustrate specific issues in the proposed 
implementation model and/or written interpretations of evidence.17  The variation in defining a 
conceptual model is likely to be due to the paucity of literature around the process of model 
development within health economic modelling. For example, key health economic evaluation 
textbooks do not describe the conceptual modelling process,2;3 and the conceptual modelling 
process is not considered within systematic reviews of Public Health economic evaluations 
undertaken to date.45-48  
 
The need for a conceptual modelling framework 
Importantly, within the study by Chilcott et al. approximately 70% of the discussion about elements 
which might contribute towards errors in decision making focused upon the conceptual modelling 
process.17  Conceptual modelling is the first part of a modelling project, which guides and impacts 
upon all other stages. This means that if this is done poorly, all subsequent analysis, no matter how 
mathematically sophisticated, is unlikely to be useful for decision makers.49 
 
Some literature describes conceptual modelling as an ‘art’ rather than a science, and hence the skills 
need to be developed by experience.1  This may be true to some extent since subjective judgements 
are central to the development of model structures. However, Forrester states that any worthwhile 
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venture emerges first as an art, and as such the outcomes are special cases and are poorly 
transferable, but that this can then be transformed into a science by understanding the foundations 
of the art, making it more useful to new situations.50  If one takes this view, this would suggest that 
conceptual modelling is treated as an ‘art’ because the methods are in their infancy, rather than 
because conceptual modelling truly should be an ‘art’. In the context of the defence field, Pace 
suggested that modeller professionalism could be improved by the development of conceptual 
modelling frameworks.51  Several researchers have suggested that domain-specific frameworks are 
required, due to the difficulty in specifying a generic conceptual modelling framework.1;52 
 
Benefits of a conceptual modelling framework 
Based upon the book by Robinson et al. titled ‘Conceptual Modeling for Discrete Event Simulation’, 
some of the key benefits of a conceptual modelling framework may be: (i) improved model 
requirements (which may include improved understanding of the problem and the development of 
an appropriate model scope); (ii) improved credibility (i.e. stakeholder acceptance of the model) 
both by stakeholder involvement and clear documentation when developing the model structure; 
(iii) improved model validity (i.e. developing the right model) by facilitating the specification of 
appropriate structural assumptions; (iv) improved model verification (i.e. developing the model 
right) by providing a method for comparing the quantitative model with the intended structural 
assumptions; (v) guidance for testing alternative options; and (vi) clear model documentation which 
may facilitate independent validation and verification and model reuse.1  A conceptual modelling 
framework may also facilitate the characterisation of structural uncertainties by understanding 
which areas remain uncertain and how, and as such helping to identify where primary research may 
be valuable. Consequently this primary research should help to reduce structural uncertainty within 
future models by providing evidence describing the relationship between factors where it was 
previously weak. The benefits of a conceptual modelling framework will be considered in further 
detail as part of the literature review of conceptual modelling frameworks in Chapter 4.  
 
Model complexity 
One of the key issues for consideration when developing a model is the level of complexity 
incorporated. The idea of parsimony has frequently been recommended in the context of model 
development.18;44  Although there is wide agreement that a model should be as simple as possible in 
theory, practically there are limited methods for helping the modeller decide upon the level of 
complexity within the model. A conceptual modelling framework could help modellers to make 
decisions about the complexity of the model structure within Public Health economic evaluation. 
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1.4 Academic and philosophical position 
My academic background and position 
My academic background is in Mathematics and Operational Research, with Health Economic 
experience gained through application of these. Thus, my conceptual modelling framework has been 
developed with Operational Research at the core. However, the research reported in this thesis is 
inevitably at the intersection of a range of disciplines including Operational Research, Public Health, 
Health Economics, Econometrics, Psychology and Sociology, and these have been investigated and 
embraced throughout the development of the framework for this work. Whilst my academic 
background is in quantitative research, qualitative research has been undertaken as part of this 
thesis and I have developed my skills in this area.  
 
My applied research experience in this area led to the identification of a perceived requirement for a 
conceptual modelling framework and thus at the start of this research I had a strong belief that this 
is an important gap. This has shaped my research question. I have endeavoured to be open to the 
possibility that a conceptual modelling framework may not be useful for all circumstances, and this 
has been discussed within the evaluation (see Chapter 8). I am examining the research question 
from the perspective of a health economic modeller which is consistent with my intended audience 
of the thesis. However, I am aware that my research experience may impact upon my interpretation 
of the data (see my ontological position below).   
 
Paradigms 
There are many different ways of thinking about a problem. In The Structure of Scientific Revolutions, 
Kuhn offers a way of dealing with these different perspectives.53 Kuhn’s central organising concept is 
paradigm. He argues that a paradigm is a set of agreed practices followed by groups of researchers, 
usually for some time period within a sub discipline within a broader disciplinary community. Within 
a paradigm there are shared preconceptions which in turn influence the methods for the collection 
of and the interpretation of evidence. These paradigmatic methods and processes often constitute 
the taken for granted assumptions of the sub discipline. For individuals who are very familiar with a 
particular sub-discipline, the paradigm is often assumed to be reality itself. This in turn means that 
evidence which does not fit with these shared preconceptions is likely to be rejected. Kuhn observed 
that this rejection will continue until such a point when not only is the evidence incompatible with 
current assumptions but also the adherents to the old ways of thinking no longer exert power over 
journal publication, control of grant awards and the appointment of new staff. At that point a new 
social order emerges and a paradigm shift occurs; the ways of thinking are revised.53   
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Our understanding of any topic at any point in time is constrained by the current paradigm. For 
example, our understanding of medicine employs a particular paradigm, within which in Western 
societies we expect to be healthy well beyond middle age.54  Within the discipline of Public Health, 
several paradigm shifts have occurred from God being responsible for disease, to ‘bad air’, to germ 
theory, to the current paradigm that disease can be understood in terms of multiple risk factors.55  
These current broad assumptions within Public Health may also be contested.56  The process of 
relating factors causally within a model is another example and this research is placed within the 
current paradigms associated with Public Health and causality. Throughout the research I will 
endeavour to identify the assumptions that I make as a researcher about data collection and analysis 
and the degree to which this may influence the inferences and conclusions made (see reflexivity 
within the thesis section over page). 
  
My ontological position 
A key philosophical issue within this work is around what reality is, since we are trying to understand 
and represent key aspects of reality. Ontology is about the nature of the world and what we can 
know about it.57  There are three main ontological stances, although there are a number of 
variations around these. A realist stance argues that reality exists independently of people’s beliefs 
and understanding, and that there is one true reality. A materialist stance also claims that reality 
exists independently of people’s beliefs and understanding and that there is one true reality, but 
that it is defined by material aspects of the world such as physical or economic things. In contrast, an 
idealist stance argues that reality is constructed through human understanding and as such there are 
multiple realities.57  There is no agreement about which ontological stance is the most appropriate 
or correct. Within this work, a subtle realist perspective is employed; which is a type of realism 
influenced by idealism, in that whilst it is assumed that there is one true reality, it is only knowable 
through human understanding and socially constructed meanings.57  This Kantian position means 
that I may interpret data differently to another researcher, although the same methods should not 
generate contradictory conclusions between researchers. In the context of modelling, a subtle realist 
perspective means that it is important to share and question the assumptions of modellers, decision 
makers and other stakeholders so that our human understanding tends towards reality.  
 
My epistemological position 
Epistemology is about ways of knowing and learning about the world.57  It may be argued that there 
are two main epistemological stances; positivism and interpretivism.58  A positivist stance assumes 
that the results of the data analysis are objective, and independent of values, ‘knowledge’ and 
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views, and as such objective methods of analysis are considered to be appropriate such as 
hypothesis testing.58  Quantitative researchers often take a positivist perspective although they may 
recognise that aspects such as research design may affect the results of the research. In contrast, 
many qualitative researchers suggest that qualitative data analysis cannot be completely objective 
and that it is likely to be affected by the perspectives of the participants as well as the researcher’s 
values, ‘knowledge’, views and research interests.57  This is an interpretivist perspective and it is the 
perspective taken within this research. For example, participants may have different opinions about 
a social issue and within interview transcripts the researcher is likely to only analyse data that is 
relevant to the research question. I view health economic modelling from an interpretivist 
perspective since it is dependent upon subjective assumptions and values. However, it is worth 
noting that some people regard the results of these quantitative models as if they are an objective 
tool, thus taking a positivist stance in their interpretation.  
 
Combining qualitative and quantitative research 
Some researchers have suggested addressing research questions, where relevant, using pragmatic 
multi-methodology approaches, rather than being overly concerned by the philosophical positions of 
each approach.57  However, other researchers have argued that multi-methodology approaches 
should be limited to using methods from the same epistemological stance since combining methods 
from different stances ignores the philosophical underpinnings of each of the research methods.57  
There is still no agreement about this, even between mixed methodologists.57  
 
Qualitative analysis is generally associated with an inductive approach which involves looking for 
patterns from observations to generate theory, associated with an interpretivist epistemology. 
Quantitative research is generally associated with a deductive approach, which is consistent with a 
positivist epistemology, where a hypothesis is proven or disproven, when making generalisations 
from qualitative data.57  Mason suggests that it could be argued that all research employs both 
deduction and induction since if taking a deductive approach the initial hypothesis is likely to be 
based upon existing data, and if taking an inductive approach the research question is likely to be 
developed based upon existing theory.58  This research uses both deduction and induction in that the 
initial research question is based upon relevant theory and developed further during the research.    
 
Reflexivity within the thesis   
Reflexivity is the idea that meaning from research within an interpretivist paradigm is developed 
based upon the complex relationship between the understanding of the participant and the 
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researchers prior to the research combined with the additional meaning gained from the research.59  
Throughout the research I take a reflexive approach. Thus, for example, within the qualitative 
research described within Chapter 5, meaning is developed based upon my prior understanding, the 
initial understanding of the participants involved, plus the iterative process of developing and 
describing meaning throughout the data collection. This new meaning in turn impacts upon the 
participants’ and my understanding subsequent to the data collection setting. It is therefore 
important for me to be aware of my impact upon the research and identify any assumptions and 
preconceptions that I have which may impact upon my interpretation of data.59   
 
Conceptual modelling employs a reflexive process whereby modellers, decision makers and other 
stakeholders are continuously sharing and establishing meaning and assessing what to do based 
upon prior meaning and activity. This conceptual modelling process mirrors the learning process and 
development of this research. Stakeholders are defined for the purposes of this research as ‘any 
person who might impact upon or be impacted upon by the system of interest’. 
 
Range of research methods and writing styles within the thesis 
Part of my learning within this thesis was about the use of different types of research methods. 
Several different research methods are employed throughout and different writing styles are used as 
appropriate for each of these research methods. The literature reviews are written in the third 
person so as to present a relatively objective analysis of the papers identified, removing as much of 
my personal opinion and perspective as possible. In contrast, the qualitative research is written in 
the first person so as to remain in line with the reflexive approach taken. The critical reflection of the 
draft conceptual modelling framework case study is also written in the first person and is intended 
to provide more of an exploratory perspective.  
 
The focus on the development of the conceptual modelling framework 
The Medical Research Council Guidelines for Developing and Evaluating Complex Interventions 
suggest that in order to understand whether an intervention is successful it needs to be developed, 
piloted, evaluated, reported and implemented.60  These guidelines highlight the particular 
importance of adequate development and piloting work in order to lead to successful subsequent 
stages. I therefore focus upon the development and piloting of the conceptual modelling framework 
within this research. Full evaluation, reporting and implementation can be pursued within 
subsequent research following this work. 
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Diagnosis 
Planning 
Analysis 
Reflectio
n 
1.5 Approach taken 
Throughout the thesis, a process of cyclical learning has been undertaken of diagnosis, planning, 
analysis and reflection as shown in Figure 1.4. My research question at the start of this work was 
‘What might a conceptual modelling framework for Public Health economic evaluation comprise and 
what could its potential be to improve model quality?’ Following the research undertaken within 
Chapters 4 and 5, the research question was expanded to be clearer about the definition of ‘quality’. 
The process of defining what the conceptual modelling framework would comprise was led by 
understanding how the framework might improve the quality of Public Health economic model 
structures. In addition, the conceptual modelling framework that has been developed is not 
intended to be a final unchangeable framework, but rather a starting point which can be continually 
revised following its use within different Public Health economic modelling projects and according to 
developments within other related research areas.  
 
Figure 1.4: Cyclical approach to methods development 
 
 
 
 
1.6 Thesis structure 
The structure of the thesis is presented within Figure 1.5. Chapters 2-6 describe the methodological 
development of a conceptual modelling framework. The outcomes of the research presented within 
each of these chapters inform data collection and interpretation within multiple other chapters as 
shown within Figure 1.5, due to the cyclical approach to methods development taken. The exact way 
that each chapter feeds into each other is described within the relevant chapters.   
 
Chapter 2 reviews the literature around the key methodological challenges within Public Health 
economic modelling in order to highlight key aspects of Public Health which may need to be 
considered within the model development process and to place my own research in the context of 
other research on Public Health economic modelling.  
 
Chapter 3 considers, in more depth, some of the issues raised within the literature review in Chapter 
2 where it was thought that further exploration would be useful. This involves consulting broader 
literature within the fields of complexity theory and systems thinking, Public Health, Sociology and 
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Psychology. It reflects upon what a dynamically complex system is and whether all Public Health 
systems are dynamically complex, the use of systems thinking for modelling such complex systems, it 
reviews the literature around the social determinants of health, and considers how models of 
Psychology and Sociology might be used to model behaviour within health economic models.  
 
Chapter 4 presents a literature review of conceptual modelling frameworks. The aim of the review is 
to understand (a) what comprises existing conceptual modelling frameworks, in terms of the stages 
of model development considered, the level of detail provided, the definition of a conceptual model, 
the methods / methodologies recommended and the relationships between them, and the theory 
associated with the framework, and (b) the strengths and limitations of these frameworks, how they 
have been evaluated, and their potential application within Public Health economic modelling. 
 
Chapter 5 describes modellers’ experiences with developing the structure of Public Health economic 
models and their views about the benefits and barriers of using a conceptual modelling framework 
in order to facilitate the development of a useful conceptual modelling framework. The qualitative 
research methods employed are outlined, and the results of the analysis are described.  
 
Chapter 6 describes my experience and critical reflections on the use of the draft conceptual 
modelling framework within a case study assessing the cost-effectiveness of prevention 
interventions for type 2 diabetes in order to further develop the framework.  
 
The conceptual modelling framework for Public Health economic evaluation is described within 
Chapter 7, with justification for the methods presented based upon Chapters 2 - 6. An example to 
illustrate the methods is included using the diabetes case study described within Chapter 6. 
 
Chapter 8 considers whether the research question has been addressed by (1) reflecting upon the 
theoretical basis of the conceptual modelling framework developed, including whether the 
framework might be associated with any negative implications for model quality, and (2) presenting 
the analysis of a focus group of modellers who provide their views on the utility of the framework.  
 
Chapter 9 describes the contribution of each chapter of the thesis in the context of other research, 
with a particular focus upon the contribution of the conceptual modelling framework presented 
within Chapter 7. It also outlines the strengths and limitations of the research and the conclusions 
and further research recommendations. 
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Figure 1.5: Thesis structure 
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Chapter 2: Methodological challenges 
characterising Public Health economic model 
development 
 
2.1 Chapter outline 
A literature review of the key methodological challenges within Public Health economic modelling is 
presented. It aims to highlight key aspects associated with Public Health which may need to be 
considered within the model development process and to place my own research in the context of 
other research on Public Health economic modelling. Section 2.2 and 2.3 describe the methods and 
results of the review respectively. The review is divided into four key themes which were developed 
from the findings of the included papers; (A) inclusion of non-healthcare costs and outcomes; (B) the 
inclusion of equity; (C) multi-component interventions and complex systems; and (D) technical 
modelling issues. Section 2.4 provides a discussion of the review and Section 2.5 presents the 
implications of the review upon methods development.   
 
2.2 Methods of review of key methodological challenges of Public Health modelling 
The traditional Cochrane search aims to identify all studies that meet pre-specified inclusion and 
exclusion criteria.61  Methodological reviews often require alternative search strategies which allow 
the scope of the search to develop as the reviewer’s understanding of the methods increases,62 with 
the aim of using the reviewing process to enhance understanding. Thus, for this review, papers were 
identified using an iterative approach to searching,63 using a range of different search techniques 
described in more detail below. The inclusion and exclusion criteria developed as a result of the 
search is described within Section 2.3.  
 
Article identification 
In order to develop an initial understanding of potential methodological issues; (1) papers relating to 
economic evaluation resulting from the work of the Public Health Excellence Centre at NICE were 
identified by searching for key people from the website as authors in Medline; (2) the publications 
written by the Public Health Research Consortium, a collaboration between eleven UK institutions to 
strengthen the evidence base for interventions to improve health, were hand searched; and (3) a 
Medline search for terms relating to problems in Public Health economic modelling was undertaken. 
Due to the results of this step, key Public Health journals were subsequently searched (Journal of 
Public Health, European Journal of Public Health, American Journal of Public Health, International 
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Journal of Public Health) using search terms relating to economic evaluation. This was feasible due 
to the limited published data around Public Health economic modelling. 
 
All of the retrieved literature was screened at title and abstract level for potential relevance, and the 
full paper was retrieved where insufficient detail was provided within the abstract to determine 
potential relevance. For those considered relevant to the review, citation searching, reference 
searching and key author searching was undertaken. The search was not limited to peer-reviewed 
publications if additional key information was presented within “grey literature” including relevant 
working papers and presentations from workshops and conferences. The process was repeated until 
theoretical saturation i.e. no new relevant material was identified. The search was undertaken in 
December 2010 and citation searching of the included papers was repeated in August 2013. Figure 
2.1 shows the methods for the literature search. The search strategies are shown in Appendix A. 
 
Figure 2.1: Methods for literature search 
     Step 1                                                     Step 2                                                  Step 3 
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2.3 Results of review of key methodological challenges of Public Health modelling 
Defining relevance resulting from the search process 
During the search process, papers describing methods for valuing equity or health outcomes (as 
against the incorporation of these within a model) were not considered relevant because they 
related to parameterisation rather than model structuring. 
 
The identified paper by Weatherly et al.64 was based upon a more extensive report by Drummond et 
al.48 and part of the report presented a systematic review of economic evaluations of Public Health 
interventions. The report identified and described the results of three other systematic reviews of 
Public Health economic modelling studies; West et al.,45 Rush et al.46 and McDaid and Needle.47  The 
main limitations associated with the Public Health economic evaluations identified by the four 
systematic reviews were that many different outcome measures are used making comparison 
difficult, that the perspective adopted is often too narrow (i.e. health service perspective) and that 
many studies adopt a limited time horizon, all of which were identified by the included theoretical 
papers. Consequently, published case studies of economic evaluations within Public Health and 
these systematic reviews were not included within this review as it was considered that they were 
unlikely to offer any new methodological challenges. Thus studies defined as relevant for the review 
met the inclusion / exclusion criteria shown in Table 2.1 below. 
 
Table 2.1: Review inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
A methodological paper on economic modelling 
in Public Health 
Case studies of economic evaluations 
 Methods for valuing equity or health outcomes 
(as against the incorporation of these in a model) 
 “Grey literature” if the content is already 
published in a peer reviewed journal 
 
Included articles 
Eighteen articles identified from the search were considered to be relevant. A summary table of the 
included articles is provided in Appendix A. The articles have been divided into four categories which 
emerged from the review, shown in Table 2.2 below.  
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Table 2.2: Number of articles identified per category 
Author (year) Category 
Inclusion of non-
healthcare costs 
and outcomes 
Inclusion of 
equity 
Complex systems & 
multi-component 
interventions 
Other 
modelling 
issues 
Kelly et al. (2005)65 √  √  
Weatherly et al. (2009)64 √ √ √  
Claxton et al. (2007)66 √    
Mooney (2007)67 √    
Shiell (2007)68 √  √  
Smith and Petticrew 
(2010)69 
√  √  
Anderson (2010)70 √ 
 
√ √ 
Cookson et al. (2009a)71  √   
Richardson (2009)72  √   
Shiell (2009)73  √   
Cookson et al. (2009b)74  √   
Plsek and Greenhalgh 
(2001)75 
  √  
Shiell and Hawe (1996)76   √  
Whitehead (2010)77   √  
Rickles (2009)78   √  
Rappange (2009)79    √ 
Total per category 7 5 9 2 
 
A. Inclusion of non-healthcare costs and outcomes (7 articles) 
Seven studies were identified which describe issues with identifying and including all relevant costs 
and outcomes.64-69   
 
Incorporating all benefits and risks of an intervention 
An opinion piece by Mooney suggests that it may be difficult for stakeholders to agree upon the 
benefits and risks associated with a Public Health intervention and as a result all relevant outcomes 
might not be included within economic evaluations.67  For example, is a health promotion campaign 
successful if people are more informed but do not change their lifestyle? The author suggests that 
the ‘costs’ of necessary changes in lifestyle need to be considered (eg. the ‘cost’ of getting up at 6am 
to go to the gym). However, this opinion piece does not suggest methods for determining relevant 
costs and benefits. 
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Similarly, Shiell,68 Anderson70 and Smith and Petticrew69 suggest that the cost-effectiveness of Public 
Health interventions may be underestimated if all health and non-health impacts of an intervention 
are not considered. Shiell suggests that whilst many costs and benefits cannot be or are difficult to 
measure within Public Health, it may not be appropriate to simply identify these outcomes 
qualitatively within the report (instead of including them within the quantitative analysis), as 
recommended by Drummond2 for health technology assessments. This is because of the substantial 
impact they could have upon the model results within Public Health. He illustrates this with an 
economic evaluation of the walking school bus (eight children and two adults walking to school 
together) which was estimated to cost Aus $1 million per disability-adjusted life year gained when 
the analysts included only health benefits. However, this intervention was not designed solely to 
improve health and there are many non-health benefits of the intervention such as less traffic 
pollution and congestion and increased sense of community, which means that the analysis does not 
demonstrate the broader cost-effectiveness of the intervention. Smith and Petticrew suggest that 
Public Health economic modelling should focus upon broader outcomes such as ‘happiness’ as one 
way of attempting to capture these broader costs and outcomes.69  
 
The QALY outcome measure 
Kelly et al. and Weatherly et al. suggest that the QALY outcome measure may be insufficient for 
economic evaluations of Public Health interventions. This is because the QALY does not capture the 
mental and social outcomes associated with some Public Health interventions or non-health 
outcomes such as education or crime.64;65  Both papers suggest a potential solution may be to 
undertake a cost-consequence analysis from the perspective of each sector as a supplementary 
analysis, as also recommended by Anderson.70  However, there remain practical issues relating to 
the way in which decision makers should use this information to compare interventions, which are 
not addressed within these papers. Kelly et al. also suggest that discrete choice experiments (where 
the public rank different real-world scenarios based upon several dimensions) may have the 
potential to be used within Public Health intervention evaluation.65  Discrete choice experiments 
could be used to provide a broader outcome measure than the QALY. 
 
Compensation test for public sectors 
Claxton et al. propose an alternative potential solution for the inclusion of intersectoral costs and 
benefits,66 which is also referred to within the paper by Weatherly et al.64 This involves estimating 
the net benefit of the Public Health interventions from all relevant sectoral perspectives and then 
applying a compensation test as shown in Figure 2.2.  
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Figure 2.2: Compensation test approach 
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Whilst this approach seems theoretically reasonable, the paper does not try to address the practical 
issues with this approach. Valuation methods, metrics and thresholds differ by sector and the 
cooperation of other sectors would be required for this approach to be feasible. A key issue, which is 
of particular concern to this work, is that there are no methods for identifying relevant intersectoral 
costs and outcomes for inclusion within the model. A more recent paper by Payne et al. around 
valuing the economic benefits of complex interventions agrees with Claxton et al. that healthcare 
maximisation is not a sufficient objective when costs and outcomes fall upon other sectors.80  The 
authors outline several alternative approaches to capturing the broader outcomes of complex 
interventions and suggest that further methodological research is still required.  
 
Summary 
Seven papers all highlight a number of difficulties in defining relevant costs and outcomes for the 
evaluation. Only three of the six studies which have been identified suggest potential methods and 
all three of these studies are associated with practical issues.64-66  All three of the suggested 
approaches attempt to present the results of the analysis in an alternative format in order to help 
decision makers understand where costs and outcomes are incurred. However, none of the papers 
explicitly focus upon how these costs and outcomes might be identified during the early stages of 
model development, nor do they consider recommending any communication with stakeholders to 
help to tackle these choices. This is the case even though all authors highlight that one of their key 
concerns is in identifying and including all relevant costs and outcomes. I would suggest that the 
presentation of alternative results is helpful only if relevant costs and outcomes have been 
incorporated within the analysis.  
 
  
Do not fund 
intervention 
Total net benefit of intervention > 0 
Fund intervention. The sector 
that is gaining compensates the 
other by the amount it is losing. 
Sector-specific net benefit of 
intervention for each sector > 0 
Fund intervention 
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B. Inclusion of equity (5 articles) 
The UK Government aims to both increase overall health and reduce health inequities as outlined 
within the 2010 Public Health White Paper.81  In many cases these two objectives may require 
different interventions, and hence one could argue that there is a greater need to develop methods 
for including equity considerations within economic evaluations of Public Health interventions, as 
suggested by Kelly et al.65  Five papers were identified by the review which discuss the incorporation 
of equity within Public Health economic modelling.64;71-74 
 
Weatherly et al. suggest that the inclusion of equity is one of the four key methodological challenges 
within Public Health economic modelling, along with attribution of outcomes (i.e. quantifying the 
effectiveness of the interventions), measuring and valuing outcomes and inclusion of intersectoral 
costs and consequences.64 However, there is no clear justification for the choice of the four 
methodological challenges outlined within this paper.  
 
Potential methods for incorporating equity 
Cookson et al. discuss the need for the explicit incorporation of equity within economic evaluation of 
Public Health interventions and suggest four potential methods for doing this.71  This is followed by a 
series of responses by Richardson,72 Shiell,73 and the original authors.74  The authors highlight that 
health inequity reduction is a key policy objective in the field of Public Health, yet whilst value 
judgements relating to equity are currently made, equity considerations are not typically addressed 
within economic evaluations. They suggest three types of equity consideration; (1) reducing health 
inequalities; (2) prioritising specific groups (eg. children); and (3) adhering to ethical rules or 
procedures. The authors suggest that society would be willing to pay more per QALY gained for 
certain groups such as children, the severely ill and the socioeconomically disadvantaged, than for 
other members of the population, although Richardson disputes this in his response.72 
 
The four methods for considering equity within economic evaluations of Public Health interventions 
proposed by Cookson et al. are: 
(1) The identification of relevant equity considerations and a review of existing literature 
around this to provide qualitative discussion around relevant equity issues; 
(2) Quantitative analysis of key subgroup data from trials where available around the impact of 
the intervention upon health inequities; 
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(3) Estimating the opportunity cost of including equity considerations in terms of health 
foregone (i.e. the comparison of health foregone if adopting the equitable option with that 
of maximising health); 
(4) Valuing health inequality reduction by quantitatively weighting health outcomes according 
to equity considerations. 
 
Within their paper, Weatherly et al. also highlight options (3) and (4) as potential approaches,64 
which is likely to be due to the overlap of authors between the two papers. Cookson et al. suggest 
that any of these approaches would be worthwhile only in situations where a targeted Public Health 
intervention is not considered to be cost-effective, where there are multiple alternatives or where a 
population intervention is dependent upon behaviour which may differ for different groups. They 
conclude that it is not possible at this stage to specify the most appropriate approach and that 
testing of each is required.71  The necessity for Cookson et al. to suggest approaches (1) and (2) 
above highlights to Richardson how underdeveloped equity considerations are.72   
 
Shiell’s response to this paper suggests that valuing the health inequality reduction associated with 
clinical and lifestyle interventions (i.e. ’downstream’ interventions) is less worthwhile than 
undertaking primary research and modelling around the effectiveness of interventions tackling the 
social determinants of health (i.e. ‘upstream’ interventions).73  Upstream interventions include 
health promotion interventions (eg. workplace health promotion interventions) and non-health 
sector interventions (eg. providing affordable housing). Shiell explains that downstream 
interventions are unlikely to reduce health inequities substantially, whilst upstream interventions 
have the potential to.73  Richardson suggests that it may be more useful to think about the broader 
consideration of ‘social objectives’ rather than the trade-off between ‘equity’ and ‘efficacy’.72 
 
Summary 
All of these papers highlight the importance of considering equity in some capacity within economic 
evaluations of Public Health interventions. There is currently no agreement over the most 
appropriate approach. Methods for valuing equity are considered to be beyond the scope of this 
work; however consideration of the social determinants of health inequities will be considered 
further within Chapter 3. 
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C. Complex systems and multi-component interventions (9 articles) 
Nine identified papers describe the complexity of Public Health systems in the context of economic 
evaluation.64;65;69;75-78;82  
 
Comparing complex systems with ‘complex’ interventions 
Shiell et al. describe what is meant by a complex system and distinguish this from complex 
interventions.82  The authors define a complex system as one which ‘is adaptive to changes in its 
local environment, is composed of other complex systems and behaves in a non-linear fashion’. Thus 
the stock market would be an example of a complex system. They define a complex, or multi-
component, intervention as ‘built up from a number of components, which may act both 
independently and inter-dependently’ as defined by the Medical Research Council.83  Shiell et al. 
argue that whilst multi-component interventions are more difficult to evaluate, methodology for 
economic evaluation of multi-component interventions is not fundamentally different since it is not 
necessary to understand how the intervention works within an economic evaluation. They also state 
that MRC guidelines exist for evaluating multi-component interventions.83  However, Kelly et al. 
suggest that from a policy perspective it is important for a model to address what aspects of an 
intervention make it successful or unsuccessful.65 This is to help decision makers understand how 
different approaches may be used to overcome barriers to change and whether interventions may 
be generalisable in other settings. Kelly et al. suggest that this is important in terms of economic 
evaluation if part of the objective is to reduce inequities in health, where the impact on specific 
subgroups needs to be modelled (see Chapter 3 for further discussion of this).65  
  
Shiell et al. argue that the evaluation of interventions within complex systems presents new 
methodological challenges and hence it is important to understand whether an intervention is being 
evaluated within a complex system.82  The paper suggests that the usual approach to economic 
evaluation is to assume that the effects of an intervention can be assessed without considering the 
impact of the environment upon its effectiveness. This meant that the social structure and people’s 
interactions with each other are not considered. However, this assumption will be inadequate within 
a complex system where feedback loops are important and aspects of the environment cannot be 
assumed to be constant. The authors suggest that economic evaluations of interventions within 
complex systems need to consider ecological theory (which relates human development to an 
ecological system), interactions between the interventions and their environment, non-linearity 
(that the effect is not proportional to the cause), multiplier effects (small changes in initial conditions 
can have large impacts upon the outputs), and the interaction between the intervention and 
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subsequent behaviour.82  Similarly, Plsek and Greenhalgh discuss the challenge of complexity in 
healthcare systems and suggest that the science of complex adaptive systems is appropriate for 
addressing this challenge.75  This means modelling a system by considering the behaviour of the 
parts and the relationships between those parts, rather than taking a purely reductionist approach 
to science which breaks a system down into parts and ignores the relationship between those 
parts.84  This is discussed in more detail in Chapter 3. Whilst the theory within both of these papers is 
logical, they do not go further to describe how the science of complex adaptive systems could be 
used or how the theory may be tested.  
 
Anderson also suggests that some of the key reasons for Public Health economic evaluation being 
more challenging than Health Technology Assessment (HTA) modelling are due to the interventions 
being multi-component, with tailored, dynamic and evolving implementation which may be at the 
community / population level rather than the individual level.70  He suggests that within Public 
Health there are long causal chains and the causal mechanisms may be social and behavioural as 
well as biological, and that heterogeneity may be important, making results of models of the 
‘average’ person potentially meaningless.70 
 
Community interventions within complex systems 
Within another paper, Shiell and Hawe suggest that for interventions which have the community 
rather than the individual as the focus, the total impact of the intervention may be greater than the 
sum of the individual impacts.76 This is because there may be additional community impacts such as 
empowerment (developing a sense of community and the knowledge, skills, networks and 
opportunities to improve future health of the community) and competence.76  Therefore, if these 
broader community impacts are excluded, the cost-effectiveness of these interventions will be 
systematically underestimated by the methods employed. The paper suggests that the effects of 
community interventions will take longer to appear; however their effects are more likely to be 
sustained and these impacts need to be measured and included within economic evaluations.  Shiell 
and Hawe suggest that the major challenge is in capturing community-level change as distinct from 
the aggregate outcomes of individuals. This relates to the idea of social structure described within 
Chapter 1. Similarly, Smith and Petticrew suggest that there is a need to focus on the effects of the 
interventions upon communities and populations, as well as on individual effects.69  A response to 
this paper was published by Whitehead who argues that there are Public Health evaluations which 
have been undertaken using a macro-level analysis such as within tobacco control.77  This response 
argues that it is the funders of Public Health economic modelling who encourage a micro-level 
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approach rather than the analysts. Again, many issues are raised within these papers, but no 
potential solutions are provided.  
 
Understanding causality within complex systems 
Correlation is the linear association between two quantitative variables.85  Causal relationships are 
such that a change in the value of one variable causes the value of another variable to change.86  
Two correlated variables may appear to be causally related, because changes in one variable appear 
to lead to changes in another variable, but there may be a third variable which is causing both of 
these effects. Rickles considers how causality is established within complex intervention research 
such as Public Health.78  This paper does not consider methods of economic evaluation, but adds to 
the discussion about the key characteristics of Public Health modelling and hence was considered 
relevant to this review. Rickles quotes Hausman and Woodward to highlight the importance of the 
difference between causation and correlation in terms of the potential to affect outcomes: “When X 
and Y are correlated and X does not cause Y, one expects that when one manipulates X, the 
correlation will break down. By contrast, if X causes Y, one expects that for some range of values of 
X, if one is able to manipulate those values, one can thereby control the value of Y.” 78  The paper 
discusses the limitations associated with understanding causality within randomised controlled 
trials, observational studies and causal modelling. The author points out that within Public Health, 
understanding causality is more complex than within other health areas due to the risk factors, 
otherwise termed the ‘determinants of health’, often being social. This means that health outcomes 
are not only dependent upon characteristics of the individual, but also upon the social structure (see 
Chapter 1 for description of the social structure) and there is strong interdependence between the 
variables. The determinants of health are discussed in more detail in Chapter 3. 
 
As in the papers by Shiell 82 and Plsek and Greenhalgh,75 Rickles discusses the issue that a small 
difference in initial conditions may lead to widely different outcomes.78  This means that it is 
important to understand the key variables for the occurrence of an effect, as also discussed by 
Kelly.65  In this regard, Rickles suggests that effectiveness is difficult to estimate even with a 
randomised controlled trial, the recognised ‘gold standard’ for comparing two or more 
interventions. This is because trial participants are generally randomised according to variables (such 
as age and sex); however if not all variables that might impact upon the trial outcomes are 
controlled for, then the outcomes of the trial may be different to the outcomes within the 
population. Trials of Public Health interventions are likely to be too small to control for all relevant 
variables appropriately. The author discusses similar, amplified issues with observational studies. He 
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also suggests that simulation studies do not provide a better solution to estimating causality since it 
is necessary to assume a causal structure to implement a simulation in the first place and it is not 
possible to know the unknown variables in the system which may have a large impact upon the 
outcomes. Again, the purpose of this paper is to highlight a research gap rather than to suggest new 
methodologies. Whilst they are all relevant issues, decision makers need to make policy decisions in 
the face of these uncertainties. The author does not consider the implications of this in terms of 
model development and validation. Being explicit about what is ‘known’ within a model provides a 
good starting point for understanding what is not known. In addition, there may be external data 
against which to validate a simulation model.  
 
Weatherly et al. suggest that more use should be made of econometric methodology for analysing 
non-experimental data.64  This includes techniques such as time series analysis, propensity score 
matching (a technique used to select individuals to form a control group with similar observable 
characteristics to those of the treatment group) and difference-in-difference techniques (comparing 
the treatment group before and after treatment and to some other control group to allow for the 
fact that there may have been effects other than the intervention effect over time). Similarly, Kelly 
et al. suggest that econometric analysis may be useful.65   
 
Summary 
These papers all suggest that Public Health interventions operate within complex systems. This has 
important implications for the development of the model structure and the science of complex 
adaptive systems is proposed for dealing with this; however none of these papers propose methods 
for model development. Due to the emerging importance of this issue for structural development of 
models, Chapter 3 expands upon the theory relating to complex systems. 
 
D. Other modelling issues (2 articles) 
A paper and a workshop presentation identified within the review discuss other modelling issues 
associated with Public Health economic evaluation.70;87  
 
Differences between modelling Public Health and clinical interventions  
Within a workshop presentation, Anderson suggests that there are two special cases in Public Health 
where modelling is well established; (1) vaccination programmes and communicable diseases, and 
(2) screening and surveillance programmes.70  He suggests that for all other Public Health modelling, 
there are two widely divergent approaches being employed; “back of a fag packet” (i.e. very simple 
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models) or “cerebral meltdown” (for example, the Foresight obesity system map41). A key gap 
implied here is justification for the level of complexity employed. Based upon another presentation 
from the same workshop, Anderson suggests that decision trees (cohort modelling approach 
outlining decisions and their possible consequences within a tree-like structure) and cohort Markov 
models (modelling approach describing all relevant health states and the probability of transitioning 
between them), which are typically employed within HTA, may not be adequate for Public Health 
modelling. Anderson explains that this is due to the non-discrete behavioural changes, the complex 
long causal chains and the requirement to simulate many health and non-health outcomes.70  This is 
consistent with the literature showing that Public Health systems are complex.  
 
Anderson succinctly describes some of the differences between Public Health and modelling clinical 
interventions in the context of HTA, summarised in Table 2.3. He highlights many of the issues which 
have already been raised by this review including the inclusion of non-healthcare costs and 
outcomes and the complexity of Public Health systems and interventions.  In addition, Anderson 
highlights that in Public Health the population of interest, the starting point for the simulation and 
the care pathway may be less well defined. He suggests that due to all of these differences and the 
nature of the evidence within Public Health research, modelling should potentially be more 
exploratory, with results presented in terms of sensitivity analyses rather than a ‘base case’. As 
described within Chapter 1, such a retrospective approach alone is unlikely to be sufficient and could 
potentially benefit from methods for understanding the system and choosing relevant model 
structures in addition. 
 
Anderson also suggests that modelling may be better used to explore the cost-effectiveness of 
individual components of interventions rather than the overall cost-effectiveness of Public Health 
interventions. However, this has the disadvantage of ignoring the complexity of the system being 
modelled, as discussed by other papers within this review,65;69;75-78;82 and of underestimating the 
intervention effectiveness due to interaction effects. 
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Table 2.3: Differences between Public Health and clinical intervention models outlined by Anderson 
Issue Clinical interventions Public Health 
interventions 
Relation to other 
categories within 
review 
Outcomes associated 
with intervention 
Health Health and non-health Relates to ‘Inclusion of 
non-healthcare costs 
and outcomes’ section 
within review 
Range of outcomes Few key outcomes Many different 
outcomes across sectors 
Scale of impact of 
intervention 
Individual Community / population Relates to ‘Complex 
systems and multi-
component 
interventions’ section 
within review 
Causal mechanism of 
intervention 
Chemical / biological / 
mechanical 
Social and behavioural 
Role of context / 
boundary on 
intervention 
effectiveness 
Low interaction with 
context 
High interaction with 
context, leading to high 
heterogeneity – central 
estimate of analysis may 
have limited meaning 
Length of causal chain Short causal chains Long causal chains 
Complexity of 
intervention 
Single component Multi-faceted 
component 
Degree of 
standardisation of 
intervention 
Pre-specified and 
static components 
Tailored or dynamic and 
evolving 
implementation 
Entity The patient with a 
specific disease 
A population with risk 
factors but no specific 
disease 
These issues have not 
been identified 
previously by review 
Starting point for 
simulation 
Diagnosis or failure of 
previous treatment 
At any point in time 
Care pathways Specifiable disease 
stages with clinical 
events 
Difficult to define and 
variable between 
individuals 
 
Accounting for future illness 
Rappange et al. suggest that the cost-effectiveness of Public Health interventions may be 
overestimated because the costs associated with future illnesses, which would not have occurred if 
the person had died at a younger age in the absence of the intervention, are not included within 
economic evaluations.79 They suggest that illnesses which are prevented by Public Health 
interventions such as heart disease and cancer are later replaced by chronic diseases which generally 
affect older people, such as dementia. This is also an issue within economic evaluations of clinical 
interventions, although it is accentuated within Public Health economic evaluation due to the 
potential life years gained. The key argument for including future costs which are unrelated to the 
disease within the evaluation is that of internal consistency. Health utilities are obtained from the 
general population who are receiving healthcare interventions and thus the resource use associated 
with future life years is implicitly included within the QALYs gained.88  One of the main arguments for 
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the exclusion of future illness costs is a practical one in terms of the lack of comprehensive data over 
the long term and being unable to predict what conditions are likely to develop. In addition, it has 
been argued that it is politically inappropriate to include unrelated medical consumption during the 
additional life years gained and that since both healthcare and non-healthcare consumption costs 
would be incurred in these additional years, then both would need to be incorporated throughout 
the lifetime of the individual.87  Currently the NICE methods guide states that the costs of future 
illness should not be included within economic evaluations, and hence they will not be considered 
within my methods development;5 however these might be able to be incorporated within future 
research.   
 
Summary 
These papers describe some of the key differences between economic evaluation of Public Health 
interventions and clinical interventions, as well as consideration of whether models should account 
for future illness which is exacerbated within Public Health. It is suggested that modelling should be 
more exploratory within Public Health economic evaluation than for the assessment of clinical 
interventions.  
 
2.4 Discussion 
Methodological papers about Public Health economic modelling have generally only been published 
since the turn of the 21st Century and there is currently much debate around how to address the 
challenges as demonstrated by the many opinion pieces and response papers published. Economic 
evaluations within Public Health are generally different to economic evaluations of clinical 
interventions since they usually require the development of models of multi-component 
interventions with complex causal chains operating within dynamically complex systems, dependent 
upon the social determinants of health, as against models of simple interventions which generally do 
not depend upon human behaviour operating within relatively clear system boundaries. It is also 
often much less clear what a 'good' outcome of a Public Health intervention is. In addition, a key 
objective of Public Health is to reduce health inequities. Very few of the studies propose any 
methodology for dealing with the issues they raise, and of those that do, they generally focus upon 
alternative ways of presenting the model results. Whilst many of the papers highlight issues 
associated with understanding the problem and model scoping, none of them consider methods for 
this conceptualisation process. Anderson suggests there is a dichotomy, with some analysts 
developing very simple Public Health models and others developing highly complex ones.70  These 
very different model structures are generally developed with limited justification for the level of 
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complexity. A conceptual modelling framework for Public Health economic evaluation could provide 
methodology for helping the modeller choose an appropriate level of complexity.  
 
2.5 Chapter summary and implications for methods development 
This chapter reviewed the literature around the key methodological challenges within Public Health 
economic modelling. Key implications for methods development are that a conceptual modelling 
framework for Public Health economic evaluation would need to consider: 
 The inclusion of non-health costs and outcomes; 
 Equity; 
 Methods for dealing with dynamic complexity; 
 Analysis of poorly defined multi-component interventions impacting upon broad populations 
with no specific disease; 
 Variable care pathways. 
A review of existing conceptual modelling frameworks is presented within Chapter 4, one objective 
of which is to consider whether there are any existing frameworks meeting these requirements. 
 
Issues requiring further exploration 
The review suggests that a key methodological challenge relates to Public Health systems being 
complex. Current approaches tend to assume simple cause and effect when developing model 
structure, and do not consider the impact of feedback loops and unintended consequences upon 
other parts of the system. These are likely to provide inadequate representations of the problem. 
Given the importance of handling complexity within Public Health economic models, this is explored 
further within Chapter 3. Chapter 3 considers what a dynamically complex system is and whether 
Public Health interventions always operate within dynamically complex systems.  The use of systems 
thinking for handling this complexity is also considered within Chapter 3. 
 
Many of the key challenges raised within the review relate to the social determinants of health and 
health inequities, introduced within Chapter 1. This includes the dynamic complexity of Public Health 
systems, as well as equity issues and the inclusion of non-health costs and outcomes. Within the 
Public Health literature, the determinants of health and health inequities have been studied 
considerably in order to understand how policy might improve population health and health 
inequities. Thus Chapter 3 explores this literature in order to understand how it might feed into a 
conceptual modelling framework. Finally, the review suggests that human behaviour affects 
intervention effectiveness and thus the Sociology and Psychology literature are explored within 
Chapter 3 in order to understand how models of behaviour might be incorporated.  
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Chapter 3: Additional exploration of some of the 
key methodological challenges 
 
3.1 Chapter outline 
This chapter aims to review, in more depth, some of the issues raised within the literature review in 
Chapter 2 where it was thought that additional literature from other disciplines might be useful for 
methods development. This involved consulting literature within the fields of complex adaptive 
systems, otherwise known as complexity theory, systems thinking, Public Health, Sociology and 
Psychology. Section 3.2 reflects upon what a dynamically complex system is and whether all Public 
Health systems are dynamically complex, whilst Section 3.3 considers the use of systems thinking for 
modelling such complex systems. Section 3.4 reviews the literature around the social determinants 
of health which contribute to the dynamic complexity, as well as being important with regards to the 
inclusion of non-health outcomes and costs and the issue of equity. Finally, Section 3.5 considers 
how models of Psychology and Sociology might be used to model behaviour within Public Health 
economic models.  
 
3.2 Complexity within Public Health modelling 
A key challenge arising from the review within Chapter 2 is that of handling complexity. This section 
considers in more detail what a dynamically complex system is and whether Public Health 
interventions always operate within dynamically complex systems. It is mainly based upon my 
reading of two books; ‘Complex Adaptive Systems’ by Miller and Page84 and ‘Business Dynamics: 
Systems Thinking and Modeling for a Complex World’ by Sterman.89  
 
What is a dynamically complex system? 
Dynamically complex systems have been studied within many different disciplines including 
Anthropology, Artificial Intelligence, Biology, Chemistry, Computer Science, Economics, 
Meteorology, Neuroscience, Operational Research, Physics, Psychology and Sociology.  As such there 
is no standard definition, and there are many different perspectives and definitions for the same 
ideas.84 However, the following aspects of dynamically complex systems are generally agreed upon 
across disciplines.  
 
Interactions between elements are important 
Bertalanffy describes a system as ‘an entity which maintains its existence 
through the mutual interaction of its parts’.90  For example, water is a system made up of hydrogen 
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and oxygen, but it has different characteristics to both of its elements and this is due to the 
interaction between the elements. Complexity arises when the interactions between elements 
within the system and between the elements and their environment are important in defining 
outcomes, although the elements themselves do not need to follow complicated rules. The 
behaviour of the system may therefore be understood by learning about the behaviour of the 
elements within the system and their interactions.89   
 
Characterised by feedback loops (non-linearity)  
The dynamics of complex systems arise from the interaction between positive feedback loops 
(where an increase [decrease] in one factor leads to an increase [decrease] in another, which in turn 
causes the first factor to increase [decrease], which would lead to exponential growth [decay] if no 
other factors were present) and negative feedback loops (where an increase [decrease] in one factor 
leads to a decrease [increase] in another, which in turn causes the first factor to decrease [increase], 
which often leads to self-correcting behaviour).89  The interaction between these feedback loops 
often produces counter-intuitive behaviour, particularly where there are long time delays between 
cause and effect, and hence makes it difficult for the human mind to be able to predict this 
behaviour.89  Thus outcomes of complex systems are rarely proportional to the cause (i.e. they are 
non-linear).89  If one aspect within a dynamically complex system is modified, it is inevitable that 
other parts of the system will be affected, both in terms of other elements within the system and in 
terms of the environment.  
 
Variability is important, which may result in emergent behaviour 
Variability between elements within complex systems is important since this may stabilise or 
destabilise the system.84  For example, people may try to avoid busy roads each with different 
thresholds around how much traffic they are willing to travel within and this would lead to some of 
the people choosing different routes, thus eventually stabilising the system so that people travel on 
many different roads. Alternatively, a person cycling to work might cause one other person to cycle, 
which might just be sufficient to cause another person to cycle, which might just be sufficient to 
cause another person to cycle to work, and so on, thus destabilising the system so that the majority 
of people cycle to work rather than drive. Modelling the ‘average’ person would be misleading in 
these cases because it would not capture the emergent behaviour of the system.   
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Timing and time delays are important 
The timing of events within dynamically complex systems is important.84  Factors within the system 
change over time and the rate of change of different factors will vary. Outcomes may be affected by 
when particular events happen. Time delays within feedback loops mean that long term outcomes 
are often incorrectly predicted by policy makers due to the interactions between feedback loops, the 
limited learning cycles available as a result of changing policies and the difficulty of holding other 
variables within the system constant within trials for longer time periods.89   
 
Characterised by self-organisation, dependent upon networks  
In addition, space within dynamically complex systems may be important.84  Each element within a 
system is only aware of some of the other elements within the system and its environment. Each 
element does not understand the behaviour of the system as a whole within a complex system and 
hence the system is said to be self-organising.89  Elements may organise themselves so that elements 
with similar preferences group together.84  An example of this is the social groups within society, 
discussed by Kelly et al.40  
 
There may be unintended consequences of the interventions 
Unintended consequences may occur as a result of policy makers not appreciating the impact of 
time delays, non-linearity, variability and social networks as discussed above. In addition, the 
outcomes of an intervention are often unanticipated because of the responses of other people 
within the system who the intervention is not aimed at and who have different aims to the policy 
makers.91  An example is smoking companies trying to offset the impacts of anti-smoking campaigns.  
 
No clear boundary around the system 
Defining the boundary around a complex system is not trivial since the wider environment also 
impacts upon the behaviour of the system.89  All systems are subsystems of a bigger system, and it is 
important to define the system of interest at a level where all important interactions between the 
elements for the purpose of the model are captured.92  For example, a map of the local area is a 
subset of a map of the country, which is a subset of a map of the world; each of which have different 
purposes and hence different boundaries. 
 
Elements adapt over time 
Elements within a dynamically complex system may learn over time and change their behaviour 
accordingly.89  Moreover, individual behaviours tend to reinforce one another through their 
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interactions, such that the system as a whole is dependent upon the amount of strategic ability the 
individual agents have.84 
 
These characteristics of a dynamically complex system are summarised in Box 3.1. 
 
Box 3.1: Characteristics of a dynamically complex system 
 
 
 
 
 
 
 
 
 
 
The characteristics of a dynamically complex system outlined within Box 3.1 are employed as the 
definition of a complex system within all subsequent analysis.  
 
Public Health example: contraceptive services 
A Public Health economic modelling project assessing the cost-effectiveness of interventions to 
encourage young people to use contraceptives and contraceptive services which I have previously 
worked on is described in order to illustrate dynamic complexity within a practical example. This 
example, hereafter described as ‘Contraception project’, will also be referred to throughout the 
remainder of the thesis. The ‘Contraception project’ was a project for NICE for which I undertook the 
modelling work in 2010. The decision makers’ focus was around preventing unintended pregnancies 
rather than preventing STIs and the analysis took a public sector perspective. Interventions 
considered included school-based dispensing of contraceptives, advanced provision of emergency 
hormonal contraception and intensive case management to prevent repeat teenage pregnancy. 
Table 3.1 outlines why this is a dynamically complex Public Health system. 
 
  
- Interactions between elements are important; 
- Characterised by feedback loops (non-linearity); 
- Variability is important, which may result in emergent behaviour; 
- Timing and time delays are important; 
- Characterised by self-organisation, dependent upon networks; 
- There may be unintended consequences of the interventions; 
- No clear boundary around the system; 
- Elements adapt over time.  
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Table 3.1: Illustration of a dynamically complex system 
Key aspects of a dynamically 
complex system as described 
within Box 3.1 
Contraception project example 
Interactions between 
elements are important 
 
The rate of pregnancies and STIs is dependent upon the sexual 
interactions between people. 
Characterised by feedback 
loops (non-linearity) 
Positive: An unintended teenage birth is thought to be associated 
with an increased probability of the child having a disadvantaged 
background which is associated with unintended pregnancy in later 
life. Negative: Poor contraceptive use may lead to the development 
of a STI which may lead to better contraceptive use. 
Variability is important, which 
may result in emergent 
behaviour 
The decision of one person to use contraception might just be 
sufficient to encourage another person to use contraception and so 
on until there is a general change in attitudes and behaviour 
towards contraceptive use.  
Timing and time delays are 
important 
The time at which a person has a baby during their lifetime may 
affect outcomes. In addition, differences in socioeconomic 
outcomes may not be seen for a number of years. 
Characterised by self-
organisation, dependent upon 
networks 
The sexual activity and contraceptive behaviour of young people is 
not centrally organised. The groups young people associate with 
will influence their sexual activity, their contraceptive use and 
attitude towards STIs and pregnancy. 
There may be unintended 
consequences of the 
 interventions 
Encouraging young people to use intrauterine devices (IUDs) may 
decrease the number of pregnancies but increase the number of 
STIs. In addition, condom companies may increase advertising if the 
government were to advertise other forms of contraception. 
No clear boundary around the 
system 
Interventions to reduce initial disadvantage may have impacts in 
addition to reducing unintended teenage pregnancies such as 
decreasing crime rates. 
Elements adapt over time Young people may change their contraceptive use over time. For 
example, after having a STI a person may be more likely to use 
condoms in the future. 
 
Which Public Health systems are dynamically complex systems? 
It is important to understand which types of Public Health systems are dynamically complex in order 
to develop appropriate methods for model development for different Public Health intervention 
evaluations. It should be noted that the complexity of the model per se is not being contemplated at 
this stage; rather it is the complexity of the system upon which the model will be based which is 
being considered. Defining a ‘system’ for the purpose of relevance to an economic evaluation within 
Public Health is not trivial as it does not have clear system boundaries. Based upon the aim of 
economic evaluation as defined by Drummond,2 a system in this context includes any persons, 
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organisations or resources whose associated costs and/or outcomes are affected, directly or 
indirectly, by some intervention or its comparator(s). The system is therefore determined by the 
interventions being assessed. Thus, in order to understand whether all Public Health systems are 
complex, different types of Public Health interventions need to be explored. 
 
A taxonomy of Public Health interventions 
Previous research has attempted to understand and classify different types of behaviour change 
techniques and interventions.22;93-95  The NICE guidance on behaviour change divides these 
interventions into policy, education or communication, technologies, and resources, and according 
to the population that is targeted and/or affected by the intervention. Table 3.2 below shows 
examples of interventions for the combination of these typologies. 
 
Table 3.2: Typology of Public Health interventions with examples 
 Individual Community Population 
Policy Workplace ergonomics Cycle lanes Cancer screening 
programmes 
Education or 
communication 
GP advice to reduce 
alcohol consumption 
Community healthy eating 
classes 
Campaign for quitting 
smoking 
Technologies Breathalysers for drivers Vascular health checks in 
disadvantaged communities 
Seat belt legislation 
Resources GP providing free 
condoms 
Free leisure centre entry Free nicotine 
replacement therapy 
 
In order to understand whether each type of Public Health intervention operates within a 
dynamically complex system, each of the examples within Table 3.2 were assessed against the 
criteria for complex systems outlined within Box 3.1 in a similar way as is done within Table 3.1 for 
the Contraceptive project example. The result of this exercise was that all of these examples operate 
within dynamically complex systems. This suggests that most, if not all, Public Health interventions 
operate within dynamically complex systems. 
 
Decision making within dynamically complex systems 
The human brain is unable to fully understand dynamically complex systems and people tend to 
think in terms of simple cause and effect and use heuristics (or ‘rules of thumb’) to estimate 
outcomes.96  Moreover, if there is one cause that can explain an effect, people often stop searching 
for alternative causes.96  This means that decision makers will not necessarily be choosing the 
optimal decision due to the simplifications they may have made about the system. This is known as 
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bounded rationality.97  In addition, it is more intuitive for people to attempt to treat the symptom of 
a problem, than treating the underlying cause96; for example preventing teenage pregnancy rather 
than initial disadvantage. It is therefore important to develop tools which can help us to understand 
these complex systems for Public Health economic modelling. 
 
Additional types of complexity  
Within Public Health economic modelling there could be considered to be three levels of complexity; 
the first relates to the complexity of the system being modelled as discussed above, the second 
relates to the complexity of the model, whilst the third relates to the complexity of the decision 
making process (i.e. having multiple stakeholders). The conceptual modelling framework should aim 
to address all three levels of complexity. Methods for judging the complexity of the model will be 
considered within Chapter 4. Flood and Jackson make the distinction between the complexity of the 
system and the complexity of having multiple stakeholders within the decision making process in 
their book ‘Creative Problem Solving: Total Systems Intervention’.92  They categorise the complexity 
of the system into complex and simple, in the way described above. They then categorise the level of 
stakeholder agreement as unitary (stakeholders agree on goals and have similar views and beliefs), 
pluralistic (stakeholders act on agreed objectives but they have divergent views and beliefs and may 
need to compromise on their goals) and coercive (stakeholders have conflicting views, beliefs and 
goals and genuine compromise is not possible). From these classifications, Flood and Jackson suggest 
which systems approaches might be used given the particular type of problem.  
 
The theoretical basis of Public Health economic modelling means that the ultimate goal for each 
assessment is to estimate the cost-effectiveness of competing interventions and as such there is 
general consensus around this goal. Moreover, the topics considered within decision making 
processes tend to be constrained by what is regarded as politically and culturally acceptable (see 
Chapter 5 for further discussion of this), thus the processes that are typically employed exclude any 
decision problems where some level of agreement is not possible. I would therefore argue that the 
level of stakeholder agreement within most decision making contexts for assessing the cost-
effectiveness of Public Health interventions is not coercive. However, there are a number of 
intermediate goals which may not be agreed upon by all stakeholders. I would argue that a key use 
of the model should be to help to answer the question of whether the intervention under 
consideration is effective in the long term, taking into account all consequences. There may be 
disagreement between stakeholders about how to measure effectiveness and what the 
consequences of the intervention are. There may also be disagreement about the long term 
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outcomes of current practice and what current practice is. In addition, subjective decisions around 
model scoping or value judgements may be required. As such, I would suggest that these problems 
are pluralist rather than unitary. Thus, within Flood and Jackson’s classification, Public Health 
problems are generally Complex-Pluralist.92  Flood and Jackson suggest that problem structuring 
methods (described in Section 3.3 below) are appropriate for these types of problems. If a 
fundamental shift were to occur in the way that topics within Public Health are divided up, then the 
decision problems could become Complex-Coercive, for which no methods have currently been 
identified.92 
 
Summary 
This section concludes that Public Health systems tend to be dynamically complex. This means that 
they are characterised by feedback loops (leading to non-linearity), that heterogeneity, interactions 
between elements, and timing and time delays are important, they are characterised by self-
organisation which are dependent upon networks, there may be unintended consequences of the 
interventions, there is no clear boundary around the system, and elements adapt over time. This 
section also highlights two levels of complexity in addition to the dynamic complexity of the system; 
that of the model and that of the decision making process. 
 
3.3 Systems thinking for complex systems 
Case studies within Public Health have been published which adopt a systems thinking, or a systems 
approach, to attempt to handle the complexity of the systems.41;98  A systems approach takes a 
holistic way of thinking about complex systems, and focuses upon the interactions between the 
entities and between entities and their environment, rather than assuming that a system can be 
understood by breaking it down into its individual entities and studying each part separately. Within 
a systems approach, it is recognised that by considering one aspect of a system in isolation, there 
may be unintended consequences which, if ignored, may make the problem worse. It is infeasible to 
take a completely systemic approach as this would involve modelling the whole world; and it is thus 
important to understand the most appropriate boundary around the model in order to avoid 
excluding important consequences of an intervention. This section aims to review existing literature 
and the potential use of systems thinking for Public Health systems. 
 
Key systems approaches 
Key systems approaches for modelling are shown in Table 3.3 based upon a four volume book on 
Systems Thinking by Midgley and a book on Total Systems Intervention by Flood and Jackson.92;99 
These key systems approaches are referred to within the review below.   
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Table 3.3: Main systems approaches for modelling 
Approach Description 
Critical systems 
heuristics & 
boundary critique 
A qualitative approach which involves the analyst identifying the boundary 
judgements (what is included in the system and what is part of its external 
environment), questioning the practical and ethical implications of those 
judgements with all relevant stakeholders (the choice of stakeholders being 
part of the boundary judgement in itself), and challenging claims of the 
stakeholders using factual knowledge. 
Problem structuring 
methods 
 
Qualitative techniques to draw out the structure and nature of a problem 
situation from all stakeholders’ perspectives in an exploratory and 
transparent manner, acknowledging uncertainties.  
Network analysis Qualitatively mapping and measuring relationships between entities 
including people and groups. 
Cybernetics Quantitatively describing the flow of information around a system, and the 
way in which this information is used by the system as a means of controlling 
itself. 
System dynamics 
modelling 
A quantitative cohort simulation modelling approach which captures the 
stocks and flows and positive and negative feedback loops within the system 
over time. 
Agent-based 
modelling 
A quantitative individual-level simulation modelling approach which is made 
up of agents (which may be people or other entities) which follow a set of 
rules about their interactions with other agents and their environment. 
 
Review of the use of systems thinking in Public Health modelling 
A basic additional search was undertaken to identify key methodological challenges in modelling in 
Public Health associated with systems approaches to understand whether there are any additional 
methodological challenges which have been substantially explored by previous researchers which 
are not considered within the economic modelling literature. As such, the broad search terms ‘public 
health’, ‘method’, ‘model’ and ‘systems thinking’ / ’systems approach’ were employed as keywords 
within the databases Medline, Scopus and Web of Knowledge. It was not intended to be an 
exhaustive search and case studies were not included in order to develop a manageable review.  
 
Seven relevant papers were identified, all of which were included within a special issue of the 
American Journal of Public Health which was published in 2006 around ‘Systems Thinking and 
Modeling in Public Health’. All of the included papers provide discussion around the benefits and/or 
issues associated with the use of systems thinking within Public Health modelling.91;100-105  
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Papers discussing the potential use of systems thinking within Public Health 
Within the editorial paper, Leischow and Milstein argue that systems thinking provides a useful way 
forward for Public Health action by capturing the dynamic complexity of Public Health.105  The 
authors raise key challenges with the application including understanding the interactions between 
people, linking data and information between disciplines and organisations and matching the Public 
Health problem with the appropriate systems approach given the numerous methods available.   
Green raises questions about the benefits of systems science to Public Health and the best way of 
bringing the two together.100  This paper reflects upon the introduction of Sociology to Public Health 
forty years earlier and how previous pitfalls might be avoided. The author suggests that either Public 
Health practitioners should be trained in systems thinking and/or that systems scientists should be 
employed in Public Health.100  
 
Papers describing the potential of using causal diagrams  
Joffe and Mindell describe the benefits of using causal diagrams for analysing the impacts of Public 
Health interventions.104  They compare these with conceptualisations of the determinants of health, 
such as Dahlgren and Whitehead’s (see Section 3.4), which give an indication of the complexity of 
the factors which affect health but do not specify these relationships. They suggest that causal 
diagrams are a useful way of summarising information about causal relationships for communication 
and analysis (see Chapter 4 for more detail around causal diagrams), although they state that 
quantifying the diagrams and the use of feedback loops is beyond the scope of the paper. The 
authors highlight the similar benefits of causal diagrams and quantitative models including that they 
allow assumptions to be made explicit and facilitate the identification of data gaps. The authors 
suggest that causal diagrams can be used to control for confounding factors in a similar way to the 
use of instrumental variables within Econometrics.104  
 
Papers describing the potential of using simulation models 
Sterman describes the issues with policy making in a complex world, as described within Section 3.2 
(based upon Chapter 1 of Business Dynamics by Sterman89) and suggests that simulation modelling is 
required to understand this complexity within public health.91  This paper suggests that simulation 
models such as system dynamics allow the analyst to learn about a system and the impact of 
interventions upon that system much faster than in real time and at low cost. They allow 
experiments to be repeated under the same conditions or for extreme scenarios to be tested. 
Sterman also suggests that the model must capture key features of the real world being modelled 
and they must have a useful user interface which allows learning to occur. He highlights that in the 
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absence of either of these, a simulation model can potentially do more harm than good. He suggests 
that in order for these models to be tested for quality, they should be fully documented. Finally, 
Sterman highlights the dangers of testing lots of options within the simulation model and not 
stepping back and thinking about what analysis would be most useful.91  Similarly, Homer and Hirsch 
highlight the benefits of the use of systems dynamics within Public Health given the dynamic 
complexity of Public Health.102   
 
Practical challenges of using systems thinking in Public Health 
Trochim et al. present the results of a study of 133 practising Public Health professionals from two 
systems-based Public Health initiatives (Syndemics Prevention Network and the Initiative on the 
Study and Implementation of Systems (ISIS) project) to highlight practical challenges with the use of 
systems thinking within Public Health. One hundred key challenges were identified, from which eight 
rules were derived which were that Public Health professionals should: (i) support dynamic and 
diverse networks, (ii) inspire integrative learning, (iii) use systems measures and models, (iv) foster 
systems planning and evaluation, (v) expand cross-category funding, (vi) utilise system incentives, 
(vii) show the potential of systems approaches, and (viii) explore systems paradigms and 
perspectives.103  Whilst the paper seems comprehensive in identifying the key challenges, limited 
discussion is provided around how to deal with the key challenges identified. In addition, whilst the 
eight rules identified have interesting implications for the use of modelling and are informative 
about the fact that the use of systems thinking within Public Health is in its infancy, they focus upon 
the Public Health practitioner’s role rather than the role of modelling. 
 
Methodological pluralism 
Finally, Midgley describes a range of systems thinking methods that he has found useful within 
Public Health: boundary critique; system dynamics; problem structuring methods including 
interactive planning and Soft Systems Methodology (SSM); the viable systems model from 
cybernetics (five functions required of a viable organisation); and critical systems heuristics (see 
Table 3.3).101  The author highlights the benefits of methodological pluralism in two senses; (i) 
building upon existing methods to constantly improve them; and (ii) using a range of methods for a 
decision problem. In particular, he suggests that boundary critique should be used alongside 
methodological pluralism, which he defines as systemic intervention, so that the weaknesses of each 
approach can be recompensed by another. The benefits of methodological pluralism are well 
described within this paper, although there may be practical issues with its use which would need to 
be considered further. This approach appears to be a variant of Total Systems Intervention described 
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by Flood and Jackson92 (see Section 3.2 for a brief description), which was not developed for Public 
Health modelling, but advocates the use of a range of systems approaches which are appropriate to 
the decision problem. It may be useful to consider multiple systems approaches in further detail (see 
Chapter 7). 
 
Summary 
This section provides evidence that systems approaches are appropriate for modelling Public Health 
systems, that it is not yet standard practice, and that it may be useful to combine systems 
approaches. There may be practical issues associated with adopting these systems approaches 
within Public Health modelling. 
 
3.4 Determinants of health and health inequities 
The determinants of health are individual, community and population level factors which affect 
health.40  Within the Public Health literature, the determinants of health and health inequities have 
been studied considerably in order to understand how policy might improve population health and 
health inequities. For example, in 2010 the World Health Organisation published a report aiming to 
establish what governments and Public Health can do to improve population health and health 
inequity via consideration of the social determinants of health.106  As highlighted by Bonnefoy et al., 
the factors which are causally related to better health may not necessarily decrease health inequity; 
thus, the determinants of health inequity are different to the determinants of health.34  The broader 
determinants of health relating to the community and the population create the dynamic complexity 
discussed within Section 3.2 due to the interactions between individuals and their social structure. In 
addition, a description of the determinants of health could facilitate consideration of non-healthcare 
costs and outcomes and equity issues. Thus, the determinants of health are important within 
assessments of the effectiveness and cost-effectiveness of interventions, yet little consideration is 
currently given to them within the health economic literature (see Chapter 2). This section aims to 
understand what the determinants of health and health inequity consist of and how different 
classifications of the determinants of health vary in order to identify how such models might feed 
into a conceptual modelling framework.  
 
Exploring classifications of the determinants of health and the determinants of health inequities 
There are many different classifications of the determinants of health and the determinants of 
health inequities. It would not be worthwhile undertaking a systematic search of all such models in 
order to achieve the above aim since there are many. Instead a recent classification by Kelly et al. 
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was identified which includes a brief summary of key existing models23 and these seven models of 
the determinants of health / health inequities are explored further below.  
 
Classifications emphasising intervention targeting at different levels 
Dahlgren and Whitehead developed perhaps the most well known model within a document for the 
WHO which aimed to describe the determinants of health inequities.28  The figure developed to 
illustrate the main influences on health consists of five layers including inherent characteristics, 
lifestyle factors, social and community networks, living and working conditions and the structural 
environment. These five layers are then each divided into a number of subcategories. The authors 
imply that each of the layers affect outcomes within other layers; however the mechanism for these 
causal relationships is not considered. The authors suggest that strategies to improve health are 
often considered at one of these levels when they would be more effective if considered at several 
levels simultaneously. They also highlight that positive influences at one level could be detrimental 
at another, suggesting that outcomes should be considered at all levels.28  
 
Similarly, Krieger defines the determinants of health inequities in terms of levels (global, national, 
regional, area or group, household, individual), pathways (the lifecourse including in utero, infancy, 
childhood and adulthood) and power (in terms of the political economy and ecology within a context 
of class, racial / ethnic and gender inequity).107  Limited detail is provided around each of these and 
their causal relationships. 
 
Classifications emphasising the role of the environment 
Taylor and Repetti ask ‘what is an unhealthy environment and how does it get under the skin?’108 
They identify socioeconomic status and race as key factors which will determine an individual’s 
environment which in turn affects health. The authors argue that the focus on individual lifestyle 
factors for illnesses affected by behaviour means that the role of the environment is often 
overlooked. Thus, this paper focuses upon the evidence relating environmental factors to health and 
to lifestyle factors, whilst not considering the evidence linking lifestyle factors and health. They 
divide aspects of the environment into community, the family social environment, the peer social 
environment, adult social environment and work. The authors suggest that environmental 
characteristics can impact upon biological outcomes directly or via chronic stress, mental health, 
coping strategies or health habits and they explore the evidence upon each of these mechanisms in 
substantial depth.108 
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Building upon Taylor and Repetti, Warnecke et al. divide the determinants of disparate health 
outcomes into 3 levels; distal, intermediate and proximal, which relate to the population, 
community and individual respectively.109  The distal level is divided into social conditions and 
policies and institutional context, the intermediate level is divided into social context, social 
relationships and physical context, and the proximal level is divided into individual demographics, 
risk behaviours, biological responses and genetic pathways. Whilst this model explicitly shows the 
determinants impacting upon disparate health outcomes, it does not depict any other causal 
mechanisms between the different levels. 
 
Kelly et al. classify the determinants of health as the following; environmental vector (eg. infectious 
diseases and environmental hazards), organisational vector (eg. school, work, clubs), population 
vector (eg. nationwide legislation and taxation) and societal vector (i.e. social, economic and cultural 
circumstances).40  The authors highlight that there is a complex interaction between human 
behaviour and the social structure, and that it is important to capture both the societal patterns of 
behaviour and individual variation. They suggest that the causal relationships within and between 
the vectors can be explained by the ideas of the life course (accumulation of ‘insults’ and ‘benefits’ 
which can be magnified or cancelled out by key life events) and the life world (our perceived 
environment, inhabited by ourselves and the people we regularly interact with). The framework 
outlined by the authors is currently employed by NICE for developing the scope for assessments of 
Public Health interventions.5  Kelly et al. suggest that interventions might be more effective if given 
at specific stages within the life course. They also highlight that in order to alter Public Health, 
interventions generally need to be multi-faceted, including educational, organisational, economic 
and environmental components.40   
 
Classifications emphasising causality 
Evans and Stoddart divide the determinants of health into social environment, physical environment 
and genetic environment, and these each are causally related to several individual outcomes, 
including lifestyle and genetic factors, as well as health outcomes.110;111  The diagram developed 
shows the complexity of these causal relationships, with many determinants causally related to 
many others. Within this model, population level factors are not considered. 
 
Classifications emphasising the difference between the determinants of health and health inequities  
Starfield aims to consider the impacts of the determinants of health upon both equity in health and 
average health. The model of the determinants of health and health inequities begins with the 
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political context and population policies. It describes causal relationships between these and 
environmental characteristics, wealth, power relationships, behavioural and cultural characteristics 
and health system characteristics. These are then linked to both equity in health and average health. 
Whilst it illustrates potentially different impacts for health equity and average health, it does not 
suggest how they might be different. 
 
Warnecke et al. distinguish between unfair health outcomes resulting from differences in 
distribution or access to health (inequitable health outcomes) and those resulting from factors which 
are not due to policy (differences), such as biological factors, and suggest that different interventions 
may be required in each case.109 
 
Summary 
All of the papers reviewed are shown in Table 3.4 to aid comparison. The use of the population, 
community and individual level classification for the row headings are based upon the NICE guidance 
on behaviour change.22  Many of the papers consider all levels and the relationships between them. 
There is an abundance of evidence around the causal relationships between the determinants of 
health; however, Kelly et al. suggest that whilst much is known about the general relationship 
between health and social factors, the precise causal pathways are not yet fully understood.40   
Key implications for methods development that have been identified from the studies are that: 
- Causal relationships should be considered across the individual, community and population 
determinants of health; 
- The most effective outcomes are likely to result from interventions targeted simultaneously 
at the individual, community and population levels; 
- The context within which interventions are provided and the stage within the individual life 
course will impact upon effectiveness; 
- The modeller should be aware that the determinants may impact upon overall health and 
health inequities in different ways; 
- Health outcomes are affected by culture and politics in a multitude of ways. 
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Table 3.4: Summary of papers describing the determinants of health inequities 
Levels and 
outcomes 
 
Author 
Dahlgren and 
Whitehead
28
 
Taylor and 
Repetti
108
 
Evans and 
Stoddart
111
 
Starfield
112
 Warnecke et al.
109
 Krieger
107
 Kelly et al.
40
 
Population 
factors 
General 
socioeconomic, 
cultural and 
environmental 
conditions 
  Occupational, 
environmental, social, 
economic & health policy 
Social conditions 
and policies 
Institutional 
context 
Global/ National Population-
wide vector 
Historical health 
disadvantage 
Environmental 
vector 
Community 
factors 
Living and working 
conditions* 
Work Physical 
environment 
Health system 
characteristics 
Physical context 
 
Regional/ Area or 
group/ Household 
 Organisational 
vector 
Social and 
community 
networks 
Community 
 
Social environment Wealth: level & 
distribution 
Social context 
Social 
relationships 
 
Social vector 
Adult social 
environment 
Power relationships 
The family 
environment 
Environmental 
characteristics 
The peer social 
environment 
 
Individual 
factors 
Individual lifestyle 
factors 
 Individual 
behaviour 
Behavioural & cultural 
characteristics 
Individual risk 
behaviours 
Individual Life-course & 
life-world 
Age, sex and 
constitutional 
factors 
Socioeconomic 
status & race 
Genetic 
endowment 
 Individual 
demographics 
 
Health 
outcomes 
 Biological 
outcomes 
(precursors/ 
disease) 
Biology, disease, 
well-being, health 
and function 
Equity in health Biological 
responses 
Biologic/ genetic 
pathways 
Population 
distribution of 
health 
Health & well-
being Average health 
Other 
outcomes 
  Prosperity     
*including agriculture and food production, education, work environment, unemployment, water and sanitation, health care services and housing. 
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3.5 Modelling human behaviour within complex systems 
Within the review of key challenges in public health economic modelling in Chapter 2 it was 
recognised that individual and societal behaviour is important for evaluating Public Health 
interventions, yet no studies were identified which considered how human behaviour might be 
incorporated into health economic models. The complex systems literature suggests that modelling 
heterogeneity and interactions between individuals is important in predicting outcomes within such 
systems (see Section 3.2). This section therefore investigates the possibility of incorporating human 
behaviour within a conceptual modelling framework for Public Health economic evaluation by 
exploring the disciplines of Psychology and Sociology. Psychology is the study of individual 
behaviour, whilst Sociology is the study of people’s interactions in shaping the behaviour of groups 
within society.  
 
Within Psychology, hundreds of models of human behaviour have been developed which provide an 
understanding of the individual factors required for the adoption of a specified behaviour. However, 
only a small number of these have had empirical applications. A review by Taylor et al. identified the 
Health Belief Model, the Theory of Reasoned Action, the Theory of Planned Behaviour and the 
Trans-Theoretical Model as the most commonly used cognitive models within health promotion.113  
This review suggested that none of these four models adequately capture social, economic or 
environmental factors as predictors and determinants of health behaviour.113  Recently, case studies 
have been undertaken to consider incorporating human behaviour into mathematical models of 
Public Health;114-116 however there were difficulties with parameterisation in these cases. Whilst 
theoretically all four of the above behavioural models could be used to quantitatively model how 
behaviour changes within Public Health, this requires substantial methodological research both in 
terms of practical implementation and in terms of methods for parameterisation. Currently, health 
economic modelling has largely overlooked the incorporation of Psychology models and this could 
be an important area of further research in Public Health economic modelling. Similarly, research 
around the potential benefits of employing behavioural economics, which integrates Psychology 
with neo-classical economics, may be useful.117 However, it is not feasible to undertake this research 
within the scope of my work. 
 
Sociology seeks to provide insights into the many forms of relationship between people (including 
cultural, economic and political) to understand how society works.118  It provides an evidence-based 
perspective of society, questioning conventional assumptions within society, and could provide tools 
for modelling the impact of interactions within society upon outcomes. Several sociologists have 
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taken a systems thinking perspective, such as Giddens.119  He describes the idea of structuration 
which considers whether it is individuals or social forces (eg. cultural groupings or the law) that 
shape social reality. He suggests that social outcomes are shaped by both micro and macro impacts, 
and that it is impossible to disentangle the cause and effect between them. This mirrors the theory 
associated with complex systems, which considers the interactions between individuals and 
between individuals and their environment in order to understand the outcomes of the system. As 
was suggested within Section 3.2, one way to attempt to disentangle these effects is via the use of 
feedback loops. The idea of structuration is also consistent with the economic theory of Smith’s 
Invisible Hand which suggests that the independent choices of all of the individuals within a society 
to maximise their own gains within a free market (where the price is determined according to supply 
and demand) will also benefit society overall.120  
 
Within the last decade Sociology has been linked with complex adaptive systems to form a discipline 
defined as Sociology and Complexity Science (SACS).121  Both Sociology and Complexity Science 
follow a non-reductionist, subjective approach, making use of qualitative research methods (as well 
as quantitative methods in the case of Complexity Science). Many of the terms which have arisen in 
Complexity Science including autopoiesis (self-replicating), emergence (behaviour arising from the 
interaction of the elements) and collective behaviour (the behaviour of a group of individual entities 
which leads to patterns in the behaviour of the group), have been researched within Sociology. Two 
of the biggest areas of work within SACS are computational Sociology and complex social network 
analysis.121  Computational Sociology is the use of computationally intensive methods to analyse 
social systems. To date within computational Sociology, many models have made assumptions about 
behaviour based upon limited or no data i.e. they present theoretical models which require future 
primary research to clarify the model structure and define the parameters.115  Complex social 
network analysis involves the use of a range of techniques including agent-based modelling and 
social network analysis (mapping social networks to understand who is at the hub of the network). 
Agent-based modelling is an individual-level simulation approach which uses ‘rules’ to define the 
interactions between agents and their environment (see Table 3.3).122  Methods for producing this 
model type are sufficiently developed to be able to incorporate it within the conceptual modelling 
framework, and due to similarities with other model types, it would be viable for health economic 
modellers to learn.  Social network analysis could be applied within agent-based models. 
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3.6 Chapter summary and implications for methods development 
This chapter has considered what a dynamically complex system is and concluded that Public Health 
interventions tend to operate within dynamically complex systems. A systems approach is expected 
to be an appropriate approach for modelling these dynamically complex systems, taking a holistic 
view of the system and focusing upon the interactions between variables. A systems approach would 
also facilitate the inclusion of relevant costs and outcomes within the model. It may be useful to 
combine multiple systems approaches.  
 
Health economic models help to make predictions about the future and it is not possible to do this 
well without an understanding of underlying mechanisms. There are a large number of classifications 
of the determinants of health; however many of them comprise similar factors (see Table 3.4). Many 
of the papers reviewed highlighted that there are causal effects between many of the determinants 
of health. In order to provide better long term predictions of the impact of the interventions upon 
health, the model is likely to need to describe the interactions between each level of the 
determinants of health; the individual (including the biological and human behaviour), the 
community and the population level. In addition, interventions are likely to be more effective if 
targeted at all three levels simultaneously.  
 
The context within which interventions are provided and the stage within the individual life course 
will impact upon effectiveness. There may often be discrepancies between the data provided by 
intervention effectiveness studies and the evidence required for models in relation to the 
determinants of health. Intervention effectiveness studies may capture all or some of the effects of 
the broader determinants of health and their interactions within the outcomes presented. However, 
they do not tend to report how the determinants of health impact upon outcomes, making 
extrapolation of the outcomes over the long term or to other contexts challenging. The modeller 
should be aware that the determinants may impact upon overall health and health inequities in 
different ways. In addition, unless the mechanism of the interventions upon outcomes is well 
understood, it will be challenging to model the interaction of the effectiveness of multiple 
interventions being provided simultaneously. Capturing the heterogeneity between individuals 
within the model in terms of the broader determinants of health is likely to be important because it 
is this heterogeneity that impacts upon the effectiveness of the interventions. Importantly, if 
sufficient people adopt a type of behaviour, it might lead to a step-change within society and this 
should be considered within the modelling work. It may also be important to capture the changes 
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over time of the social determinants of health. The culture and politics of the system should be 
considered during conceptual modelling, as highlighted within Soft Systems Methodology.123 
  
Given the dynamic complexity and importance of the social structure within Public Health, methods 
such as agent-based modelling and social network analysis are likely to be useful within Public 
Health economic modelling. There is enormous scope for advancing modelling methods within 
Public Health economic evaluation through collaboration with the disciplines of Public Health, 
Psychology and Sociology to combine the existing knowledge of the social determinants of health 
and individual and population behaviour with existing modelling and health economic expertise. 
Development in this area is considered to be beyond the scope of the current research; however it 
will be highlighted as a key area for further research. 
 
Thus, based upon the research presented within this chapter, a conceptual modelling framework for 
Public Health economic evaluation would need to consider: 
 The use of systems thinking; 
 The social determinants of health; 
 The potential assessment of interventions at the population, community and individual level 
simultaneously; 
 Heterogeneity between individuals; 
 The culture and politics of the system; 
 Modelling methods to enable broader social determinants of health to be incorporated such 
as agent-based simulation and social network analysis. 
 
A review of existing conceptual modelling frameworks and their potential applicability to Public 
Health economic evaluation based upon the considerations identified within Chapters 2 and 3 is 
presented within Chapter 4. 
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Chapter 4: Literature review of conceptual 
modelling frameworks  
 
4.1 Chapter outline 
This chapter presents a literature review of existing conceptual modelling frameworks. The aim of 
the review is: 
 To understand what comprises existing conceptual modelling frameworks, in terms of the stages 
of model development considered, the level of detail provided, the definition of a conceptual 
model, the methods / methodologies recommended and the relationships between them, and 
the theory associated with the framework. 
 To understand the strengths and limitations of these frameworks, how they have been 
evaluated, and their potential application within Public Health economic modelling. 
Sections 4.2 and 4.3 describe the methods and results of the review respectively. The review has 
been divided into five sections; (i) Stages of model development included within the conceptual 
modelling frameworks; (ii) Methods / methodologies employed within the frameworks, including 
strengths, limitations and potential application to Public Health economic modelling; (iii) Methods of 
evaluation of the frameworks and their theoretical underpinnings; (iv) Benefits of a conceptual 
modelling framework; and (v) Areas identified by the authors for further research. Section 4.4 
presents a discussion of the review, whilst Section 4.5 summarises the findings of the review and the 
implications for methods development. 
 
4.2 Methods of review of conceptual modelling frameworks 
As explained within Chapter 2, methodological reviews often require alternative search strategies to 
the traditional Cochrane search.61  This is because methodological reviews aim to enhance 
understanding about the methods, rather than aiming to identify all studies which describe or use a 
preconceived idea of the methods. This review aims to capture key information around conceptual 
modelling frameworks. If a Cochrane-type of search was undertaken, in which strict inclusion and 
exclusion criteria were identified at the start, important information may have been lost if it did not 
fit into my initial understanding of a conceptual modelling framework. Therefore, it was appropriate 
to explore and inform the scope of relevance via the searching process using an iterative approach 
to searching.63  I used my initial understanding of conceptual modelling frameworks to develop a 
search strategy to identify key literature, which was then explored in order to inform further 
retrieval using hand searching of bibliographies of retrieved articles, citation searching of retrieved 
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articles, key author searching and title searching of new, relevant terms that emerged from the 
initial search. This process was repeated for any relevant articles identified. 
 
These methods helped to identify papers where the term ‘conceptual modelling framework’ is not 
employed and is also a more efficient way of searching given that the term ‘conceptual model’ has 
numerous meanings within different contexts.  
 
My initial understanding of ‘conceptual modelling frameworks’ 
My initial understanding of conceptual modelling frameworks was based upon: (i) a book by 
Robinson from 2011 reviewing conceptual modelling for discrete event simulation (DES);1 (ii) a 
Health Technology Assessment (HTA) monograph by Chilcott et al. published in 2010 about avoiding 
and identifying errors within HTA;17  and (iii) the discussion generated with colleagues whilst co-
authoring a Model Structuring chapter of a NICE DSU Technical Support Document on identifying 
and reviewing evidence to inform the conceptualisation and population of cost-effectiveness 
models.14  These helped to define the following requirements for a conceptual modelling framework; 
(1) it should aim to develop a quantitative model since this is required in order to compare the costs 
and benefits of the interventions; (2) judgements are required about what to include within and 
exclude from the model; and (3) the type of quantitative model required is not predefined; it is 
dependent upon the characteristics of the specific problem (see Brennan et al.124).  
 
Search strategy 
Based upon this initial understanding, a search was undertaken to identify potentially relevant 
articles. The following databases were searched; MEDLINE 1950 to Aug 2011; Scopus 1960 to Aug 
2011; Web of Science 1965 to Aug 2011. Three sets of search terms were combined with ‘AND’; (1) 
Terms for conceptual models (limited to title with the aim of ensuring that this is the main focus of 
the article); (2) Terms for quantitative models (to help to limit studies to those in which the aim of 
the conceptual model is to develop a quantitative model); and (3) Terms for development (to help to 
focus the search on methods for development of conceptual models rather than on case studies 
reporting the output of a conceptual model). The search strategy is presented in Appendix B. 
Searches were not limited by discipline due to the lack of conceptual modelling methods within 
Public Health economic modelling, as discussed within Chapter 2. In addition, searches were not 
limited by study type, publication date or language. The search methodology is presented within 
Figure 4.1. 
 
61 
 
Figure 4.1: Search methodology 
               Step 1                                                      Step 2                                                    Step 3 
 
 
 
 
 
 
 
 
 
 
 
     
Study screening and selection 
All of the identified literature was screened by me at title and abstract level for relevance, and the 
full paper was retrieved when insufficient detail was provided within the abstract to determine 
relevance. Relevance was determined based upon the learning from the searching process, the 
results of which are described within Section 4.3.1 below.  
 
Data extraction      
Following article retrieval, data extraction was undertaken for studies considered relevant using a 
data extraction form which was specifically developed for this review (shown in Appendix B). The 
data extraction form was developed after selection of the included articles, following the learning 
about the topic during the search process. 
 
4.3 Results of review of conceptual modelling frameworks 
Firstly, the results of the searching process are described in order to specify relevance for the 
review, and secondly a critical review of the included studies is presented. 
 
4.3.1 Results of the searching process in determining relevance 
The searching process was used to increase my understanding of (a) conceptual modelling 
frameworks and (b) the amount of literature available in this area; the combination of which led to a 
definition of relevance for the review. 
 
Until no new methods 
identified 
Initial reading 
(Robinson;1  Chilcott et 
al.17)  
Initial understanding (based 
on experience & discussion 
of DSU chapter14) 
Initial search  
Citation searching 
Reference searching 
Key author searching 
Title searching 
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Definition of a conceptual model 
The term ‘conceptual model’ is used across a wide range of disciplines, and has many meanings, 
although broadly it is some form of diagram used to represent the perceived key aspects of a system 
at a point in time. When focusing on conceptual models employed with the aim of developing a 
quantitative model there remains no agreement for the definition of the term; it has been termed as 
a mental model of the problem,123 a written description of the problem17 or a written qualitative 
description of the quantitative model that will be (or has been) developed.8;125  In the case of the 
latter, the description can range from a basic depiction of the scope of the model125 to an exact 
representation of all of the elements within the quantitative model.8  A conceptual model may be 
described using more than one diagram, as in Software Engineering.126  In many cases, the term 
‘conceptual model’ is not employed at all when developing models.127-129   
 
Understanding what comprises a conceptual modelling framework 
There is little agreement around what comprises a conceptual modelling framework within the 
literature and the searching process helped to understand what might be included. Given the 
substantial variation, it was not possible to be more prescriptive than to consider any article to be 
relevant that described a set of principles and methods / methodologies which facilitate the 
development of a model structure. Since a reasonable number of conceptual modelling frameworks 
were identified which provided a process for developing a quantitative model (as is required within 
Public Health economic evaluation), any frameworks solely considering the conceptualisation of the 
problem without the conceptualisation of a quantitative model were not considered relevant.   
 
The searching process suggested that formal problem structuring methods (PSMs) are often 
employed for understanding the problem (see the systems approaches described within Chapter 3). 
PSMs are ‘soft’ Operational Research approaches used to facilitate the exploration of ‘messy’ or 
complex problems. They are beneficial for problems which are poorly defined, which have multiple 
stakeholders, differing perspectives, conflicting interests, outcomes which are difficult to quantify 
and uncertainties.130  PSMs are expected to improve understanding of complex decision problems 
from all stakeholders’ perspectives in an exploratory and transparent manner, acknowledging 
uncertainties. They may be employed alone, or as a preliminary analysis to quantitative modelling.44 
PSMs have been developed across a wide range of disciplines within the UK, although their 
application is limited in most other countries.131  However, there are very few published studies of 
the use of formal PSMs within health economic modelling to date and PSMs are not mentioned 
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within guidance to health economic modellers such as within the NICE Public Health intervention 
evaluation methods guide.5;132 
 
Initially, it was unknown whether the understanding of the problem situation was considered to be 
part of the conceptual modelling process or a preceding step. The searching process suggested that 
this is usually considered to be a substantial part of a conceptual modelling framework. Based upon 
an initial reading of a book of key problem structuring methods by Rosenhead,130 the conceptual 
modelling frameworks which were identified generally employ the most methodologically developed 
PSMs133 and they also have the greatest potential of being applicable to Public Health economic 
modelling. This is because many of the alternative PSMs focus either upon relieving high levels of 
conflict between stakeholders or upon organisations within which decisions can be continually 
revisited. I had initially thought that a separate review of PSMs might be useful, however because of 
the findings of the searching process, a separate review was not considered to be worthwhile. 
 
Conceptual modelling frameworks for different model types 
The search also highlighted that many conceptual modelling frameworks are developed for a specific 
model type, for example DES or system dynamics, and in some cases no or very limited aspects of 
the framework were likely to be useful if an alternative model type was required. There are a 
number of health economic modelling papers which highlight the importance of choosing the model 
type according to the characteristics of the problem.124;134;135  Therefore, articles were only 
considered to be relevant if some aspect of the conceptual modelling framework is able to offer 
insight beyond one particular model type. 
 
Stakeholder involvement 
During the searching process, many of the studies that were identified considered stakeholder 
involvement in the model development process and these suggested that this involvement was 
essential in developing valid and credible models. Based upon my initial understanding and the 
learning from the searching process, stakeholder involvement was thought to be an important 
characteristic of the conceptual modelling frameworks. Hence, only those which considered 
stakeholder involvement, in a greater capacity than as a tool for discussion and debate of the final 
model, were considered to be relevant for the review.   
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Other exclusions 
Having developed a clearer idea of what types of articles were available, a number of types of 
articles were excluded from this review because more relevant articles were available. This includes 
those articles solely describing the steps involved within a conceptual modelling framework without 
describing methods for development. A large number of case studies of conceptual models of the 
model structure were identified which did not provide detail about the methodological approach or 
reporting of the conceptual model(s). These were not included within the review because the 
methodological papers were considered to be more useful for developing a conceptual modelling 
framework. 
 
It is important to represent the conceptual modelling in a format that allows communication 
between modellers and stakeholders.1  However, it was not considered to be worthwhile to review 
all papers describing conceptual model representations given that the papers that describe the 
conceptual modelling frameworks also consider conceptual model representation. Therefore, those 
articles describing only the diagrammatic / tabular representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation were not 
considered to be relevant. In a similar way, those articles describing software tools for the 
development of a conceptual model, without describing a new conceptual modelling framework 
were not considered to be relevant. Finally, those articles solely making a contribution of theory 
such as the requirement for conceptual modelling or the issues with combining ‘soft’ and ‘hard’ OR 
methods were excluded since they do not facilitate specific methods development. Some of these 
papers provided useful background material and are considered within the discussion of the review.  
 
Since it is a methodological review which does not aim to be exhaustive, included articles must 
report a conceptual modelling framework which has not been presented elsewhere. Identified 
sources which were considered to be relevant with the fullest description of each framework were 
included. If several articles presented the same framework to the same standard, priority was given 
to the most recent article. 
 
Table 4.1 describes the inclusion and exclusion criteria for those articles included within the review.  
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Table 4.1: Inclusion and exclusion criteria for conceptual modelling framework review 
Inclusion criteria Exclusion criteria 
Must describe a set of principles and methods/ 
methodologies which facilitate the development 
of a model structure. 
Articles solely describing the steps involved 
within a conceptual modelling framework 
without describing methods for development. 
The conceptual modelling framework presented 
must be aimed at developing a quantitative 
model. 
Case studies of conceptual model development 
which did not provide detail about the 
methodological approach or reporting of the 
conceptual model(s). 
Some aspect of the conceptual modelling 
framework must be able to offer insight beyond 
one particular model type. 
Articles describing only the diagrammatic/ 
tabular representation of a conceptual model 
without describing methods for choosing what is 
included or excluded within the representation. 
Must consider stakeholder involvement, in a 
greater capacity than as a tool for discussion and 
debate of the final model. 
Articles describing software tools for the 
development of a conceptual model, without 
describing a new conceptual modelling 
framework. 
Must report the fullest description of a 
conceptual modelling framework if presented in 
more than one source. If several articles present 
the same technique to the same standard, 
priority is given to the most recent article. 
Articles solely making a contribution of theory 
such as the requirement for conceptual 
modelling or the issues with combining ‘soft’ and 
‘hard’ OR methods. 
 
Within this review, articles are excluded which Robinson has included in his book on Conceptual 
Modeling for Discrete Event Simulation.1  Robinson does not define how he determined relevance 
within his book; however many of the chapters are discussions around improving understanding of 
conceptual modelling or conceptual modelling notation such as how Software Engineering 
representation may be used within DES development, rather than the description of conceptual 
modelling frameworks which propose methods for developing the structure of quantitative models. 
It seems that many researchers focus solely upon how a conceptual model is represented, rather 
than the process of development, which is the focus within my research. Several conceptual 
modelling frameworks from the defence and computer science fields were identified within the 
search; however these were excluded from the review. Many of the computer science conceptual 
modelling papers described how to represent the system within a model rather than describing a 
process for making judgements about what to include and exclude within the model and they did 
not aim to develop a quantitative model. The defence conceptual modelling frameworks generally 
did not consider stakeholder involvement. Excluded studies and reasons for exclusion are shown 
within Appendix B. 
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Articles included within the review 
Eight conceptual modelling frameworks were considered to be relevant for the review, identified as 
shown in Table 4.2. 
 
Table 4.2: Identification of included articles for conceptual modelling framework review 
Stage of 
search 
Activity No. of articles 
considered to 
be relevant 
Included articles. Author (year) 
Stage 1 Initial reading 2 Kaltenthaler et al. (2011)14 
Robinson (2011)8 
Stage 2 Initial search 2 Tako et al. (2010)136 
Vennix and Gubbels (1992)128 
Stage 3 Reference, citation, 
author & title searching    
  
    Iteration 1 1 Fernández and Kekäle (2008)125 
    Iteration 2 
 
2 Howick et al. (2008)127 
Rodriguez-Ulloa and Paucer-Caceres (2005)129 
    Iteration 3 0  
- Identified informally 
subsequently to the 
search  
1 Roberts et al. (2012)18 
 
4.3.2 Stages of model development included within the conceptual modelling frameworks 
Of the included studies only Robinson provides a definition of a conceptual modelling framework, 
described as ‘A specific set of steps that guide a modeller through development of a conceptual 
model’.8  The processes included in the conceptual modelling frameworks within the studies are 
shown in Table 4.3. The title row of Table 4.3 was developed based upon the findings of the studies, 
rather than the findings of the studies being matched to some pre-specified idea of a conceptual 
modelling framework. It suggests that there is substantial variation in what constitutes a conceptual 
modelling framework.  
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Table 4.3: Stages within conceptual modelling frameworks 
Author Understand the problem situation and set objectives                              Choose model options, determine model scope and level of detail,                                                                                                                             
‘                                                                                                                            identify assumptions & determine model type 
Roberts et al.18 
 
Statement of the decision problem and modelling objectives Determine model perspective, outcomes, 
options, model scope, structure, time 
horizon, level of detail & key uncertainties 
Identify 
appropriate model 
type 
Kaltenthaler et 
al.14 
Understand the decision 
problem & the system in which 
this exists (problem-oriented) 
 Determine model outputs, scope, level of 
detail & key structural assumptions  
(design-oriented) 
Identify 
appropriate model 
type 
Robinson8 Understand the problem 
situation 
 Determine the modelling and 
general project objectives 
Identify model outputs 
and options 
Determine the 
model scope and 
level of detail 
Identify any 
assumptions and 
simplifications 
Tako et al.136 Initiate the 
study 
Structure the 
situation of 
interest 
Determine study objectives  Identify model outputs 
and options 
Determine model 
content 
Identify 
assumptions and 
simplifications 
Howick et al.127 Gain a deep and rich 
understanding of the problem 
Objectives implicitly identified 
from understanding the problem 
Determine endogenous and exogenous 
variables to arrive at appropriate level of 
detail 
Identify 
inconsistencies in 
structural 
assumptions 
Fernández and 
Kekäle125 
    Identify factors that 
might affect the goal 
Prioritise important 
variables to include 
 
Rodriguez-Ulloa 
and Paucar-
Caceres129 
Immerse self in 
unstructured 
problem 
situation 
Capture the 
problem 
situation 
Capture the 
system from 
each 
stakeholders' 
perspective 
Capture the 
system 
incorporating the 
stakeholders’ 
perspectives 
Check model 
represents adequately 
what is happening in 
the real world 
Look for culturally 
feasible and 
systemically 
desirable changes 
Iterations to check 
the model matches 
the problem 
situation  
Vennix and 
Gubbels128 
Define the policy questions Develop preliminary conceptual 
model 
Knowledge elicitation to establish model 
structural assumptions & relevant variables 
Final conceptual 
model 
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Distinction between understanding the problem and developing a design-oriented conceptual model 
Within six of the eight included studies, there is a clear distinction between understanding the 
problem and developing a qualitative description of the quantitative model.8;14;18;127;129;136  Vennix 
and Gubbels do not provide a method for model scoping; thus understanding the problem situation 
is not distinct from the representation of the model,128  whilst Fernández and Kekäle do not provide 
methods for understanding the problem.125  Table 4.4 describes the terminology employed for each 
of these two stages which shows that there is no consistent terminology between frameworks.  
 
Table 4.4: Terminology for understanding the problem  
Author Understanding the problem Qualitative description of 
quantitative model 
Roberts et al.18 Conceptualising the problem Conceptualising the model 
Kaltenthaler et al.14 Problem-oriented conceptual 
model 
Design-oriented conceptual model 
Robinson8 Abstract model Conceptual model 
Tako et al.136 Not defined Conceptual model 
Howick et al.127 Cognitive / cause map Influence diagram / system 
dynamics formal influence diagram 
Fernández and Kekäle125 None included Conceptual model 
Rodriguez-Ulloa and 
Paucar-Caceres129 
Problem oriented Solving oriented 
Vennix and Gubbels128 None included Conceptual model 
 
Stages of developing the design-oriented conceptual model 
Within the included studies, the development of a qualitative description of the final quantitative 
model generally consists of choosing potential options, model scoping, determining the level of 
detail and defining the structural assumptions. However, there does not appear to be an agreed 
order for these activities. For example, Robinson considers the potential options prior to model 
scoping and determining the level of detail,8 whilst Rodriguez-Ulloa and Paucer-Caceres develop the 
model scope and then look for ‘culturally feasible and systemically desirable’ changes.129  I would 
suggest that there are advantages and disadvantages to both of these approaches. The conceptual 
modelling framework by Robinson allows a model to be developed which is specifically able to 
answer questions about the chosen options.8  This helps to guide the model scope, which may lead 
to efficient model development; however it may fail to identify some options which are relevant, 
meaning that the outcomes of the system might not be optimised. Conversely, the conceptual 
modelling framework by Rodriguez-Ulloa and Paucer-Caceres uses the model to help to identify 
potential options.129  This may lead to a model with a broader scope, which could make the model 
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development less efficient; however it may be useful for situations where it is unclear which options 
to compare within the model. 
 
Iteration between stages of conceptual modelling 
Many of the conceptual modelling frameworks suggest that some of the stages are iterative and 
hence should not be followed in a purely linear fashion.8;14;127;129  This is also suggested by Robinson 
within his book reviewing conceptual modelling in DES.1  Within his conceptual modelling 
framework, Robinson suggests that whilst the understanding of the problem is used to develop the 
qualitative description of the quantitative model (termed the conceptual model), this understanding 
is often enhanced by later stages of model development. He also suggests that there may be an 
iterative process between the conceptual model developed and the data collection; the conceptual 
model should be developed without being driven by the availability of data, but if data are not 
available to parameterise the initially conceptualised model, then the conceptual model may be 
changed, leading to new data requirements.8  Howick et al. suggest that the initial model should be 
developed by moving linearly between the model development stages; however the development of 
one model stage may lead to learning about a previous model stage, and hence subsequently the 
modeller can amend any stage providing they amend each intermediary stage in turn.127  For the 
conceptual modelling framework developed by Rodriguez-Ulloa and Paucar-Caceres, the authors 
recommend that model development should be an iterative process across all stages.129   
 
Kaltenthaler et al. also suggest that there may be an iterative process of development between the 
design-oriented conceptual model and the quantitative model, however it differs to the above 
frameworks in that the problem-oriented conceptual model should be developed first and should 
not be changed as a result of the process.14  The rationale for this is that whilst data may change 
what is modelled, the system within which the problem exists does not change.14  However, the 
qualitative research described within Chapter 5 suggests that the relationship between 
conceptualisation and data collection means that it is not possible to undertake the tasks as two 
completely discrete stages. This is because evidence in some form is required to understand the 
problem, and a certain level of understanding of the problem is required to inform the collection of 
evidence. If our understanding of reality was perfect then our understanding of the system would 
not change as we collected more evidence as Kaltenthaler et al. suggest; however in practice our 
understanding of that system may be revealed to be imperfect as more evidence is identified. Thus I 
would argue that the problem-oriented conceptual model could be changed at a later stage in the 
process provided that any changes are documented.  
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All four of the above frameworks suggest that the design-oriented conceptual model is not 
completed prior to the quantitative model development, but that it may be iteratively revised 
according to data availability and/or inconsistencies identified during the development of the 
quantitative model.8;14;127;129  All other included conceptual modelling frameworks do not explicitly 
state that there should be iterations between stages.18;125;128;136   
 
Semantic differences between the frameworks 
Within these frameworks, the term ‘conceptual model’ is defined only within the study by 
Robinson,8 based upon a previous related paper by the author.137  The same definition is also 
employed by Tako et al.136  The definition provided is ‘a non-software specific description of the 
computer simulation model describing the objectives, inputs, outputs, content, assumptions and 
simplifications of the model.’8  However, Pidd argues that this definition is broad and may be more ‘a 
conceptualization of a simulation model or a simulation project, rather than a conceptual model’.138  
Within other literature discussing conceptual models they have been referred to with different 
meanings, as ‘a description of one’s understanding of the system’17 or ‘a mental model of the 
problem’.123  Within the framework by Kaltenthaler et al., the term conceptual modelling is defined 
as ‘the abstraction and representation of complex phenomena of interest in some readily 
expressible form, such that individual stakeholders’ understanding of the parts of the actual system, 
and the mathematical representation of that system, may be shared, questioned, tested and 
ultimately agreed.’ I would suggest that the term ‘conceptual model’ seems suggestive of only one 
diagram, whilst the phrase ‘conceptual modelling’ depicts a broader set of activities which might 
encompass developing one or more diagrams with accompanying text.  
 
Similarly, there is no consistency around the definition of who should be involved in the model 
development process. Roberts et al., Kaltenthaler et al., and Rodriguez-Ulloa and Paucar-Caceres 
and Tako et al. all use the term ‘stakeholder’, but each have different definitions of what this 
includes. Roberts et al. do not define the term but consider ‘subject experts’ and ‘decision makers’ in 
addition to stakeholders.18  Conversely, Kaltenthaler et al. include within their definition of 
stakeholders, modellers, decision makers, health professionals and ‘others who impact upon or are 
impacted upon by the decision problem’.14  Similarly, Rodriguez-Ulloa and Paucar-Caceres include 
‘system dynamics practitioners, clients, actors and problem owners’ as stakeholders.129  Tako et al. 
do not define who their stakeholders would include.136  Robinson, Howick et al., Fernández and 
Kekäle, and Vennix and Gubbels do not use the term ‘stakeholder’. Robinson refers to ‘clients’, ‘the 
modeller’ and ‘domain experts’,8 whilst Howick et al. uses the term ‘client group’, without providing 
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specific information about who this would include.127  Vennix and Gubbels similarly use the term 
‘client’ and define these as multiple audiences including non-scientific and scientific / expert 
audiences.128  Finally, Fernández and Kekäle use the term ‘respondents’, who have experience and 
background of the topic of interest.125  
 
These semantic differences often lead to inconsistencies and confusion around what people within 
the same or similar disciplines are trying to achieve. The key implication is that I need to ensure that 
my research is clear about what is included within a conceptual modelling framework and which 
groups of people might be involved in the model development process. If the term ‘conceptual 
model’ is employed within the framework it needs to be clearly defined.  
 
4.3.3  Methods and methodologies employed within the frameworks, including strengths, 
limitations & potential application to Public Health economic modelling 
This section briefly outlines the methods and methodologies employed within the conceptual 
modelling frameworks. It focuses upon any strengths and limitations of the frameworks highlighted 
by the authors, as well as my own judgements of their strengths and limitations for their potential 
application to Public Health economic modelling, using the research presented within Chapters 2 
and 3. To aid comprehension, the frameworks are divided into four non-mutually exclusive groups; 
(i) conceptual modelling frameworks with non-prescriptive methods;8;14;18 (ii) those employing 
diagrams denoting causal relationships;127-129 (iii) those based on Soft Systems Methodology;129;136 
and (iv) those using Delphi methods.125;128  These groups were chosen, using the data extraction 
forms, as the most useful way of combining and comparing the conceptual modelling frameworks 
based upon the key methods employed within the frameworks.  
 
Before reporting a critical analysis of each of the conceptual modelling frameworks, some of the key 
methods employed within the frameworks are described. 
 
4.3.3.1    Description of methods / methodologies used within the frameworks 
Methods for developing diagrams denoting causal relationships 
Cognitive mapping 
Cognitive mapping, as used within Management Science, is a method for capturing stakeholders’ 
views in order to understand the possible options available to them.139  The map is made up of 
nodes, or ‘concepts’, which depict the ideas and views of stakeholders (preferably in their own 
language), connected by arrows which depict the relationships between concepts. Concepts are 
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usually phrases with an active verb. Concepts at the tail of the arrow lead to concepts at the head of 
the arrow, unless accompanied by a negative sign which suggests that the concepts at the tail of the 
arrow will have negative implications for the concepts at the head of the arrow. The ultimate goal of 
the person is stated at the top of the map, with intermediate goals below, and options for achieving 
the goals at the base of the map. Cognitive maps are intended to portray perceptions of a complex 
problem and hence each concept does not need to be able to take a discrete value. The process of 
the development and analysis of cognitive maps is known as Strategic Options Development and 
Analysis (SODA),139 which is a type of problem structuring method. Cognitive maps can be developed 
via individual interviews and then combined via a facilitated workshop into a strategic map, 
otherwise termed a cause map,127 (SODA I), or the cause map can be developed jointly using focus 
groups (SODA II, otherwise known as Journey Making).139 It is possible to develop cognitive and 
cause maps within specialised software such as ‘Decision Explorer’140 or ‘Group Explorer’141 or they 
may be developed using pen and paper, for example, with the use of post-it notes. Cognitive / cause 
maps can be used to establish whether there are any positive or negative feedback loops within the 
system, and whether there are any clusters of factors which have greater impact upon the goals 
than single factors.  
 
Causal diagrams 
A causal diagram is similar in appearance to a cognitive / cause map; however it represents the 
causal relationships between events or consequences of an intervention within a system, rather 
than the relationships between stakeholder views.129  Each event or consequence has the potential 
to be a variable within a quantitative model, in that each can take a discrete number of values and 
can be structurally related by equations to dependent variables. As for cognitive / cause maps, 
variables are connected by arrows, where those at the head of the arrow are dependent upon those 
at the tail of the arrow. Next to each arrow a positive or negative sign is used to denote the direction 
of the relationship; a positive (negative) sign is used if an increase in the independent variable leads 
directly to an increase (decrease) in the dependent variable.129 An influence diagram (or causal loop 
diagram) is conceptually the same as a causal diagram; however feedback loops are graphically 
specified as either positive or negative.89  It should be noted that there is an alternative meaning 
when developing mathematical models for the term ‘influence diagram’, which can also be used for 
a diagram which does not consider feedback loops and is isomorphic to a decision tree, including 
outputs, decision variables and stochastic variables.142 
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Concept maps 
A concept map links a group of concepts via arrows with a verb or preposition used to connect each 
pair of concepts. As such concept maps do not require positive or negative signs to denote the 
direction of the causal relationship. Whilst concept maps do not necessarily focus upon one goal as 
for cognitive mapping, they should be arranged in a hierarchical structure with the most general 
concepts at the top of the map and the most specific concepts at the base.143  
 
Figure 4.2 shows examples of a cognitive map, a causal diagram and a concept map. 
 
Figure 4.2: Example of a cognitive map, a causal diagram and a concept map 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Soft Systems Methodology (SSM) 
SSM is a type of problem structuring method which uses systems thinking (see Chapter 3). It aims to 
understand a problem in terms of the worldviews of all stakeholders in order to develop feasible and 
systemically desirable changes.123  It is a seven step cyclical process, developed by Checkland, 
divided into Real World Thinking and Systems Thinking about the Real World, as shown in Figure 4.3. 
 
Cognitive map                                                              Concept map 
Decrease in teenage pregnancies                                                      May lead to 
  _       Undertaking more sex                                                                    May lead to 
Use of contraceptives...         +                                                                                     using 
Sex without contraceptives       
              + 
Understanding of options                                                                                              may have 
available to young persons 
               + 
Advice to use contraceptives                                                                   support 
(within this diagram a +arrow means leads to, a – arrow  
means does not lead to, &  ‘...’ means ‘rather than’) 
 
Causal diagram 
Teenage pregnancy 
                                                               +              +    Sexual activity 
Poor contraceptive use   + 
                                                               - 
Contraceptive advice 
(within this diagram, a + arrow means ‘leads to an increase in’ 
& a – arrow means ‘leads to a decrease in’) 
No contraception 
Pregnancies 
Young people 
Family planning 
nurses 
sex 
+ 
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Figure 4.3: Soft Systems Methodology overview 
              Real World Thinking                                                            Systems Thinking about the Real World 
 (1) Problem situation → (2) Problem situation expressed   → (3) Root definitions of relevant systems  
      ↓ 
 (6) Feasible, desirable changes ← (5) Comparison of 2 & 4 ← (4) Purposeful activity modelling  
                        ↓ 
 (7) Action to improve the problem situation 
 
Step 1 involves the analyst immersing themselves in the current situation in order to understand it; 
the methods for doing so are not prescriptive. Step 2 entails representing this understanding within 
a diagram (a ‘rich picture’), which shows boundaries, structure, stakeholders in the system, 
communication flows and barriers in communication, conflicts / harmony, emotions, general 
attitudes and monitoring activities.123  In order to facilitate Steps 1 and 2, Checkland suggests 
considering the roles of the people involved and the culture and politics of the situation. Step 3 
moves to the systems thinking world and comprises the development of a ‘root definition’ (one 
sentence) for each stakeholder within the system using the mnemonic ‘CATWOE’; the Customers 
(people benefiting within the system), the Actors (people performing the tasks in the system), the 
Transformation (the core activity of the system), Weltanschauung (or worldview – the objective of 
the system and its underlying beliefs), the Owner (the person with the power to approve or cancel 
the system) and the Environment (external factors which may impact upon the system eg. legal 
rulings). Step 4 involves developing a Purposeful Activity Model (PAM) for each stakeholder, 
consisting of an ideal view of the activities within the system from their perspective, based upon the 
root definition. Checkland suggests considering the three ‘E’s when developing the PAM; 
effectiveness (is it the right thing to do?), efficacy (does it work?) and efficiency (are the resources 
required available?). The PAM (systems thinking world) is compared with the rich picture (real world 
thinking) to identify any mismatches, termed ‘problems’, within Step 5. Step 6 and 7 entail 
developing solutions for these ‘problems’, which may use quantitative analysis.  
 
Summary of methods proposed within the conceptual modelling frameworks 
Table 4.5 presents an overview of the suggested methods within the included conceptual modelling 
frameworks, divided by stage as discussed within Section 4.3.2.  
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Table 4.5: Overview of methods used within included conceptual modelling frameworks  
Author Understanding the problem and 
setting objectives 
Choose model options, determine model scope & level of detail, identify structural assumptions & model type                                                                                                                     
Choosing potential options Model scoping (including 
what to include & exclude) 
Model level of detail, structural 
assumptions & model type 
Roberts et al.
18 
 
Written statement by understanding 
relevant clinical & policy literature & 
reviewing existing similar models. 
Determine by the decision 
problem. 
Consideration of relevant population, time horizon, outcomes, perspective 
for costs, key uncertainties & policy context. Could use expert consultation, 
influence diagrams (isomorphic to decision trees) and/or concept mapping. 
Kaltenthaler et 
al.
14 
A disease process model and a 
service pathways model, with a list 
of issues to consider. 
According to NICE scope & 
clinical input. 
Design-oriented conceptual model, with a list of issues to consider & list of 
evidence requirements. 
Robinson
8
 Not prescriptive. Suggests formal 
PSMs incl.SSM, cognitive mapping & 
causal loop diagrams.  
Driven by how model objectives 
might be achieved.  
(1) Identify model boundary;  
(2) Identify all components; 
(3) Assess whether to include/ 
exclude. Decisions based on 
validity, credibility, utility & 
feasibility. 
A template for the level of detail is 
provided for each component identified in 
the scoping stage. This is tabulated and is 
specific to DES.  
Howick et al.
127
 Cognitive maps. Not reported. Identify & analyse feedback loops & triggers from cause map. Represented 
within an influence diagram. 
Tako et al.
136
 CATWOE & Root Definitions from 
SSM & Care System Model (map of 
key activities in the system). 
Performance Measurement Model (PMM). Patient flow diagram (equivalent to the 
process flow diagram in DES).  
Rodriguez-Ulloa 
and Paucar-
Caceres
129
 
CATWOE, Root Definitions & Rich 
Pictures from SSM & causal loop 
diagrams. 
Causal diagrams based on root definitions & system dynamics models. 
Fernández and 
Kekäle
125
 
Not reported. Not reported. Delphi & Analytic Hierarchy Process (AHP). 
Vennix
128
 Preliminary causal diagram and flow 
diagram followed by questionnaire, 
workbook & workshop to finalise the 
conceptual model. 
Not reported. Preliminary causal diagram and flow diagram followed by questionnaire, 
workbook & workshop to finalise the conceptual model. 
Note: Green cells are those stages within which stakeholders are reported to be involved. 
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4.3.3.2    Conceptual modelling frameworks with non-prescriptive methods 
Three studies by Roberts et al., Kaltenthaler et al. and Robinson were identified which present 
principles and/or methods associated with the development of a conceptual model, without 
providing prescriptive methods for each stage.8;14;18  The frameworks by Roberts et al. and 
Kaltenthaler et al. both focus upon the conceptual model development of health economic 
models,14;18 and these are the first attempting to do this within health economic modelling. Robinson 
does not present a domain-specific framework, although it is aimed at operations systems (i.e. 
systems of resources providing goods or services). All three articles suggest a detailed process to 
follow for conceptual modelling, with some examples of methods which could be used within the 
process.8;14;18    
 
Overview of framework by Roberts et al.18 
The framework by Roberts et al. (2012) suggests that a clear, written statement of the decision 
problem, modelling objectives and model scope should be developed by consulting a wide range of 
clinical experts, understanding relevant clinical and policy literature and reviewing existing similar 
models.18 It highlights the importance of identifying all relevant options for comparison in order for 
the results to be useful. It suggests that the conceptual model (of the problem) should not be 
determined by the availability of data and that an explicit process should be followed for developing 
the quantitative model from the conceptualisation of the problem such as expert consultations, 
influence diagrams or concept mapping. The authors suggest consideration of a number of issues 
prior to the development of the quantitative model including determining the relevant population, 
time horizon, outcomes, perspective for costs, key uncertainties and the policy context of the 
decision problem. The framework also suggests that it is important to choose the most appropriate 
model type for the decision problem.18  Whilst the framework highlights what should be done during 
conceptual modelling, it does not describe methods for how it might be done. For example, it 
describes the advantages of model simplicity and suggests that the model must be complex enough 
to fully represent differences between the interventions, but it does not suggest methods for making 
these judgements about the level of detail. 
 
Whilst the framework described by Roberts et al. divides the conceptual modelling into 
conceptualising the problem and conceptualising the model, the former appears to contain some of 
the latter. For example, the former section considers the time horizon of the model and data 
selection for the model. The conceptualising the problem stage mainly focuses upon ‘PICO’. This is 
the standard criteria by which the scope of health economic models is defined, and comprises 
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populations, interventions, comparators and outcomes. The conceptualising the model stage mainly 
focuses upon choosing an appropriate model type. 
 
Overview of framework by Kaltenthaler et al.14 
The conceptual modelling framework by Kaltenthaler et al. (2011) was developed building upon the 
model development process and some of the findings described within Chilcott et al.17  The 
framework is divided into problem-oriented conceptual models and design-oriented conceptual 
models.14  The former aims to understand the parts of the real world of interest based upon 
stakeholder expertise, whilst the latter aims to identify potentially feasible and credible model 
development choices including defining the model scope and level of detail according to available 
evidence, time, expertise and money. The problem-oriented conceptual model is divided into two 
parts; a disease process model which aims to capture important events within the disease natural 
history, and a service pathways model which aims to capture all treatment services associated with 
the intervention being assessed. For all conceptual models, the authors suggest a flow diagram 
representation accompanied by a text description and they provide a large number of issues for the 
modeller to think about when developing them. For the disease process model these are issues such 
as ‘Are all relevant competing risks considered?’ and ‘Should the model differentiate between 
different subgroups of patients?’, whilst for the service pathways model these are issues such as ‘Is it 
clear where and how patients enter the service?’ and ‘Does the conceptual service pathways model 
include all relevant resources components?’ For the design-oriented conceptual model, examples of 
possible issues to consider are ‘How should trial evidence be extrapolated over time?’ and ‘Which 
methodological approach is likely to be most appropriate?’ The framework suggests that where the 
design-oriented conceptual model differs from the problem-oriented conceptual models this should 
be clearly documented and explained. The paper recommends input from health professionals 
throughout the model development process.14 
 
Overview of framework by Robinson8 
Robinson divides the understanding of the problem by stakeholders into three levels; (1) Clearly 
understood and expressed, which can be handled via discussion and careful note-taking; (2) 
Apparently well understood and expressed, although it is not, which involves speaking with the right 
people, asking searching questions and suggesting alternative interpretations; and (3) Neither well 
understood nor expressed, which may require the use of formal PSMs (eg. SSM, cognitive mapping) 
or a basic simulation model for encouraging debate.8  The author does not outline methods for 
deciding which of the outlined three problem situations the modeller is dealing with.8  Robinson 
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suggests identifying the overall organisation aims and then the model objectives in terms of what 
the client hopes to achieve, performance measures and working constraints. He suggests that the 
modeller should be aware of broader considerations such as timescales and project resources, 
model flexibility needs and who the model users will be. Within the framework, model outputs and 
decision variables (different options) are determined based upon the model objectives and 
discussion with the client; and the model boundary is defined based upon these. All components in 
the real system within the boundary are identified and tabled, particularly those which connect the 
decision variables to the outputs.8  
 
The conceptual model can be assessed in terms of validity, credibility, utility and feasibility. 
Conceptual model validity (credibility) is defined by Robinson as ‘a perception, on behalf of the 
modeller (client), that the conceptual model can be developed into a computer model that is 
sufficiently accurate for the purpose at hand’. Utility is defined as ‘a perception on behalf of the 
modeller and the clients, that the conceptual model can be developed into a computer model that is 
useful as an aid to decision-making within the specified context’, whilst feasibility is defined as ‘a 
perception on behalf of the modeller and the clients, that the conceptual model can be developed 
into a computer model with the time, resource and data available’.8  Following this, a list of details 
for each component within the model boundary is tabled, along with a decision about whether to 
include (and how) or exclude (and why) the detail. Data requirements are listed based upon the level 
of detail table and any assumptions about the data are documented. Robinson suggests that 
diagrams, such as process flow diagrams or activity cycle diagrams, may be useful for 
communication of the conceptual model.8 
 
Making modelling judgements within these frameworks  
All three frameworks consider, to some extent, how to make judgements about what to include and 
exclude within the quantitative model.8;14;18  Roberts et al. provide a number of recommendations 
about what should be considered for inclusion and why, such as which types of costs and outcomes 
to include.18 However, this framework does not provide methods for choosing specific variables. 
Kaltenthaler et al. suggest that making judgements about inclusion and exclusion should be jointly 
decided with modellers, decision-makers, health professionals and other stakeholders who impact 
upon or are impacted upon by the decision problem, and this is informed by a list of questions 
relevant to modelling clinical interventions.14 The authors state that ignoring conflicting views 
between stakeholders could result in developing models which are ‘contextually naïve and 
uninformed’.14  Robinson suggests developing a table describing what should be included and 
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excluded from the model, which could be informed by the judgement of the modeller, clients and 
domain experts, past experience, analysis of preliminary data about the system or testing the effect 
of including or excluding details in part of the model.8 He suggests a method for doing this by 
considering whether each detail adds to the validity, credibility, utility and feasibility (as described 
above).  
 
Roberts et al. describe methods for choosing the model type depending upon the characteristics of 
the problem.18 Similarly, Kaltenthaler et al. suggest that the modelling approach should be 
determined during the development of the design-oriented conceptual model, although no methods 
for doing this are outlined.14  Within the framework by Robinson, it is assumed that a DES will be the 
most appropriate modelling tool from the outset.8  As such, there are no methods for choosing the 
appropriate model type. This also means that components of some of the stages relate specifically to 
DES such as the suggested ‘level of detail’ table.  
 
Stakeholder involvement within these frameworks 
These frameworks suggest that stakeholders should be involved throughout model development; 
however they do not specifically describe methods for involving stakeholders. Roberts et al. suggest 
that stakeholder involvement can facilitate the development of appropriate modelling objectives 
and may provide a deeper understanding of the values and preferences associated with the 
problem.18  Kaltenthaler et al. suggest that the problem-oriented conceptual model is highly 
dependent upon stakeholder involvement and that stakeholders can provide advice around 
geographical variation of healthcare provision.14  Robinson argues that a well-documented 
conceptual model provides a method for all stakeholders to communicate.8  
 
Potential application to Public Health economic evaluation 
There are several differences between the intended application for the conceptual modelling 
framework by Robinson8 and the requirements of a conceptual modelling framework for Public 
Health economic modelling. These include: (1) within Public Health economic modelling substantial 
extrapolation of data is usually required, whilst within operations systems data tends to be available 
for entities from model entry to model exit; (2) within Public Health economic modelling the system 
is a national average where data is inferred from observations from one or a number of examples of 
the system, rather than data being based upon observations of a specific system; and (3) capacity 
constraints are not a focus within Public Health economic modelling because traditional cost-
effectiveness analysis assumes that the system is able to cope with any resource changes, whereas 
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they are of key interest within operations systems. In addition, within Public Health economic 
modelling, the system is generally bigger with a greater number of other systems being integrated 
within the system of interest than within these applications. Compared with the framework by 
Robinson,8 the model type required is not known from the start of the project within Public Health 
economic modelling whilst it is assumed to be a DES for this framework.  In addition, the framework 
does not explicitly consider how to determine the relationships between model variables, whilst it 
would be essential to specify relationships between variables within Public Health economic 
modelling. Finally, Robinson’s ‘level of detail’ table would need to be modified in order to be usable 
within Public Health economic modelling.8  
 
The conceptual modelling frameworks described by Kaltenthaler et al. and Roberts et al. provide a 
basis for some of the considerations required within a Public Health economic conceptual modelling 
framework.14;18  However, they do not cover issues which are specific to or accentuated within Public 
Health. As described within Chapters 2 and 3, economic evaluations within Public Health are 
generally different to economic evaluations of clinical interventions because they usually require the 
development of models of multi-component interventions with complex causal chains operating 
within dynamically complex systems, dependent upon the determinants of health, as against models 
of simple interventions which generally do not depend upon human behaviour operating within 
relatively clear system boundaries. A key objective of Public Health is often to reduce health 
inequities rather than to maximise health. The frameworks do not consider these issues and in some 
cases are explicitly incompatible with them. For example, Roberts et al. suggest for the choice of 
comparators that ‘all feasible and practical strategies should be considered’,18  without highlighting 
the large number of permutations often associated with Public Health interventions. As such a 
conceptual modelling framework would need to provide methods for dealing with these additional 
issues associated specifically with Public Health economic modelling. 
 
4.3.3.3    Conceptual modelling frameworks employing diagrams denoting causal relationships 
Three key studies were identified which presented conceptual modelling frameworks employing 
diagrams denoting causality.127-129  
 
Overview of framework by Howick et al.127 
Howick et al. (2008) describe a model building process (a ‘cascade’) with the same information being 
depicted within different diagrams to enable multiple audiences to appreciate the validity of the 
models being built and their outcomes.127  Specifically, the authors suggest developing a cognitive 
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map and transforming this into a cause map, followed by an influence diagram and then a system 
dynamics formal influence diagram (a qualitative version of the system dynamics model), before 
developing a quantitative system dynamics model. The authors suggest moving back down the 
‘cascade’ to check for inconsistencies and to improve model validity.           
 
Overview of framework by Vennix and Gubbels128 
Vennix and Gubbels (1992) describe the design and implementation of an iterative group model 
building approach.128  This involves the development of a questionnaire containing a preliminary 
conceptual model (a causal diagram depicting the relationships between factors which affect the 
decisions of the stakeholders combined with a flow diagram of the physical system) upon which 
experts can feed back remotely to the analysts. This is followed by the development of a workbook 
by the analysts which reports the results of the questionnaires and asks for feedback from the 
experts on submodels of the modified conceptual model. Within the workbooks text statements 
about the causal relationships are provided followed by the same information within a diagram. 
Finally, a structured workshop is held to discuss any areas of disagreement within the model in order 
to agree a finalised conceptual model.  
 
Overview of framework by Rodriguez-Ulloa and Paucer-Caceres129 
Rodriguez-Ulloa and Paucer-Caceres (2005)129 describe and illustrate a framework for combining 
SSM and System Dynamics (SD) (see Section 4.3.3.1 for description of SSM). The framework is 
divided into three worlds; the Real World, the Problem-Situation-Oriented System Thinking World 
(i.e. using Systems Thinking to define what will be included in the model) and the Solving-Situation 
Oriented System Thinking World (i.e. using Systems Thinking to find a solution). Stakeholders 
develop a Rich Picture of the problem situation to describe the real world as in SSM. Following this, 
the Problem-Situation-Oriented System Thinking World involves developing a one sentence 
definition, using the mnemonic ‘CATWOE’ (Customers, Actors, Transformation, Worldview, Owner, 
Environment), from each stakeholder’s perspective describing the problematic transformations 
occurring, as depicted within the Rich Picture. This is different to SSM which develops solution-based 
transformations at this stage in order to try to improve the system. A diagram showing the boundary 
around the system and the flows between the external inputs and the key internal aspects of the 
system, defined as a context diagram, is developed for each of these root definitions with different 
stakeholder worldviews. The analyst then aims to describe the problematic behaviour in a causal 
diagram for each worldview developed within computer software which allows a range of different 
relationships between variables to be tested in order to understand the problematic behaviour 
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according to different worldviews. This is compared with the Rich Picture to assess whether the 
diagram adequately describes what is happening in the real world.  
 
The Solving-Situation-Oriented System Thinking World involves developing a quantitative system 
dynamics model, the outputs of which can be compared with the Rich Pictures developed initially. 
Within the system dynamics model, culturally feasible and systemically desirable changes can be 
identified by expressing them within root definitions using CATWOE and comparing them with the 
initial root definitions. These changes can then be implemented and learning points noted. An earlier 
attempt at combining these two systems approaches was described by Lane which provided a similar 
theoretical argument;144 however the approach for combining the two methods was largely 
underdeveloped compared with the framework by Rodriguez-Ulloa and Paucer-Caceres.129  
 
Making modelling judgements within these frameworks  
All of these frameworks provide methods for understanding the problem and for moving from this 
initial understanding to the development of a conceptual model describing the variables to be 
included within a quantitative model and the relationships between them. Howick et al. suggest 
using the initial cause maps developed by stakeholders, and analysing the feedback loops and 
triggers in order to help to define relevant variables for the subsequent model.127  Similarly, Vennix 
and Gubbels suggest relevance of variables should be defined through an iterative process with 
stakeholders, although they do not suggest any formal analysis to facilitate this.128  Rodriguez-Ulloa 
and Paucer-Caceres suggest using the analyst’s interpretation of each stakeholder’s context diagram 
to choose relevant variables by developing a model which is sufficient to replicate the problematic 
behaviour seen in the real world.129  However, no methods are provided for doing this and it is 
unclear to what extent the model should ‘replicate’ reality. 
 
In a similar way to the conceptual modelling framework by Robinson,8 within all of these frameworks 
no methods are provided for choosing the most appropriate model type after understanding the 
problem. Instead, it is assumed that a system dynamics model will be developed. This application of 
causal diagrams seems intuitive; however it should not constrain the application of these methods. It 
seems possible to develop other model types from causal diagrams, such as agent-based models, 
providing that the key causal relationships described by the conceptual models are included within 
the quantitative model. However, the development of alternative model types may require a 
different focus on causality, such as a focus upon the ‘rules’ for agent behaviour within an agent-
based simulation. A limitation of the system dynamics modelling approach is that it is a cohort 
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approach which does not allow for patient-level variability or a comprehensive analysis of 
uncertainty such as probabilistic sensitivity analysis (as would a DES or an agent-based simulation).  
 
Stakeholder involvement within these frameworks 
All of these frameworks aim to promote stakeholder ownership of the models by the involvement of 
stakeholders throughout the model building process and the iterative nature of the processes. 
Rodriguez-Ulloa and Paucar-Caceres use SSM to understand the problem situation from each 
stakeholder’s perspective,129 whilst Howick et al. uses cognitive and cause maps127 and Vennix and 
Gubbels uses questionnaires and workbooks to collect information about each stakeholders 
understanding of the problem.128  A potential disadvantage of the method employed by Vennix and 
Gubbels for gaining the stakeholders’ understanding of the problem is that they are presented with 
a preliminary conceptual model developed by the analysts which may influence the information 
provided by the stakeholders compared with if they presented their ideas de novo.128  The 
involvement of stakeholders within the model building process also means that all three frameworks 
developing a diagram denoting causality carry substantial time requirements for both the modeller 
and the stakeholders. Vennix and Gubbels attempt to minimise the face to face time requirements 
for the stakeholders by circulating questionnaires and workbooks prior to the workshop.128  The 
amount of stakeholder involvement in the framework by Rodriguez-Ulloa and Paucar-Caceres is 
unclear.129  Clearly, there is a balance to be struck between time requirements of the stakeholders 
and the analyst and the benefits of stakeholder involvement in the model building process. 
 
Howick et al. argue that stakeholders need to have confidence in the model outputs by 
understanding the model structure, in terms that they would use to describe the situation.127  The 
authors relate this to validity and state that models have to be both qualitatively and quantitatively 
valid. The framework which the authors present aims to convert natural language into numerical 
simulation and then back to natural language in order to increase stakeholder trust of the models. 
 
Potential application to Public Health economic evaluation 
Whilst none of these frameworks explicitly consider domain-specific factors such as the social 
determinants of health, all of them encourage the complexity of the system to be captured through 
the use of methods which describe non-linearity and feedback loops (see Chapter 3). 
 
Cognitive mapping used within the framework by Howick et al. aims to help stakeholders 
understand the entire breadth of the problem and to uncover and share the sense making systems 
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of the stakeholders rather than adopting the single worldview of the analyst. Cognitive mapping can 
be used to establish whether there are any positive or negative feedback loops within the system, 
and whether there are any clusters of factors which have greater impact upon the goals than single 
factors.139  The theory behind cognitive mapping, based upon Kelly, is that every person uses a 
system of bipolar constructs (eg. happy / sad) to categorise people and situations and that this 
construct system represents reality as the person understands it.145  Each stakeholder within a 
project will have their own personal constructs about the problem based upon their background 
knowledge and experiences. By making these constructs explicit and sharing each stakeholder’s 
background knowledge and experience, it is possible to question these constructs and discuss 
disagreements around the causal relationships. For each construct, the analyst can ask ‘why?’ to 
establish the consequences of the construct and ‘how?’ to express potential options for change, 
leading to a hierarchy of goals at the top of the map, then intermediate goals or actions, with 
options at the bottom of the map.139  This is useful as it provides an intuitive method for developing 
and interpreting the map. However, because cognitive mapping was designed to be used within 
organisations, there is a focus upon how things are managed rather than on prediction. Rather than 
providing answers to a single problem at one point in time, it aims to provide an approach that 
people within an organisation can continue to use for making decisions. In contrast, within Public 
Health economic modelling the aim is not necessarily to impart how to make better decisions, but to 
develop a useful quantitative model. In addition, each concept within the cognitive map should 
begin with a verb, for example, employ more staff, which generally cannot be translated easily into a 
quantitative model. These are normative perceptions of the stakeholders; however, for modelling 
within Public Health generally positivist factors are of interest such as the number of cardiovascular 
events which is causally related to the number of deaths.   
 
Causal diagrams, used within the frameworks by Vennix and Gubbels and Rodriguez-Ulloa and 
Paucar-Caceres, can also be used to establish whether there are any positive or negative feedback 
loops within the system and whether there are any clusters of factors which have greater impact 
upon the goals than single factors. In contrast to cognitive maps, each of the concepts within the 
diagrams are variables which could be used within a quantitative model as required within Public 
Health economic modelling. However, there are no specific methods for developing causal diagrams 
or for involving stakeholders within that development. Whilst a causal diagram can provide an 
explicit description of our hypotheses about causal relationships, the challenge within Public Health 
economic modelling is to be able to justify the causal assumptions made. 
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Missing information within these frameworks 
There are details missing from all three of the studies in order to understand each framework fully. 
For example, within the study by Howick et al. it is unclear how the endogenous variables which are 
identified from the cause map are dealt with for inclusion within the influence diagram.127  It is also 
unclear how changes made to the structural assumptions within the model when moving up the 
cascade should be documented. It seems that each map should be modified in turn; however this 
seems to contradict what is said within the discussion of the article about having a transparent audit 
trail, unless these changes are documented during each iteration of model development. In addition, 
Howick et al. suggest that the methodology is not entirely simple to use, and in particular point to 
challenges in moving from the influence diagram to the system dynamics formal influence 
diagram.127  However, they do not elaborate on this further so it is unclear what the challenges with 
using the methodology are, or how they might be overcome. Within the study by Rodriguez-Ulloa 
and Paucer-Caceres, it is unclear how the culturally feasible and systemically desirable options are 
identified.129  Finally, within the frameworks by Howick et al. and Vennix and Gubbels there is no 
consideration of how to choose options to test within the model.127;128 
 
4.3.3.4    Conceptual modelling frameworks based on Soft Systems Methodology 
Two studies were identified which presented conceptual modelling frameworks based on Soft 
Systems Methodology (SSM).129;136  
 
Overview of framework by Rodriguez-Ulloa and Paucer-Caceres129 
The study by Rodriguez-Ulloa and Paucer-Caceres (2005) is described above.129  The authors suggest 
that a weakness of SSM is that it is not a ‘problem solving methodology’,129 as also discussed by 
Flood and Jackson92 and Mingers,146 and it does not offer a technological tool to assess the impact of 
culturally feasible and systemically desirable options. Therefore, the authors argue that combining 
SSM with another systems approach would help to address this weakness. The study specifically 
focuses upon combining SSM with system dynamics. System dynamics employed independently has 
the weaknesses that it does not consider the different worldviews of the stakeholders and the 
implications of this, or whether the solutions provided by the analysis are culturally feasible and 
systemically desirable. The authors argue that combining the two approaches will make use of the 
strengths of both systems approaches whilst overcoming these weaknesses.129 
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Overview of framework by Tako et al.136   
Tako et al. (2010) describe a participative conceptual modelling framework for healthcare 
applications which involves developing root definitions using the mnemonic CATWOE and a map of 
key activities in the healthcare system.136  This map is defined as a Care System Model, adapted from 
the Purposeful Activity Model within SSM, and includes long- and short-term clinical activities, 
managerial activities and research activities, using verbs to describe the activities. These are agreed 
within an initial workshop. Within a second workshop, the three performance criterion from SSM are 
employed (efficacy, efficiency and effectiveness) to establish performance measures, which 
facilitates the development of objectives, and in turn the model inputs and outputs. During this 
second workshop a flow diagram described by the authors as a Performance Measurement Model 
(PMM) is developed, with the headings ‘monitoring activities’, ‘determine if activities’ and ‘changes’.  
A patient flow diagram (PFD), equivalent to the process flow diagram in DES, is employed to choose 
the model content & level of detail alongside stakeholders. 
 
Making modelling judgements within these frameworks 
As described above, Rodriguez-Ulloa and Paucer-Caceres suggest using the analyst’s interpretation 
of each stakeholder’s context diagram to choose relevant variables by developing a model which is 
sufficient to replicate the problematic behaviour seen in the real world.129  Similarly, Tako et al. 
employ stakeholder involvement to choose relevant model variables by developing the conceptual 
model with them, although no formal methods are described for justifying the variables chosen. 136  
 
Stakeholder involvement within these frameworks 
An advantage of using SSM is that it introduces the stakeholder’s worldviews explicitly which could 
help the modeller to understand disagreements between stakeholders. However, within both of 
these studies it is unclear how consensus between stakeholders is reached where disagreements 
occur. The fact that there are no methods within SSM for resolving conflicts between stakeholders 
has been a point of criticism of SSM.92 For a specific stage of the framework (developing the 
performance measurement model) described by Tako et al. there is an exception to this, where the 
authors suggest that voting between stakeholders may be used if disagreements occur around 
determining the changes to the system to achieve the performance measures.136  It is not reported 
how this affects implementation of the options. 
 
Tako et al. do not employ Rich Pictures,136 unlike the study by Rodriguez-Ulloa and Paucer-
Caceres.129  This may be due to the negative experience of one of the authors in using Rich 
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Pictures,147 who suggests that the non-scientific appearance of Rich Pictures may lead to practical 
problems with their use. As for Vennix and Gubbels,128 Tako et al. provide the stakeholders with 
preliminary analyses and ask for feedback in order to revise these analyses.136  An advantage of this 
approach is that it minimises the time requirements of the stakeholders, although arguably increases 
the time requirements of the modeller(s). However, the major disadvantage of this approach is that 
the starting point for the stakeholders may influence the input and limit the thinking of the 
stakeholders.128  Moreover, providing root definitions to stakeholders may cause irritation if they do 
not agree. Since this is likely to be their first point of contact with the modeller, this could lead to 
difficulties in cooperation during the remainder of the project.  
 
Potential application to Public Health economic evaluation 
SSM allows the analyst to understand a problem associated with human activity using systems 
thinking, considering the different worldviews associated with the problem rather than adopting the 
single worldview of the analyst. Within SSM, stating the worldview of each stakeholder encourages 
the paradigms to become apparent (see Chapter 1) and the assumptions questioned. This allows the 
subjective judgements of the stakeholders, such as which Public Health interventions might be 
assessed and what might happen in the future, to be discussed. SSM also considers the different 
types of stakeholders who may be involved. In addition, within a large system where the expertise of 
stakeholders is unlikely to extend across all relevant issues, as for many Public Health topics, SSM 
allows the entire breadth of the problem to be understood.  
 
However, the main issue with using SSM for Public Health modelling is that it is an extensive process 
with lots of different steps to follow. Given the findings of the qualitative research that the 
conceptual modelling framework should not constrain the process, many analysts would not be 
happy using SSM for understanding the problem. Although Checkland suggests that not all of the 
seven steps associated with SSM need to be followed in order for the analyst to be doing SSM once 
they understand the general way of thinking,123 these steps would need to be undertaken initially in 
order to be able to develop this way of thinking. In addition, SSM aims to help people within an 
organisation continually make better decisions where objectives are unclear due to multiple, 
possibly conflicting worldviews, whilst within Public Health economic modelling the aim is not to 
impart how to make better decisions, but to develop a useful quantitative model. SSM is particularly 
focused within organisations, which means that many stages would need additional consideration in 
order to be applicable to Public Health economic modelling. For example, case studies of SSM tend 
to make use of observable data rather than requiring predictions a long way into the future to be 
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made. Finally, there is the concern of Tako et al. that drawing rich pictures would not appear 
‘scientific’ to the stakeholders.136 
 
4.3.3.5    Conceptual modelling frameworks using Delphi approaches 
Two studies were identified which presented conceptual modelling frameworks using Delphi 
approaches.125;128  The study by Vennix and Gubbels has been described above.128  
 
Overview of study by Fernández and Kekäle125 
Fernández and Kekäle (2008) use the Delphi method to identify factors which may affect the goal of 
the system followed by the Analytic Hierarchy Process (AHP) method to determine the most 
important factors.125  The Delphi method is an iterative process involving a group of experts who are 
asked to respond to questionnaires, and then revise their future responses according to the 
collective results of the questionnaires, with the eventual aim being convergence between the 
experts. The AHP method is a way of evaluating alternative options by defining criteria by which they 
can be judged and placing quantitative weights associated with those criteria. The authors suggest 
that the framework is most useful for problems where there is a mixture of scientific evidence and 
social values.  
 
Making modelling judgements and stakeholder involvement 
The Delphi method is employed as an iterative process whereby stakeholders critique their 
subjective opinions about important variables and possible causalities in order to reach a consensus. 
Once all possible relevant factors have been identified by the Delphi method, a questionnaire is 
developed to ask stakeholders to prioritise the factors within four separate blocks, although it is 
unclear what all four of these blocks are or how they were chosen. A method defined as 
‘aggregation of individual priorities’ is employed to develop collective priority values of all 
stakeholders, using the weighted geometric mean. The authors propose a sensitivity analysis 
whereby adjacent variables change position in the rankings based upon the measure of variation in 
weightings between stakeholders. These variables can then be used within the quantitative model.  
 
Limitations of study by Fernández and Kekäle125 
Whilst this study provides a systematic and transparent method for choosing relevant model 
variables, it has numerous flaws as a conceptual modelling framework. Firstly, it does not consider 
methods for understanding the problem situation, defining objectives or describing relationships 
between variables. Secondly, in asking stakeholders to weight the importance of variables within the 
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system, it assumes that stakeholders have a clear understanding of the causalities within the system. 
This is unlikely to be the case if the stakeholders deal only with a small part of the system or if the 
system is dynamically complex and hence feedback loops are important as is the case in Public 
Health systems. Other forms of evidence are not considered within this approach and these might 
be inconsistent with the stakeholder expertise provided. Finally, very little method detail is provided 
within the article. For example, it is unclear how factors are identified and consensus is reached 
using the Delphi method. It is also unclear exactly how the AHP is employed. 
 
Potential application to Public Health economic evaluation 
The authors state that the explanatory power of the model is dependent upon the stakeholders’ 
understanding of the system and breadth of knowledge. Stakeholders within Public Health economic 
evaluation tend to have specialist areas so that they may have an in-depth knowledge about one 
part of the system, but a poorer understanding of the system as a whole due to its size and 
complexity. For example, when assessing interventions to encourage young people to use 
contraceptives and contraceptive services, the family planning nurse had in-depth knowledge about 
contraceptives and sexually transmitted infections, whilst midwives had in-depth knowledge about 
pregnancy. This means it would be very difficult for stakeholders to prioritise variables in terms of 
their impact upon the relevant outcomes in this context. Within Public Health economic modelling, 
one of the major advantages of modelling is in understanding the system as a whole, and hence it 
would not be beneficial to employ this method within Public Health economic modelling.  
 
4.3.4 Benefits of a conceptual modelling framework 
A wide range of benefits of the use of a conceptual modelling framework are described within the 
studies, set out within Table 4.6 below. These benefits of a conceptual modelling framework have 
been used to refine my research question in order to be more specific about what ‘quality’ is within 
a conceptual modelling framework. Thus my revised research question is: ‘What might a conceptual 
modelling framework for Public Health economic evaluation comprise and what could its potential be 
to improve model quality?’, where quality is defined as providing a tool for communication with 
stakeholders, aiding the development of modelling objectives, guiding model development, 
experimentation and reuse, and improving model credibility, verification and validation.’ 
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Table 4.6: The benefits of a conceptual modelling framework described within the studies 
Benefits Roberts 
et al.20 
Kalten-
thaler  
et al.14 
Robinson
120 
Tako et 
al.129 
Howick 
et al.121 
Fernan-
dez & 
Kekäle119 
Rodriguez
-Ulloa & 
Paucar-
Caceres123 
Vennix & 
Gubbels 
122 
1.Modellers need some means to determine what to model. 
The design of the model impacts all other aspects of the study 
  √ √     
2.A tool for communication between stakeholders including 
the project team, clients, decision makers & domain experts 
√ √ √ √ √ √ √ √ 
-May uncover variations in stakeholders’ conceptualisation √ √ √ √ √ √ √ √ 
-May uncover geographical variation  √       
-Sharing assumptions highlights invalid judgements  √      √ 
-Provides the basis of the model documentation   √ √    √ 
-Encourages creativity in finding a solution   √ √  √   
-Encourages learning about the problem during model 
development 
√  √     √ 
-Encourages mutual trust between stakeholders &modellers     √ √   
3.Aids the development of clear, shared, modelling objectives. 
Minimises the likelihood of incomplete, unclear, inconsistent & 
wrong requirements 
√  √ √   √  
4.Guides model development & experimentation √ √ √ √ √ √ √ √ 
-Improves model-building efficiency √     √   
5.Adds systematicity & transparency, allowing judgements 
concerning the credibility of the model to be made which 
increases confidence in model outputs 
√ √ √ √ √ √ √  
-Avoids representing a contextually naïve & uninformed basis 
for decision-making 
 √     √  
6.Forms the basis for model verification & guides model 
validation 
 √ √ √ √ √   
7. Helps determine the appropriateness of the model or its 
parts for model reuse 
  √ √     
Dark green shading: Key benefits; Light green shading: Subsets of key benefits
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4.3.5 Methods of evaluation of the frameworks and their theoretical underpinnings 
Theory-based formative evaluation of the frameworks is undertaken within many of the articles and 
key elements of this are described throughout Section 4.3.3 above which outlines the frameworks.        
All of the identified conceptual modelling frameworks are illustrated through their application within 
a case study and any difficulties during the application have been stated. The frameworks have been 
developed during the undertaking of numerous projects by the authors, and hence in a sense they 
have been tested, improved and informally evaluated through a series of trial and error. 
 
Testing the frameworks independently of development 
Based upon a citation search of the included conceptual modelling frameworks, only two published 
case studies were identified which tested the frameworks independently of the original 
development.148;149  Both of these case studies were of the Soft Systems Dynamics Methodology by 
Rodriguez-Ulloa & Paucar-Caceres129 and were applied by the developers of the original framework. 
These showed that this conceptual modelling framework could be employed for different 
applications. The lack of use of these conceptual modelling frameworks by modellers other than the 
original authors indicates the state of development and highlights difficulties of dissemination and 
implementation. This issue is raised within the qualitative research within Chapter 5 where some of 
the modellers suggest that they would not want to follow another modeller’s approach to structural 
development. This suggests that the approach should not constrain the decision making process and 
should be simple to follow. This is assessed during the evaluation of the conceptual modelling 
framework developed.  
 
Potential methods of evaluation of the conceptual modelling frameworks 
Although no formal evaluation is undertaken, Vennix and Gubbels suggest that participant time 
requirements are likely to be reduced using the framework and that they thought that the quality of 
the conceptual model increased compared with the preliminary conceptual model.128  Vennix and 
Gubbels also state criteria for evaluating conceptual modelling frameworks including assessing the 
quality of the final conceptual model, participant time requirements and satisfaction, acceptance of 
the model by stakeholders and the insight and solutions provided by the model.128 
 
The evaluation of conceptual modelling frameworks within a completely controlled experiment is 
both theoretically and practically infeasible. When comparing the outcomes of one model developed 
using a conceptual modelling framework and another without a framework, they must either be 
developed by the same person who has a different level of knowledge at the outset of each or by 
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different people and hence variability will be introduced. Moreover, given the importance of the 
decision makers and the decision making process within the model development, it is practically 
difficult to undertake any such analysis since it is not possible to reproduce the same decision 
making arena.  
 
Evaluation of PSMs 
Although there is limited literature on the evaluation of conceptual modelling frameworks, in the 
context of PSMs the issue of evaluation has been substantially debated. There generally exist two 
different paradigms within the literature; the positivist view that PSMs should be evaluated within 
an experiment and is mainly concerned with external validity, and the interpretivist view that every 
situation is different and methods should be evaluated theoretically, focusing upon internal 
validity.150  Mingers and Rosenhead suggest that for PSMs it is generally accepted that a purely 
positivist approach would be inappropriate,151 however, there is no agreed method of evaluation.  
Pawson and Tilley argue that within evaluation it is important to understand what works for whom 
and in what contexts,152 whilst Eden and Ackermann highlight that evaluation criteria may differ for 
people with different roles.153  The most common methods of evaluation of PSMs are theoretical 
evaluation, case studies, interviews and observation.150   However, White argues that these are 
insufficient alone, and that a pragmatic approach to evaluation which combines methods depending 
upon the context should be undertaken, involving a theory-based evaluation about how an 
intervention is supposed to work.150  Applying these arguments to conceptual modelling frameworks 
suggest that the most appropriate approach may be theory-based evaluation, alongside other forms 
of evaluation such as a case study and/or feedback from modellers or stakeholders.  
 
Theoretical underpinnings of the methods employed within the frameworks 
It is useful to understand the theoretical underpinnings of the methods employed within the 
conceptual modelling frameworks to facilitate future evaluation. Cognitive mapping derives from 
Personal Construct Theory within Psychology.145  The central idea of this theory is that human beings 
try to understand their world and predict what will happen in the future based upon a set of 
constructs, or hypotheses, formed by their past experiences. These constructs are constantly 
modified as events prove them wrong in order to help manage and control future events. Thus, each 
person will have different constructs depending upon their past experiences, although some 
constructs may be shared within social groups. People may not be aware of the constructs that they 
have developed or of the constructs of others. Cognitive mapping provides an approach for sharing 
and challenging these personal constructs. Cognitive mapping and SODA are thus underpinned by 
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subjectivism in that they build upon people’s interpretation of the world. Sharing and comparing 
these worlds can be informative in terms of understanding a problem situation and deriving 
potential options for changes to the situation.  
 
SSM is grounded within systems thinking (described within Chapter 3). The methodology was 
developed via action research methods in response to the difficulty in using quantitative systems 
thinking approaches to answer questions about what action should be taken within business 
organisations. Checkland suggests that in such situations involving humans with different 
worldviews, there will never be a single testable description of the system and as such the problem 
to be answered is not always clear.123 SSM is grounded in an interpretivist, epistemological 
approach; it analyses the meanings people place on their own and others’ actions. The methodology 
provides a learning system rather than a means to an end, and as such it is important to understand 
the organisational and cultural constraints present. A fundamental idea of SSM is that the thinking 
should be divided into two ‘worlds’; one requiring logic-based enquiry (systems thinking world) and 
the other requiring cultural enquiry (the ‘real world’). These two ‘worlds’ should both be considered; 
iteratively, but distinctly.  
 
Causal loop diagrams were developed alongside system dynamics models. These are also grounded 
in systems theory, and the central idea is that the dynamic behaviour of a system can be understood 
by describing the structure of the system in terms of causal relationships.89  In contrast to SSM, these 
methods are based in quantitative systems thinking and hence these diagrams do not typically 
consider different worldviews, and as such they assume that the relationships included are factually 
correct (i.e. they assume that there is one reality, thus taking a realist ontological stance). In this way 
they do not explicitly consider social judgements.   
 
The conceptual modelling frameworks by Roberts et al.18 and Kaltenthaler et al.14 are developed 
alongside welfare economic theory, as discussed within Chapter 1. As such, standard guidance has 
been developed which aims to facilitate this, such as that all relevant comparators should be 
included within the analysis and that a sufficient time horizon to capture all relevant differences in 
costs and outcomes between interventions should be incorporated. Whilst these standard guidelines 
are outlined within both of these frameworks, numerous methods guides and publications have 
documented these ideas of what should be done previously.2-4  However, these conceptual 
modelling frameworks go some way beyond this and attempt to consider how these should be 
achieved and why. The framework by Kaltenthaler et al.14 builds upon qualitative research reported 
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within Chilcott et al. and pilot use of PSMs within a HTA study.17;132  Within the framework by 
Roberts et al. the choice of model types is based upon the theoretical underpinnings associated with 
each of the economic modelling methods. However, other aspects of the framework describing the 
process of model development are based upon experience of the authors rather than any specific 
theories. This is also the case for the framework by Robinson.  
 
Theory around combining qualitative and quantitative approaches 
Four studies within the review suggest combining PSMs with quantitative analysis.8;127;129;136 Within 
published case studies where PSMs such as SSM and SODA (including cognitive mapping) have been 
employed previously, they have more often than not been used as the sole analysis for complex 
problems, rather than for the basis of the development of a quantitative model.44  Some experts 
argue that PSMs cannot be combined with quantitative methods because of their different 
theoretical underpinnings;154 however many experts oppose this view44;155 and increasing numbers 
of successful examples of mixed methodology studies support the idea that it is possible to combine 
PSMs and quantitative methods successfully.133 According to Kotiadis and Mingers, it is practical 
rather than theoretical constraints which might prevent the combination of these methods.154  They 
suggest that in order to combine PSMs with quantitative methods the modeller needs to believe 
that it is a worthwhile thing to do, to have the type of personality which is able to switch between 
analysis of quantitative data and facilitating qualitative analysis, and to have understood and 
practiced the relevant PSM(s).154 
 
4.3.6 Areas identified by the authors for further research 
The review suggests that conceptual modelling is generally an underdeveloped area of research. This 
is evidenced by the lack of agreement of the definition of a conceptual model and of what is 
involved in the conceptual modelling process, the fact that the majority of the included articles were 
published within the last ten years and the limited learning between pockets of researchers in this 
area. There appears to be a small discrete event simulation community aiming to advance 
conceptual modelling frameworks specifically for discrete event simulation projects,8;136 and several 
system dynamics researchers progressing ‘group model building’.127-129 There are also several 
researchers within health economic modelling who have recently recognised the need for 
documenting the conceptual modelling process and using it to help to make model development 
decisions.14;18  Therefore, there is a wealth of further research required in this area, as outlined by 
the authors.  
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Robinson8 suggests that one of the purposes of his framework is to provide researchers with a basis 
upon which to undertake further research. The further research identified by Robinson is not specific 
to his framework, but is part of the conclusions within the final chapter of his book.1  The author 
provides a table reporting research themes which would benefit from further research. These 
include the use of soft Operational Research, how best to work with and use the information 
provided by subject matter experts and other sources of information, developing and evaluating 
conceptual models, how Software Engineering techniques might be used, methods for appropriate 
representation and model simplification, exploring the creative aspects of modelling, understanding 
the organisational acceptance of models, understanding the impact of other modelling stages upon 
the conceptual model, and developing university and industry courses on conceptual modelling.1 In 
his book, Robinson also suggests that domain-specific conceptual modelling frameworks would be 
useful, and in particular suggests that frameworks are required for healthcare modelling since none 
currently exist.1 Since this book was published, two conceptual modelling frameworks for health 
economic modelling which are included within this review have been developed;14;18  however both 
of these are specific to modelling clinical interventions rather than Public Health economic models. 
Tako et al. have also developed a conceptual modelling framework for healthcare process 
modelling.136 
 
Tako et al. suggest testing the proposed framework within other systems,136 whilst Vennix and 
Gubbels suggest that future research could be to assess the acceptance of the model by 
stakeholders given that they were presented with a preliminary model.128  Rodriguez-Ulloa and 
Paucer-Caceres state that the methodology is not a finished work; however no further research is 
suggested, and no later studies extending the methodology have been identified.129  Following 
Robinson’s recommendations, this research aims to develop and evaluate a domain-specific 
conceptual modelling framework and to consider the use of soft Operational Research techniques 
and methods for appropriate representation and model simplification.  
 
4.4 Discussion 
Stages within a conceptual modelling framework 
This review suggests that there are two broad stages for a modeller to undertake prior to the 
development of a quantitative model: (1) understanding the problem and setting the objectives of 
the model; and (2) choosing model options, determining the model scope and level of detail, and 
identifying structural assumptions and model type. Not all frameworks consider the former as part 
of conceptual modelling. The studies within the review suggest that it is very difficult to effectively 
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represent all of these stages within one single diagram,8;18;127;129;136 which may have led to the 
semantic confusion in this area as to which diagram is the ‘conceptual model’. The studies generally 
suggest that each of the stages should inform the other within an iterative process of conceptual 
model development. Some of the studies suggest that the development of the quantitative model 
may also inform the conceptual model.14;120;121;123   
 
Flexibility of methods 
Five conceptual modelling frameworks included within the review clearly specify the methods to 
employ for each stage of the model development process,119;121-123;129 whilst the remaining three 
frameworks are flexible about the methods which might be employed. 14;20;120;130  The study by 
Kaltenthaler et al. explains that this is because methods which are too prescriptive would ‘fail to 
reflect the unique characteristics of each individual technology appraisal and could discourage the 
development of new and innovative modelling methods.’14  These concerns are important within 
Public Health economic modelling as it is important to consider the needs of the decision makers 
and the decision making process, as also discussed within Chapter 5. Therefore, it would be 
appropriate not to provide methods which constrain the decision making process within a 
conceptual modelling framework for Public Health economic modelling. 
 
Potential methods for each stage of a conceptual modelling framework 
Most frameworks either use SSM or causal diagrams for understanding the problem. Both methods 
allow multiple stakeholder perspectives to be captured; however causal diagrams provide a method 
for considering all of the relationships between variables within a complex system. Few formal 
methods have been identified for objective setting and many frameworks do not explicitly consider 
this stage. Tako et al. suggest the use of a Performance Measurement Model (a flow diagram 
outlining ‘monitoring activities’, ‘determine if activities’ and ‘changes’).136  The problem structuring 
stage generally results in a defined set of options to assess within the model, although detailed 
methods for defining these are not provided within the identified frameworks. Five out of the eight 
frameworks identified assume that a specific type of model will be developed, either DES or system 
dynamics, irrespective of the problem.8;127-129;136  Only two sources explicitly consider alternative 
model types.14;18  Importantly, many health care modellers have suggested that the characteristics of 
the problem should guide the model type;117;127;128  hence it is important that the problem is 
understood prior to choosing the model type.  
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Conceptual model representations 
Six of the conceptual modelling frameworks identified describe several forms of conceptual model 
representation for the different stages of model development.14;20;120;121;123;129  A paper about 
conceptual model representation by Onggo et al. based upon Robinson’s framework suggests that 
since conceptual models comprise several components, more than one conceptual model is required 
for the different stages of model development to provide a more comprehensive representation.142  
Within the study by Vennix and Gubbels only one conceptual model diagram is presented which 
seems to represent understanding the problem, model scoping and describing the model level of 
detail.128  However, it is unclear whether each of these stages is appropriately handled.  
 
Within the included studies, the use of causal diagrams is strongly associated with the development 
of a system dynamics model. This is supported by the system dynamics literature where the use of 
some form of causal diagram is recommended within key texts.50;89 Whilst the two diagrams 
complement each other, there is no reason why the development of a causal diagram must lead to a 
system dynamics model; they could be used for the development of other model types. Similarly, 
Activity Cycle Diagrams are often developed prior to programming DES models; however prior 
conceptual modelling stages do not appear to be consistent across the studies, and may include 
SSM, objectives diagrams and/or tabling variables.120;129;130  Within the review, those frameworks 
employing discrete event simulation tend to focus less on the relationships between model variables 
than those employing system dynamics; however this is likely to be due to the type of system that 
they are attempting to model, which also guides the model type, rather than due to the model type 
per se. Those employing discrete event simulation tend to be answering questions around the 
impact of interventions upon capacity within organisations, whilst those employing system dynamics 
tend to be answering questions around the impact of interventions upon the costs (and possibly 
other outcomes) of a process, without considering capacity constraints.  
 
Stakeholder involvement and making judgements within the frameworks 
Studies were only considered relevant to the review if they considered stakeholder involvement. 
However, the extent to which stakeholders are involved in the model development process is highly 
variable within the frameworks and a range of methods are employed including focus groups / 
workshops, interviews and questionnaires. The majority of the studies reviewed suggest that 
stakeholder involvement is important in making judgements about what to include and exclude 
within the conceptual modelling frameworks, although three of the frameworks employ only the 
decisions of the analyst for this stage.8;18;129  Howick et al. use formal analysis of feedback loops and 
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triggers for choosing which variables are relevant for the model,127 whilst three studies employ 
guidance about what could be considered for inclusion within the model in order for the modeller 
(and the stakeholders in some cases) to think through and justify the inclusion (or exclusion) of 
each.8;14;18  Fernández and Kekäle also employ a formal process using AHP to choose relevant 
variables; however there were many limitations to this approach including that it does not consider 
the relationships between the variables and it is solely dependent upon the stakeholders’ 
understanding of the system.125  Tako et al. and Vennix and Gubbels employ stakeholder 
involvement to choose relevant model variables by developing the conceptual model with them, 
although without formal methods for justifying the variables chosen.128;136  The amount of 
stakeholder involvement in the framework by Rodriguez-Ulloa and Paucar-Caceres is unclear.129  
There are differences between each of the studies around which groups of people might be involved 
in the model development process and in most studies this is poorly defined.  
 
The potential application of the frameworks to Public Health economic evaluation 
Decisions about what factors to include and how to include those factors within an operations 
system such as a manufacturing plant may be inherently different to those required for a health 
economic model because the aims of the models, the decision making arena and the data 
requirements and data availability for the factors within the system are different. In addition, 
Robinson suggests that domain specific frameworks can provide more guidance about the approach 
than generic frameworks. In particular, he suggests that frameworks are required for healthcare 
modelling,1 and until 2010 none existed. Although three healthcare-related conceptual modelling 
frameworks have been reported in 2010 – 2012, none of these consider Public Health economic 
modelling. Thus, characteristics which are more often key considerations within Public Health 
economic modelling such as the determinants of health and non-healthcare costs and outcomes, are 
not highlighted within these frameworks. Based upon Chapters 2 and 3, these were considered to be 
important for the framework. Thus whilst all of the included conceptual modelling frameworks will 
provide useful contributions to my framework, none of the eleven existing conceptual modelling 
frameworks are sufficient for applying to Public Health in their current form.  
 
Benefits of a conceptual modelling framework 
Benefits of a conceptual modelling framework identified by the authors include: a tool for 
communications between stakeholders; aids the development of clear, shared, modelling objectives; 
guides model development and experimentation; adds systematicity and transparency and forms 
the basis for model verification and guides model validation, as well as guiding model use. 
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Evaluation of the conceptual modelling frameworks 
Limited evaluation of the frameworks has been undertaken. Most of the articles included within the 
review reported the methods and results of a case study to demonstrate the use of the conceptual 
modelling framework and some form of theory-based evaluation. Several authors also suggested 
evaluating the frameworks by speaking to stakeholders; however this was not undertaken within any 
of the included studies. Drawing upon the problem structuring methods literature suggests that the 
most appropriate approach to evaluation may be theory-based evaluation, alongside other forms of 
evaluation such as a case study and/or feedback from modellers or stakeholders.150;151 
 
4.5 Chapter summary and implications for methods development  
This chapter presented a review of existing conceptual modelling frameworks. The implications of 
the review for methods development are that: 
1) A conceptual modelling framework specifically for Public Health economic modelling has the 
potential to provide more guidance about the approach than a generic framework. 
2) A conceptual modelling framework should include, as a minimum, stages for (i) 
Understanding the problem and objective setting, and (ii) Choosing model options, 
determining model scope and level of detail, and identifying structural assumptions and 
model type.                                                                                          
3) For each stage, a different diagram should be developed. 
4) Whilst a diagram of each stage is essential for communication purposes with stakeholders 
and experts, it is the process of development of each which is particularly important for 
sharing knowledge. 
5) The purpose and intended use of the conceptual model(s) within the framework should be 
clear; is it for planning the final model or reporting the final model? If the term ‘conceptual 
model’ is employed within the framework it needs to be defined and which groups of people 
might be involved in the model development process should be clear.  
6) Key benefits are to aid the development of modelling objectives, provide tools for 
communication, guide model development, experimentation and reuse, and improve model 
validation and verification. 
7) Importantly, modellers must want to use the conceptual modelling framework. Thus, the 
framework should aid the model development process but not constrain it. It should allow 
for the variation in requirements of different Public Health economic modelling and for 
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scope for further methods development given the early phase of development of a 
framework within Public Health economic modelling.  
8) Cognitive mapping, causal diagrams and SSM may be useful for objective setting and 
developing the understanding of the problem.  
9) The conceptual modelling framework needs to be practical within a decision making context, 
and the needs of the decision makers should be of key consideration, including the time 
requirements upon the stakeholders, during methods development. 
10) Theory-based evaluation of the framework should be undertaken to explain why it is 
expected to be effective, as well as qualitatively obtaining stakeholders’/ modellers’ views. 
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Chapter 5: Qualitative research relating to 
modellers’ experiences with developing the 
structure of Public Health economic models 
 
5.1 Chapter outline 
This chapter aims to describe modellers’ experiences with developing the structure of Public Health 
economic models and their views about the benefits and barriers of using a conceptual modelling 
framework in order to facilitate the development of a useful conceptual modelling framework. More 
specifically, the objectives are as follows: 
1) To develop a description of the model development process in practice for Public Health 
economic modelling in order to (a) understand the context within which issues arise during the 
model development process and (b) be clear about if and how the conceptual modelling 
framework deviates from the way in which modellers usually develop Public Health models; 
2) To understand how and why modellers make decisions about model scope and structure in order 
to develop guidance that helps modellers to attempt to undertake this process; 
3) To establish some of the key issues during model conceptualisation in order to highlight these 
key considerations to modellers and suggest potential solutions and pitfalls to be avoided where 
possible; this includes understanding what has worked well or poorly by modellers and 
identifying some of the requirements and constraints of decision makers;  
4) To identify the potential benefits and barriers associated with the use of a conceptual modelling 
framework in order to develop a tool which will be useful to modellers. 
 
Qualitative research methods have been employed in order to achieve these objectives. Sections 5.2 
and 5.3 describe the methods and results of the analysis respectively. Section 5.4 presents a 
discussion of the qualitative research findings, whilst Section 5.5 summarises the key findings and 
the implications of these upon the development of the conceptual modelling framework.  
 
5.2 Qualitative research methods 
As discussed within Chapter 1, reflexivity is the idea that meaning from qualitative research is 
developed based upon the complex relationship between the understanding of the participant and 
the researcher prior to the research combined with the additional meaning gained from the 
research.58  Thus the researcher will always influence the outcome of the research to some extent.58  
Throughout this chapter I have employed a reflexive perspective, in that I attempt to fully consider 
my impact as a researcher upon the analysis. This is because in collecting and interpreting the data I 
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will inevitably influence the outcomes of the research, and as such it is preferable to be explicit 
about this. This is particularly important because as part of the analysis I am using my own notes as 
data, in addition to data collected from in-depth interviews and a focus group (described in more 
detail below). Because of this reflexive perspective, I have adopted the first person throughout the 
chapter. Throughout data collection and analysis I found a book by Lewis and Ritchie particularly 
useful.156  ScHARR ethical approval was obtained for this work (see Appendix C). 
 
5.2.1 Data collection 
Theoretically, the richest data around modellers’ experiences with developing the structure of Public 
Health economic models may be obtained by following model development in real time over a range 
of public health modelling projects, which could involve the use of an action research approach157; 
however this would not be practical within the time and resource constraints of this research. 
Therefore, I took a pragmatic approach to qualitative data collection comprising three phases.  
 
Phase 1: Analysis of my own notes 
Phase 1 involved using my own notes as data from a Public Health project where I had undertaken 
the health economic modelling assessing the cost-effectiveness of intervention to encourage young 
people to use contraceptives and contraceptive services, referred to hereafter as ‘Contraception 
project’ (also referred to within Chapter 3). The aim of this was to reflect upon my own experience 
of developing the structure of a Public Health economic model. The notes were written by me during 
the development of the model for the purpose of developing my own thoughts based upon the 
outcome of stakeholder meetings or literature searching, with the exception of a couple of notes 
which were written to communicate an idea to other members of the team (made up of an 
information specialist, two reviewers and a public health expert / project lead). The notes are of my 
thinking during the project in terms of understanding the decision problem and developing the 
scope and structure of the health economic model. They contain thoughts about what is important 
for inclusion in the model and how those factors chosen to be relevant for inclusion should be 
represented. I kept the notes from the project because I was applying for the fellowship funding at 
the time of the project and I thought they may be useful, although at the time I did not plan to use 
them as data as part of this analysis. This phase allowed me to reflect upon my own experience of 
developing the model structure, using my own notes as data so that my reflections were based on 
the real process rather than being biased by my perceptions of what had happened in hindsight.  
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Phase 2: Tracking the development of a Public Health economic model including undertaking and 
analysing in-depth interviews 
Concurrently to the analysis within Phase 1, Phase 2 involved tracking the development of a Public 
Health economic model by undertaking in-depth interviews with the two modellers on the team 
during the development process and making notes on the process during meetings between the 
modeller, the group of stakeholders involved in NICE Public Health decision making (referred to as 
the Programme Development Group (PDG) throughout) and the NICE Project Team. The modellers 
were recruited because of the appropriate timing of their project within my research. There was an 
additional benefit that one of the modellers was considered to be experienced, with over 20 years 
developing healthcare models, whilst the other was considered to be relatively inexperienced, 
thereby allowing for different perspectives of the same model development to be reflected in the 
analysis. The modellers were recruited by contacting them via email and providing an information 
sheet about the project (see Appendix C). A consent form was also sent to the participants (see 
Appendix C) and they were informed that the data would be anonymised, that they would be audio 
recorded and that they could withdraw from the research at any time. The NICE Project Lead was 
approached via an informant and she passed on an information sheet and consent form to the other 
members of the NICE Project Team and the Chair of the PDG, who agreed to pass the details on to 
the PDG members. All of the NICE Project Team and the PDG members were asked to sign a consent 
form prior to my taking notes at their meetings.   
 
The project that the modellers were undertaking involved an assessment of the cost-effectiveness of 
interventions to encourage people to walk and cycle, hereafter referred to as ‘Walking and Cycling 
project’. I attended and took notes at the three meetings which had the most focus upon model 
conceptualisation; one with the whole PDG and two teleconferences with the economic subgroup 
(which included six members of the PDG who had some expertise in health economic modelling and 
the modellers on the project team), all of which took place within a three month period. I also 
undertook two in-depth interviews with each of the two modellers on the project within the same 
three month period which were audio recorded and then transcribed. Some of the transcription was 
done by me and some was done by a transcription specialist; both of which were checked for 
accuracy by listening to the entire audio recording whilst reading the transcript. The participants 
seemed unaffected by the presence of the audio recorder. During the interview if an interviewee 
said something which I wanted to revisit later within the interview I discreetly noted a word down to 
remind me. An example of the questions asked within the interviews is ‘How did you go about 
making those decisions?’ and ‘Early on you mentioned about interventions, and that you would 
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probably get them from the effectiveness reviews. Do you have an idea of how you’ll be going about 
that at this stage?’ Probes were used to investigate a response in more depth such as ‘why did you 
do that?’ The questions and probes were expressed as open questions. Whilst this provided depth of 
analysis, it could not provide sufficiently varied experiences and views.  
 
Phase 3: Focus group with Public Health modellers 
Phase 3 involved holding a focus group with five modellers, each of whom were from different 
institutions within the UK, to provide a broader understanding of modellers’ views and experiences. 
Focus groups provide a forum for discussing and debating different views,17 which are likely to be 
present between different modellers given the lack of documentation in this area. In addition, since 
the participants might not have thought about some of the questions asked previously, ideas might 
be developed by each participant reflecting upon the statements and discussion of others. 
Participants were chosen purposively due to their extensive work within Public Health economic 
modelling within the UK. Some of the participants were known to me; however insider knowledge 
was considered to be an advantage because of the range of perspectives that could be accessed.158  I 
chose people who I thought might have varied perspectives from one another because they had 
worked on different types of Public Health economic modelling projects and they had different 
backgrounds and experience. For example, some of the modellers had undertaken Public Health 
economic evaluations for NICE, whilst others undertook work for other funders that had different 
decision making processes. In addition, the modellers had a mixture of backgrounds including Health 
Economics, Operational Research and Engineering. Within the focus group meeting I was not looking 
for agreement from the participants, but to understand the range of perspectives, and in what areas 
agreement and disagreement occurred. 
 
As with Phase 2, the focus group participants were recruited by contacting them directly via email 
and providing an information sheet about the project. A consent form was also sent to the 
participants and they were informed that their participation would be anonymous and that they 
could withdraw from the research at any time. I had stated within the ScHARR ethics process that 
the respondents would be sent one additional email if they did not respond, but that then they 
would not be contacted again to avoid them being pressured into participating. Six participants were 
contacted; however one of the modellers could not attend due to other work commitments. I 
expected participants to be happy to fully express themselves within the group setting given the 
insensitivity of the topic and the level of status of the participants. I suggested that it might be useful 
for each participant within the focus group to think about a specific case study that they had worked 
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on with the aim to encourage reflection rather than theoretical reasoning. The meeting was audio 
recorded and then transcribed by me. My role within the focus group was to ask open questions 
which were not aimed to influence the participants views in any way and I did not add to the 
discussion between participants with my opinions.  
 
Topic guides 
For both the in-depth interviews and the focus group, topic guides were developed to inform the 
general structure of the sessions (see Appendix C). This was a page of A4 which highlighted key areas 
to cover within the meeting. For the interview, I designed the topic guide based upon my findings 
from Chapters 2, 3 and 4; the latter of which was undertaken in parallel. The focus group topic guide 
was based upon the outcomes of Phases 1 and 2. Data from the interviews were used within the 
focus group to provide a starting point for some of the discussions, and the participants were asked 
to comment on whether they agreed or disagreed with some of the interviewee responses. Whilst 
my previous work informed what was covered within the interviews and focus group, I was aware 
that it was important to avoid using leading questions, because I was interested in the perspective of 
the interviewees and did not want this to be shaped by my perspective.  
 
5.2.2 Data analysis 
Thematic analysis and open coding of data 
I undertook thematic analysis of the data collected159 which included my own notes from the 
Contraception project, notes of the PDG meetings, the transcripts of the interviews and the 
transcript of the focus group meeting. I began the analysis after the first set of interviews and this 
was used to inform the following interviews with the modellers from the Walking and Cycling project 
and subsequently the focus group meeting. I familiarised myself with the content of the transcripts 
by reading them through so that I knew what sorts of data were available. Each sentence from the 
interview transcripts and the notes from my contraception project were subsequently copied across 
to an Excel spreadsheet into categories. The category headings were constructed according to what I 
initially thought each sentence related to, and these were gradually developed as I went through the 
notes and transcripts sentence by sentence. I strictly treated my own notes as data in the same way 
as the other data collected, such that the methods remained systematic. There was no restriction on 
the number of categories employed and during this process it was necessary to divide some of the 
initially defined categories into two categories due to the emergence of related but different issues 
as more of the transcript was coded. All data were open coded in this way,160 apart from any parts of 
the notes and transcripts considered irrelevant to the aims outlined above. This meant that all 
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perspectives were included within the analysis. Open codes were developed for the first and second 
interviews and were subsequently revised during open coding of the third interview, generally by 
dividing the codes into more categories.  
 
After open coding of the first three interviews was complete, similar categories were grouped 
together into themes. These codes and themes were then employed for the subsequent data 
analysis. For example, the focus group topic guide was set out in terms of the themes and 
subthemes which had been identified from the interviews. The focus group data were open coded in 
a similar way and individual participants were identified; however the original transcripts were also 
used within the analysis to note where participants had agreed or disagreed with each other, and 
how the quotations related to each other.  
 
Selecting quotations and interpretation of data 
For each open code, key points were identified and for each of these a quotation was selected 
according to whoever had made the point being described in the most complete and succinct way. 
Issues identified during the analysis of the interview data were based upon both what the modellers 
said they are and upon my interpretations during observations of the Walking and Cycling project. 
An outline of the data collection and analysis process is shown in Figure 5.1. 
 
Figure 5.1: Qualitative data collection and analysis process overview 
 
 
  
Phase 1:  
Analysis of my notes from the 
Contraception project 
Phase 2:  
Attendance at PDG meetings and in-depth 
interviews with modellers on the Walking and 
Cycling project & analysis of data 
Phase 3:  
Focus group meeting & analysis of data 
Learning from Chapters 2 & 3, draft of 
Chapter 4 & my previous modelling 
experience 
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5.3 Results of the qualitative research 
Three key themes were identified from the data analysis; (1) The model conceptualisation process in 
Public Health economic modelling; (2) Use of evidence in model conceptualisation; and (3) Barriers 
and benefits of a conceptual modelling framework. These themes are considered in turn within this 
section. 
 
Theme 1: The model conceptualisation process in Public Health economic modelling 
It is important to understand the model conceptualisation process in Public Health economic 
modelling in order to understand the issues which arise. This theme has been subdivided into three 
subthemes: (i) the stages of model development, (ii) how decisions are made by modellers about 
model conceptualisation, and (iii) the communication with the experts and decision makers. 
Documenting the modelling conceptualisation process can help inexperienced modellers understand 
what it involves, but it can also help more experienced modellers to identify which factors to 
consider in making modelling decisions. It also allows me to understand how my conceptual 
modelling framework will deviate from the way in which modellers usually develop models. 
 
Stages of model development 
As described within Chapter 1, Chilcott et al. undertook a qualitative research study about avoiding 
and identifying errors for the Health Technology Assessment programme in 2010 and one of the key 
findings of the study was that the stages of model development within health economic evaluation 
are not well defined.17  This has also been highlighted within a NICE Technical Support Document by 
Kaltenthaler et al.14  It is useful to have an understanding of the current model development process 
within Public Health economic modelling to enable the development of a conceptual modelling 
framework.  
 
It is clear from the interviews and focus group that the modellers do not share a vision of the stages 
of model development. The less experienced modeller interviewed indicates the lack of a formalised 
model development process and the uncertainty that this creates in the process that they are 
involved in. 
 
Modeller 1 (interview data): “You must realise this is the first time I’ve done this, so this is the 
first time I’ve been the one making the decisions, so I don’t really know what’s around the 
corner yet.” 
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The more experienced modeller interviewed suggested that the initial stages of model development 
include identifying the decision, understanding what the problems are, and what the issues 
associated with these are, and then looking at the available evidence and iterating between the 
evidence and the data analysis.  
 
Modeller 2 (interview data): “So I start with the problem and the thinking and so it kind of goes 
okay what is the decision, what are the problems, what are the issues that link into that and 
then go well that is the first map of that, what is the evidence about that, have we got the 
trials, what’s your databases, where do we get some stuff from and then start cycling, like here 
between data available, data analysis.”  
 
This indicates a reflective process, and does not mention the involvement of other people. The use 
of the word ‘map’ is interesting as it implies a representation at a particular level of abstraction, 
which could be otherwise termed a conceptual model. He hints that this map may change as data 
are obtained.  The modeller mentions the use of trials and databases, but implies that sources for 
other evidence are less clear. When the modellers within the focus group meeting were asked 
whether they agree or disagree with the above statement, the modellers generally agreed that it is 
an iterative process. Modeller 7 also said that he agreed with the importance of deciding what the 
question is. 
 
Modeller 7 (focus group data): “The bit that chimed with me I guess was the bit about trying to 
decide what the question is, because most of the models are decision support models so 
they’re aiming to help people make decisions. So whenever I’ve done this I’ve tried to 
concentrate on, well, what is that they need from the modelling, and that kind of has primacy 
over any subsequent decisions, except when they’re in support of trying to identify those 
things.” 
 
This highlights that the purpose of the models within Public Health economic evaluation is to help 
decision makers make decisions, as opposed to trying to represent reality. The modeller puts the 
decision makers and the question that they are trying to answer at the forefront of his modelling 
activities, and this informs future decisions about the model structure.  
 
In practice it may be that understanding the problem evolves throughout the project rather than 
something which is completed in the early stages. For example, within the second economic 
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subgroup meeting on the Walking and Cycling project, one of the modellers said that he wanted to 
link walking and cycling to overall physical activity since some studies report walking outcomes and 
some report cycling outcomes, and it is overall physical activity that affects morbidity and mortality. 
By this stage in the process the modellers had undertaken numerous analyses of datasets and had 
developed a first draft of an implemented model; however it is the first time that they discussed 
having an outcome of ‘physical activity’ with the PDG and NICE.  
 
Within the second economic subgroup meeting on the Walking and Cycling project, Modeller 2 
stated that he would be able to split the time doing physical activity into more categories within the 
model but that he thought he would need to restructure the model to do it. This illustrates the 
benefits of model planning prior to implementation. However, when asked towards the end of the 
project ‘is there anything that you did and changed because it didn’t go so well or you would do 
differently?’ Modeller 2 said the following: 
 
Modeller 2 (interview data): “I do think that we could layer some more things on top; we could 
layer that lag to full effect that I was talking about, we could layer something keeping the 
cohorty structure but somehow layer something about prevalence of diseases related to 
sedentary versus physically active on top.” 
 
This highlights that model development may be constrained by the time and resources within the 
decision making process. The use of the term ‘layer’ within the data above gives the idea of a 
pragmatic approach where a basic model structure can be gradually built upon to become more and 
more complex if time and resources allow. This layering is undertaken following initial model 
implementation, which suggests potential iteration between model conceptualisation and 
implementation.  
 
When asked within the focus group meeting whether the modellers develop conceptual models, 
they generally said that they develop some form of diagram or qualitative description of the model, 
although they do not necessarily call it a conceptual model, and between the modellers there was 
no agreed way of presenting it. 
 
Modeller 3 (focus group meeting): “When you asked the question in the first instance, I 
thought no we never bother doing conceptual models, but actually we do quite a lot in terms 
of, we know we’ve got to write the model up and present it. So it tends to be not such a 
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separate process, but an integral part of the model development process that we’re writing 
down the links that we’re making, we’re writing those down as fundamental assumptions of 
the model. Apart from anything we’re communicating with our systematic review colleagues 
as to what sort of data we’re going to need from them.” 
 
This participant intimates that modellers have to go through some sort of conceptual modelling 
process and develop some form of communication of the model, even if it is not a formal process. 
He suggests that one of the reasons for communicating the model during the early stages of model 
development may be to communicate with the systematic reviewers in order for them to extract 
appropriate evidence for the model. The modeller talks about ‘writing down the links’ which relates 
to the causal relationships, which were consistently described as being an integral part of a 
conceptual model by the modellers. One of the modellers makes the distinction between causation 
and association within a conceptual model he developed. 
 
Modeller 5 (focus group data): “...I came up with a conceptual model, where it wasn’t just that 
there were different boxes with arrows, but different coloured arrows depending on how 
strong the evidence was first of association and second of causation and even reverse causality 
in some cases.” 
 
This modeller suggests that a conceptual model depicting causal relationships needs to be 
developed gradually and that it can differentiate between types and strengths of evidence of those 
relationships. The modeller reported that the project team found the use of different colours to 
represent the level of causality useful and created discussion. 
 
Many of the modellers within the interviews and focus group talked about drawing evidence from a 
wide range of sources and bringing all of the information gathered together into the model.  
 
Modeller 1 (interview data): “We’ve drawn a lot of stuff together and its like a huge jigsaw and 
I suppose from now is when we start putting the pieces together; we’ve got to make sure 
we’ve got the right pieces and how we start putting it together.” 
 
This simile of putting together a jigsaw used to describe the process implies that it is a complex task 
which requires different pieces of evidence to fit together. It involves both excluding available pieces 
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of evidence which are not relevant or do not fit together within this particular problem and 
obtaining missing pieces before it can be completed.  
 
The members of the focus group generally agreed that it is important near the start of the project to 
understand what other models have been developed and whether these could be used as a basis for 
the current modelling. Modeller 2 stated that a useful way to develop the model structure is to think 
about a few specific interventions, whilst the focus group members extended this and agreed that 
the model structure would be driven by the interventions chosen. Some of the focus group 
modellers also suggested that one of the things they do at an early stage is to understand the 
baseline situation and what evidence is available to model that baseline situation. 
 
Modeller 2 had developed a draft paper drawing on his previous experience to define a framework 
for helping modellers develop alcohol policy models which outlines seven issues that he considers 
during model development which he described during an interview.  
 
Modeller 2 (interview data): “The first issue is classifying and defining population subgroups of 
interest, the second issue is identifying and defining harms and outcomes for inclusion in the 
model, the third is thinking about modifiable components of risk... ...and then I have got 
specifying the baseline position on policy variables... ...so five is estimating the effects of 
changing the policy variables on the risk factors... ...And then risk functions relating risk factors 
to harm... ...in one sense that is your model, that is what you usually think of as your model, 
how do you estimate your longer term outcomes. And then finally monetary valuation, how do 
you think about the value of these things.”  
 
The use of the word ‘issue’ for describing the themes within this framework indicates that each of 
these can be problematic. I would suggest that this framework may have been developed as a result 
of the lack of guidance for modellers about the Public Health economic model conceptualisation 
process, although this was not stated by the modeller. Issues 1 - 4 relate to specifying the scope of 
the model, whilst issues 5 – 6 relate to defining the model structure and issue 7 is about 
parameterising the costs and outcomes. I have referred to these, where relevant, throughout 
subsequent analysis within this Chapter. 
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Non-evidence related considerations during model conceptualisation 
It is important to understand the key issues and considerations during the conceptualisation process 
in Public Health economic evaluation in order for them to be addressed or highlighted within the 
conceptual modelling framework. The review within Chapter 2 identified some fundamental issues 
including the dynamic complexity of Public Health systems, the potential requirement to include  
non-healthcare outcomes and the impact of the determinants of health upon outcomes; however 
there are additional practical issues which modellers have experienced during model 
conceptualisation.  
 
I noted within one of the Walking and Cycling PDG meetings that the PDG were constrained by the 
project scope, for example, they were not allowed to make recommendations on national policy; it 
had to be local policy. When Modeller 2 was asked within the in-depth interview ‘You mentioned 
knowing what the (modelling) question was earlier, what did you mean by that, you said that that 
was an issue?’ he suggested that this was not a big issue. 
 
Modeller 2 (interview data): “Well, I think that is often an issue at the beginning, but I think in 
this case it wasn’t that difficult because the scope was quite clearly set, we needed to look at 
the cost effectiveness of interventions that encouraged walking and cycling in local 
communities and they explicitly wanted something done on congestion and that was it. So the 
big picture question was set, what wasn’t set was exactly what interventions would get 
included. So that was quite a lot and you are best off talking to the reviewers about that.”  
 
This illustrates that the model scope may be reasonably well defined by the decision makers; 
however one of the key scoping issues for the Walking and Cycling project related to which 
interventions to include within the model. This was echoed by the modellers within the focus group 
meeting. Modeller 2 stated that the reviewers are best placed to talk about the interventions, which 
implies that it was the reviewers who made decisions about which interventions to model rather 
than the modellers or the experts involved. The choice of interventions is discussed further within 
Theme 2. 
 
Within the focus group meeting, the modellers highlighted that the choice of model population and 
subgroups is a key consideration which drives structuring decisions. 
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Modeller 7 (focus group data): “We knew that there were certain things that we needed to 
know about like different subgroups in society that they (the PDG) were interested in finding 
out about, and obviously that also drove the structuring decisions in the model.”  
 
The modeller implies that the choice of subgroups is driven by what the experts and decision makers 
want to explore. This suggests that these decisions are not led by the modeller, although it is the 
modeller’s interpretation of what the stakeholders want to explore which drives model 
development. There is no reference by the modellers to these decisions being dependent upon 
evidence.  
 
One of the PDG members on the Walking and Cycling project raised the issue of the interventions 
steepening the social gradient and that this needs to be considered within the modelling since the 
health gains will be smaller if the intervention increases walking and/or cycling for people with a 
lower socioeconomic status more than for people with a higher socioeconomic status, as discussed 
within Chapter 1. 
 
One of the key considerations during model conceptualisation described by many of the modellers 
involved in this work was what a ‘good’ outcome would be, as discussed within the review in 
Chapter 2. Within the Walking and Cycling project one of the PDG members suggested that the 
interventions may change somebody’s knowledge, which may change physical activity levels in five 
years’ time, and this may not be identified within short term studies. Within the Contraception 
project, there was a question about what would render an intervention which prevented a 
pregnancy successful, as this raises questions about what would happen in the future and when the 
optimal time to become pregnant is, as illustrated below.  
 
My notes on Contraception project: “If an unwanted pregnancy is delayed it may later become 
a wanted pregnancy, it might be aborted, or it might result in an unwanted birth. What is it 
that we wish to avoid? If a pregnancy is delayed from age 14 to age 16 by the intervention is 
this a good outcome? Is there an 'acceptable' age at which to have children or is it about it 
being unintended?” 
 
This suggests that social value judgements underlie, either explicitly or implicitly, what is considered 
when determining a ‘good’ outcome, for which there may be disagreements between stakeholders. 
One issue is whether behaviour is being prevented or delayed, which may be difficult to determine 
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from the evidence available. How to resolve these sorts of disagreements was not discussed by the 
modellers; this is considered further within Chapter 6.  
 
Within the Contraception project, the decision makers and I also considered potentially negative 
outcomes associated with the interventions such as increases in sexual activity; however we decided 
that this would be captured within those studies reporting pregnancy outcomes. Within the focus 
group meeting the modellers indicated that some of the decision makers within projects assessing 
the outcomes of harmful substances, such as ecstasy or alcohol, had debated whether the 
pleasurable effects of these drugs should be considered as benefits or harms since it is these effects 
which make them addictive. In addition, within the focus group meeting, one of the modellers 
highlighted the difficulty of incorporating potentially unintended consequences of the intervention, 
as also discussed within Chapter 2. 
 
Modeller 7 (focus group data): “But I think there’s others (factors) that you just don’t know, 
the (un)known unknowns or whatever that you haven’t even thought about, that may still be 
important. Particularly with sort of macro-level behaviour change, where there’s a lot of 
unintended consequences, you know that’s something that’s likely to arise in practice.” 
 
The modeller intimates that unintended consequences may be sufficiently important to affect the 
decision and may be more prominent for interventions which alter behaviour on a macro-level, but 
that they may be difficult to identify.  
 
The modellers and PDG members have considered the implications of having a heterogeneous 
population upon the outcomes, which is identified as one of the key features of a complex problem 
within Chapter 3.  
 
My notes from Contraception project: “What are the benefits of preventing pregnancy for a 
girl who would or would not go on to further education? What about for a girl who can/ 
cannot cope? Is ethnicity important? Is it possible across all women to say when it is best to 
have a baby?” 
 
From the Contraception project, I have questioned whether the heterogeneity between different 
groups of young women may lead to different benefits of preventing pregnancy. The questions 
raised relate to possible factors which might impact upon the woman’s life trajectory, illustrating 
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that there may be variation in causality at the individual level. Similarly, for the Walking and Cycling 
project a PDG member focuses upon subgroups where the risk factors for different subgroups are 
expected to have differential impacts upon the outcomes.  
 
My notes on Walking and Cycling economic subgroup meeting: “A PDG member said that 
people that are doing the most walking for transport do not have a car, whereas the more 
affluent people who are more likely to live in the suburbs where it is not practical to walk, walk 
for pleasure in the countryside. This means interventions will have different impacts upon 
these different subgroups.”  
 
The PDG member above makes the assumption that the ability to own a car leads to the amount of 
walking for transport and does not consider explicitly other plausible explanations such as that the 
ability to walk for transport may lead to whether or not the person owns a car. I would suggest that 
a key issue is that this assumption is not questioned. One of the modellers within the focus group 
meeting raised the issue of modellers knowing what assumptions they are making. 
 
Modeller 7 (focus group data): “I think a key is sort of knowing what assumptions you’re 
making when you decide on a structure, and I’m not sure that that’s necessarily a very simple 
task particularly in the macro-level population things, where you have dynamic effects, and 
second order effects, third order effects.”  
 
He implies that it is important for modellers to fully understand the implications of the structural 
choices they make. The modeller suggests that this is not straight-forward, especially when there are 
not only direct causal effects of the intervention, but also additional impacts caused by interactions 
between people, or indirect effects of the intervention such as a response to the intervention by a 
third party and the impact of this to consider.  
 
The modellers consider the most appropriate outcome to employ, even for those projects for NICE 
which has a Reference Case. For example, within the contraception case study the use of the QALY 
would have led to difficulties due to lack of evidence, controversial value judgements about 
abortions, and the fact that the intervention was aiming to prevent life rather than extend or 
improve the quality of life. My notes highlighted the difficulty with choosing the most appropriate 
outcome.  
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My notes on Contraception project: “By not considering QALYs, we're almost saying an 
abortion doesn't have an effect on mother or child. If just (apply a) cost (to) an abortion 
(without valuing outcomes of an abortion) it may be better in the model if everyone had an 
abortion than to encourage contraceptive use.” 
 
My notes on Contraception project: “Cost per under age x pregnancy averted... ...allows the 
decision maker to place more weight on <16 than <18 etc. It lets the decision makers make the 
value judgements.” 
 
The former data illustrates the issue of deciding upon a meaningful outcome and making sure that 
all key factors are valued in the model appropriately in terms of both costs and outcomes. The latter 
relates to what is considered to be the most useful outcome for decision makers given the valuation 
issues. Within the Walking and Cycling project, similar issues were raised in terms of producing 
meaningful outcomes.  
 
Modeller 2 (interview data): “So we had to work out a way of getting a cost per QALY and a 
way of getting some kind of outputs that were meaningful in terms of reduced congestion as 
you encourage more people to walk and cycle and they almost became two separate parts of a 
project that we had to keep linking together.” 
 
Here there are two different outcomes which need to be brought together in such a way that would 
help the decision makers to make decisions. 
 
The perspective of the analysis was considered in substantial detail in the contraception work as it 
was unclear whether it was methodologically most appropriate to include or exclude government 
funded Benefit payments such as Income Support within a Public Sector Perspective. This is because 
it was uncertain to what extent impacts would be being included within both the cost and effect 
side. Within the Contraception project, I included the costs associated with maternity care but did 
not include benefits associated with having a baby. 
 
My notes from Contraception project: “If intervention reduces the number of babies the 
woman has, then it will save the cost of maternity care. This implies that it is better to have 
less babies in a lifetime (unless also include the associated benefits of the baby). Discounting 
emphasises this issue.” 
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This also raises the issue of whose costs and benefits should be included within the evaluation. 
Within the contraception project, intergenerational impacts were considered but not included 
within the model, with my notes on the project asking “teen mother likely to lead to teen mother?”.  
 
Making decisions about the model conceptualisation 
Model development is inevitably a subjective process which requires modellers throughout the 
process to make decisions about what factors should be included and excluded and how those 
included factors should be represented. It is useful to understand how and why those decisions are 
made in order to develop guidance which allows modellers to attempt to undertake this process.  
 
The inexperienced modeller interviewed suggested that he is unsure about how to make decisions 
about model conceptualisation, on a number of occasions throughout the interview voicing “I don’t 
know”.  He indicates the frustration which may occur for inexperienced modellers in trying to make 
the ‘right’ decisions but being told that they are not appropriate and perhaps not really 
understanding the reasons why.  
 
Modeller 1 (interview data): “Well, he (Modeller 2) decides the best way it is - well he does 
decide; he keeps telling me to but he does it himself anyway. If I make the wrong one, he puts 
me right. He tells me to make the decision and if he agrees with me that’s fine, and if he 
doesn’t agree he changes it.” 
 
His use of the word ‘wrong’ here could imply that the modeller believes that his decisions would be 
considered to be inappropriate by all modellers such that it is universally wrong, or it could be that 
he believes his decisions could be considered to be appropriate but that the other modeller has a 
different opinion on these subjective judgements. Chilcott et al. highlight the difficulty in defining 
and agreeing on what constitutes a model error within the Health Technology Assessment around 
avoiding and identifying errors.17  The term ‘reasonable’ is used in many contexts where there is not 
an objective right and wrong answer, for example deciding whether somebody has broken the law 
(“beyond reasonable doubt”). This is about modellers making a judgement around how reasonable a 
modelling decision is considered to be.   
 
A range of methods for making decisions about the model conceptualisation were suggested by the 
modellers.  Modeller 1 proposed that one approach to making decisions is through discussions with 
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the other modeller(s) on the team, whilst Modeller 2 described making decisions by understanding 
the importance of each potential factor.  
 
Modeller 1 (interview data): “Well its just its me and Modeller 2, discussing it, and deciding.”  
 
Modeller 2 (interview data): “I can tell that this could be important or it could be not quite big 
but given my level of uncertainty as to how important this is and how it might affect the 
priorities of the activities that we do on the project, I need to find out about this.” 
 
Here, Modeller 2 talks about the process of not knowing which factors are the most important and 
needing to find out about potentially important factors in order to make decisions about how the 
project is organised. He explains that more time will be spent during the project on the more 
important factors which suggests that the modeller is acutely aware of the time and resource 
constraints of the decision making process. This implies that the modeller is not trying to develop 
the ‘best’ model that he could possibly build, but that he is developing the most appropriate model 
given the constraints of the decision making process. This pragmatic approach is resonated with the 
modellers from the focus group meeting. 
 
Modeller 3 (focus group data): “In terms of one of the big practical issues that determines the 
complexity and structure is the time you’ve got to do it, particularly in relation to reporting to a 
committee that you know is going to meet. And at the very least you’ve got to get a report in 
on time that says this is the model you want, or this model cannot be built to the complexity 
you want for the following reasons, and therefore you need to make the sort of changes that 
Modeller 4’s been talking about, and change the focus of your work. But at least you’ve got to 
get a report within a certain time.” 
 
This intimates that delivering the model by the deadline is considered to be a priority, and may be 
outside of the influence of the modellers. The modeller implies that it would be more culturally 
acceptable to change the focus of the work than to rearrange committee meetings or report 
deadlines. He agrees with another of the focus group modellers that it may be necessary to change 
the focus of the work so that it becomes more exploratory, suggesting that the process followed 
needs to be aligned with the constraints of the decision making context. One of the modellers within 
the focus group meeting indicated that it is unlikely that a Public Health economic modelling project 
would ever be without time pressures. 
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Modeller 7 (focus group data): “I think in terms of timescales, I can’t imagine there ever being 
a decision analytic model that’s got a long timescale on it. I just think the nature of it is that 
you’re trying to support a decision and that six months, a year, are the sort of time... I just 
can’t imagine it turning into a blue sky modelling exercise where you can explore all of these 
different model structures and do something which is slightly unusual and not anchored as a 
modelling method.” 
 
The modeller suggests that it will never be possible to develop the ‘best’ model, or develop a model 
with multiple possible structures, but that compromises will be required due to time constraints. He 
implies that the nature of decision making in Public Health is such that decisions need to be made 
relatively quickly. The modeller also highlights that models may be ‘anchored’ as a result of the time 
constraints, in that the structure will be largely dependent upon the structure of previous models 
that have been identified in that area. Similarly, Modeller 2 explained that the decision about model 
type is not necessarily about the type of problem being considered, but that this also depends upon 
the time and resources available and the other circumstances surrounding the project. He 
mentioned the need to have total control to meet the deadline rather than depending upon the 
input of other modellers, and that this may be dependent upon the circumstances of the other 
modellers. Modeller 2 also described the influence of the customer upon this decision, as illustrated 
below. 
 
Modeller 2 (interview data): “…and I knew that there was nothing in existence on walking and 
cycling really that went very far in terms of cost per QALY and the model that both, that the 
PDG had used most, the HEAT tool, Health Economic Analysis Tool for walking or something 
used this Copenhagen study, so I knew that there was some kind of acceptance of it amongst 
the customers really.”  
 
Modeller 2 suggests that it is important to them that the model is seen as credible by the customers. 
It illustrates the influence of previous health economic modelling work upon the expectations of the 
current modelling work, as already described by one of the modellers within the focus group.  
 
The modeller states that he ‘knew’ that there were not many economic models on walking and 
cycling. This relates to the idea of bounded rationality whereby rationality in making a decision is 
limited by the information a person has, their cognitive limitations and the time available.97  The 
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modeller has, possibly subconsciously, made the decision that it was a better use of time to make 
sense of the existing relevant information rather than to spend time searching for more evidence. 
Paisley explains that this is an enrichment strategy.63   In reality, the modeller cannot ever ‘know’ 
that relevant information is not being missed; modellers can only collect what they consider to be 
sufficient evidence to be able to make such a judgement. Thus methods to help to minimise 
prejudiced judgements may be beneficial. 
 
When I asked the focus group about the tensions between using a flow chart to determine model 
type and the constraints of the project, Modeller 3 explains what he thinks are the two key issues 
that can really be considered with these sorts of flow charts. 
 
Modeller 3 (focus group data): “I really think they come down to four groups, as soon as you’ve 
really decided these two issues; are you looking for infections or not, and are you able to 
classify into cohorts or not, then I think you’ve gone past the usefulness of that sort of thing. 
Then it’s the issue of what features you’re including in the model, and again they more or less 
choose the model type.... ...How much of the richness of the real world structure needs to be 
included in the richness of the structure of the model? Then the model type just drops out from 
that I think.” 
 
He indicates that other than deciding whether to include interactions and whether you need a 
cohort or individual level model, the model type required will be clear from deciding what the most 
important features of the problem are. He suggests that there is a decision to be made about how 
much of the complexity of the real world structure needs to be included in the model structure, 
although he does not expand on how this decision is made. One of the modellers from the focus 
group also highlighted that “...where the algorithms or flow charts might be useful, even if you have 
constraints of time, is that they make you aware of things that you might be missing out if you don’t 
use a more complex model so that you can at least flag them up as important things.”  
 
Within the focus group meeting there was a discussion about what factors affected the decisions 
about model structure and the modellers did not agree on the key trade-offs. Modeller 4 indicated 
that they were transparency, accuracy and credibility, whilst Modeller 3 suggested that they were 
adequacy, efficiency and transparency. I would argue that, based upon what has been discussed 
within the interviews and focus group meeting, the key trade off is developing an appropriate 
structure for the problem versus ability to meet deadlines.  
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One of the modellers within the focus group raised the issue of appropriately highlighting the 
structural uncertainty to the decision makers, either by quantifying it or by qualitatively describing it 
within the report. 
 
Modeller 5 (focus group data): “I think on that issue of the sort of transparency versus realism 
trade off, I think one of the key elements I think I’ve found is correctly conveying uncertainty in 
the results... ... I think when we do simplify models it’s really important to say well even if we 
can’t quantify these areas of uncertainty they do exist it’s just we’ve not incorporated them 
into our modelling.” 
 
This modeller intimates the need to specify what is not incorporated within the model i.e. that the 
scope of the model can be defined by what is excluded from the model rather than by what is 
included. The above quote reiterates the idea that the purpose of these models is for decision 
making, and not to produce a model which simulates reality. Thus models need to be transparent 
and provide decision makers with all of the caveats and uncertainties associated with the model and 
the evidence. The same modeller also suggests that decision makers often prefer simpler models. 
This relates to the credibility of the model, discussed previously. There was a discussion within the 
focus group meeting about building in alternative structural assumptions within the model. 
 
Modeller 4 (focus group data): “We often talk about model structures as if they are irreversible 
choices, and I guess for many of the short timeline projects we work on they feel pretty 
irreversible because once you’ve committed to and once you’ve invested time in collecting 
data, you reach a point where it’s... But there are other things within models which are 
structural where you can test alternatives, and you leave them open, and you can have 
switches in the model that turns bits of it on and off.” 
 
This modeller highlights that model structures can be modified at any time during the model 
development process, although within the time constraints of the decision making process this may 
be difficult. He suggests that different structural assumptions can be tested within the model. 
However, one of the other modellers argued that in practice this rarely happens. 
 
One of the modellers from the focus group indicates that the choice of structural assumptions may 
depend upon how likely the intervention is to be considered to be cost-effective.  
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Modeller 3 (focus group data): “... the results were so clear cut that we could take hugely 
conservative assumptions and still get a very favourable result, and so in that case we were 
able to use a very simple model. I think, possibly in primary prevention more generally that 
may well be the case if you’re talking about population wide programmes.” 
 
The modeller intimates that if the incremental cost of the intervention is expected to be small then it 
would be possible to make assumptions which are more likely to underestimate effectiveness and 
overestimate costs and show that the intervention is cost-effective. He suggests that this means that 
a very simple model can be used in these situations. This implies that the modeller began with a 
‘back of the envelope’ approximation in order to facilitate making these structural assumptions.  
However, even within a very simple model it is necessary to make decisions about what factors are 
important, and how these factors are chosen are not discussed here. Modeller 1 mentioned the NICE 
process as a contributing factor as to why some decisions are made. However, the same modeller 
also suggested that this process does not constrain many of the decisions about model assumptions 
when asked how these decisions are made. 
 
Modeller 1 (interview data): “Sometimes I think it’s almost protocol, it’s the way things are 
done, or maybe it’s the way NICE has decided they want it done.”  
 
Modeller 1 (interview data): “Completely ad hoc I reckon, the way things are going at the 
moment; we don’t seem to be straight-jacketed into a particular routine, we can pretty much 
decide what we want to do, what we want to include and how we’re going to do it.”  
 
The same modeller indicated that making decisions may have implications for future decisions for 
the same model, although again he highlighted his uncertainty with the process. 
 
Modeller 1 (interview data): “I’m guessing that once we start making a few hard and fast 
decisions, then that’s going to affect other decisions later on, but I’ll wait to find out.” 
 
This is likely to be the case only if the structural assumptions have already been implemented into a 
quantitative model. Within the focus group, there was a lot of discussion around the influence of the 
modelling culture within Health Economics upon structural decisions. 
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Modeller 5 (focus group data): “I think in infectious disease evaluations there’s sort of like two 
worlds; there’s the world of infectious disease modellers… …doing extremely sophisticated 
models to predict how flu pandemic will spread around the world with people moving between 
cities and flights and things like that. And then there’s the Health Economics world where the 
sort of modelling expertise is in things like how do we capture uncertainties and probabilistic 
sensitivity analysis and so on... ...And there’s not that many people who try to bridge (the 
gap)... And sometimes that’s not too helpful for decision making because what you need is a 
combination of both.” 
 
This suggests that the modellers’ backgrounds and the culture of the discipline may influence the 
decisions they make about model structure. Modellers with an infectious disease modelling 
background are likely to develop dynamically complex models, whilst modellers in Health Economics 
may develop simpler models which focus upon capturing the uncertainties within the model results. 
These alternative methods are due to the different paradigms within each of these disciplines, as 
discussed within Chapter 1. Modeller 5 is suggesting that it is important to merge the learning from 
each of the disciplines in order to more usefully help decision makers. This observation highlights the 
absence of any methods guidance for developing model structures which would help to align the 
two ‘worlds’ and the importance of methods for sharing existing knowledge and assumptions. The 
modellers from the focus group meeting all agreed that decisions about model structure will be 
affected by the skills of the modeller. 
 
Modeller 4 (focus group data): “...we’re all limited by the modelling tools, you know I’ve never 
done agent-based modelling, I don’t know how to do system dynamics modelling. There’s all 
sorts of different varieties of modelling because I’ve come mainly from a HTA background, you 
know I can do decision trees, I can do Markov models, I can do some sort of individual or 
stratified models sometimes, but each of us has our own spectrum of software and experience 
for modelling different things.” 
 
Specifically, this modeller who has a background in HTA, states that he does not know how to 
develop agent-based models or system dynamics models. This is likely to be true of other modellers 
with a HTA background since these types of models are generally not required for cost-effectiveness 
analyses of clinical interventions (see Chapter 2). One of the modellers within the focus group 
indicated that modelling for Public Health economic evaluation may follow a ‘Public Health 
tradition’. 
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Modeller 7 (focus group data): “We kind of went down a particular route that was mostly 
informed by a public health tradition in modelling in that you had various population and 
subpopulation level models like Prevent from the 1980s that are quite seminal, and guided our 
thinking. And so the alcohol model as it stands is a public health model essentially very much. 
But then the Institute for Fiscal Studies who are now our collaborators on the behaviour 
change elements of the alcohol model, and independently produced their own conclusions 
from us as a team; It’s really quite interesting to read their discussion documents, which are 
essentially around modelling, and how they’re culturally different. So they have discussions 
around the externalities due to drinking, they think about it in a very fiscal way.” 
 
Modeller 7 suggests that there is a Public Health tradition in modelling that focuses upon the 
impacts of the interventions upon the population as a whole (which may be divided into 
subpopulations) rather than on individuals, although one of the other modellers asked for more 
explanation about this because he was not aware of such a tradition. Modeller 7 contrasts the Public 
Health tradition with the view of collaborators from the Institute for Fiscal Studies who focus to a 
greater extent on the impact of the interventions on third parties such as crime or accident rates 
that affect other individuals. He highlights that the same piece of work can be interpreted in 
different ways depending upon who is reading it and their cultural perspective. Related to this, the 
modeller suggested that within the bigger Public Health economic modelling projects large groups of 
people might make decisions about different parts of the model structure, each with different 
expertise. He implied that the decision about how to divide the modelling work up within the team 
helps make some of the decisions about the level of complexity of the model structure. 
 
Theme 1 Summary 
The data suggest that model development within Public Health economic evaluation is iterative but 
that modellers do not follow a set process for model development, which is likely to create 
uncertainty in the process, particularly for inexperienced modellers. Modellers may not have 
thought about how to make decisions about what to include and exclude within a model, and it may 
cause frustration for inexperienced modellers in trying to make the ‘right’ decisions. It is clear that 
modellers have to go through some sort of conceptual modelling process and develop some form of 
communication of the model, although there is no consistent terminology associated with this 
process. Many modellers develop diagrams of the causal relationships between factors. The data 
suggest that some of the issues which modellers are facing during model conceptualisation within 
Public Health economic evaluation are how to define a ‘good’ outcome (including dealing with social 
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value judgements), how to handle heterogeneity, what the most appropriate outcome measure and 
perspective is and differentiating between causation and association. Additional issues include 
identifying unintended consequences, ensuring that the impacts of the intervention are 
incorporated within both the costs and benefits and determining whether to include 
intergenerational impacts.  
 
Modellers suggest that they tend to develop an understanding of the question before making 
structural decisions, although in practice it may be that the understanding of the problem continues 
throughout model development. The impact of the interventions upon the social gradient may need 
to be considered as well as the overall effectiveness of the interventions, as discussed within 
Chapters 2 and 3. The data suggest that the choice of interventions and the model population and 
subgroups are key considerations which drive structuring decisions, and these may be driven by 
what the experts and decision makers want to explore, although there is variability between 
modellers around the basis of these choices. The modelling work is constrained by the project scope 
and the decision making process. Model credibility is important to modellers, as also discussed 
within Chapter 4. Some methods for making decisions about the model structure outlined by the 
modellers are: (i) reviewing the strengths and weaknesses of previous models, (ii) having discussions 
between other modellers, experts or decision makers, or (iii) finding out more information to assess 
how important a factor is. The choice of structural assumptions may depend upon how likely the 
intervention is to be considered to be cost-effective. The data suggest that some decisions may be 
limited by the skill set of the modeller, standard processes and the culture of the discipline, or 
previous decisions which have been made. Within bigger modelling teams, decisions about how to 
divide the modelling work up may help to make decisions about the level of complexity of the 
model. Different structures can be incorporated into the model, although this is rarely done in 
practice. Modellers suggest that they should fully understand the implications of the structural 
choices they make.  
 
Modellers are generally clear that the purpose of model development is to help decision makers 
make decisions, as opposed to trying to reproduce reality. Model development is constrained by the 
time and resources available within the decision making process and modellers are acutely aware of 
this. This means that modellers are not aiming to build the ‘best’ model, but the most appropriate 
given these constraints, and this includes decisions about model type (for example, cohort Markov 
models versus individual-level simulation). There is thus a need to specify what is not incorporated 
within the model. Models may be ‘anchored’ as a result of the time constraints, in that the structure 
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is likely to be largely dependent upon the type and complexity of previous models that have been 
identified in that area. This is one example of the enrichment strategies modellers use by making 
sense of existing relevant information rather than spending time searching for more evidence, as 
described by Paisley.63  Modellers must collect sufficient evidence to be able to judge whether they 
are making appropriate simplifications. Due to time constraints, modellers may ‘start simple and 
build’, as proposed by Pidd,44 which would require iterations between model conceptualisation and 
model implementation. Finally, the data suggest that time restrictions may lead to changing the 
focus of the work so that it becomes more exploratory. 
 
Theme 2: Use of evidence in model conceptualisation 
It is important to understand the influence of evidence upon the model conceptualisation process, 
and the way in which the two interact, in order to incorporate these considerations into the 
conceptual modelling framework. Similarly, the sort of evidence that informs decisions about model 
conceptualisation, and how and why, might be included within the conceptual modelling framework. 
Each of the following subthemes are considered in turn: (i) The role of evidence; (ii) Effectiveness 
review; (iii) Other literature; and (iv) Communication with the experts and decision makers. 
 
The role of evidence  
Within Public Health economic evaluation, different forms of evidence are generally available than 
evidence for health economic models of clinical interventions.64  Good practice guidelines for 
modelling in health economic evaluation have suggested that the development of model structures 
should not be data-led.18;161  However, developing a conceptual model without any knowledge of the 
data available could lead to a number of subsequent iterations of altering the model structure 
according to the availability of data.  
 
The iterative nature of model conceptualisation and the collection of evidence are highlighted within 
my notes. I have written numerous questions about whether any evidence is available to show 
specific relationships such as the relationship between teenage pregnancies and social care. There is 
a cycle of setting hypotheses, testing them with evidence and then generating new hypotheses. The 
first cycle is based upon background reading and discussions with the PDG. Subsequent cycles are 
based upon other literature and further discussions with the PDG. One of the interview participants 
suggested that different modellers use data in different capacities during model conceptualisation, 
and that this varies according to the mindset and preference of the modeller.  
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Modeller 2 (interview data): “I don’t take too long to get round to it (looking at data), so you 
could contrast my mind set with some other modellers who can live with just conceptualising 
the whole and even parameterising and writing the software for the whole model before they 
have thought about what data might fit in those bits.” 
 
The use of the term ‘can live with’ implies that Modeller 2 would find it very difficult to work by 
conceptualising the whole model prior to looking at the data. This indicates that modellers may find 
it difficult to adapt their processes, which should be borne in mind when developing the conceptual 
modelling framework. Theme 3 (benefits and barriers of the use of a conceptual modelling 
framework) considers this in more depth. 
 
The same modeller highlighted the inevitably iterative nature of the model development process 
between model conceptualisation and data use.  
 
Modeller 2 (interview data): “If the data is not there in some sense that frees up your 
conceptualisation because you don’t have to fit the conceptualisation to the data and if you 
are going to make assumptions or elicit you reconstruct the configuration of the model to fit 
how you are going to make the assumptions or how you are going to elicit more easily from an 
expert or from yourself what the shape or a curve might be or whatever else.”  
 
This suggests that the relationship between conceptualisation and data collection means that it is 
not possible to undertake the tasks as two completely discrete stages. This could be likened to the 
idea that researchers can state that they are taking an inductive approach (where data leads to 
theory) or a deductive approach (where data either proves or disproves a theory), when to some 
extent the researcher inevitably has to work both inductively and deductively.58  For example, 
evidence in some form is required to understand the problem, and a certain level of understanding 
of the problem is required to inform the collection of evidence. The focus group members generally 
agreed that it is an iterative process between collecting evidence and structural development, 
although some may start using data at an earlier stage in the process than others.  
 
Modeller 2 stated that a lack of data is not necessarily an issue, but that he does not feel happy 
developing a model without knowing what data are available.  
 
128 
 
Modeller 2 (interview data): “It doesn’t bother me no data, what does bother me is ignoring 
whether there is data or not. Because what I find is that issues emerge from the data, so it re-
conceptualises; you find out, I don’t know what we will find but…” 
 
The modeller suggests that the reason that he does not like ignoring whether there are data or not is 
because issues emerge from the data. This may relate to the idea raised within Theme 1 that the 
modeller is developing the most appropriate model given the constraints of the decision making 
process. I would suggest that the modeller prefers short iterations between model conceptualisation 
and data collection perhaps because he is aware of tight deadlines within the decision making 
process. If the availability of data is not considered until a later stage in the process and issues 
emerge from the data at this stage, it could lead to more cycles between model conceptualisation 
and data collection which could lead to a longer model development process. The modellers within 
the focus group meeting resonate this. 
 
Modeller 5 (focus group data): “There are kind of like two types of subprojects if you like... 
...one is you have a tight timeline with a pretty narrow kind of question; what is the cost-
effectiveness of this intervention to this decision maker? And that’s where it’s really that 
process; what data is available and how did it influence the structure of the model. And the 
other kind of work I get is maybe something with a much longer timeline, and a much more 
loosely defined question, like well what are potentially cost-effective interventions in this 
disease area? And that’s where it might be over several years. There’s more of an opportunity 
not just to say what data are available but also how can we influence data collection over 
these years.”  
 
He implies that given more time for a project, it is more feasible to think about the model structure 
without considering data availability, because there may be time to collect the data required by the 
model structure. However, given tight project timeframes where it is unlikely to be possible to 
collect more data, it is necessary to think about data availability at an early stage in the process as it 
is likely that the model structure will need to be modified accordingly. The latter was reiterated by 
Modeller 3 within the focus group who said “then you’re getting into what data’s available and so 
on, and invariably there isn’t the right data, so then you’re getting into compromises.” The theory of 
not developing data-led models seems to be in conflict with the practical necessities in order to 
complete the work. The quote by Modeller 5 above also indicates that the timeframe may affect 
how the interventions being assessed are chosen; given short timeframes the interventions being 
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assessed may be clearly pre-specified, whilst longer timeframes may allow more scope for assessing 
which of a broad range of interventions are likely to be cost-effective. Importantly, this highlights 
that different projects may require different processes to be followed and hence any conceptual 
modelling framework would need to be flexible for different decision making jurisdictions. 
 
In response to this focus group discussion, another modeller stated that these models are developed 
for the purpose of prediction, and as a result it is not possible to simply use the data that are 
available to develop the model structure. 
 
Modeller 7 (focus group data): “...ultimately you’re in the business of prediction. And for 
prediction, if you just look at data modelling then you’ve got a static view of the world, okay 
you can look at a trend line maybe and extrapolate it a bit, but you’re just in the data whereas 
really what you’re trying to do is causal ultimately... ...so for me it has to go, you can look at 
that data structure to start with but there’s more to it.” 
 
This modeller is suggesting that models need to estimate what will happen in the future within 
Public Health economic evaluation, and as such it is not possible to have all the data. This means that 
a key element of the modelling must be in estimating causal relationships, and hence the structural 
assumptions cannot be developed based upon datasets alone. 
 
The modellers indicated that lack of data may affect both the intervention(s) and the population(s) 
being modelled. This relates to the first and second issues identified within the model development 
framework described by Modeller 2 (classifying and defining population subgroups of interest and 
identifying and defining harms and outcomes for inclusion in the model). For example, within the 
Contraception project, the population identified within the project scope was socially disadvantaged 
young people; however lack of effectiveness data for socially disadvantaged young people meant 
that it was not possible to focus only on this subgroup of the population despite the fact that 
outcomes would be different for this subgroup. 
 
My notes on Contraception project: “Proportions of births, miscarriages & abortions are 
affected by deprivation. No effectiveness evidence by deprivation. If [the intervention] targeted 
specifically socially deprived [populations], can only approximate [effectiveness].” 
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One of the modellers within the focus group suggested that lack of evidence may lead to changing 
the purpose of the model so that it becomes more exploratory. 
 
Modeller 4 (focus group data): “…the cost-effectiveness estimates, or the cost benefit 
estimates we’re going to be producing are going to be so heavily qualified and based on such 
strong assumptions, we’ve definitely been in the situation where we’ve just gone back to NICE 
and said shall we turn it into this kind of an exercise instead, where we just explore these 
different things. And so actually part way through the model development process… …it 
actually changes what sort of structural decisions you start making because you say right this 
is explicitly going to be a model for exploring internal trade offs within the model, rather than 
one that’s all geared up for producing one specific answer.” 
 
The modeller implies that there is a point at which models may be based upon too many 
assumptions and there is insufficient evidence for the results to be considered valid. He indicates 
that structural decisions are directly related to the purpose of the model, and that this purpose may 
change from what was agreed at the start of the project to be more exploratory if limited evidence is 
identified.  
 
Modeller 2 suggests that one of the problems is in terms of deciding what evidence to use and how 
to use it. 
 
Modeller 2 (interview data): “So I think that the big questions were exactly what evidence to 
use, and exactly how to translate that evidence into a coherent framework that would allow 
one model to analyse very disparate interventions.” 
 
This highlights that interventions which are assessed within the model may be very different and 
hence difficult to compare.  
 
Effectiveness review 
A review of the effectiveness literature is common practice within national Public Health decision 
making jurisdictions.5  Modeller 2 described the iterative nature of using the effectiveness evidence 
in a similar way as for other evidence as described within the ‘Role of Data’ section above. 
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Modeller 2 (interview data): “And now that I say it to you it is quite simple you do minutes 
walking to minutes cycling, physical activity, kilometres driving but when you didn’t know what 
data existed you didn’t know exactly until the evidence reviews was produced, which is quite 
late in terms of constructing the model, what the evidence looked like before the interventions, 
how they were measuring effectiveness, it kind of all went round in many circles for quite a 
long time.” 
 
This illustrates the additional work created due to the constraints of the process in terms of the 
timing of the delivery of the evidence reviews. It suggests that the modelling work must fit into the 
wider process required for making a decision, which the modeller may have little or no control of. 
However, Modeller 4 from the focus group implied that the effectiveness evidence would be the 
main starting point for the modelling. Both of these modellers suggested that what is modelled is 
dependent upon the effectiveness evidence available and it was stated that they must have a 
“reasonably well designed effectiveness study conducted on them”. Importantly, whilst the 
modellers indicated that the outcomes of the intervention review are a key influence upon the 
model scope and structure, none of the modellers described the starting point for the intervention 
review and how this is determined. The modellers also did not discuss any of the complexities 
associated with reviewing Public Health interventions (that they are often multi-component and 
non-standardised, as discussed within Chapter 2). This implies that, from the modellers’ perspective, 
the review of the effectiveness evidence is considered to be the job of the reviewer(s) and 
information specialist(s) rather than the modeller, with the modellers generally making use of the 
output of the review. Conversely, some of the modellers from the focus group suggested that the 
experts or decision makers would choose which interventions to assess. 
 
Modeller 7 (focus group data): “We elicited that there were certain interventions that they (the 
PDG) wanted to model.” 
 
This highlights the lack of consensus around the way in which interventions are chosen for assessing 
within the model. Within the focus group, the modellers indicated that the intervention must not be 
current practice and should be feasible.  
 
The modellers tried to understand the full short term impact of the intervention which may not be 
captured by the effectiveness studies. This relates to the third issue identified within the model 
development framework described by Modeller 2 (modifiable components of risk). My notes from 
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the contraception study suggest that the effectiveness studies do not capture all relevant 
consequences of the comparators and interventions. This relates to identifying unintended 
consequences, described in Theme 1 and Chapter 3. A large proportion of my notes are asking 
questions to try and understand the possible consequences of the interventions and to assess 
whether evidence will be available to allow modelling of these consequences.  
 
My notes to ask the PDG from Contraception project: “Do you know of any evidence of a 
relationship between contraceptive use and (i) knowledge of contraception; (ii) intent to use 
contraception; and (iii) service provision.” 
 
My notes and the other modellers suggest that the studies of effectiveness usually have short term 
follow up and that one of the issues within Public Health modelling is in terms of lack of long term 
evidence of the impact of the intervention. This relates to the sixth issue identified within the model 
development framework described by Modeller 2 (risk functions relating risk factors to harm). 
Modeller 2 implied that this is an important issue and said that he wanted to “make clear to the 
research community that long terms impacts are important to collect, and he will be suggesting 
further research within the report”. Within the contraceptive work I have noted: 
 
My notes from Contraception project: “We have one data point (% pregnant) and need to 
extrapolate this over time.” 
 
Modeller 2 highlights that decay in the effectiveness of the interventions needs to be considered, 
which is unlikely to be captured within the short term studies. 
 
Modeller 2 (interview data): “…it became clear that for some interventions like pedometers 
you give somebody a pedometer, they use it for a while, and then they stop using and they are 
back to square one by the end of the year. So you can measure the effectiveness at the three 
months and six months but you also need to account for the fact that there is a decay in 
effectiveness so we had to build in a decay.”  
 
Problems were identified with modelling the outcomes over time for both the comparator and the 
intervention. My notes from the Contraception project suggest that modellers need to distinguish 
between cause and correlation, as was highlighted within Theme 1. Econometric techniques were 
133 
 
used to control for factors which have not or cannot be controlled for within a trial within the 
Contraception project.  
 
Other literature 
One of the major benefits of modelling is to draw together evidence from a wide range of sources.2  
It is useful to know how and why those sources are chosen for the model conceptualisation in order 
to incorporate some guidance about relevant types of sources into the conceptual modelling 
framework. 
 
The modellers from the interviews and the focus group were generally in agreement that they try to 
identify models in the same area near the beginning of the project to see if there is an existing 
model that could be adapted or if there are aspects of them that could help to develop their own 
approach. This may involve a formal systematic review or informal searches.  
 
Modeller 3 (focus group data): “That’s one of the first things we try to do. Is there a model and 
is it fit for purpose for the current decision? Is there a model for a related decision that can be 
adapted?” 
 
One of the modellers also indicated that he tries to identify what is relatively conservative 
methodology and what is more advanced methodology in that area. The modellers suggested that 
experts are consulted, both via the information on their websites and personally, to understand 
alternative methodological approaches and what data are available in that area. 
 
Modeller 2 (interview data): “We had a look at some of the websites from the Department for 
Transport… …and we had at least two teleconferences with people from the Department for 
Transport who are somehow connected with the NICE process to ask them how things work 
there, what they do, what good datasets would be.” 
 
This highlights that different sectors may develop models differently and have different cultural 
norms, as discussed in Theme 1. The modeller proposes understanding what modellers in that area 
do and what datasets may be useful. One of the issues raised within the focus group meeting is the 
difficulty in gathering all of the evidence together because of the diversity of the evidence within 
Public Health economic modelling.  
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Modeller 7 (focus group data): “I think in your more clinical stuff it’s a much more well 
described and scoped problem and it all fits together quite nicely. Whereas here, you’re 
looking over here for information, you’re looking over here for information; there’s this real 
sort of discovery exercise in terms of trying to gather the evidence, and the quality of the 
evidence is variable across that landscape. And you’re doing different things with different bits 
of evidence… …There’s this view (by peer reviewers) that these mixed hierarchies and mixed 
levels of abstraction are fundamentally wrong in some way to do that, in ways that are never 
fully described.”  
 
This highlights that within Public Health economic modelling the evidence is from a much broader 
sphere and the information tends not to be coordinated or designed for use within health economic 
evaluation, such that there may be difficulties with combining these different types of diverse 
sources. Because the quality and type of evidence available are often variable, this leads to different 
levels of abstraction within a model. The modeller emphasises the issue that there may be an 
expectation by peer reviewers that, when synthesising evidence, the level of abstraction will be 
consistent across each part of the model. 
 
The use of the term ‘discovery exercise’ within the above quote suggests that this is not a systematic 
process and indicates a lack of a definable and explicit process when searching within the literature 
to inform the model structure. This may also be why the modellers did not spend much time talking 
about how literature for models is identified. In addition, the modellers did not refer to different 
types of literature such as Psychology and Sociology sources for facilitating the development of the 
model structure, as discussed within Chapter 3. 
 
Communication with the experts and decision makers 
Research around simulation modelling for operations systems suggests that communication with 
experts during model development can have a number of advantages including encouraging learning 
about the problem, developing appropriate model requirements, facilitating model verification and 
validation, helping develop credibility and confidence in the model and its results, guiding model 
development and experimentation, and encouraging creativity in finding a solution.1  
 
Reasons described by the modellers for communication with experts and decision makers included 
finding what modelling work is useful to them, updating them on progress and receiving feedback, 
helping with developing appropriate model assumptions and obtaining data and expertise. 
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Modeller 1 (interview data): “So there are things we’re concentrating on to get some material, 
apart from that its just to update them (the PDG), and see whether we’re doing the right thing, 
what they want, and whether they’ve got any other ideas, because obviously several of them 
are experts in this field, that’s what they’re there for, so they’ll know better than us... 
...Hopefully we’ve picked their brains a bit, and not just got their approval, we need to get 
some constructive criticism out of them as well.” 
 
It is interesting that the modeller has mentioned both ‘doing the right thing’ and ‘what they want’, 
which implies that these are not necessarily the same thing. For all of the reasons for 
communication with the experts described by Modeller 1, they are actively helping to make 
decisions in order to facilitate the model scoping or conceptualisation. The need for the experts to 
actively provide their expertise, rather than more passively agreeing with what has been done is 
clearly highlighted by one of the modellers. The use of language within this text, ‘we need to get 
some constructive criticism out of them’, suggests that the experts are considered by the modellers 
to be a tool for facilitating model development in much the same way as any other source of 
evidence. The same modeller talked about communication with the PDG as a required process.  
 
Modeller 1 (interview data): “So its not specifically the PDG will have to tell us what this is, its 
more of a we’re going to talk to them anyway so we might as well see what they want and 
what their opinions are, rather than just going ahead and then they say you shouldn’t have 
done it that way, we want something else.” 
 
This intimates that it is more efficient to obtain the PDG’s input at an earlier stage in the process 
rather than having to amend the model at a later stage as a result of feedback. One of the members 
of the focus group also stressed the importance of involving experts in the early discussions to give 
an idea of the issues that they think will be relevant. The same modeller also emphasised the 
importance of credibility. 
 
Modeller 3 (focus group data): “There is always a chance that the decision maker, even if 
they’ve commissioned the model, may decide not to use it. So we have to present the model in 
a way that actually they will believe the results, and that means if there’s something that they 
want to see there, it’s got to be there.” 
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This highlights that it is important for the decision makers to know how the model works and what 
assumptions it is comprised of. The modeller also implies that even if something does not impact 
upon the model results, it may be important to include it so that the decision makers are happy with 
the model. The modellers within the focus group generally agreed that it is important to have a 
shared understanding between the modelling team and the decision makers. 
 
The modellers also considered the impact of the process from the perspective of the experts and 
decision makers and the implications of this.  
 
Modeller 1 (interview data): “In fact, all they (the PDG) want from us is a cost per QALY at the 
end of it I guess; really just one number in amongst all the other considerations, so maybe they 
haven’t put a great deal of thought into what they want.”  
 
This suggests the possibility that the PDG members may be waiting for the model results before they 
provide input because of their other priorities within the process. There may be a lack of 
understanding of what would be helpful to the modelling team throughout the process. This is in 
conflict with the idea of efficiency of communication with the PDG at an early stage in the modelling 
process, and hence it seems important to align these expectations of the modellers and the experts 
and decision makers, as was highlighted by one of the focus group members. In contrast to Modeller 
1’s view above, some of the modellers within the focus group meeting agreed that the development 
of the model could be used as a tool for thinking about the issues for the stakeholders. 
 
Modeller 4 (focus group data): “...sometimes the model is just a tool for deliberation. It’s like a 
numerical thought experiment that gets the people in whatever committee it is that are having 
to develop and finalise this policy thinking about the issues in a different way, so then I don’t 
know if heuristic is the right word, but it just serves as an on-the-hoof learning device about 
what are the implications of us making the policy in this way as opposed to this way.” 
 
The modeller implies that the model can provide an alternative way of understanding the issues 
which can then allow learning about the potential impact of interventions which otherwise may not 
be possible. The data above refers to the implemented model, however some of the modellers also 
talked about this being an outcome of the model development process itself. 
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The modellers who were interviewed mentioned that it may be that the PDG members can provide 
more useful input into the modelling work if they have some initial work to critique rather than 
being asked more broad questions.  
 
Modeller 2 (interview data): “So had we gone on Tuesday and just waffled about the 
framework again it would have been a waste of their time and our time, so I insisted that we 
get nitty gritty because they said we are happy with the framework, we can give better 
feedback when we get nitty gritty.” 
 
Within the interviews Modeller 2 explained that ‘nitty gritty’ meant “data, specifics, how we are 
going to do stuff”. This highlights the iterative nature of model conceptualisation and obtaining 
expert advice, in much the same way as the iterative use of other evidence has been described. The 
modellers agreed within the focus group that the use of the PDG within NICE projects is good 
because it is an iterative process where the committee are not just being shown the finalised model, 
and because “the development of the model and the choices about what the model’s going to be for, 
were done jointly together in a very large group, who were very sensibly the same group who were 
also beginning to flesh out and think well what pieces of recommendation, on the basis of the 
effectiveness evidence (are we developing).” 
 
Based upon my notes from the Walking and Cycling PDG meetings, generally the modellers 
presented something to the PDG and they provided feedback or asked questions about the 
assumptions. This generated some discussion, from which either a decision about how to proceed 
was made, or the modellers subsequently made a decision about how to proceed following the PDG 
meeting which was discussed at the next meeting. 
 
Within PDG1 of the Walking and Cycling project, the presentation by the modelling team focused 
upon what they were doing and what data they were using, rather than why they were doing it. 
However, some of the PDG asked questions about why certain analysis was being done. My notes 
state: 
 
My notes from Walking and Cycling PDG meeting: “The PDG had less than ten minutes to 
comment on the presentation and only 4 or 5 PDG members out of 11 provided feedback. It is 
only the subset of PDG members that are familiar with economics which input into this 
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feedback. The majority of this was about data sources the PDG knew of rather than decisions 
about what to include and exclude within the model.” 
 
This suggests that PDG members who have no economic background may feel less confident about 
providing input into the modelling work. It also highlights the constraints of the process upon the 
stakeholders’ involvement in the modelling work. Within this PDG 1 meeting held near the start of 
the project there was a focus upon data sources. During the project, the modellers asked the PDG 
about a wide range of information including current service provision within England and Wales, 
identification of data sources, reasons for data not tallying, and appropriateness of structural 
assumptions, as well as methodological input from the Walking and Cycling economic subgroup.  
 
Within both the Walking and Cycling and the Contraception project recommendations were 
suggested by the PDG based upon the short term effectiveness studies and then the modelling was 
used to assess whether the interventions recommended were cost-effective almost as a distinct 
stage in the process. Modelling did not take a central role in understanding the problem or helping 
to develop the initial recommendations through estimating the long term intervention effectiveness.  
 
Within one of the Walking and Cycling PDG meetings, I noted that there is “very little discussion of 
the long term effectiveness; much more focus on generalisability of short term outcomes”. However 
three PDG members did ask about long term evidence and the review group reported that this was 
presented within the evidence review where available. The modelling team were not present at this 
part of the meeting to promote a more detailed discussion about this, which may have been useful. 
However, Modeller 2 indicates that the experts and decision makers place much more weight on the 
effectiveness outcomes from the modelling work than upon the cost estimates within the model. 
 
Modeller 2 (interview data): “…And nobody has got any idea about whether those costs are 
right, except you play them in front of people and nobody says anything. So they could easily 
be 50% wrong in any direction… …and you can talk for hours about the effectiveness evidence 
and do days and days worth of work and literally I would say all the costings were done in one 
day.”  
 
Modeller 2 is suggesting that the amount of time spent on the effectiveness and the costs is 
inappropriately imbalanced. It highlights the great influence that the process, culture and the 
experts must have upon the modelling work, since it is the modeller who is so openly unhappy about 
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this process, and yet it is him that has developed the model in this way. It is unclear whether he is 
suggesting that the experts and decision makers were not interested in the cost-effectiveness 
estimates generally or whether they were not interested in the costing assumptions resulting in 
those estimates.  
 
Within the focus group meeting there was a discussion about who should provide expert advice 
during model development. It was stated that some experts see cost-effectiveness modelling and 
the decision-making process as a “threat to their autonomy” or “fundamentally object to decision 
modelling”. One of the modellers indicated that there may be ongoing debates within a topic area, 
such as valuation of alcohol pleasure, which experts may feel strongly about, and the modelling 
team needs to be aware of this. One of the modellers within the focus group meeting suggested that 
the choice of experts could affect the interventions and comparators modelled. 
 
Modeller 4 (focus group data): “I think in public health it’s more likely that you’ll end up with a 
few, a much more limited range of ways of specifying a given policy. And it’s those specific 
ways that are chosen to be modelled which will be driven by that kind of committee preference 
and what they think the country will find palatable at this point in time.”  
 
This modeller indicates that the policies evaluated within a model are constrained by what the 
committee believe to be politically and culturally acceptable. The use of the term ‘palatable’ 
suggests that any highly controversial topics and approaches will be avoided. This means that there 
is likely to be a higher level of agreement between stakeholders than if more controversial topics 
were considered or if the decision problems were divided up differently (see Chapter 3 for discussion 
of stakeholder agreement). The modeller also implies that the choice of committee could affect 
what interventions are assessed within the model. For example, within the Contraception Project, 
one of the interventions modelled was dispensing condoms in schools. Other committees during 
different political times may have decided that that was not an appropriate intervention to model 
given the law on sexual activity below age 16. Modeller 5 suggested that to obtain an overview of 
what people think in a particular area, one idea is to go to a conference on that subject if one exists, 
and another is to “think from the outset, can we get some dissenting voices that actually have a 
stake in the other direction”. 
 
Within the second economic subgroup meeting on the Walking and Cycling project, whilst the 
members of NICE involved with this project were generally happy with the work that had been done, 
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they said that they thought “the draft economic modelling report was too difficult to understand”. It 
is unclear whether this meant that it was too difficult for them to understand personally or too 
difficult for a lay person to understand; however it illustrates that clear written communication for a 
non-technical audience is important. 
 
Theme 2 Summary 
The data suggest that modellers inevitably iterate between model conceptualisation and collection 
of evidence by oscillating between setting hypotheses, testing them with evidence and then 
generating new hypotheses. This applies to all types of evidence including the effectiveness studies 
and communication with decision makers and experts. Different modellers use data in different 
capacities during model conceptualisation. Given more time for a project, it may be more feasible to 
think about the model structure without considering data availability; however, given tight project 
timeframes where it is unlikely to be possible to collect more data, it is necessary to think about data 
availability at an early stage in the process as it is likely that potential model structures need to be 
modified accordingly. Modellers suggest that limited data availability may lead to the purpose of the 
model changing so that it becomes more exploratory, which may change structural decisions. 
However, models within Public Health economic evaluation need to estimate what will happen in 
the future and are thus inevitably causal, and as such it is not possible to have all of the required 
data. 
 
Modellers suggest that within Public Health economic modelling the evidence is from a much 
broader sphere than for modelling of clinical interventions and the information tends not to be 
coordinated or designed for use within health economic evaluation. Thus there may be difficulties 
with combining these different types of diverse evidence and different levels of abstraction may be 
required within the same model, which may cause criticism of the model. When the scope of the 
model extends beyond health, it is important for modellers to understand the modelling methods 
and outcomes in these other sectors. Models may also be improved via exploration of different 
types of literature such as Psychology and Sociology sources for facilitating descriptions of how 
behaviour might affect outcomes. 
 
The effectiveness studies often do not capture all relevant consequences of the comparators and 
interventions and there is generally no long term follow up within the effectiveness studies. 
Therefore, modelling could take a more central role in understanding the problem and helping 
stakeholders understand the possible long term effectiveness of the interventions. Econometric 
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techniques could be used to help distinguish between cause and correlation. The data suggest that 
lack of evidence may sometimes prevent subgroup analyses and limit the interventions assessed. 
Interventions may be diverse, making them difficult to compare. There is variability around how the 
short term effectiveness evidence is employed; however the modellers tend to view the 
construction and development of the review of effectiveness evidence as the job of the reviewers, 
with the modellers generally only making use of the output of the review. It may be more useful for 
the modeller to be involved throughout the development of the review and this process is 
considered further within Chapter 6. 
 
Modellers use other people’s models and consult other experts in order to help develop their own 
approach. The data suggest that experts and decision makers are actively involved in helping 
modellers make decisions about model scope and structure by discussing what is useful to them and 
providing feedback on the work in terms of current service provision, identification of data sources, 
reasons for data not tallying, appropriateness of structural assumptions, and methodological input. 
The choice of experts could affect what interventions and populations are modelled. The experts 
seem to provide more useful input into the modelling work if they have some initial work to critique 
rather than being asked more broad questions. It also seems important to align the experts’ and 
decision makers’ expectations of the process and their requirements with the modellers’ 
expectations. Moreover, the decision making process has a substantial impact upon the modelling 
work due to cultural norms. Different projects may require different processes to be followed. 
 
The data suggest that a shared understanding of how the model works and what assumptions are 
being made between the modelling team and the decision makers and experts is beneficial because 
it encourages learning about the problem as well as confidence in the model results. An iterative 
process with the experts seems to be useful. The model development process and the model itself 
may be used as a tool for thinking. Modellers should be aware of any ongoing issues of social 
judgement within the topic area. In addition, the report to the experts and decision makers needs to 
be communicated in such a way that they understand what has been done without requiring an 
extensive mathematical background.  
 
Theme 3: Barriers and benefits of a conceptual modelling framework 
It is important to understand the potential barriers and benefits of a conceptual modelling 
framework within Public Health economic modelling so that these can be considered during the 
conceptual modelling framework design. This theme is divided into three subthemes: (i) Potential 
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barriers associated with the adoption of a conceptual modelling framework; (ii) Possible constraints 
upon a conceptual modelling framework; and (iii) Potential benefits of a conceptual modelling 
framework. 
 
Potential barriers associated with the adoption of a conceptual modelling framework 
In order to attempt to address, during methods development, any potential barriers associated with 
the use of a conceptual modelling framework for Public Health economic evaluation, it is useful to 
understand modellers’ perceived barriers to the adoption of such a framework. 
 
One of the modellers from both the interviews and the focus group indicated that some modellers 
may resist guidance around developing the model structures of Public Health economic models. 
 
Modeller 7 (focus group data): “If I was at my most pessimistic… …all of this soft stuff that 
we’ve been discussing it is experiential almost, it’s like an art. And there’s also an almost 
personal, even if you’re working in a team, there’s a sort of human factor, personal element to 
it that it comes about through a process of osmosis and working with other experts, and 
there’s some sort of, there’s something to it this element of quality, if you like, to it, that makes 
a reductionist approach to this issue (big pause) unpalatable… …I can feel myself sort of 
resistance to doing that, you know this is how I go about doing conceptual modelling or 
problem structuring and talking to different people and I don’t need some flow chart to sort of 
help me with that... ...That you don’t apply the same modelling methods to your own process 
of modelling, I think there’s something like that going on.” 
 
The modeller identifies the conceptual modelling process as an art rather than a science, as it has 
been described within some of the literature (see discussion within Chapter 1). He suggests that it 
requires the input of other experts and it is not possible to follow set rules to undertake the process. 
He uses the term ‘reductionist’ to describe such an approach which implies that he thinks it is not 
possible to capture the complexity of the process within a conceptual modelling framework. As a 
result, he feels he would resist trying to follow this sort of guidance. He highlights that each modeller 
does not even have a consistent approach to the conceptual modelling process between their own 
individual projects, and consequently he intimates that it does not seem possible to develop 
successful guidance for all modellers to follow.   
 
143 
 
Not all of the modellers felt this way; however the focus group modellers all agreed that it was 
important that the conceptual modelling framework was not imposed on modellers as something 
they need to adhere to. Modeller 3 emphasised that “it must not contain the word ‘must’!” In 
addition, Modeller 4 said that he would try using the guidance, but may stop using it if he found it 
restrictive and he implied that it should not be hard to use in practice, since this may be a barrier to 
the use of the conceptual modelling framework. 
 
One of the modellers who was interviewed highlighted an issue of generalisability of a conceptual 
modelling framework outside of the UK decision making process. 
 
Modeller 2 (interview data): “But I think as well there will be an issue of generalisability with 
the work that you are doing and about to do; how that would feel in the US in the Harvard 
School of public health, or in Brazil or in the World Health Organisation in Geneva, or in India 
might be very different.”  
 
He suggests that a conceptual modelling framework for the UK Public Health decision making 
process might not be applicable to the decision making processes in other countries. In addition, 
Modeller 2 states that it is important not to over claim on what the conceptual modelling framework 
can do. 
 
Modeller 2 (interview data): “…one of the barriers is that if you over claim on the power of the 
conceptual model and disappoint modellers and stakeholders and analysts that when you tried 
it it cannot deliver with this value, then it can get chucked aside.” 
 
Modeller 2 is suggesting that it is important to be clear about what the conceptual modelling 
framework can and cannot do so that when it is employed it provides the guidance that the user is 
expecting, or there is a risk that people will be disappointed with it and it will not be reused.  
 
Possible constraints upon a conceptual modelling framework 
It is important to understand the possible constraints upon a conceptual modelling framework for 
Public Health economic modelling so that these can be considered within the framework. 
 
The modellers proposed several possible constraints within which the conceptual modelling 
framework may need to be designed to operate within. These included practical considerations 
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within the decision making process such as time requirements and modellers’ skills, as well as 
cultural acceptability of the requirements of the conceptual modelling framework. 
 
Modeller 2 (interview data): “I think it’s going to be time, fit, cultural acceptability to both the 
client and the stakeholders and the modellers, the data custodians.” 
 
Modeller 2 suggests that one of the constraints for a conceptual modelling framework is that it 
needs to be acceptable for use within the decision making process which means that it must be a 
credible approach for the modellers, the client and the stakeholders to employ. For example, the 
modeller recommends that the conceptual modelling framework should be sensitive to the time 
available and the processes followed within the decision making process. Within Theme 2 one of the 
modellers intimates that insufficient time is spent on costing the interventions, however I would 
suggest that part of the reason may be because this is considered to be an appropriate part of the 
process by the experts and decision makers i.e. it is culturally acceptable.  
 
The modellers within the focus group also discussed the constraints associated with the skills of the 
modellers, as was described within Theme 1. 
  
Modeller 4 (focus group data): “...we’re all limited by the modelling tools... ...And I guess that 
always inevitably limits the scope of structures and methods that you use.” 
 
It is thus important that a conceptual modelling framework should take this into account.  
 
Within the focus group meeting, Modeller 4 highlighted that there may be a ‘conceptual model’ 
already developed by other parts of the team or the decision makers to understand the problem.  
 
Modeller 4 (focus group data): “…there will be a conceptual model there already, developed by 
either the other parts of the team, or by NICE… …And for us to go off in a different direction 
with our modelling and either completely ignore that model or not try and create a model 
that’s somehow emulated their breakdown of how the problem unfolds would have created 
problems.” 
 
The modeller highlights that it is important not to ignore any conceptual models developed by other 
parts of the team or to do something different from what they have developed. Thus it will be 
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important to consider and use these other diagrams developed within the process within the 
conceptual modelling framework. 
 
Potential benefits of a conceptual modelling framework 
It is useful to understand the potential benefits of a conceptual modelling framework for Public 
Health economic evaluation so that, where appropriate, these can be captured within the 
framework. 
 
The modellers generally agreed that a conceptual modelling framework could help with 
communication. This includes communication between people within the modelling team, with the 
systematic reviewers, and with the stakeholders and decision makers. When asked about the 
benefits and barriers of a conceptual modelling framework, one of the modellers within the focus 
group described how communication with stakeholders may help. 
 
Modeller 6 (focus group data): “Do you think it’ll be useful for the stakeholders? Because you 
know so many people talk about the black box and you’re privileged and experienced enough 
to understand what goes into that black box. But many people use the information and it can 
all just seem like magic. So conceptualisation, even if some of it could be argued against, at 
least it might provide a sort of framework for stakeholders to, perhaps a simplified way for 
them to understand what we’re trying to do?” 
 
This modeller from the focus group meeting uses the terms ‘black box’ and ‘magic’ to describe some 
stakeholders’ perceptions of Public Health economic models, because they may understand the 
model outputs but they may not understand how those outputs are produced. She suggests that 
some form of conceptual modelling might help with this. Similarly, within the interviews, Modeller 2 
indicated that conceptual modelling is important for communication. 
 
Modeller 2 (interview data): “But I do think that the conceptual model... ...is a boundary 
object... ...the central purpose of the pathways model wasn’t to develop the model it had a 
social purpose which was to act as something that all people from different places could 
engage with kind of like Strictly Come Dancing for a family; you can all sit there and watch and 
laugh at what’s his name in his gold suit.” 
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The use of the term ‘boundary object’ was originally defined by Star (1989) as ‘those objects that are 
plastic enough to be adaptable across multiple viewpoints, yet maintain continuity of identity.’162 
Using the metaphor of Strictly Come Dancing, the modeller explains that a conceptual model would 
allow people from different social groups to communicate and take action, without everyone having 
to understand exactly how it is being used by each of the involved groups. This means that all 
stakeholders could communicate their expertise and assumptions and understand those of the other 
stakeholders, so that all assumptions can be questioned.  
 
The modellers also generally agreed that a conceptual modelling framework could be used to help 
the modeller themselves in understanding the problem. 
 
Modeller 7 (focus group data): “... helping us to understand, to try and understand the causal 
pathway, so there’s an understanding for us in developing that conceptual model.” 
 
One of the modellers suggested that a conceptual model “...helps the audience and the modeller be 
clear about what’s in the model and what’s not in the model”, which the other modellers from the 
focus group agreed with. 
 
The modellers intimated that it would be helpful within a conceptual modelling framework to 
provide methods for deciding which simplifications are viable and acceptable and which are not. 
 
Modeller 2 (interview data): “When you are modelling you will take some short cuts, you will 
say that is good enough for that bit... ...The problem is that in an application in a quantified 
model there might be 20 such short cuts and you would like your conceptual modelling 
framework or something about theory or something to help you decide which of those short 
cuts is viable and acceptable and which are over simplifications and need breaking out.”  
 
This modeller uses the term ‘short cuts’ to mean simplifying assumptions within the model. The idea 
of a short cut is that you come out where you would have done if you had taken the alternative 
route but it is quicker, and this is the aim of short cuts within the modelling work; we wish the result 
to be in the same vicinity as if a more complex option had been taken. Modeller 2 indicates that the 
problem is that there are a lot of these decisions to make about how to simplify the model and that 
it would be useful for the conceptual modelling framework to help make these decisions.  
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Within the focus group meeting, modeller 5 suggested that they could “...see the value of an 
educational tool with some examples and principles to say well these are some things you might 
consider as you develop your models, especially for junior modellers, for whom there’s a lot of these 
unconscious processes that could be made explicit for them.” Here the modeller highlights that there 
are a lot of processes which are currently not explicit for which it would be helpful if they were, 
especially for junior modellers. The modeller also proposes using some examples within the 
conceptual modelling framework to illustrate what is being said.  
 
Theme 3 Summary 
The data suggest that some modellers may not be happy adopting a conceptual modelling 
framework, particularly if it is too prescriptive. One modeller raised the issue that we do not follow 
the same conceptualisation process ourselves for each project, so it may be difficult to develop a 
framework that is helpful to all modellers for all projects. The modeller suggests that 
conceptualisation is more of an art than a science, as discussed within Chapter 1. The modellers 
agreed that a conceptual modelling framework should not be imposed on modellers and should not 
contain words such as ‘must’. However, the modellers generally could see value in an educational 
tool with some examples and principles to make the process explicit, especially for junior modellers. 
In addition, the modellers agreed that a conceptual modelling framework should not be restrictive, 
but it should take into account that modellers will have different skill sets. The framework should 
not be hard to use in practice and should be culturally acceptable. It is also important not to over 
claim on what a conceptual modelling framework will do and it may not be possible to generalise to 
all Public Health economic modelling contexts. 
 
The data suggest that it would be useful if the conceptual modelling framework helped the modeller 
to judge what would be appropriate simplifications of the problem. The framework should also 
consider any diagrams developed by other parts of the team on the same project. Examples could 
also be used to illustrate the approach. The modellers suggest that one of the benefits of a 
conceptual modelling framework would be that it allows communication with the project team and 
stakeholders and that it helps these and the modeller to be clear about what is included and what is 
excluded from the model. A conceptual modelling framework could also be used to help the 
modeller themselves in understanding the problem.  
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5.4 Discussion 
The outcomes of this qualitative research are generally consistent with the literature in the small 
number of instances where literature is available. For example, in the study by Chilcott et al. on 
avoiding and identifying errors for the Health Technology Assessment programme, one of the key 
findings of the study was that the stages of model development within health economic evaluation 
are not well defined,17 as was suggested by the modellers within this qualitative research.  Within 
the same study, Chilcott et al. suggest that some health economic modellers divide model 
conceptualisation and model implementation into two stages, whilst others do not distinguish 
between the two.17  In general, the modellers within this qualitative research did not distinguish 
between these two stages. This qualitative research highlighted a number of advantages of 
conceptual modelling frameworks including helping the modeller and stakeholders understand the 
problem, facilitating communication between the modellers, other members of the team, decision 
makers and experts, and helping develop credibility and confidence in the model and its results. 
These are consistent with research about simulation modelling for operations systems by Robinson 
et al.1  
 
The modellers suggested that the model structure would be driven by the interventions being 
assessed. However, across the themes identified, the modellers were inconsistent with respect to 
how interventions would be chosen for assessment within the model. They suggested that: (i) the 
reviewers chose them based upon an evidence review; (ii) experts or decision makers chose them, 
based upon an evidence review and/or based upon what is considered to be culturally and politically 
acceptable; and (iii) decision makers specify them given shorter timeframes, but given longer 
timeframes they may be specified based upon the modelling activity. This suggests that there is 
substantial variability associated with defining interventions, which the modellers described drives 
the model structure. Within the literature it is suggested that decisions made by the government 
and organisations are dependent upon public readiness for the intervention being considered.163  As 
such it follows that the decision makers will, as a minimum, be involved in making these decisions if 
the interventions are controversial. The way in which to choose which options to assess within the 
model was considered in more depth within the review of conceptual modelling frameworks within 
Chapter 4.  
 
The modellers describe activities associated with understanding the problem and making 
judgements about the model structure; however the distinction made between these two activities 
is less prominent compared with the distinction made within most of the conceptual modelling 
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frameworks reviewed within Chapter 4. In practice, the iterative nature of model development and 
the lack of a formal process for conceptual modelling may mean that modellers are not conscious of 
the two different activities. 
 
Modellers are however acutely aware of the time and resource constraints of the project. This is 
consistent with the literature where the importance of these constraints has been highlighted within 
the defined purpose of a decision model. Griffin et al. state that this purpose is ‘to provide unbiased 
estimates of expected costs and effects, and of decision uncertainty, in a timely fashion and within 
resource constraints as determined by the decision-maker that commissions the model.’164 
 
The modellers raised many of the issues described within Chapter 2 about the key challenges of 
Public Health economic modelling, including issues with incorporating relevant costs and outcomes, 
the relevant perspective and the inclusion of unintended consequences. However, whilst a couple of 
the modellers touched on the issue of dynamic complexity, it was not apparent that the majority of 
the modellers had a thorough grasp of the implications of Public Health systems being complex 
systems and it was not something which they generally reported as a key concern. 
 
There are several outcomes identified within this research which to my knowledge have not 
previously been raised within published literature. These comprise: 
 General requirements of a conceptual modelling framework for Public Health economic 
evaluation (see Section 5.5; points 1 - 17); 
 The identification of specific considerations for modellers of Public Health economic models 
including: 
o Encouraging understanding of the modelling requirements in other sectors when the scope 
of the model extends beyond health and wellbeing; 
o Considering whether behaviour is being prevented or delayed; 
o Encouraging reflection upon whether there are other consequences not considered by the 
effectiveness studies; 
o Considering whether a more exploratory analysis may be more useful given the time and 
data constraints. 
 
One clear omission from the data collected here is how evidence is used within model development.  
For example, evidence may be used for a wide range of reasons during the development of the 
model structure including testing a possible model structure which is based on theory, comparing 
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against other evidence to decide on a model structure, or refining a model structure. Similarly, the 
modellers did not spend much time talking about how literature for developing model structures is 
identified. The lack of data in this area is not a result of this not being included within the topic 
guide, but may be due to the lack of an explicit definable process. Apart from discussions about the 
effectiveness review and previous Public Health economic models and databases (which were not 
described further), the data sources used to develop the model structure were not described by the 
interviewees or the focus group participants. Recently a PhD thesis by Paisley has suggested that 
modellers tend to begin with high yield sources and develop further searches for evidence based 
upon these in order to develop their understanding of the problem and the model structure.63  This 
is discussed further within Chapter 6. Notably, the modellers did not refer to different types of 
literature such as Psychology and Sociology sources for facilitating the development of the model 
structure, as discussed within Chapter 2. The modellers suggested that there is a need to specify 
what is excluded from the model. Paisley suggests that the scope is defined by what is excluded 
rather than what is included since what is excluded helps to justify what is included.63   
 
As described within Chapter 1, this work follows an interpretivist epistemology and a subtle realist 
ontological perspective. I have described the systematic methods which have led to the outcomes of 
this research and reflected upon the possible meanings of the data in order to present a valid and 
reliable analysis. Although my notes from the Contraception project were written prior to this 
research, I knew how it was developed and why, and the analysis of these data was systematic. It 
thus seemed preferable to include this valuable information within the analysis, than to discard it 
because it was not collected as part of this research. The use of these notes provided additional 
reflection on developing the model structure within the time and resource constraints of the project, 
and had the advantage that the notes were not affected by the research project in any way.  
 
The participants involved within the qualitative research were from six different institutions within 
the UK, and whilst data were not collected to the point at which theoretical saturation was reached 
due to time and resource constraints, there was substantial resonance between participants on 
these issues. Thus, the outcomes of this qualitative research should facilitate the development of a 
conceptual modelling framework which is appropriate for modellers within UK Public Health 
economic modelling. It may not be possible to generalise this research to other public health 
decision making jurisdictions outside of the UK because there were no non-UK participants and 
hence it would be useful to test the conceptual modelling framework developed outside of the UK as 
further research. 
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5.5 Chapter summary and implications for methods development 
This chapter presented qualitative data collection and analysis to describe modellers’ experiences 
with developing the structure of Public Health economic models and their views about the benefits 
and barriers of using a conceptual modelling framework. The implications of the qualitative data 
collection and analysis for the development of the requirements of a conceptual modelling 
framework are that it should aim to: 
1) Be clear about what it can and cannot do; 
2) Not constrain the decision making process; 
3) Take into account that modellers have different skill sets and encourage modellers to recognise 
potential skill set biases and moderate impact; 
4) Be simple to use in practice and be culturally acceptable; 
5) Consider any diagrams developed by other parts of the team on the project; 
6) Provide a general outline of the model development process in Public Health economic 
modelling; 
7) Provide a tool for communication with the project team and stakeholders; 
8) Consider the trade off between developing an appropriate structure for the problem versus 
ability to meet deadlines; 
9) Help modellers determine appropriate and inappropriate simplifications of the problem; 
10) Encourage the use of modelling for helping stakeholders to develop policy recommendations via 
increasing their understanding of the problem and estimating long term effectiveness, as well as 
by producing cost-effectiveness estimates. 
11) Incorporate the iterative nature of model development between model conceptualisation and 
data collection. Given tight project timeframes where it is unlikely to be possible to collect more 
data, it is necessary to think about data availability at an early stage in the process; 
12) Highlight the difference between cause and correlation and suggest techniques for disentangling 
this such as econometric techniques; 
13) Facilitate a clear description of the methods for the report to stakeholders, including highlighting 
ways of communicating what is not in the final quantitative model; 
14) Consider, in some form, each of the following: (i) classifying and defining population subgroups 
of interest, (ii) identifying and defining harms and outcomes for inclusion in the model, (iii) 
thinking about modifiable components of risk, (iv) specifying the baseline position on policy 
variables, (v) estimating the effects of changing the policy variables on the risk factors, (vi) risk 
functions relating to risk factors to harm, (vii) monetary valuation. 
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15) Include an example to illustrate the methods; 
16) Provide a transparent approach for choosing model interventions; 
17) Consider a process for searching for evidence to develop the model structure; 
18) Encourage the modeller to think about:   
a) Helping decision makers make decisions, as opposed to trying to reproduce reality; 
b) Fully understanding the implications of the structural choices that they make; 
c) At an early stage, developing an understanding of the question and the interventions and 
the model population and subgroups of interest; 
d) The trade-off between providing stakeholders with something to critique and limiting their 
thinking; 
e) Evidence requirements; 
f) The most appropriate outcome measure and perspective to report to decision makers; 
g) Heterogeneity and whether there are any appropriate subgroups, including socioeconomic 
status; 
h) Whether there are other consequences (positive or negative) not considered by the 
effectiveness studies; 
i) Intergenerational impacts; 
j) Whether behaviour is being prevented or delayed; 
k) The exact meaning of topic specific terminology which also has a lay meaning; 
l) Questioning the assumptions of the experts and decision makers; 
m) The likely cost-effectiveness of the intervention;  
n) Consideration of equity and the social gradient; 
o) The influence of standard methods guidance (eg. NICE methods guide); 
p) The constraints of the project scope; 
q) Use of existing models in the same area; 
r) Understand the modelling requirements in other sectors when the scope of the model 
extends beyond health; 
s) The choice of experts and the implications of these choices; 
t) The impact of interactions and heterogeneity upon model type; 
u) Aligning the stakeholders’ expectations of the process and their requirements with the 
modellers’ expectations; 
v) Whether a more exploratory analysis may be more useful given the time and data 
constraints.  
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Chapter 6: Critical reflections upon a diabetes 
prevention case study 
 
6.1 Chapter outline  
A draft conceptual modelling framework was developed based upon the research presented within 
Chapters 2 – 5. This chapter aims to describe my experience and critical reflections on the use of this 
draft conceptual modelling framework within a case study assessing the cost-effectiveness of 
screening and prevention interventions for type 2 diabetes in order to further develop the 
conceptual modelling framework. Section 6.2 describes the methods of analysis employed within the 
chapter and Section 6.3 describes a brief overview of the conceptual modelling framework in order 
to place the reflections upon the diabetes project in context (Chapter 7 presents the full revised 
conceptual modelling framework resulting from the research undertaken within Chapters 2 – 5 and 
this critical reflection). Section 6.4 describes the case study around the cost-effectiveness of 
screening and prevention interventions for type 2 diabetes and Section 6.5 describes my reflections 
upon the use of the draft conceptual modelling framework within the case study. Finally Section 6.6 
summarises the key implications of these reflections upon methods development.  
 
6.2 Methods of analysis 
As described within Chapter 1, all of the research undertaken within this thesis follows a cyclical 
learning process of diagnosis, planning, analysis and reflection. Following multiple cycles of this 
process, I piloted the draft conceptual modelling framework within a diabetes prevention case study 
and reflected upon its use in order to develop the framework further. My reflections upon the use of 
the earlier stages of the draft conceptual modelling framework in some cases led to modifications of 
aspects of later stages of the framework, through a process of diagnosis and planning, prior to these 
later stages being tested within the diabetes case study. These were subsequently tested within the 
case study, followed by further reflection, diagnosis and planning.   
 
The approach taken within this chapter is critical reflection and, as such, the chapter takes a more 
exploratory perspective. As such, this chapter is written in the first person. However, the reader 
should note the change in the style of writing within this chapter compared with the preceding 
chapters. Reflective writing involves a description of the situation and attempts to find meaning 
within this, supported by ideas and theories.165  Critical reflection also involves consideration of the 
broader context associated with the situation. Throughout the chapter, I reflect upon my learning in 
a systematic way by (1) outlining the relevant guidance within the draft conceptual modelling 
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framework (the data); (2) describing what happened within the diabetes project; and (3) critically 
reflecting upon this data. The resulting revisions to the conceptual modelling framework are 
outlined within Section 6.6. To aid the critical reflection I drew upon a list of questions from the book 
titled ‘Practising critical reflection: a resource handbook’ by Fook and Gardner.165 
 
6.3 Brief overview of the draft conceptual modelling framework 
A draft conceptual modelling framework was developed based upon the research presented within 
Chapters 2 – 5. The conceptual modelling framework following revisions based upon the reflections 
from this case study is described within Chapter 7, along with the justification for each part of the 
framework. In order to put the reflections upon the diabetes project into context, a brief outline of 
the draft conceptual modelling framework is required here (although all of the detail is omitted).  
 
The draft conceptual modelling framework comprises four key principles of good practice, a 
proposed methodology and some suggestions for processes which may be followed if considered 
appropriate. In order to develop valid, credible and feasible Public Health economic models, the four 
key principles of good practice are that; (1) a systems approach to Public Health modelling should be 
taken; (2) developing a thorough documented understanding of the problem is imperative prior to 
and alongside developing and justifying the model structure; (3) strong communication with 
stakeholders and members of the team throughout model development is essential; and (4) a 
systematic consideration of the determinants of health is central to identifying all key impacts of the 
interventions within Public Health economic modelling. 
 
An outline of the approach described by the draft conceptual modelling framework is shown in 
Figure 6.1.  
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Figure 6.1: Overview of draft conceptual modelling framework for Public Health economic evaluation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.4 The diabetes project 
Aims and objectives of the diabetes project 
Two diabetes prevention / screening models have previously been developed within ScHARR; one to 
assess the effectiveness and cost-effectiveness of lifestyle interventions to prevent type 2 diabetes; 
and one to assess the effectiveness and cost-effectiveness of different screening options for 
Impaired Glucose Tolerance (raised blood glucose levels) and type 2 diabetes. It is not possible 
within these models to compare the cost-effectiveness of screening with lifestyle interventions since 
the models consist of different structural assumptions, particularly relating to the disease natural 
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history of diabetes and its associated complications. Thus, a third diabetes project was proposed to 
develop a model which is able to compare these interventions in a consistent and appropriate way 
with the aim of supporting commissioners of Public Health services and other stakeholders in their 
decision making. This third diabetes project, referred to hereafter as ‘the diabetes project’, was used 
to pilot the draft conceptual modelling framework. The diabetes project is a two year project which 
was funded by the NIHR as part of collaborative research between eight leading academic centres in 
England within the NIHR School for Public Health Research.  
 
Why use this project as a case study? 
This project was chosen for its suitability and its timing relative to this research. A key part of the 
project involved conceptualising the model structure and it began at the point when I had developed 
a draft conceptual modelling framework. Some of the features of the diabetes project are different 
to the other key Public Health research projects that have contributed to the development of the 
draft conceptual modelling framework including the Contraception Project and the Walking and 
Cycling project.166;167  For example, there is greater data availability and there are a substantial 
number of existing health economic models assessing diabetes prevention and screening 
interventions. In addition, the project proposal was developed by modellers based upon previous 
research rather than the requests of specific decision makers. Thus, there was more flexibility in 
terms of the project process compared with some decision making arenas and it was our 
responsibility to identify all stakeholders. These differences were beneficial because it facilitated 
consideration of whether the conceptual modelling framework is sufficiently flexible for a variety of 
types of problems and decision making arenas. 
 
The diabetes project continues until March 2014; however the main part of the conceptual 
modelling had been completed by March 2013. The draft results of the model will be discussed at 
the third stakeholder workshop in January 2014. The intention of this case study is not to consider 
the impact of the conceptual modelling framework upon the model results, but to reflect upon the 
use of the framework for developing the model structure. 
 
Key documentation developed during the project 
The data associated with the critical reflection, including the conceptual modelling protocol and 
discussion documents for stakeholders, are shown in Appendix D and these are referred to where 
appropriate throughout the chapter. 
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Key roles within the diabetes project 
My role within the diabetes project was to undertake the conceptual modelling using the draft 
framework. The rest of the project team consisted of two project leads who jointly managed the 
project, an expert in diabetes modelling who had developed the previous two ScHARR type 2 
diabetes models and provided advice throughout model development, an information specialist who 
undertook the literature searches and reviewed the literature, and a health economic modeller who 
began working on the project after the first six months in order to undertake the review of economic 
evaluations of diabetes screening and prevention and to develop the mathematical model.  
 
A group of stakeholders were recruited to provide advice throughout model development. Two 
stakeholder workshops were held: (1) to discuss the understanding of the problem and (2) to discuss 
the development and justification of the model structure. Table 6.1 shows the stakeholders involved 
within the project and whether they attended the stakeholder workshops. 
 
Table 6.1: Description of stakeholders involved in the diabetes project 
Description of stakeholder Attended 
workshop 
1 2 
Initially a GP. Currently based in academic research of Public Health interventions. Has a 
diabetes background and interested in screening & prevention. 
Yes Yes 
Previously Director of Public Health in North Eastern Derbyshire. Now based in academic 
research into the effectiveness and cost-effectiveness of Public Health interventions. 
Yes Yes 
Lead commissioner in a Doncaster PCT. Yes No 
GP in Sheffield with a special interest in diabetes. PCT diabetes lead. Yes Yes 
Type 2 diabetic. Had bariatric surgery 4 years ago, but put weight back on. Is currently 
diet rather than insulin controlled. Member of many local and national patient groups. 
Yes Yes 
Type 2 diabetic. Involved in patient groups for 7 years. Described himself as GP’s worst 
patient because he has spent many years not adopting the lifestyle changes advised. 
Yes Yes 
Health psychologist specialising in diabetes, obesity and CVD.  Yes No 
Consultant specialising in diabetes. No Yes 
GP specialising in diabetes and obesity. No Yes 
Clinical specialist in diabetes and obesity. No Yes 
Clinical specialist in cardiovascular disease and stroke. No Yes 
Clinical specialist in cardiovascular epidemiology. No Yes 
Clinical lecturer in diabetes. No Yes 
Professor of clinical diabetes. No Yes 
Statistician specialising in longitudinal data analysis. No No 
Professor of Health Economics currently undertaking research on diabetes prevention. No Yes 
Researcher evaluating key diabetes prevention studies. No Yes 
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6.5 Critical reflections upon the use of the draft conceptual modelling framework 
The critical reflection of the use of the draft conceptual modelling framework is described below. To 
illustrate which stage of the conceptual modelling framework the reflection is relevant to, the 
section numbers have been added to the outline of the draft conceptual modelling framework in 
Figure 6.2 below. 
 
Figure 6.2: Outline of process for developing the model structure within Public Health economic 
modelling prior to modifications resulting from the diabetes case study 
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6.5.1 Aligning the framework with the decision making process 
Relevant guidance from the draft conceptual modelling framework 
Different potential options around process within the conceptual modelling framework are outlined 
throughout so that the modeller can consider, subject to agreement with the project team and 
stakeholders, the most appropriate process for developing the model structure. There is no phase 
within the framework for outlining how it will be employed within the particular project context.  
 
What happened within the diabetes project 
Within an initial meeting with the project leads about the project plan (w/c 14/05/12), we discussed 
how the draft conceptual modelling framework would be used within the diabetes study. The 
project lead subsequently requested a protocol outlining the project plan which was developed 
using the draft framework as a basis (w/c 30/07/12) (see Appendix D1 for protocol).  
 
Critical reflection 
The draft conceptual modelling framework outlines a methodology with generic scalable processes 
which can be adapted according to the decision making process and requirements. Reflecting upon 
the discussion with the project leads, there is a generic need at the start of a project to define the 
processes according to the project requirements and constraints in order to develop a project plan. 
Outlining this within a protocol document meant that the project leads could ensure that the project 
was planned to run appropriately and the project team knew what work needed doing throughout 
the project and could refer to the timescales and deadlines throughout. Key process decisions that 
were made during this phase relate to the frequency and timing of stakeholder workshops, the focus 
of formal literature searches, and the time and resources available for each step of the framework. 
The constraints of time and resources were also identified within the qualitative research in Chapter 
5 as key impacts upon the modelling process, yet these constraints are not explicitly considered 
within existing conceptual modelling frameworks. 
 
6.5.2 Choosing stakeholders 
Recruiting stakeholders 
Relevant guidance from the draft conceptual modelling framework 
The draft conceptual modelling framework suggests the types of stakeholders to involve to provide 
advice throughout the project, including customers (patient representatives, lay members), actors 
(methods experts, clinical and epidemiologic experts) and system owners (policy experts), but it does 
not suggest how to recruit these stakeholders.  
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What happened within the diabetes project 
Within the diabetes project, stakeholders were identified based upon existing relationships with the 
project leads, previous NICE PDG members, advice from a diabetes modeller within the project team 
and searches for specific types of stakeholders on the Internet. I sent emails to potential 
stakeholders describing the project and what we would require from them in terms of expertise and 
time (see Appendix D2 for an example email). The majority of the stakeholders recruited within the 
diabetes project were those who had existing professional relationships with one or more members 
of the project team. It was much more difficult to recruit experts who did not have a connection 
within the team.  
 
Critical reflection 
Within the diabetes project when recruiting stakeholders I was depending upon altruism or upon 
experts thinking that they would benefit from their contribution in some way. Checkland discusses 
the importance of stakeholder worldviews within Soft Systems Methodology (described within 
Chapter 4).123  He suggests defining the worldviews of each stakeholder in order to understand 
conflicts between stakeholders. Upon reflection it may have been useful to understand more clearly 
the possible worldviews and motivations of each of the potential stakeholders in order to inform the 
mode of engagement with them. Potential stakeholders may be more willing to be involved if the 
initial request is phrased in a way which aligns the aims of the project with the expected motivations 
of the stakeholders. For example, some stakeholders may be more interested in the outcomes of the 
project than the methods being employed so the initial information provided could describe the 
potential outcomes of the project. Another potential approach is for a more senior colleague 
involved in the project who is renowned in their field to contact the experts, potentially raising the 
prestige of the project and increasing the perceived benefits to the expert of being involved.   
 
Choice of lay members 
Relevant guidance from the draft conceptual modelling framework 
The draft conceptual modelling framework describes the types of stakeholders to approach. It is 
suggested that lay members should be involved to ensure that views and experiences of the wider 
public inform the work.  
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What happened within the diabetes project 
The lay members of the stakeholder group volunteered for the role after contact via Diabetes UK. 
Both lay members involved within the diabetes project are white, retired/ semi-retired men who are 
also lay members for a number of other diabetes projects.  
 
Critical reflection 
The perspectives provided by the lay members do not necessarily represent those of all diabetes 
patients/ the general population. In particular, they do not represent the more vulnerable groups 
within society who are unlikely to volunteer for such a role.168  Importantly for the diabetes project, 
they also do not represent ethnic minorities, some of which tend to have a different disease natural 
history to white British people. If these relevant groups are not represented, then the views and 
experiences of the wider public may not be heard by the stakeholders and project team. This could 
lead to unrealistic assumptions about a particular subgroup of the population who behave 
differently to those represented within the stakeholder group. In addition, according to the theory 
associated with complex systems discussed within Chapter 3, social networks might impact upon the 
effectiveness of the interventions. The social networks of those people who are most vulnerable in 
society are different to those who participate in research, and as a result the interventions are often 
less effective within these vulnerable groups. By definition ‘hard to reach groups’ are not easily 
accessible, but their input is likely to improve model validity.  
 
6.5.3 Use of a causal diagram and associated questions to develop the understanding of the 
problem 
Terminology associated with the causal diagram 
Relevant guidance from the draft conceptual modelling framework 
The development of a diagram describing the understanding of the problem by representing 
hypothesised causality is proposed within the framework.  
 
What happened within the diabetes project 
During a meeting reviewing the material for the first stakeholder workshop (w/c 17/09/12), Project 
Lead 1 highlighted that the ‘causal diagram’ does not necessarily only include causal relationships at 
this stage. This intermediate stage was also suggested by one of the modellers within the qualitative 
research (see Chapter 5). As a result, the name of the diagram was changed to ‘problem-oriented 
conceptual model’ as defined by Kaltenthaler et al.14  Subsequently, the information specialist/ 
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reviewer on the project team suggested that this term might be too technical for stakeholders, so 
this was further revised to ‘conceptual model of the problem’. 
 
Critical reflection 
The review of conceptual modelling frameworks described within Chapter 5 suggests that the term 
‘conceptual model’ has a range of meanings and studies are inconsistent.8;14;17;123;126  The term 
‘conceptual model of the problem’ was used within the discussion document for the diabetes case 
study with an aim of being explicit about what the conceptual model represented. Upon further 
reflection there is an advantage of using the term ‘causal’ to be more informative about the aim of 
the diagram, whilst recognising that the analysts will not know whether the factors are truly causal 
at this stage. Thus, it would be more explicit to use the term ‘a conceptual model of the problem 
describing hypothesised causal relationships’. 
 
Describing the disease natural history 
Relevant guidance from the draft conceptual modelling framework 
No information is provided within the draft conceptual modelling framework around how to 
incorporate disease natural history.  
 
What happened within the diabetes project 
When developing the conceptual model of the problem within the diabetes case study (see 
Appendix D3), moving from normal blood glucose levels to having diabetes is not causally related. I 
therefore represented the disease natural history by arrows from risk factors to blood glucose levels 
(divided into ‘Impaired Glucose Regulation’ and ‘diabetes’) since these are causally related.  
 
Critical reflection 
Transitioning from a ‘normal’ state to the first stage of disease is not directly causally related, but 
affected by behaviour. As such the causal chain can show the relationship between the behaviour 
and the disease. Within the diabetes case study, a decrease in physical activity might lead to an 
increase in blood glucose levels. Following the onset of disease, the disease natural history can be 
described by probabilistic causation. For example, somebody with impaired glucose regulation has 
an increased probability of developing diabetes.  
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Representation of time within the conceptual model of the problem 
Relevant guidance from the draft conceptual modelling framework 
There is no explicit discussion of how time should be incorporated into the conceptual model of the 
problem within the draft conceptual modelling framework.  
 
What happened within the diabetes project 
Within a meeting before the first workshop (w/c 10/09/12), project lead 2 said that he felt that there 
was insufficient consideration of time within the conceptual model of the problem, in particular in 
relation to the disease natural history of diabetes. Since blood glucose levels are on a continuous 
scale, the trend over time was not captured diagrammatically by causal arrows in the same way as if 
the disease states were discrete categories. Thus, a small graph was included within the diagram to 
show blood glucose levels over time (See Appendix D4).  
 
Critical reflection 
One of the reasons for developing the conceptual model of the problem is for communication with 
the project team and the stakeholders. Thus it is important that all relevant issues are clear within 
the diagram. Experience from the diabetes project suggested that where the disease natural history 
is not depicted by discrete health states, additional graphical representations are helpful. In 
addition, literature around causal diagrams for system dynamics models suggests that time lags 
between discrete factors can be highlighted by adding the term ‘delay’ to the arrows if there are 
substantial time delays between cause and effect.89  
 
Describing the impact of the determinants of health upon the decision problem  
Relevant guidance from the draft conceptual modelling framework  
In order to facilitate development of the conceptual model of the problem, a number of questions 
are proposed for the modeller. One of these questions is: 
‘Are the following determinants of health (taken from Dahlgren and Whitehead28) important in 
determining outcomes and in what way:   
o Age, sex and other inherent characteristics of the population of interest? 
o Individual lifestyle factors? 
o Social and community networks? 
o Living and working conditions and access to essential goods and services?  
(including unemployment, work environment, agriculture and food production, 
education, water and sanitation, health care services and housing) 
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o General socioeconomic, cultural and environmental conditions?’ 
 
What happened within the diabetes project 
During the understanding of the problem phase, age, sex, ethnicity and family history of diabetes 
were incorporated as well as physical activity, diet, BMI, smoking, use of antihypertensive therapy, 
use of corticosteroids, diagnosed CVD and waist circumference. ‘Risk factors of the next generation’ 
were also included which is one aspect of social and community networks, but other aspects were 
ignored at this stage. Social networks were reconsidered and excluded at the justifying the model 
structure phase due to insufficient evidence and resources within the project. No factors were 
included during the understanding of the problem phase regarding ‘living and working conditions’ 
and only the risk factor Townsend Score was included in terms of ‘general socioeconomic, cultural 
and environmental conditions’ (see Figure C4 within Appendix D3). The main reason for the inclusion 
of some of these factors and not of others is because I had identified several risk equations 
associated with diabetes and recorded the factors included within these in the conceptual model of 
the problem. Therefore, at the time of answering the questions within the conceptual modelling 
framework, I thought that the factors included within the risk equations were sufficient. However, 
the risk equations were developed in order to easily identify whether a person is at high risk of 
diabetes rather than to identify all of the determinants of health associated with diabetes incidence. 
Thus, variables tested for inclusion within the equations tended to be those which could be easily 
obtained from the patient or their records. This means that there could be additional factors which 
would affect outcomes which are not captured by the individual characteristics of the person.  
 
Critical reflection 
To some extent I had a natural tendency to exclude the broader determinants of health such as 
social networks from the conceptual model for ease of modelling. A systematic consideration of the 
social determinants of health is one of the four key principles of the framework because of the 
importance of these upon outcomes. However, as discussed within Chapter 3, currently these are 
generally not included within economic evaluations, which is likely to be due to modellers applying 
the same thinking from modelling clinical interventions to Public Health interventions. Even if time 
and resource constraints prevent inclusion of the broader determinants of health within the model, 
the conceptual model of the problem should capture these so that the exclusion of the factor and 
the reason for exclusion is transparent.1  Thus, it is worth noting this tendency so that modellers can 
be aware of it when developing the conceptual model of the problem.  
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There are so many determinants of health that it is unlikely to be feasible to capture all of them 
which have a minor impact upon the problem. However, it is important to understand which 
determinants of health are key drivers of the problem in order to appropriately estimate the 
difference in costs and effects between the interventions given the dynamic complexity of Public 
Health systems (see Chapters 2 and 3). This could be facilitated by a literature search based upon 
relevant theory associated with the problem.  
 
In addition, there are a substantial number of questions to facilitate the development of the 
conceptual model of the problem and conceptual model development is iterative (as highlighted 
within Chapters 4 and 5). There is therefore a risk when first answering these questions that they 
will not be addressed in sufficient depth and so revisiting them throughout development is likely to 
be useful.  
 
Using the determinants of health to describe the relationship between the interventions and the 
decision problem 
Relevant guidance from the draft conceptual modelling framework  
Within the draft conceptual modelling framework, the problem and its consequences are identified 
and subsequently the types of interventions which might be assessed within the model are 
incorporated into the conceptual model of the problem. Any potential consequences of the 
interventions not already included within the conceptual model of the problem are then 
incorporated. There is an implicit assumption that the impact of the interventions upon the problem 
can be assessed directly and there is no discussion around the reported outcomes of the 
interventions or the determinants of health at this stage within the draft conceptual modelling 
framework. 
 
What happened within the diabetes project 
Within the discussion document for Stakeholder Workshop 1, I related BMI to blood glucose levels/ 
diabetes, but not behavioural outcomes such as fruit and vegetable intake or increases in physical 
activity (see Appendix D3). When looking at some of the intervention studies, it became clear that 
BMI and diabetes outcomes were rarely reported, and that most studies reported changes in 
behaviour. This was also raised within the first stakeholder workshop. Thus the understanding of the 
problem was expanded to capture these behaviours (see Appendix D4). 
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Critical reflection 
Economic evaluation, as defined by Drummond, is 'the comparative analysis of alternative courses of 
action in terms of both their costs and consequences'.2  This definition highlights that the key focus 
is the alternative courses of action. This is echoed by the findings from the qualitative research 
within Chapter 5 which suggests that modellers view the purpose of model development to be to 
help decision makers make decisions about the alternative options, as opposed to trying to 
reproduce reality. Thus, the factors included within the model should be driven by the interventions 
being assessed. As such, it is important that the understanding of the problem is sufficiently broad to 
capture all of the factors associated with the interventions which might be included within the 
model. Where the outcomes described within the conceptual model of the problem are not those 
presented within the intervention effectiveness studies, then the additional causal chains associated 
with the reported outcomes need to be described.  
 
Chapter 3 highlights the importance of social structure upon the effectiveness of an intervention, 
suggesting that the effects of an intervention should be assessed by considering the impact of the 
environment and the interaction between the intervention and subsequent behaviour. The 
determinants of health might be associated with the interventions in a number of different ways. I 
have divided this into three alternative ways by reflecting upon the diabetes case study and 
considering whether this is applicable for the other Public Health projects I have worked on. The 
determinants of health: (1) could be modifiable with the intervention; (2) could define the 
population for the intervention (including subgroups which may reflect equity considerations); 
and/or (3) could indirectly affect intervention effectiveness. These are shown in Table 6.2 with 
examples of each based upon the diabetes case study. 
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Table 6.2: Implications of the determinants of health 
Determinant of health There is potential for the determinant of health to... 
Be modifiable with 
intervention  
Define the population 
for intervention 
Indirectly affect 
intervention effectiveness 
Age, sex and other 
inherent characteristics of 
the population of interest 
No Yes  
(eg. South Asians) 
No 
Individual lifestyle factors Yes  
(eg. diet advice) 
Yes  
(eg. BMI > 30) 
Yes  
(eg. BMI reduction might 
increase smoking) 
Social and community 
networks 
Unlikely No Yes  
(eg. obese people with 
obese social networks are 
less likely to lose weight) 
Living/ working conditions 
and access to essential 
goods and services 
Yes  
(eg. workplace 
meals) 
Yes  
(eg. factory workers) 
No   
General socioeconomic, 
cultural and environmental 
conditions 
Yes 
(eg. fiscal policy) 
Yes  
(eg. low SES) 
No 
 
Using the existing ‘knowledge’ of the project team 
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework does not explicitly describe how to deal with the existing 
‘knowledge’ of the project team.  
 
What happened within the diabetes project 
Several of the diabetes project team had previously worked on diabetes projects and had knowledge 
of varying levels. This existing knowledge was used to identify relevant stakeholders and evidence 
and to internally validate each stage of the model development prior to it being circulated to 
stakeholders. However, other than a report to NICE outlining the existing work, this knowledge was 
not recorded at the start of the project. Any preconceptions of the project team associated with 
diabetes were not recorded prior to developing the understanding of the problem. 
 
Critical reflection 
Within an interpretivist perspective, it is important for the researcher to recognise their initial 
assumptions, or ‘conceptual baggage’,169 in order to consider the impact of them upon 
interpretations during the research. This theory can be applied to developing the understanding of 
the problem. Within Public Health it is likely that the project team may have some ‘knowledge’ 
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about the subject. For example, this may be based upon personal experience, media coverage or 
previous research. Some of the ‘knowledge’ that the diabetes project team had was quite dated 
because they had worked on diabetes for a long time and they were slow to move away from 
established views and respond to new evidence which provided a fundamental shift in how the 
disease is considered. Checkland describes the importance of worldviews and the dominance upon 
our thinking of unquestioned worldviews.123  He suggests that the human mind is more likely to 
explain new information which is inconsistent with what we know by slightly revising theories rather 
than making a fundamental shift in our worldview, as was indicated within the diabetes project. This 
is consistent with several Psychology theories including anchoring, selective perception and 
confirmation bias.96   There is thus a need for the project team to question each other’s assumptions 
throughout the conceptual modelling process. It is important for the modeller to be ready to 
acknowledge that the beliefs that they had about the system may not be the most appropriate and 
be willing to alter fundamental assumptions according to new evidence. 
 
6.5.4 Describing current resource use 
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework suggested that resource use should be identified during 
the understanding of the problem phase. The justification for this was that if stakeholders are 
meeting, it is a good opportunity to investigate resource use in practice as this can be quite different 
to that described within the literature. In addition, some knowledge about resource use can help to 
decide whether specific factors within the diagram can be excluded or should be included.  
 
What happened within the diabetes project 
In practice, when developing the discussion document for circulating to stakeholders prior to 
Stakeholder Workshop 1 (see Appendix D3), it was necessary to establish the general resource 
processes (for example, diabetes diagnosis and treatment pathways) prior to being able to describe 
detailed resource use (for example, the amount of each drug provided for diabetes patients). In 
addition, it seemed inefficient to include detailed information about resource use for each factor 
within the understanding of the problem phase given that some of the factors may be excluded from 
the model.  
 
Critical reflection 
The general resource processes associated with key components of the conceptual model were 
described during the understanding of the problem phase and detailed resource use was described 
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during the developing and justifying the model structure phase. The conceptual modelling 
framework by Kaltenthaler et al., described within Chapter 4, suggests that service pathway models 
should be developed to describe resource use as part of the problem-oriented conceptual modelling. 
Service pathway models are flow diagrams of a service with an accompanying textual description 
that do not describe detailed resource use.14  This is consistent with the way resource use was 
described within the diabetes project. 
 
6.5.5 Working with the information specialist to develop the searches  
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework suggests that literature reviews should be undertaken to 
inform the understanding of the problem and the model structure, but it does not explain how this 
should be done. 
 
What happened within the diabetes project 
A key consideration within the diabetes project was how to describe the disease natural history for 
which we undertook a literature review. The search was poorly defined because initially we did not 
have a clear understanding of the types of literature available and what the disease natural history 
might include. Following a project team discussion of what we initially thought we wanted to 
achieve, the information specialist undertook some general searching and retrieval of potentially 
relevant papers. Based upon the content of the papers identified, I suggested a slightly more well-
defined specification for the next iteration. The information specialist and I continued to meet 
regularly, during which I suggested the focus for the next search based upon the literature she had 
identified. In this way, I constructed an iterative series of predefined search questions, which 
gradually became more specific, for the information specialist.  
 
Critical reflection 
It is not standard practice for the information specialist to help the modeller with the searches for 
developing the understanding of the problem and the model structure. The PhD thesis by Paisley 
defined the requirements of a search approach for evidence for developing the model structure.63  
She suggests using ‘search techniques that focus on efficiency and maximising the retrieval of 
relevant information, gathering information a bit at a time from a complex search environment and 
taking into account the dynamic nature of relevance decisions characteristic of the model 
development process.’63 However, the research by Paisley did not define particular strategies or 
techniques for doing this.  
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The approach taken within the diabetes project required adjustments in working for both the 
information specialist and the modeller. For the information specialist, the established methods for 
reviewing effectiveness evidence are based upon a pre-defined search question.61  Thus, for the 
purposes of developing the model structure, the information specialist needed to adopt a new way 
of thinking and learn new skills to work in a way where they are constantly changing and refining the 
search according to the evidence identified. It is currently a more challenging way of working for the 
information specialists because the methods are not fully developed and there is no shared language 
for these types of searches.63  In addition, modellers are accustomed to undertaking searches to 
inform the model structure themselves, although often not transparently or systematically.63  Thus, I 
found it difficult not to carry out quick searches whilst I was developing my understanding of the 
problem. This may also be because of the complexity and subtlety associated with choosing what is 
relevant and the difficulty in relaying this to another person, and in doing this within a time 
constrained process.  
 
Paisley highlights the importance of applying information theory in developing information retrieval 
techniques.63  Information foraging theory suggests that information retrieval is a set of activities 
leading to another higher level goal.63  In this case, the higher level goals are to develop a conceptual 
model of the problem and subsequently to develop a model structure. The modeller has greater 
knowledge about the higher level goal, whilst the information specialist holds the searching 
expertise. Thus, it follows that within the diabetes project information gathering was mainly 
undertaken by the information specialist whilst information processing was undertaken by both the 
information specialist and the modeller because this is where the expertise lay.  
 
As discussed within the qualitative research in Chapter 5, time constraints are an important factor 
when developing a model. The iterations between the systematic reviewer and the modeller are 
likely to increase the time required for the search. Methods for reducing these iterations such as the 
modeller and the information specialist working together in real time to identify appropriate search 
strategies might be useful. In addition, the modeller could undertake searches, providing that they 
are systematic, meaning that the search should be documented and that the modeller must reflect 
upon what has been found by the search and the process taken so that alternative potential theories 
or findings are considered rather than focusing upon the first theory or type of findings identified.  
 
  
171 
 
6.5.6 Stakeholder consensus 
Relevant guidance from the draft conceptual modelling framework  
Within the draft conceptual modelling framework there is no guidance for modellers around how to 
deal with conflicting advice from stakeholders.  
 
What happened within the diabetes project 
Within the diabetes project, generally the stakeholders were in agreement, however where there 
were disagreements the general consensus was described within the conceptual model of the 
problem. This approach was not explicit when presenting the diagram.  I did not describe where 
stakeholder consensus was reached and where only one person had suggested an idea.  
 
Critical reflection 
There was a natural tendency to limit the understanding of the problem by capturing only those 
aspects for which there was no disagreement, so that the full set of complexities and nuances were 
not recorded. For transparency, it could be argued that it is most appropriate to develop the full 
understanding of the problem with all of the uncertainties associated with this understanding, and 
then reduce the set of relevance when defining the model structure (as suggested by the first 
principle of good practice within the draft conceptual modelling framework). However, according to 
Russo and Schoemaker, too many ideas can lead to information overload for participants.170 Thus, 
there is a balance between discussing convergent views and limiting the number of ideas so that 
they are manageable during communication with stakeholders. Within Strategic Options 
Development and Analysis (SODA), a problem structuring methodology employing stakeholder 
workshops, described within Chapter 4, the first stage of the workshop is described as divergent and 
the second stage as convergent.139  This means that the key uncertainties can be explored but it is 
the crucial concepts and issues that are eventually described.44  This echoes theory from the Delphi 
approach,171 also described within Chapter 4, which suggests that the discussion between experts 
encourages stakeholders to consider issues and perspectives which they may not have previously 
considered themselves and stakeholders may then revise their perspectives as a result of the 
discussion. Thus, the theories associated with these methodologies suggest that stakeholder views 
are likely to generally converge after ideas are shared and thus divergent views will be reduced. 
Practically, there is a trade off between covering all relevant topics and providing sufficient time to 
discuss disagreements and explore new ideas within the workshop. 
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6.5.7 Difficulties with setting up the stakeholder workshops 
Relevant guidance from the draft conceptual modelling framework  
No guidance around setting up the stakeholder workshops was provided within the draft conceptual 
modelling framework.  
 
What happened within the diabetes project 
Setting up the first stakeholder workshop was time consuming. Many of the stakeholders were busy 
months ahead by virtue of being so highly regarded in their area. After the date was agreed, some 
stakeholders who had said they could attend chose not to at a later date due to other priorities. 
Those stakeholders who said they would like to be involved but could not attend the workshop were 
asked if they were available to video/ teleconference for any part of the workshop, and if not, they 
were asked to provide feedback on the discussion document prior to the workshop. A meeting was 
also held with one of the diabetologists to discuss the key issues when he was visiting Sheffield.  
 
Critical reflection 
The variety of approaches for involving stakeholders, whilst relatively time consuming, allowed a 
range of views to be incorporated which otherwise may have been ignored. It is thus important to 
have more than one way of communicating with stakeholders and to be flexible with the approach. 
 
6.5.8 Choosing interventions 
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework included a stage for choosing model interventions based 
upon discussion between stakeholders and the project team of the effectiveness review findings. 
 
What happened within the diabetes project 
It was difficult to define the boundary for the effectiveness review due to the broad range of 
interventions which could potentially be considered within the project scope and the large number 
of studies available. Several iterative search strategies were used and the results were presented 
within stakeholder workshops. Stakeholders were more forthcoming to identify interventions that 
were not included within the review than to limit the interventions being considered. Thus, in order 
to reduce the interventions to a manageable number, based upon the workshop discussion the 
project team divided the interventions into key categories and then specified a particular 
intervention to assess within each category. The excluded interventions from each category were 
also listed so that stakeholders could subsequently propose alternative interventions for each 
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category without increasing the number of interventions considered, until a set of interventions 
were agreed.  
 
Critical reflection 
As identified within Chapter 4, the current approach for choosing which specific interventions to 
assess within the model is not well defined, and this is variable between projects. Ultimately, the 
model is being developed to help decision makers make judgements about which interventions to 
provide. Thus it seems appropriate for these decision makers to determine which interventions to 
consider within the model if possible, based upon evidence reviews and input from other 
stakeholders. As the diabetes project illustrates, it may not be possible to review systematically the 
effectiveness of all types of potentially relevant model interventions and stakeholders may be 
reluctant to limit the interventions assessed. 
 
6.5.9 Model boundary and level of detail 
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework describes in the text potential considerations when 
defining the model boundary and level of detail.  
 
What happened within the diabetes project 
After undertaking the conceptual modelling of the problem, I began to consider how to convey to 
the rest of the project team the next steps of the conceptual modelling framework, without 
everyone needing to read the draft conceptual modelling framework. I developed a diagram 
depicting how the reviews feed into the model boundary, level of detail and model type and also a 
flow diagram for helping to define the model boundary and a box of key considerations for the level 
of detail. I described these during meetings on 20/11/12 and 11/12/12.  
 
Critical reflection 
There is a lot of text within the conceptual modelling framework throughout the developing and 
justifying the model structure phase and this is not particularly accessible for the project team or 
stakeholders. As described by the adage ‘a picture is worth a thousand words’, a flow diagram or box 
describing a summary of the suggestions within the text provided a more accessible way of 
highlighting the key considerations when conceptualising the model structure.  
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6.5.10 Stakeholder workshops 
Content of workshops 
Relevant guidance from the draft conceptual modelling framework  
The conceptual modelling framework proposes holding workshops with stakeholders if time and 
resource constraints allow. However, no guidance about the content of the stakeholder workshops 
was provided.  
 
What happened within the diabetes project 
When developing the diabetes project plan, through discussions with the project leads (w/c 
14/05/12) it was agreed that there was sufficient time and resources available to hold stakeholder 
workshops. I proposed that we should hold three workshops during the project. The first workshop 
was held within the first few months of the project (05/10/12) to discuss the understanding of the 
problem, the types of interventions and populations to consider, potential model perspectives and 
outcomes and resource pathways. The second workshop was to discuss the review of the 
effectiveness evidence, the model boundary and the key model assumptions (07/03/13). The final 
workshop will be to discuss the draft model results (in January 2014).  
 
Critical reflection 
The decision about the number of workshops to hold during the project was based upon a balance 
between providing contact with stakeholders at each significant stage of the model development 
process and minimising the amount of stakeholders’ time required, and the two workshops for 
conceptualisation worked well. The outcome of the discussion around model perspectives, 
outcomes, potential interventions and populations within the first workshop had the potential to 
substantially expand the requirements for the modelling. This is because it was initially anticipated 
that a NHS and PSS perspective would be appropriate, whilst the stakeholders suggested that a 
societal perspective should be employed, with a breakdown of other outcomes presented. The 
interventions being considered were also broadened. As a result of the discussion, it was necessary 
to expand the conceptual model of the problem. Moreover, the model boundary is dependent upon 
these decisions and if these issues were not discussed at this stage, subsequent modelling decisions 
would either be delayed or are likely to be incorrectly specified. In addition, these discussions may 
have encouraged participation by all stakeholders within discussions about the model structure.  
 
Resource requirements 
Relevant guidance from the draft conceptual modelling framework  
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No guidance about the resource requirements of the stakeholder workshops was provided within 
the draft conceptual modelling framework.  
 
What happened within the diabetes project 
The workshops were run by four members of the project team; two gave brief presentations 
throughout to remind stakeholders of key points from the discussion document and facilitated group 
discussions; whilst two took notes of the discussions, timed the sessions and wrote the feedback 
from group discussions onto a whiteboard. Where diagrams or tables were used, these were printed 
on A3 and handed out to each group so that they could scribble and make notes on them.  
 
Critical reflection 
The resource requirements during the workshops were substantial, with four members of the 
project team playing important roles in running the workshop. This high level of involvement was 
necessary in order to maintain engagement with the stakeholders, record what was said and process 
and collate information developed during the workshop to share with the group later within the 
meeting. The A3 diagrams were a useful tool which encouraged the stakeholders to share ideas and 
make immediate modifications. It also provided a good record of the suggestions which had been 
made by the stakeholders. 
 
Introductions within Stakeholder Workshop 1 
Relevant guidance from the draft conceptual modelling framework  
No information is provided within the draft conceptual modelling framework around introductions 
of each of the stakeholders within the first workshop.  
 
What happened within the diabetes project 
Before the first workshop project lead 2 suggested that it would be useful to allow a substantial 
amount of time for stakeholders to introduce themselves. Within the workshop, reflecting upon the 
ideas of different stakeholder worldviews within Soft Systems Methodology,123 project lead 1 
explained that we wanted people to spend 2-3 minutes introducing themselves in order to describe 
their perspective, what they thought they could give to the project and what they would like out of 
their involvement.  
 
Critical reflection 
Drawing upon Checkland,123 the worldviews described within the diabetes project allowed us to: 
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 Explore different views and the reasons for these between the stakeholders within workshops. 
 Identify concerns which may not otherwise have been identified. For example, the issue of 
equality of patient access was raised by two of the stakeholders within their worldviews, which 
may not otherwise have been identified.  
 Assess the stakeholders’ potential contribution towards the project rather than our expectation 
around what they may be able to input. 
 Identify who it may be most appropriate to contact to ask specific questions or for clarifications 
outside of the workshop setting. 
 Put what the stakeholders say into the context of their worldview so that any assumptions about 
the world can be more easily identified. 
 Ensure that future workshops and correspondence aims to address the aims and motivations of 
the stakeholders so that they remain engaged within the project.  
They also encourage each stakeholder to feel valued and give each stakeholder chance to talk in 
order to promote later involvement in discussions.123  
 
6.5.11 Response to the use of the conceptual modelling framework by the project team 
Relevant guidance from the draft conceptual modelling framework  
The draft conceptual modelling framework aimed to be flexible within different decision making 
processes and to accommodate modellers’ preferences because the qualitative research within 
Chapter 5 suggested that the framework should be sensitive to the time available and the processes 
followed within the decision making process.  
 
What happened within the diabetes project 
One of the project leads who is a health economic modeller implied that he would like to see 
analysis of datasets at an earlier stage in the project, alongside the understanding of the problem 
stage, which contravenes one of the key principles of good practice outlined by the framework. The 
project lead showed some discomfort with the principles and methods of the conceptual modelling 
framework being followed.  
 
Critical reflection 
Within the qualitative research, described within Chapter 5, a finding was that some modellers do 
not like to follow a specified method for model development. However, this is a larger issue than the 
one described within the qualitative research as the modeller was not only reluctant to follow the 
principles and methods of the framework, but he did not seem to believe that they were useful to 
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deliver the model the team were aiming to develop. However, the same modeller also stated after 
the first stakeholder workshop that he had not thought that it was going to be particularly useful but 
having attended the workshop and witnessing the discussion he thought it was very worthwhile for 
the project. This suggests that the conceptual modelling framework may not be readily adopted.  
 
According to Kotiadis and Mingers, in order to combine problem structuring methods with 
quantitative methods the modeller needs to believe that it is a worthwhile thing to do, to have the 
type of personality which is able to switch between analysis of quantitative data and facilitating 
qualitative analysis, and to have understood and practiced the relevant problem structuring 
methods.154  There is a certain culture within health economic modelling of developments in 
quantitative modelling methods increasing prestige and very little interest or knowledge about 
conceptual modelling methods, as suggested by the qualitative research within Chapter 5. Based 
upon the background of the health economic modellers within the NICE Technology Assessment 
Groups, many come from a highly quantitative background and begin working in the profession 
because they are good at (and may enjoy) mathematics. Conversely, they tend to have no or 
minimal training in (and may not enjoy or think important) conceptual modelling. Encouragingly, the 
other project team members did not seem to have had the same reservations about the use of the 
conceptual modelling framework. Importantly, however, not only does the modeller doing the work 
have to be convinced that the approach is appropriate and useful in practice, but the project lead 
also needs to agree to its use. These issues will need to be considered during dissemination and 
championing of the conceptual modelling framework, as well as within future case studies. 
 
6.6 Chapter summary and implications for methods development 
This chapter provides a critical reflection of the use of the draft conceptual modelling framework 
within a case study assessing the cost-effectiveness of interventions for screening and prevention of 
type 2 diabetes. In general, the framework was helpful in developing an appropriate understanding 
of the problem and documenting the transition from that understanding to the model structure. The 
diabetes case study raised some practical issues which had not been considered within the literature 
reviews and the qualitative research. These can be incorporated into the final conceptual modelling 
framework. Based upon these reflections, the key implications for methods development are: 
 
Aligning the framework with the decision making process 
1) There should be a first step describing the necessity to align the framework with the decision 
making process and develop a project plan. 
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Stakeholder involvement 
2) Stakeholder recruitment is not a trivial task and the project team should reflect upon potential 
stakeholder worldviews to understand their motivation for involvement in order to raise the 
efficiency of recruitment. 
3) Where feasible, it would be valuable to choose lay members to represent different types of 
people within society where those differences are likely to be important to the topic area (eg. 
ethnic minorities, lower BMI, lower socioeconomic status). 
4) There is a need for flexibility with the approach for involving stakeholders within the model 
development process and several means of communication may be required. It may be 
appropriate to try and hold workshops or meetings with stakeholders around relevant 
conferences or meetings. Whilst workshops have the advantage of allowing issues to be 
discussed and debated, one-to-one meetings or telephone conversations may be employed in 
addition to, or instead of, workshops. 
5) The substantial resource requirements during the stakeholder workshops should be highlighted 
within the conceptual modelling framework as an important consideration when choosing 
whether or not to run workshops. A3 diagrams (eg. of the conceptual model of the problem and 
resource pathways) are a useful tool for sharing ideas and recording them. 
6) Within any workshops, stakeholders should be told that the aim is not necessarily to reach 
consensus; however after sharing divergent views, it is useful for the project team to limit these 
to a few key concepts and issues. During the understanding of the problem phase, it would be 
valuable to provide some sort of description of the degree of consensus/ disagreement between 
stakeholders. 
7) Stakeholders could spend 2-3 minutes at the beginning of the first stakeholder workshop (or a 
paragraph of written text if not within a workshop) describing their perspective, what they think 
they can give to the project and what they would like out of their involvement.  
 
Developing the understanding of the problem 
8) The diagram developed within the understanding of the problem phase can be described as a 
‘conceptual model of the problem depicting hypothesised causal relationships’. 
9) To represent the disease natural history within the conceptual model of the problem, the causal 
chain can show the relationship between the behaviour and the disease (eg. a decrease in 
physical activity might lead to an increase in blood glucose levels). Following the onset of 
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disease, the disease natural history can be described by probabilistic causation (eg. impaired 
glucose regulation increases the probability of diabetes). 
10) Where the disease natural history is discrete rather than continuous, the importance of 
depicting time within the conceptual model of the problem needs to be highlighted. This can be 
done by adding a graph to the diagram. The term ‘delay’ could also be added between cause and 
effect of relevant model factors. 
11) The modeller should be aware of the tendency to oversimplify when considering the impact of 
the determinants of health and relevant theory should be consulted to inform which 
determinants of health to consider. 
12) The modeller should revisit the questions within the conceptual modelling framework to 
facilitate the development of the conceptual model of the problem throughout its development. 
13) The following additional questions around the determinants of health should be added to 
accompany the conceptual model of the problem: 
a) When interventions are being added to the conceptual model of the problem: 
 Are there any determinants of health reported by the effectiveness studies which are not 
included within the diagram? 
 Are there any additional types of potentially relevant interventions given potential impacts 
upon the problem of interest of individual lifestyle factors, living and working conditions and 
access to essential goods, and general socioeconomic, cultural and environmental 
conditions which affect the problem of interest? 
 Are there any substantial impacts of social networks upon intervention effectiveness and of 
the interventions upon other lifestyle factors? 
b) When the model population is being chosen, in order to incorporate equity considerations: 
 Is there a bigger problem in a particular subgroup or is the intervention more effective in a 
particular subgroup? These subgroups might be based upon the age, sex and other inherent 
characteristics of the population of interest, individual lifestyle factors, living and working 
conditions and access to essential goods, and general socioeconomic, cultural and 
environmental conditions. 
14) There is a need for the project team to question each other’s assumptions throughout the 
conceptual modelling process. It is important for the modeller to be ready to acknowledge that 
the beliefs that they had about the system may not be the most appropriate. 
15) The description of resource use can be undertaken as a two-stage process in order to increase 
efficiency of model development; first establishing very generally what sort of resource 
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processes there are for key components of the conceptual model of the problem; and second 
describing resource use in detail during the justifying and developing the model structure phase. 
16) A possible information retrieval approach for developing the understanding of the problem and 
model structure is shown below. Further development of methods and techniques will be 
required within future work. 
 
 
 
 
 
 
 
 
 
17) It should be suggested that the model perspectives, outcomes, potential interventions and 
populations are discussed at an early stage of the project, particularly if the project question and 
scope have been developed by researchers rather than decision makers. If stakeholders broaden 
the potential interventions being assessed, the understanding of the problem needs to be 
expanded. 
 
When justifying and developing the model structure 
18) Decision makers should determine which interventions to consider within the model, based 
upon evidence reviews and input from other stakeholders. Discussions between the project 
team and the stakeholders may be required to limit the breadth of the search for the 
effectiveness review.   
19) A flow diagram or box describing a summary of the suggestions within the text provides a much 
more accessible way than lots of text for highlighting the key considerations. 
 
Introducing the conceptual modelling framework 
20) The introduction of the conceptual modelling framework should clearly and concisely describe 
why it is beneficial. A discussion about the preconceptions that modellers may have which might 
be inconsistent with the conceptual modelling framework could also be described. In addition, 
the key principles and methods within the framework need to be well justified and evidence-
based where possible.   
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Chapter 7: A conceptual modelling framework for 
Public Health economic evaluation 
 
7.1 Chapter outline 
This chapter describes a conceptual modelling framework for Public Health economic evaluation, 
developed based upon the research presented within Chapters 2 – 6. Throughout this chapter, a 
green shaded background is used to denote the stand-alone conceptual modelling framework 
document which was presented to a focus group for evaluation purposes (see Chapter 8 and 
Appendix E). Non-shaded parts provide justification for each aspect of the framework. Section 7.2 
presents the requirements of the framework based upon the findings of Chapters 2 – 6. The 
conceptual modelling framework is described within Section 7.3. An example to illustrate the 
methods is included using the diabetes case study described within Chapter 6. This is denoted 
throughout by the heading ‘Diabetes project example’. Whilst suggestions about the processes 
which may be followed are made within the conceptual modelling framework, it does not aim to 
provide a specific, prescriptive process. The processes followed will be dependent upon the decision 
making context, the resources available and the preferences and judgements of the project team. 
However, process suggestions are included throughout in italics within boxes.  
 
7.2  The requirements of the conceptual modelling framework 
Definition of a conceptual modelling framework 
There is no agreed definition for a conceptual modelling framework within the literature. Based 
upon the definition of a conceptual modelling framework by Robinson137 and the definition of a 
conceptual model by Kaltenthaler et al.,14 a conceptual modelling framework for current purposes is 
defined as: ‘A methodology that helps to guide modellers through the development of a model 
structure, from developing and describing an understanding of the decision problem to the 
abstraction and non-software specific description of the quantitative model, using a transparent 
approach which enables each stage to be shared and questioned.’ 
 
Aim of the framework 
The aim of this framework is to provide a methodology which can be moulded according to different 
situations by different users123 to help modellers develop model structures for Public Health 
economic models.  It acts as a tool to help modellers make decisions about the model structure, but 
it does not provide automated solutions to these choices. It is intended to be used by any modellers 
undertaking Public Health economic evaluations; for inexperienced modellers it provides a 
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transparent process to follow; for experienced modellers it provides Public Health-specific 
considerations such as the determinants of health and understanding and describing dynamically 
complex systems, as well as a standardised approach which will help decision makers/ clients to 
input into and use the model developed. 
 
Benefits of the conceptual modelling framework 
Conceptual modelling is the first part of a modelling project, which guides and impacts upon all 
other stages. This means that if this is done poorly, all subsequent analysis, no matter how 
mathematically sophisticated, is unlikely to be useful for decision makers.49  Key potential benefits of 
this conceptual modelling framework and what pitfalls these aim to avoid, based upon a review of 
conceptual modelling frameworks and qualitative research with modellers, are shown within Table 
7.1 below. 
 
Table 7.1: Potential benefits of the conceptual modelling framework 
Potential benefit What pitfalls can be avoided 
To aid the development 
of modelling objectives 
 Answering the wrong (or less useful) question with the model. 
 
To provide tools for 
communication with 
stakeholders 
 
 
 Representing a contextually naïve and uninformed basis for decision-making, 
including misunderstandings about the problem, producing unhelpful model 
outcomes, and incorporating inappropriate and/ or invalid model assumptions. 
 Ignoring important variations between stakeholders’ views. 
 Model results which are not trusted by stakeholders. 
To guide model 
development and 
experimentation 
 Inefficient model implementation (i.e. repeatedly making structural changes to 
the implemented model) 
 Inadequate analyses 
To improve model 
validation (developing 
the right model) 
 
 Answering the wrong (or less useful) question with the model. 
 Misunderstanding the key issues associated with the problem. 
 Using the first theories identified from the evidence to develop the model. 
 Not having a basis for justifying the model assumptions and simplifications.    
To improve model 
verification (developing 
the model correctly) 
 Not having an intended model with which to compare the implemented model. 
 
 
To allow model reuse 
 
 Other experts not being able to identify or correctly interpret key model 
assumptions and simplifications and why these have been made. 
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Development of the framework 
The conceptual modelling framework has been developed based upon the implications for methods 
development identified from the research presented within Chapters 2 – 6. These have been divided 
into categories according to the type of impact they would have upon the development of a 
conceptual modelling framework. Some of these relate to what the framework should do which 
defines the nature of the framework rather than its specific content (framework aims), whilst others 
relate to the general principles that the modeller should follow and these need to be described as 
part of the framework (general principles). Some of the identified implications for methods 
development specify methods which need to be included within the framework (methodological 
considerations), whilst others outline key issues which the modeller should consider including within 
Public Health economic models (consideration of relevant issues). Finally, some of the implications 
for methods development identified within Chapters 2 – 6 are suggestions about processes which 
may be helpful to the modeller, although alternative processes may be followed (process).  Table 7.2 
summarises these.  
 
The framework aims have been used as a general guide whilst developing the framework. The four 
implications relating to the general principles are described within the framework as four key 
principles of good practice. The methodological considerations have been used to develop the 
specific steps of the conceptual modelling framework, whilst the consideration of relevant issues 
have been included directly into the framework. Finally, the process suggestions have been included 
throughout in grey boxes in italics.  
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Table 7.2: Implications for the development of the framework based upon Chapters 2 – 6 
Framework aims  Based upon Chapter 
2 3 4 5 6 
A conceptual modelling framework specifically for Public Health economic modelling has the potential to provide more guidance 
about the approach than a generic framework. 
Y Y Y   
To aid the model development process but not constrain it. It should allow for the variation in requirements of different Public 
Health economic modelling and be clear that there is scope for further methods development given the early phase of 
development of a framework within Public Health economic modelling.  
  Y Y  
To provide a general outline of the model development process in Public Health economic modelling.    Y  
To provide a tool for communication with the project team and stakeholders.    Y  
To help modellers make decisions about what to include and exclude within a model.    Y  
To help modellers determine appropriate and inappropriate simplifications of the problem.    Y  
To provide a transparent approach for choosing model interventions.    Y Y 
To encourage understanding of the implications of the structural choices that the modellers make.    Y  
To help decision makers make decisions, as opposed to trying to represent reality.    Y  
To facilitate clear reporting of the model structure and the process by which it was developed.    Y  
To encourage modellers to question the assumptions of the experts and decision makers.    Y  
To take into account that modellers have different skill sets and encourage modellers to recognise potential skill set biases and 
moderate impact. 
   Y  
To include an example to illustrate the methods.    Y  
To be clear about what the framework can and cannot do.    Y  
To be culturally acceptable and simple to use in practice (use of flow diagrams, tables and boxes rather than large chunks of text).    Y Y 
To clearly and concisely describe why a conceptual modelling framework is beneficial. A discussion about the preconceptions that 
modellers may have which might be inconsistent with the conceptual modelling framework could also be described. In addition, the 
key principles and methods within the framework need to be well justified and evidence-based where possible. 
    Y 
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General principles: How the modeller should approach the problem Based upon Chapter 
2 3 4 5 6 
A systems approach is an appropriate approach for modelling Public Health systems, taking a holistic view of the system and 
focusing upon the relationships between components. This involves understanding the complex causal chains, including feedback 
loops, and the unintended consequences of the comparators and interventions upon other parts of the system. 
Y Y    
A systematic consideration of the determinants of health is central to identifying all key impacts of the interventions within Public 
Health economic modelling. 
 Y    
To involve stakeholders within each stage of conceptual model development in order to encourage learning about the problem, 
develop appropriate model requirements, facilitate model verification and validation, help develop credibility and confidence in the 
model and its results, guide model development and experimentation, and encourage creativity in finding a solution. 
  Y   
To specify modelling objectives and develop a thorough documented understanding of the problem, and subsequently choose 
model options, determine the model scope and level of detail, and identify structural assumptions and model type, with a different 
representation for each. This model development process is iterative. 
  Y Y Y 
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Methodological considerations: Things the modeller should do during conceptual modelling Based upon Chapter 
2 3 4 5 6 
To consider the use of modelling methods to enable the broader determinants of health to be incorporated such as agent-based 
simulation and social network analysis.  
Y    
To be practical within a decision making context by considering the needs of the decision makers, including the time requirements 
upon the stakeholders.   
Y   
Cognitive mapping, causal diagrams and SSM may be useful for objective setting and developing the understanding of the problem.   Y   
To consider the most appropriate outcome measure and perspective to report to decision makers.    Y  
To consider the choice of experts and the implications of these choices.    Y  
To consider any diagrams, such as logic models, developed by decision makers or other parts of the team on the project.    Y  
To recognise relevant methods guidance (eg. NICE methods guide).    Y  
To consider the likely cost-effectiveness of the interventions in making decisions about model structure.    Y  
To consider the trade off between developing an appropriate structure for the problem versus ability to meet deadlines.    Y  
To consider the trade-off between providing stakeholders with something to critique and limiting their thinking.    Y  
To explore the use of existing models in the same area.    Y  
To consider whether a more exploratory analysis may be more useful given the time and data constraints.    Y  
To suggest that the question of interest, model perspectives, outcomes, potential interventions and populations are discussed at an 
early stage of the project, particularly if the project question and scope have been developed by researchers rather than decision 
maker. 
   Y Y 
To undertake a first step to align the framework with the decision making process and develop a project plan.     Y 
To describe resource use as a two-stage process in order to increase efficiency of model development; first establishing very 
generally what sort of resource processes there are for key components of the conceptual model of the problem; and second 
describing resource use in detail during the justifying and developing the model structure phase. 
Y 
  
 Y 
For the project team to question each other’s assumptions throughout the conceptual modelling process. It is important for the 
modeller to be ready to acknowledge that the beliefs that they had about the system may not be the most appropriate.    
 Y 
To revisit the questions within the conceptual modelling framework to facilitate the development of the causal diagram throughout 
the development of the understanding of the problem.    
 Y 
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Consideration of relevant issues: Specific issues for the modeller to consider including within the model  Based upon Chapter 
2 3 4 5 6 
To consider equity and the social gradient. Y Y  Y  
To consider non-health costs and outcomes and what is a 'good' outcome (Eg. Is it better to have a baby at age 19 than age 17? Is it 
a good thing to return employees to work more quickly if they are less productive?). 
Y   Y  
To consider stakeholders within the system who might act to reduce or increase the impact of the intervention. (Eg. the smoking 
industry may increase marketing if smoking is banned from public places). 
 Y    
To incorporate outcomes dependent upon the determinants of health and consider step-changes in societal behaviour due to 
sufficient people adopting a type of behaviour.  
 Y    
To consider assessing population, community and individual-level interventions.  Y    
To consider the culture and politics of the system.  Y    
To consider heterogeneity and whether there are any appropriate subgroups, including socioeconomic status.   Y  Y  
To highlight the difference between causation and association.    Y  
To choose model type according to interactions and heterogeneity.    Y  
To consider intergenerational impacts.    Y  
To explore the population, outcomes and other biases such as trial design associated with the effectiveness studies.    Y  
To encourage understanding of the modelling requirements in other sectors when the scope of the model extends beyond health 
and wellbeing. 
   Y  
To think about the constraints of the project scope.    Y  
To encourage modellers to explore the exact meaning of topic specific terminology which also has a lay meaning.    Y  
To consider whether behaviour is being prevented or delayed.    Y  
To encourage reflection upon if there are other consequences (positive or negative) not considered by the effectiveness studies.    Y  
To consider, in some form, each of the following: (i) classifying and defining population subgroups of interest, (ii) identifying and 
defining harms and outcomes for inclusion in the model, (iii) thinking about modifiable components of risk, (iv) specifying the 
baseline position on policy variables, (v) estimating the effects of changing the policy variables on the risk factors, (vi) risk functions 
relating to risk factors to harm, (vii) monetary valuation. 
   Y  
To describe how to incorporate the disease natural history within the conceptual model of the problem.     Y 
To highlight the importance of depicting time within the conceptual model of the problem.     Y 
To consult relevant theory to choose which determinants of health to include.     Y 
To incorporate additional questions around the determinants of health to accompany the conceptual model of the problem.     Y 
To expand the understanding of the problem if stakeholders broaden the potential interventions being assessed.     Y 
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Process: Suggestions about the process the modeller might follow, although there may be alternative processes which would allow the 
general approach to be taken.  
Based upon Chapter 
2 3 4 5 6 
If the term ‘conceptual model’ is employed within the framework it needs to be defined and which groups of people might be 
involved in the model development process should be clear.  
  Y   
To encourage the use of the model for understanding the effectiveness of the interventions as well as the cost-effectiveness.    Y Y 
To align the stakeholders' expectations of the process and their requirements with the modellers’ expectations.     Y  
To highlight that stakeholder recruitment is not a trivial task and that the project team should reflect upon potential stakeholder 
worldviews to understand their motivation for involvement in order to raise the efficiency of recruitment. 
    Y 
To choose lay members to represent different types of people within society where those differences are likely to be important to 
the topic area (eg. ethnic minorities, lower BMI, lower socioeconomic status) where feasible. If this is not possible, modellers could 
consider whether the assumed chains of behavioural causation developed within the conceptual model of the problem are likely to 
be violated by a particular subpopulation. 
    Y 
To describe a possible information retrieval approach for developing the understanding of the problem and model structure.    Y Y 
The modeller should revisit the questions within the conceptual modelling framework to facilitate the development of the 
conceptual model of the problem throughout its development. 
    Y 
To highlight that within any workshops, stakeholders should be told that the aim is not necessarily to reach consensus; however 
after sharing divergent views, it is useful for the project team to limit these to a few key concepts and issues. During the 
understanding of the problem phase, it would be valuable to provide some sort of description of the degree of consensus/ 
disagreement between stakeholders. 
    Y 
To highlight that there is a need for flexibility with the approach for involving stakeholders within the model development process 
and several means of communication may be required. It may be appropriate to try and hold workshops or meetings with 
stakeholders around relevant conferences or meetings. Whilst workshops have the advantage of allowing issues to be discussed 
and debated, one-to-one meetings or telephone conversations may be employed in addition to, or instead of, workshops. 
    Y 
To highlight that the resource requirements during the workshops are substantial in order to maintain engagement with the 
stakeholders, record what is said and process and collate information developed during the workshop to share with the group later 
within the meeting.  
    Y 
Stakeholders could spend 2-3 minutes at the beginning of the first stakeholder workshop (or a paragraph of written text if not 
within a workshop) describing their perspective, what they think they can give to the project and what they would like out of their 
involvement. 
    Y 
The diagram developed within the understanding of the problem phase can be described as a ‘conceptual model of the problem 
depicting hypothesised causal relationships’. 
    Y 
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7.3 The conceptual modelling framework 
7.3.1 Key principles of good practice 
Although modellers within the focus group meeting suggested that the conceptual modelling 
framework should not be too prescriptive (see Chapter 5), findings from the research presented 
within Chapters 2 – 6 strongly suggested that in order to develop valid, credible and feasible models 
there are four key principles of good practice that need to be followed by modellers. 
In order to develop valid, credible and feasible Public Health economic models, the four key 
principles of good practice are that; (1) a systems approach to Public Health modelling should be 
taken; (2) developing a thorough documented understanding of the problem is imperative prior to 
and alongside developing and justifying the model structure; (3) strong communication with 
stakeholders and members of the team throughout model development is essential; and (4) a 
systematic consideration of the determinants of health is central to identifying all key impacts of the 
interventions within Public Health economic modelling. These are each described in detail below. 
Justification should be provided by modellers if these principles are not followed. 
 
Key principle of good practice 1: A systems approach to Public Health modelling should be taken 
Chapter 3 suggests that Public Health systems are generally dynamically complex and that a systems 
approach is appropriate for dealing with these types of problems. 
Public Health economic modelling generally involves understanding dynamically complex systems.82  
This means that they are non-linear systems where the whole is not equal to the sum of the parts, 
they are history dependent, there is no clear boundary around the system being analysed, 
heterogeneity and self-organisation impact upon the outcomes, and people affected by Public 
Health interventions may learn over time and change their behaviour accordingly.91  
 
Within complex systems there may be positive feedback loops, whereby if Factor A increases 
[decreases], the number of Factor B increases [decreases], which leads to Factor A increasing 
[decreasing] further, which would lead to exponential growth [decay] if no other factors were 
present.91  For example, an increase in population obesity might lead to an increase in population 
mental illness which in turn leads to an increase in obesity, and so on. There may also be negative 
feedback loops, where an increase [decrease] in Factor A leads to an increase [decrease] in Factor B 
which in turn leads to a decrease [increase] in Factor A.91  For example, an increase in eating will lead 
to an increase in weight gain (all other things being equal) which may lead to a decrease in eating. 
The dynamics of complex systems arise from the interaction between positive and negative 
feedback loops, and this may occur over a long period of time, often producing counter-intuitive 
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behaviour.91  The economy is an example of a complex system which displays such counter-intuitive 
behaviour. Within these dynamically complex systems, factors are constantly changing over time, 
and a sudden change in behaviour may arise as a result of a number of smaller changes, such as a 
stock market crash. Making assumptions of simple cause and effect may lead to inappropriate 
results. See the paper ‘Learning from Evidence in a Complex World’ by Sterman for a good discussion 
of dynamic complexity.91   
 
A systems approach, or systems thinking, is a holistic way of thinking with the philosophy that to 
understand a problem it is important to understand the interactions between parts within a system 
and with its environment.90;172  Figure 7.1 depicts the multiple system levels, whereby the system of 
interest is subjectively defined and there is always a higher level system within which it belongs and 
a lower level system which describes detailed aspects. The challenge within health economic 
modelling is to determine which level will be that of the system of interest (the model), by having 
sufficient knowledge about the higher level system (the broader understanding of the problem), and 
subsequently to be able to define an appropriate level of detail for the system of interest. Within 
systems thinking, the importance of not considering one aspect of a system in isolation is 
emphasised to avoid ignoring unintended consequences. Soft systems thinking also recognises the 
impact of culture and politics upon a situation,123  which is interlocked with Public Health policy 
evaluation. Culture and politics affect the process by which decisions are made, what is modelled 
(eg. the identification of the problem, stakeholder involvement, the interventions assessed and the 
perspectives and outcomes of the analysis) and the effectiveness of the interventions (eg. service 
provision and the behaviour of individuals and society). Thus, a systems approach is suited to 
modelling these dynamically complex public health systems.  
 
Figure 7.1: Systems thinking  
The defined system – 
adapts according to the 
higher level system 
Higher level system – 
constantly changing. 
Culture and politics 
important. 
Lower level  
systems 
Relationships between 
parts within the system 
are important 
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Key principle of good practice 2: Developing a thorough documented understanding of the 
problem is imperative prior to and alongside developing and justifying the model structure in 
order to develop valid, credible and feasible models  
The majority of the conceptual modelling frameworks identified within the literature review within 
Chapter 4 divide into two separate phases; (i) understanding the problem and (ii) making 
judgements about how to simplify that understanding in order to develop a valid, credible and 
feasible qualitative description of the quantitative model.8;14;18;127;129;136  This has a number of 
advantages. 
 
It is valuable to have an initial understanding of the problem and to document this understanding 
prior to making simplifications when developing the model structure because of both theoretical 
and practical reasons. Theoretically, it provides a basis for validation by facilitating the specification 
of an appropriate scope and structural assumptions and for credibility by supporting stakeholder 
involvement and producing clear documentation when developing the model structure.14  We learn 
by building upon what we already know, and how we see the world or a problem is constrained by 
our previous ‘knowledge’.89  As such, if a model is data-led and/or based only upon the analyst’s 
interpretation of the data, it may lead to a narrow view of what should be included within the 
model.  Documenting an understanding of the problem prior to analysing available datasets allows 
that understanding to be reflected upon and shared. This reduces the risk of ignoring something 
which may be important to the model outcomes, which is particularly important given the potential 
dynamic complexity of the system. In terms of systems thinking (see key principle of good practice 
1), documenting an understanding of the problem (the higher level system) allows the modeller to 
be able to define the boundary of the system of interest for modelling (see Figure 7.1). This 
description of the understanding of the problem should also help the modeller to understand the 
impact of potential simplifying assumptions they are making within the model. 
 
Practically, if the problem is not sufficiently understood an inappropriate model structure may be 
developed which, if recognised at a later stage of model development, may take a long time to alter 
within the computer software. This is particularly true if an alternative model type needs to be 
developed (for example, a DES rather than a Markov model). Thus taking the time at the beginning 
of the project to understand the problem could actually reduce overall time requirements. 
Documenting the understanding of the problem also enables communication with stakeholders and 
the project team (see key principle of good practice 3). An additional benefit is that the 
documentation of the understanding of the problem could be used (alongside any logic models 
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developed) to help stakeholders understand all of the impacts of the interventions in order to inform 
the scoping and/or the interpretation of systematic reviews of intervention effectiveness. Finally, 
documenting the understanding of the problem will enable researchers and policy makers who are 
not involved within the project to understand the problem and the basis for decisions about the 
model structure. 
 
Thus, as also proposed by Kaltenthaler et al. within the context of clinical economic modelling,14  it is 
recommended that the model structure be developed in two phases. The first is to develop an 
understanding of the decision problem which is sufficiently formed to tackle the above theoretical 
and practical issues and should not be limited by what empirical evidence is available (see Section C). 
The second is to specify a model structure for the decision problem that is feasible within the 
constraints of the decision making process (see Section D).  
 
The understanding of the problem will inevitably continue to form during model development; 
however this initial documented understanding provides a basis for comparison and any major 
changes to this understanding can subsequently be documented.  
 
Key principle of good practice 3: Strong communication with stakeholders and members of the 
team throughout model development is essential for model transparency, validity and credibility 
The qualitative research described within Chapter 5 highlighted that the modelling work within 
Public Health economic evaluation is based around the requirements of the decision makers. The 
modellers suggested that the model must be easily communicable and credible to the decision 
makers, and as such the decision makers and other relevant stakeholders should be involved during 
the development of the model. The review of conceptual modelling frameworks described within 
Chapter 4 also highlighted the importance of involving stakeholders in model development.  
 
A stakeholder is defined here as ‘any person who might impact upon or be impacted upon by the 
system of interest’. Literature suggests that stakeholders can encourage learning about the problem 
(including geographical variation of healthcare provision and stakeholders’ values and preferences), 
help to develop appropriate model objectives and requirements, facilitate model verification and 
validation, help to develop credibility and confidence in the model and its results, guide model 
development and experimentation, encourage creativity in finding a solution and facilitate model re-
use.1;14;18;125;127-129  Additionally, stakeholders can help to define the meaning of subject-specific 
terminology which has a different lay meaning. Pidd has used the metaphor of taking a photograph 
193 
 
of a scene, whereby each person involved might see different aspects of the scene and frame the 
photo differently.44  The more frames provided by people with different interests (which may be 
affected by culture and politics), the better our understanding of the scene, and differences between 
perspectives can be discussed explicitly. Section B of the framework describes the types of 
stakeholders which may be involved. 
 
The modeller is encouraged to question the assumptions of the stakeholders92 and the project team 
throughout the model development process in order to uncover inconsistent and invalid 
assumptions. Within topics where the project team have existing ‘knowledge’, it is important for 
them to be aware of the tendency to anchor to initial beliefs and be open to accepting new theories 
in order to develop valid models.96;123  Effective ways of communicating information such as using 
clear diagrams should be used in order to share information and describe assumptions.  
 
Key principle of good practice 4: A systematic consideration of the determinants of health is 
central to identifying all key impacts of the interventions within Public Health economic modelling 
Chapter 3 highlights the importance of the broader determinants of health for modelling the Public 
Health interventions and suggests that systems thinking can be applied to the idea that an 
individual’s behaviour cannot be considered in isolation, but that our social structure impacts upon 
an individual’s actions which in turn impacts upon the social structure.24  As was established within 
Chapter 3, there are several different classifications of the determinants of health and the 
determinants of health inequities. The model by Dahlgren and Whitehead is used here because it 
provides a clear diagram outlining population, community and individual level factors affecting 
health, and it includes a number of specific categories within each of these which the modeller could 
consider.28  Although the diagram does not include the causal mechanisms of the determinants upon 
health and health inequities, the review presented within Chapter 3 essentially suggested that all 
factors might impact upon all other factors across the population, community and individual levels.   
 
The determinants of health which include the social, economic and physical environment, as well as 
the person’s individual characteristics, are central in the consideration of Public Health 
interventions. The determinants of health as described by Dahlgren and Whitehead are shown 
within Figure 7.2.28  Individual behaviours (or lifestyle factors) impact upon the broader 
determinants of health, which in turn impact upon individual behaviours.27  Thus, it is important to 
consider these broader determinants of health in order to be able to predict the full impact of the 
interventions upon health outcomes. In addition, the determinants of health could be used to think 
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through all of the non-health outcomes associated with the interventions that it might be useful to 
report, such as transport or employment.  
 
Consideration of the broader determinants of health also facilitates identification of potential types 
of interventions, for example those which might impact upon individual health through making 
community and population-level changes, such as food production, as well as those which might 
impact upon health through changing individual lifestyle factors. Similarly, subpopulations that 
might benefit from the intervention could be identified, given that reduction of health inequities is 
often an objective of Public Health. Finally, the consideration of social network effects might affect 
the analytical model type chosen, and subsequently the predicted impact of the interventions.  
 
Figure 7.2: Determinants of health 
 
 
It would not be appropriate or feasible to include all of the determinants of health within the model; 
however, they should be systematically reflected upon during the understanding of the problem 
phase to consider which determinants it might be important to include within the model so that all 
important mechanisms and outcomes of the interventions can be captured. 
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7.3.2 Overview of steps within the conceptual modelling framework 
Figure 7.3 describes an outline of the phases within the conceptual modelling framework, which 
includes (A) Aligning the framework with the decision making process; (B) Identifying relevant 
stakeholders; (C) Understanding the problem; and (D) Developing and justifying the model structure.  
 
Figure 7.3: Overview of conceptual modelling framework for Public Health economic modelling 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An iterative approach 
The research within Chapters 4 - 6 suggests that model development is necessarily an iterative 
process.  
B) Identifying relevant 
stakeholders 
A) Aligning the framework with 
the decision making process 
C) Understanding the problem 
iii) Developing a conceptual model of the problem describing hypothesised causal 
relationships and modelling objectives 
 
 
iv) Describing current resource pathways 
D) Developing and justifying the model structure 
vii)Reviewing existing economic evaluations 
 
 
viii)Choosing specific model interventions 
 
 
ix) Determining the model boundary 
 
 
x) Determining the level of detail 
 
 
xi) Choosing the model type 
 
 
xii)Developing a qualitative description of the quantitative model 
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Choosing stakeholders and aligning the framework with the decision making process will generally 
need to be undertaken in parallel because the choice of stakeholders and their ideal level of 
involvement will depend upon the decision making process, but the availability of the stakeholders 
may have a substantial impact upon the process which is followed. It may be necessary to iterate 
between choosing relevant stakeholders and developing the understanding of the problem since the 
understanding of the problem step may highlight the need to include stakeholders with specific 
expertise. Similarly, whilst it is important to develop an understanding of the problem prior to 
developing and justifying the model structure (see principle of good practice 2), in practice the 
understanding of the problem is never complete and it may be necessary to transparently revise this 
understanding at a later stage. These iterations are described by arrows within Figure 7.3. The steps 
within the developing and justifying the model structure phase are also iterative. Evidence 
identification is not described as a separate stage within Figure 7.3 (apart from reviewing existing 
models) since it is an activity required within the majority of the outlined stages. However, iterations 
are inevitable between appropriate conceptualisation and data collection because there is unlikely 
to be the exact evidence available that has been specified.  
 
7.3.3 Detailed methods of the framework       
A) Aligning the framework with the decision making process  
Based upon the findings of Chapters 4 and 5, the Public Health conceptual modelling framework 
aims to be flexible within the different decision making jurisdictions. Thus the framework outlines a 
generic scalable approach. Reflecting upon a discussion within the initial meeting of the diabetes 
project with the project leads (see Chapter 6), there was a need at the start of the project to adjust 
the processes according to the project requirements and constraints in order to develop a project 
plan.  
 
The conceptual modelling framework is intended to be flexible for different decision making arenas 
which means that decisions about how to employ the framework within the process are required. 
For example, the project team may need to operate differently according to the nature of the 
engagement with decision makers and clients within the project. If the client is the decision maker, 
then the scope of the model in terms of the interventions, comparators, populations, outcomes and 
perspectives may be better defined than if the client is not the decision maker (eg. a research 
funding body). This may influence the approach to evidence searching (in particular the search for 
intervention effectiveness evidence) and the time and resources required for model scoping. If the 
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client is not the decision maker, the project team will need to identify the relevant decision makers 
and include them within the stakeholder group (see part B of the framework). 
 
A protocol document outlining the project plan can be produced using the framework as a basis for 
discussion between the project team and stakeholders. This helps the clients to understand whether 
the project is planned to run appropriately and the project team with project planning. Key process 
decisions to be made during this phase relate to the relevant modes of stakeholder engagement, the 
approach to evidence searching, and the time and resources available for the modelling project and 
each step of the framework. 
 
B) Identifying relevant stakeholders 
Key principle of good practice 3 highlights the importance of stakeholder involvement and key 
principle of good practice 1 proposes the use of systems thinking which involves consideration of all 
relevant perspectives. The range of expertise which might be relevant is described within Chapter 5. 
 
Range of expertise 
There are a number of different types of stakeholder within any Public Health project including 
clinical experts, decision makers and lay members, all of whom provide different expertise. The 
choice of stakeholders involved with the development of the model will inevitably affect the model 
developed and the interventions assessed because modelling is subjective. For instance, 
stakeholders help define the model scope, make value judgements, use their expertise to 
recommend structural assumptions such as extrapolating short term trial data over the long term, 
and choose which interventions to assess within the model. These will be affected by what is 
considered to be culturally and politically acceptable, which is entirely appropriate in order for the 
model to be useful, but provides an additional reason to obtain input from a range of stakeholders. 
Within some projects, the experts who inform the model development are chosen by the modelling 
team, whilst within others a group of experts are chosen by a decision making body, such as within 
the NICE process (see Section A). 
 
These experts are nominated because of their expertise in a particular area and it may be that 
stakeholders with views which strongly conflict with the aims and scope of the project may not be 
chosen to be involved (see Chapter 5). Thus, depending upon how the experts are chosen, they may 
be less likely to disagree with each other and the decision makers than a randomly chosen group of 
experts.  
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There is, however, usually the opportunity to involve additional experts chosen by the project team. 
A group of experts who will provide different expertise over a range of perspectives can be identified 
(see below). Practically, the approach to stakeholder communication needs to be flexible and some 
stakeholders will provide more input than others. 
 
Customers, actors and system owners 
Within the review of conceptual modelling frameworks within Chapter 4, few of the frameworks 
consider how to choose stakeholders. Roberts et al. suggest that clinical, epidemiologic, policy and 
methods experts should be consulted, as well as patient representatives.18  Within the classification 
from Soft Systems Methodology (SSM), stakeholders include the people benefiting within the system 
(the customers), the people performing the tasks in the system (the actors) and the people with the 
power to approve or cancel the system (system owners, which may overlap with the actors of the 
system).123   
Based upon Soft Systems Methodology (SSM)123 and the conceptual modelling paper by Roberts et 
al.18, the types of stakeholders to involve are: 
1) Customers which might include patient representatives and lay members; 
2) Actors which might include methods experts, clinical and epidemiologic experts for all 
relevant diseases; 
3) System owners which might include policy experts (in addition to some of the people 
identified as actors).  
The relationships between the customers, actors and system owners can be considered in order to 
think about whether any relevant stakeholders have not been identified. For example, if a general 
practitioner (actor) has been identified as a stakeholder, this could help identify the non-diabetic lay 
member (customer). The person with the power to stop the actor giving the customer a service is 
the local commissioners (system owners). Stakeholders should be involved during the understanding 
of the problem phase and the development and justification of the model structure phase. 
 
DIABETES PROJECT EXAMPLE 
Within the diabetes project, stakeholders that might be involved could be a diabetic patient and a 
non-diabetic lay member (the customers), a general practitioner, experts in diabetes, cardiovascular 
disease, microvascular disease, cancer and osteoarthritis and an expert in statistical analysis of 
longitudinal data (the actors), and local and national commissioners (the system owners).  
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Process suggestions which may be helpful to modellers 
Resource requirements for stakeholder recruitment: It may require substantial time and effort to engage 
stakeholders. It may be necessary to approach more stakeholders than required as some will not have the time 
to be involved. Stakeholder workshops are useful if there are sufficient resources within the project budget 
because they allow stakeholders to debate and question the assumptions and beliefs of each other. Substantial 
administrative time is likely to be required to organise stakeholder workshops due to the probable busy 
schedules of the stakeholders. For this reason, it is also likely that any workshops will need to be organised at 
least two months before they are due to take place.  
 
Stakeholder worldviews and motivations: Checkland suggests defining the worldviews of each stakeholder in 
order to understand conflicts between them.
123
  An understanding of the possible worldviews and motivations 
of each of the potential stakeholders allows the project team to compare these with the project aims. Potential 
stakeholders may be more willing to be involved if the initial request is phrased in a way which aligns the aims 
of the project with the expected motivations of the stakeholders. For example, some stakeholders may be more 
interested in the outcomes of the project than the methods being employed so the initial information provided 
could describe the potential outcomes of the project. Another potential approach is for a more senior colleague 
involved with the project who is renowned in their field to contact the experts, potentially raising the prestige 
of the project and increasing the perceived benefits to the expert of being involved.   
 
Stakeholder expectations: Stakeholders who are unfamiliar with modelling may not expect to be involved in 
shaping the modelling work. At the start of the project it is valuable to be clear with all of the stakeholders 
about the expectations of their involvement throughout the model development process and the importance of 
their input. Assumptions being made by the decision makers and other stakeholders throughout model 
development should be questioned.
92  
 
Lay members: Lay members are involved to ensure that views and experiences of the wider public inform the 
group’s work. Where possible, lay members should represent different types of people within society where 
those differences are likely to be important to the topic area (eg. lower socioeconomic status). If this is not 
possible, the project team should be aware that the perspectives provided by the lay members do not 
necessarily represent those of all patients in that disease area/ the general population. In particular, they may 
not represent the more vulnerable groups within society who are unlikely to volunteer for such a role.
168
  If 
these relevant groups are not represented, then the views and experiences of the wider public may not be 
heard by the stakeholders and project team. This could lead to unrealistic assumptions about a particular 
subgroup of the population who behave differently to those represented within the stakeholder group. 
Modellers should consider whether the assumed chains of behavioural causation are likely to be different 
within particular subpopulations. 
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C) Understanding the problem 
One of the four principles of this framework is that developing and documenting an understanding 
of the problem is at the core of developing an appropriate model structure. This is about 
understanding what is relevant to the problem, and should not be limited by what empirical 
evidence is available.14  The understanding of the problem phase within Figure 7.3 includes: (i) 
developing a conceptual model of the problem describing hypothesised causal relationships; and (ii) 
describing current resource pathways.  
 
Potential methods for developing an understanding of the problem 
Problem structuring methods are expected to improve understanding of complex decision problems 
from all stakeholders’ perspectives in an exploratory and transparent manner, acknowledging 
uncertainties.130  Franco argues that PSMs provide the potential for the quality of the 
communication between the modeller and the stakeholders to improve by encouraging a dialogue 
between them rather than debate, persuasion or negotiation.173  They should allow all stakeholders 
to be equally included within the communication and they encourage stakeholders to think beyond 
their current perceptions by considering the perceptions of other stakeholders. Within the review of 
conceptual modelling frameworks in Chapter 4, the methods presented for understanding the 
problem included Soft Systems Methodology (SSM), cognitive mapping and developing causal 
diagrams. Within Chapter 4 a detailed description of these approaches is described, along with 
discussions about their potential application to Public Health economic evaluation.  
 
Proposed method for developing an understanding of the problem 
One way of gaining a shared understanding of the problem is to combine the benefits of each of the 
above approaches. The advantages and disadvantages of these methodologies are summarised in 
Table 7.3, and the method developed for the conceptual modelling framework is based upon the 
features within the left hand column. Diagrams such as that suggested here encourage holistic 
thinking as they can be taken in as a whole.123 
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Table 7.3: Pros and cons of SSM, SODA and causal diagrams for Public Health economic modelling 
Useful aspects for Public Health economic modelling Disadvantages for Public Health economic modelling 
SSM 
Allows the entire problem to be understood. Long process with lots of different steps to follow, 
which may not be practical for the stakeholders or 
accepted by the modellers. 
Aims to uncover and share the sense making systems 
of the stakeholders rather than adopting the single 
worldview of the analyst. Types of potential 
stakeholders are considered. 
Aims to help people within an organisation continue 
to solve problems; within Public Health economic 
modelling the aim is not to impart how to solve these 
problems, but to develop a useful quantitative model. 
 Aimed at use within organisations, which are 
generally focused on shorter term observable 
outcomes, rather than predicting outcomes which are 
not directly observable over the lifetime of the 
relevant population as in Public Health economic 
modelling.  
SODA/ Cognitive mapping 
Allows the entire problem to be understood. Focuses on how things are managed within an 
organisation rather than on prediction. 
Aims to uncover and share the sense making systems 
of the stakeholders rather than adopting the single 
worldview of the analyst. 
Aims to help people within an organisation continue 
to solve problems; within Public Health economic 
modelling the aim is not to impart how to solve these 
problems, but to develop a useful quantitative model. 
Allows causal relationships to be captured, which is 
essential within Public Health economic modelling. 
Tend to include normative rather than positivist 
statements which generally cannot be translated into 
a quantitative model. 
The hierarchical structure of goals, actions & options 
is a useful and intuitive method for thinking through 
the problem with stakeholders.  
 
Can be used to establish whether there are any 
positive or negative feedback loops within the 
system, and whether there are any clusters of factors 
which have greater impact upon the goals than single 
factors. 
 
Causal diagrams 
Allows the entire problem to be understood. There is no specific approach for developing the 
causal diagram. 
Allows causal relationships to be captured and each 
concept within the diagram is a variable which could 
be used within a quantitative model. 
Does not typically help uncover and share the sense 
making systems of the stakeholders. 
Can be used to establish whether there are any 
positive or negative feedback loops within the 
system, and whether there are any clusters of factors 
which have greater impact upon the goals than single 
factors. 
 
 
i) Developing a conceptual model of the problem describing hypothesised causal relationships 
This section describes a methodology for developing a conceptual model of the problem by using the 
notation of causal diagrams, borrowing some of the methods from cognitive mapping,139 and 
ensuring that the worldview of each of the stakeholders is considered.123;139 This provides a 
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systematic approach for developing an understanding of the problem at an appropriate and 
manageable level of relevance.  
 
A causal diagram depicts the relationships between factors by arrows, using a + or – sign to indicate 
a positive or negative causal relationship. Causal diagrams allow feedback loops to be described 
which depict the dynamic complexity of the system. Each factor is a quantity such that one factor 
leads to an increase or decrease in another factor. For example,  
 
mean an increase in CVD events leads to an increase in costs and a decrease in quality of life 
respectively. The hypothesised causal relationships associated with the problem can be depicted 
using this notation, bringing together the understanding of relevant diseases, human behaviour and 
societal influences. Drawing upon cognitive mapping, the ultimate aims can be stated at the top of 
the diagram (by asking ‘why is x a problem?’), with intermediate outcomes below and options for 
change underneath (by asking ‘how can the problem be avoided?’).139  Detailed steps to develop the 
diagram are described overleaf. 
 
Within cognitive mapping, theoretically a diagram would be developed to represent the background 
knowledge and judgement of each stakeholder in order to communicate the construct system of 
each before bringing these together into one diagram (see Chapter 4).139  Practically, there is unlikely 
to be time for each stakeholder to develop a diagram of their beliefs and assumptions. It is more 
feasible in most cases to develop one diagram which aims to describe a set of causal relationships 
which can be questioned and discussed with stakeholders who have alternative constructs.  
 
Whilst the goal is to develop a causal diagram with positivist factors, it is unlikely that stakeholders 
will provide all of their input in a form which can be input directly into the diagram, and there will be 
an iterative process of translating the stakeholder’s normative statements into the diagram. 
However, people do intuitively think in terms of causal relationships because causal reasoning is 
learnt from a young age, for example, crying causes mum to come and see me.86  Causal knowledge 
is gradually built up through personally manipulating variables and from other information sources. 
Thus, the development of the conceptual model of the problem describing hypothesised causal 
relationships alongside stakeholders who have not been trained in developing these diagrams 
should be feasible.  
 
+ CVD event Cost       and         CVD event                
_ 
Quality of life 
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Evidence for developing the conceptual model of the problem 
Causal assumptions for policy prediction will necessarily be based upon experience and judgement 
since observational data can only be used to assess the statistical association between the specified 
causal relationships.86  The proposed diagram can provide an explicit description of our hypotheses 
about causal relationships and the challenge is to be able to justify the causal assumptions made. 
The diagrams can be developed based upon a range of sources including the project scope, 
literature, stakeholder input, the team’s previous work in the area and any other diagrams which 
have been developed by the rest of the current project team or the decision makers to depict their 
understanding of the problem, as described within Figure 7.4 below. By developing the diagram with 
input from stakeholders, it allows their assumptions and beliefs to be made explicit so that they can 
be agreed upon or questioned. The iterative process using all of the evidence sources outlined 
within Figure 6.4 provides multiple opportunities to question and adapt the causal assumptions. 
Ultimately, the conceptual model of the problem will depict the modeller’s assumptions and beliefs 
about the causal relationships based upon all of these sources of evidence. In doing so, some forms 
of information may dominate over others according to the modeller’s views of the validity of the 
information. 
 
Figure 7.4: Sources used for developing the conceptual model of the problem 
 
Step 1: What is the problem? 
The first step, based upon cognitive mapping,139 is to ask ‘what is the problem?’ This is the key 
problem from the decision makers’ perspective and could be based upon the project scope if 
Starting with high 
yield sources 
Individual stakeholder 
assumptions & beliefs 
Stakeholder    
discussion 
Modeller assumptions 
& beliefs 
Project scope 
Literature 
sources 
Existing diagrams/ 
previous work       
Conceptual model of the problem 
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What is the problem?          
                                                   Blood glucose levels/ diabetes 
                                                                             + 
                                                                                                        
Risk factors (including age, sex, a measure of physical activity and diet, family history of diabetes, 
ethnicity, etc.) 
 
available. The cause of the problem described should include a potentially modifiable component.  
The importance of defining the modelling objective is highlighted by many researchers.1;123  The 
model objective is likely to be (although not necessarily) to assess the effectiveness and cost-
effectiveness of interventions which might decrease this problem. Beginning the development of the 
diagram by identifying the key problem encourages a focused boundary around the understanding 
of the problem. 
 
 DIABETES PROJECT EXAMPLE 
 
Step 2: Why is this a problem? 
The modeller can then ask ‘why is this a problem?’, and continue to ask ‘why?’ or ‘what are the 
implications of this?’ until no more factors are identified, again based upon the methods of cognitive 
mapping.139   Within Public Health economic modelling the goal may be to maximise net benefit by 
maximising health and minimising costs or equity may be considered of primary importance.  
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Why is this a problem? 
Maximise health within a budget constraint 
     
                                                                          
 
                         QALYs QALYs                                                               Costs to NHS & PSS, the individual                                                                                                                        
                              _                                                                       & costs of productivity loss 
                                                                                                                                      +                            
                                                                                                                                                                            
 
 
 
                                                                                                      Neuropathy                                                                                  
                                   Cancers                                                              +   
                                                                             CVD                                     Nephropathy 
                                             +                                    +                                              +         Retinopathy 
                                                                                                                                               +         
                                                                                                                                                               
What is the problem?                                                                                                                                                            
 
                                                                                   
                                                                       +       
 
Risk factors (including age, sex, ethnicity, BMI, family history of diabetes, etc.)                                
NB. These differ for different diseases but some factors overlap eg.BMI. 
 
     Blood glucose levels (BGL)¤ 
DIABETES PROJECT EXAMPLE 
 
 
  
                New links within the diagram 
 *Different tests (OGTT, FPG, HbAc) identify different individuals & diagnostic criteria have changed 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
Normal       Time        IGR*      Time        Diabetes* 
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Step 3: Developing additional causal links 
A set of questions have been constructed which may be useful to help develop the diagram further.   
These are based upon the findings of Chapters 2, 3 and 4 and ensuring all considerations within the 
taxonomy used to help choose the most appropriate model type are reflected upon (see part D of 
the framework). Many of the questions draw upon systems thinking (key principle of good practice 
1) by considering unintended consequences and feedback loops. 
These are shown in Box 7.1. The development of the understanding of the problem is iterative, and 
hence it may be useful to continually revisit these questions. 
 
Incorporating disease natural history 
Any relevant disease natural histories will not be causal in that having a ‘normal’ health state does 
not cause a disease to develop. For example, moving from having normal blood glucose levels to 
having diabetes is not causally related. However, the interventions being assessed within Public 
Health tend to be those which reduce morbidity and mortality by aiming to change behaviour. Thus 
where there is a disease natural history, it is likely to be affected by behaviour and as such the causal 
chain can show the relationship between the behaviour and the disease. For example, a decrease in 
physical activity might lead to an increase in blood glucose levels. Following the onset of disease, the 
disease natural history can be described by probabilistic causation. For instance, somebody with 
impaired glucose regulation has an increased probability of developing diabetes.  
 
Defining factors for inclusion 
The arrows between the factors within the diagram would ideally be definable by one relationship. 
For example, if the relationship between risk factors and stroke and risk factors and heart disease is 
known to be different, then it is preferable for these factors to be separated out within the diagram 
rather than being combined within the factor CVD. If this is not possible in order for the diagram to 
remain clear, then a note could be added to describe the different subsets within that factor.  
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Box 7.1: Questions about the decision problem to help with developing the diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A1. Questions relating to the disease and the determinants of health include: 
- Have any relevant disease natural histories been captured? 
Example: Disease natural history associated with diabetes 
- Are the following determinants of health (taken from Dahlgren and Whitehead) important in 
determining effects and in what way:   
o Age, sex and other inherent characteristics of the population of interest? 
o Individual lifestyle factors? (incl. diet, physical activity, smoking, alcohol/ drug misuse) 
o Social and community networks? (incl. friends, family including intergenerational 
impacts, wider social circles) 
o Living and working conditions and access to essential goods and services? (incl. 
unemployment, work environment, agriculture & food production, education, water & 
sanitation, health care services, housing) 
o General socioeconomic, cultural and environmental conditions? (incl. economic activity, 
government policies, climate, built environment including transportation, crime)  
Example: Relationship between age, ethnicity, BMI, smoking and blood glucose levels  
 
A2. Questions to help ensure the understanding of the problem is sufficiently broad include: 
- Are there any other (positive or negative) consequences of each concept? 
Example: Increases in BMI may also lead to increases in osteoarthritis incidence. 
 
A3. Questions to ensure that the dynamic complexity of the system has been captured are: 
- Could there be any other factors which explain two outcomes, for links which may not be 
causal, but correlated.  
Example: BMI may help explain both CVD incidence and increased blood glucose levels rather 
than CVD causing increased blood glucose levels directly. 
- Are there any other possible causal links between the factors? (with the aim of establishing 
whether there are any feedback loops) 
Example: increased BMI leads to increased diabetes incidence which leads to an increase in 
mental illness which may lead to increased BMI. 
- Are there interactions between people which affect outcomes? (see social networks above)  
Example: People interacting with friends and family with higher BMI are more likely to have 
a higher BMI. 
- Is timing/ ordering of events important? 
Example: Timing and type of CVD events may affect other disease outcomes. 
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Maximise health within a budget constraint 
                                                                                        
 
 
                         QALYs QALYs                                                    Costs to NHS & PSS, the individual                                                                                                                        
                                                                                                 & costs of productivity loss 
                             _                                                                                          +  
                                                                                                                           
 
 
                                                                  
                                                                                                                                                                                             
          
                                                                                       
      Mental illness                         
                                          +         + 
 
 
                                                                                                                       Neuropathy                                                  
                                                                                                                                  + 
                                                                                                                                      Nephropathy 
                                        +       
            CVD                                                                                                                                      Retinopathy 
                          +                                                                                                                      +              
                       +                                                                                                                                    
 Cancers      +                                                                                                                                                                            
            +                                                                       
                              
                                                                        +             
 
+                                                                                                                                                                                                                            
                                                                                                               Risk factors of next generation  
                                                                                                                   +                                                                                                                     
                                                                                                                                                       Osteoarthritis 
                                                                                                                    +                                                        + 
 
Risk factors (including age, sex, ethnicity, BMI, family history of diabetes, etc.)                               
NB. These differ for different diseases but some factors overlap eg.BMI. 
 
 
 
 
 
                                                                                                    
 
 
 
                      
     Blood glucose levels (BGL)¤ 
DIABETES PROJECT EXAMPLE 
 
                New links within the diagram 
 *Different tests (OGTT, FPG, HbAc) identify different individuals & diagnostic criteria have changed 
 
Normal       Time        IGR*      Time        Diabetes* 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
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Step 4: Incorporating types of intervention 
Within dynamically complex systems like Public Health systems, the possible points at which 
interventions might affect outcomes associated with the decision problem may not be easily 
definable at the start of the project prior to developing a sufficient understanding of the problem. 
Thus, how to avoid or reduce the impact of the described problem should be considered in order to 
identify potential types of interventions. It is useful to firstly know what is considered to be current 
practice. Intervention types can be categorised by the population they target and their impact. 
Combinations of individual, community and population interventions may be considered, since a 
combination is likely to be most effective. These different potential types of interventions can be 
added to the conceptual model based upon the project scope, any effectiveness studies identified, 
and by considering within the diagram where interventions may be beneficial. One way of doing this 
is to consider which of the potentially modifiable determinants of health (individual lifestyle factors; 
living and working conditions and access to essential goods; and general socioeconomic, cultural and 
environmental conditions) affect the decision problem. It is not expected that the final specific 
interventions being assessed within the model will have been chosen at this stage. However, it is 
important to define the types of interventions which might be assessed within the model so that 
their impact upon model factors, including those not already incorporated into the diagram, may be 
considered.  
 
A set of questions have been constructed which may be useful for considering the impacts of the 
interventions, shown in Box 7.2. 
These are based upon the findings of Chapters 2, 3 and 4.  
These should be considered in the context of each type of intervention potentially being assessed 
within the model. 
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Box 7.2: Questions about the interventions and their impacts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B1. Questions relating to the constraints of the decision making process are: 
- Are there constraints on the project scope? (eg. are we constrained by the types of 
interventions we are assessing? What about the population?)  
 
B2. Questions relating to the goals and mechanisms associated with the interventions are: 
- What is considered to be a good outcome? 
Example: Would it be a good outcome if the intervention led to people understanding the 
benefits of healthy behaviours but chose not to adopt them? 
- What would happen in the absence of the interventions versus as a result of the 
interventions – would negative outcomes be prevented or delayed? 
- Example: Would there be fewer diabetes and related-disease outcomes in total or would 
they simply be delayed by x years? What might x be? 
- What evidence exists to describe the outcomes of the intervention/ comparator over time? 
Are behavioural outcomes important? If so, do any relevant models of behaviour from 
psychology, sociology or behavioural economics exist to help describe the behaviour 
resulting from the intervention or the comparator? This will require additional targeted 
literature searches. 
- Are there any determinants of health reported by the effectiveness studies which are not 
included within the causal diagram? Can such a relationship be described? 
Example: Access to healthy foods may be reported rather than diet, physical activity or 
weight-related outcomes. 
 
B3. Questions relating to the dynamic complexity of the system are: 
- Might a third party act to reduce the impact of interventions? 
Example: Might fast food restaurants increase advertising if sales drop as a result of the 
intervention? 
- Are there any substantial impacts of social and/or community networks upon intervention 
effectiveness? Will these impacts be captured over the long term within the effectiveness 
evidence?  
Example: The intervention may be more effective if friends and family are also receiving it. 
- Are there any substantial impacts of the interventions upon other lifestyle factors? 
Example: Healthy eating could also be linked to reduction in binge drinking.  
- Might the interventions have other impacts not already considered? 
Example: Walking/ cycling interventions may be associated with environmental outcomes. 
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Maximise health within a budget constraint 
                      
                                                                                        
 
                         QALYs             QALYs                                                                      Costs to NHS & PSS &                                                                                                                      
                                                                                                                            Wider societal costs 
                                             _                                                                                              
                                                                                                                                          + 
 
Environmental outcomes                                               Hypoglycaemia                                 
(congestion, CO,                                                             & weight gain 
  pollutants)                                                                                                                                                                                            
          
                                                          Mental                            Pharmacological 
                             illness     +                           interventions 
                                                           +        +          Lifestyle                                                                                       Infectious 
                                                                              Interventions                                                                                    diseases 
                                                 Fatigue                                 
                                                         +                                                                            Neuropathy                                          +          
                                                                                                                        Erectile         +   
                                     Non-alcoholic                                                        dysfunction              Nephropathy 
                                      fatty liver                                                                              +                   +         Retinopathy 
                               CVD      +          +                                                                                                               + 
                            +            +                                                                                                                            +              
                                      +                                                                  _                                                                  
                  Cancers       +                                                                                                                                                                   
                              +                                                                                            
                          
          
   +     Lifestyle interventions for     
   Screening tests for                                                             high risk individuals 
                  high risk individuals                                                                                                                       +                                             
                                                                                                                               Risk factors of next generation 
             Obstructive sleep apnoea                                                                  + 
                                                  +                                                                                                                            Osteoarthritis           
  Gestational diabetes/        +                                       +         +                                                             +                                                 
  Pregnancy complications                                                                                                      +         
                                                                                                                                                                                                                                                                                                                                                   
Risk factors (including age, sex, ethnicity, a measure of physical activity & diet, family history of diabetes, etc.)** 
NB. These differ for different diseases but some factors overlap eg.BMI. 
                                                            _                          
Population-level lifestyle interventions                                                                      
 
        
 
  
DIABETES PROJECT EXAMPLE 
            Potential interventions 
             Affects usage of alternative intervention 
 
*Different tests (OGTT, FPG, HbAc) identify different  
individuals & diagnostic criteria have changed 
 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
 
  +++  ++ 
 
 
 
                                 Blood glucose levels (BGL)¤ 
 
                       +    Diagnosed IGT*    +   Diagnosed diabetes*~ 
 
Normal     Time    Undetected IGT  Time    Undetected diabetes 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
**Risk factors may be worse in the future as lifestyles become more sedate 
CVD, retinopathy & hypoglycaemia may affect driving ability 
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Process suggestions which may be helpful to modellers 
Literature searching for developing the conceptual model of the problem: There is a dearth of defined methods 
associated with searching for evidence to inform the understanding of the problem and model development. A 
doctoral thesis by Paisley investigates how evidence to inform clinical intervention model development might 
be identified.
63
  This thesis suggests that a range of methods are likely to be required, which may include using 
known sources of information such as a previous model (direct acquisition), a formal literature search to 
identify specific information (directed acquisition) and/or identifying information on one topic during a search 
for information on a different topic which allows new ideas and options to emerge, as well as evidence which 
may not be picked up by a standard search such as grey literature (indirect retrieval).
63
  This process will be 
cyclical in that literature will increase the modeller’s understanding of the problem which will in turn direct 
where to search next for data. The modeller may begin this cyclical process by thinking about which sources of 
information may provide an initial high yield of information about the decision problem.
63
 For example, the 
modeller might begin by examining previous similar models and undertaking a broad search for reviews of the 
topic area. It is useful during this process to flag any literature which is identified which may be useful in 
specifying the structure of the model or model parameters.
63
   
 
Paisley suggests that literature search strategies should focus on maximising the retrieval of relevant 
information using an efficient, dynamic approach such as Berry Picking or Information Foraging.
63
  It is 
important to work closely with information specialists and reviewers and ensure that there is a shared 
understanding of what is required, particularly due to the dynamic nature of this type of search. The modeller 
has greater knowledge about the higher level goal, whilst the information specialist holds the searching 
expertise. Thus, a possible approach to information retrieval for understanding the problem and developing the 
model structure, based upon information theory, is described by Figure 7.5 below. Methods for reducing the 
iterations between the systematic reviewer and the modeller, such as the two working together in real time to 
identify appropriate search strategies, might be useful. 
 
Figure 7.5: Information retrieval for developing the understanding of the problem and model structure 
 
Iterative process between information specialist and 
modeller to identify relevant studies 
Developing initial understanding to be 
able to describe what would like to find 
to information specialist 
Initial 
systematic 
information 
gathering by 
modeller 
 
Informatio
n 
processing 
by 
modeller 
Systematic 
information 
gathering by 
information 
specialist 
 
Information 
processing by 
information 
specialist 
 
 
Informatio
n 
processing 
by 
modeller 
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Use of existing economic models: One of the sources of evidence for understanding the problem may be 
existing economic models since they can provide useful information about the problem in an efficient way. It is 
important to be mindful that these may have been developed for a slightly different problem/ context. 
Moreover, it is important to understand the current decision problem in its own right without being led by how 
others have modelled the topic. 
 
Mapping review for potential interventions: A useful approach which has been employed within the School of 
Health and Related Research at the University of Sheffield to facilitate the identification of potential types of 
interventions is to undertake a mapping review.
174
  This involves carrying out an initial broad search to 
understand what sort of evidence is available for interventions which fall into the project scope in order to 
define a more specific search. If there are too many possible types of interventions to assess within the 
constraints of the decision making process, decisions about which types of interventions to focus upon should 
be made through discussion with the stakeholders. If stakeholders broaden the potential types of interventions 
being assessed, the conceptual model of the problem may need to be expanded accordingly to capture any 
additional impacts of the interventions.  
 
Use of existing diagrams of the problem: The decision makers or other parts of the project team may have 
developed diagrams of their understanding of the problem.  For example, within the NICE process, logic models 
are developed by the decision makers to describe the relationships between actions and outcomes, 
incorporating relevant theory, in order to inform the project scope, including highlighting areas for potential 
interventions.
5
  The conceptual model of the problem may therefore build upon any other diagrams which have 
been developed by the rest of the project team or the decision makers, and importantly it should be consistent 
with them. If these diagrams were inconsistent, the reasons for these differences should be explained. Where 
such diagrams have not been developed, the conceptual model of the problem could be used for a similar 
purpose in terms of identifying potential interventions (according to potentially modifiable determinants of 
health) and informing the searches for intervention effectiveness evidence.  
 
Stakeholder involvement: The extent to which stakeholders can be involved in the development of the 
conceptual model of the problem will depend upon the specific project as discussed previously, but it could be 
developed or validated during a workshop with experts and decision makers (as in Strategic Options 
Development and Analysis
139
). Group judgements tend to be more accurate than individual judgements, 
particularly if a facilitator ensures that all people have chance to input.
96
  By each stakeholder sharing their 
beliefs and assumptions these can be questioned and discussed.
139
  However, practically it is likely that more 
than one way of communicating with stakeholders and a flexible approach will be necessary. For example, if 
holding stakeholder workshops, those that cannot attend the full workshop may be able to join for part of it by 
tele- or video-conference, and/or to provide comments upon circulated documents so that these can feed into 
the workshop. It may be appropriate to hold workshops/ meetings around relevant conferences or meetings to 
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increase attendance. One-to-one meetings, telephone conversations and/or email communication may be 
employed in addition to, or instead of, workshops.  
 
Stakeholder introductions: Drawing upon Checkland,
123
 understanding the worldviews of the stakeholders can 
help to:  
-Explore different views and the reasons for these between the stakeholders; 
-Identify concerns which may not otherwise have been identified; 
-Assess the stakeholders’ potential contribution towards the project rather than our expectation around  what 
they may be able to input; 
-Identify who it may be most appropriate to contact to ask specific questions or for clarifications; 
-Put what the stakeholders say into the context of their worldview so that any assumptions about the world 
can be more easily identified; 
-Ensure that future workshops/ correspondence aims to address the aims and motivations of the stakeholders 
so that they remain engaged within the project. 
Thus, it may be valuable for each stakeholder to describe their perspective, what they think they can give to the 
project and what they would like out of their involvement either for 2-3 minutes at the start of the first 
workshop or within a paragraph of written text and for the modeller to refer back to these throughout the 
project. Within workshops, a 2-3 minute introduction also encourages each stakeholder to feel valued and gives 
each stakeholder chance to talk in order to promote later involvement in discussions.
123
  
 
Handling stakeholder disagreement: Throughout this process it is important to question the assumptions of the 
stakeholders involved. If discussion does not resolve any disagreements between stakeholders, and there is no 
evidence to suggest a preference, then it may be due to value judgements, in which case it would be most 
appropriate to incorporate all alternatives within the understanding of the problem. 
 
Suggested processes if running workshops - project team requirements: Providing some sort of description of 
the degree of consensus/ disagreement between stakeholders could help with model validity and credibility. A3 
diagrams (eg. of the conceptual model of the problem at various stages of development) are a useful tool for 
stakeholders to share ideas and record them within workshops. When choosing whether or not to run 
workshops, the project team should be aware that the resource requirements during the workshops are 
substantial in order to facilitate, maintain engagement with the stakeholders, record what is said and process 
and collate information developed during the workshop. If the conceptual model of the problem is developed 
during the workshop, it could be developed using specialist computer software such as Group Explorer (which 
allows each member of the group to anonymously add to the diagram) or using a pen, post-it notes and a white 
board.
139
   
 
Suggested processes if not running workshops: If resources, time requirements and/or availability of 
stakeholders do not allow for a workshop to take place, then it would be possible for the modeller to develop a 
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diagram of their perception of the problem based upon background reading and any previous diagrams 
developed for the project, and then circulate the initial version of the conceptual model of the problem for 
comment from the stakeholders.  
 
Causal assumptions: It is likely that several versions of the conceptual model of the problem will be developed 
due to the iterative process of building up the understanding of the project team and stakeholders. Some 
evidence may suggest, or stakeholders may perceive, factors as causal (where one factor directly causes 
another) when in fact they are correlated (there may be a third factor which causes both outcomes so that they 
appear to be causal but are not). Causality might be well established for some relationships, such as the 
relationship between CVD events and mortality. For other relationships, background knowledge and literature 
should be used to be able to justify the causal assumptions made (see Figure 7.4). Econometric studies (for 
example, least squares regression, instrumental variables, structural equation models, propensity score 
matching) can be used to establish the statistical association between these specified causal relationships. 
Causality could be graded according to the strength of evidence which might be done visually within the 
diagram, for example, by varying the width of arrows as was done within the Foresight map of obesity.
41
 In 
contrast to facilitation for problem structuring methods where the main benefits might be in terms of the 
learning that takes place whilst developing the diagram rather than the output of the diagram, the modeller 
needs to complete a diagram which will be useful for specifying and justifying the quantitative model structure. 
 
Depicting time: Time lags between discrete factors could be highlighted by adding the term ‘delay’ to the 
arrows if there are substantial time delays between cause and effect, as for causal loop diagrams within system 
dynamics.
89
  An illustrative graph depicting time could also be incorporated where time effects are unclear from 
the causal structure. 
 
Reporting the conceptual model of the problem: Different colours, dotted lines or types of arrow can be used to 
depict different characteristics of the problem. More detailed notes can accompany the diagram. If the diagram 
becomes too unwieldy the ultimate aims could be removed and considered within a separate diagram or table 
since many of the factors are likely to link to these. The conceptual model of the problem can be input into the 
final report. The understanding of the problem may change; however, the diagram of the group’s initial 
understanding provides a foundation for comparison should the understanding of the problem change at a 
later stage within the project, and this can then be documented.  
 
As Roberts et al. suggest, the policy context of the modelling project needs to be clear, particularly in 
terms of the funder, the policy audience and whether the model is planned to be for single or 
multiple use.18 
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ii) Describing current resource pathways 
Two conceptual modelling frameworks, by Kaltenthaler et al. and Roberts et al. were identified 
within the review in Chapter 4 which were specific to health economic modelling. They both explain 
the need to describe current practice in order to be able to make a comparison between the 
intervention(s).14;18  Roberts et al. do not provide an explanation of how to describe current resource 
use; however Kaltenthaler et al. state that describing current practice is a complex information 
requirement which is unlikely to be fulfilled by doing one single search for evidence, and for which 
empirical effectiveness studies, expert advice and routine data may be consulted.63  The description 
of current practice was also recognised within the qualitative research (see Chapter 5) as one of the 
pieces of information which may be obtained from stakeholders. Kaltenthaler et al. suggest 
developing a service-pathway model which is a diagram of the treatment pathways of the 
population being considered.14  Within Public Health systems, resource use may be broader than 
healthcare, and thus such a flow diagram may or may not be appropriate. Based upon the critical 
reflection of the diabetes case study presented within Chapter 6, there should be two phases; first 
establishing very generally what sort of resource processes there are for key components of the 
conceptual model of the problem; and second describing resource use in detail during the justifying 
and developing the model structure phase. 
  
The conceptual model of the problem phase can be used to inform what resources might need to be 
considered. This does not need to be a detailed description of resource use at this stage, since some 
factors within the conceptual model may be excluded from the quantitative model and hence it 
would be inefficient to collect detailed information. It also means that the general pathways can be 
validated with stakeholders prior to collecting detailed information. Flow diagrams, tables and/or a 
textual description of the resource pathways can be useful to inform assessments of the impact of 
the factors within the conceptual model of the problem upon the model results. This can be used to 
help choose which factors to include and exclude from the model as is discussed within the model 
boundary stage of the framework (see Section D(iii)).  
 
DIABETES PROJECT EXAMPLE 
For the diabetes case study, a number of flow diagrams were used from existing NICE guidance to 
describe the different elements of screening and treatment of disease. 
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C) Developing and justifying the model structure 
This section aims to outline an approach for specifying an appropriate model structure for the 
problem which is feasible, valid and credible to develop into a quantitative model. As described 
within Figure 7.3, this includes: (i) reviewing existing health economic models; (ii) choosing model 
interventions and comparators; (iii) determining the model boundary; (iv) determining the level of 
detail; (v) choosing the model type, and (vi) developing a qualitative description of the quantitative 
model. This may be described as the design-oriented conceptual modelling phase, as defined by 
Kaltenthaler et al.14   
 
The stages described above were chosen based upon the review of conceptual modelling 
frameworks (see Chapter 4), with an additional stage for reviewing existing health economic models 
based upon a finding of Chapter 5. 
 
Terminology 
Terminology used within other conceptual modelling frameworks, as described within Chapter 4, has 
been reviewed here. The term ‘model interventions’ has been employed rather than ‘model options’ 
since the former is the terminology which tends to be used within Public Health economic 
evaluation. In addition, the term ‘model scope’ has been replaced with ‘model boundary’ because 
the term ‘scope’ within health economic evaluation is so synonymous with defining the Population, 
Interventions, Comparators and Outcomes (or PICO), which is more narrow a consideration than is 
intended here.  
 
Determining the model boundary involves deciding what factors are included within the model 
rather than being part of its external environment. The level of detail is defined as the breakdown of 
what is included for each factor within the model boundary and how the relationships between 
factors are defined. The model type is the analytic modelling technique employed, for example a 
decision tree, a Markov model, a DES, an ABS or a system dynamics model.  
 
Development of methods for developing and justifying the model structure 
The implications developed from the research undertaken within Chapters 2 – 5 (outlined within 
Table 7.2) provide a weaker theoretical basis upon which to develop methods for justifying and 
developing the model structure compared with developing the understanding of the problem phase. 
The analysis undertaken within the qualitative research (see Chapter 5) and the thesis by Paisley 
provide an indication about why this might be. The decisions made when choosing what is relevant 
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for including within the model structure are complex and subtle and the criteria by which these 
judgements are made are unlikely to be known to the modeller.63  Thus, whilst some of the methods 
proposed are based upon published evidence or the qualitative research described within Chapter 5, 
a substantial proportion of the methods within this phase are based upon reflecting upon previous 
Public Health projects, testing and reflecting upon this within the diabetes case study (presented 
within Chapter 6) and subsequently developing them further. 
 
i) Reviewing existing health economic models 
It is standard practice within health economic evaluation to undertake a systematic review of 
existing health economic models in the same area. Existing models may have been used to develop 
the understanding of the problem, but a systematic review at this stage can be used in a number of 
ways175: 
 To determine whether there is already a model which could be used, either in part or as a whole, 
based upon your understanding of the problem; 
 To consider the strengths and limitations of existing economic evaluations, which can be used to 
inform the model development, including considering the strengths and limitations of different 
model types in that area; 
 To compare and contrast how other modellers have chosen to structure the model and estimate 
key variables, and how the model results differ based upon these choices. This may involve 
considering the use of mathematical relationships such as risk equations or parameters which 
have been included within previous models if their source and justification has been 
appropriately explained; 
 To identify which variables are important in influencing model results (including any which have 
not been highlighted during the understanding of the problem phase) and which do not 
substantially affect the differences in outcomes between the interventions and comparators; 
 To provide an insight into the sort of data available which may inform the level of detail included 
within the model. 
 
ii) Choosing model interventions and comparators 
As identified within the review of conceptual modelling frameworks and the qualitative research 
(see Chapters 4 and 5), the current approach for choosing which specific interventions to assess 
within the model is not well defined, and this is variable between projects. Based upon the critical 
reflection within Chapter 5, it seems appropriate for decision makers to determine which 
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interventions to consider within the model if possible, based upon evidence reviews and input from 
other stakeholders.  
 
Method for choosing interventions to assess within the model 
Specific interventions to be modelled can be defined from the types of interventions identified 
within the understanding of the problem phase. The decision makers (with consideration of the 
clients’ needs if they are not the decision makers) should define which specific interventions to 
model grounded within the results of an evidence review and according to expertise from other 
stakeholders. Figure 7.6 shows how the specific interventions may be chosen based upon the project 
aims, the understanding of the problem and the intervention evidence review. Not all stages may be 
required depending upon the breadth of the study. If it was not possible to systematically review all 
potentially relevant interventions, then decision makers may have been asked to prioritise 
interventions to determine the inclusion and exclusion criteria for the systematic review at the 
understanding of the problem phase. The decision makers may use the systematic review of 
effectiveness evidence to further limit interventions by discussing trial populations, outcomes and 
other possible biases such as trial design associated with the effectiveness studies. It is possible that 
one good study or a number of studies can be used to estimate the short term effectiveness, 
depending upon the evidence available. As far as possible, the comparator can be based upon the 
same studies as the interventions if this is representative in practice. If practice is substantially 
different, then an adjustment on the effectiveness estimate would be required. Given that economic 
evaluation is a comparative analysis, the model results are only meaningful in relation to the 
comparators chosen.18 
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Figure 7.6: Choosing model interventions 
 
 
 
Extrapolation of study outcomes  
Which outcomes the effectiveness studies report will guide the development of the model structure. 
For example, within the diabetes project, if all of the studies reported disease outcomes rather than 
physical activity/ diet outcomes, it may be appropriate to exclude these behaviours as explicit 
factors from the model structure. If the intervention has an effect, the mechanism behind the 
effectiveness can be discussed to develop assumptions for extrapolating these effects beyond the 
trial data (see level of detail section).  
 
Use of the reviews to develop the model boundary, level of detail and model type 
The review of existing economic evaluations and the review of intervention effectiveness can be 
used to facilitate decisions around the model boundary, level of detail and model type as shown 
within Figure 7.7 below.  
Project aims/ specification/ scope 
Causal diagram of the problem 
Mapping review to identify 
breadth of intervention evidence 
Discussion with decision makers to prioritise 
interventions for systematic review 
Systematic review of effectiveness evidence 
Discussion with decision makers to inform which 
specific interventions to consider within the model 
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Figure 7.7: Defining the model boundary, level of detail and model type 
 
Develop understanding of the 
problem 
Assess whether there is 
an existing model which 
could be employed 
Identify strengths & 
limitations of different 
model structures 
Identify strengths & 
limitations of different 
model types 
Identify key variables which 
generally affect model results 
(incl. any not already 
identified) & key variables 
included within the causal 
diagram which do not 
Identify the sort 
of data available 
Identify factors with not many 
causal links & assess whether 
they would have a substantial 
impact upon the difference 
between outcomes of 
interventions & comparators 
Identify types of 
outcomes reported 
Identify long term 
evidence & mechanisms 
Describe effectiveness of 
interventions (to help 
choose which to model 
& for parameterisation) 
Model boundary Model detail Model type 
Discuss potential model perspectives, 
outcomes, interventions & 
populations with stakeholders 
Review existing health 
economic models 
Review effectiveness of 
relevant interventions 
Review evidence of 
relationships between 
factors 
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iii) Determining the model boundary 
Determining the model boundary is about deciding, based upon the understanding of the problem, 
what factors should be judged as relevant for inclusion within the model and which can be excluded 
given the constraints of the decision making process. The boundary of the model structure must 
differ from the boundary of the understanding of the problem in order to be able to make informed 
judgements about what it is important to include within the model structure (see Figure 7.1). It is 
important to define the boundary of the model such that all important interactions between the 
elements of the system identified within the understanding of the problem are captured.92   
 
Model perspectives and outcomes 
Based upon the reflections of the diabetes study (see Chapter 6), the model perspectives, outcomes, 
interventions and populations/ subgroups should be discussed with stakeholders at an early stage of 
the project, particularly if the project question and scope have been developed by researchers 
rather than decision makers. Within Chapters 2 – 6, no methods were identified for choosing 
appropriate model outcomes and perspectives, thus a method for doing this has been developed 
based upon reflections of personal modelling experience, informal discussions with other modellers 
and application and reflection within the diabetes case study. 
 
Often within health economic evaluation, the NHS and PSS perspective is employed.3  However, 
within Public Health economic modelling, other perspectives are likely to be relevant because 
substantial costs and benefits may extend beyond these sectors. Alternative perspectives include 
(but are not limited to) a societal perspective, a Public Sector perspective or the perspective of the 
particular agencies involved within the system. The system owners identified within Section B of the 
framework can be used to identify key perspectives for consideration. For example, if employers are 
considered to be system owners, then it is likely to be useful to consider an employer perspective. It 
should be noted that there are currently unresolved issues around using these alternative 
perspectives in terms of (i) whether it is possible or desirable to make social value judgements 
associated with the value of health relative to the value of other costs and benefits and (ii) the 
practicality of transferring costs and benefits between sectors.66  Nonetheless, if substantial costs 
and benefits are expected to fall outside of the NHS and PSS, presenting these alternative 
perspectives is likely to be informative for decision makers.  
 
In order to be able to compare interventions across different populations in terms of health costs 
and outcomes, the incremental cost per QALY may be employed, based upon New Welfare 
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Economics.2  Where the model boundary extends beyond health, it may be valuable to understand 
the modelling requirements in other sectors so that relevant outcomes may be presented. One way 
of presenting multiple outcomes for different sectors is to present a cost-consequence analysis 
alongside the cost-effectiveness analysis.64;65;70  Decision makers can suggest which model outcomes 
it would be useful to report. For both perspectives and outcomes, the modeller should follow any 
specific requirements of the decision makers such as the use of the NICE Public Health Methods 
Guide. The method for choosing model outcomes and perspectives has been outlined in Figure 7.8. 
 
Figure 7.8: Method for choosing appropriate modelling perspectives and outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIABETES PROJECT EXAMPLE 
 NHS & Personal Social Services 
(PSS) perspective 
Employer perspective (given 
the number of workplace-
based interventions) 
Societal perspective 
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e 
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The intervention and its delivery 
to the NHS and PSS 
The intervention and its 
delivery to the employer 
All costs of the intervention and 
its delivery (including to the 
patient) 
Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
 Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
and patients and carers 
(including travel costs) 
 Lost productivity Lost productivity 
  Lost leisure time 
O
u
tc
o
m
e
s 
Life years (LY) of the patient  Life years (LY) of the patient 
Quality-adjusted life years 
(QALYs) of the patient and carers 
 Quality-adjusted life years 
(QALYs) of the patient and carers 
Incremental cost per LY gained  Incremental cost per LY gained 
Incremental cost per QALY gained  Incremental cost per QALY 
gained 
  Environmental outcomes  
1) Consider what is theoretically appropriate and what is required under a reference case if 
applicable for (a) perspectives and (b) outcomes.  
When considering (b) model outcomes, how do the model perspectives affect this?  
 
2)    Consider by whom the results of the research will be used to consider whether additional 
(a) perspectives and (b) outcomes may be useful. 
3)    Discuss with stakeholders those perspectives and outcomes identified within (1) and (2) 
and ask if there are any additional (a) perspectives and (b) outcomes that it might  
be useful to consider. 
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Model population and subgroups 
The model populations can be discussed with the stakeholders, informed by the populations within 
the studies identified by the effectiveness review. The modelling team and the stakeholders could 
consider whether there is a bigger problem in a particular subgroup or whether the intervention is 
more effective in a particular subgroup and if there is sufficient data to undertake any subgroup 
analysis. These subgroups might be based upon the determinants of health outlined within Figure 
7.2 including age, sex and other inherent characteristics of the population of interest, individual 
lifestyle factors, living and working conditions and access to essential goods, and general 
socioeconomic, cultural and environmental conditions.  
 
DIABETES PROJECT EXAMPLE 
 
 
 
 
 
 
 
 
Additional model boundary considerations 
Robinson defines four criteria for helping to determine the model boundary (see Chapter 4).8  These 
include validity and credibility (the modeller and client’s perceptions that the designed model will be 
sufficiently accurate for the purpose), utility (the client and modeller’s perceptions that the designed 
model will be useful for the purpose) and feasibility (the client and modeller’s perceptions that the 
designed model can be developed given the time, resource and data available). This criterion was 
used, alongside development and reflection within the diabetes project, to develop an algorithm to 
help modellers choose the model boundary.  
 
An algorithm to help define the model boundary is shown within Figure 7.9 and can be considered 
for each factor within the diagram. Within Figure 7.9, the question ‘does the factor have many 
causal links?’ aims to identify which factors are central and should be included within the model, 
even in the absence of data (lots of links), and which factors are less important (not many links to 
other factors). This can be done formally within computer software if preferred.139  The question 
The populations and subgroups of interest were: 
- General population; 
- Local communities; 
- High-risk individuals including 
o Non-diabetic hyperglycaemic; 
o Women with gestatational diabetes;  
o South Asian individuals. 
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around whether the  impact of a factor is substantially captured by other factors attempts to exclude 
any double counting within the understanding of the problem phase (for example, including fatigue 
and diabetes) as far as possible from the quantitative model.  
 
It is valuable to predict very approximately the results of the model to facilitate model verification. 
These predictions can also help with defining the model boundary. Figure 7.9 encourages the 
modeller to think about whether it is worthwhile including non-central factors given the expected 
results of the model and the anticipated direction of effect of the factor upon those results, as well 
as the differential impacts of the interventions upon that factor. If different interventions impact the 
factor by different mechanisms, then including or excluding the factor may lead to different 
conclusions based upon the incremental analysis. 
 
In terms of the question within Figure 7.9 around whether the factor is likely to have a substantial 
impact upon the difference between costs and effects of the interventions, this entails having an 
understanding of the magnitude of the cost and outcomes associated with the factor and the extent 
to which the interventions might change these. These subjective judgements will inevitably be 
considered in the context of the time available for modelling and the potential future uses of the 
model. Whether or not the factor will impact substantially upon the model results is a subjective 
judgement which, practically, may be influenced by the time available to develop the model. 
However, the model boundary stage should not be overly dependent upon the evidence or time 
available as this can be accommodated for by the level of detail incorporated. It is likely to be more 
appropriate to crudely include a factor which is expected to substantially affect the model results 
than to exclude it from the model completely.  
 
Finally, in order to maintain the credibility of the model, stakeholders can be asked whether they are 
happy, given the above justifications, with the exclusion of factors. One way of reporting this stage is 
to produce a table of the excluded factors and the justification for exclusion as suggested by 
Robinson.8  An example of this is illustrated below Figure 7.9. 
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Figure 7.9: Defining the model boundary 
 
Does the factor have many causal links? 
 
Yes No 
Is the factor likely to have a substantial 
impact upon the difference between costs & 
effects of the interventions? This may be 
based upon (though not limited to):  
(1) the review of economic evaluations; 
(2) the description of resource pathways; 
(3) clinical papers describing the causal links; 
(4) existing models in similar areas which 
describe the impact of the factor; 
(5) methodological choices eg. discounting; 
(6) expert advice. 
 
Yes No 
INCLUD
E 
Is the factor associated with the interventions, 
populations & outcomes being modelled? 
 
EXCLUD
E 
INCLUD
E 
EXCLUD
E 
Yes No 
Yes 
Is the impact of the factor predominantly 
captured by other included factors? 
Yes 
EXCLUD
E 
No 
Would stakeholders prefer to 
include the factor for model 
credibility AND is it relatively easy 
to incorporate in terms of 
modelling skill & data availability? 
INCLUD
E 
No 
Are all interventions likely to be cost saving/ have a low ICER 
AND does the factor further increase benefits/ decrease costs 
AND do all interventions affect the factor in the same way? 
Yes 
No 
To be considered in the context of the time available for modelling & potential model reuse 
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DIABETES PROJECT EXAMPLE 
Factor Include/ exclude Reason for inclusion/ exclusion 
Risk factors Include Key component. 
Blood glucose levels/Diabetes Include Key component. 
Gestational diabetes Include As a subgroup of the population who will be given intervention. 
Osteoarthritis Include From a random sample of 3664 members of the Dutch population aged >25 years, Tukker reports that ‘for each 
unit increase in BMI respondents were 8% more likely to report OA or chronic pain’ and the Foresight report 
highlights the high prevalence of osteoarthritis within the UK population. In addition, the report by Gillett et al. 
suggests that the cost of osteoarthritis is comparable to the cost of diabetes. 
Risk factors of next 
generation 
Exclude Within the high risk group, only a minority of people will parent a young child due to the age of the people 
affected. Within the general population, Whitaker et al. suggest that parental obesity more than doubles the risk 
of adult obesity among their children, but because these costs and outcomes would occur so far in the future, by 
applying a discount rate to both costs and effects, there would be minimal impact upon the model results.  
Hypoglycaemia & weight gain  Include (but not as a 
separate factor) 
The quality of life implications of hypoglycaemia and weight gain will be captured within the quality of life of 
people with diabetes. The costs of hypoglycaemia will be explicitly included within the cost of diabetes treatment. 
Non-alcoholic fatty liver Exclude as a seperate 
factor 
This is likely to be implicitly included within the costs and quality of life estimates associated with diabetes and 
obesity. 
Fatigue Exclude as a separate 
factor 
The quality of life implications of fatigue are likely to be captured within the quality of life of people with disease. 
There will be minimal additional costs associated with fatigue above those associated with treating disease.  
Nephropathy Include Key outcome associated with diabetes. 
Retinopathy Include Key outcome associated with diabetes 
Neuropathy Include Key outcome associated with diabetes. 
Erectile dysfunction Include (but not as a 
separate factor) 
This is likely to be included within the costs and quality of life impacts of neuropathy. 
Infectious diseases Exclude Relative to other model factors, this is likely to have a smaller impact upon the model outcomes. 
 
Cancers (post-menopausal 
breast cancer, colorectal 
cancer) 
Include The report by the World Cancer Research Fund (WCRF) Panel on Food, Nutrition, Physical Activity and the 
Prevention of Cancer suggests that BMI and physical activity is associated with colorectal cancer, postmenopausal 
breast cancer and endometrial cancer. Prevalence of colorectal cancer and post-menopausal breast cancer within 
the UK population is high and they are associated with substantial impacts upon costs and quality of life.  
CVD  Include Has a substantial impact upon both costs and effects.  
Mental illness (incl. 
dementia) 
Include The relationship between mental illness and diabetes is complex and currently not completely understood. 
Evidence suggests that approx. 18-28% of diabetics have depression (Egede 2005), which is substantially higher 
than within the general population and this has substantial impacts upon costs and QALYs. 
Obstructive sleep apnoea Exclude as a seperate 
factor 
The relationship between risk factors and CVD is expected to capture those events resulting from obstructive 
sleep apnoea.  
Environmental outcomes Exclude Majority of the interventions would not substantially affect this outcome; focus upon health-related outcomes. 
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iv) Determining the level of detail 
The level of detail is defined as the breakdown of what is included for each factor within the model 
boundary and how the relationships between factors are defined.  
 
Existing evidence for determining the level of detail 
Within the review of conceptual modelling frameworks (see Chapter 4), limited consideration was 
given to making judgements associated with the model level of detail, and only two of the studies 
provide clear guidance. Kaltenthaler et al. provide a list of questions to help understand data 
requirements and data availability in the context of the decision problem, to encourage the modeller 
to think about requirements for extrapolation of trial evidence and consider what simplifications 
might be made and their implications.14  Robinson suggests that the level of detail should be 
determined by the model inputs and outputs and the level of accuracy required.8   
The decision about which parts of the model are likely to benefit from a more detailed analysis can 
be made a priori in order to avoid situations in which the modeller focuses upon specific parts of the 
model because they are more easily dealt with and subsequently run out of time to develop other 
parts in detail. Essentially, determining the level of detail involves a mini cost-benefit analysis within 
which modellers can weigh up, based upon the documented understanding of the problem and the 
defined model boundary, whether the time required to do one analysis at a specific level of detail 
within the model is likely to have more of an impact upon the model results compared with the 
same time period spent upon other analysis, given the current evidence available and the overall 
time constraints. 
 
Key types of model assumptions and simplifications 
Four key types of model assumptions/ simplifications were identified from the qualitative research 
(Chapter 5) and during the diabetes project (Chapter 6): 
a) The relationship between the included factors over time; 
b) The extrapolation of study outcomes; 
c) The level of detail used to describe each included factor including the outcomes (eg. costs 
and utilities) associated with each; 
d) How interventions will be implemented in practice. 
For each of these, key questions for the modeller were identified based upon the types of 
judgements modellers make according to the qualitative research within Chapter 5 and my 
reflections upon the diabetes project.  
Box 7.3 summarises key questions for the modeller to help choose an appropriate level of detail.  
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Box 7.3: Questions to help in making judgements about the model level of detail 
 
General 
1) Is the time required to do the analysis at a specific level of detail likely to have more of an 
impact upon the model results than the same time period spent upon other analyses, 
given the evidence available and the overall time constraints? 
 
To describe the relationship between the included factors over time 
 What outcomes are reported within the review of intervention effectiveness?  
(to help choose which causal links to include) 
 What evidence is available to model the causal links and the outcomes of the factor? 
(to avoid relying on the first available evidence) 
 What do other economic evaluations suggest are the strengths and limitations of 
different mathematical relationships between model factors? 
 Which determinants of health are key drivers of the problem according to relevant 
theory? 
 
To extrapolate study outcomes 
 What outcomes are reported within the review of intervention effectiveness? 
 What evidence is available for long term follow up? 
 Is there sufficient evidence and time available to model social networks given the 
expected impact upon model results (based upon the understanding of the problem)? 
 
The level of detail used to describe each included factor  
 Which are the specific aspects of each factor that are likely to have a substantial impact 
upon the model results? 
o Is all costly resource use captured? 
o Are all substantial benefits and disbenefits captured using measures acceptable 
to the decision maker given the available evidence? 
 Are impacts included within both costs and benefits where appropriate? 
 
How interventions will be implemented in practice 
1) What do the effectiveness studies describe? 
2) What do stakeholders suggest would happen in practice and is this likely to lead to 
different estimates of effectiveness to those within the study? 
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Distinction between model assumptions and simplifications 
Robinson highlights the distinction between model assumptions and simplifications; model 
assumptions ‘are made either when there are uncertainties or beliefs about the real world being 
modelled’ and model simplifications ‘are incorporated in the model to enable more rapid model 
development and use, and to improve transparency’.137  Thus, model assumptions are uncertain and 
alternative plausible assumptions can be tested within the model, whilst model simplifications are 
chosen because they are likely to have limited impact upon the model results. It is important to be 
explicit about both of these when describing the level of detail and highlight model assumptions 
which could be tested within sensitivity analyses. 
 
Searching for evidence 
Data for inclusion for specifying the model structure and for the parameters will need to be 
identified at this point if it has not been already. This could be based upon literature identified 
during the development of the conceptual model of the problem for which specific literature was 
noted as useful, although additional specific searches may also be required. Data collection and the 
development of a description of the level of detail for the model will be a highly iterative process. 
Sufficient evidence is required to be able to justify why the modelling choices have been made.63  It 
is important to note that elements for which there is a lack of empirical data which are considered to 
have key differential impacts upon the comparator(s) and the intervention(s) may be informed by 
expert elicitation. One consideration at this stage is likely to be the derivation of the disease natural 
history parameters which may be taken from existing studies or calibrated using statistical methods 
such as the Metropolis Hastings algorithm.176  
 
Reporting level of detail 
The simplifications and assumptions should be described and explained, initially for communication 
purposes with stakeholders and the project team to develop model validity and credibility, but also 
to facilitate future modelling projects in the same area. A document can be developed which 
specifies all of the key model simplifications and assumptions for discussion with stakeholders, 
ideally within a second stakeholder workshop (see Appendix D5 for example from the diabetes 
project). This can help to identify the most appropriate evidence for the model and also improve 
model validity and credibility. Writing down all of the key simplifications and assumptions and their 
justification provides a mechanism for systematically questioning them within project team 
discussions and with the stakeholders; thus enhancing the appropriateness of the model 
simplifications and assumptions.   
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Expressing structural uncertainty 
It may be that where there is more than one plausible assumption it is appropriate to develop model 
structures for each assumption in order to undertake posterior analysis of structural uncertainty, for 
example model averaging. This would be undertaken by creating a parameter to be included within 
the probabilistic sensitivity analysis to represent the probability of each structure being appropriate. 
This parameter and its distribution could then be estimated by elicitation with experts.12  
 
The level of detail will be affected by the model type chosen, and hence it will be an iterative process 
between identifying an appropriate level of detail and choosing the model type. 
 
v) Choosing the model type 
Within the qualitative research described within Chapter 5, modellers suggested that it may not be 
possible or necessary within the constraints of the decision making process to develop the model 
type identified by a taxonomy based upon the characteristics of the problem.  Based upon Chapters 
4 and 5, six key issues have been identified which may affect the type of model structure developed: 
 The most appropriate method for the characteristics of the problem; 
 The requirements of the decision maker including time/ resources available; 
 Data availability; 
 The availability of and access to the use of existing relevant good quality economic models 
which could be used as a starting point; 
 The expertise and previous experience of the modeller; 
 The likelihood of the intervention being cost-effective in combination with the requirements 
of the model for future use. 
These have been used to develop a method for helping the modeller choose the model type. 
 
Most appropriate method given the characteristics of the problem 
It is important to understand the most appropriate method given the characteristics of the problem, 
even if it is not practical to develop this model type, so that the modeller can understand the 
simplifications they are making. A number of existing papers outline taxonomies for deciding upon 
appropriate model types given the characteristics of the problem for health economic 
modelling.124;134;135  The taxonomy developed by Brennan et al. is used here,124  although others may 
be employed. It can be summarised by asking whether interaction, timing and stochasticity are 
important, and whether there is sufficient data for an individual level model rather than a cohort 
model, each of which leads to a preferred model type (see Table 7.4 over page). Whilst decision 
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trees and Markov models are most often employed within Health Technology Assessment,135 
because of the complexity associated with Public Health systems it is likely that alternative model 
types may be more appropriate. 
  
Agent-based simulation (ABS) is not included within the taxonomy by Brennan et al. (or any other 
health economic modelling taxonomies identified); however it may be useful for modelling 
dynamically complex Public Health systems and so has been added to the taxonomy. ABS is an 
individual-level simulation modelling approach and is compared with the individual-level simulation 
approach DES which is included within the taxonomy. DES is a top-down approach where the 
behaviour of the centralised system is defined by the modeller and entities within the model are 
passively affected by the rules of the system. Conversely, ABS is a bottom-up approach where the 
behaviour of the system is a result of the defined behaviour (based upon a set of rules) of individual 
agents and their interactions within the system.122 These agents can learn over time. Therefore, DES 
may be preferable when the interaction between the agent and the environment is important (for 
example, a person has surgery which changes the probability of subsequent outcomes); whilst ABS 
may be preferable when the interactions between heterogeneous agents are important in addition 
to their interactions with the environment (for example, infectious disease modelling). Importantly, 
ABS more easily allows the analyst to capture spatial aspects in order to model appropriate 
interactions (for example, family and friend networks for transmission of a contagious disease).122  
Studies have shown such social network impacts of Public Health behaviours such as physical activity 
and diet.177  Table 7.4 shows a revised version of Brennan’s taxonomy with an additional row 
incorporated for ABS. 
Table 7.4: Revised version of Brennan’s taxonomy 
 A B C D 
Cohort/ aggregate level/ counts Individual level 
Expected value, 
continuous state, 
deterministic 
Markovian, discrete 
state, stochastic 
Markovian, discrete 
state 
Non-Markovian, 
discrete state 
1 No 
interaction  
Untimed Decision tree 
rollback 
Simulation decision 
tree 
Individual sampling model: Simulated 
patient-level decision tree 
2 Timed Markov model 
(deterministic) 
Simulation Markov 
model 
Individual sampling model: Simulated 
patient-level Markov model 
3 Interaction 
between 
entity and 
environment  
Discrete 
time 
System dynamics 
(finite difference 
equations) 
Discrete time 
Markov chain 
model 
Discrete-time 
individual event 
history model 
Discrete individual 
simulation 
4 Continuous 
time 
System dynamics 
(ordinary 
differential 
equations) 
Continuous time 
Markov chain 
model 
Continuous time 
individual event 
history model 
Discrete event 
simulation 
5 Interaction between 
heterogeneous entities/ 
Spatial aspects important  
X X X Agent-based 
simulation 
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It is important to note that the choice of model type is not completely clear cut.124  For example, it 
would be possible to incorporate some timing into a decision tree or to develop a system dynamics 
model with some individual level behaviour; however many of these ‘work arounds’ often become 
more time consuming to program than employing the more complex model type. 
 
Most appropriate model type based upon broader considerations 
It may not always be practical to employ the model type which is most appropriate for the 
characteristics of the problem. Figure 7.10 provides an outline of how the modeller might decide on 
the most appropriate model type according to broader practical issues. 
 
Figure 7.10: Choosing the model structure 
 
Determine the most appropriate model type for the characteristics of the problem using Table 7.4. 
Is this feasible within the time and resource constraints of the decision making process given: 
(i) the data available? 
 AND 
(ii) the accessibility of any existing relevant good quality economic evaluations for use as 
a starting point?  
AND 
(iii) the expertise of the modeller? 
 
Are you intending to use the 
model again for other projects? 
Can you answer the question with a few 
provisos with a simpler model type, given 
your understanding of the problem? 
Yes No 
Explore with the 
decision maker the 
most useful purpose of 
the modelling given 
the project constraints 
Develop the simpler 
model type, documenting 
the provisos, uncertainties 
& implications of the 
simplifications 
No Yes 
Do you think a simpler 
model type would lead to 
the same conclusions, 
given your understanding 
of the problem? 
Develop 
the 
model 
Yes No 
Develop the more 
complex model 
Develop the simpler model, 
documenting the provisos, 
uncertainties & implications 
of the simplifications 
Yes No 
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DIABETES PROJECT EXAMPLE 
Within the diabetes project, the most appropriate model type, based upon the understanding of the 
problem and the revised version of Brennan’s taxonomy was an agent-based simulation model. 
However, given the constraints of the project, a discrete event simulation was considered to be most 
appropriate and the provisos, uncertainties & implications of not modelling the social network 
effects of obesity were documented and highlighted as areas of further research. 
 
 
vi) Qualitative description of the quantitative model 
A qualitative diagram of the quantitative model alongside the development of the model structure 
can facilitate clear communication of the final model structure to stakeholders, other members of 
the team and people who may want to understand the model in the future. This will depend upon 
the model type developed but may take the forms outlined in Table 7.5. 
 
Table 7.5: Suggested diagrams to represent the implemented model  
Model type developed Suggested diagram 
Decision tree Decision tree diagram 
Markov model State transition diagram 
System dynamics Influence diagram / stock and flow diagram 
Individual event history model State transition diagram 
DES Activity cycle diagram 
Agent based model A flow diagram 
 
Whilst the design-oriented conceptual model can be specified prior to the quantitative model 
development, the conceptual model may be iteratively revised according to data availability and/or 
inconsistencies identified during the development of the quantitative model.8;14;127;129  These 
modifications should be documented throughout so that there is transparent justification for the 
final model developed. 
 
7.4 Chapter summary 
This chapter collated the implications for methods development from Chapters 2 – 6 of the thesis 
and presented the conceptual modelling framework resulting from this research and the justification 
for the methods developed. The conceptual modelling framework used for evaluation within 
Chapter 8 (green shaded sections from this chapter) is presented within Appendix E.  
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Chapter 8: Evaluation of the conceptual modelling 
framework 
 
8.1 Chapter outline 
My research question is ‘What might a conceptual modelling framework for Public Health economic 
evaluation comprise and what could its potential be to improve model quality?’, where quality is 
defined as providing a tool for communication with stakeholders, aiding the development of 
modelling objectives, guiding model development, experimentation and reuse, and improving model 
credibility, verification and validation. This chapter aims to critically assess whether this research 
question has been addressed by: 
1) Reflecting upon the theoretical basis of the conceptual modelling framework developed, 
including considering whether the framework might be associated with any negative 
implications for model quality; 
2) Presenting the analysis of a second focus group of modellers providing their views on the 
utility of the framework.  
The response of modellers and health economists to the conceptual modelling framework presented 
at a Health Economics Study Group meeting is also presented as an informal evaluation. Sections 8.2 
and 8.3 present the methods and results of the evaluation respectively. A discussion of the 
evaluation is presented within Section 8.4 and Section 8.5 provides a chapter summary. 
 
8.2 Methods of evaluation  
A traditional positivist approach is not considered to be appropriate for the evaluation of this 
research, as discussed within Chapter 4. The review of conceptual modelling frameworks within 
Chapter 4 suggested that the most appropriate approach may be theory-based evaluation, alongside 
other forms of evaluation such as a case study and/or feedback from modellers or stakeholders. 
Therefore, the conceptual modelling framework is evaluated by the following methods: (i) a 
reflection on the theoretical basis of the framework; (ii) analysis of a second focus group of 
modellers which aimed to provide views on the framework developed; and (iii) as an informal 
evaluation I also consider the response of modellers and health economists to the conceptual 
modelling framework presented at a Health Economics Study Group (HESG) meeting. These methods 
are outlined in more detail below. 
 
As discussed in Chapter 1, this thesis has focused upon the development of the conceptual 
modelling framework based upon the MRC guidelines that highlight the importance of adequate 
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development of a complex intervention.60  The methods described below aim to provide an initial 
evaluation of the framework. Further evaluation, reporting and implementation can be pursued 
within subsequent research and dissemination following this work. Future research may involve 
qualitative research collection and analysis from stakeholders and other modellers following their 
use of the framework within case studies. Throughout this chapter, I have adopted the first person 
so as to be explicit about my role within the evaluation.  
 
8.2.1 Theory-based evaluation methods 
The theory-based evaluation has four components;  
1) My reflections upon the strengths and limitations of the methods employed to develop the 
conceptual modelling framework;  
2) I consider how the key issues identified within Chapters 2 – 6 (see Table 7.2) have been 
incorporated and whether there might be further scope for consideration of some of these 
issues within the framework; 
3) I describe the potential benefits of the framework by considering how it might help 
modellers to avoid the potential pitfalls described in Chapter 7 (Table 7.1, developed from 
Chapters  4 and 5); 
4) I reflect upon the potential weaknesses of the conceptual modelling framework.  
 
8.2.2 Qualitative research methods 
Data collection 
The qualitative research element of the evaluation of the conceptual modelling framework involved 
holding a focus group meeting with five health economic modellers. A focus group meeting was 
chosen for data collection as it can provide a range of views relatively quickly and encourages 
discussion and debate of different perspectives.17  Participants were chosen and recruited as for the 
focus group which contributed to methods development described within Chapter 5. I identified 
different experts to those invited to the earlier focus group since it could be argued that the people 
who contributed to the development of the framework are less likely to be critical. The focus group 
was arranged to take place in Birmingham due to the ease of access for all participants. Further 
research ethics approval was obtained. In order to reduce coercion and for participants to be able to 
openly provide their views about the conceptual modelling framework that I had developed, I invited 
a colleague who had previously undertaken both health economic modelling and qualitative 
research to facilitate the meeting. I introduced the framework at the start of the meeting, but 
subsequently left the room; although I was in the next room in case anybody had any questions. The 
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conceptual modelling framework was circulated three weeks before the meeting so that participants 
could read the document prior to attending. I developed a topic guide to inform the general 
structure of the session which was designed to facilitate critical assessment of the research question, 
including questions exploring the key benefits and issues of the framework and whether it has the 
potential to improve model quality, in what circumstances and for whom the framework might be 
beneficial and the requirements for successful implementation (see Appendix F for topic guide). The 
information sheet and consent form were similar to those developed for the qualitative research 
within Chapter 5. As for the earlier focus group, the meeting was audio recorded. The recording was 
transcribed by a transcription specialist and then checked for accuracy by me listening to the entire 
audio recording whilst reading the transcript.  
 
Thematic analysis and open coding of data 
As for the analysis of the earlier focus group data described within Chapter 5, I undertook thematic 
analysis.159  Each sentence from the focus group transcript was copied across to an Excel 
spreadsheet into categories. These categories were developed gradually as I went through the 
transcript sentence by sentence, having already familiarised myself with the content by reading it 
through. All data were open coded in this way,160 apart from any parts of the transcript considered 
irrelevant to the aims. This meant that all perspectives were included within the analysis. After open 
coding was complete, similar categories were grouped together into themes. The original transcript 
was also used within the analysis to note where participants had agreed or disagreed with each 
other, and how the quotations related to each other. For each open code, key points were identified 
and for each of these a quotation was selected according to whoever had made the point being 
described in the most succinct way.  
 
8.2.3 Paper presentation at the HESG meeting 
The HESG annual meeting was held the week following the focus group meeting. Unlike typical 
conferences, at HESG, all people attending the session are expected to have read a pre-circulated 
paper (shown in Appendix F) and another health economist or modeller will give a 20 minute 
Powerpoint presentation describing it. The author will then have 5 minutes to clarify any issues, 
followed by a 35 minute discussion with the other attendees. This discussion was not recorded due 
to ethical reasons, but it allowed an informal yet useful additional evaluation of the framework 
which I briefly reflect upon.  
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8.3 Results of the evaluation 
My reflections regarding the four components of the theory-based evaluation of the conceptual 
modelling framework developed (See Section 8.2.1) are presented within Sections 8.3.1 – 8.3.4. The 
results of the qualitative research are described within Section 8.3.5 and my consideration of the 
HESG meeting feedback is presented within Section 8.3.6. 
 
8.3.1 Strengths and limitations of the methods employed to develop the framework 
Whilst quantitative and qualitative data analysis requires different types of evaluation, most 
researchers would agree that data analysis should be done in a valid (or credible) and reliable 
way.58;156  Validity relates to whether the study measures what it is supposed to be measuring, whilst 
reliability has been defined as the extent to which research findings can be replicated.58  
 
Validity/ credibility 
Many qualitative researchers argue that it is not possible to validate qualitative data due to the 
difficulty of ascertaining the truth within the social world. However, they recognise that some way of 
assessing the quality of the research is required and suggest terms such as ‘credibility’ and 
‘plausibility’ rather than ‘validity’.58  
 
The literature reviews followed an iterative approach to searching, although a clear aim was stated 
prior to undertaking the searches. There was more than one starting point for each review to avoid 
identifying studies in only one small area of the relevant literature, and citation, reference and 
author searches were undertaken for each relevant paper. Within the qualitative research, the 
combination of interviews and a focus group provided a pragmatic approach to obtain both depth 
and diversity. I chose participants purposively based upon their varied experience within Public 
Health economic modelling from different key centres around the UK so that the views presented 
would be relevant and comprehensive. For example, some participants had undertaken projects for 
NICE whilst others had not, and one participant was an expert in infectious disease modelling. I 
audio recorded the interviews and focus group meetings to obtain accurate data and checked the 
transcriptions by reading them whilst listening to the recordings. I attempted to identify alternative 
meanings for each piece of data and actively looked for data which might suggest opposing views. I 
also used literature sources to assess the validity of my findings where available, although due to the 
limited research in this area this was not possible for many of the findings. The cyclical learning 
process of diagnosis, planning, analysis and reflection taken throughout the research encouraged me 
to question my findings and adjust my subsequent activities accordingly. 
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The conceptual modelling framework was developed via a range of methods including two literature 
reviews, qualitative research involving analysis of my own notes, interviews and a focus group, and 
critical reflection of pilot use within a diabetes prevention case study. Since each method is 
associated with different potential biases, this methodological triangulation is useful to strengthen 
the validity of the results where they overlap.58  Moreover, I actively looked for findings from the 
different methods of data collection which contradicted each other and no key inconsistencies were 
identified. The methodological triangulation also provides a more comprehensive analysis of the 
justification and requirements of a conceptual modelling framework for Public Health economic 
modelling. The variety of methods enabled analysis of both what modellers think and what 
modellers do in practice, derived from the qualitative research and the case study respectively.  
 
Reliability 
There has also been much debate about reliability in qualitative research. Some researchers argue 
that findings could not and should not be replicated because of the complexity and dynamic nature 
of the social world.178  Seale suggests that complete replication is more of a practical problem than a 
philosophical issue.160  For example, if the same respondents are asked the same questions again 
they are unlikely to provide the exact same responses. Lewis and Ritchie suggest that in order to 
assess the reliability of the analysis, qualitative researchers should describe the procedures which 
have led to the study’s conclusions through reflexivity and carry out internal checks on the quality of 
the data and its interpretation.156  Similarly, Mason suggests that researchers should focus upon the 
bigger issues of quality and rigour.58 
 
I have endeavoured to document the systematic and reflexive approach taken throughout the 
development of the conceptual modelling framework so that the methods and choices can be 
questioned and justified (mirroring one of the aims of the conceptual modelling framework). For 
example, the literature reviews were undertaken using a systematic search strategy (see Appendix A 
and B) and a data extraction form was used to obtain information from the identified articles. For 
the qualitative research, I systematically coded each sentence of the transcripts in order to develop 
themes. I also described each change I made to the draft conceptual modelling framework resulting 
from the diabetes case study using critical reflection. I have described my position as a researcher 
throughout and the potential impact I might have upon the analysis.  
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A potential weakness of the qualitative research was that it may not have reached theoretical 
saturation and it was not possible to continue collecting data due to time and resource constraints 
(see Chapter 5 for further discussion of the methods). However, the point of saturation is a 
contested concept which is not precisely defined.179 There was substantial overlap between the 
views within the depth interviews and the focus group meeting and some ideas were repeated 
within the focus group meeting, suggesting that sufficient data was collected to enable a reasonable 
analysis. Finally, it was not possible for a second researcher to check my coding within the 
qualitative research or to check study inclusion for the literature reviews.  
 
Generalisability 
The intention of the conceptual modelling framework is that it should be possible to employ it across 
any Public Health economic modelling context; however the generalisability has not been tested 
within this research. In addition, the conceptual modelling framework has not been used by other 
modellers who were not involved in its development. These are key areas for further research.  
 
Further applicability of the framework 
It has been suggested that the framework may be useful beyond the Public Health field. There is 
limited methodology for developing health economic models more broadly17 and whilst this 
framework includes some aspects which focus upon Public Health (such as the broader determinants 
of health), they may be applicable in some clinical contexts and not all aspects of the framework 
need to be employed. Thus, whilst the intention of the framework is that it will be employed for 
helping modellers to develop Public Health economic models, it may be useful in other health 
economic projects. This would need to be tested within future case studies. 
 
8.3.2 Verification that the requirements of the framework are addressed 
Within Chapter 7, Table 7.2 specifies the requirements of the conceptual modelling framework 
based upon the implications of the research within Chapters 2 – 6. Each of these is considered in 
turn to assess how they are incorporated into the framework in order to verify that they are all 
addressed. This is tabled in Appendix F and suggests that all of the features which were identified as 
important within the research in Chapters 2 – 6 are incorporated within the framework. However, 
there are several areas where revisions to the framework or further research might be useful to 
improve the conceptual modelling framework.  
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Firstly, the version circulated to the focus group participants does not state that it is intended that 
the framework will continually be revised as appropriate, although this is stated within the 
discussion section of the HESG paper. Secondly, one of the requirements identified from Chapter 5 
was that it is important to be clear about what the framework can and cannot do. This is broadly 
specified when describing the aim of the framework; however more detail could be added based 
upon the analysis of the focus group data and any future evaluation. The focus group evaluation 
highlights the potential for modellers to misunderstand the purpose of the framework and hence 
the importance of clearly describing the purpose (see Section 8.3.2). Similarly, the qualitative 
research within Chapter 5 highlighted that the framework should be culturally acceptable and simple 
to use in practice; however the qualitative research presented within this chapter suggests that 
there is currently too much text (see Section 8.3.2 for discussion of the format of the framework). 
 
I would suggest that one of the weakest areas of the framework is in helping modellers determine 
appropriate and inappropriate simplifications of the problem. Within the conceptual modelling 
framework, Box 7.3 provides a set of questions which might help modellers think about the 
appropriate level of detail based upon the understanding of the problem and the model boundary. 
However, these questions only help the modeller to think about relevant tradeoffs rather than 
providing an approach to help the modeller make judgements about the level of detail. This may be 
because it is not possible to develop any useful algorithms to help choose an appropriate level of 
detail because there is such a broad and subtle range of factors affecting these decisions, and thus 
the most useful approach is to have a good understanding of the problem and consider the outlined 
questions within the framework. However, it may be that a better approach could be developed if 
the process of making these judgements about the level of detail could be better understood across 
a broad range of projects. It would be useful to investigate this within further research. 
 
It is highlighted within the framework that equity might be an important aim within Public Health, 
however there is no further discussion of this from a Public Health perspective which may be helpful 
to modellers within future versions of the framework. The research within Chapter 3 suggested that 
the framework should consider heterogeneity as it is particularly important within complex Public 
Health systems. Questions around the determinants of health which highlight heterogeneity are 
included within the understanding of the problem phase and the benefits of including social network 
effects within the modelling and of using patient-level simulation are considered. In addition, the 
identification of subgroups for the modelling is considered within the Determining the Model 
Boundary stage of the framework. However, due to the potential importance of heterogeneity upon 
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the model results, more detail could be provided around how this might be incorporated into the 
model. The framework suggests that modelling approaches such as agent-based simulation might be 
used to model the social determinants of health; however in practice the application of such 
modelling methods in Health Economics is absent. This means that most modellers would need 
more training and guidance around how to undertake these modelling approaches, which was 
considered outside of the scope of this work. Publishing work of the methods and application of 
methods which enable the social determinants of health to be incorporated such as agent-based 
modelling and social network analysis would be useful to help modellers when considering these 
approaches.  
 
8.3.3 Potential benefits of the conceptual modelling framework 
Two existing conceptual modelling frameworks for health economic modelling have been identified 
within the review presented in Chapter 4,14;18  however both were developed for the economic 
modelling of clinical interventions. As discussed within Chapter 2, Public Health economic modelling 
is generally more complex than economic modelling of clinical interventions. The conceptual 
modelling framework developed within this research provides a systematic approach to developing a 
Public Health model structure, and in particular, systematic consideration of the broader 
determinants of health, dynamic complexity (feedback loops, unintended consequences), and the 
transition from an understanding of the problem to a description of the model structure. It also 
provides an approach for choosing and involving stakeholders. The framework provides new 
methods for: 
A) Developing an understanding of the problem; 
B) Defining the model boundary; 
C) Defining the level of detail; 
D) Choosing the model type.  
A table of potential benefits and pitfalls which might be avoided by the use of a conceptual 
modelling framework was previously developed based upon the review of conceptual modelling 
frameworks presented within Chapter 4 and the qualitative research within Chapter 5 (Table 7.1). 
Table 8.1 overleaf provides an extended version of this table with an additional column describing 
the mechanism within the developed framework which addresses the potential pitfalls. An 
additional row has also been included to represent the benefit outlined within Chapter 1 that a 
conceptual modelling framework might help to characterise structural uncertainties and identify 
primary research needs. Table 8.1 suggests that the framework has the potential to prevent possible 
pitfalls in each of the areas in which they were identified in order to improve model quality. 
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Table 8.1: How the conceptual modelling framework helps modellers avoid potential pitfalls  
Potential benefit What pitfalls can be avoided Mechanism within the framework 
To aid the development of 
modelling objectives 
 Answering the wrong (or less useful) question with 
the model. 
 A method for developing a conceptual model of the problem which begins with the 
key problem and is subsequently developed alongside stakeholders to describe 
relevant hypothesised causal relationships, including specifying relevant outcomes. 
To provide tools for 
communication with 
stakeholders 
 Representing a contextually naïve and uninformed 
basis for decision-making, including 
misunderstandings about the problem, producing 
unhelpful model outcomes, and incorporating 
inappropriate and/ or invalid model assumptions. 
 
 Ignoring variations between stakeholders’ views. 
 Process/model results not trusted by stakeholders. 
 An approach for considering all stakeholder types, encouraging capture of different 
perspectives. A method for developing a conceptual model of the problem 
describing hypothesised causal relationships, beginning with the key problem and 
linking this to relevant outcomes and systematically considering the broader 
determinants of health, followed by a transparent approach to describing the model 
structure based upon the understanding of the problem. 
 Highlighted as a consideration within the understanding of the problem phase. 
 The approach presented is transparent for stakeholders to follow. 
To guide model development 
and experimentation 
 Inefficient model processes (eg. repeatedly making 
structural changes to the implemented model) 
 
 
 
 Inadequate analyses 
 A method for documenting the understanding of the problem based upon 
hypothesised causal relationships, with accompanying questions for the modeller to 
help identify relevant issues including feedback loops, interactions and the broader 
determinants of health, and then considering model structure with stakeholder 
input prior to developing the quantitative model. 
 The recommendation to involve stakeholders during both the understanding of the 
problem phase and the model structuring phase to produce useful analyses. 
To improve model validation 
(developing the right model) 
 Answering a less useful question with the model. 
 Misunderstanding the key issues associated with 
the problem. 
 Using the first theories identified from the 
evidence to develop the model. 
 
 Not having a basis for justifying the model 
assumptions and simplifications.    
 See row 1 of table. 
 Documenting the understanding of the problem so that it can be questioned and 
discussed by stakeholders and the project team. 
 The framework specifically warns against this. Documenting the difference between 
the understanding of the problem and the model structure encourages modellers to 
think about these judgements. 
 Documenting the understanding of the problem provides a basis for justifying the 
model assumptions and simplifications. 
To improve model verification 
(developing the model 
correctly) 
 Not having an explicit description of the model 
with which to compare the implemented model. 
 Documenting the model structure, through: (1) tabling the perspectives and 
outcomes and describing the interventions, comparators and populations to assess; 
(2) tabling what is included and excluded within the model (and why) compared 
with the understanding of the problem; (3) recording key model assumptions and 
simplifications with justification; (4) Providing a diagram of the model structure. 
To allow model reuse  Other experts not being able to identify key model 
assumptions/ simplifications and why these have 
been made. 
 A transparent reporting process from documenting the understanding of the 
problem to describing the model structure. 
To help characterise structural 
uncertainties and identify 
primary research needs 
 Ignoring structural uncertainties. 
 Not improving the evidence base for future 
decisions. 
 The conceptual model of the problem should highlight any areas of disagreement 
between stakeholders which can be used to highlight primary research needs. 
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8.3.4 Potential weaknesses of the conceptual modelling framework 
Drawing upon systems thinking, it is important to consider whether there might be any unintended 
negative consequences of the framework. As suggested by the qualitative research within Chapter 5, 
model development is necessarily constrained by the time and resources available within the 
decision making process. Using the proposed conceptual modelling framework takes time; in 
particular, communicating with stakeholders throughout model development and providing explicit 
documentation around the understanding of the problem and the justification for the model 
structure may increase time requirements compared with current practice.  Whilst the modeller is 
spending time on these, they are not spending time on other modelling activities. In order that the 
framework does not lead to negative outcomes, the benefit of undertaking these conceptual 
modelling activities must be at least commensurably large. Section 8.3.3 highlights the many 
potential benefits of the conceptual modelling framework which indicates that the opportunity cost 
associated with these activities is likely to be lower than that associated with other modelling 
activities. In addition, Robinson highlights the importance of conceptual modelling as the first part of 
a modelling project, which guides and impacts upon all other stages.49  Moreover, the framework 
includes an explicit phase, Phase A (aligning the framework with the decision making process), for 
considering how much time might be spent upon each modelling activity. Previously, this process 
may not have been undertaken a priori. This phase highlights that the time spent on conceptual 
modelling activities should be flexible such that the modeller can consider how the framework 
should be used according to the decision making context. See Section 8.3.5 for further discussion of 
this within the evaluation focus group analysis. 
 
As with any guidance, the conceptual modelling framework may be subject to misuse. An example of 
this is the Liverpool Care Pathway for which a 2013 review suggested that the core principles were 
appropriate for improving quality of care but that the implementation led to a reduction in 
quality.180  The review criticised the fact that the document was treated as a ‘tick box exercise’ which 
takes insufficient account of individual circumstances and that the document is not a substitute for 
staff training. Similar issues could arise from the use of the conceptual modelling framework; indeed 
the comments from the focus group participants around reducing the document to a checklist (see 
Section 8.3.5) indicated a propensity for movement in that direction. A checklist may promote a 
sense of complacency whilst an intention of the conceptual modelling framework is that it will help 
modellers to think about their approach and avoid making assumptions without questioning them. 
Thus, it is important to be clear about the aims of the framework and how it should be used, and this 
could be improved within the current version (as also discussed within Section 8.3.2). 
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8.3.5 Results of the qualitative research 
Three key themes were identified from the focus group data analysis; (1) The potential of the 
conceptual modelling framework to improve the quality of models; (2) Current format of the 
conceptual modelling framework; and (3) Specific comments on the content of the conceptual 
modelling framework. These themes are considered in turn within this section. The modellers within 
the focus group made an assumption that because they were presented with this document that the 
framework would be disseminated in this way. Thus, much of the discussion is focussed around the 
current format of the conceptual modelling framework, with the participants expressing that the 
document needs to be more user friendly.  
 
Theme 1: The potential of the conceptual modelling framework to improve the quality of models 
My research question is ‘What might a conceptual modelling framework for Public Health economic 
evaluation comprise and what could its potential be to improve model quality?’, where quality is 
defined as providing a tool for communication with stakeholders, aiding the development of 
modelling objectives, guiding model development, experimentation and reuse, and improving model 
credibility, verification and validation. The focus group participants considered whether the 
conceptual modelling framework developed does have the potential to improve the quality of Public 
Health economic model structures. The definition of quality specified above was not described by 
the facilitator; however all of the above aspects of quality were considered to some extent by the 
participants. Aiding the development of modelling objectives is considered within Theme 2. The 
subthemes are not directly aligned with these attributes of quality because of the way participants 
raised the issues. The six subthemes are: (i) Difficulties with assessing the quality of models; (ii) 
Guiding model development; (iii) Model justification; (iv) Model communication; (v) Applicability to 
different contexts; and (vi) Dissemination. 
 
Difficulties with assessing the quality of models 
All of the focus group participants said that the conceptual modelling framework had the potential 
to be useful. However, the difficulty with assessing the quality of models, discussed within Section 
8.2, was reiterated by the participants when they were asked in what ways the conceptual modelling 
framework might improve model quality. 
 
Modeller 9: “Well I think your question supposes that we know a way that we can measure 
successfulness of Public Health models, and I’m not sure that we do. How do we measure 
whether a model is an effective model or not?” 
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The participant is highlighting the difficulty of assessing model quality, and hence the problem with 
evaluating the conceptual modelling framework developed. The use of the term ‘measure’ suggests 
that the modeller believes that the only way to assess quality is quantitatively, but as participant 12 
says, “you don’t know the truth”, implying that it would not be feasible to compare model results 
with real data. Modeller 9 uses the terms ‘successfulness’ and ‘effective’ when asked about model 
quality, which implies their interpretation of model quality is to produce a model which will help 
decision makers make the right decision. This echoes the participants of the first focus group who 
emphasised that model development was not an end in itself but a tool for facilitating decision 
making. It would suggest that model quality might alternatively be assessed by retrospectively 
assessing whether the right decision was made based upon the model; however this too would not 
be feasible due to the absence of a comparator. Whilst the participants do not suggest a viable 
approach for assessing model quality, they do begin to make some inferences about how the 
conceptual modelling framework might be useful.  
 
Guiding model development 
Many of the modellers highlighted that the conceptual modelling framework could help with guiding 
model development in terms of helping to identify the key issues.  
 
Modeller 9: “I think a document like this can certainly be important in encouraging people to 
think about the key issues that they should be thinking about to produce a decent model... ...it 
could be useful in encouraging us to be more critically aware of some of the key aspects of how 
we produce models and what things need to be included.” 
 
This participant suggests that models are developed habitually rather than the modeller thinking 
about the conceptual modelling process consciously. They imply that there is no existing document 
outlining the conceptual modelling process for Public Health economic evaluation and that 
documenting how models might be produced could enable modellers to critique that process. This 
relates to the discussion within Chapter 1 about whether modelling is an art or a science. If the 
conceptual model development process for Public Health economic evaluation is not written down it 
makes it difficult to critique the model development process. The conceptual modelling framework 
document provides a starting point for modellers to be able to discuss the model development 
process in Public Health economic evaluation, even if they would want to make revisions to the 
conceptual modelling framework developed.  
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Modeller 8 highlights that a benefit of the conceptual modelling framework would be consistency 
across projects. 
 
Modeller 8: “I guess it would introduce some sort of consistency and you’d know that people 
were considering the same issues as they were developing these models, so that would be one 
advantage. I guess that there is quite a lot of variability depending on who is doing these 
things.” 
 
This participant implies that there is a lot of variability in approaches. They suggest that modellers 
may not consider all relevant issues when developing Public Health economic models and, as also 
suggested by Modeller 9 above, the conceptual modelling framework could help modellers to 
identify these.  
 
Model justification 
Model justification may improve model validity, verification and credibility and facilitating model 
reuse.1  Modeller 10 suggests that the conceptual modelling framework could help with justifying 
the model assumptions and structure. 
 
Modeller 10: “And also the justification for everything else, in terms of the assumptions, the 
structure, I think that’s important as well... …one of the comments here that I thought was 
very important but I didn’t really know what it meant was to document your understanding.” 
 
This modeller recognises that justification of the model structure and assumptions is important. 
They do not go on to say why justification is important, perhaps because the advantages of this are 
considered to be obvious. Modeller 10 also recognises that part of the model justification stems 
from documenting the understanding the problem; although, it is of concern that they do not know 
what this means given that much of the document outlines a method for documenting that 
understanding. This may be related to the current form of the document not being user friendly (see 
Theme 2). However, modeller 8 implies that they do know what it means to document the 
understanding of the problem (see Model communication subtheme). 
Modeller 8 agreed that justifying the model structure is important, but that they may not do this for 
an uncontroversial model within a time constrained process.   
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Modeller 8: “It (justifying the model) is obviously good practice, I mean, I think perhaps to me 
[what] didn’t come out as much in this document as it could do is, there’s obviously, there’s 
ideal practice, I mean it’s like the how detailed does your model need to be, you can have an 
ultra detailed model but a lot of detail’s unnecessary; I think that it’s also the same with how 
much effort one goes into justification of the model you know. [In] some circumstances, for a 
straight forward model, with time limitations, [it] makes sense to do something fairly brief. 
With other models, where perhaps it’s more controversial, then it’s more necessary to adopt 
those processes.” 
 
The modeller suggests, as highlighted within the qualitative research in Chapter 5, that there are 
typically time constraints around the decision making process and if the modeller is spending time 
justifying the model structure, they are not spending time on other modelling activities. This is an 
important practical consideration as discussed within Section 8.3.4. The modeller is suggesting that 
as model controversy increases, the benefits of justifying the model assumptions increases. I would 
suggest that if there is less controversy, then model justification is likely to take less time (for 
example, less time is required to understand and document the problem, the data is likely to be 
more consistent, existing models may show what factors are likely to be important within the model, 
there may be well established causal relationships, and so on). Thus, time requirements associated 
with model justification are likely to be relative to the benefits of doing this. Moreover, Phase A of 
the conceptual modelling framework highlights that the framework should be adapted according to 
the specific requirements of the project. Thus, I would suggest that model justification is always 
good practice, but that the same level of justification is not required for each model developed. 
 
Model communication 
All of the participants agreed that the conceptual modelling framework might help with 
communication of the model developed.  
 
Modeller 9 suggests that the conceptual modelling framework would “allow communication within 
the team and to help the project manager time things so that they are in the right place.”  In 
addition, several of the modellers highlighted that it would be useful for communication with 
stakeholders. 
 
Modeller 11: “And I think this sort of framework is also quite useful, building on your point 
really, for communication as well isn’t it, for stakeholders and people like that because you can 
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actually show what processes you have gone through to get to where you have got to. Where 
it is often quite difficult you know to explain things sometimes to clinicians and stuff. That 
would actually help make you think about why did I make that decision, or why am I doing it 
like this.” 
 
This modeller implies that it is useful to be able to justify the model that is developed to 
stakeholders, which may be difficult, and the framework provides a way of doing this. They do not 
explicitly specify why this is useful, but imply that it is related to model credibility. They also suggest 
that by documenting the conceptual modelling process this in itself will help the modeller critically 
evaluate why they are making the decisions they are. Modeller 8 agrees with this and highlights that 
conceptual model documentation would be useful for model reuse to avoid repeating work. 
 
Modeller 8: “I mean it obviously is useful to write things down and perhaps one is not always 
very good at it, because in the early stages I think it is easy to think along certain ways and 
perhaps be driven a bit by the literature that you find in terms of the associations so it 
obviously is good practice to write down, explicitly, why you’ve selected what you have 
selected, and what you have ruled out, if nothing else if somebody else is there looking at that 
work and wanting to build a model in that area they can say, yes although this isn’t in the 
model they explicitly ruled it out because, rather than oh they didn’t think about it, I need to go 
and investigate whether it’s necessary.” 
 
This modeller suggests that whilst it is obviously good practice to write down the process the 
modeller has followed, it is not necessarily done in practice. They imply that by writing down why 
things are done it will encourage modellers to explore alternative model assumptions rather than 
using the first structural assumption identified. This also indicates that this modeller has an 
appreciation of the approach for documenting the understanding of the problem in contrast to 
modeller 10 (see Model Justification subsection). 
 
The same modeller expresses that documenting the conceptual modelling process would also help 
the modeller that has developed the model know what they have done and why in the future. 
 
Modeller 8: “And to help yourself remember, you know sometimes these projects can go on for 
some time and you know 8 or 9 months down the line you’re asked why didn’t you include this 
and you sort of think... (group laughter) and I am sure we have all been there!” 
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This modeller implies that it is common practice not to be able to answer questions about why the 
model is structured as it is after the project has finished because it has not been formally 
documented. The laughter implies identification from the other modellers with this problem.  
 
Applicability to different contexts 
One of the requirements of the conceptual modelling framework developed from the qualitative 
research presented within Chapter 5 was that it should clearly specify what it can and cannot do. 
Modeller 11 suggests that one potential weakness of the conceptual modelling framework is that it 
is quite theoretical because it has to apply to such a range of topics which constitute Public Health.  
 
Modeller 11: “I agree with you that to get something generic is extremely difficult because of 
all these examples are very varied. And that’s why we have a document like this, that’s quite 
abstract, because how do you get to specifics when, you know, it’s very, very difficult. And 
[with] the examples I’ve done it’s very hard to see similarities across [them], you know, they 
are very, very different from each other. And I don’t know how you get round that; that’s why 
at the beginning I said that this is extremely ambitious because to get something that’s useful 
it sort of has to apply to all the different areas, and to achieve that, I don’t know, it’s very 
hard.”  
 
The participant implies that it is appropriate that the conceptual modelling framework aims to apply 
to the broad and varied area of Public Health economic modelling in order to be useful rather than 
having a framework for a particular Public Health topic. However, they suggest that this is a difficult 
task and perhaps the current version of the framework has not quite achieved this. This may relate 
to the current format of the framework discussed within Theme 2, where one solution would be to 
include more examples. This could be tested within future research within different case studies. 
 
The participants also highlighted the diversity of Public Health decision making contexts. Modeller 9 
thought that the framework could be useful in a range of contexts by applying it in different ways.  
 
Modeller 9: “Going to the other example of the work with Public Health that we have done, it 
was very different from that where we talked to the Public Health Intelligence Team. They 
didn’t have a clear question, they knew they had a kind of issue that they wanted to tackle, but 
they didn’t specify it clearly. So, you know, I think that there are many, many different contexts 
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under which you might want to do an economic model in public health and in some of those 
contexts this framework might be extremely useful... ...I think that it could potentially be useful 
in either situation but it could be applied in very different ways and the flavour of the 
framework that you might need in those different situations might vary.” 
 
This modeller provides an example of different contexts in terms of the status of model 
specification, but they imply that there are lots of ways that the context may vary, and that how the 
framework is used can be adjusted accordingly. In contrast, another modeller questioned whether it 
is the role of the modeller to help define the interventions given that they had previously been given 
a scope which precisely defined the interventions. A discussion highlighted that the participants had 
different experiences of this in different contexts, but within this discussion the modellers did not 
recognise that the conceptual modelling framework is designed to be moulded according to the 
particular decision making context as described within Phase A of the framework. Again, this may be 
due to the current format of the conceptual modelling framework (see Theme 2). There was also a 
debate between two of the modellers around whether the conceptual modelling framework could 
be used for infectious disease modelling.  
 
Modeller 12: “No no, that (infectious diseases) is completely different. I want to rule that one 
out from this stuff here anyway, that’s a different question.” 
 
Modeller 10: “I’m not sure if it is because we do cover issues like, I mean we have got a model 
where what happens to one patient impacts on the next patient because as soon as you have 
got patient interaction you are beginning to think in terms of the techniques used in infectious 
diseases... ...I think one of the things that is very, very important actually is on page 42; the 
revised version of Brennan’s taxonomy... ...it covers these issues of interaction and that’s what 
it is really, this issue of interaction.” 
 
Modeller 12 states that infectious disease modelling is a different sort of question, whilst modeller 
10 argues that it is not distinct because as soon as there are patient interactions it is a similar type of 
problem. He supplements this with an example within the framework of where patient interactions 
are considered. Thus, modeller 10 presents a strong argument for why the framework is appropriate 
for use within infectious disease modelling. 
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When asked about the use of the conceptual modelling framework for modellers with different 
levels of experience, modeller 8 suggested that the framework “could be useful to anybody”.  
 
Dissemination 
The modellers proposed different ways of encouraging the use of the conceptual modelling 
framework; one is to use it and publish its use, the other is to get it cited in the NICE Public Health 
methods guide. There was agreement that the latter of these options would be effective quickly, 
certainly in the NICE context, if it was possible, although both options could be attempted. 
 
Modeller 10: “I think that I would use it and acknowledge its use, say that we have used this, 
and that would be one way, and that would be a very slow drip process of doing it, I mean 
what’s one publication, but I think that it’s important that if you use these things you 
acknowledge them because, over time, it does add credibility to what you are doing.” 
 
Modeller 11: “The other thing is to get it cited in the NICE method Public Health guide.” 
 
Modeller 10 refers to the credibility of the framework and suggests that this could be increased by 
having published examples. This implies that the framework must have been shown to be useful 
before modellers will adopt it. Thus, further work could involve the application of the conceptual 
modelling framework within different case studies and the publication of this work.   
 
Theme 1 Summary 
The modellers agreed that the conceptual modelling framework has the potential to improve the 
quality of Public Health economic models although, as will be discussed within Theme 2, perhaps not 
in its current format. The modellers did highlight difficulties associated with assessing the quality of 
these models, as highlighted within Section 8.2. When describing aspects of the conceptual 
modelling framework which might be beneficial to model quality, the modellers made some 
assumptions which were not questioned about why this ultimately might be. For example, the 
modellers highlighted that the conceptual modelling framework might improve model justification, 
although they did not explain why this is important. The modellers suggested that the framework 
might guide model development by helping the modeller to identify key issues, which would also 
introduce some sort of consistency. They also highlighted that the conceptual modelling framework 
would provide a tool for communication with stakeholders, the project team, themselves, and 
anybody wanting to develop a similar model in the future. The modellers also suggested that the 
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framework might improve model justification, which could lead to improved model validity, 
verification and credibility.1 
 
The modellers stated that the framework is currently quite theoretical, which may relate to the 
current format of the framework discussed within Theme 2, where one solution would be to include 
more examples. There was general agreement that the framework could be applied in a range of 
contexts by modellers with varying levels of experience. The modellers suggested that in order for 
the framework to be used, its application within case studies would need to be published to 
demonstrate its usefulness or it would need to be citied in the NICE Public Health methods guide. 
 
Theme 2: Current form of the conceptual modelling framework 
Much of the focus group discussion focussed upon the current format of the conceptual modelling 
framework document. It is important that the framework is presented in a form that will encourage 
modellers to use it. Two subthemes were identified; (i) Multiple versions of the conceptual 
modelling framework; and (ii) The use of examples. 
 
Multiple versions of the conceptual modelling framework 
All modellers agreed that the document was too long in its current form to be used by modellers in 
practice and some of the participants suggested that there might be two documents; one shorter 
document, perhaps in checklist form, which references a longer document. 
 
Modeller 10: “There is a lot of justification for this framework in this document so I think that is 
absolutely fine, but when you are actually coming to use it I think that there is going to be a 
separate document, there is going to be this and there is going to be some kind of checklist 
which is a two page thing, which actually makes it useable. Because in this form it is not 
useable, I don’t believe it’s useable. I believe all the ideas are great, but you can’t use a 47 
page document on your desk, to actually use it to assist you, but I did think that a lot of the 
points in it were very good, and I completely agree with the idea of the checklist.” 
 
Modeller 10 suggests that he thinks that the content of the framework is good, but that the longer 
conceptual modelling framework could be referenced within a shorter two-page checklist which 
would be more user-friendly. As discussed within Chapter 1, checklists for good modelling practice 
allow modellers to review a model and check that what is done is reasonable; but they do not 
describe how models might be developed. The aim of the conceptual modelling framework is to 
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describe how model structures might be developed. Modeller 8 suggested that there is too much 
text within the framework and that the diagrams are more useful. This was echoed by Modeller 9. 
 
Modeller 8: “I mean a lot of it is buried in the text and I thought that some of the sort of 
diagrams, some of the decision diagrams etc you know are more useful because if you’ve got a 
sentence buried in the text you’re not going to find it.” 
 
The use of the word ‘buried’ here suggests that the modeller finds the value of the different parts of 
text variable and that less useful text to this modeller is hiding the more useful text. Modeller 8 
suggested that an index page would be useful. 
 
Whilst I would argue that the conceptual modelling framework cannot be reduced to a checklist, a 
shorter good practice document which references a longer document may be more useful to 
modellers (see Section 8.3.6 for the informal feedback from the shorter document presented at the 
HESG meeting). Based upon the modellers’ comments, I think signposting could also be improved in 
order for the framework to be accessible to different modellers, including the use of a contents page 
and a ‘how to use this framework’ introduction. As suggested by a member of HESG, I think a user-
friendly way of presenting the framework could be to develop it into an online tool, where the 
modeller would click on links for further detail, to be used as a reference and educational tool.  
 
The use of examples 
There was general agreement within the focus group that it would be more helpful to move the 
example to an Appendix than to have it integrated throughout the text. 
 
Modeller 8: “I think that it would have been better if the example had just been maybe given in 
an Appendix at the end so you see how it followed through, because you get a little bit and 
then it sort of stops doesn’t it and then you get a bit more, and you don’t really get the feel for 
the example.” 
 
The modeller suggests that it is difficult to follow the example as it is currently presented in sections. 
The modellers also agreed that ideally more examples would be helpful. 
 
Modeller 8: “But I think that the example is also, the way her thesis was structured she’s 
followed one project through, so the example is almost there because that was the one that 
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she was following rather than because it elucidates what she said in the text, and from the 
point of view of this it would be more useful to have examples which illustrate the point she’s 
making in the text and I think the diabetes examples aren’t always particularly useful for that.” 
 
Modeller 9: “I would just like to echo the point about [having more] examples, because I think 
that is a major weakness of that, as it stands. There is nothing like good case study examples 
to make things more real and to bring out some of these issues in much more vivid ways, so I 
would agree with that.”   
 
Modeller 8 suggests that by having more than one example, where the diabetes example does not 
illustrate a point well, there would be another example that does do so. Modeller 9 uses the terms 
‘real’ and ‘vivid’ to describe some of the advantages of having more examples, implying the 
framework is currently too theoretical with just one example, as also highlighted within Theme 1. 
 
By integrating the diabetes example within the framework I was intending to illustrate the methods 
so that the practical application is clear. However, the consensus within the focus group that the 
example would work better if it were collated persuades me that this format would be preferable. I 
agree that additional examples would be useful to illustrate the methods since the diabetes example 
does not precisely illustrate all of the key issues. 
 
Theme 2 summary 
The modellers generally suggested that the current format of the conceptual modelling framework is 
too long to be useful, and that it would be preferable if there were two versions of the document; a 
shorter document which is simple to use which references a longer document. The modellers 
discussed the use of a checklist which brings into question their understanding of the purpose of the 
document. The modellers were also in agreement that the diabetes example should be collated and 
put into an Appendix. They suggested that having more than one example would illuminate, and be 
more illustrative of, some of the issues. 
 
Theme 3: Specific comments on the content of the conceptual modelling framework 
The modellers generally thought that it was the format of the conceptual modelling framework 
which required modification rather than much of the content, with modeller 10 expressing that they 
“believe all the ideas are great”.  However, each modeller had feedback about the content of specific 
parts of the framework. Some modellers suggested including topics that were already in the 
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framework, for example, ‘review of existing models’, which may be because the framework is 
currently too long (see Theme 2). Other content suggestions have been divided into four subthemes: 
(i) Defining the research question; (ii) Use of problem structuring methods; (iii) Addressing the key 
features of Public Health economic modelling; and (iv) Comparison with existing practice. 
 
Defining the research question 
The modellers recognised that the conceptual modelling framework helped to define the modelling 
objectives. However, modeller 10 suggests that the research question should be made more explicit 
within the overview diagram of the conceptual modelling framework (Figure 7.3). 
 
Modeller 10: “I think it (the research question in Figure 7.3) needs to be more explicit. I think 
that’s the most important… it’s so so important.” 
 
The modeller states that they think that defining an appropriate research question is the most 
important part of model conceptualisation. This echoes one of the findings of the literature review 
of conceptual modelling frameworks within Chapter 4. Within Figure 7.3 in the framework 
document, this is captured within ‘developing a conceptual model of the problem describing 
hypothesised causal relationships’, as highlighted by some of the other focus group modellers in 
response; however as this modeller suggests, the process of defining the research question is not 
explicitly stated within Figure 7.3. I agree with modeller 10 that the overview diagram of the 
conceptual modelling framework would be improved by explicitly stating where the research 
question is defined.  
 
Use of problem structuring methods 
One of the participants highlights that the use of problem structuring methods can help to 
understand the nuances of the problem which is often important in decision making for issues which 
are not included within the model. 
 
Modeller 12: “Actually I’m not sure that they’ve (problem structuring methods) had a lot to do 
with the modelling but when it comes to making the decisions they’re often the most crucial... 
...all the things to do with the soft sciences and so on, they all get brought in because that’s 
where most of the richness is, they can’t easily be modelled, but they are part of the decision 
making process and very often most of the recommendations are based on that.” 
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The participant highlights the difference between the boundary of the understanding of the problem 
and the mathematical model and suggests that a key benefit of the conceptual modelling framework 
is in describing the understanding of the problem to help with the decision making because of the 
‘richness’ which it is difficult to capture within a model. 
 
Addressing the key features of Public Health economic modelling 
Some of the modellers highlighted key features of Public Health economic modelling which they did 
not think the conceptual modelling framework fully captures.  
 
Modeller 9: “I’m not convinced that she’s pulled out all the distinctive features of what makes 
public health different from other areas of health care... ... the outcome measures are very 
hard to define very often in Public Health and very rarely measured... ...because it’s to do with 
things like behaviour and attitude and you know and specifying that and trying to quantify it 
and then quantify how all those changes in behaviour impact on likely further events and 
consequences, which you know, if you’re trying to measure it in QALYs you often get totally 
stuck because, how do you go from there to QALY outputs, it’s very difficult.” 
 
This modeller raises one of the key issues identified within Chapter 2 of the thesis. They assume that 
QALYs would be the outcome of interest which may not always be the case.66  Within the conceptual 
modelling framework there is limited suggestion of how to value health because the outcomes of 
interest would be dependent upon the particular decision making context and valuation issues were 
considered to be beyond the scope of this work. The same modeller also suggests that the 
framework does not address the issue of differential intervention effectiveness according to the 
context within which they are provided. 
 
Modeller 9: “There’s another distinctive feature which I think we’ve omitted is the diversity of 
context that you get with Public Health interventions that comes into play in a way that it 
doesn’t with clinical interventions... ...if you’re planning an intervention in Public Health you 
might be planning it in a rural environment or a metropolitan environment and what’s 
effective and what isn’t effective might vary very differently dependant on those contexts.” 
 
Within the conceptual modelling framework there is a section about identifying the model 
population and subgroups. It also states that ‘if practice is substantially different, then an 
adjustment on the effectiveness estimate would be required’. However, the framework does not 
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specify an approach for adjusting the effectiveness estimates to allow for different contexts if there 
are no relevant studies in each context. To review methods for doing this is beyond the scope of this 
work since this relates to the parameter inputs rather than the model structure.  
 
These comments of modeller 9 highlight that what the conceptual modelling framework does not do 
is to specify all of the key features which are specific to Public Health economic modelling compared 
with economic modelling of clinical interventions. I think it may be useful within future work to 
include a supplementary document which tables all of the key features associated with Public Health 
economic modelling based upon the review in Chapter 2 of the thesis and how they are dealt with in 
the framework, including referencing ongoing research in each area. For example, Chapter 2 
considers issues such as whether the QALY is the most appropriate measure for Public Health 
interventions, as recognised by another focus group participant, and how costs and outcomes to 
non-health sectors should be dealt with. It would be informative to include the references to this 
existing research within a supplementary document to the framework in future versions. 
 
Another participant highlights that other issues which are specific to Public Health are captured 
within the conceptual modelling framework.  
 
Modeller 8: “I thought the other public health issues apart from outcomes [are considered]; the 
model boundaries I think is quite often much more of an issue than the clinical one and in the 
framework it does discuss that, you know, thinking about how to tackle that.” 
 
The modeller uses the example of defining the model boundary to suggest that other issues specific 
to Public Health are considered within the framework. The modeller also recognises that the 
framework proposes ‘how’ to tackle these issues and not just ‘what’ to do (see Theme 2). 
 
Comparison with existing practice 
Modeller 8 highlights that developing the model boundary table, which is based upon an approach 
by Robinson for operations systems,8 is something that they would not normally do.  
 
Modeller 8: “I think that this is something that I wouldn’t normally do but I thought was a 
great way of summarising your thoughts and what you thought about and what decision 
you’ve made.” 
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This modeller considers only the reporting aspect of this stage, rather than the method for helping 
make those judgements. Generally, the modellers did not recognise the new methods presented. 
One of the modellers suggested that the conceptual modelling framework describes what they 
would normally do. Later on within the discussion, other modellers said that the most novel thing 
about the framework is that it brings all of these things together rather than providing new methods 
for the modellers.  
 
Modeller 8: “This conceptual framework very much describes what I would say is sort of 
routinely what I would do. I think that there is arguing for more explicit sort of recording 
perhaps of that than I would probably do, so I find it quite difficult to sort of comment in the 
sense that a lot of this is what I do already. So having the conceptual framework here wouldn’t 
make very much difference except, as we have already discussed this, it would be quite useful 
to have a checklist to make sure that you have considered everything as you should really.” 
 
Modeller 9: “I think probably the most novel thing is that it’s an attempt to do something that 
not many people have tried before, so although the component parts of what she writes about 
may not be novel at all, putting them all together in one place might be a new thing.”  
 
The modellers recognised that the conceptual modelling framework brings together diverse 
information. However, they also suggest it would simply be used to check that all of the key issues 
have been considered and perhaps encourage more transparent reporting of the model structure, 
rather than recognising new methods. See Theme 2 for a discussion of the use of a checklist.  
 
I would argue that there are new methods included within the framework which are listed within 
Section 8.3.3. In addition, an alternative framework does not currently exist which means that there 
is substantial variability in practice, as highlighted within Theme 1. Furthermore, the conceptual 
modelling framework aims to highlight key considerations which may otherwise be overlooked, 
including the broader determinants of health and the dynamic complexity of the system. Literature 
shows that these issues are not generally considered appropriately, if at all (see Chapter 2). Yet the 
modellers within the focus group suggested that they were already doing much of this. I would 
suggest potential reasons for this incongruence may be because (i) the modellers did not appreciate 
all of the aspects of the conceptual modelling framework because of the current format of it (see 
Theme 2); (ii) modellers tend to obtain what they think they need quickly from the literature and 
discard the remainder, so they may have applied this technique to their reading of the framework; 
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(iii) the participants want to avoid showing any potential shortcomings in the presence of colleagues 
(which would be a weakness of the methods used); and/or (iv) as suggested within the qualitative 
research within Chapter 4, there may be reluctance to adopt new methods so modellers may 
(probably unconsciously) ignore these aspects of the framework. The psychology theory of selective 
perception might help to explain the latter. Plous presents a number of experiments suggesting that 
"when people have enough experience with a particular situation, they often see what they expect 
to see.”96  There are a number of other reasons which may also help to explain this phenomenon 
including that we are creatures of habit, that we may have insecurities about new approaches, and 
that we may feel that we have no spare resource for innovation.181  The same issues will apply if 
people attempt to use the conceptual modelling framework in the future; thus it is important to 
attempt to address it within future versions. Modifying the format of the framework and including 
multiple examples to illustrate the methods (as discussed within Theme 2) may help to address 
these issues and encourage its use. 
 
Theme 3 Summary     
The modellers expressed that they were generally happy with the content; however they suggested 
that: (1) identifying the research question should be explicitly shown within Figure 7.3 of the 
framework; (2) one of the benefits of problem structuring methods is that they might help with 
decision making directly as well as via helping to develop the mathematical model structure; and (3) 
a discussion of outcome measures and a discussion of the impact of different settings upon 
intervention effectiveness should be incorporated. 
 
The modellers suggested that the conceptual modelling framework describes an approach which is 
similar to existing practice. I would argue that whilst some of what is described is based upon 
existing practice there are new methods within the framework. Two key potential reasons that these 
may not be recognised are because of the current format of the framework and due to selective 
perception. This could potentially be addressed by improving the format of the framework and 
incorporating more examples to illustrate the methods. 
 
  
261 
 
8.3.6 Feedback from the HESG meeting  
The feedback from the HESG meeting was generally much more positive compared with that of the 
focus group. A higher than average number of participants attended the session (approx 50 people) 
which implies interest in the topic. The discussant who presented the framework described it very 
succinctly and showed a clear grasp of the aim of the framework and the proposed methods. Within 
an email in response to me asking for a copy of his Powerpoint slides, he said that ‘the paper was so 
comprehensive (and comprehensible) that you didn’t leave me much to say’. Many of the 
participants attending the session provided very favourable comments about the framework such as 
‘This is great’ and ‘Thank you for doing this’, with a general atmosphere of interest which highlighted 
the timeliness of the work. There was some constructive feedback including that there could be 
more consideration of equity and that the methods could be illustrated by an example (since the 
diabetes example was not included within the HESG paper). The discussant highlighted that there is 
limited description of the methods used to develop the framework within the document. One of the 
participants suggested that the framework might be applied more broadly than Public Health, 
including assessing the cost-effectiveness of clinical interventions. Finally, there was a brief 
discussion about how the conceptual modelling framework might be published so that it is used by 
modellers and one participant suggested making it into an online tool.  
 
Potential reasons for the differences in feedback between the focus group and HESG 
This more positive feedback could potentially be due to the culture of each group, my presence or 
the differences in the format of the document. Firstly, HESG is for academics to help each other with 
developing ongoing work and hence the feedback tends to be constructive, whilst the focus group 
aimed to critically evaluate the framework and it may be that the focus group participants thought 
that it was more useful to highlight weaknesses than to acknowledge positive features. Related to 
this, my presence at HESG may have made it more difficult for people to be critical of the work, 
although within such an academic environment critical assessment of the work is standard practice. 
Finally, a different version of the conceptual modelling framework document was presented at the 
HESG conference because the specification was that the document must be no more than 20 pages 
excluding the abstract and references and no more than 7,500 words. This was achieved by: 
 omitting the diabetes example and stating that it was available on request; 
 omitting the process boxes (shown in italics) and stating that they were available on request; 
 decreasing the left and right margins; 
 omitting the figure for the method of choosing model interventions; 
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 omitting two paragraphs, a couple of sentences and revising the model type section by 
considering whether every sentence was essential, so that each section fitted onto 1 or 2 pages 
and the next section began at the start of the next page. 
The other differences between the two documents were that the HESG paper had an abstract, a 
slightly revised introduction and the addition of a discussion. This revised document for HESG 
addressed most of the issues discussed within Theme 2 within Section 8.3.5 (apart from having 
several examples), even though it was submitted prior to holding the focus group meeting. Both the 
document for the focus group and the document for HESG are shown in Appendix F for comparison. 
 
8.4 Discussion 
Validity and reliability of the framework 
The theory-based evaluation suggested that the methods used to develop the framework were 
generally valid and reliable, that it meets the requirements which were developed within Chapters 2 
– 6 and that it contains features which aim to prevent the pitfalls highlighted within Chapter 4. 
However, several areas of improvement were identified. Upon critical reflection I suggested that one 
of the weakest areas of the framework is in helping modellers determine appropriate and 
inappropriate simplifications of the problem. It may be that a better approach could be developed if 
the process of making these judgements about the level of detail could be better understood across 
a broad range of projects and it would be useful to investigate this within further research.  
 
Generalisability 
The intention of the conceptual modelling framework is that it could be employed across any Public 
Health economic modelling context; however the generalisability has not been tested within this 
research. In addition, the framework has not been used by modellers who were not involved in its 
development. These are key areas for further research. Whilst the intention of the framework is for 
it to help modellers to develop Public Health economic models, it may be useful in other health 
economic projects; however this would need to be tested within future case studies. 
 
Potential weaknesses of the framework 
A key potentially negative impact of using the conceptual modelling framework, identified by both 
my critical reflection and one of the focus group participants, is that whilst the modeller is spending 
time undertaking the conceptual modelling they are not completing other modelling activities. Thus, 
the time taken to undertake these activities should be flexible according to the decision making 
process and the particular project, which is considered within Phase A of the framework. In addition, 
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as with any guidance document, it has the potential to be misused. Thus, it is important to be clear 
about the aims of the framework and how it should be used, as highlighted by the focus group data.  
 
Format of the conceptual modelling framework 
The focus group participants were generally happy with much of the content of the conceptual 
modelling framework, but suggested that the format of the conceptual modelling framework is not 
currently useful. They suggested that it should be much shorter, referencing a longer document, and 
that a number of case study examples would be useful to illustrate the methods. The HESG 
participants were generally much more positive about the conceptual modelling framework than the 
focus group participants and this may be because of the differences in the culture of the groups or 
the differences in the format of the document, including that it is shorter. Based upon the comments 
of the focus group participants, it is clear that the conceptual modelling framework needs to be in a 
form which is easily accessible and importantly, as highlighted above, that the aim of the document 
needs to be made extremely clear. Within the document circulated to the focus group participants, 
the aim of the framework was described as ‘to provide a methodology to help modellers develop 
model structures for Public Health economic models’. However, it did not provide a clear description 
of how it might be used. I would envisage modellers understanding the entire conceptual modelling 
framework and following it throughout the project as appropriate. Once familiar with the 
framework, a shorter version to remind modellers of the overall process and key methods for 
making judgements might be useful. As suggested by a member of HESG, a user-friendly way of 
presenting the framework may be to develop it into an online tool, where the modeller would click 
on links for further detail, and this version could be used as a reference document and educational 
tool. Based upon the modellers’ comments, signposting could also be improved in order for the 
framework to be accessible to different modellers, including the use of a contents page and a ‘how 
to use this framework’ introduction. It would be useful to modify the format of the document and 
reassess its use in future research. 
 
How the framework might improve the quality of Public Health economic models 
The focus group participants suggested that the framework has the potential to improve the quality 
of Public Health economic models by helping to: (1) identify modelling objectives, (2) guide model 
development by helping to identify key issues, which would also introduce some sort of consistency, 
(3) provide a tool for communication with stakeholders, the project team, themselves, and anybody 
wanting to develop a similar model in the future, and (4) improve model justification which may 
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enhance model validity, verification and credibility. There was general agreement that the 
framework could be applied in a range of contexts by modellers with varying levels of experience. 
 
The inclusion of new methods 
Whilst the focus group participants thought that it was novel to have brought all of the information 
together within a conceptual modelling framework, they generally did not recognise new methods 
within the framework. This may be due to selective perception which suggests that "when people 
have enough experience with a particular situation, they often see what they expect to see,”96 thus 
reinforcing further the importance of future work to improve the user friendliness of the conceptual 
modelling framework and of illustrating the methods with examples. 
 
Capturing features which are specific to Public Health 
Several focus group participants suggested that some features which are particularly important 
within Public Health economic modelling such as valuing health outcomes and the impact upon 
intervention effectiveness of different contexts should be considered further within the conceptual 
modelling framework. These were considered to be beyond the scope of the work since the 
framework aims to provide methods for modellers to develop the model structure rather than 
considering methods for estimating parameters. However, a supplementary document could 
accompany future versions of the framework which tables all of the key features associated with 
Public Health economic modelling based upon the review in Chapter 2 and how they are dealt with 
in the framework. Other key suggestions by the participants which I would propose incorporating 
into the framework were that the identification of the research question should be explicitly shown 
within Figure 7.3 and that one of the benefits of the understanding the problem phase is that it 
might help with decision making directly as well as via helping to develop the mathematical model 
structure. Importantly, the conceptual modelling framework document provides a starting point to 
enable modellers to discuss the model development process in Public Health economic evaluation, 
even if they would want to make revisions to the current version of the conceptual modelling 
framework. It could also encourage additional methods to be developed by setting out the process 
so people can see where new methods might be useful. 
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8.4.1 Strengths and limitations of the methods employed to evaluate the framework 
The combination of theory-based evaluation, focus group analysis and informal analysis of the HESG 
meeting provide complementary approaches of evaluating the conceptual modelling framework. 
The theory-based evaluation allowed me to verify that the framework follows the requirements 
which I had set out based upon Chapters 2 – 6 (see Table 7.2 within Chapter 7). It also provided a 
critical assessment of how the conceptual modelling framework might help modellers to avoid 
potential pitfalls which were identified from the literature. However, this type of evaluation does not 
consider the views of other people who might potentially use the framework. The focus group 
meeting and the HESG meeting allowed a range of views to be discussed and debated.  
 
Data collection 
Checkland suggests that one way to test a new methodology is to aim to refute it, rather than 
finding evidence only to support it.123  Within the qualitative research some of the questions 
specifically aimed to question the usefulness of the conceptual modelling framework.  The use of an 
impartial facilitator to run the focus group was preferable in order that participants did not avoid 
making contributions of a negative nature about the framework and to ensure that the questions 
could be posed in an impartial way. However, this also meant that the participants may not have 
been asked questions which provided the types of information required from the meeting, despite 
having a topic guide, because of the fast-paced nature and flexibility required of running a focus 
group when less familiar with the topic. Many of the statements by the participants were not 
followed by probes in order to gain more depth. In particular, the participants often did not express 
why they made a statement which makes what they have said difficult to interpret in depth. This is 
one of the potential weaknesses of focus groups and may have occurred had I or another facilitator 
taken this role. Within the focus group there were expected to be seven participants, but one 
participant could not attend due to other priorities and one participant had problems with the trains 
which meant that she missed the meeting. The discussion with five people was perhaps not as 
diverse as if more participants had attended.  
 
Data analysis 
Because I have been working on this thesis for almost three years, the initial response during 
evaluation was naturally to be defensive of what I have developed. However, in order to present an 
objective evaluation, I followed the systematic process described within Section 8.2.2 and when 
analysing each quote I spent time reflecting upon it rather than presenting any initial emotive 
responses. It was not possible to incorporate feedback from the HESG meeting into the formal 
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evaluation because I did not collect a sufficiently detailed record of the discussion; however the 
informal consideration of this meeting helped to strengthen the overall evaluation by providing 
feedback from a larger group of potential users of the framework.  
 
Further evaluation 
Given more time and resources for the evaluation, it would have been preferable to undertake 
several focus group meetings to investigate if any new ideas emerge. Due to time and resource 
constraints of the PhD this was not possible; however the purpose of the focus group was to provide 
a forum for discussion of the framework and it was not essential that this was exhaustive at the 
current stage of evaluation. The informal evaluation of the feedback from the HESG meeting 
provided a larger number of modellers’ views of the framework; however it is currently unclear 
whether the more positive feedback from HESG was due to the culture of the group, my presence or 
the revised format of the conceptual modelling framework. The next step is to make the 
modifications suggested to the format and test its use within case studies. 
 
8.5 Chapter summary 
This chapter aimed to provide an initial evaluation of the conceptual modelling framework, with the 
intention to undertake more substantial evaluation via its use within case studies in future research. 
The difficulty of evaluating a conceptual modelling framework has been highlighted and the 
methods and results of the theory-based evaluation and qualitative research described. Throughout 
the development of the framework a process of cyclical learning has been undertaken of diagnosis, 
planning, analysis and reflection. This evaluation forms the final stage for the purposes of this thesis 
but it is intended that future work will continue this cycle in order to improve the conceptual 
modelling framework.  
 
Key areas of further work resulting from the evaluation include: 
 The modification of the current format of the framework to make it more accessible by: 
o Reducing the length;  
o Increasing signposting; 
o Increasing the number of examples and moving them to an Appendix. 
 Within the framework adding: 
o More text to clarify the purpose of the framework; 
o A discussion of the importance of equity from a Public Health perspective;  
o An explicit statement to identify the research question within Figure 7.3; 
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o That a benefit of problem structuring methods is that they might help with decision 
making directly as well as via helping to develop the mathematical model structure; 
o A discussion of the impact of different settings upon intervention effectiveness; 
o More discussion about how intervention heterogeneity might be incorporated into 
the model; 
o The inclusion of a supplementary document which tables all of the key features 
associated with Public Health economic modelling. 
 The potential development of an online tool for reference and educational purposes. 
 The development and publication of more case study examples. 
 The use and evaluation of the conceptual modelling framework by other modellers and the 
evaluation of the conceptual modelling framework by stakeholders. 
 Research to develop a better understanding of the process of making judgements about 
model level of detail across a broad range of projects. 
 Publication, training and guidance for modellers around methods which allow the social 
determinants of health to be incorporated into models.   
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Chapter 9: Discussion, conclusions and further 
research 
 
9.1 Chapter outline 
This chapter aims to provide a discussion of the research presented within this thesis and outlines 
the conclusions and recommendations for further research. Section 9.2 describes the contribution of 
each chapter of the thesis in the context of existing research, with a particular focus upon the 
contribution of the conceptual modelling framework presented within Chapter 7. Section 9.3 
outlines the strengths and limitations of the research. Sections 9.4 and 9.5 outline further research 
recommendations and the conclusions about the role and value of the research respectively.  
 
9.2 Contribution of this work in the context of other research 
Current status of research in this area 
When this research began, there were no publications about conceptual modelling within health 
economic evaluation. While conducting this research the lack of guidance about conceptual 
modelling has been recognised as an issue within the Health Economics community; the ISPOR-
SMDM Joint Modeling Good Research Practices Task Force has developed guidance to inform 
conceptual modelling for health economics and a Technical Support Document has been developed 
for the NICE Decision Support Unit for identifying and reviewing evidence to inform the 
conceptualisation and population of cost-effectiveness models.14;18  Both of these are reviewed 
within Chapter 4 of the thesis. I was involved within the development of the Technical Support 
Document; however the ISPOR-SMDM guidance was developed independently. This parallel 
development highlights the importance and timely nature of this work. The conceptual modelling 
framework developed here complements and adds to these existing frameworks by focusing upon 
Public Health economic modelling.  
 
Chapter 2  
Chapter 2 reviewed the literature around the key methodological challenges within Public Health 
economic modelling. Economic evaluations within Public Health are generally different to economic 
evaluations of clinical interventions since they usually require the development of models of multi-
component interventions with complex causal chains operating within dynamically complex systems, 
dependent upon the social determinants of health, as against models of simple interventions which 
generally do not depend upon human behaviour operating within relatively clear system boundaries. 
It is also often much less clear what a 'good' outcome of a Public Health intervention is. In addition, a 
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key objective of Public Health is often to reduce health inequities rather than to maximise health. 
The review highlighted the many issues with the conceptualisation of the model; however none of 
the papers considered methods for this conceptualisation process. The review highlighted key issues 
to be explored further within Chapter 3. 
 
Chapter 3 
Chapter 3 considered, in more depth, some of the issues raised within the literature review in 
Chapter 2. Drawing upon literature within the fields of complexity theory and systems thinking, this 
chapter described what a dynamically complex system is and concluded that Public Health systems 
tend to be dynamically complex. A key finding was that due to this dynamic complexity of most 
Public Health systems, a systems approach is expected to be appropriate for modelling Public Health 
interventions, taking a holistic view of the system and focusing upon the interactions between 
variables. The Public Health literature around the social determinants of health was also reviewed 
and it was found that whilst there are a large number of different classifications, many of them 
comprise similar factors. Many of the papers reviewed highlighted that there are causal effects 
between many of the determinants of health and that due to the interaction between the individual, 
community and population level, interventions and their outcomes should be considered at all levels 
simultaneously. Finally, models of behaviour from other disciplines such as Psychology and Sociology 
were found to be potentially useful for Public Health economic modelling; the use of these models 
within this context is highlighted as a further research recommendation.  
 
Chapter 4 
Chapter 4 reviewed the literature relating to existing conceptual modelling frameworks within the 
broader literature. A key finding of the review was that a conceptual modelling framework should 
include, as a minimum, stages for (i) understanding the problem and objective setting, and (ii) 
choosing model options, determining model scope and level of detail, and identifying structural 
assumptions and model type. The benefits of a conceptual modelling framework include aiding the 
development of modelling objectives, providing tools for communication with stakeholders, guiding 
model development, experimentation and reuse, and improving model validation and verification. 
Other key findings were that the framework should not be overly prescriptive about specific 
methods and it should allow for the variation in requirements of different Public Health economic 
modelling and the needs of the decision makers. Finally, the review suggested that theory-based 
evaluation of the framework might be appropriate to explain why it is expected to be effective, as 
well as qualitatively obtaining stakeholders’/ modellers’ views. 
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Chapter 5 
Chapter 5 provided an overview of the qualitative data collection and analysis of data which 
described modellers’ experiences with developing the structure of Public Health economic models 
and their views about the benefits and barriers of using a conceptual modelling framework. Key 
findings were that for a conceptual modelling framework to be useful it should be clear about what 
it can and cannot do, not be overly prescriptive or restrictive, be simple to use in practice and 
culturally acceptable and consider any diagrams developed by other parts of the team on the 
project. The research also suggested that a conceptual modelling framework for Public Health 
economic evaluation should provide a general outline of the model development process in Public 
Health economic modelling, consider the trade-off between developing an appropriate structure for 
the problem versus ability to meet deadlines, help modellers determine appropriate and 
inappropriate simplifications of the problem, incorporate the iterative nature of model development 
between model conceptualisation and data collection, highlight the difference between causation 
and correlation and point towards econometric techniques, and facilitate a clear description of the 
methods for the report to stakeholders. The qualitative research also highlighted key issues which it 
might be useful for Public Health economic modellers to consider.  
 
Chapter 6 
Chapter 6 provides a critical reflection of the use of the draft conceptual modelling framework 
within a case study assessing the cost-effectiveness of interventions for screening and prevention of 
type 2 diabetes. Key findings were that the introduction of the conceptual modelling framework 
should clearly and concisely describe why it is beneficial and there should be a first step describing 
the necessity to align the framework with the decision making process and develop a project plan. 
When making judgements about the model structure, a flow diagram or box is more accessible than 
lots of text for highlighting the key considerations. In addition, there is a need for the project team 
to question each other’s assumptions throughout the conceptual modelling process. A possible 
information retrieval approach for developing the understanding of the problem and model 
structure was developed. 
 
Chapter 7 
Chapter 7 described the conceptual modelling framework and the justification for key methods and 
processes. The main contribution of the conceptual modelling framework developed is that it 
provides a systematic approach to developing a Public Health model structure, and in particular, 
systematic consideration of: (i) the social determinants of health; (ii) the dynamic complexity 
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(feedback loops, unintended consequences); (iii) the understanding of the problem; (iv) moving from 
an understanding of the problem to the model structure; (v) stakeholder involvement. Each of these 
is considered in turn in terms of the contribution of the framework in the context of other research. 
 
Systematic consideration of the social determinants of health 
There is currently no systematic approach for identifying relevant factors which might impact upon 
model outcomes. In addition, modellers do not generally have an understanding of Public Health as 
a discipline. Thus, it would be unsurprising if modellers failed to identify relevant factors, and current 
studies show that the social determinants of health are often not included within the model.45  By 
drawing upon the Public Health literature and highlighting specific broader determinants of health 
for consideration at relevant points within the framework, it should help modellers identify relevant 
factors which can subsequently be included or intentionally and transparently excluded from the 
model. The framework also highlights that these determinants of health might be used to help 
choose relevant interventions and subgroups.  It should be noted that there is limited effectiveness 
evidence around the impact of the interventions upon the social determinants of health and further 
primary research would be beneficial in this area.73  Similarly to transferring methods for economic 
modelling from clinical interventions to Public Health interventions, a paradigm shift may be 
required in order to collect appropriate effectiveness evidence in this area.  
 
Currently, no guidance links the use of Psychology and Sociology models to health economic models, 
yet there is huge potential to combine them.  The framework makes an initial contribution by 
suggesting that modellers draw upon these behavioural models where relevant. However, very few 
economic evaluations have previously incorporated these and further research would be useful 
around how these behavioural models might be employed within Public Health economic 
evaluation.  
 
Systematic consideration of dynamic complexity 
Within health economic modelling, current approaches tend to assume simple cause and effect for 
developing the model structure. Feedback loops and unintended consequences are often not 
considered. However, within Public Health where interventions often operate within dynamically 
complex systems and the scope is generally broader and less well defined, modellers accustomed to 
developing models for clinical interventions may exclude important relationships because their 
habitual way of thinking is insufficient. The framework draws upon systems thinking to present an 
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approach which aims to help modellers consider these issues so that all relevant relationships and 
consequences of the interventions are identified.  
 
Approach for describing the understanding of the problem 
Whilst this research was being undertaken, some of the Health Economics community began to 
recognise the need for describing the understanding of the problem prior to developing the 
mathematical model.14;18  The ISPOR guidelines do not propose methods for developing this 
understanding.18  The study by Kaltenthaler et al. proposes some key issues and considerations for 
modellers developing a conceptual model of the problem;14 however there are many issues which 
are specific to Public Health which are not incorporated within their report since it was developed to 
aid the development of HTA models. Within this conceptual modelling framework, a new method is 
proposed which draws upon cognitive mapping, causal diagrams and soft systems methodology. The 
suggested method aims to strike a balance between exploring the problem sufficiently so as not to 
exclude any important impacts of the potential interventions and providing an efficient, focused 
approach. It provides a mechanism for the modeller, along with the stakeholders and project team, 
to think through all of the potential causal links between the relevant factors associated with the 
problem. It is centred on the key problem and builds from this in a causal way in relation to the 
types of interventions of interest to the stakeholders. This approach should prevent an unwieldy 
conceptual model of the problem which is so big that it is not helpful within the constraints of the 
decision making process. For example, arguably a diagram like the Foresight obesity map41 (see 
Figure 1.3 within Chapter 1) provides too much detail around factors which either cannot or will not 
be changed by intervention.  
 
The converse is the development of an oversimplified understanding of the problem. There is a step 
between the modeller considering the evidence identified (both written and through expert advice) 
and documenting this within the diagram, which occurs within the mind of the modeller. This step 
involves the modeller deciding whether to include the information that they have identified within 
the conceptual model of the problem. The method described within the framework provides a tool 
for doing this, but there remains an element of judgement. Because the diagram is being developed 
by modellers, it may be that subconsciously modellers exclude factors if they are not likely to be 
included within the model, which may lead to disposing of some issues too quickly. This could lead 
to a situation where the understanding of the problem looks very similar to the design-oriented 
conceptual model. The method attempts to encourage modellers to incorporate relevant factors 
which may be affected by an intervention, even if they are unlikely to be included within the model 
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because of limited data or expected minimal impacts, in order to enhance model validity and 
credibility.  
 
To my knowledge, this is the first explicit contribution around how a modeller might consider the 
breadth of the understanding of the problem in Public Health economic evaluation, and it is hoped 
that future use of the framework and further research around this issue may build upon the 
proposed method. 
 
Moving from an understanding of the problem to the model structure 
Whilst the conceptual modelling framework by Kaltenthaler et al. describes key considerations for 
the problem-oriented and design-oriented conceptual models, it does not provide a method for 
moving between the two.14  Similarly, the existing ISPOR conceptual modelling guidance explains 
what should be done but does not describe how to do it.18 Within the conceptual modelling 
framework developed here, there are three key new methods described for moving from an 
understanding of the problem to a description of the model structure. The first is a flow diagram 
which aims to help modellers determine whether the factors identified within the understanding of 
the problem should be included or excluded from the model boundary. The second is a series of 
questions for modellers to consider when defining the level of detail based upon the understanding 
of the problem and the model boundary. The third is a flow diagram which aims to help modellers 
choose the most appropriate model type given the characteristics of the problem and the 
constraints of the decision making process.  There are also suggestions about how the model 
structure may be developed following the documentation of the understanding of the problem 
which have not been combined into one document previously.  
 
Stakeholder involvement 
NICE has an approach for choosing and involving stakeholders within the decision making process; 
however there is no existing guidance for modellers around choosing and involving stakeholders 
independently of this process. Drawing upon Soft Systems Methodology, the conceptual modelling 
framework provides an approach for identifying relevant types of stakeholders. It also makes 
suggestions about what processes might be followed to obtain a sufficiently broad range of 
stakeholder expertise throughout model development. For example, a key recommendation is the 
use of stakeholder workshops if time and resource constraints allow and suggestions for how these 
might be run are proposed. 
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Chapter 8 
Chapter 8 provided an initial evaluation of the conceptual modelling framework developed, with the 
intention to undertake more substantial evaluation via its use within case studies for future 
research. The difficulty of evaluating a conceptual modelling framework was highlighted. A 
verification process suggested that the framework considers all of the key recommendations from 
previous chapters, although a couple of areas for further development are identified. A key finding 
was that whilst the theoretical evaluation and modellers taking part within the qualitative research 
suggested that the content of the framework could potentially improve the quality of Public Health 
economic models, the format of the framework requires revision in order for it to be useful to 
modellers. A number of key areas of further research were recommended (see Section 9.4). 
 
9.3 Strengths and limitations of this research 
There are a number of strengths and limitations of the methods used to develop the framework 
which have previously been considered within Section 8.3.1, so these will not be repeated here. This 
section outlines additional strengths and limitations of the research. 
 
Breadth of decision-making contexts considered 
The review of key challenges within Public Health and the review of conceptual modelling 
frameworks were not limited by country or decision making context, meaning that these findings 
have international relevance. Whilst no non-UK participants were involved within the qualitative 
research, some of the participants have experience with international decision making contexts. 
Although many of the participants involved within the qualitative research and I have substantial 
experience in developing health economic models for NICE, we also have experience with other 
decision-making contexts which prevents the research only being relevant within the context of 
NICE. The case study within diabetes prevention and screening was commissioned by the NIHR 
under the School for Public Health Research and thus presents another decision making context. It 
would, however, be useful within future research to test the use of the conceptual modelling 
framework within different national and international contexts. 
 
Interdisciplinary perspective 
The research draws upon literature from the fields of Public Health, Health Economics, Operational 
Research/ systems thinking, and Sociology and Psychology. This interdisciplinary approach prevented 
an insular perspective and thus encouraged innovation and is sensitive to the broader requirements 
of economic modelling within Public Health. For example, the search strategy for the review of 
conceptual modelling frameworks was not constrained by discipline and this breadth meant that 
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methods development was not limited by what is currently done within the field of Health 
Economics. The interdisciplinary approach also highlighted the crossovers between disciplines, for 
example, the idea of the whole not being equivalent to the sum of the parts was present within all of 
the above disciplines (except Psychology), albeit presented in different forms.  
 
Timeliness 
As highlighted previously, when this research began no conceptual modelling framework existed 
within health economic modelling; however during the time period of this work two such 
frameworks were developed for assessing the cost-effectiveness of clinical interventions. This 
suggests that this sort of framework is timely, and participants of HESG expressed this in the context 
of Public Health. In addition, 14 out of the 17 papers included within the review about the key 
challenges within Public Health economic modelling (see Chapter 2) were published within the last 
six years, which highlights the increasing interest in economic modelling in Public Health. Moreover, 
increasing numbers of Public Health economic models are being commissioned and developed.47  
Thus, this conceptual modelling framework has been developed at a key time for the development 
of Public Health economic models.  
 
Generalisability 
Whilst the breadth of decision-making contexts considered within methods development is 
considered to be a strength of the research, the application of the conceptual modelling framework 
developed is currently limited, thus its generalisability has not been tested. As suggested previously, 
further research should test the use of the conceptual modelling framework within different 
national and international contexts.  
 
The development of economic approaches within Public Health economic evaluation 
Public Health economic evaluation is a relatively new field and as such there are many areas where 
further research is required, which could feed into the conceptual modelling framework developed, 
but is beyond the scope of the current work. For example, the approaches for incorporating equity 
and broader outcomes (such as the compensation test described within Chapter 2 and the use of 
cost-benefit analysis) within the economic evaluation are important areas for further research. The 
conceptual modelling framework is designed to be flexible within a range of decision making 
contexts and as such the fundamental principles and methods would remain. Any such 
methodological advances could be incorporated within the framework as further research and 
recommendations are made within the health economics literature.  
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9.4 Recommendations for further development and research 
Modification of the format of the conceptual modelling framework 
The current framework needs to be made more accessible to modellers in order for it to be used. 
This could be done by reducing the length, increasing signposting and moving the example to an 
Appendix. More case study examples could also be provided. In addition, it may be useful to include 
supplementary material which tables all of the key features associated with Public Health economic 
modelling based upon the review in Chapter 2 of the thesis and how they are dealt with in the 
framework. The conceptual modelling framework could also be developed into an online tool, where 
an overview would be provided and the modeller would click on links for further detail for each part 
of the framework, to be used as a reference and educational tool.  
 
Further evaluation of the conceptual modelling framework 
This research focussed upon appropriate development of the conceptual modelling framework. 
Further research should involve extensive evaluation of the framework. Other modellers could 
employ the framework within a range of case studies. In-depth interviews could be undertaken with 
these modellers and key stakeholders to investigate whether the conceptual modelling framework 
might improve model quality and whether there are any additional benefits and issues from using 
the framework for Public Health economic modelling. In addition, it would be useful to assess how 
the conceptual modelling is used for model verification and validation in practice.  
 
Encouraging use of the conceptual modelling framework 
After revisions to the format of the conceptual modelling framework have been made in the light of 
the comments from the evaluation focus group, I plan to encourage its use by attending national and 
international conferences and through peer-reviewed publication. In addition, the development and 
publication of more case study examples will help to encourage its use. 
 
The development and use of modelling methods to incorporate the social determinants of health 
such as agent-based simulation and social network analysis  
Modelling approaches should be developed to provide the ability to incorporate social network 
impacts associated with Public Health behaviours such as diet, exercise, smoking, binge drinking and 
sexual activity,177;182;183 as well as the community effects associated with upstream interventions 
such as improving housing. For example, agent-based simulation is likely to be identified as an 
appropriate model type for many projects based upon the characteristics of the problem. The use of 
agent-based simulation and social network analysis within health economic evaluation is essentially 
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non-existent and there is a lack of expertise in this area. In addition, data availability within some 
topic areas may limit application of this type of modelling.  There is limited effectiveness evidence 
around the social determinants of health and further primary research would be beneficial in this 
area. However, lack of primary evidence should not prevent methods development in this area. 
Further research around the use of methods such as agent-based simulation and social network 
analysis is crucial for progressing Public Health economic evaluation, and would facilitate the 
assessment of the impact of interventions upon health inequities. One approach would be to 
undertake qualitative research in order to inform the ‘rules’ of the agents, including facilitating 
understanding of how and why interventions work. Outside of health economic modelling, this 
approach has been proposed and applied by several authors.184   
 
Drawing upon other disciplines 
Whilst the research undertaken here has drawn upon the disciplines of Public Health, Psychology 
and Sociology, there is enormous scope for advancing modelling methods within Public Health 
economic evaluation through collaboration with these disciplines to combine the existing knowledge 
of the social determinants of health and individual and population behaviour with existing modelling 
and health economic expertise. Further methodological developments within Public Health around 
the interaction between Epidemiology, behaviour and social structure could help to improve Public 
Health economic models and this could be incorporated into the conceptual modelling framework. 
Similarly, within the field of Public Health, research is ongoing around what causes health inequities 
and how to prevent them, and methodological research within this area could feed into the 
conceptual modelling framework. 
 
Research to understand how modellers make judgements about level of detail 
The questions presented for developing an appropriate level of detail help the modeller to think 
about relevant tradeoffs. It may be that a better approach could be developed if the process of 
making these judgements about the level of detail could be better understood across a broad range 
of projects. It would be useful to investigate this within further research. 
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9.5 Conclusions regarding the role and value of the conceptual modelling framework 
The aim of this research was to develop a conceptual modelling framework which has the potential 
to improve the quality of Public Health economic model structures. Such a framework has been 
developed and the theoretical and practical reasons why a conceptual modelling framework could 
improve the quality of Public Health economic models have been derived. The key benefits of a 
conceptual modelling framework that have been identified within this thesis are that a framework 
could aid the development of modelling objectives, provide tools for communication, guide model 
development, experimentation and reuse, improve model validation and verification, and help 
characterise structural uncertainties and identify primary research needs. 
 
At the start of this research, there was an absence of any conceptual modelling framework within 
health economic modelling and substantial variability in practice.17  The main contribution of this 
research is that it draws upon several disciplines to provide a systematic approach for developing 
Public Health model structures, and in particular, systematic consideration of: 
 The social determinants of health; 
 The dynamic complexity (feedback loops, unintended consequences); 
 The understanding of the problem; 
 Moving from an understanding of the problem to the model structure; 
 Stakeholder involvement. 
This systematic approach should help to improve the quality of Public Health economic models 
which could lead to a more efficient allocation of scarce resources within the decision making 
process, which would improve overall morbidity and mortality.  
Initial evaluation of the conceptual modelling framework suggested that the format of the 
framework should be made more accessible to modellers for dissemination purposes. This could be 
done with the addition of more examples and by developing an online tool. This would make the 
framework accessible to all modellers with different experience and backgrounds, and allow it to be 
used differently according to existing experience with the conceptual modelling framework. It is 
anticipated that the conceptual modelling framework could be used as a good practice document, 
and that the online tool could be used for reference and as an educational tool. Within the 
framework there is a phase for aligning it with the decision making process, with the intention, 
supported by the modellers who critically evaluated the framework, that it will be useful within a 
variety of contexts.  
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The use of the conceptual modelling framework developed requires a paradigm shift in the way 
some modellers who are used to developing models of clinical interventions approach decision 
problems. This may lead to slow adoption of the framework; however this shift is essential if model 
development in Public Health economic evaluation is to be improved. Training may also be required 
for some modellers to expand their skills beyond developing decision trees and Markov models. It 
will be important that the framework is disseminated in a user-friendly manner in order to 
encourage its use. 
 
The focus throughout this research upon the engagement of stakeholders during the model 
development process may encourage decision makers to change  the way in which they organise the 
decision making process. This could lead to a fundamental shift in the decision making process, not 
only to accommodate stakeholder input throughout model development, but also so that modelling 
takes a more central role throughout the decision making process. For example, it could help 
stakeholders to identify key issues associated with the problem and to understand the possible long 
term effectiveness of the interventions.  
 
As described within Chapter 1, Forrester states that ‘any worthwhile venture emerges first as an art, 
and as such the outcomes are special cases and are poorly transferable, but that this can then be 
transformed into a science by understanding the foundations of the art, making it more useful to 
new situations’.50  The research presented here aims to improve and make transparent the current 
understanding of conceptual modelling in Public Health economic evaluation in order to advance the 
art towards a science. It provides modellers within Public Health economic evaluation with a 
conceptual modelling process that they are able to critique, which has not existed prior to this 
research. It is intended that it will continually be improved following its use within different Public 
Health economic modelling projects and according to developments within other related research 
areas such as modelling human behaviour and quantifying relevant outcomes. It also contributes to 
fulfilling existing research recommendations from other researchers by presenting a domain-specific 
framework.1;52  Given the early stage of research in this area, another key contribution of this work is 
the identification of further research requirements (see Section 9.4). 
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Appendix A: Review of key challenges within Public Health economic 
modelling 
Appendix A1: Search strategies 
Stage 1: 
MEDLINE 
1. "public health".mp 
2. challenge$.mp 
3. issue$.mp 
4. problem$.mp  
5. method$.mp 
6. "cost-effective$".ti 
7. "economic evaluation$".ti 
8. 2 or 3 or 4 or 5 
9. 6 or 7  
10. 1 and 8 and 9 
MEDLINE 
1. Kelly.m.au 
2. "cost-effective$".ti 
3. "economic evaluation$".ti 
4. 2 or 3 
5. 1 and 4 
 
Stage 2: 
International Journal of Public Health, Journal of Public Health, European Journal of Public Health, 
American Journal of Public Health 
1. "cost-effective$".mp 
2. "economic evaluation$".mp 
3. 1 or 2 
 
Stage 3: 
Author searching in MEDLINE: 
1. Author name 
2. "cost-effective$".ti 
3. "economic evaluation$".ti 
4. 2 or 3 
5. 1 and 4 
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Appendix A2: Summary of papers included within review of key challenges within Public Health economic modelling 
Inclusion of non-healthcare costs and outcomes 
Author 
(year) 
Title (type of article) Key issues raised  Recommended approach 
Kelly et al. 
(2005)  
Economic appraisal of public 
health interventions. (Briefing 
paper) 
-QALY outcome may not be a sufficient measure; 
 
 
-Greater need to develop methods for including equity considerations; 
-It is important for a model to address what aspects of an intervention 
are successful/ unsuccessful. 
-Cost consequence analysis from perspective of 
each sector as additional analysis; Discrete 
choice experiments may be used for valuation. 
-None provided; 
-None provided. 
Weatherly 
et al. (2009)  
Methods for assessing the 
cost-effectiveness of public 
health interventions: Key 
challenges and 
recommendations. (Full 
journal article) 
Four key methodological challenges: 
-Quantifying the effectiveness of interventions; 
 
-Measuring and valuing outcomes; 
-Inclusion of intersectoral costs and consequences;       
                                                    
-Inclusion of equity. 
-More use could be made of techniques for 
analysing non-experimental data (eg. 
econometric analysis); 
-Compensation test approach (Claxton et al.) 
-Cost consequence analysis from perspective of 
each sector as additional analysis; 
-None provided. 
Claxton et 
al. (2007)  
Mark versus Luke? 
Appropriate methods for the 
Evaluation of Public Health 
interventions. (Working 
paper) 
Costs and benefits across sectors should be incorporated. Compensation test approach. 
Mooney 
(2007)  
Economic evaluation of 
prevention: we need to do 
better but first we need to 
sort out what the good is. 
(Opinion piece) 
Relevant costs and benefits may be difficult to agree upon. None provided. 
Shiell (2007)  In search of social value. 
(Opinion piece) 
Insufficient to qualitatively include non-health impacts. None provided. 
Smith and 
Petticrew 
(2010) 
Public health evaluation in the 
twenty-first century: time to 
see the wood as well as the 
trees. (Full journal article) 
-Public Health economic modelling should focus upon broader 
outcomes such as ‘happiness’;  
-There is a need to focus on the direct and indirect effects of the 
interventions upon communities and populations, as well as on 
individual effects. 
-None provided; 
 
-None provided. 
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Inclusion of equity 
Author 
(year) 
Title (type of article) Key issues raised  Recommended approach 
Weatherly 
et al. (2009)  
Methods for assessing the 
cost-effectiveness of public 
health interventions: Key 
challenges and 
recommendations. (Full 
journal article) 
Four key methodological challenges: 
-Quantifying the effectiveness of interventions; 
 
-Measuring and valuing outcomes; 
-Inclusion of intersectoral costs and consequences;       
                                                    
-Inclusion of equity. 
-More use could be made of techniques for 
analysing non-experimental data (eg. 
econometric analysis); 
-Compensation test approach (Claxton et al.) 
-Cost consequence analysis from perspective of 
each sector as additional analysis; 
-None provided. 
Cookson et 
al. (2009a)  
Explicit incorporation of 
equity considerations into 
economic evaluation of public 
health interventions. (Full 
journal article) 
-There is a need for explicit incorporation of equity; 
-Policy makers would not fund cost-effective interventions if they 
infringe individual liberties or discriminate against the individual; 
-Society would be willing to pay more per QALY gained for certain 
groups such as children, the severely ill and the socioeconomically 
disadvantaged. 
4 proposed methods: (1) Qualitative discussion 
around relevant equity issues; (2) Quantitative 
evidence around the impact of the intervention 
upon health inequalities; (3) Estimating the 
opportunity cost of equity considerations in 
terms of health outcomes willing to forego; (4) 
Equity weighting of health outcomes. 
Richardson 
(2009)  
Is the incorporation of equity 
considerations into economic 
evaluation really so simple? A 
comment on Cookson, 
Drummond and Weatherly. 
(Response article). 
Potential value of the methods for including equity within economic 
evaluations proposed by Cookson et al. 
None provided. 
Shiell (2009)  Still waiting for the great leap 
forward. (Response article) 
Political issues associated with the inclusion of equity in economic 
evaluations. 
None provided. 
Cookson et 
al. (2009b)  
Explicit incorporation of 
equity considerations into 
economic evaluation of public 
health interventions – Reply 
to Richardson & Shiell 
(Response article) 
Response to above issues. Four proposed methods above. 
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Complex systems and multi-component interventions 
Author 
(year) 
Title (type of article) Key issues raised Recommended approach 
Shiell et al. 
(2008)  
Complex interventions or 
complex systems? 
Implications for health 
economic evaluation. (Full 
journal article) 
-Public Health systems are complex, and as such they present new 
methodological challenges.  
-The fact that Public Health interventions are often multi-component 
does not present new methodological challenges. 
None provided. 
Kelly et al. 
(2005)  
Economic appraisal of public 
health interventions. (Briefing 
paper) 
-QALY outcome may not be a sufficient measure; 
 
 
-Greater need to develop methods for including equity considerations; 
 
-It is important for a model to address what aspects of an intervention 
are successful/ unsuccessful. 
-Cost consequence analysis from perspective of 
each sector as additional analysis; Discrete 
choice experiments may be used for valuation. 
-None provided; 
 
-None provided. 
Weatherly et 
al. (2009)  
Methods for assessing the 
cost-effectiveness of public 
health interventions: Key 
challenges and 
recommendations. (Full 
journal article) 
Four key methodological challenges: 
-Quantifying the effectiveness of interventions; 
 
-Measuring and valuing outcomes; 
-Inclusion of intersectoral costs and consequences;       
                                                    
-Inclusion of equity. 
-More use could be made of techniques for 
analysing non-experimental data (eg. 
econometric analysis); 
-Compensation test approach (Claxton et al.) 
-Cost consequence analysis from perspective of 
each sector as additional analysis; 
-None provided. 
Plsek  and 
Greenhalgh 
(2001)  
Complexity Science: The 
challenge of complexity in 
health care. (Full journal 
article) 
There is a challenge to address complexity within healthcare. Point to the science of complex adaptive 
systems, but no specific approach described. 
Shiell and 
Hawe (1996)  
Health promotion community 
development and the tyranny 
of individualism. (Full journal 
article) 
Community impacts of interventions should be incorporated, which is 
more than the sum of the individual impacts. 
None provided. 
Smith and 
Petticrew 
(2010)  
Public health evaluation in the 
twenty-first century: time to 
see the wood as well as the 
trees. (Full journal article) 
-Public Health economic modelling should focus upon broader 
outcomes such as ‘happiness’;  
-There is a need to focus on the direct and indirect effects of the 
interventions upon communities and populations, as well as on 
individual effects. 
-None provided; 
 
-None provided. 
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Complex systems and multi-component interventions (cont) 
Author 
(year) 
Title (type of article) Key issues raised Recommended approach 
Whitehead 
(2010)  
The right wood, but barking 
up the wrong tree. 
(Commentary - response to 
Smith and Petticrew) 
-There are Public Health interventions which have been undertaken 
using a macro-level analysis, contrary to what was discussed by Smith 
and Petticrew.  
-It is the funders of Public Health economic modelling which encourage 
a micro-level approach rather than the analysts. 
None provided. 
Rickles et 
al.(2009)
71
 
A simple guide to chaos and 
complexity. (Journal article 
‘glossary’) 
There are limitations associated with understanding causality, which is 
more complex in Public Health due to the risk factors (the determinants 
of health) often being social. 
None provided. 
 
 
Technical modelling issues 
Author 
(year) 
Title (type of article) Key issues raised Recommended approach 
Anderson 
(2010)  
Modelling and evidence 
synthesis: challenges, value 
and issues for discussion. 
(Workshop presentation) 
-The differences between HTA and Public Health economic modelling; 
 
 
-Decision trees and Markov models may not be adequate due to the 
non-discrete behavioural changes, the complex long causal chains and 
the requirement to simulate many health and non-health outcomes. 
-Modelling should be more exploratory, with 
results presented as a sensitivity analysis rather 
than a ‘base case’; 
-May need to consider alternative methods 
which can deal with the complexity of Public 
Health systems. 
Rappange 
(2009)  
Lifestyle intervention: from 
cost savings to value for 
money. (Full journal article) 
The cost-effectiveness of Public Health interventions may be 
overestimated because the costs associated with future illnesses are 
not included within the analysis. 
Costs associated with future illness should be 
included within the analysis. 
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Appendix B: Review of conceptual modelling frameworks 
Appendix B1: Search strategy 
Stage 2: 
MEDLINE 
1. “conceptual model$”.ti  
2. “conceptual framework$”.ti 
3. “problem formulation$”.ti 
4. “economic model$”.mp 
5. “economic evaluation$”.mp 
6. “mathematical model$”.mp 
7. “decision-analytic model$”.mp 
8. “quantitative model$”.mp 
9. simulation$.mp 
10. “markov model$”.mp 
11. “decision tree$”.mp 
12. “system dynamics”.mp 
13. “agent-based model$”.mp 
14. “how to”.mp 
15. generat$.mp 
16. develop$.mp 
17. process$.mp 
18. stage$.mp 
19. or/1-3 
20. or/4-13 
21. or/14-18 
22. 19 and 20 and 21 
 
Scopus and Web of Knowledge: 
1. “conceptual model*”.ti  
2. “conceptual framework*”.ti 
3. “problem formulation*”.ti 
4. “economic model*”.mp 
5. “economic evaluation*”.mp 
6. “mathematical model*”.mp 
7. “decision-analytic model*”.mp 
8. “quantitative model*”.mp 
9. simulation*.mp 
10. “markov model*”.mp 
11. “decision tree*”.mp 
12. “system dynamics”.mp 
13. “agent-based model*”.mp 
14. “how to”.mp 
15. generat*.mp 
16. develop*.mp 
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17. process*.mp 
18. stage*.mp 
19. or/1-3 
20. or/4-13 
21. or/14-18 
22. 19 and 20 and 21 
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Appendix B2: Data extraction form for conceptual modelling frameworks 
 
Author, year 
 
 
Aim of paper 
 
 
Definition of conceptual modelling 
 
 
Steps in conceptual modelling process 
 
 
Proposed approach 
 
 
Evaluation of approach 
 
 
Strengths 
 
 
Weaknesses 
 
 
Potential generalisability to public health economic models 
 
 
Theoretical underpinnings of the framework 
 
 
Areas identified for further research 
  
302 
 
Appendix B3: Excluded studies and reason for exclusion 
Author, year Reason for exclusion 
Amblard et al., 2001
1
 Does not aim to develop a quantitative model. 
Andersen and 
Richardson, 1997
2
 
Does not describe a set of principles and methods/ methodologies which facilitate the 
development of a model structure. 
Arbez and Birta, 
2011
3
 
?? 
Ares and Pazos, 
1998
4
 
Does not aim to develop a quantitative model. 
Baldwin et al., 2004
5
 Does not describe a set of principles and methods/ methodologies which facilitate the 
development of a model structure. 
Bérard, 2010
6
 Describes current status of group model building, but does not describe a set of principles 
and methods which facilitate the development of a model structure. 
Chwif et al., 2013
7
 No stakeholder involvement is considered. 
Cook and Ferris, 
2007
8
 
Does not aim to develop a quantitative model. 
Curtis et al., 2006
9
 Does not aim to develop a quantitative model. 
Derrick and Balci, 
1992
10
 
Describes only the diagrammatic representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation. 
Derrick et al., 1989
11
 Reviews frameworks describing the steps involved within a conceptual modelling 
framework without describing methods for development. 
Fernández et al., 
2010
12
 
Solely a contribution of theory. 
Franco and 
Montibeller, 2010
13
 
Solely a contribution of theory. 
Franco, 2006
14
 Solely a contribution of theory. 
Heavey and Ryan, 
2006
15
, 2011
3
 
Describes only the diagrammatic representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation. 
Jun et al., 2011
16
 Does not describe a set of principles and methods which facilitate the development of a 
model structure. 
Juristo and Moreno, 
2000
17
 
Does not describe a set of principles and methods which facilitate the development of a 
model structure. 
Kotiadis and 
Robinson, 2008
18
 
A case study of using Soft Systems Methodology. 
Kotiadis, 2011
3
 Not the fullest description of this conceptual modelling framework. 
Lacy et al., 2001
19
 Provides a review of existing work on conceptual modelling, but does not describe a set 
of principles and methods which facilitate the development of a model structure. 
Lane and Oliva, 
1998
20
 
Not the most recent article describing this conceptual modelling approach. 
Montevechi et al., 
2008
21
 
Describes only the diagrammatic representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation. 
Montevechi et al., 
2010
22
 
Describes only the diagrammatic representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation. 
Nance, 1994
23
 Describes the steps involved within a conceptual modelling framework without 
describing methods for development. 
Norese, 1995
24
 Does not aim to develop a quantitative model. 
Onggo, 2009
25
, 2011
3
 Describes only the diagrammatic representation of a conceptual model without 
describing methods for choosing what is included or excluded within the representation. 
Pace, 2011
3
 No stakeholder involvement is considered. 
Robinson*, 2011
3
 Not the fullest description of this conceptual modelling framework. 
Rouwette et al., 
2009
26
 
Does not describe a set of principles and methods which facilitate the development of a 
model structure. 
Siau and Tan, 2005
27
 Does not aim to develop a quantitative model. 
Sokolowski et al., 
2008
28
 
No stakeholder involvement is considered. 
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Author, year Reason for exclusion 
Sotoodeh and 
Kruchten, 2008
29
 
Does not describe a set of principles and methods/ methodologies which facilitate the 
development of a model structure. 
Van der Lei, 2011
30
 Does not aim to develop a quantitative model. 
Van der Zee et al., 
2010
31
 
Does not describe a set of principles and methods/ methodologies which facilitate the 
development of a model structure. 
Van der Zee, 2007
31
, 
2011
3
 
No stakeholder involvement is considered. 
Vennix, 1999
32
 Solely a contribution of theory. 
Wang and Brooks, 
2007
33
, 2011
3
 
Does not describe a set of principles and methods/ methodologies which facilitate the 
development of a model structure. 
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Appendix C: Qualitative research 
Appendix C1: Ethical approval letter 
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Appendix C2: Participant consent form 
 
 
  
 
 
 
 
Participant Consent Form 
 
Title of Research Project: A methodological framework for developing the structure of 
public health economic models 
 
                                                                                                                                                 
Please initial box 
1. I confirm that I have read and understand the information sheet 
 dated [insert date] explaining the above research project 
and I have had the opportunity to ask questions about the project. 
 
2. I understand that I will be being observed during PDG meetings and taking                                      
part in interviews before and after the PDG meetings, all of which will be                                        
audio recorded. 
 
3. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason and without there being any negative 
consequences.  
 
4. I understand that my responses will be kept strictly confidential. 
I give permission for members of the research team to have access to my 
anonymised responses. I understand that my name will not be linked with 
the research materials; however it may be possible for other experts to identify  
me from the content of the material reported from the research.   
 
5. I agree for the data collected from me to be used in future research.  
 
 
6. I agree to take part in the above research project and to be audio recorded. 
 
 
________________________ ________________         ____________________ 
Name of Participant Date Signature 
 
_________________________ ________________         ____________________ 
Name of Researcher Date Signature 
School Of  
Health 
And 
Related  
Research. 
. 
Hazel Squires 
ScHARR 
Regent Court 
30 Regent Street 
Sheffield 
S1 4DA 
Tel:      0114 2220765 
Email: h.squires@sheffield.ac.uk 
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 Appendix C3: Information sheet for modellers 
 
 
 
 
 
 
Information sheet for modellers 
You are being invited to take part in a research project titled ‘A methodological framework for 
developing the structure of Public Health economic models’. This information sheet explains what 
the research involves and why it is being done so that you can decide whether to participate. Please 
take time to read the following information carefully and ask me if there is anything that is not clear 
or if you would like more information. My contact details are as follows: 
Hazel Squires; h.squires@sheffield.ac.uk; Tel: 0114 2220765. Thank you for reading this. 
 
Background 
I have been awarded a 3-year NIHR Doctoral Training Fellowship which began in November 2010 to 
produce a conceptual modelling framework for developing the structure of Public Health economic 
models. Conceptual modelling involves understanding the problem and deciding how the problem 
will be modelled, in a way that allows clear communication with stakeholders and experts. Currently 
there are no formal methods for doing this within Public Health economic modelling. Three 
supervisors from the School of Health and Related Research (ScHARR) at the University of Sheffield 
are involved in this work including Professor Ron Akehurst, Jim Chilcott and Dr Jennifer Burr. During 
the first year of the research I undertook a literature review around the key challenges within Public 
Health economic modelling and a multidisciplinary review of existing conceptual modelling 
frameworks. 
 
Qualitative data collection and analysis 
Within the second year of the research, as part of the methodological development of the 
conceptual modelling framework, I am planning on undertaking some qualitative data collection and 
analysis to: 
1) Understand the model development process in practice for Public Health economic modelling; 
2) Understand how and why modellers make decisions about model scope and structure; 
Hazel Squires 
ScHARR 
Regent Court 
30 Regent Street 
Sheffield 
S1 4DA 
 
Tel:      0114 2220765 
Email: h.squires@sheffield.ac.uk 
School Of  
Health 
And 
Related  
Research. 
. 
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3) Establish some of the key issues during model conceptualisation and what has worked well or poorly 
within Public Health economic modelling; 
4) Understand the potential feasibility and barriers to the use of a conceptual modelling framework; 
5) Understand some of the requirements and constraints of decision makers. 
 
 
This will be achieved by observing several Programme Development Group meetings at NICE and 
interviewing the modellers involved within these. I would like to invite you to participate by allowing 
me to observe the model development process within key modelling PDG meetings of the Walking 
and Cycling Project (which I would like to audio record) and by interviewing you prior to and 
following the meetings to confirm what has been done to date, how decisions have been made and 
what your next steps will be and why.  
 
An outline of the qualitative data collection & analysis within the wider project is shown below. 
 
Fram
ew
o
rk d
evelo
p
m
en
t                                          
Evalu
atio
n
 
Observation of selected PDG meetings from 
a project at NICE & in-depth interviews of 
modellers involved in the project 
Nov ‘11 
March ‘12 
July ‘12 
Nov ‘12 
March ‘13 
July ‘13 
Data 
analysis 
Literature review of key challenges within public health 
modelling and of existing conceptual model frameworks 
 
Conclusions of research 
 
Conceptual modelling framework development 
 
 
Testing the framework within a case study 
Project completion:  
Oct 2013 
Project start: Nov 2010 
 
Evaluation of framework 
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Key details: 
 
What would participation involve and what would be expected of me if I take part? 
There are usually 2-3 PDG meetings which focus upon the modelling at NICE which I would attend. 
Within the PDG meetings you would be expected to act as you would normally. I would take notes 
during the meetings in order for analysis to be undertaken following the meeting. You would be 
required to take part in an interview the week before each of the 2-3 PDG meeting and to take part 
in an interview immediately after each, each of which would not last longer than 40 minutes. These 
will be audio recorded and subsequently analysed to identify key themes. In order to take part, you 
will need to sign a consent form for the research (see attached) either prior to or at the beginning of 
the first interview. 
 
Will my taking part in this project be kept confidential? 
The name of participants will be anonymised within the study; however it should be noted that 
experts in the area may be able to recognise you based upon what you have said or the case study 
being evaluated. Audio recordings will be copied onto my personal computer which is password 
protected for the data analysis and they will be deleted from the audio recorder after they have 
been copied over, as soon as possible after the PDG meetings and interviews. The audio recorder 
and meeting notes will be kept securely during travel. The audio recordings and meeting notes will 
be used only for analysis and for illustration within research outputs including publications and 
conference presentations. No other use will be made of them without your written permission, and 
no one outside the project will be allowed access to the original recordings. 
 
What will happen to the results of the research project? 
The results of the research will be reported within a PhD thesis upon completion of the work. The 
qualitative data collection and analysis may also be reported within peer-reviewed publications and 
conference presentations. A copy of any outputs of the research will be circulated to you as soon as 
possible, and you will be anonymously acknowledged within them.  
 
Do I have to take part? 
Taking part in the research is entirely voluntary. If you do decide to take part you will be given this 
information sheet to keep and you will also be asked to sign a consent form prior to your 
involvement. You can withdraw at any time without it affecting any benefits that you are entitled to 
in any way, and you do not need to give a reason. 
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Additional questions you may have: 
 
Why have I been chosen? 
You have been chosen due to the timing of the project at NICE within my research. 
 
What are the possible benefits of taking part? 
It is anticipated that by taking part in this research you may facilitate methodological progression in 
this underdeveloped area. 
 
Who has ethically reviewed the project? 
This project has been ethically approved via ScHARR’s ethics review procedure. The University’s 
Research Ethics Committee monitors the application and delivery of the University’s Ethics Review 
Procedure across the University. 
 
What happens if the research study stops earlier than expected? 
If the research study was stopped earlier than expected for any reason, the reasons for this would be 
explained to you.  
 
What if I am not happy with the research? 
If you have any queries or concerns, you can contact me at any time throughout the project. If you 
have any complaints about the research you should contact Dr Jennifer Burr 
(j.a.burr@sheffield.ac.uk). If you feel that any complaints are not handled adequately, you should 
contact the Registrar and Secretary at the University of Sheffield (registrar@sheffield.ac.uk). 
 
Please contact me if you have any additional questions about the research. 
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Appendix C4: Topic guide for the qualitative interview before the PDG meeting 
Aim: To understand 
1) what has been done prior to the first meeting with stakeholders; 
2) how modellers make decisions about model scope and structure and the reasons why; 
3) key issues during model conceptualisation. 
 
Participant’s background: 
-Tell me about your background in health economic modelling. 
-What public health modelling have you been involved in? 
-What did you do after that?  
Have you been involved in any other public health modelling? 
 
Details of the experience: 
-Tell me about what you have done so far on the Walking and Cycling project. 
-Tell me about the key problems you have had so far. 
 
-How did you go about understanding the problem? 
-Have you developed a model scope? What does that consist of and how did you develop it?  
-How did you go about conceptualising the model structure? 
-How did you consider the level of detail to include within the model? 
-Have you thought about the type of model you might develop?  
 
Additional probes 
What did you do after that?  
You talked about… Tell me more about… It would be useful to explore x further… 
What do you mean by…?  
Why did you do it that way? In what way…? 
What about the interventions you’re assessing? 
What evidence is that based upon? 
How do you decide what to include and exclude?  
 
Reflections on the experience: 
-Are you concerned about any aspects of the work you have done so far? 
-What aspects of the proposed approach do you think the PDG will be concerned about? 
-Why have you chosen to develop the model to this particular point for the PDG meeting? 
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-What do you think about your current understanding of the problem? 
Can you think of anything else the PDG might question? 
What about the model scope? 
What about the model structure? 
Is there anything else you’d like to say about this? 
 
PDG meeting observation 
Aim:  
1) To understand how stakeholders are involved and affect decisions of model structuring; 
2) To understand some of the requirements and constraints of decision makers. 
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Appendix C5: Topic guide for the qualitative interview after the PDG meeting 
Aim: To understand 
1) what has changed and what the modellers next steps are as a result of the meeting with 
stakeholders; 
2) what the modeller thinks went well and not so well in terms of their approach; 
3) what the modeller thinks of as a conceptual modelling framework and the potential feasibility and 
barriers to using a conceptual modelling framework. 
 
Reflecting on the experience: 
-What are your next steps following the PDG meeting? 
How has the PDG meeting affected your next steps? Would you have done that anyway? 
-How has the PDG meeting altered your initial thoughts on the modelling? 
Why do you think that? 
Will it alter the model scope? Will it alter the model structure? 
 
-What do you think went well within the meeting? 
Are there any other things you think went well? 
-Are there any aspects which you think didn’t go so well? 
Are there any other aspects you don’t think went so well? 
 
-What do you think of as a conceptual modelling framework? 
Does it include understanding the problem/ model scoping/ level of detail/ structural assumptions/ 
choosing model type? 
-Do you think model development within Public Health economic modelling would benefit from a 
conceptual modelling framework? 
Why do you think that? Can you think of any other benefits? 
 
-What do you think would be the barriers to using a conceptual modelling framework within public 
health economic modelling for a decision making process such as NICE? 
Why do you think that? 
-What aspects of model development do you think are least well developed in terms of guidance for 
modellers for public health economic modelling?   
Are there any other aspects? 
-Do you think systems approaches may be helpful in developing public health economic modelling?   
What about the use of formal problem structuring methods? What about the use of causal mapping?   
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Appendix C6: Topic guide for the focus group meeting 
Preliminaries 
1) Introduce myself 
2) Outline of the research topic, purpose (important for participation), funder 
3) Confidentiality, audio recording, what will happen to the data, dissemination. 
4) Please could everyone treat what is said as confidential and not repeat it outside of the session 
without permission from the relevant participant. 
5) Indication of expectations – want to have a discussion, participants should not wait to be invited 
before speaking (although don’t talk over each other), everyone’s views are of interest, want to hear 
as many different thoughts as possible, as such if agree or disagree with other participants say so. 
6) Ask everyone to introduce themselves – names & brief background focusing upon Public Health 
modelling, one recent case study that they will focus upon and who the work was for. 
7) Could highlight the diversity/ similarity of the group as a whole. 
 
Topic guide 
How do you go about understanding the problem? 
Why do you do it that way? 
What is the role of evidence? 
 
How do you decide what the model scope will be?  
How do you go about conceptualising the model structure? 
How do you decide what to include and exclude within the model?  
How do you consider the level of detail to include within the model?  
At what stage do you decide what type of model you will develop?  
Why?  
What is the role of evidence? 
 
What are the main issues you have experienced during model conceptualisation? 
What has worked well to address these? 
What has worked not so well? 
 
How much stakeholder input do you obtain during model conceptualisation?  
For what, how, why? 
 
Do you develop a conceptual model?  
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Can you describe it?  
What does it help with? 
What do you think of as a conceptual modelling framework? 
Does it include understanding the problem/ model scoping/ level of detail/ structural assumptions/ 
choosing model type? 
 
Do you think model development within Public Health economic modelling would benefit from a 
conceptual modelling framework? 
Why do you think that? 
Can you think of any other benefits? 
What do you think would be the barriers to using a conceptual modelling framework within public 
health economic modelling within a decision making process such as NICE? 
Why do you think that? 
 
Do you think systems approaches may be helpful for developing Public Health economic models?   
What about the use of formal problem structuring methods? 
What about the use of causal mapping?  
 
Is there anything else you’d like to say around what we’ve talked about today? 
 
Generic probes 
Why do you think that? 
What did you do after that?  
You talked about… Tell me more about… 
It would be useful to explore x further… 
What do you mean by…?  
 
Other notes about running the focus group 
Pressure on participants to conform: Ask whether anyone has any different views or ask a person 
who is likely to have a different view 
Dominant person: That’s really helpful; does anybody else have a view on this? 
Quiet person: What do you think? Or you said xxx previously, what… 
Recording non-verbal behaviour: ‘Everyone’s nodding  a lot – why is that?’  
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Appendix D: Documents developed within the diabetes project 
 
Appendix D1: Protocol for conceptual modelling phase 
Introduction 
The conceptual modelling phase of the project will be based upon the Conceptual Modelling 
Framework for Public Health Economic Modelling1 and will follow the general stages outlined within 
Figure 1 below. As shown it will be divided into three key parts; (1) identifying relevant stakeholders; 
(2) understanding the problem and (3) developing and justifying the model structure. 
 
Figure 1: Outline of process for the conceptual modelling phase  
 
 
 
 
 
2) Understanding the problem 
i) Developing a causal diagram 
 
ii) Establishing current resources 
 
 
3) Developing and justifying the model structure 
i) Review of existing models 
 
ii) Choosing the model interventions 
 
iii) Determining the model boundary 
 
iv) Determining the level of detail 
 
v)  Identifying the model type 
 
vi) Developing a qualitative description of the quantitative model 
 
1) Identifying relevant 
stakeholders 
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1) Identifying relevant stakeholders 
A sufficient understanding of the decision problem to be able to identify a relevant group of 
stakeholders for the project will be developed. We plan to identify the following types of 
stakeholders to facilitate with model scoping and development as a minimum: 
o 3 diabetes epidemiology specialists, identified through discussions with Mike Gillett, Liddy 
Goyder and Nick Payne, and the external project collaborators. Snowballing will be used if 
required. 
o 1 CVD specialist. This will be Simon Capewell, one of the collaborators; 
o 1 clinician with expertise around obesity, identified through discussions with Mike Gillett; 
o 1 statistical expert. This will be Peter Diggle, one of the collaborators; 
o 2 patient representatives/ lay members, identified through diabetes UK; 
o 3 decision makers (preferably 2 local, 1 national), identified through discussions with Mike 
Gillett, Liddy Goyder and Nick Payne and including contacting Directors of Public Health, the 
South Yorkshire GP commissioning group specialising in diabetes, NHS Diabetes and the UK 
Screening Committee. 
 
This is likely to involve contacting a much greater number of stakeholders as it is expected that some 
of the key diabetes experts and policy makers may not have time to be involved in the project. This 
will need to be carried out over a number of iterations of waiting for responses and contacting 
additional potential stakeholders.  
 
We plan to involve the stakeholders in all stages of model development. As part of this, the 
stakeholders will be invited to attend three workshops throughout the project, as well as being 
asked to read draft documents produced by the project team. The first two of the workshops relate 
to the conceptual modelling stages of the project, whilst the final workshop is to present the draft 
report of the methods and results of the model. Any stakeholders who cannot attend a workshop 
will be asked to comment on papers produced for the workshop in advance so that their views can 
be incorporated. 
 
Workshop 1 will be held around October 2012, and the objectives will be (1) to aid in the 
development of a causal diagram of diabetes natural history and the implications of this upon other 
diseases; (2) to establish current resource use for diabetes prevention and treatment; and (3) to 
begin to develop the scope of the model including the model perspective and outcomes and the 
types of interventions for consideration within the model. 
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Workshop 2 will be held around the end of February/ beginning of March 2013 (depending upon 
stakeholder availability) and the objectives will be (1) to consider the review of interventions in 
order to determine which specific interventions should be considered within the model; (2) to 
review potential model assumptions.  
 
Briefing papers will be sent to stakeholders prior to each workshop for discussion within the 
workshop. 
 
 
2) Understanding the problem 
i) Developing the causal diagram 
A causal diagram will be developed prior to the first workshop for discussion at this workshop about 
the decision problem and its causal relationships. The first step for developing the causal diagram is 
to use the project proposal to describe the problem. The next step is to outline all of the causal links 
associated with the problem as well as those associated with the types of interventions being 
considered within the model. The project proposal outlines the scope of the work including the 
types of interventions being considered within the project, which will be used to facilitate this. The 
causal diagram will include the disease natural history of diabetes and the causal links with other 
diseases. A review of the disease natural history of diabetes (discussed in more detail below) will be 
undertaken in parallel to the development of this causal diagram and will be used to inform it. The 
role of the causal diagram will be: 
 to allow communication with the stakeholders, thus improving our understanding of the 
problem, as well as helping to raise model credibility;  
 to encourage reflection around the decision problem in a structured way and to help the 
modeller to understand what simplifying assumptions they are making within the model. 
 to provide a basis for validation for the model by transparently describing the understanding of 
the problem which allows what is included and excluded within the model to be justified; 
 to help choose the most appropriate analytical model type to develop (eg. discrete event 
simulation); 
 to be included within the methods of the report so that researchers and policy makers who are 
not involved within the project can see our understanding of the problem and follow what has 
been done and the reasons for our model choices. 
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Review of type 2 diabetes disease natural history 
A review of the disease natural history of type 2 diabetes will be undertaken with the aim of firstly 
understanding the key components and issues associated with the disease natural history and 
secondly facilitating a mathematical description of this disease natural history. A standard Cohrane 
style of review of the disease natural history of type 2 diabetes would be unmanageable due to the 
amount of evidence in this area. Thus we will follow an iterative search process, using a number of 
different search techniques, as described by Paisley (2012).2  The first stage of the searching is to 
identify high yield sources of information from which future searches can be developed. Thus, the 
previous economic models developed at ScHARR and any existing reviews of the disease natural 
history of type 2 diabetes will be used as a starting point for the search. From these, another 
iteration of sources will be identified. For example, the ScHARR economic modelling report includes 
a description of the QDScore, from which a key paper might be searched for as potentially relevant. 
The definition of relevance will be developed as part of the search process. Each iteration of the 
search process will be described within the methods of the report.  
 
Data extracted during the first stage of defining relevance will be the population, the approach 
employed, the conclusion and key points from the discussion. During the later stages of the review, 
more detail around the methods and results of included studies will be extracted, in order to define 
appropriate data for the mathematical model. This will include the equation(s) developed as well as 
the quality of the study. This review will be presented as part of the main report, rather than being a 
standalone document. 
 
ii) Identifying current resources 
This will involve describing the resources required for each factor within the causal diagram. For 
example, the factor ‘clinically diagnosed diabetes’ would include the resources associated with 
treatment of diabetes. These will be identified by any relevant literature identified during the search 
for the disease natural history of diabetes, as well as additional informal literature searches. A table 
of current resources will be produced for discussion at Stakeholder Workshop 1.  
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3) Developing and justifying the model structure 
i) Review of existing models 
A review of existing diabetes prevention and screening economic models will be undertaken, again 
following the methods described by Paisely (2012).2  The review will begin with identifying relevant 
existing reviews and these will be updated and additional searches undertaken as necessary. The 
review will be used to facilitate choices about model structuring. The inclusion criteria will be 
dependent upon the number and types of studies identified by the searches. A modified version of 
the Drummond checklist will be used for data extraction.3 
 
ii) Choosing the model interventions 
Following Stakeholder Workshop 1, a review of relevant interventions for screening and prevention 
of type 2 diabetes will be undertaken. The review will begin with identifying relevant existing 
reviews of interventions to avoid repeating existing work as it is known that other reviews have 
previously been carried out. These reviews will then be updated as appropriate. Data extraction will 
include interventions and comparators (including resource requirements), populations, outcomes, 
study design, key results and study limitations. The exact interventions for consideration within the 
model will be discussed within Stakeholder Workshop 2 based upon the findings of this review. 
 
iii) Determining the model boundary 
We will discuss with stakeholders the most appropriate model outcomes and perspective. It is likely 
that a cost per QALY analysis will be presented from an NHS perspective in the base case analysis. It 
may also be appropriate to present a cost-consequence analysis alongside the cost-effectiveness 
analysis. This will be discussed within Stakeholder Workshop 1. 
 
Following identification of the relevant interventions (described above), we will consider the 
appropriate comparators, model population and whether there are any relevant subgroups which 
should be modelled. These will be discussed within Stakeholder Workshop 2. 
 
For each factor within the causal diagram which does not have many links to the remaining factors, 
we will assess whether removing it will impact substantially upon the model results; that is, the 
extent of the expected difference between the intervention(s) and comparator(s). This will be 
informed where evidence is available by the review of existing economic models in the area. Where 
factors from the causal diagram are excluded, the reason for exclusion will be documented. An 
example of a factor which may be included within the understanding of the problem because it will 
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be affected by the interventions but subsequently be excluded from the model is pancreatic cancer, 
due to the relatively small impact the interventions will have upon pancreatic cancer incidence in 
comparison to diabetes and CVD.  
 
iv) Determining the level of detail 
The level of detail included within the model will be specified according to the interventions and 
comparators being assessed and the defined model boundary. For each factor identified within the 
model boundary, the level of detail will be moderated by the availability of data. Data for inclusion 
for specifying the model structure and for the parameters will be identified at this point. This will be 
based upon any literature identified during the development of the causal diagram for which specific 
literature was noted as useful as well as additional specific searches. Decisions about when to stop 
searching for information may be made based upon the expected impact of that factor upon the 
model results compared with the information retrieved for representing other factors within the 
model, given the constraints of the decision making process. Again, sufficient evidence is required to 
be able to justify why the modelling choices have been made.2  Elements for which there is a lack of 
empirical data which are considered to have key differential impacts upon the comparator(s) and the 
intervention(s) may be informed by expert elicitation. At this stage we will choose the most 
appropriate approach for estimating the disease natural history parameters, which may be taken 
from existing studies or calibrated using statistical methods such as the Metropolis Hastings 
algorithm.4  Building upon the work by Robinson (2011),5  for each factor included within the model 
boundary, a table will be developed outlining the level of detail being included.  
 
i) Identifying the model type 
The model type will be determined based upon the taxonomy by Brennan et al. (2006)6 using the 
understanding of the problem that has been developed in addition to the requirements of the 
decision maker including time/ resources available, data availability, the availability and access to 
the use of existing relevant good quality economic models which could be used as a starting point 
and the likelihood of the intervention being cost-effective in combination with the requirements of 
the model for future use. Based upon our current understanding of the problem and data availability 
it is likely that the model will be a patient-level simulation. 
 
ii) Developing a qualitative description of the quantitative model 
A qualitative description of the quantitative model will be developed for including within the report. 
This enables transparent communication of the model between the project team, the stakeholders 
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and researchers and policy experts not involved within the project who would like to understand the 
model. A different modeller (PW) will take the lead for developing the quantitative model and the 
diagrams developed will be used within the handover phase. 
 
  
323 
 
Project timescales  
Model 
development 
stage 
Activity When undertaken By whom 
Develop 
conceptual 
description our 
understanding 
of the decision 
problem 
Targeted background reading 
& discussion with Mike & Jen 
about key issues 
July HS 
Formal review of disease 
natural history 
Aug – Nov LP 
Draft causal diagram Aug – Sept HS 
Description of current 
resources 
Sept LP & HS 
Stakeholder workshop 1: 
Discuss causal diagram, 
current resources & model 
outcomes 
Beg Oct All 
Develop 
description of 
the model 
structure 
Review of previous diabetes 
prevention/ screening models 
(& obesity prevention 
models?) 
Oct – 15th Nov HS/ PW 
Review of model interventions 
(systematic reviews) 
Dec - Feb LP 
Choosing the model 
interventions 
15th Nov – end Feb HS 
Determining the model 
boundary 
15th Nov – end Feb HS 
Determining the level of detail 15th Nov – end Feb HS 
Identifying the model type  15th Nov – end Feb HS 
Stakeholder workshop 2: 
Agree final model 
interventions, discuss model 
boundary & assumptions 
End Feb/ March 2013 All 
Develop & 
analyse 
Developing & validating the 
quantitative model 
March – Aug 2013 PW 
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quantitative 
model 
Running model strategies Sept 2013 PW 
Stakeholder workshop 3: 
Discuss draft report with 
results 
Oct 2013 All 
Respond to stakeholder 
comments including re-
running analyses if necessary 
Oct - Nov 2013 PW 
Dissemination Dissemination of findings Dec 2013 – April 2014 PW/ All 
Project team: Hazel Squires (HS), Louise Preston (LP), Jim Chilcott (JC), Penny Watson (PW), Alan 
Brennan (AB), Mike Gillet (MG) 
Throughout the conceptual modelling phase of the project HS, LP and JC will hold weekly meetings. 
MG will attend around half of these meetings as appropriate and AB will be invited to attend the 
meetings on a monthly basis. PW will begin attending meetings in October following the completion 
of her PhD thesis. 
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 (6)  Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of 
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Appendix D2: Example email to potential stakeholders 
Dear xxx, 
 
The NIHR School for Public Health Research is funding the development 
of a common modelling framework for the clinical and economic 
assessment of population/community public health interventions and 
targeted identification and screening interventions for prevention of 
type 2 diabetes. This project is being undertaken as a collaboration 
between ScHARR at the University of Sheffield, Cambridge Institute of 
Public Health, Peninsula College of Medicine and Dentistry and LiLac. 
The aim of the project is to support commissioners of public health 
services and other stakeholders in their decision making concerning 
strategies for diabetes prevention in order to provide overall health 
improvement and support the reduction of health inequalities. We would 
like to ask for your support in this exercise through contribution to 
a stakeholder/expert group. This will involve attending (or otherwise 
contributing to) 3 four-hour stakeholder workshops in Sheffield (1 on 
5th October this year & 2 next year) and commenting on up to 3 
documents throughout the course of the project. 
 
The objectives of the first workshop will be 1) to aid in the 
development of a causal diagram of diabetes prevention, natural 
history and management, 2) develop the scope of the model and 3) 
consider the types of interventions for detailed consideration within 
the model. If you can attend the meeting then further details and 
discussion documents will be provided in advance. 
 
Please let me know if you would like to be involved or if you would 
like further details. 
 
Best wishes, 
 
Hazel. 
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Appendix D3: Discussion document for Stakeholder Workshop 1 
Overview of general project process 
This project aims to support commissioners of public health services and other stakeholders in their 
decision making concerning strategies for diabetes prevention in order to provide overall health 
improvement & support the reduction of health inequalities. The process for developing the 
structure of the diabetes screening and prevention model is described in Figure A.  
 
Figure A: Outline of conceptual modelling process  
  
 
 
 
4) Understanding the problem (Stakeholder Workshop 1) 
iii) Developing a conceptual model of the problem  
                                       (incl. a review of the disease natural history of diabetes) 
 
iv) Describing current resources 
 
 
5) Justifying and developing the model structure (Stakeholder Workshop 2) 
vii) Review of existing models 
 
viii) Choosing the model interventions (informed by a systematic literature review) 
 
ix) Determining the model boundary 
 
x) Determining the level of detail 
 
xi)  Identifying the model type 
 
xii) Developing a qualitative description of the quantitative model 
 
 
 
2) Identifying relevant stakeholders 
4)     Quantitative model development & analysis (Stakeholder workshop 3) 
July 
2012 
 
 
 
 
 
 
Oct 
2012 
 
 
 
 
 
 
 
 
 
 
Mar 
2013 
 
 
 
 
 
 
 
 
 
 
Oct 
2013 
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The first phase of this process has been undertaken and we have a team of stakeholders involved 
including decision makers, diabetes/ cardiovascular (CVD) experts and lay members. This first 
workshop aims to facilitate Phase 2 (understanding the problem). We will also begin to think about 
the model scope. The second workshop, to be held around March 2013, will facilitate Phase 3 
(developing and justifying the model structure). The third workshop, to be held around October 
2013, will be to discuss the draft modelling report. 
 
Within this document we are aiming to set out our current understanding of the problem and the 
sources upon which this is based. This is not necessarily what will be included within the final model; 
however after incorporating your feedback, it provides a basis for us to be able to make decisions 
about what can be included within the model and what it is reasonable to exclude. 
 
Specific objectives of Stakeholder Workshop 1: 
1) To develop a conceptual model describing the decision problem 
2) To identify any key evidence which may be useful for the modelling 
3) To agree the types of interventions to be considered within a systematic literature review 
(eg. lifestyle interventions for subgroups of the general population, pharmacological 
interventions for people with IGR) 
4) To discuss model perspective(s), outcomes, & populations 
5) To discuss resource use 
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Objective 1: To develop a conceptual model describing the problem 
A conceptual model which aims to capture potentially causal relationships associated with the 
problem has been developed for discussion. It includes the disease natural history of diabetes and 
potentially causal links with other diseases. The role of the conceptual model is: 
 to provide a tool for communication, thus improving our understanding of the problem;  
 to encourage reflection around the decision problem in a structured way and to help the 
modellers to be clear about the simplifying assumptions they are making within the model; 
 to transparently describe the understanding of the problem which allows what is included and 
excluded within the model to be justified; 
 to help choose the most appropriate analytical model type to develop; 
 to be included within the methods of the report so that researchers and policy makers who are 
not involved within the project can see our understanding of the problem and follow what has 
been done and the reasons for our model choices. 
We would like your input into this problem-oriented conceptual model in order to develop it further. 
The current version aims to provide a tool for communication about the problem and to generate 
discussion about aspects you agree/ disagree with, or feel that are missing.  
 
The problem-oriented conceptual model has been developed iteratively using the project proposal, 
existing ScHARR modelling reports, ScHARR diabetes modelling experts and targeted literature 
searches. The project proposal was the starting point for the development of the diagram, followed 
by the existing ScHARR modelling reports and discussions with ScHARR diabetes modelling experts. 
From these, targeted literature searches have been undertaken to further develop the problem-
oriented conceptual model. Potentially relevant papers were identified through citation searching, 
reference searching and author searching of the initial papers identified. Papers were identified to 
define each of the relationships within the conceptual model. A review of the disease natural history 
of diabetes is being undertaken in parallel and has been used to inform the conceptual model.  
 
A simplified version of the conceptual model is shown in Figure B below so that you can see the sort 
of factors we will be considering. The following pages focus on specific parts of the figure and 
describe how they have been developed and we will go through each of these in turn within the 
workshop. Within this figure: 
 
 
 
X          +      Y   should be interpreted as an increase in X leads to an increase in Y                                                                                                                       
.                         (thus a decrease in X leads to a decrease in Y) 
X          _      Y   should be interpreted as an increase in X leads to a decrease in Y                                      
.                          (thus a decrease in X leads to an increase in Y) 
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Maximise health/ reduce inequalities/ reduce the number of people progressing to diabetes/IGR    
within a budget constraint 
                      
                                                                                        
 
                         QALYs QALYs                 Costs  
 
                             _                                                                                               
                                                                              + 
 
 
                                                                  
                                                                                                                                                                                             
          
                                                                                       
            Mental illness                         
                         +        + 
 
    
                              Microvascular complications   
                                                          +                    
                
                                                
                    CVD  +                                                                                                                                     
                          +                                                                                                                                    
                                                                                                                                                          
 Cancers    +                                                                                                                                                                            
      +                                                                                
                              
                                                                        +             
 
                                                                                                                                            
            
                                                                                                                    
                                                Diseases associated with high BMI 
                                                              +                                         + 
 
 
Risk factors (including age, sex, ethnicity, BMI, family history of diabetes, etc.)                               
NB. These differ for different diseases but some factors overlap eg.BMI. 
 
 
 
 
 
 
 
 
 
     Blood glucose levels (BGL)¤ 
Figure B: Problem-oriented conceptual model of diabetes prevention 
 
*Different tests (OGTT, FPG, HbA1c) 
identify different individuals & diagnostic 
criteria have changed 
 
Normal       Time        IGR*      Time        Diabetes* 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
 
330 
 
Part I: The key problem 
The starting point for the diagram was to consider the key problem based upon the project proposal. 
This was identified to be that high blood glucose levels are associated with diabetes and Impaired 
Glucose Resistance (IGR). There are modifiable and non-modifiable risk factors associated with high 
blood glucose levels which include (but are not limited to) age, sex, BMI, family history of diabetes, 
use of antihypertensive therapy and ethnicity, and these affect the probability of having higher 
blood glucose levels.  
 
Disease natural history based upon blood glucose levels or IGR/ diabetes 
The disease natural history of diabetes over time may be described using blood glucose levels over a 
continuous scale, or by using the discrete classifications of IGR and diabetes. Ideally we would want 
to describe the disease natural history in terms of blood glucose levels rather than IGR/ diabetes 
because: (1) the definition of diabetes has changed and existing evidence generally relates to the 
previous definition; and (2) evidence suggests that there is a continuously increasing risk of diabetes-
related complications associated with blood glucose levels (see discussion in Part II). For the latter, it 
is not unusual to use discrete categories to characterise continuous processes when describing 
diseases. However, because we have evidence relating blood glucose levels to complications on a 
continuous scale in addition to the change in definition of diabetes, using discrete categories of IGR 
and diabetes is less preferable than using blood glucose levels directly if possible. 
 
The literature generally suggests that diabetes is a chronic progressive disease. However, some 
evidence suggests that type 2 diabetes is reversible following bariatric surgery 163 and Lim et al. 
suggest that a reduction in dietary intake can reverse diabetes in terms of both beta cell function 
and hepatic insulin sensitivity 164. Clarification is required around whether when using the health 
states ‘normal’, ‘IGR’ and ‘diabetes’, regression from diabetes to IGR and from IGR to normal is 
possible in terms of both the clinical definition and the risk of complications associated with each of 
these health states (see discussion of complications in Part II). 
 
The need for understanding the relationship between risk factors and blood glucose levels 
A review of studies assessing the effectiveness of interventions is planned to be undertaken, building 
upon existing reviews, and some of these studies are expected to show the trend of blood glucose 
levels over time for both the interventions and the comparators. If all of the intervention studies 
reported a measure of blood glucose levels then it would not be necessary to describe the 
relationship between the risk factors and blood glucose levels; we could directly describe the blood 
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glucose levels over time and the impact of the interventions upon these. However, it is expected, 
based upon existing systematic reviews of the interventions, that many of the intervention studies 
will report behaviour changes (eg. measures of physical activity/ diet) or BMI/ weight outcomes 
rather than blood glucose levels 165;166. Thus, one way of describing the disease natural history over 
time in order to be able to understand the impact of the interventions upon this disease natural 
history is to describe the risk factors over time and then relate those risk factors to blood glucose 
levels.  
 
Risk scores  
We have not identified any studies which describe the relationship between the risk factors and 
blood glucose levels directly using a statistical model. There are a large number of studies which 
describe the relationship between the risk factors and the risk of diabetes within a statistical model 
167. Studies identified by targeted literature searches suggest that it is important that studies relating 
the risk factors to diabetes are developed in the populations they will be used within 167;168. Thus we 
have focused upon risk scores which have been developed within the UK population only. Targeted 
literature searches identified four UK risk scores associated with diabetes. The Cambridge Risk Score 
predicts those currently at high risk of having diabetes within the UK 169, whilst the Leicester Risk 
Assessment Score and the Leicester Practice Computer Risk Score predict those currently at high risk 
of having IGR or diabetes within the UK  170;171. The QDiabetes predicts the 10-year risk of diabetes 
172. This score includes only clinically detected diabetes by GPs rather than screen-detected diabetes. 
 
The risk factors included within these studies are shown in Appendix A. All four risk scores include 
age (some studies used a continuous measure, others divided into categories), sex (male/ female), 
BMI (some studies used a continuous measure, others divided into categories), family history of 
diabetes in first degree relative (yes/ no, some studies divided ‘yes’ into parent or sibling had 
diabetes/ parent & sibling had diabetes) and use of antihypertensive therapy (yes/ no) as risk 
factors. Additional risk factors included in some but not all of the studies are ethnicity (some studies 
used white European/ other, others divided ‘other’ into more categories), smoker (yes/ no, some 
studies also included ex-smoker), Townsend Score (a measure of deprivation), diagnosed CVD (yes/ 
no), use of corticosteroids (yes/ no) and waist circumference (categorised).  
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Diagnosis criteria for IGR/ diabetes 
Clinical guidelines from the National Institute for Health and Clinical Excellence (NICE) based upon 
the World Health Organisation (WHO) criteria suggest that either HbA1c levels or Fasting Plasma 
Glucose (FPG) levels may currently be used to diagnose diabetes and IGR (see Figure D within the 
Resource Use section for the criteria). The three tests which have been used in standard practice for 
assessing blood glucose levels (HbA1c, FPG, OGTT) identify different individuals who may be 
associated with different outcomes 173. Only the Leicester Practice Computer Risk Score uses the 
current World Health Organisation diagnostic criteria 174. 
 
Risk factors and blood glucose levels over time 
If we can define the relationship between the risk factors and blood glucose levels (or diabetes risk if 
this is not possible), then by understanding what happens to these risk factors over time it would be 
possible to estimate blood glucose levels (diabetes risk) over time. Some of the risk factors cannot 
be altered (eg. ethnicity), whilst others change over time and are either non-behaviour related (eg. 
age) or behaviour-related (eg. BMI). Clearly we know the trajectory of age, however the trajectory of 
BMI, waist circumference, family history of diabetes, use of antihypertensive treatment and 
corticosteroids, and smoking habits are more difficult to describe. Some intervention studies report 
these changes over time 165;166. However, where this information is not available, it should be 
possible to identify longitudinal evidence for each of these factors. For example, Livshits et al. has 
analysed data from a longitudinal study over 15 years of a population of UK women aged 45 – 68 
years which shows the trajectory of BMI over time 175. 
 
Figure C1 below shows the key causal relationship that an increase in risk factors associated with 
diabetes leads to an increase in blood glucose levels. It also aims to describe the other issues 
discussed above. 
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Risk factors (including age, sex, BMI, family history of diabetes, ethnicity, etc.) 
            etc. 
Figure C1: Conceptual model of the key problem 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key questions for stakeholders: 
1) Do you agree/ disagree with the discussion around Figure C1? 
2) Are there any other key issues associated with these relationships which you would like to 
highlight?  
3) Do you know of any evidence upon which we could predict blood glucose levels over time 
based upon risk factors? 
4) Would it be possible to use any existing datasets to do this? 
5) Is regression from diabetes to IGR and from IGR to normal possible in terms of both the 
clinical definition and the risk of complications associated with each of these health 
states? 
6) Is BMI a sufficient measure for estimating blood glucose levels for predicting the impact 
of lifestyle interventions given the different mechanisms of diet and physical activity upon 
blood glucose levels? 
 
*Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
Normal       Time        IGR*      Time        Diabetes* 
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Part II: Diabetes-related complications 
To develop our understanding of the problem further, the next step was to consider the key reasons 
why the increase in blood glucose levels is considered to be a problem. Existing ScHARR modelling 
reports were used as a starting point for undertaking targeted searches around the relationship 
between diabetes and diabetes-related diseases. It was established that the key aim in identifying 
diabetes and IGR is to identify and provide interventions to those people who are at an increased 
risk of future complications including retinopathy, nephropathy, neuropathy and cardiovascular 
disease (CVD). CVD includes hypertension, coronary heart disease (leading to heart attacks and 
angina), congestive heart failure, peripheral artery disease (including leg claudication and gangrene) 
and cerebrovascular disease (including stroke and dementia).  
 
The continuous nature of the risk of complications 
Models exist which relate diabetes to the risk of the above diabetes-related complications, in 
particular the analysis of the UKPDS study outcomes 176. However, evidence suggests that the risk of 
these complications is continuous and increases prior to the diagnosis of diabetes 177-179. Thus the 
probability of having complications is not dependent upon whether or not diabetes is clinically 
diagnosed, but upon the individual’s blood glucose levels. The benefits of any interventions which 
delay or prevent the diagnosis of diabetes may be overestimated if these complications are assumed 
to only follow a clinical diagnosis of diabetes. In addition, this will have differential effects on 
interventions provided at different points in the screening and prevention pathway, making this 
important for comparisons between interventions. Whilst some studies suggest that the risk of 
complications below currently recommended diabetes diagnosis levels (HbA1c levels below 6.5%, 
FPG levels below 7mmol/L) is relatively low 177; others suggest a substantial increase in the risk of 
complications associated with HbA1c levels of over around 5.5% 178;179. 
 
Use of evidence to describe the relationship between blood glucose levels and complications 
Some studies consider the relationship between HbA1c / blood glucose levels and the complications 
in diabetic populations 176;180, whilst others consider non-diabetic populations 179;181, and some 
combine the two populations  177;178. Considering only the diabetic population (generally based on 
FPG or OGGTT levels) is insufficient because complications may have onset prior to clinical diagnosis 
of diabetes, whilst considering only the non-diabetic population does not generally provide 
information around the relationship between higher blood glucose levels and the complications. 
Those people who have been diagnosed with diabetes will have screening for retinopathy, 
neuropathy, nephropathy and risk factors of CVD, and thus these may be picked up at an earlier 
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stage than in the non-clinically diagnosed population. This is likely to lead to differences between 
the diabetic and non-diabetic populations in the relationship between HbA1c levels and these 
complications (due to the use of statins, photocoagulation and other treatments). Thus there is a 
question about the most appropriate evidence to use here. 
 
An iterative, targeted literature search suggested that HbA1c levels have been shown to be better 
predictors of the risk of retinopathy, nephropathy and CVD than FPG or OGTT tests 177;178;182. Whilst 
there is generally a similar sort of relationship between HbA1c levels and the complications as 
between FPG/ OGTT levels and the complications, FPG/ OGTT levels are much more variable (on a 
daily basis) and each of the tests identifies different groups of people 173. Most studies suggest that 
the risk of complications can be represented by a J-shaped curve, whereby beyond HbA1c levels of 
around 5.5% there is a continuous increase of complications 177;178;181;183. For CVD, this has been 
shown to be the case independently for hypertension, coronary heart disease, heart failure and 
cardiovascular mortality. Evidence has also been identified which suggests that there may be a 
relationship between HbA1c levels and colorectal cancer and postmenopausal breast cancer 183. 
There is a greater association with cancer mortality than cancer incidence which suggests that 
HbA1c levels may influence cancer progression more than cancer initiation 183. A study of the risk of 
cause-specific mortality by the Emerging Risk Factors Collaboration also suggests that diabetes is 
associated with an increased risk of mortality from liver, pancreas, ovary, colorectal, lung, bladder 
and breast cancer 184. 
 
Disease natural history of diabetes-related complications over time 
There is a disease natural history associated with each of these complications included within Figure 
4. The evidence described above highlights when people display symptoms of the complications/ are 
diagnosed, rather than the onset of the complications which will be at an earlier point in time. The 
evidence above does not describe the progression of the complications. Clarke et al. have 
undertaken analysis on the UKPDS dataset to describe the outcomes associated with each of the 
complications over time following diabetes diagnosis 176. However, no such analysis has been 
identified for the outcomes of the complications over time prior to diabetes diagnosis. 
 These potentially causal relationships are shown in Figure C2 below. 
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Blood glucose levels (BGL) ¤ 
Figure C2: Conceptual model of key diabetes complications 
 
 
 
 
 
 
 
 
 
 
Key questions for stakeholders: 
1) Do you agree/ disagree with the discussion around Figure C2? Are there any additional 
complications associated with high blood glucose levels which should be considered? 
2) Are there any other key issues associated with these relationships which you would like to 
highlight?  
3) Will treatment for diabetes substantially affect the relationship between blood glucose 
levels and diabetes-related complications? What would be the most appropriate evidence 
for understanding the relationship between blood glucose levels and complications? 
4) Is there any evidence of the relationship between HbA1c levels/ FPG levels & neuropathy? 
5) Is there any analysis of the risk of complications over time prior to clinical diagnosis of 
diabetes? 
             New links within the diagram 
                 
              
 
*Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
 
*Different tests (OGTT, FPG, HbA1c) identify diffe*Different tests (OGTT, FPG, HbA1c) identify different 
individuals & diagnostic criteria have changed 
rent individuals & diagnostic criteria have changed 
 
*Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
 
Normal       Time        IGR*      Time        Diabetes* 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
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Part III: Higher level goals associated with the interventions 
The next step considers the ultimate goals associated with what we are trying to achieve to help 
resolve the decision problem.  
 
Costs and QALYs 
All of the complications associated with type 2 diabetes lead to a reduction in survival and/or quality 
of life, typically expressed as Quality-Adjusted Life Years (QALYs) within health economics. QALYs are 
estimated by summing health utility scores over a lifetime, where 1 is equivalent to full health and 0 
is equivalent to death. For example, if a person spent 20 years in health state A which is associated 
with a utility of 0.8, followed by 30 years in health state B which is associated with a utility of 0.5, the 
total QALYs for that person would be 20 x 0.8 + 30 x 0.5 = 31. All of the complications associated 
with type 2 diabetes are also associated with costs to the National Health Service and Personal Social 
Services (NHS and PSS), the individual and lost productivity and leisure time. Which of these costs we 
want to include within the modelling will need to be discussed. 
 
Equity 
A goal may be to increase health within a specific budget constraint; however there may be primary 
or secondary goals associated with equity. For example, it might be that a goal is to reduce type 2 
diabetes and its associated complications in those people from certain ethnic origins such as people 
of South Asian origin who evidence suggests on average have higher blood glucose levels than 
people of white ethnic origin 171. Evidence shows that people with a higher socioeconomic status 
tend to benefit more from Public Health interventions than people with a lower socioeconomic 
status; thus an intervention for the general population which improves average health may widen 
the gap 33.  
 
It is therefore for discussion about what the goals of this analysis should be. These potential higher 
level goals are shown in Figure C3 below. 
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     Blood glucose levels (BGL)¤ 
Figure C3: Conceptual model of diabetes prevention with higher level goals 
 
                New links within the diagram 
 *Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
 
Normal       Time        IGR*      Time        Diabetes* 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
 
339 
 
 
 
 
 
 
 
 
 
Key questions for stakeholders: 
1) Which types of costs would you like the model to consider (eg. Costs to NHS & PSS, Cost 
to the individual, the cost of productivity loss, any others?)? 
2) How should interventions be chosen? Do you want to maximise the health of the 
general population within a budget constraint or reduce inequalities within the general 
population by maximising the health of specific subgroups of the population within a 
budget constraint? 
 
340 
 
Part IV: Additional potentially causal relationships 
The next step considers whether there are any other potentially causal relationships which should 
be included within the diagram.  
 
Other diseases associated with diabetes risk factors 
There are other diseases associated with some of the same risk factors associated with diabetes, in 
particular BMI and age. If interventions are used to alter the risk profiles of individuals in terms of 
BMI then this will affect other diseases as well as diabetes. The risk of some types of cancers would 
be affected, including postmenopausal breast cancer, colorectal cancer, oesophagus cancer, kidney 
cancer, endometrium cancer, gallbladder cancer and pancreatic cancer  185. In addition, evidence 
suggests that there is a direct impact of BMI upon the risk of CVD 186. It is important not to double 
count the impact of BMI upon the risk of CVD through this potential duel mechanism. Studies also 
suggest that dementia is independently associated with BMI 187, and the same issue of double 
counting the impact of BMI upon the disease applies. Osteoarthritis has also been shown to be 
associated with BMI 188.  
 
Inter-generational impacts 
In addition, risk factors within one generation are associated with risk factors for the next 
generation. The family history of diabetes is a direct link; however there is also evidence that 
parents’ lifestyle behaviours will affect children’s lifestyle behaviours 189. Thus if interventions are 
effective at changing lifestyle behaviours and preventing diabetes, the next generation will have an 
increased probability of better outcomes. 
 
Association with mental illnesses 
Diabetes has been shown to be associated with an increased risk of depression 190 and mental 
illnesses more generally 184. The relationship between depression and diabetes is complex and 
currently not completely understood. However, it has been suggested that people with clinically 
diagnosed diabetes have an increased probability of developing depression, which in turn is 
associated with a reduction in metabolic control, and that some of the risk factors associated with 
diabetes may also affect the probability of developing depression 190. Diabetes has also been shown 
to be associated with self harm 184. 
 
These potentially causal relationships are shown in Figure C4 below. 
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Figure C4: Problem-oriented conceptual model of diabetes prevention 
 
                New links within the diagram 
 *Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
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Objective 2: To identify any key evidence which may be useful 
In discussing the problem-oriented conceptual model we will hopefully have identified some useful 
literature sources/ datasets. The references for the current document are included at the end of the 
document.  
 
 
 
 
 
Key questions for stakeholders: 
1) Do you agree/ disagree with the discussion around Figure C4? 
2) Are there any other key issues associated with these relationships which you would like to 
highlight?  
3) Do you disagree with any of the potentially causal links? 
4) Are there any other (positive or negative) consequences of each factor? For example, 
Seshasai et al. (2011) suggest that diabetes is associated with an increased risk of 
mortality from infectious diseases and injuries; should these be included within the 
conceptual model and, if so, where? 
5) Are there any links which may be correlated rather than causal i.e. two factors that 
appear to be causally related which can be explained by a third. 
6) Are there any other possible causal links between the factors? 
 
Key questions for stakeholders 
1) Are there any literature sources or datasets which have not already been highlighted 
which may be useful in describing these relationships? 
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Objective 3: To agree the types of interventions to be considered within a systematic literature 
review 
There are several potential types of interventions for consideration within the model and these have 
been incorporated into the conceptual model within Figure C5. This includes comparing population/ 
community level interventions & targeted intervention through identification of high risk individuals/ 
screening. A systematic literature review will be undertaken to identify evidence on the 
effectiveness of relevant types of interventions in preventing and screening type 2 diabetes and we 
would like to agree the scope of this review. The review will build upon existing relevant systematic 
reviews. The potential types of interventions which have currently been identified are: 
 
In the general population/ subgroups of the general population 
1) Lifestyle interventions 
2) Different combinations of risk assessment/ screening strategies in order to identify IGR/ 
diabetes 
 
In those with IGR 
1) Lifestyle interventions 
2) Pharmacological interventions 
Pharmacological interventions are associated with an increased risk of hypoglycaemia and other AEs 
191. If people with IGR employ lifestyle interventions, they may reduce the necessity for 
pharmacological interventions and thus reduce these adverse events.  
 
Outcomes of intervention studies 
Based upon existing systematic reviews of some of these types of interventions, a small number of 
intervention studies report impacts upon HbA1c directly and some report BMI outcomes; however 
many studies report behavioural outcomes such as increase in fruit and vegetable intake and 
increase in physical activity. Thus there is another potentially causal link between these behavioural 
factors and the risk factors, which have not explicitly been incorporated into Figure C5. This 
relationship could be described using data from the Health Survey for England as was done within 
the previous ScHARR modelling work for NICE 192. 
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The impact of clinical diagnosis of diabetes upon diabetes-related complications 
Screening tests for high risk individuals will increase the number of clinically diagnosed IGR and 
diabetes cases. Following a diagnosis of diabetes, screening for diabetes-related complications is 
undertaken, including CVD risk factors and microvascular complications (neuropathy, nephropathy 
and retinopathy) 191. Thus earlier clinical diagnosis may improve outcomes associated with diabetes 
complications, although evidence to date from intervention in screen-detected cohorts has not been 
entirely compelling 193;194. 
Key questions for stakeholders relating to the types of interventions to be considered: 
1) Do we want to assess alternative screening options within the model? 
2) Do we want to consider pharmacological interventions for IGR or are we interested 
solely in lifestyle interventions? 
3) Are we interested in lifestyle and self-management interventions for people with 
diabetes? 
4) Should we focus upon any of these intervention types more than others? Are there any 
additional types of interventions we should consider? 
5) What would happen in the absence of the interventions versus as a result of the 
interventions – would behaviour be prevented or delayed? What is the best evidence for 
this? What would be considered to be a good outcome of an intervention? 
6) Might some other organisation (for example, a fast food company) act to substantially 
reduce the impact of interventions? 
7) What are the important adverse events associated with pharmacological interventions? 
8) Would the interventions have any other impacts not already considered? 
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Figure C5: Conceptual model of diabetes prevention with potential types of intervention 
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Objective 4: To discuss model perspective(s), outcomes, & populations 
It is useful for all of the stakeholders to provide input around what would be the most appropriate 
modelling perspectives, outcomes and populations in order for the model results to be useful to 
commissioners of diabetes prevention services. The specific model populations considered within 
the model will be dependent to some extent on data availability. 
 
Modelling perspective: 
The modelling perspective is what types of costs and outcomes should be included within the model. 
For example, the NICE Public Health methods guide recommends taking a Public Sector Perspective 
or a NHS and Personal Social Services (PSS) perspective as appropriate, which would mean that a 
model needs to include all costs and outcomes incurred by all Public Sectors or the NHS and PSS 
respectively. Another example of a perspective that may be taken includes the societal perspective 
which includes all costs to society. We have previously considered this issue to some extent when 
discussing Figure C3. If the question being answered relates to how to spend a budget for 
healthcare, then a NHS and PSS perspective may be most appropriate.  
 
 
 
 
 
Model outcomes: 
It is important for us to know at this stage which outcomes would be most useful to commissioners 
of diabetes prevention services. Typically, depending upon the perspective(s) taken, the outcomes 
presented would be the Incremental Cost per Quality-Adjusted Life Year (QALY) gained, the 
Incremental Cost per Life Year Gained (LYG) as well as incremental costs, incremental QALYs and 
incremental LYs. The QALY measure includes both survival and quality of life impacts. The 
incremental cost per QALY gained enables comparisons of the cost-effectiveness of the diabetes 
prevention and screening interventions with interventions for other diseases to be made, as well as 
enabling comparisons to be made between different diabetes prevention and screening 
interventions. 
 
It may be that it would be useful to have a type of budget impact model where the people in the 
model represent the current distributions of age, ethnicity, BMI etc. within the population in order 
to estimate: 
Key questions for stakeholders 
1) What do you think would be the most appropriate perspective(s) for the modelling? 
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- Number of patients requiring screening per year 
- Number of IGR patients identified per year 
- Number of diabetes patients identified per year 
- Total costs over the next 1, 2, 3, 4, 5,..., n years 
These outputs would be dependent upon the geographical area served and hence better estimates 
would be predicted by local commissioners inputting their own data about the population. 
 
 
 
 
 
 
Model population: 
The model population will depend to some extent on the studies identified for the effectiveness of 
the interventions. However, it would be useful to know if there are specific subgroups which you 
think should be considered. Some possibilities are listed below, although this is not necessarily an 
exhaustive list. 
1) Those without clinically diagnosed diabetes/ IGR: 
a. General population 
b. Specific age groups 
c. Specific ethnic groups 
d. Overweight/ obese group 
e. Smokers 
f. Geographical areas with higher levels of deprivation 
g. Clinically diagnosed CVD  
h. People being treated for hypertension 
i. People using corticosteroids 
j. Pregnant women (with or without gestational diabetes) 
2) Those with IGR 
3) Those with diabetes 
 
Key questions for stakeholders 
1) What would be the most useful outcomes from the model for you? 
 
Key questions for stakeholders: 
1) Are there any specific groups which you think should be considered within the model if 
evidence allows?  
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Objective 5: To discuss resource use 
Eventually within the model we will need to include detailed costings associated with resource use 
for each of the factors included within the model. We would like at this stage to develop an 
understanding of the resource processes associated with some of the key factors within the 
conceptual model. Figures D and E1-E5 show the processes associated with diagnosis and treatment 
of type 2 diabetes according to NICE guidelines. Please let us know if this does not represent current 
practice. 
 
It is likely that the costs associated with each of these will be based upon existing costing or cost-
effectiveness studies due to the substantial analysis which has already been undertaken in this area. 
Thus, this will help us to be able to identify existing studies which incorporate appropriate resource 
use, and to know if clinical practice has altered substantially since these NICE guidelines were 
produced. 
 
The resource use associated with the delivery of the interventions will be based upon the studies 
identified within the effectiveness review. 
 
Key questions for stakeholders: 
1) Do the processes shown within Figures D and E1 – E5 represent current practice? 
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Figure D: NICE recommendations for risk assessment and screening of diabetes195 
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Figure E1: Diabetes management 
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Figure E2: Pharmacotherapy for type 2 diabetes196 
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Figure E3: Pharmacotherapy for type 2 diabetes 191 
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Figure E4: Diabetic symptomatic neuropathy management 191 
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Figure E5: Foot care management 197 
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Next steps 
We will update this document according to your feedback and re-circulate: 
1) The updated problem-oriented conceptual model; 
2) The types of interventions we will be considering within the systematic review; 
3) The modelling perspective(s) and outcomes. 
 
We will then be working out the best way of translating this understanding of the problem into a 
model. At the next workshop we will discuss the effectiveness review and exactly which 
interventions to assess within the model, and the structural assumptions to be included within the 
model. 
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Appendix A: Risk factors & derivation of diabetes risk scores 
 
Name of risk score Age Sex Ethnicity BMI Smoking 
Family 
history 
Townsend 
score 
Use of 
antihypertensive 
drugs CVD 
Current use of 
corticosteroids 
Qdiabetes √ √ √ √ √ √ √ √ √ √ 
Cambridge risk score √ √ - √ √ √ - √ - √ 
Leicester Risk Assessment Score √ √ √ √ - √ - √ - - 
Leicester Practice Computer Risk Score √ √ √ √ - √ - √ - - 
 
 
Name of risk score Derivation External validation Test used 
Qdiabetes 172 198  Clinical diagnosis by GP 
Cambridge risk score 169  199;200 OGTT 
Leicester Risk Assessment Score 170  170  OGTT 
Leicester Practice Computer Risk Score 171 171 HbA1c/ OGTT 
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Appendix D4: Outcomes of Stakeholder Workshop 1 
1. Conceptual model of the problem 
The conceptual model was discussed and revised, as shown in Figure 1 below. The green parts of the 
conceptual model are those which have been added as a result of stakeholder input. 
 
There was a discussion around whether blood glucose levels should be considered as a risk factor for 
the long term outcomes associated with diabetes alongside the other risk factors for diabetes such 
as age, sex and ethnicity. This alternative conceptual model is shown in Figure 2. 
 
There was a discussion around the use of the term IGR and there was some consensus that the term 
IGT was more commonly used.  
 
The marked heterogeneity of type 2 diabetes was highlighted. 
 
 
 
 
 Please let me know if you think anything else should be included/ changed within the 
conceptual model. 
 
 Please comment on whether you think it is appropriate to link the risk factors (including blood 
glucose levels) directly to retinopathy, neuropathy and nephropathy, as shown in Figure 2.  
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Figure 1: Conceptual model of diabetes prevention with potential types of intervention 
            Potential interventions 
             Affects usage of alternative intervention 
 
*Different tests (OGTT, FPG, HbA1c) identify different  
individuals & diagnostic criteria have changed 
 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
 
      +++  ++  
 
 
 
                                 Blood glucose levels (BGL)¤ 
 
                       +    Diagnosed IGT*    +   Diagnosed diabetes*~ 
 
Normal     Time    Undetected IGT  Time    Undetected diabetes 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
**Risk factors may be worse in the future as lifestyles become more sedate 
CVD, retinopathy & hypoglycaemia may affect driving ability 
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Figure 2: Alternative conceptual model of diabetes prevention with potential types of intervention 
            Potential interventions 
             Affects usage of alternative intervention 
 
*Different tests (OGTT, FPG, HbA1c) identify different  
individuals & diagnostic criteria have changed 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
 
¤ All included factors change over  
time, shown here in graphical form 
for blood glucose levels to highlight  
the consideration of time 
 
**Risk factors may be worse in the future as lifestyles become more sedate 
CVD, retinopathy & hypoglycaemia may affect driving ability 
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2. Types of interventions (and populations) for consideration 
Stakeholders listed which interventions they thought were important to consider within the model, 
shown in Table 1 below.  
 
 
 
 
It was highlighted that some interventions are statutory, such as the Health Checks and Children 
measurement programme, so these should be included as a baseline. The issue about opportunity 
costs and whether it will be important to consider what we should do less of was raised. The 
discussion suggested that it would be useful to do this. There was also discussion of basic Health 
Check versus Health Check plus including diabetes and/or CKD. 
 
It was suggested that the sustainability of programmes is very important. Often programmes are 
short term or cancelled which can leave patients without ongoing support. A package of 
interventions should be considered to avoid rebound after the intervention has finished.  
 
Similarly, there was a discussion around there not being one intervention that works for everyone, 
but that it is important to have a package of options for achieving weight loss. 
 
It was highlighted that commissioners are not making decisions about pharmacological 
interventions. 
 
 If you think there are any additional interventions which are not listed within this table 
which would be important to consider, or you would like to reword any which you have 
written, please let me know. 
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Table 1: Interventions identified by stakeholders 
Intervention Target population Who would pay Who would deliver Any unintended effects 
Screening interventions 
NHS Health Checks Adults PH/LA Private Provider  
General CVD and associated risk assessment 
screening 
Targeted by age, sex and 
ethnicity 
NHS Primary Care  
Self-assessment risk analysis online advertised by 
GPs, Diabetes UK etc 
Everyone Patient   
Sugar, HbA1c measurement 
Those deemed at risk by the 
GP, CVD screening, high blood 
pressure, patient request 
GP GP  
Sugar, HbA1c measurement 
Racial populations known to 
be at raised risk e.g. south 
Asian 
GP 
PH 
Primary Care 
Decliners 
Specific ethnic group checking data e.g. HbA1c Ethnic groups 
Special Government 
fund 
Pharmacy/nurses Alienate ethnic population 
Community based screening e.g. church 
All adults over 25 or selected 
high risk groups as per NICE 
NHS CCG 
LA H&WB groups 
Primary Care 
Pharmacies 
Community groups as 
per NICE 
Anxiety (not much) 
National Child Measurement Programme (NCHP) Reception and  Year 6 PH/LA School Nurse Service  
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Pharmacological 
Interventions 
  
Metformin 
Those unable to achieve 
adequate response to lifestyle 
interventions to prevent 
diabetes 
CCG Prescriptions GI side effects (flatulence!) 
  
Diet and Exercise 
Interventions 
  
Group based exercise interventions 
Physically inactive in 
potentially at risk groups 
LA LA  
Facilities for exercise 
Physically inactive in 
potentially at risk groups 
NHS NHS  
Leisure Facilities/referral to Activity Sheffield 
Health Champions 
People who self assess as 
needing. 
Targeted at inactive 
GP CCG 
Sheffield City Council 
CCG 
SCC 
Health problems like arthritic knees 
YMCA exercise class 
Those who already have a 
healthy diet 
Exercise on referral 
(CCG) 
YMCA qualified 
instructor 
Possible additional stress from 
needing to attend extra class 
Exercise on referral schemes Moderate to high risk of T2D 
CCG’s 
LA’s 
Private Health Insurers 
Commercial Providers  
Commercial Physical Activity one to one 
interventions e.g. Fitness First 
Moderate to high risk of T2D 
CCG’s 
LA’s 
Private Health Insurers 
Commercial Providers  
Weight Watchers Style Programme Overweight Local/NHS/Council 
Specialised External 
body 
Yo Yo effect of weight loss 
To have direct access to dieticians when newly 
diabetics are diagnosed by GPs for the system to 
work closely with all services 
Newly diagnosed diabetics CCGs  GPs and NHS together  
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Weight Management e.g. Weigh Ahead Dietetics  Those with BMI over 35 
GP 
City Council 
PH set up 
Community dieticians 
DNA’s 
Group based lifestyle intervention based around 
diet and exercise (similar to DESMOND) 
Those identified at high risk of 
diabetes 
GP CCG 
Nurse or dietician or 
exercise physiologist 
Possible additional stress from 
needing to attend extra class 
Private sector weight loss classes e.g. slimming 
world 
Those needing to loose large 
amount of weight 
Initially GP or CCG then 
patient 
Weightwatchers 
Possible additional stress from 
needing to attend extra class 
Dietician led education course 
Those for whom significant 
increase in physical activity is 
problematic 
CCG 
Specialist diabetes 
dieticians 
Stress to patient 
Group based weight loss interventions e.g. 
-WeightWatchers, other commercial programmes 
-Primary Care Led e.g. CounterWeight, Waste the 
Waist 
Moderate to high risk of T2D 
(as per NICE) 
CCG’s  
LA’s (H and WB) 
Private Health Insurers 
Commercial Providers 
Primary Care Staff 
 
Commercial Diabetes Prevention Programmes in 
Development e.g DESMOND-DP, NDPS, X-POD 
Moderate to high risk of T2D 
(as per NICE) 
CCG’s  
LA’s (H and WB) 
Private Health Insurers 
Commercial Providers 
Primary Care Staff 
 
Individual behaviour change interventions (one to 
one, unlikely to be cost effective) 
Moderate to high risk of T2D 
(as per NICE) 
CCG’s  
LA’s (H and WB) 
Private Health Insurers 
Commercial Providers 
Primary Care Staff 
 
Mixed model weight loss interventions 
Moderate to high risk of T2D 
(as per NICE) 
CCG’s  
LA’s (H and WB) 
Private Health Insurers 
Commercial Providers 
Primary Care Staff 
 
Community interventions e.g. cooking 
demonstrations, work with restaurants to make 
healthier options available 
All 
CCGs 
Las 
LA’s and associated 
providers 
 
Training of health professionals to deliver brief 
interventions for lifestyle change 
Health Professionals NHS NHS Increase in inequalities 
Health trainers and health champions to support 
individuals in lifestyle change 
Local communities ? ? ? 
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Brief Intervention Training  All PH/LA Providers  
Tier 1,2,3 obesity services Adult PH/LA Local dietetic and MDT  
Childhood obesity interventions Children and families PH/LA Leeds Met  
Weight Management (WW) Adults/families PH/LA GP’s  
Population-level interventions 
Change in transport policy 
Transport Plans 
General Population Government   
Affordable access to healthier foods 
Universal and targeted at 
groups at greater risk e.g. 
deprived/BME 
LA’s LA’s and third sector 
Increased inequalities as better off 
more able to take advantage of the 
interventions 
Taxation/Prohibition/Advertising bans in respect of 
e.g. sugary soft drinks i.e. empty calories 
Esp. young people Food industry 
Central Government 
Local Government 
Legislation 
 
Walking and cycling (transport and leisure) 
initiatives 
Universal and targeted at 
groups at greater risk e.g. 
deprived/BME 
LA’s LA’s and third sector 
Increased inequalities as better off 
more able to take advantage of the 
interventions 
Change in agricultural policy General Population Government   
We need to work with supermarkets in promoting 
healthy food and farmers in affordable production 
Everyone 
Sainsburys etc. Would 
need financial 
incentives 
Supermarkets 
PH champions 
Patients Budget concerns 
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Organisational level – something about overall 
responsibility at LA level and their responsibility for 
mix of interventions 
    
People with other issues other than diabetes which 
bring the onset of diabetes such as CVD 
People not yet diagnosed 
with diabetes 
CCG GPs and NHS together  
Diabetes UK roadshows and publicity (they have 
their own risk calculator) 
Everyone Diabetes UK Charity   
Healthy Schools/School Meals     
Olympics Health Moneys Everyone 
The money allocated 
to Sheffield ?£60m? 
Private consortia  
Green Space (Environment) All LA PH and LA  
Vegan Lifestyle (suggested this week to the UN) All ? 
Government 
Intervention 
Food Industry rejections 
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3. Model perspectives and outcomes 
The discussion of model perspectives and outcomes suggested that the perspective should be 
broader than a NHS and Personal Social Services (PSS) perspective and that a societal perspective 
would be of interest to stakeholders, with a breakdown of costs and outcomes presented. A number 
of relevant groups of interest were discussed: 
1) The Private Health Insurer will have an interest to raise profits, and avoid long term costs. 
They may have an incentive to introduce programmes to improve their PR and advertising.  
2) Social services and local government will want to lower costs to the public sector and meet 
other objectives within departments, such as education. There is a problem in that the 
payers of the interventions are not necessarily in the department that will benefit further 
down the line. Public sector responsibilities can affect several different departments.  
3) There are also parties outside of the public sector that are affected. For example the 
Academies in education can be considered outside of the local government.  
4) The involvement of Housing Associations should also be considered if modifications to the 
home are needed and patients are not the home owner.  
5) The Well@Work programme involves employers and this perspective might want to be 
considered.   
6) Most interventions are funded by government in some form, but the delivery can be very 
different. The costs should also consider the time and human resource costs and who 
eventually performs the intervention.  
7) The cost to the population at risk should be considered, for example, testing costs (linked to 
driving). A patient perspective should consider the costs of lifestyle changes, expensive diet 
or weight watchers. Pharmacological interventions are free for diabetics, so they may be 
cheaper for the individual patients. Other patients in related risk groups, such as high blood 
pressure are not eligible for free prescriptions. This may have cost implications for screening 
programmes.  
8) Pharmaceutical companies have an interest in screening programmes to raise sales as more 
diabetes patients are identified.  
9) The Charity and voluntary sector were also briefly mentioned. 
10) Societal costs will be important, such as work absence and caregiver costs.  
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Discussion around commissioning and who funds which interventions 
There was a discussion around the changes to the PCTs and the new plans for how the 
responsibilities will be divided. It was highlighted that who will commission interventions will be 
different around the country. 
 
The Health and Well-being board will commission services specifically for the prevention and 
screening of diabetes. The CCG will have a seat on that board, but it will not take responsibility for 
the programmes. The budgets between the two groups will not be transferable in the short term. 
The CCG does not have a direct role in screening and prevention of diabetes, but has an interest in it 
because they commission the secondary care treatment. The Health and Wellbeing board cannot say 
they want to cut the budget of the CCG (in terms of secondary care) and increase their budget for 
prevention of diabetes from the saved money, but the CCG could fund prevention which may be in 
their interests.  
 
Weight management programmes will be the responsibility of Public Health. Health Checks will be 
funded by the Local Authority. Part of education programmes will be funded by CCGs, whilst part will 
be funded by the Local Authority. Pharmaceutical interventions sit between several funding streams. 
 
 
 
 
 
 
 
 Please let me know if this summary of the discussion of model perspectives and outcomes 
does not capture any issues raised. 
 
 Please let me know if you think that anything that was discussed at the workshop is not 
reflected within this document. 
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Appendix D5: Discussion document for Stakeholder Workshop 2 
This document aims to outline our draft scope and key assumptions for the economic model so that 
we can: 
a) discuss which specific interventions should be considered within the model; 
b) agree on the boundary of the model; 
c) discuss the appropriateness of alternative key model assumptions; 
d) agree upon the perspectives & outcomes of the model; 
e) discuss the appropriateness of alternative assumptions to describe the cost and quality of 
life inputs. 
 
This document includes: 
(1) A summary of a review of intervention effectiveness evidence; 
(2) A summary of a review of similar cost-effectiveness models and the implications for this 
model;  
(3) A description of the type of model being developed; 
(4) A draft model boundary; 
(5) Specification of key model assumptions;  
(6) The perspectives & outcomes of the model; 
(7) Costs & utility assumptions associated with the relevant diseases. 
We present key questions that we have within each section. 
 
1. Summary of intervention effectiveness evidence for type 2 diabetes screening and prevention 
We have divided the potential interventions into the following population groups: 
A) For the general population to reduce risk factors for diabetes; 
B) For people with non-diabetic hyperglycaemia; 
C) For people within the general population who are at high risk of developing non-diabetic 
hyperglycaemia and type 2 diabetes, including identification and risk assessment (eg. 
overweight or obese, low socioeconomic status, South Asian, those with CVD, those picked 
up by health checks). 
 
Systematic reviews produced for NICE projects already exist for (B) and (C) above.1;2 We have 
undertaken a literature review for population-level interventions (A above). This was limited to a 
review of systematic reviews due to the large number of studies in this area. We used the 
interventions you identified within the first stakeholder workshop to help develop the searches. The 
search strategy is described in Appendix 1. We did not identify any evidence on walking and cycling/ 
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transport policy interventions within our review of systematic reviews; however an existing NICE 
report describes a recent review of this area.3 
 
All of the above reviews are made up of heterogeneous studies in terms of population, intervention, 
comparator, outcomes and country. Thus, meta-analysis of many of the studies is not appropriate. 
Therefore, the effectiveness and cost of each intervention assessed will generally be based upon one 
specific study. From the reviews, Table 1 shows the interventions we have identified for possible 
comparison within the model, along with the studies we could use to model the effectiveness of 
these interventions. Table 1 also lists the studies which we have identified but that were not 
considered to be relevant or of sufficient quality, based upon the criteria below:  
 
Intervention grouping level 
1) Intervention is not generalisable to the UK in any of the studies due to substantial differences in 
current practice (e.g. transport infrastructure in the Netherlands) or populations (e.g. 
intervention provided to only a Hispanic population); 
   OR 
2) Intervention is not effective in any of the studies within the systematic reviews; 
OR 
3) Intervention already exists as standard practice within the UK. 
 
Individual study level 
4) No outcomes reported related to diet, exercise or blood glucose levels (e.g. only impact upon 
traffic congestion reported) or only subjective outcomes reported (e.g. only increased 
knowledge about diet or intention to exercise reported)  
 OR 
5) Only poor evidence exists around intervention effectiveness due to: 
a. short term follow up 
b. poor study design 
c. poor reporting of the study (e.g. the intervention, comparator, population, 
outcomes or study design are unclear). 
 
Table 2 shows key details of the studies which we are proposing could be used within the model. 
 
No effectiveness evidence has been identified within our search for systematic reviews around the 
following interventions which were suggested within the first stakeholder workshop: 
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1) Affordable access to healthier foods ; 
2) Change in agricultural policy; 
3) Work with supermarkets in promoting healthy food; 
4) Increase green space; 
5) Vegan lifestyle. 
 
Screening 
Based upon an email discussion with stakeholders, there is variation in diabetes screening practice 
and GPs may use FPG, RPG or HbA1c. OGTT is rarely used in practice, apart from for small specific 
groups of patients such as pregnant women. More HbA1c tests can be undertaken per day and the 
cost is likely to be reduced as these tests are used more often. Questions which you may want us to 
consider within the model are: 
1) What should the frequency of repeat screening tests be for people with non-diabetic 
hyperglycemia?  
2) Currently IGR and/or IGT may be classed as high risk groups. Which groups of people should 
be most appropriately classified as high risk groups in terms of their risk of complications?  
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Table 1: Interventions and related effectiveness evidence 
Population Intervention Effectiveness evidence which could be 
used within model 
Effectiveness evidence identified but not planned to be used (reason) 
General 
Population 
Taxation of snacks Oaks, USA, 
Kim & Kawachi, USA 
(in Thow et al. 2010
4
) 
Asfaw, Egypt (population) 
(in Thow et al. 2010
4
) 
Taxation of soft drinks Fletcher et al., USA 
(in Thow et al. 2010
4
) 
Tefft, USA (incompatible outcome measure); Bahl, Ireland (as above) 
(in Thow et al. 2010
4
) 
Community-based health 
education plus counselling 
& environmental change  
Jenum et al., Norway 
(in Sheill et al. 2008
5
) 
- 
Community-based health 
promotion 
Howard et al., USA 
Women’s Healthy Lifestyle Project, 
USA (Kuller et al. and Simkin-Silverman 
et al.) (in Mernagh et al. 2010
6
) 
- 
University-based health 
education 
Hivert et al., Canada 
(in Mernagh et al. 2010
6
) 
- 
Workplace-based 
environmental change 
(high intensity) 
Emmons, USA 
Sorensen, USA 
(in Mhurchu et al. 2010
7
) 
Cook, NZ (smaller sample size); Linenger, USA (weaker study design) (in Anderson et 
al. 2009
8
); Saarni, Finland (weaker study design, no comparator); Hope et al. Ireland 
(as above); Lassen et al. Denmark (as above); Kwak et al. Netherlands (weaker study 
design, non-randomised) (in Maes et al. 2011
9
); 
Sorensen (2007), US (smaller sample size) (in Mhurchu et al. 2010
7
) 
Workplace-based 
environmental change 
(low intensity) 
Holdsworth, UK (2004) 
(in Mhurchu et al. 2010
7
) 
Holdsworth, UK (1999) (2004 study was a better design) (in Mhurchu et al. 2010
7
); 
Tanaka et al. Japan (population) (in Sheill et al. 2008
5
); Oshaug et al. Norway (weak 
quality) (in Maes et al. 2011
9
) 
Workplace-based health 
checks (high intensity) 
Gomel, Australia 
 (in Anderson et al. 2009
8
) 
Elliot, USA (limited follow up), Gill et al. Sweden (weak quality – case study); Murza et 
al. Germany (weaker study design – no comparator) (in Maes et al. 2011
9
) 
Workplace-based health 
checks (low intensity) 
Hanlon et al., Scotland 
(in Maes et al. 2011
9
) 
Connell, USA 
(in Verweij et al. 2011
10
) 
Shimizu, Japan (population); Erfurt, USA (population) (in Anderson et al. 2009
8
); 
Racette, USA (smaller sample size) (in Verweij et al. 2011
10
); Campbell, USA (smaller 
sample size, population); Braekman, Holland (shorter follow-up) (in Mhurchu et al. 
2010
7
) 
 
Workplace-based health 
education/promotion 
(high intensity) 
Aldana, USA 
(in Anderson et al. 2009
8
) 
Anderson, US (older); Crouch, US (smaller sample size); DeLucia, US (as above); Muto, 
Japan (population); Proper, Netherlands (shorter follow-up); Robison, US (as above); 
Weir, US (dated, no comparison); WHO, Europe (dated) (in Anderson et al. 2009
8
) 
Workplace-based health Talvi, Finland Bruno, US (dated, shorter follow-up); Brownell, US (smaller sample size); Cockcroft, 
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education/promotion (low 
intensity) 
(in Maes et al. 2011
9
) 
Elberson, USA 
(in Anderson et al. 2009
8
) 
UK (shorter follow-up); Forster, US (as above); Fukahori, Japan (population); Furuki, 
Japan (population); Gerdle, Sweden (smaller sample size); Briley, USA (smaller sample 
size); Gomel, Australia (weaker study design); Hedberg, Sweden (smaller sample size); 
Pohjonen, Finland (as above) (in Anderson et al. 2009
8
); Von Thiele Schwarz, Sweden 
(population narrow – female dentists) (in Verweij et al. 2011
10
); Pratt, 17 countries 
(General Electric employees) (weaker study design, no comparator) (in Mhurchu et al. 
2010
7
); Nisbeth, Denmark (smaller sample size); Siggaard, Denmark (as above); 
Papadaki, Scotland (as above and weaker study quality) (in Maes et al. 2011
9
) 
Sustainable Travel Towns Sloman et al., UK
11
 - 
Pedometer interventions Baker et al., UK 
12
 - 
Non-
diabetic 
hyper-
glycaemia 
Diet and exercise if 
screening identifies non-
diabetic hyper-glyceaemia 
DPS, Finland (in Jones et al.) DPP, USA (less relevant than Finnish DPP); Indian DPP (setting); Da Qing, China 
(population); Japanese DPP (population); FHS, UK (small sample); Malmo, Sweden 
(not randomly assigned); Malmohus, Sweden (dated); ODES, Norway (follow up 
shorter, sample size smaller than US & Finnish trials); Asti DPP, Italy (as previous); VIP, 
Sweden (as previous). (in Jones et al.) 
High-risk 
of non-
diabetic 
hyper-
glycaemia
/ diabetes  
(low SES) 
Education to promote 
increased fruit &veg intake  
Ashfield-Watt et al. (2007)
13
 
Bremner et al. (2006)
14
 
- 
Behavioural counselling - Steptoe et al. (2004)
15
 (The NICE PDG agreed unsuitable) 
Workplace counselling - Proper et al. (2003)
16
 (as above) 
Exercise consultation - Lowther et al. (2002)
17
 (Had negative impact on physical activity) 
Access to internet portal - Lindsay et al. (2008)
18
 (as above) 
Broad dietary education/ 
cooking skills 
McKellar et al. (2007)
20
  
Wrieden et al. (2007)
19
  
- 
Opening of a new food 
retail outlet 
Cummins et al. (2008)
21
 
 
- 
Small scale multi-
component 
Gray et al (2009)
22
 - 
Large-scale, region-wide 
multi-component 
Schuit et al. (2006) 
23
 
 
- 
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Table 2: Key details of studies 
Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
Oaks (2005) 
in Thow et 
al (2010)
4
  
State tax of 5.5% of soft drinks and 
snacks. 
USA 15 years Not stated 
in SR 
Ecological Obesity 
prevalence 
No relationship. 
Kim & 
Kawachi 
(2006) in 
Thow et al 
(2010)
4
 
Change in state taxes on soft drinks 
or snack foods. 
USA  Not stated in 
systematic 
review (SR) 
Not stated 
in SR 
Ecological Obesity 
prevalence 
No association with obesity point 
prevalence. With no tax more than 4 
times as likely to experience a high 
relative increase in obesity prevalence; 
those that repealed a tax were more than 
13 times as likely. 
Fletcher et 
al. (2011)
24
 
State soft drinks tax, average 3%. USA 16 years Not stated 
in SR 
Ecological BMI 1% tax decreased BMI by 0.003 points. 
Jenum et al. 
(2003, 
2006) in 
Sheill et al 
(2008)
5
 
Community-based health 
education plus environmental 
change plus counselling. 
Intervention duration was 3 years. 
Norway, 
community 
setting (2 
multi-ethnic 
districts of 
Oslo) 
Not stated in 
SR 
Not stated 
in SR 
Interven-
tion 
Physical activity 
(measured by 
self-report); 
BMI 
Increase in PA in I (+9.5%, p<0.01) 
compared to minor changes in C (exact 
change not reported in original study). 
Smaller increase in BMI in I compared to C 
(exact difference not stated in SR). 
Howard et 
al. (2006) in 
Mernagh et 
al (2010)
6
 
Community based health 
promotion to promote a decrease 
in fat intake and increases in 
vegetable, fruit, and grain 
consumption. 18 group sessions in 
year 1, then 4 per year for the 
duration of the trial. 
USA, 
community-
based from 4 
clinical 
centres, 50-79 
years old 
Mean 
follow-up 
7.5 years, 
change at 1 
year also 
reported in 
SR 
48, 835 
women 
RCT Change in body 
weight; BMI; 
waist 
circumference 
Change at  1 year 
Weight 
I: -2.2kg (p<0.001) 
C: No change 
 
At the end of follow-up differences were 
observed between I & C in weight (0.5kg, 
p=0.01), BMI (0.3kg/m
2
, p<0.001) and 
waist circumference (0.3cm, p=0.04). 
Kuller et al. 
(2001) & 
Simkin-
Silverman et 
al. (2003) in 
Mernagh et 
al (2010) 
Community based health 
promotion. Cognitive-behavioural 
programme with duration of 5 
years. 
USA, 
community-
based, 44-50 
years old 
6, 18, 30, 42 
and 54 
months after 
randomis-
ation 
Up to 535 
women 
RCT Weight; BMI; 
Body fat (%); 
waist 
circumference 
Change at 54 months (from baseline) 
Weight  I: 0.08 C: 2.36 (p<0.01) 
BMI I: 0.05±2.0 C: 0.96±1.8 (p<0.001) 
Body fat I: -0.5±4.1 C: 1.1±3.9 
(p<0.01) 
Waist circumference I: -2.90 
C: -0.46 (p<0.01) 
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Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
Hivert et al. 
(2007)
25
 
Small-group interactive seminars to 
educate students and modify diet/ 
exercise behaviour. Fortnightly for 
the first 2 months of the semester, 
monthly for the rest of the 2 years 
(total = 23 seminars) 
Canada, 
university 
students 
1 year & 2 
years 
I: 58 
C:57 
RCT Weight (kg); 
BMI 
Change at 2 years 
Weight I: -0.6±0.5 C: +0.7±0.6 
(p<0.05) 
BMI I: -0.3±0.2 C: +0.2±0.2 
(p<0.05) 
Holdsworth 
(2004)
26
 
Environmental (low intensity) - 
changes to cafeteria menus. 
Duration of intervention was 6 
months 
UK, 
workplace-
based, 4 
intervention 
workplaces 
and 2 control 
1 year 577 
employees 
at 6 
worksites 
I: 453 
C: 124 
Quasi-
experimen
tal study 
Dietary habits 
measured using 
a food 
frequency 
questionnaire 
Vegetable consumption 
I: 27% made +ve changes 
C: 19% made +ve changes 
Fruit consumption 
I: 37% made +ve changes 
C: 25% made +ve changes 
Emmons 
(1999) in 
Mhurchu et 
al (2010)
7
 
Workplace based environmental 
change – risk factor education 
programmes and changes to 
nutrition policy and practice.  
USA, 
workplace-
based 
intervention 
130 weeks 397 
employees 
at 22 
worksites 
Cluster 
RCT 
Total fat, fibre 
and fruit and 
vegetable 
intake (FFQ) 
Total fat 
I: -2.2% 
C: -1.8% 
Fruit & vegetable servings/day 
I: +0.2 
C: -0.2 
Sorensen 
(2003) in 
Mhurchu et 
al (2010)
7
 
Workplace based environmental 
change – worker participation in 
programme planning, worksite 
environmental changes & 
individual behaviour change 
programmes 
USA, 
workplace-
based 
intervention 
104 weeks 5156 
employees 
at 15 
manufac-
turing 
worksites 
Cluster 
RCT 
Dietary intake 
(fruit and 
vegetable 
screening 
questionnaire) 
Fruit and vegetable servings/day 
I: -0.1 (7 sites) 
C: +0.05 (8 sites) 
Connell 
(1995) (in 
Verweij et 
al. (2011)
10
 
Workplace based health checks – 3 
intervention groups and control. Ia: 
Health promotion + Health risk 
appraisal (HRA) booklet, Ib: Health 
promotion, Ic: HRA booklet, C: 
HRA. 
USA, 
workplace-
based 
intervention 
with office 
workers, 
nurses & 
instructional 
staff 
 
1 year 801 
employees 
Ia: 142  
Ib: 248  
Ic: 253  
C: 158 
Cluster 
RCT 
BMI Significant decrease in Ia, Ib, Ic vs. C:  
ß: −0.05 (p < 0.01),  
ß: −0.05 (p < 0.01),  
ß: −0.04 (p < 0.05)  
vs. ß: 0 
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Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
Hanlon et 
al. (1995, 
1998) (in 
Maes et al. 
2011
9
) 
Workplace based health checks. 
Health checks followed by a health 
education package that included an 
interview backed up by written 
information and feedback on risks. 
Intervention duration 12 months. 
Scotland 5 months & 
1 year 
1,632 RCT BMI; Diet; 
Physical activity 
No significant effect on BMI or physical 
activity. Effect on diet. 
Aldana 
(2005) (in 
Anderson et 
al. 2009
8
) 
Workplace based health 
education/promotion – lectures, 
pedometers, books, shop tours, 
cooking demonstrations, health 
knowledge test, compared to no 
contact. Intervention duration 1.5 
months, maintenance not 
reported. 
USA, 
workplace 
based 
intervention 
targeted to 
care provider 
employees. 
6 months 145 RCT Weight(kg) Significant decrease in I compared with C. 
I: -4.4 
C:-1.0 
(p<0.0001) 
Talvi (1999) 
(in Maes et 
al. 2011
9
) 
Workplace based health checks 
and education/promotion - 
employees were offered special 
counselling according to their 
individual needs in 9 target areas. 
Intervention duration different for 
each health promotion action. 
Finland, oil 
refinery 
workers, one 
rig with 
intervention 
compared to 
one rig with 
minimal 
intervention 
3 years I: 412 
C: 473 
Non-RCT BMI, Diet, 
Physical activity 
habits 
No effect on BMI or diet. Effect in the 
targeted direction on physical activity. 
Elberson 
(2001) (in 
Anderson et 
al. 2009
8
) 
Workplace based health checks 
and education/promotion – Ia 
(structured): planned exercise 
classes, Ib (unstructured): access to 
gym, no classes, Ic: all of the above. 
Intervention duration 12 months, 
maintenance not reported. 
 
USA, 
workplace 
based 
intervention. 
1 year 374 Retro-
spective 
cohort 
BMI Structured: Baseline BMI 25.01, change at 
12 months -0.57 (within group p=0.185) 
 
Unstructured: Baseline BMI 27.97, change 
at 12 months +0.30 (within group 
p=0.001) 
Gomel 
(1993) (in 
Anderson et 
Workplace-based health checks & 
education/promotion - risk 
assessment & feedback on risk 
Australia, 
workplace 
based 
1 year 431 Cluster 
RCT 
BMI No difference between intervention 
groups and control. 
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Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
al. 2009
8
) factor profile; up to 6 life-style 
counselling sessions over a 10-
week period; incentives incl. lottery 
tickets & money for achieving 
goals. Intervention 6 months. 
intervention 
with 
ambulance 
employees 
Sloman et al 
2010
11
 
Sustainable travel towns which 
implemented intensive town wide 
Smarter Choice Programmes to 
encourage use of non-car options; 
bus use, cycling and walking, and 
less single occupancy cars 
United 
Kingdom 
30 Months 12,000 Ecological/
Cluster 
RCT 
Cycle trips per 
head, walking 
trips per head 
Cycle trips per head grew by 26-30%. 
Comparison towns cycle trips decreased. 
Walking trips per head grew substantially 
by 10-13% compared to a national decline 
in similar towns. 
Baker et al. 
(2008) 
12
 
Walking programme with goals set 
in steps using an open pedometer 
for feedback 
United 
Kingdom 
52 Weeks 63 RCT Step counts Intervention (77%) vs.Control (54%) 
achieved week 4 goals (X2= 4.752, p=0.03) 
Significant decrease in count week 16-52. 
DPS, Finland 
(in Jones et 
al. ) 
Control group: lifestyle advice was 
given as ‘standard care counselling' 
at baseline. Intensive intervention 
group: given individualised, 
detailed dietary counselling, with 7 
sessions during the first year & 
every 3 months thereafter. 
Finland, with 
IGT. All were 
middle-aged 
(40–64 years) 
& BMI>25 
kg/m2 at 
baseline. 
3 years  522 (172 
men and 
350 
women)  
RCT Multiple 
outcomes 
including BMI, 
weight, waist 
circumference 
and incidence of 
diabetes. 
During the first three years of the study, 
22 subjects (9%) in the intervention group 
and 51 (20%) in the control group 
developed diabetes (p= 0.0001, 2 test). 
Ashfield-
Watt et al. 
(2007)
13
 
 
Initiatives that involved building 
community networks to increase 
fruit and vegetable intakes in five 
deprived communities by 
improving awareness, attitudes & 
access to fresh fruits & vegetables. 
Intervention duration 12 months. 
Residents in 5 
UK deprived 
areas 
1 year 1554 Non-RCT Fruit & 
vegetable 
intake, 
measured using 
a short dietary/ 
attitude 
questionnaire 
Median total fruit and vegetable intakes 
decreased significantly over one year in 
the control group (-0.4 portions per day, 
p<0.01), but there was no significant 
change in total fruit and vegetable intakes 
in the intervention group. 
Bremner et 
al. (2006)
14
 
‘5-a-day‘ community intervention 
to increase fruit & vegetable 
intake, including home delivery & 
transport links, voucher schemes, 
media campaigns, growing & 
cookery skills & encouraging 
Residents in 
66 (former) 
UK health 
authorities 
with the 
highest levels 
Baseline 
(pre-test) 
was in 2003 
and follow-
up (post-
test) was in 
98,640 Non-RCT Fruit & 
vegetable 
intake and 
knowledge 
Fruit consumption (unadjusted): 
Experimental and control group 
respondents were more likely to consume 
fruit as a between meal snack at follow-up 
(significance not reported). 
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Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
networking in groups involved in 
promoting healthy eating. Duration 
not specified but at least 1 year. 
of deprivation 
and poorest 
health status. 
2005. Vegetable consumption (unadjusted):  
Experimental and control group 
respondents were more likely to consume 
vegetables as portions with main meals at 
follow-up (significance not reported).  
Wrieden et 
al. (2007)
19
  
Informal food skills and food 
education sessions, following a 
‘CookWell‘ manual. Intervention 
duration 7 months. 
Adults in rural 
& urban 
communities 
in Scotland 
aged 30-55 in 
lower SES 
groups who 
do not 
exercise often. 
2 & 6 
months 
93 Non-RCT Fruit & 
vegetable 
intake; other 
eating habits 
(e.g. tuna and 
total fish intake) 
At T2, a mean change equivalent to one 
portion a week was seen in the 
intervention group for fruit (P= 0.047), but 
no other significant changes were seen. 
This change was not sustained and there 
was no significant difference between the 
intervention and comparison groups (T1–
T3). 
McKellar et 
al. (2007)
20
 
Mediterranean-type diet 
intervention involving a cookery 
course, weekly 2-hour sessions. 
Intervention duration 6 weeks. 
Females with 
rheumatoid 
arthritis living 
in urban areas 
of deprivation 
in Glasgow. 
3 & 6 month 130 Non-RCT Fruit & 
vegetable 
intake; weight 
control; 
consumption of 
high fat foods; 
physiological 
measurements 
Evaluation of cardiovascular risk factors 
showed a significant drop in systolic blood 
pressure by an average of 4 mm Hg in the 
intervention group (p=0.016), while the 
control group showed no change. 
Consumption of fruit, vegetables & 
legumes was below the recommended 
minimum of 5 portions a day, in both 
groups at baseline. By 3 months this had 
improved significantly in the intervention 
group who were attending cooking 
classes. This group also had a significant 
improvement in ratio of monounsaturated 
:saturated fats consumed. 
Cummins et 
al. (2008)
21
 
Provision of a new food 
hypermarket within the 
intervention area (natural public 
health intervention). Intervention 
duration 1 year. 
Residents of 
households in 
two deprived 
areas of 
Glasgow. 
1 year 603 Pros-
pective 
cohort 
study 
Fruit and 
vegetable 
consumption, 
self reported & 
psychological 
health, & socio-
Weak evidence for an effect of the 
intervention on mean fruit consumption (-
0.03, 95% CI -0.25 to 0.30), mean 
vegetable consumption (-0.11, 95% CI -
0.44 to 0.22), and fruit and vegetables 
combined (-0.10, 95% CI -0.59 to 0.40).  
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Author 
(year) 
Intervention (incl. length of time 
provided & maintenance) 
Population/ 
setting 
Follow up 
period 
Sample 
size 
Study type Outcomes Effectiveness 
demographic 
variables. 
Odds ratios & 95% confidence intervals of 
reporting fair to poor self-reported health 
and poor psychological health for the 
intervention compared with comparison 
community. 
Gray et al 
(2009)
22
 
Camelon weight management 
group programme, tailored to men, 
incorporating advice on physical 
activity, diet and alcohol 
consumption. Intervention 
duration 12 weeks. 
Male 
residents of a 
deprived 
community in 
Scotland. 
Pre-
programme, 
short-term 
(12-week, 
immediately 
post-
programme, 
long-term (1 
to 49 
months after 
programme) 
110 Case series Weight loss, 
waist 
circumference 
reduction, BMI 
reduction. 
Short-term (end of 12 weeks programme) 
weight loss for completers was a mean 
weight loss of 4.98 kg. 44.3% achieved a 
weight loss of 5% to 10%. 
Long-term weight loss maintained an 
average 3.7% weight loss (range = 32.6 
weight loss to 25.6% weight gain) 
compared with their baseline weight (no 
further information on what this actually 
meant). Compared with pre-programme 
weight, 14 weighed less, 2 were stable 
(±0.5 kg) 4 weighed more; no further 
detail reported. 
Schuit et al. 
(2006) 
23
 
Over 5 years 790 interventions 
were implemented in the local 
population and targeted groups. 
Netherlands 5 years 3895 Cohort 
study 
Body mass 
index, waist 
circumference, 
blood pressure, 
serum glucose 
& serum total & 
high-density 
lipoprotein 
(HDL) 
cholesterol 
Difference in mean change in risk factors 
between intervention & reference group 
for BMI: −0.36kg/m2 in men & −0.25 
kg/m2 in women; waist circumference 
−2.9cm in men & −2.1cm in women; 
systolic blood pressure: −7.8mmHg in men 
and −5.5mmHg in women; cholesterol 
0.11 mmol/L in women & serum glucose 
−0.23 mmol/L in women. (p<0.05) 
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Key questions for stakeholders: 
1) Do you think we should compare all of the interventions listed in Table 1/ which of 
these should we prioritise? 
2) Are you happy with the effectiveness evidence we have identified to use to model 
these interventions shown in Table 1?  
3) Do you think we should do additional specific searches for effectiveness evidence of the 
five interventions described above Table 1 which were not included within the 
systematic reviews? 
4) Should we assume that the screening strategy as set out in the NICE guidance is current 
practice? Do you think it would be useful to investigate the two questions relating to 
screening above Table 1 or any others relating to screening? 
5) Limited evidence has been identified for the effectiveness of targeted interventions 
within the South Asian ethnic group. Should we be considering assessing the cost-
effectiveness of a hypothetical targeted intervention for this subgroup? 
6) Are there any other groups of people who you might want to aim interventions at in 
practice? 
7) How would socioeconomic status be usefully described? 
8) Which combinations of interventions should we consider which would be most 
important for potential implementation? 
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2. Results of cost-effectiveness model review for type 2 diabetes screening and prevention 
interventions 
The purpose of this literature review was to facilitate development of the model boundary and 
assumptions by considering: 
i) What structural assumptions have been made in previous economic evaluations and the 
strengths and weaknesses of these approaches? With particular focus on: 
a. Patient transition from high risk states to diabetes 
b. Patient progression to further complications 
ii) What data have been used to estimate progression to diabetes? 
iii) Which model parameters have the greatest impact on the cost-effectiveness outcomes? 
A brief summary is presented here, although more detailed information about the methods and 
findings can be found within Appendix 2 for the interested reader. Findings from this literature 
review are included within subsequent sections of this document where relevant. 
 
The literature review identified 42 articles describing 34 simulation models for interventions to 
prevent progression to Type 2 diabetes.  
 We identified a broad range of public health interventions 
o Seventeen studies reported a targeted lifestyle intervention 
o Seven studies reported targeted lifestyle interventions and pharmacological 
interventions 
o Eight studies reported pharmacological interventions 
o One study reported policy changes 
o Two studies reported policy changes and targeted lifestyle interventions 
o Six studies reported screening and lifestyle intervention programmes 
o One study reported surgery 
 The studies were grouped into five model structure categories  
o Population multistate life-tables (n=9) 
o Pre-diabetes based structure (n=16) 
o BMI only based structure (n=9) 
o Other and multiple risk factor structure (n=6) 
o Archimedes Model (n=1) 
 Multistate model studies report results from three models 
o The ACE-prevention model used 5 year follow-up Australian cohort data to estimate 
baseline risk of diabetes 
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o The RIVM chronic disease model used Dutch cohort data to estimate baseline risk of 
diabetes 
o A single study reported a model for Australian using survey data from Australia 
 Pre-diabetes intervention models used different methods to estimate baseline risk of 
diabetes 
o Ten studies used individual trials 
 Six studies used the Diabetes Prevention Programme 
 Three studies used the Finnish Diabetes Prevention Study 
 One study used an older lifestyle intervention trial 
 One study used a drug trial 
o One study used a meta-analysis of trials 
o Five studies used observational data 
 BMI interventions models used more observational cohort data to estimate baseline risk of 
diabetes 
o Two studies used data from trial 
o Seven studies used observational data 
 Obesity models tend to stratify risk by BMI 
o Two studies assume a single obese state 
o Ten studies assume risk is variable with BMI 
o Three studies also stratify risk by age 
 The overall conclusions of the review were that: 
o The model should simulate risk factors for diabetes and cardiovascular risk as 
continuous variables 
o The trajectory of blood glucose, and risk of CVD should be estimated as a function of 
multiple risks, (e.g. diet, physical activity, obesity) 
o Correlation between the multiple risk factors should be described in the simulation 
o The model should simulate the general population to allow multiple sub-groups to 
be identified 
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3. The type of model being developed 
The aim of a health economic model is to capture all of the differences between the costs and 
effects associated with two or more different interventions. For chronic diseases such as diabetes, 
this involves calculating costs and effects over the lifetime of individuals. Models are simplifications 
of reality. There is always a trade off between developing a model which more closely represents 
reality and the time taken to develop the model. Models also require assumptions to be made when 
bridging the gap between available evidence and the need to incorporate key facets of the problem. 
Model assumptions can be tested within sensitivity analyses which involves assessing the impact of 
alternative plausible assumptions upon the model results.  
 
The studies identified in the economic evaluation review suggested that a broad range of simulation 
methods have been used to describe progression to Type 2 Diabetes.  
o Six studies reported a decision tree model 
o Nineteen studies reported a Markov model 
o Nine studies reported a Multi-state life table 
o Nine studies reported a patient level simulation 
We plan to develop a patient-level simulation which means that individuals will be followed over 
their lifetime and it will be possible to model the heterogeneity between individuals. It will also 
allow timing of events to be modelled more flexibly. These are important given the impact of 
different risk factors upon disease progression and the competing risks of developing different 
diseases.  
 
The type of model being developed is based upon the algorithm shown in Appendix 3 for the 
interested reader. 
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4. Draft model boundary 
From the conceptual model of the problem developed within Stakeholder Workshop 1, decisions 
about whether to include or exclude factors within the model need to be made. We are limited by 
time and resources so cannot include everything within the model.  
 
The review of economic evaluation studies identified that most studies only included cardiovascular 
disease as a long term complication. 
o Nine models did not include long term complications of Type 2 Diabetes. 
o Twenty-five models assume a risk of cardiovascular disease. 
o Nine assume a risk of retinopathy. 
o Ten assume a risk of nephropathy. 
o Seven assume a risk of neuropathy. 
o Three assume a risk of osteoarthritis. 
o Six assume a risk of cancer. 
o None assumed a risk of mental illness, fatigue, pregnancy complications, or the risk 
for future generations.  
Overall, very little sensitivity analysis was undertaken within these existing studies around the 
impact of each of the diseases to assess whether they are likely to impact upon the model results 
substantially. The conceptual model from Stakeholder Workshop 1 is shown in Figure 1 below and 
Table 3 below suggests which factors might be included within the model and which might be 
excluded from the model. This potential model boundary based upon Table 3 is then shown within 
Figure 2. The algorithm used to help choose which factors to include and exclude are shown in 
Appendix 3 for the interested reader. 
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Figure 1: Conceptual model of diabetes prevention with potential types of intervention 
Obstruction 
sleep 
apnoea       
            Potential interventions 
             Affects usage of alternative intervention 
 
*Different tests (OGTT, FPG, HbA1c) identify different  
individuals & diagnostic criteria have changed 
 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
 
      +++  ++  
 
 
 
                                 Blood glucose levels (BGL)¤ 
 
                       +   Identified NDH*    +   Diagnosed diabetes*~ 
 
Normal     Time    Undetected NDH    Time   Undetected 
diabetes 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
**Risk factors may be worse in the future as lifestyles become more sedate 
CVD, retinopathy & hypoglycaemia may affect driving ability 
CVD, retinopathy & hypoglycaemia may affect driving ability NDH: Non-diabetic hyperglycemia 
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Table 3: Diabetes model boundary table 
Factor Include/ exclude Reason for inclusion/ exclusion 
Risk factors Include Key component of causal diagram 
Gestational diabetes/ 
pregnancy complications 
Exclude This is a small subgroup and is not considered to be a focus of this project. 
Osteoarthritis Include From a random sample of 3664 members of the Dutch population aged >25 years, Tukker reports that ‘for each 
unit increase in BMI respondents were 8% more likely to report OA or chronic pain’ and the Foresight report 
highlights the high prevalence of osteoarthritis within the UK population. In addition, the report by Gillett et al. 
suggests that the cost of osteoarthritis is comparable to the cost of diabetes. 
Risk factors of next generation Exclude Within the high risk group, only a minority of people will parent a young child due to the age of the people 
affected, thus there would be limited impact upon the next generation. Within the general population, Whitaker 
et al. suggest that parental obesity more than doubles the risk of adult obesity among their children. This could 
bear substantial future costs and effects; however because these costs and outcomes would occur so far in the 
future, by applying a discount rate to both costs and effects (a method recommended by NICE, where more 
weight is placed on current costs and effects than those in the future), there would be minimal impact upon the 
model results. Thus time would be better spent on other factors within the model. See Section 5a for a brief 
discussion of social network effects. 
Blood glucose levels/ Non-
diabetic hyperglycaemia/ 
Diabetes 
Include Key component of causal diagram. 
Hypoglycaemia & weight gain 
associated with 
pharmacological interventions 
Include (but not as 
a separate factor) 
The quality of life implications of hypoglycaemia and weight gain are likely to be captured within the quality of life 
of people with diabetes. There are likely to be minimal additional costs associated with hypoglycaemia and weight 
gain above those associated with treating the disease. 
Non-alcoholic fatty liver Include (but not as 
a separate factor) 
This is likely to be included within the costs and quality of life estimates associated with diabetes and obesity. 
Fatigue Include (but not as 
a separate factor) 
The quality of life implications of fatigue are likely to be captured within the quality of life of people with disease. 
There are likely to be minimal additional costs associated with fatigue above those associated with treating 
disease.  
Neuropathy Include Key outcome associated with diabetes. 
Erectile dysfunction Include (but not as 
a separate factor) 
This is likely to be included within the costs and quality of life impacts of neuropathy. 
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Factor Include/ exclude Reason for inclusion/ exclusion 
Nephropathy Include Key outcome associated with diabetes. 
Retinopathy Include Key outcome associated with diabetes 
Cancers (post-menopausal 
breast cancer, colorectal 
cancer) 
Include The report by the World Cancer Research Fund (WCRF) Panel on Food, Nutrition, Physical Activity and the 
Prevention of Cancer suggests that BMI has a significant impact upon the incidence and mortality of post-
menopausal breast cancer, colorectal cancer, oesophagus cancer, kidney cancer, endometrial cancer, gall bladder 
cancer and pancreatic cancer. It also suggests that physical activity is associated with colorectal cancer, 
postmenopausal breast cancer and endometrial cancer. In addition, a study by Joshu suggests a relationship 
between HbA1c levels and cancer incidence (particularly post-menopausal breast cancer and colorectal cancer). 
Prevalence of colorectal cancer and post-menopausal breast cancer within the UK population is high and they are 
associated with substantial impacts upon costs and quality of life. The EPIC trial also supports this. 
CVD including hypertension, 
coronary heart disease (leading 
to heart attacks & angina), 
congestive heart failure, 
peripheral artery disease (incl. 
leg claudication & gangrene) 
and cerebrovascular disease 
(incl. stroke & dementia) 
Include Has a substantial impact upon both costs and effects. 
Mental illness (incl. dementia) Partly include (but 
not as a separate 
factor) 
The relationship between mental illness and diabetes is complex and currently not completely understood. Part of 
the relationship is associated with the incidence of cerebrovascular disease and the impact of mental illness will 
be captured within these costs and outcomes. The remaining associations, such as the direct increase in mental 
illness as a result of being diagnosed and living with diabetes, are difficult to untangle and are expected to have a 
small impact upon the model outcomes relative to other model factors. 
Obstructive sleep apnoea Include (but not as 
a separate factor) 
The relationship between risk factors and CVD is expected to capture those events resulting from obstructive 
sleep apnoea. The quality of life associated with people who are overweight is likely to include poorer quality of 
life resulting from obstructive sleep apnoea. In the instances where sleep apnoea is treated, the cost is minimal. 
Infectious diseases Exclude Relative to other model factors, this is likely to have a smaller impact upon the model outcomes. 
Environmental outcomes 
(congestion, CO2, pollutants)  
Not currently clear This depends upon the choice of interventions within the model (see Section 1). 
390 
 
    Ultimate aim?? 
                      
 
                                                                                        
 
                         QALYs      Costs to NHS & PSS                                                              QALYs                                                                                                                
      & wider societal costs                                                     _ 
                            +                +                                                                                           
                                                                                               
 
Environmental outcomes                                                                                
(congestion, CO2,                                                              
  pollutants)                                                                                                                                                                                            
  +          
                                                                        
 
                                                           Lifestyle                 
                                                                              Interventions                  
                                                         
                                                                                  Neuropathy   
                                                                                         +   
                                                         Nephropathy 
                                                                                                                                         +          Retinopathy 
                               CVD                                                                                                                                   + 
                                        +                                                                                                                            +              
                                      +                                                                  _                                                                  
                  Cancers      +                                                                                                                                                                          
                  +                                                                                                
                               
          
   +     Lifestyle interventions for     
   Screening tests for                                                             high risk individuals 
                  high risk individuals                                                                                                                                                                    
                                                                          
              
                                                                               _       _                                 Osteoarthritis           
  Gestational diabetes/          +                                 +                                                         +                                                  
  Pregnancy complications                                                                                                      +         
                                                                                                                                                                                                                                                                                                                                                   
Risk factors (including age, sex, ethnicity, a measure of physical activity & diet, family history of diabetes, etc.)** 
NB. These differ for different diseases but some factors overlap eg.BMI. 
                                                            _                          
Population-level lifestyle interventions                                                                       
       
 
         
 
          
Figure 2: Potential model boundary 
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*Different tests (OGTT, FPG, HbA1c) identify different  
individuals & diagnostic criteria have changed 
 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
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Key questions for stakeholders: 
1) Are there any excluded factors which you strongly think should be included within the 
model? 
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5. Specification of key model assumptions/ simplifications 
There are four types of key model assumptions/ simplifications which we need to make: 
a) Extrapolation of study outcomes; 
b) How interventions will be implemented (including maintenance); 
c) The relationship between the factors included within Figure 2 above; 
d) The costs and utilities of the factors included within Figure 2 above. 
Decisions about these assumptions were facilitated by some key questions shown in Appendix 3 for 
the interested reader. 
 
a) Extrapolation of study outcomes  
Where long term evidence is available for the intervention (for example, the Finnish DDP) we can 
use that trend to extrapolate over the long term. We are currently assessing whether there is a 
differential impact upon outcomes between interventions from the studies we have identified with 
longer term follow up so that we can make assumptions about the long term effectiveness of 
interventions which are reported within studies with shorter term follow up. 
 
It is possible that social networks will impact upon the effectiveness of the interventions because (a) 
an intervention given to an individual may also impact upon the individual’s family and friends 
indirectly27 and (b) an intervention given to lots of individuals that know each other, may have a 
greater impact than if the individuals receiving the intervention do not know each other. If the study 
assessing the effectiveness of interventions is carried out within the same population as the 
population would be in practice, then the effect of the latter would be captured within the mean 
estimate and the effect of the former would be largely captured. However, when extrapolating 
beyond the study follow up, it may be that these impacts would lead to a step change in population 
behaviour. We do not currently have sufficient evidence or sufficient resources within this project to 
be able to model these social networks over time; however we are looking into the potential of a 
future research project around this. 
 
b)  How interventions will be implemented  
We plan to generally assume that the interventions within Table 2 will be implemented as described 
by the studies outlined within Table 2; however we may try to extrapolate to other subpopulations. 
 
 
 
393 
 
c) The relationship between the included factors 
Baseline population 
A population representing the characteristics of the overall population of England can be simulated 
using data from the Health Survey for England based upon the model by Gillett et al.28  The survey 
includes information from a representative sample of over 15,000 adults in England around blood 
pressure, height, weight, BMI, waist circumference, smoking, alcohol, fruit & veg, general health, 
CVD, diabetes and physical activity. The 2008 survey includes additional information about diet and 
exercise. Within the model by Gillett et al., missing values were imputed by randomly sampling 
characteristics based upon all those individuals of the same age and gender. In addition, the Social 
Economic Grouping collected within the Health Survey for England was used as a proxy for 
Townsend Score.28  We plan to follow this same approach. The prevalence of each of the diseases 
will be sourced from the Health Survey for England if included within this dataset; otherwise 
alternative sources such as the Office for National Statistics will be used to describe disease 
prevalence.  
 
The relationship between the risk factors and CVD outcomes 
We plan to use the QRisk2 score to estimate each individual’s first CVD outcome since this risk 
equation was developed within a UK population and includes diabetes as a risk factor.29  The QRisk2 
score estimates an individual’s 10-year risk of a CVD event based upon age, sex, ethnicity, Townsend 
score, smoking status, treated diabetes, family history of CVD, cholesterol, blood pressure, BMI, 
kidney disease, rheumatoid arthritis and atrial fibrillation. We prefer the QRisk2 score to the UKPDS 
risk equations because our focus within the model is those who are non-diabetic and the UKPDS risk 
equations were developed within a diabetic population. QRisk2 was developed within a population 
containing both diabetics and non-diabetics and contains a variable to denote this. However, it does 
not contain a variable denoting blood glucose levels. From the UKPDS dataset it has been shown that 
blood glucose levels affect CVD outcomes following diabetes diagnosis and we do not want to 
systematically bias against screening interventions over population prevention interventions. Rather 
than using the UKPDS equations following diabetes diagnosis which is likely to lead to 
inconsistencies, we plan to investigate the feasibility of using the UKPDS data to estimate 
a HbA1c covariate within the QRisk2 equation for the people with diabetes, adjusting for the mean 
diabetes HbA1c value within the QRisk2 dataset.  
 
 
 
Key questions for stakeholders: 
1) Do you think that this is reasonable? 
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The relationship between risk factors & microvascular complications 
A review of studies assessing the relationship of blood glucose levels and microvascular 
complications was undertaken for the WHO consultation around the use of HbA1c in the diagnosis of 
diabetes.30  This review suggests that there is a small risk of retinopathy prior to the current cut-off 
points for diabetes diagnosis. We have also identified evidence for retinopathy which suggests that 
other factors in addition to raised blood glucose levels affect the risk of the disease. The best 
evidence that we identified for this was a paper by Van Leiden et al. based upon the Hoorn study.31  
This describes the relative risk of retinopathy according to sex, age, diabetes status, HbA1c level and 
hypertension.  
 
We have not identified any similar evidence for nephropathy and neuropathy. For nephropathy, we 
could either (a) use the UKPDS risk equations to estimate the risk of nephropathy and make the 
assumption that nephropathy does not occur until diabetes is diagnosed,32 or (b) use the analysis by 
Selvin et al. (2011) which estimates hazard ratios of nephropathy according to blood glucose levels 
(and not other risk factors) within a combined diabetic and non-diabetic US population.33  
 
Neuropathy is not included within UKPDS, although amputation is.32  Thus, for neuropathy we could: 
(a) include only the risk of amputation following diabetes diagnosis from UKPDS32; (b) use a risk 
equation (including duration of diabetes, HbA1c, triclycerides, cholesterol, BMI, smoking, 
hypertension, albumin excretion rate) developed within a type I diabetes population from the 
European Diabetes (EURODIAB) Prospective Complications Study34; or (c) use a study by Bongaerts 
which assesses the association between blood glucose levels and polyneuropathy (and not other risk 
factors) in a German mixed diabetic and non-diabetic population.35   
 
 
 
 
 
The relationship between the risk factors and cancer 
A report by the World Cancer Research Fund (2007) ‘Food, nutrition, physical activity and the 
prevention of cancer: a global perspective’ has been identified which gives meta-analyses on each 
cancer in terms of a relative risk per 5kg/m^2 (I.e. BMI).36  The EPIC trial aims to look at this, but 
many of the papers are too specific for our purpose. We have identified two potential papers; 
Key questions for stakeholders: 
1) Which of the above do you think would be the most appropriate data sources for 
modelling the risk of retinopathy, nephropathy and neuropathy? 
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Pischon (2006) and Lahmann (2004) which provide relative risks of colorectal cancer and breast 
cancer given different measures of body size.37-39   
 
 
 
 
 
 
The relationship between the risk factors and osteoarthritis 
We have undertaken a literature search and identified a paper by Mork et al. which assesses the 
effect of BMI and physical exercise on risk of knee and hip osteoarthritis within a Norwegian 
population.40 
 
 
 
 
Environmental outcomes 
The inclusion of environmental outcomes will depend upon the interventions assessed within the 
model and the perspective of the analysis (see Section 6).  
 
The relationship between the risk factors and blood glucose levels, cholesterol and blood pressure  
The review of economic evaluations identified that most other models had assumed that there was a 
single risk factor for Type 2 diabetes (i.e. IGT or BMI).  
 Most pre-diabetes models assumed a single transition rate to diabetes 
o Nine studies assumed a single transition rate to diabetes 
o Seven studies assumed differential risk for NGT, IGT, IFG, and IFT and IGT 
o One study assumed that risk varies by HbA1c score 
 Models where risk was related to BMI tended to use observational cohort data to estimate 
baseline risk of diabetes 
o Two studies used data from trial 
o Seven studies used observational data 
 Models that estimated multiple risk factors for diabetes used multivariate risk scores 
o One study assumed the metabolic syndrome increases risk 
o One study used the QDScore to estimate risk 
Key questions for stakeholders: 
1) Do you know of any multivariate statistical analysis which has been done relating 
colorectal cancer and breast cancer to weight gain from a longitudinal UK dataset? 
Key questions for stakeholders: 
1) Do you know of any better evidence in this area? 
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o One study modified risk by positive risk factor score 
o Two studies used a risk score that includes FPG, BMI, Systolic blood pressure and 
HDL 
BMI, waist circumference, glucose regulation, physical activity, and diet are all risk factors associated 
with Type 2 diabetes. The risk factors are likely to be correlated, but may have independent and 
additive effects on the incidence of Type 2 diabetes. Therefore, there are benefits of using multiple 
risk factors to improve the accuracy of the incidence of Type 2 diabetes if the intervention affects 
multiple patient characteristics. Thus, we want to estimate multiple risk factors for diabetes and 
cardiovascular disease and describe the correlation between changes in risk factors over time.  
 
These relationships are planned to be estimated using the Whitehall II dataset. This is a longitudinal 
dataset which follows a cohort of working men and women from 1985 (10,308 participants) to 2009 
(6761 participants). It includes demographic information, behavioural factors, clinical measures 
(such as blood glucose levels, cholesterol and blood pressure) and some information about disease 
history. The main advantages of the Whitehall II dataset over other similar datasets are that it 
provides more follow up points and information on both FPG and HbA1c. This allows us to 
approximate, using statistical analyses, the relationship between diet and exercise and the clinical 
measures relating to diabetes and other related diseases over time. It is important to understand 
trajectories over time rather than at one point in time, because incidence of disease is dependent 
upon behaviours and other factors (such as age) over time rather than at one point in time. The 
following describes the analysis that is planned for the Whitehall II dataset. 
 
Diet and physical activity can be incorporated in terms of frequency of fruit and vegetable 
consumption and frequency of exercise per week respectively. Other measures of diet and physical 
activity may be considered depending upon the outcomes reported by the intervention studies. Soft 
drink consumption and fat intake have been reported as outcomes in intervention studies, and the 
impact of these outcomes on BMI or waist circumference may need to be estimated. These diet and 
exercise measures over time can be used to estimate abdominal fat over time since this has been 
shown to be the most appropriate measure of weight for estimating disease outcomes. BMI, waist 
circumference and waist to hip ratio can be used to approximate abdominal fat since abdominal fat 
is not measured within the Whitehall II study. Abdominal fat over time can then be used to predict 
blood glucose levels, blood pressure (total, systolic and diastolic) and cholesterol over time. Due to 
the data collected within the Whitehall II dataset, data for the OGTT will have to be used to estimate 
blood glucose levels. However, statistical analysis can be undertaken to relate FPG measures and 
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HbA1c measures to OGTT measures, incorporating some patient characteristics to allow for the fact 
that the different measures identify different people. Blood glucose levels, blood pressure and 
cholesterol over time can then be used to estimate the incidence of each of the relevant diseases (as 
described within the headings above). An assumption is that all trajectories are linear over time, 
apart from blood glucose levels which can be allowed to take alternative functions. Existing analysis 
of the Whitehall dataset suggests that the most appropriate function for blood glucose may be linear 
followed by a quadratic function as insulin resistance develops. Examples of these functions are 
shown below.  
      Linear function    Quadratic function 
       
 
 
 
 
 
After an individual has been diagnosed with CVD, treatment is likely to affect the risk factors and 
future risks of diabetes. To incorporate this, the use of statins can be included as a covariate. Other 
variables which may also affect the outcomes of interest including age, gender, ethnicity, family 
history of diabetes and CVD, smoker and Townsend score will be incorporated into the analysis. 
Whilst rheumatoid arthritis and atrial fibrillation are included within QRisk2, they have not been 
included as covariates within this analysis because existing evidence does not suggest that they have 
a direct impact upon blood glucose levels, cholesterol or blood pressure.  
 
This analysis will allow us to estimate the causal relationships between these factors, taking into 
account the correlation between variables. It can also allow us to investigate differences in the 
relationships between subgroups and to estimate random variation between individuals. Figure 3 
below illustrates the assumptions we are currently making about the pathways between risk factors, 
and the characteristics we are assuming affects them.  
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Figure 3: Assumptions about the pathways between risk factors 
 
 
We assume the following relationships between covariates: 
 Smoking, deprivation, gender and ethnicity directly affect diet. 
 Smoking, age and gender directly affect physical activity. 
 Diet, physical activity, age, deprivation and a family history of cardiovascular disease directly 
affect abdominal fat. 
 Abdominal fat, family history of diabetes, deprivation, statins, ethnicity, age and gender 
directly affect blood glucose. 
 Abdominal fat, statins, age, and gender directly affect HDL cholesterol. 
 Abdominal fat, statins, age, and gender directly affect Total cholesterol. 
 Abdominal fat, ethnicity, age, gender, family history of cardiovascular disease and smoking 
directly affect diastolic blood pressure. 
 Abdominal fat, ethnicity, age, gender, family history of cardiovascular disease and smoking 
directly affect systolic blood pressure. 
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Key questions for stakeholders: 
1) Do you have any concerns about using the Whitehall dataset for this analysis? 
2) Do you disagree with any of the links we have made, and can you identify important 
predictors that we have missed? 
3) Do you agree that abdominal fat is the best predictor of disease outcomes? 
4) Should there be a direct link between physical activity or diet and blood glucose, 
cholesterol and/or blood pressure? I.e. would an increase in physical activity without a 
loss in abdominal fat reduce blood glucose levels/ cholesterol/ blood pressure? If so, if 
effectiveness studies report only weight change impacts, we would have to make 
assumptions about the extent to which these were affected by diet and exercise. 
5) We have currently assumed that blood glucose, cholesterol and blood pressure are 
correlated through a common causal link with abdominal fat. Should blood pressure or 
cholesterol directly predict blood glucose? 
6) Is it reasonable to assume that the blood pressure of an individual increases over time? Do 
you know of any evidence for this? Can you draw the shape of the change over time? 
7) Is it reasonable to assume that the cholesterol of an individual increases over time? Do 
you know of any evidence for this? Can you draw the shape of the change over time? 
8) FPG and HbA1c tests may identify different individuals; do you know of any key 
characteristics of the individual that are more likely to lead to being identified with one 
test than the other?  
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6. Model perspectives & outcomes 
Following the discussion from Stakeholder Workshop 1, the suggested model perspectives and 
outcomes are listed in Table 4 below. The model perspective is what types of costs and outcomes 
should be included. 
 
Table 4: Proposed model perspectives and outcomes 
 NHS & Personal Social Services 
(PSS) perspective 
Employer perspective (given the 
number of workplace-based 
interventions) 
Societal perspective 
Th
e 
co
st
 o
f.
..
 
The intervention and its delivery 
to the NHS and PSS 
The intervention and its delivery 
to the employer 
All costs of the intervention and 
its delivery (including to the 
patient*) 
Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
 Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
and patients and carers 
(including travel costs) 
 Lost productivity Lost productivity 
  Lost leisure time 
O
u
tc
o
m
e
s 
Life years (LY) of the patient  Life years (LY) of the patient 
Quality-adjusted life years 
(QALYs) of the patient and carers 
 Quality-adjusted life years 
(QALYs) of the patient and carers 
Incremental cost per LY gained  Incremental cost per LY gained 
Incremental cost per QALY 
gained 
 Incremental cost per QALY 
gained 
  Environmental outcomes (if 
necessary) 
*Patients who are diagnosed with chronic diseases get free prescriptions. 
If transport interventions are included, we could also include transport-related outcomes including 
the value of deaths avoided using the statistical value of a life approach, as undertaken by Brennan 
et al. for their analysis developed for NICE for interventions to promote Walking and Cycling.41 
 
  
Key questions for stakeholders: 
1) Are there any outcomes/ cost savings which you think it would be useful for the model 
to report that are not included above? For example, would it be useful to estimate the 
budget impact of the interventions? 
2) Should we maximise net benefit or should we be weighting equity in some way? 
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7. The costs and utilities of the factors included within Figure 2  
We want to capture the life years, costs and quality of life associated with each of the diagnosed 
diseases within the model.  
What are utility scores? 
A health utility score is used to reflect the quality of life associated with each health state within the 
model. It is a value which typically lies between 0 and 1, where 0 reflects a health state equivalent to 
death and 1 denotes a health state equivalent to full health.42  Each health state within the model is 
assigned a utility score and these are weighted over the time frame of the model according to time 
in each state to produce total quality-adjusted life years (QALYs) associated with each intervention. 
 
We do not plan to build into the model the flexibility to assess the cost-effectiveness of 
interventions given to patients once they have a disease. This means that we do not need to develop 
a formal natural history model for each disease; we can estimate when the person will die according 
to the probability of death from that disease given the age of diagnosis, and then calculate the costs 
and utilities associated with the time they are alive. This can be done by applying a cost per year 
from onset of disease (which could be constant or change over time) and a utility associated with 
the disease for each year that the person is alive. Whilst the time of death can vary by person 
according to the probability of death, these costs and utilities will be averages rather than varying by 
person. We have already estimated some relevant costs and utilities within previous ScHARR models 
and these will be described where appropriate for you to consider whether they are still valid. As for 
the model by Gillett et al., utility values for the baseline population who do not have a chronic 
disease can be obtained from the EQ5D scores within the Health Survey for England dataset.28  The 
effect of weight on utility, estimated from the Health Survey for England dataset, is a decrement of 
0.005 per unit increase in BMI.28  Alternatively, there is also a paper by Maheswaran et al. which 
estimates EQ-5D utility values according to behavioural risk factors including BMI.43 
 
Costs and utilities associated with diabetes 
We plan to assume that the probability of dying does not increase due to a diagnosis of diabetes per 
se (it would be due to the increase in related diseases).  
 
The resource use of antihyperglycaemic medication and annual monitoring for diabetes as described 
by Gillett et al. are shown in Table 5 and Table 6 below.28  In order to estimate switching between 
therapies, the effectiveness of antihyperglycaemic medication will be based upon UKPDS33 as 
reported by Gillet et al.44  For patients treated with chlorproramide and glibenclamide, this study 
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shows an initial drop in HbA1c followed by a linear increase of around 0.2% until patients receive 
insulin. We plan to assume that this pattern is the same for all therapies. Once patients are on 
insulin, Gillet et al. assume that HbA1c remains between 8% and 9%. 
 
Table 5: Resource use associated with antihyperglycaemic medication  
Therapy Dose 
Metformin Three 500mg or 850mg per day 
Sulphonylurea 
(gliclazide) 
Average 210mg per day 45 
Sulphonylurea 
(gliclazide MR) 
Assumed equivalent of 210mg gliclazide (30mg of MR formulation is 
approximately equal to 80mg of non-MR formulation as per BNF46)  
Sulphonylurea Based on use of non-MR and MR formulations of gliclazide in ratio 8:1) 
Insulin The cost of glargine is considered to be a reasonable estimate of the average cost 
of insulins currently used for Type 2 diabetes in the UK. 60 units per day. Dose is 
variable according to year since initiation of insulin. 
 
Table 6: Annual resource requirements for monitoring patients with Type 2 diabetes 
Resource  Annual number of visits 
Nurse at GP (to check HbA1c & proteinuria, pulse check, feet, flu jab) 2 
GP clinic 2 
Dietitian 0.5 
HbA1c test 2 
Eye screening  1 
 
Uptake of annual monitoring following diabetes diagnosis can be based upon the National Diabetes 
Audit 2010-2011.47 
 
The utility associated with complication-free diabetes is assumed to be the same as a person within 
the general population (age-adjusted) with a decrement of 0.005 per unit increase in BMI as 
described above. 
 
  Key questions for stakeholders: 
1) What is current practice for providing pharmaceutical interventions for diabetes? 
2) Do the above assumptions seem reasonable? 
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The costs and utilities associated with CVD events 
Based upon Gillett et al., CVD events can be divided into coronary and stroke events using the 
dataset underpinning the QRisk2 score based upon gender. This can be further subdivided into 
stable angina, unstable angina, non-fatal myocardial infarction (MI), fatal MI, transcient ischaemic 
attack (TIA), non-fatal stroke or fatal stroke according to gender and age using a HTA assessment of 
statin therapy.48  This is shown in Table 7 below.  
 
Table 7: Probability of experiencing each CVD event  
 Age Stable 
angina 
Unstable 
angina 
MI rate Fatal 
CHD 
TIA Stroke Fatal 
CVD 
Men 45 28.7% 10.0% 27.6% 6.6% 7.4% 15.9% 3.7% 
55 36.4% 7.9% 19.1% 9.6% 7.0% 16.2% 3.8% 
65 27.6% 10.7% 22.3% 12.5% 6.2% 16.8% 3.9% 
75 28.1% 11.9% 23.7% 9.3% 4.3% 18.4% 4.3% 
85 28.4% 12.7% 24.6% 7.3% 1.0% 21.1% 4.9% 
Women 45 37.8% 13.6% 9.3% 4.3% 12.6% 18.1% 4.3% 
55 40.9% 8.6% 10.9% 4.6% 7.4% 22.4% 5.2% 
65 28.8% 7.4% 17.2% 11.5% 4.7% 24.5% 5.8% 
75 29.5% 6.7% 20.2% 8.5% 5.1% 24.2% 5.7% 
85 30.0% 6.4% 22.0% 6.6% 4.3% 24.9% 5.8% 
Range for each CVD 
event 
27.6%-
40.9% 
6.4%-
13.6% 
9.3%-
27.6% 
4.3%-
12.5% 
1.0%-
12.6% 
15.9%-
24.9% 
3.7%-
5.8% 
 
Secondary CVD events and the probability of death from these different types of CVD event by age 
can be based upon the HTA assessment of statin therapy.48  We plan to assume that following the 
first CVD event, any interventions employed to prevent diabetes do not reduce secondary CVD 
events since we have no evidence on this. 
 
The costs and utility impacts of CVD have been estimated in a previous HTA of Statins in 
cardiovascular disease.48   These parameters are shown in Table 8 below. The costs can be uplifted to 
2012 estimates. 
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Table 8: Costs and utilities for CVD events 
CVD event 1st year cost Subsequent cost Fatality cost Disutility 
Stable Angina £171 £171   0.808 
Unstable Angina £440 £171   0.77 
MI £4448 £171 £1166 0.76 
TIA £1064 £264   1 
Stroke £8046 £2163 £7041 0.629 
 
 
 
 
 
 
 
 
The costs and utilities associated with microvascular complications, cancer and osteoarthritis 
The review of existing economic evaluations suggested that those studies which included 
microvascular complications, colorectal cancer, breast cancer, and/ or osteoarthritis were generally 
non-transparent in terms of the costs and utilities that they employed. Thus, these will need to be 
established from other sources.  
 
Retinopathy and neuropathy are not expected to substantial impact upon survival. Survival 
associated with nephropathy can be estimated based upon UKPDS64.49  We propose using annual 
costs of treatment for microvascular disease based upon UKPDS65.50  Utilities are assumed to be the 
same as those used within the model by Gillett et al. which were based upon UKPDS62, Coffey et al 
and data supplied from the Mount Hood IV conference.51;52 
 
The survival of colorectal and breast cancer patients can be based upon data from the Office for 
National Statistics, which describes relative survival rates. Colorectal cancer costs and utilities can be 
based upon an economic model currently being developed within ScHARR for early awareness 
interventions for colorectal cancer. Breast cancer costs can be based upon the total programme 
budgeting estimates by the Department of Health for the years 2011-12 and the prevalence of 
breast cancer. Breast cancer utility estimates can be based upon an existing economic model for 
breast cancer screening recently developed within ScHARR. 
 
Osteoarthritis is not expected to substantial impact upon survival compared with the general 
population. We plan to assume that the costs of osteoarthritis are mostly due to replacement 
Key questions for stakeholders: 
1) Does the division of CVD events shown in Table 7 seem reasonable? Is the exclusion of 
peripheral arterial disease likely to be important? 
2) Has treatment for CVD altered substantially since the above costs were estimated in 
2007? If so, in what way? 
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surgery. We have estimated the cost of Hip and Knee surgery from NHS reference costs and 
identified UK studies of the lifetime risk of Hip and Knee replacement surgery. From this we have 
estimated the expected cost of Hip and Knee osteoarthritis assuming a single surgical procedure. The 
utility associated with osteoarthritis is reported in a HTA report for glucosamine in knee 
osteoarthritis. These are shown in Table 9. 
 
Table 9: Cost and utility assumptions for osteoarthritis 
Parameter Hip Knee Source 
Lifetime risk of Osteoarthritis 0.25 0.45 Culliford 2012 
Lifetime risk of surgery women 0.11 0.11 Culliford 2012 
Lifetime risk of surgery men 0.07 0.08 Culliford 2012 
Lifetime risk of surgery 0.09 0.09 Imputed 
Proportion of osteoarthritis with surgery 0.35 0.20 Imputed 
NHS weighted average cost of surgery 6420.63 4802.13 NHS reference costs 2011 
Total cost of osteoarthritis  3249.34  
Osteoarthritis utility  0.69 HTA: The clinical effectiveness of 
glucosamine and chondroitin 
supplements in slowing or arresting 
progression of osteoarthritis of the 
knee: a systematic review and 
economic evaluation (2009) 
 
 
Other costs and utilities 
Cost of the intervention 
This will be calculated based upon the description of the interventions within the effectiveness 
studies. Sources such as NHS Reference Costs and Unit Costs of Health and Social Care will be used 
for unit healthcare costs. 
 
Cost of productivity loss – if societal perspective taken 
We plan to assume that this is equivalent to the average salary in England and Wales. A friction cost 
approach is planned which assumes that there are a sufficient number of unemployed members 
of society making it possible to replace a sick worker after a certain period of time to allow for 
the advertising and recruitment period, the ‘friction period’.42  Costs would be included for 
advertising and recruiting new workers, and for the salary of the new worker following the 
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friction period. The cost of the employer’s national insurance contributions which must be paid 
on top of the employee’s salary would also been included. It would be assumed that the 
productivity and salary of the new employee would be the same as that of the person who they 
have replaced. 
 
Costs of lost leisure time- if societal perspective taken 
The cost of lost leisure time can be valued from zero to average overtime earnings. This could 
include the lost leisure time of carers and the lost leisure time of patients whilst undertaking the 
interventions (eg. physical activity). Utilities associated with carers can also be considered. 
 
Other quality of life considerations 
For patients experiencing more than one disease at a time, utilities can be multiplied, as 
recommended by the NICE Decision Support Unit.53  We also plan to undertake some analysis of the 
EQ-5D data collected within the Whitehall II study and compare this with the above utilities.  
 
Standard methodological assumptions 
General mortality will be modelled using standard life tables, adjusted for the diseases included 
within the model. 
Costs and utilities will be discounted at 1.5% as recommended by the NICE Public Health methods 
guide.54  A discount rate of 3.5% will also be tested within sensitivity analysis. 
 
  
 
 
 
 
  
Key questions for stakeholders: 
1) For microvascular complications, are treatments likely to have changed substantially 
since the UKPDS resource use was estimated? 
2) Do you know of any evidence around the average number of days spent with sickness 
absence from work per person with each disease? 
3) Do the above assumptions and data sources seem reasonable?  
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Appendix D6: Outcomes of Stakeholder Workshop 2 
Session 1: Interventions 
The discussion within the workshop suggested that given the current rate of change in this area it is 
important that the model is flexible and not fixed within a static environment because it is likely to 
become outdated very quickly. It also suggested that the choice of interventions should not be 
limited by the evidence available. The NHS Health Checks should be incorporated into the model, 
but should be considered for possible disinvestment. The group suggested that we construct a set of 
interventions based on a stratification of intervention intensity and population risk. The spectrum of 
intervention types discussed were taxation, community education, agricultural policy, food retailer 
interventions, physical activity for transport, workplace interventions and risk assessment. Given the 
constraints of the project we need to limit the interventions included within the final model and 
based upon the discussion within the workshop we have attempted to select a subset of 
interventions for inclusion in the model. Table 1 reports the intervention types we have selected for 
inclusion and exclusion.  
At the national level we opted to use a taxation policy. We have identified evidence for the 
effectiveness of the intervention and can use modelling studies to estimate the price elasticity of 
taxable products. A concern has been raised around considering taxation due to (i) the possibility of 
consumption of poor alternatives and (ii) implementation issues given the power of the food 
industry. We will attempt to address the former by using evidence which reports alternative 
consumption and including this within the model. For the latter, we will make sure that when 
assessing the impact of combinations of interventions, taxation is excluded within some of these 
analyses. We chose not to include agricultural policy at this point in the project. This is mainly due to 
the absence of evidence and the complexity of the systems relating policy to individual 
consumption. However, we are doing some work around the possibility of incorporation into the 
model in the future.  
At the community level we have included workplace interventions, local transport policy, retailer 
policy and community education programmes. 
At the individual level we plan to consider three targeted groups: (1) those identified as high-risk 
through a risk assessment and blood test strategy; (2) women with gestational diabetes; and (3) 
ethnic groups. Of the other targeted groups identified in the stakeholder meeting we have opted to 
exclude children (and other primordial prevention rather than primary prevention), due to the 
added complexity of modelling a life course, particularly as disease progression is currently based on 
the Whitehall cohort. We will note this as an area for further research within the model report. 
Jobseekers and attendees at food banks will not be included in the primary analysis since the 
workshop discussion suggested that, whilst these groups are important, the three groups above 
should be prioritised. However, the model will be sufficiently flexible to enable these to be explored 
in the future without requiring many changes to the model.  
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Table 1: Types of interventions considered for inclusion in the model 
Intervention Coverage Selected for Inclusion Selected for Exclusion 
General Population (Indiscriminate 
National Policy) 
Taxation Agricultural Policy 
Communities  Workplace   
Transport Policy  
Retailer policy  
Community education 
programme 
 
High-risk individuals* Non-diabetic hyperglycaemic 
(including exploring frequency of 
repeat tests) 
Children/ early years  
Gestational diabetes Jobseekers 
Ethnicity Food banks 
*These will be interventions that are feasible within the real world (translational) 
Within the intervention types listed in Table 1 there are a large number of interventions that could 
be implemented. We have described specific interventions in Table 2 for each of these intervention 
types. We have selected specific interventions from the studies that we listed in the discussion 
document, but have not limited our selection of interventions to those that were identified within 
the search for evidence.  
For our taxation policy we plan to focus on the taxation of soft drinks.1  An alternative study has 
assessed the effects of taxation and snacks, but the substitution effects of switching away from 
multiple products may be complex to estimate. For the workplace intervention, we propose focusing 
on environmental changes, rather than health checks or education programmes.2  This will ensure 
that a broad range of intervention types are considered, rather than implementing similar 
interventions in different sub-groups of the population. The transport policy intervention will reflect 
the sustainable travel towns programme, which included walking and cycling promotion, public 
transport promotion, cycle lanes, and car-sharing programmes.3  For the retailer policy, we plan to 
model opening a large supermarket in a deprived area to improve access to fruit and vegetables, 
rather than focusing on within store merchandising of healthy foods. We have identified studies 
from three community education programmes including promoting weight management in men 
from deprived areas, health promotion in ethnically diverse urban areas, and increasing fruit and 
vegetable consumption in deprived areas.4-6 
The high risk identification strategy targeting non-diabetic hyperglycaemia will be a translation 
programme which would be feasible in practice. We plan to consider use of a study by Costa et al. 
and the ‘New Life, New You’ intervention for modelling this as suggested by stakeholders.7-9  
Identification of individuals is likely to be based upon the NHS Health Checks; however this will be 
flexible within the model to allow for variations to this. We have not identified a specific 
intervention for gestational diabetes but we will conduct searches for this. The intervention may be 
aimed at women who have gestational diabetes who are pregnant or those that have previously 
been pregnant with gestational diabetes, depending upon the evidence identified. The Wein study 
and the MAGDA trail have been highlighted for consideration for this. We plan to base the 
intervention targeting ethnic groups on the PADOSA trial in South Asian groups. It is noted that other 
ethnic groups, such as African, have an elevated risk, but there is a lack of intervention evidence. 
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We have tried to describe within column 2 of Table 2 a manageable number of interventions to 
assess within the model, which cover the key interventions and subpopulations which were 
discussed and prioritised within the workshop.  
Table 2: Specific details of intervention programmes 
Intervention type Details of programmes to be 
assessed 
Other programmes discussed 
that we have excluded 
Taxation Soft drinks Soft drinks and snacks 
Taxing fat content 
Alcohol pricing 
Workplace  Environmental changes  Health checks, education 
programmes 
Transport Policy Sustainable towns Pedometer walking  
Retailer policy Access to fruit and veg Merchandising within store 
Community education programme Group sessions  
Non-diabetic hyperglycaemic Translational study Efficacy study which is not 
feasible in practice 
Gestational diabetes To be identified Gestational diabetes prevention 
Ethnicity PODOSA trial (South Asians) Other ethnic groups 
 
We will take into account the uncertainty around the outcomes within these studies that are self-
reported. We will also undertake further work around possible approaches for modelling the 
maintenance profile of the interventions. The model will aim to be sufficiently flexible to allow 
assessment of the majority of the excluded interventions without substantial adaptation 
requirements of the model within future work.  
Intervention combinations and interactions 
We plan within the model to assess combinations of the above interventions, which is likely to 
include an intervention from each risk level (population, community and individual). This means that 
some individuals will be exposed to more than one intervention particularly if a soft drinks taxation 
is employed. Within the workshop we discussed the potentially interactive effects of a person 
receiving more than one intervention and the lack of evidence for quantifying these impacts. 
Therefore, we plan to construct the model structure so that it is possible to include these synergistic 
effects. However, it may be that refining these model parameters will require future work. One 
study by Salopuro et al. for facilitating this has been suggested which will be considered. 
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Session 2: Model boundary 
This table has been updated to reflect the discussion within the workshop. 
Factor Include/ exclude Reason for inclusion/ exclusion 
Risk factors Include Key component of causal diagram 
Gestational diabetes Include As a subgroup of the population who will be given intervention 
Osteoarthritis Include From a random sample of 3664 members of the Dutch population aged >25 years, Tukker reports that ‘for each 
unit increase in BMI respondents were 8% more likely to report OA or chronic pain’ and the Foresight report 
highlights the high prevalence of osteoarthritis within the UK population. In addition, the report by Gillett et al. 
suggests that the cost of osteoarthritis is comparable to the cost of diabetes. 
Risk factors of next 
generation 
Exclude Within the high risk group, only a minority of people will parent a young child due to the age of the people 
affected, thus there would be limited impact upon the next generation. Within the general population, Whitaker 
et al. suggest that parental obesity more than doubles the risk of adult obesity among their children. This could 
bear substantial future costs and effects; however because these costs and outcomes would occur so far in the 
future, by applying a discount rate to both costs and effects (a method recommended by NICE, where more 
weight is placed on current costs and effects than those in the future), there would be minimal impact upon the 
model results. Thus time would be better spent on other factors within the model. See Section 5a for a brief 
discussion of social network effects. 
Blood glucose levels/ Non-
diabetic hyperglycaemia/ 
Diabetes 
Include Key component of causal diagram. 
Hypoglycaemia & weight gain 
associated with 
pharmacological 
interventions 
Include (but not as a 
separate factor) 
The quality of life implications of hypoglycaemia and weight gain are likely to be captured within the quality of life 
of people with diabetes. The costs of hypoglycaemia will be explicitly included within the cost of diabetes 
treatment. 
Non-alcoholic fatty liver Exclude as a seperate 
factor 
This is likely to be implicitly included within the costs and quality of life estimates associated with diabetes and 
obesity. 
Fatigue Exclude as a separate 
factor 
The quality of life implications of fatigue are likely to be captured within the quality of life of people with disease. 
Quality of life is planned to be based upon the EQ-5D which considers mobility, self care, usual activities, pain/ 
discomfort and anxiety/ depression. There are likely to be minimal additional costs associated with fatigue above 
those associated with treating disease.  
Nephropathy Include Key outcome associated with diabetes. 
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Factor Include/ exclude Reason for inclusion/ exclusion 
Retinopathy Include Key outcome associated with diabetes 
Neuropathy Include Key outcome associated with diabetes. 
Erectile dysfunction Include (but not as a 
separate factor) 
This is likely to be included within the costs and quality of life impacts of neuropathy. 
Cancers (post-menopausal 
breast cancer, colorectal 
cancer) 
Include The report by the World Cancer Research Fund (WCRF) Panel on Food, Nutrition, Physical Activity and the 
Prevention of Cancer suggests that BMI has a significant impact upon the incidence and mortality of post-
menopausal breast cancer, colorectal cancer, oesophagus cancer, kidney cancer, endometrial cancer, gall bladder 
cancer and pancreatic cancer. It also suggests that physical activity is associated with colorectal cancer, 
postmenopausal breast cancer and endometrial cancer. Prevalence of colorectal cancer and post-menopausal 
breast cancer within the UK population is high and they are associated with substantial impacts upon costs and 
quality of life. The EPIC trial also supports this. 
CVD  Include Has a substantial impact upon both costs and effects. This includes hypertension, coronary heart disease (leading 
to heart attacks & angina), congestive heart failure, peripheral artery disease (incl. leg claudication & gangrene) 
and cerebrovascular disease (incl. stroke & dementia). 
Mental illness (incl. 
dementia) 
Include The relationship between mental illness and diabetes is complex and currently not completely understood. 
However, stakeholders have suggested that this is an important factor to include and evidence suggests that 
approx. 18-28% of diabetics have depression (Egede 2005), which is substantially higher than within the general 
population. 
Obstructive sleep apnoea Exclude as a seperate 
factor 
The relationship between risk factors and CVD is expected to capture those events resulting from obstructive 
sleep apnoea. The quality of life associated with people who are overweight is likely to include poorer quality of 
life resulting from obstructive sleep apnoea. In the instances where sleep apnoea is treated, the cost is minimal. 
Infectious diseases Exclude Relative to other model factors, this is likely to have a smaller impact upon the model outcomes. 
Environmental outcomes 
(congestion, CO2, pollutants)  
Exclude The majority of the interventions considered would not substantially affect this outcome so we will focus upon 
the health-related outcomes. 
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Session 3: Predicting risk factors 
We plan to speak with Irene Stretton regarding the choice of retinopathy risk models, and Andre 
Boulton and Soloman Tesafaye regarding neuropathy. We propose waiting to receive details of the 
updated UKPDS risk models before doing this so that this can be considered within the potential 
options. 
From the stakeholder workshop an additional study from the United States was identified regarding 
the relationship between BMI and several cancers.10  We plan to continue to model breast cancer 
and colorectal cancer only, but we will consider including the evidence from this study. 
We proposed to relate osteoarthritis events to BMI and diabetes, due to the identification of a study 
which found an independent effect of diabetes in addition to BMI on the risk of osteoarthritis.11  The 
feedback from the stakeholder workshop was that the independent effect is plausible and will be 
included in the model.  
Stakeholders have suggested that there may be different relationships between the risk factors and 
the different types of CVD (eg. hypertension is more of a risk factor for stroke). Given current 
evidence it is unlikely that these differential effects will be fully taken into account within the model; 
however we will consider whether there is sufficient evidence to divide the different types of CVD by 
BMI, age and sex and we will highlight this issue within the report. 
Based upon stakeholder feedback, we have decided to include depression explicitly within the 
model. We propose: 
1) To use the HSE data to assign depression in the general population at baseline. The 2010 HSE 
asked respondents to report anxiety or depression. 
2) To assume that depression develops in a proportion of patients without a history of 
depression on diagnosis of diabetes and/or CVD. We will estimate the prevalence of 
depression from published studies such as Egede 2005 and adjust them downwards to 
account for overlap in CVD and diabetes patients. 
3) To estimate the additional healthcare costs of depression and utility decrement associated 
with depression and apply this to diabetics and non-diabetics in the model. 
What will not be accounted for: 
 We will not assume variation in the severity of depression; 
 Following a diagnosis of diabetes, onset of depression will not be associated with 
demographic factors such as age, gender or socioeconomic status; 
 Treatment effect will not be affected by depression, although uptake can be adjusted; 
 Mortality will not be affected by depression. 
What may be added in the future: 
 We will investigate whether it will be appropriate to assume poor blood glucose control in 
diabetic patients with depression.  
 We will investigate whether previous research has identified important risk factors for 
depression in diabetes and CVD.  
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Session 4: Risk factors analysis plan 
Whitehall Cohort 
The discussion within the workshop suggested that the rationale for adopting the Whitehall cohort is 
acceptable, but more could be done to investigate the limitations of the dataset. The dataset will not 
be representative of women, unemployed and those living in the north of England. It would be 
beneficial if the model could be validated in a similar external dataset. We should note that the 
Whitehall cohort used the OGTT test so will have identified more cases of OGTT defined diabetes 
than would be identified in practice using the HbA1c test. 
The revised diagram for the planned statistical analysis is presented below in Figure 1. The following 
changes have been made: 
 Ethnicity has been linked to Physical Activity 
 Deprivation has been linked to Physical Activity with an interaction term with gender to 
account for manual labour jobs. 
 Diet and physical activity have been directly linked to the other risk factors except physical 
activity with cholesterol. 
 Menopause has been linked to cholesterol 
 Deprivation has been linked to total cholesterol. 
Figure 1: Conceptual map for risk factor analysis plan 
 
Abdominal fat  
It is appropriate to include multiple measures for abdominal fat because there are limitations to all 
of the measures. Changes in waist circumference are often observed before changes in BMI, 
particularly if exercise increases the muscle mass. Waist-height ratio has also found to be a useful 
measure of obesity and the data are available in the dataset. 
There was a discussion about the face validity of using abdominal fat since this is never measured in 
practice, and it will be important in the final report to explain clearly the advantages of using 
abdominal fat as a latent variable.  
Abdominal fat 
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Physical Activity and Diet 
Different types of changes in diet will have different impacts on the risk factors. For example salt 
intake will affect blood pressure more than a Mediterranean diet. We also know from the Finnish 
DPS data that different components (fibre, fat, saturated fat) have independent associations with 
diabetes incidence (over and above overall weight loss). Alcohol intake may also affect the risk 
factors. We will consider whether it is feasible (in terms of the evidence and time available) to model 
diet in terms of these different components rather than as a single variable. 
It was highlighted that physical activity may also be associated with weight loss maintenance. We 
plan to review the literature around weight loss maintenance associated with the interventions. 
Other covariates 
Only statins were included in the model to describe the increased risk of diabetes. However, other 
treatment was identified in the discussions that are related to increased risk of diabetes. Beta-
blockers and thiazides, oral steroids (not eye-drop steroids) and anti-psychotic drugs could be 
extracted from the data where possible. Ace-inhibitors do not increase the risk of diabetes, so do not 
need to be included. However, it was also noted that including these treatments might be making 
the model overly complex, given that they will have a much smaller impact compared with other 
covariates. For example, obesity massively outweighs all other variables apart from age. Therefore, 
given the additional work required to incorporate this, we anticipate that we will not include other 
treatments as covariates for blood glucose. 
The group suggested that there may be interactions between changes in behavioural variables; for 
example diet and smoking may be linked. This is likely to be a minimal effect compared with some of 
the other considerations within the model and there is limited evidence around this so we will note 
this, but are unlikely to include the effect within the model. 
Longitudinal trajectories 
There is unlikely to be a gradient in Total Cholesterol and HDL cholesterol, however cholesterol may 
rise after menopause. This can be incorporated into the analysis. There is a paper titled ‘Life course 
trajectories of systolic blood pressure using longitudinal data from 8 UK cohorts’ by Wills et al. which 
could be used to understand the trajectory of blood pressure over time.12 
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Session 5: Perspectives, outcomes and equity 
The following is compiled from the original discussion document with amendments arising from 
workshop discussion. 
 Model perspectives:  
 Societal perspective 
 Public service perspective (NHS & Personal Social Services (PSS), education, leisure etc) 
 Interventions in the public health system will impact on, involve and be subject to different 
providers from the public, private and voluntary sectors. Outcomes (costs, benefits etc) 
should be identifiable by group. 
Outcomes:  
 Costs, including the costs where feasible of: 
o the intervention and its delivery to the public sector (NHS, PSS , other) 
o the intervention and its delivery to the private and voluntary sector agencies (eg 
including employers for workplace interventions,  
o diagnosis, treatment and follow up of the relevant diseases to the NHS and PSS,  
o diagnosis, treatment and follow up of the relevant diseases to the patients and 
carers,  
o lost productivity, 
o lost leisure time. 
 Life years (LY) of the patient and carers 
 Quality-adjusted life years (QALYs) of the patient and carers 
 Incremental cost per LY gained 
 Incremental cost per QALY gained 
In addition to or expanding on the above stakeholders identified the Public Health Outcomes 
Framework as being an important set of indicators for agencies in the public health system. Table 3 
presents the full indicator set and highlights those outcomes that may be relevant for the diabetes 
prevention model (light yellow indicates those outcomes which may be considered to be relevant to 
the scope of the model but that we are not currently planning to include). 
Where there is uncertainty around who pays for the intervention (NHS, workplace, individual), a 
sensitivity analysis can be undertaken to assess the impacts of alternative options. 
 
  
421 
 
VISION
To improve and protect the nation’s health and wellbeing, and improve the health of the poorest fastest.
Outcome measures
Outcome 1: Increased healthy life expectancy, ie taking account of the health quality as well as the length of life.
Outcome 2: Reduced differences in life expectancy and healthy life expectancy between communities (through greater 
improvements in more disadvantaged communities).
1. IMPROVING THE WIDER DETERMINANTS OF HEALTH
Objective
Improvements against wider factors that affect health and wellbeing and health inequalities Indicators
Indicators
• Children in poverty
• School readiness (Placeholder)
• Pupil absence
• First time entrants to the youth justice system
• 16-18 year olds not in education, employment or training
• People with mental illness or disability in settled accommodation
• People in prison who have a mental illness or significant mental illness (Placeholder)
• Employment for those with a long-term health condition including those with a learning difficulty/disability or mental 
illness
• Sickness absence rate
• Killed or seriously injured casualties on England’s roads
• Domestic abuse (Placeholder)
• Violent crime (including sexual violence) (Placeholder)
• Re-offending
• The percentage of the population affected by noise (Placeholder)
• Statutory homelessness
• Utilisation of green space for exercise/health reasons
• Fuel poverty
• Social connectedness (Placeholder)
• Older people’s perception of community safety (Placeholder)
2. HEALTH IMPROVEMENT
Objective
People are helped to live healthy lifestyles, make healthy choices and reduce health inequalities
Indicators
• Low birth weight of term babies
• Breastfeeding
• Smoking status at time of delivery
• Under 18 conceptions
• Child development at 2-2.5 years (Placeholder)
• Excess weight in 4-5 and 10-11 year olds
• Hospital admissions caused by unintentional and deliberate injuries in under 18s
• Emotional wellbeing of looked-after children (Placeholder)
• Smoking prevalence – 15 year olds (Placeholder)
• Hospital admissions as a result of self-harm
• Diet (Placeholder)
• Excess weight in adults
• Proportion of physically active and inactive adults
• Smoking prevalence – adult (over 18s)
• Successful completion of drug treatment
• People entering prison with substance dependence issues who are previously not known to community treatment
• Recorded diabetes
• Alcohol-related admissions to hospital
• Cancer diagnosed at stage 1 and 2 (Placeholder)
• Cancer screening coverage
• Access to non-cancer screening programmes
• Take up of the NHS Health Check Programme – by those eligible
• Self-reported wellbeing
• Falls and injuries in the over 65s
Table 3: Public Health Outcomes Framework 
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3. HEALTH PROTECTION
Objective
The population’s health is protected from major incidents and other threats, while reducing health inequalities
Indicators
• Air pollution
• Chlamydia diagnoses (15-24 year olds)
• Population vaccination coverage
• People presenting with HIV at a late stage of infection
• Treatment completion for tuberculosis
• Public sector organisations with board-approved sustainable development management plans
• Comprehensive, agreed inter-agency plans for responding to public health incidents (Placeholder) 
4. HEALTHCARE PUBLIC HEALTH AND PREVENTING PREMATURE MORTALITY
Objective
Reduced numbers of people living with preventable ill health and people dying prematurely, while reducing the
gap between communities
Indicators
• Infant mortality
• Tooth decay in children aged five
• Mortality from causes considered preventable
• Mortality from all cardiovascular diseases (including heart disease and stroke)
• Mortality from cancer
• Mortality from liver disease
• Mortality from respiratory diseases
• Mortality from communicable diseases (Placeholder)
• Excess under 75 mortality in adults with serious mental illness (Placeholder)
• Suicide
• Emergency readmissions within 30 days of discharge from hospital (Placeholder)
• Preventable sight loss
• Health-related quality of life for older people (Placeholder)
• Hip fractures in over 65s
• Excess winter deaths
• Dementia and its impacts (Placeholder)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equality considerations are at the heart of the Public Health Outcomes Framework, explicitly 
agencies are required to focus on:  
 socioeconomic group 
 area deprivation (or postcode)> 
 age 
 disability 
 ethnicity 
 gender 
 religion 
 sexual orientation. 
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Session 6: Resource use and Utilities 
We have translated our understanding of the workshop discussion around resource use for 
monitoring diabetes into Table 4. We are uncertain about whether we have reflected this discussion 
appropriately, so would greatly appreciate any corrections to this table. 
Table 4: Revised estimates of diabetes monitoring costs 
Resource Previous estimate Revised estimate 
Nurse at GP  2 3 
GP clinic 2 3 
Health care assistant 0 3 
Dietician 0.5 0.33 
HbA1c test  2 3 
Urine test 0 3 
Eye screening 1 1 
Screen for lipids, microalbuminuria, dipstick 
haematuria, liver function test, renal function (eGFR), 
creatinine. B12. 
0 3 
Smoking cessation 0 3 
 
We had initially intended to cost individual treatment strategies for patients with diabetes. However, 
it was suggested at the workshop that treatment practices are variable across the country and that 
the NICE guidelines were not representative of real world practice. In order to simplify the modelling 
it was recommended that we obtain data on the mean prescription costs per patient and apply 
these in the model without needing to make assumptions about the specific treatments 
administered. However, we have discussed the potential of doing this since the workshop and one of 
the benefits of high risk identification may be that diabetes is diagnosed at an earlier stage. This 
means that people may be diagnosed when they have a lower HbA1c such that they may be able to 
control their HbA1c level on metformin for a longer period prior to moving on to the more expensive 
drugs than in the absence of high risk identification. In order to capture this effect whilst keeping the 
treatment model as simple as possible, we propose dividing treatment into three groups; (i) 
metformin, (ii) other more expensive treatment, followed by (iii) insulin. With this approach, 
individuals would remain on metformin until they reached a level of HbA1c which would trigger 
other more expensive treatment options. Thus, if they are diagnosed with diabetes at a lower level 
of HbA1c due to high risk identification, it would take them longer to reach the trigger to switch to a 
more expensive treatment option.  
Within the workshop we proposed to assume that diabetes is associated with no additional 
mortality risk or utility decrement compared with the general population in individuals who have no 
associated complications. The workshop discussion suggested that this would be inappropriate and 
as a result we will modify these assumptions. We will explore recent literature on the excess 
mortality associated with Diabetes from the GPRD dataset.  
The workshop discussion also suggested that it is inappropriate to assume that diabetes patients 
who do not have any complications have the same utility as those people in the general population, 
even after adjusting for weight. The main reasons stated for this were the disutility associated with 
the label of diabetes and having the monitoring and treatment, and depression associated with the 
diabetes label. It is thus important to incorporate these quality of life decrements, preferably 
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explicitly but alternatively implicitly within a utility associated with diabetes (but avoiding double 
counting of disutilities associated with the explicitly included complications).  
It was suggested that treatment for CVD has changed since the 2007 statins report. The total 
cholesterol level for statins is now accepted to be 4 rather than 5.  
It was discussed that the costs and utilities of the relevant diseases may be estimated using the 
updated UKPDS when it is available. 
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Appendix E: Conceptual modelling framework 
Appendix E1: Conceptual modelling framework for focus group meeting 
 
1. Introduction 
This document describes a conceptual modelling framework for Public Health economic evaluation. 
A conceptual modelling framework is defined as: ‘A methodology that helps to guide modellers 
through the development of a model structure, from developing and describing an understanding of 
the decision problem to the abstraction and non-software specific description of the quantitative 
model, using a transparent approach which enables each stage to be shared and questioned.’  
 
Aim of the conceptual modelling framework 
In 2011, Chilcott et al. highlighted the lack of formal methods for model development within health 
economics.1  The aim of this framework is to provide a methodology, which can be moulded 
according to different situations by different users,2 to help modellers develop structures for Public 
Health economic models. It acts as a tool to help modellers make decisions about the model 
structure, but it does not provide automated solutions to these choices. It is intended to be used by 
any modellers undertaking Public Health economic evaluations; for inexperienced modellers it 
provides a transparent process to follow; for experienced modellers it provides Public Health-specific 
considerations such as the determinants of health and understanding and describing dynamically 
complex systems, as well as a standardised approach which will help decision makers/ clients to 
input into and use the model developed. 
 
It does not aim to provide a specific, prescriptive process. The processes followed will be dependent 
upon the decision making context, the resources available and the preferences and judgements of 
the project team. However, process suggestions are included in italics within boxes throughout. An 
example to illustrate the methods is employed using a case study assessing the cost-effectiveness of 
interventions to prevent diabetes.  
 
Benefits of the conceptual modelling framework 
Conceptual modelling is the first part of a modelling project, which guides and impacts upon all 
other stages. This means that if this is done poorly, all subsequent analysis, no matter how 
mathematically sophisticated, is unlikely to be useful for decision makers.3  Key potential benefits of 
this conceptual modelling framework and what pitfalls these aim to avoid, developed based upon a 
review of conceptual modelling frameworks, are shown within Table 1 below. 
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Table 1: Potential benefits of the conceptual modelling framework 
Potential benefit What pitfalls can be avoided 
To aid the development 
of modelling objectives 
 Answering the wrong (or less useful) question with the model. 
To provide tools for 
communication with 
stakeholders 
 Representing a contextually naïve and uninformed basis for decision-making, 
including misunderstandings about the problem, producing unhelpful model 
outcomes, and incorporating inappropriate and/ or biased model assumptions. 
 Ignoring important variations between stakeholders’ views. 
 Producing model results which are not trusted by stakeholders. 
To guide model 
development and 
experimentation 
 Inefficient model implementation (i.e. repeatedly making structural changes to 
the implemented model) 
 Inadequate analyses 
To improve model 
validation (developing 
the right model) 
 Answering the wrong (or less useful) question with the model. 
 Misunderstanding the key issues associated with the problem. 
 Using the first theories identified from the evidence to develop the model. 
 Not having a basis for justifying the model assumptions and simplifications.    
To improve model 
verification (developing 
the model correctly) 
 Not having an intended model with which to compare the implemented model. 
To allow model reuse  Other experts not being able to identify or correctly interpret key model 
assumptions and simplifications and why these have been made. 
 
Development of the framework 
The conceptual modelling framework was informed by two literature reviews, qualitative research 
with modellers and a pilot study. The literature reviews aimed to: (1) describe the key challenges in 
Public Health economic modelling and (2) review existing conceptual modelling frameworks within 
the broader literature. The qualitative research aimed to understand the experiences of modellers 
when developing Public Health economic model structures and their views about the barriers and 
benefits of using a conceptual modelling framework. This involved; (i) following the development of 
a Public Health economic model including observing key meetings and undertaking in-depth 
interviews with the modellers involved; (ii) systematically analysing my own notes from a previous 
Public Health economic project; and (iii) holding a focus group meeting with modellers. A draft 
version of the conceptual modelling framework was piloted within a project assessing the cost-
effectiveness of interventions for diabetes screening and prevention. 
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2. The conceptual modelling framework 
The conceptual modelling framework is made up of four key principles of good practice and a 
methodology consisting of four phases: (A) Aligning the framework with the decision making 
process; (B) Identifying relevant stakeholders; (C) Understanding the problem; and (D) Developing 
and justifying the model structure. Each of these will be described. 
2.1 Key principles of good practice 
The four key principles of good practice are that; (1) a systems approach to Public Health modelling 
is appropriate; (2) developing a thorough documented understanding of the problem is valuable 
prior to and alongside developing and justifying the model structure; (3) strong communication with 
stakeholders and members of the team throughout model development is essential; and (4) a 
systematic consideration of the determinants of health is central to identifying all key impacts of the 
interventions within Public Health economic modelling. 
 
1) A systems approach to Public Health modelling is appropriate 
Public Health economic modelling generally involves understanding dynamically complex systems.4  
This means that they are non-linear systems where the whole is not equal to the sum of the parts, 
they are history dependent, there is no clear boundary around the system being analysed, 
heterogeneity and self-organisation impact upon the outcomes, and people affected by Public 
Health interventions may learn over time and change their behaviour accordingly.5  
 
Within complex systems there may be positive feedback loops, whereby if Factor A increases 
[decreases], the number of Factor B increases [decreases], which leads to Factor A increasing 
[decreasing] further, which would lead to exponential growth [decay] if no other factors were 
present.5  For example, an increase in population obesity might lead to an increase in population 
mental illness which in turn leads to an increase in obesity, and so on. There may also be negative 
feedback loops, where an increase [decrease] in Factor A leads to an increase [decrease] in Factor B 
which in turn leads to a decrease [increase] in Factor A.5  For example, an increase in eating will lead 
to an increase in weight gain (all other things being equal) which may lead to a decrease in eating. 
The dynamics of complex systems arise from the interaction between positive and negative 
feedback loops, and this may occur over a long period of time, often producing counter-intuitive 
behaviour.5  The economy is an example of a complex system which displays such behaviour. Within 
these dynamically complex systems, factors are constantly changing over time, and a sudden change 
in behaviour may arise as a result of a number of smaller heterogeneous changes, such as a stock 
market crash. Making assumptions of simple cause and effect may lead to inappropriate results. See 
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the paper ‘Learning from Evidence in a Complex World’ by Sterman (2006) for a good discussion of 
dynamic complexity.5   
 
A systems approach, or systems thinking, is a holistic way of thinking about the interactions between 
parts within a system and with its environment.6  Within systems thinking there are multiple system 
levels, whereby the system of interest is subjectively defined and there is always a higher level 
system within which it belongs and a lower level system which describes detailed aspects. The 
challenge within health economic modelling is to determine which level will be that of the system of 
interest (the model), by having sufficient knowledge about the higher level system (the broader 
understanding of the problem), and subsequently to be able to define an appropriate level of detail 
for the system of interest. Within systems thinking, the importance of not considering one aspect of 
a system in isolation is emphasised to avoid ignoring unintended consequences. Soft systems 
thinking also recognises the impact of culture and politics upon a situation,2  which is interlocked 
with Public Health policy evaluation. Culture and politics affect the process by which decisions are 
made, what is modelled (eg. the identification of the problem, stakeholder involvement, the 
interventions assessed and the perspectives and outcomes of the analysis) and the effectiveness of 
the interventions (eg. service provision and the behaviour of individuals and society). Thus, a 
systems approach is suited to modelling these dynamically complex public health systems. Figure 1 
has been developed to depict key elements of a systems approach. 
 
Figure 1: Systems thinking 
 
 
  
The defined system – 
adapts according to the 
higher level system 
Higher level system – 
constantly changing. 
Culture and politics 
important. 
Lower level  
systems 
Relationships between 
parts within the system 
are important 
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2) The modeller should develop a thorough documented understanding of the problem prior to 
and alongside developing and justifying the model structure in order to develop a valid, 
credible and feasible model 
It is valuable to have an initial understanding of the problem and to document this understanding 
prior to making simplifications when developing the model structure because of both theoretical 
and practical reasons. Theoretically, it provides a basis for validation by facilitating the specification 
of an appropriate scope and structural assumptions, and for credibility by supporting stakeholder 
involvement and producing clear documentation when developing the model structure.7  We learn 
by building upon what we already know, and how we see the world or a problem is constrained by 
our previous ‘knowledge’.8  As such, if a model is data-led and/or based only upon the analyst’s 
interpretation of the data, it may lead to a narrow view of what should be included within the 
model. Documenting an understanding of the problem prior to analysing available datasets allows 
that understanding to be reflected upon and shared. This reduces the risk of ignoring something 
which may be important to the model outcomes, which is particularly important given the potential 
dynamic complexity of the system. In terms of systems thinking (see key principle of good practice 
1), documenting an understanding of the problem (the higher level system) allows the modeller to 
be able to define the boundary of the system of interest for modelling (see Figure 1). This 
description of the understanding of the problem should also help the modeller to understand the 
impact of potential simplifying assumptions they are making within the model. 
 
Practically, if the problem is not sufficiently understood an inappropriate model structure may be 
developed which, if recognised at a later stage of model development, may take a long time to alter 
within the computer software. This is particularly true if an alternative model type needs to be 
developed (for example, a DES rather than a Markov model). Thus taking the time at the beginning 
of the project to understand the problem could reduce overall time requirements. Documenting the 
understanding of the problem also enables communication with stakeholders and the project team 
(see key principle of good practice 3). An additional benefit is that the documentation of the 
understanding of the problem could be used (alongside any logic models developed) to help 
stakeholders understand all of the impacts of the interventions in order to inform the scoping 
and/or the interpretation of systematic reviews of intervention effectiveness. Finally, documenting 
the understanding of the project will enable researchers and policy makers who are not involved 
within the project to understand the problem and the basis for decisions about the model structure. 
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Thus, as also proposed by Kaltenthaler et al. (2011) within the context of clinical economic 
modelling,7  it is recommended that the model structure be developed in two phases. The first is to 
develop an understanding of the decision problem which is sufficiently formed to tackle the above 
theoretical and practical issues and should not be limited by what empirical evidence is available 
(see Section C). The second is to specify a model structure for the decision problem that is feasible 
within the constraints of the decision making process (see Section D).  
 
The understanding of the problem will inevitably continue to form during model development; 
however this initial documented understanding provides a basis for comparison and any major 
changes to this understanding can subsequently be documented.  
 
 
3) Strong communication with stakeholders and members of the team throughout model 
development is important for model transparency, validity and credibility 
Literature suggests that stakeholders can encourage learning about the problem (including 
geographical variation of healthcare provision and stakeholders’ values and preferences), help to 
develop appropriate model objectives and requirements, facilitate model verification and validation, 
help to develop credibility and confidence in the model and its results, guide model development 
and experimentation, encourage creativity in finding a solution and facilitate model re-use.7;9-14  
Additionally, stakeholders can help to define the meaning of subject-specific terminology which has 
a different lay meaning. Pidd has used the metaphor of taking a photograph of a scene, whereby 
each person involved might see different aspects of the scene and frame the photo differently.15  
The more frames provided by people with different interests (which may be affected by culture and 
politics), the better our understanding of the scene, and differences between perspectives can be 
discussed explicitly. Section B of the framework describes the types of stakeholders which may be 
involved. 
 
The modeller is encouraged to question the assumptions of the stakeholders16 and the project team 
throughout the model development process in order to uncover inconsistent, biased and invalid 
assumptions. Within topics where the project team have existing ‘knowledge’, it is important for 
them to be aware of the tendency to anchor to initial beliefs and be open to accepting new theories 
in order to develop valid models.2;17  Effective ways of communicating information such as using 
clear diagrams should be used in order to share information and describe assumptions.  
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4) A systematic consideration of the determinants of health is central to identifying all key 
impacts of the interventions within Public Health economic modelling 
The determinants of health which include the social, economic and physical environment, as well as 
the person’s individual characteristics, are central in the consideration of Public Health 
interventions. The determinants of health as described by Dahlgren and Whitehead are shown 
within Figure 2.18  Individual behaviours (or lifestyle factors) impact upon the broader determinants 
of health, which in turn impact upon individual behaviours.19  Thus, it is important to consider these 
broader determinants of health in order to be able to predict the full impact of the interventions 
upon health outcomes. In addition, the determinants of health could be used to think through all of 
the non-health costs and outcomes associated with the interventions that it might be useful to 
report, such as those within transport or employment. Consideration of the broader determinants of 
health also facilitates identification of potential intervention types to assess within the model 
including those which might impact upon individual health through making community and 
population-level changes, such as food production, as well as those which might impact upon health 
through changing individual lifestyle factors. Similarly, subpopulations that might benefit from the 
intervention could be identified. Finally, the consideration of social network effects could affect the 
analytical model type chosen, and subsequently the predicted impact of the interventions.  
 
Figure 2: Determinants of health 
 
 
 
 
 
 
 
 
 
 
 
It would not be appropriate or feasible to include all of the determinants of health within the model; 
however, they should be systematically reflected upon during the understanding of the problem 
phase to consider which determinants it might be important to include within the model so that all 
important mechanisms and outcomes of the interventions can be captured. 
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2.2 Overview of the phases within the conceptual modelling framework 
Figure 3 describes an outline of the phases within the conceptual modelling framework, which 
includes (A) Aligning the framework with the decision making process; (B) Identifying relevant 
stakeholders; (C) Understanding the problem; and (D) Developing and justifying the model structure.  
 
Figure 3: Overview of conceptual modelling framework for Public Health economic modelling 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
B) Identifying relevant 
stakeholders 
A) Aligning the framework with 
the decision making process 
C) Understanding the problem 
i) Developing a conceptual model of the problem describing hypothesised causal 
relationships and modelling objectives 
 
 
ii) Describing current resource pathways 
D) Developing and justifying the model structure 
i) Reviewing existing economic evaluations 
 
 
ii) Choosing specific model interventions 
 
 
iii) Determining the model boundary 
 
 
iv) Determining the level of detail 
 
 
v) Choosing the model type 
 
 
vi) Developing a qualitative description of the quantitative model 
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An iterative approach 
Choosing stakeholders and aligning the framework with the decision making process will generally 
need to be undertaken in parallel because the choice of stakeholders and their ideal level of 
involvement will depend upon the decision making process, but the availability of the stakeholders 
may have a substantial impact upon the process which is followed. It may be necessary to iterate 
between choosing relevant stakeholders and developing the understanding of the problem since the 
understanding of the problem phase may highlight the need to include stakeholders with specific 
expertise. Similarly, whilst it is important to develop an understanding of the problem prior to 
developing and justifying the model structure (see principle of good practice 2), in practice the 
understanding of the problem is never complete and it may be necessary to transparently revise this 
understanding at a later stage. These iterations are described by double headed arrows within Figure 
3. The steps within the developing and justifying the model structure phase are also iterative as 
shown within Figure 3. Evidence identification is not described as a separate stage within Figure 3 
(apart from reviewing existing models) since it is an activity required within the majority of the 
outlined stages. However, iterations are inevitable between appropriate conceptualisation and data 
collection because there is unlikely to be the exact evidence available that has been specified by the 
conceptual model. 
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2.3 Detailed methods of the framework       
A) Aligning the framework with the decision making process  
The conceptual modelling framework is intended to be flexible for different decision making arenas 
which means that decisions about how to employ the framework within the process are required. 
For example, the project team may need to operate differently according to the nature of the 
engagement with decision makers and clients within the project. If the client is the decision maker, 
then the scope of the model in terms of the interventions, comparators, populations, outcomes and 
perspectives may be better defined at the start of the project than if the client is not the decision 
maker (eg. a research funding body). This may influence the approach to evidence searching (in 
particular the search for intervention effectiveness evidence) and the time and resources required 
for model scoping. If the client is not the decision maker, the project team will need to identify the 
relevant decision makers and include them within the stakeholder group (see phase B of the 
framework). 
 
A protocol document outlining the project plan can be produced using the framework, as a basis for 
discussion between the project team and stakeholders. This helps the clients to understand whether 
the project is planned to run appropriately and the project team with project planning. Key process 
decisions to be made during this phase relate to the relevant modes of stakeholder engagement, the 
approach to evidence searching, and the time and resources available for the modelling project and 
each step of the framework. 
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B) Identifying relevant stakeholders 
There are a number of different types of stakeholder within any Public Health project including 
clinical experts, decision makers and lay members, all of which provide different expertise. The 
choice of stakeholders involved with the development of the model will inevitably affect the model 
developed and the interventions assessed because modelling is subjective. For instance, 
stakeholders help define the model scope, make value judgements, use their expertise to 
recommend structural assumptions such as extrapolating short term trial data over the long term, 
and choose which interventions to assess within the model. These will be affected by what is 
considered to be culturally and politically acceptable, which is entirely appropriate in order for the 
model to be useful, but provides an additional reason to obtain input from a range of stakeholders. 
Within some projects, the experts who inform the model development are chosen by the modelling 
team, whilst within others a group of experts are chosen by a decision making body, such as within 
the NICE process (see Section A). There is, however, usually the opportunity to involve additional 
experts chosen by the project team. A group of experts who will provide different expertise over a 
range of perspectives can be identified (see below). Practically, the approach to stakeholder 
communication needs to be flexible and some stakeholders will provide more input than others. 
 
Based upon Soft Systems Methodology (SSM)2 and a conceptual modelling paper by Roberts et al.9, 
the types of stakeholders to involve are: 
1) Customers which might include patient representatives and lay members; 
2) Actors which might include methods experts, clinical and epidemiologic experts; 
3) System owners which might include policy experts.  
 
DIABETES PROJECT EXAMPLE 
Within the diabetes project, stakeholders that might be involved could be a diabetic patient and a 
non-diabetic lay member (the customers), a general practitioner, experts in diabetes, cardiovascular 
disease, microvascular disease, cancer and osteoarthritis and an expert in statistical analysis of 
longitudinal data (the actors), and local and national commissioners (the system owners). The 
relationships between the customers, actors and system owners can be considered in order to 
identify relevant stakeholders. For example, if a general practitioner (actor) has been identified as a 
stakeholder, this could help identify the non-diabetic lay member (customer). The person with the 
power to stop the actor giving the customer a service is the local commissioners (system owners). 
Stakeholders should be involved during both the understanding of the problem phase and the 
development and justification of the model structure phase. 
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Process suggestions which may be helpful to modellers 
Resource requirements for stakeholder recruitment: It may require substantial time and effort to engage 
stakeholders. It may be necessary to approach more stakeholders than required as some will not have the time 
to be involved. Stakeholder workshops are useful if there are sufficient resources within the project budget 
because they allow stakeholders to debate and question the assumptions and beliefs of each other. Substantial 
administrative time is likely to be required to organise stakeholder workshops due to the probable busy 
schedules of the stakeholders. For this reason, it is also likely that any workshops will need to be organised at 
least two months before they are due to take place.  
 
Stakeholder worldviews and motivations: Checkland suggests defining the worldviews of each stakeholder in 
order to understand conflicts between them.
2
  An understanding of the possible worldviews and motivations of 
each of the potential stakeholders allows the project team to compare these with the project aims. Potential 
stakeholders may be more willing to be involved if the initial request is phrased in a way which aligns the aims 
of the project with the expected motivations of the stakeholders. For example, some stakeholders may be more 
interested in the outcomes of the project than the methods being employed so the initial information provided 
could describe the potential outcomes of the project. Another potential approach is for a more senior colleague 
involved in the project who is renowned in their field to contact the experts, potentially raising the prestige of 
the project and increasing the perceived benefits to the expert of being involved.   
 
Stakeholder expectations: Stakeholders who are unfamiliar with modelling may not expect to be involved in 
shaping the modelling work. At the start of the project it is valuable to be clear with all of the stakeholders 
about the expectations of their involvement throughout the model development process and the importance of 
their input. Assumptions being made by the decision makers and other stakeholders throughout model 
development should be questioned.
16  
 
Lay members: Lay members are involved to ensure that views and experiences of the wider public inform the 
group’s work. Where possible, lay members should represent different types of people within society where  
those differences are likely to be important to the topic area (eg. lower socioeconomic status). If this is not 
possible, the project team should be aware that the perspectives provided by the lay members do not 
necessarily represent those of all patients in that disease area/ the general population. In particular, they may 
not represent the more vulnerable groups within society who are unlikely to volunteer for such a role.
20
  If these 
relevant groups are not represented, then the views and experiences of the wider public may not be heard by 
the stakeholders and project team. This could lead to unrealistic assumptions about a particular subgroup of 
the population who behave differently to those represented within the stakeholder group. Modellers should 
consider whether the assumed chains of behavioural causation are likely to be different within particular 
subpopulations. 
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C) Understanding the problem 
One of the four principles of this framework is that developing and documenting an understanding 
of the problem is at the core of developing an appropriate model structure. This is about 
understanding what is relevant to the problem, and should not be limited by what empirical 
evidence is available.7  The understanding of the problem phase within Figure 3 includes (i) 
developing a conceptual model of the problem describing hypothesised causal relationships and (ii) 
describing current resource pathways.  
 
i) Developing a conceptual model of the problem describing hypothesised causal relationships 
This section outlines a methodology for developing a conceptual model of the problem by using the 
notation of causal diagrams, borrowing some of the methods from cognitive mapping,21 and 
ensuring that the worldview of each of the stakeholders is considered.2;21  This provides a systematic 
approach for developing an understanding of the problem at an appropriate and manageable level 
of relevance.  
u 
A causal diagram depicts the relationships between factors by arrows, using a + or – sign to indicate 
a positive or negative causal relationship. Causal diagrams allow feedback loops to be described 
which depict the dynamic complexity of the system. Each factor is a quantity such that one factor 
leads to an increase or decrease in another factor. For example,  
 
mean an increase in CVD events leads to an increase in costs and a decrease in quality of life 
respectively. The hypothesised causal relationships associated with the problem can be depicted 
using this notation, bringing together the understanding of relevant diseases, human behaviour and 
societal influences. Drawing upon cognitive mapping, the ultimate aims can be stated at the top of 
the diagram (by asking ‘why is x a problem?’), with intermediate outcomes below and options for 
change underneath (by asking ‘how can the problem be avoided?’).21  Detailed steps to develop the 
diagram are described overleaf. 
 
Evidence for developing the conceptual model of the problem 
Causal assumptions for policy prediction will be based upon experience and judgement since 
observational data can only be used to assess the statistical association between the specified causal 
relationships.22  The proposed diagram can provide an explicit description of our hypotheses about 
causal relationships and the challenge is to be able to justify the causal assumptions made. The 
+ CVD event Cost       and         CVD event                
_ 
Quality of life 
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causal hypotheses can be developed based upon a range of sources including the project scope, 
literature, stakeholder input, the team’s previous work in the area and any other diagrams which 
have been developed by the rest of the current project team or the decision makers to depict their 
understanding of the problem, as described within Figure 4 below. By developing the diagram with 
input from stakeholders, it allows their assumptions and beliefs to be made explicit so that they can 
be agreed upon or questioned. The iterative process using all of the evidence sources outlined 
within Figure 4 provides multiple opportunities to question and adapt the causal assumptions. 
Ultimately, the diagram will depict the modeller’s assumptions and beliefs about the causal 
relationships based upon all of these sources of evidence. In doing so, some forms of information 
may dominate over others according to the modeller’s views of the validity of the information. 
 
Figure 4: Sources used for developing the conceptual model of the problem 
 
 
Step 1: What is the problem? 
The first step, based upon cognitive mapping,21 is to ask ‘what is the problem?’ This is the key 
problem from the decision makers’ perspective and could be based upon the project scope if 
available. The cause of the problem described should include a potentially modifiable component.  
The model objective is likely to be (although not necessarily) to assess the effectiveness and cost-
effectiveness of interventions which might decrease this problem. Beginning the development of the 
diagram by identifying the key problem encourages a focused boundary around the understanding 
of the problem. 
 
Starting with high 
yield sources 
Individual stakeholder 
assumptions & beliefs 
Stakeholder    
discussion 
Modeller assumptions 
& beliefs 
Project scope 
Literature 
sources 
Existing diagrams/ 
previous work       
Conceptual model of the problem 
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What is the problem?          
                                                   Blood glucose levels/ diabetes 
                                                                   + 
                                                                                                        
Risk factors (including age, sex, a measure of physical activity and diet, family history of diabetes, 
ethnicity, etc.) 
 
 DIABETES PROJECT EXAMPLE 
 
Step 2: Why is this a problem? 
The modeller can then ask ‘why is this a problem?’, and continue to ask ‘why?’ or ‘what are the 
implications of this?’ until no more factors are identified, again based upon the methods of cognitive 
mapping.21  Within Public Health economic modelling the goal may be to maximise net benefit by 
maximising health and minimising costs or equity may be considered of primary importance. 
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Why is this a problem? 
Maximise health within a budget constraint 
     
                                                                          
 
                         QALYs QALYs                Costs to NHS & PSS, the individual                                                                                                                         
  _                                               & costs of productivity loss 
                                                                                                                                      +                            
                                                                                                                                                                            
 
 
    
                                               Neuropathy                                                     
       Cancers                                                               +   
            CVD           Nephropathy 
                                             +                                    +                                              +          Retinopathy 
                                                                                                                                               +         
                                                                                                                                                               
What is the problem?                                                                                                                                                            
 
                                                                                         
                                   +       
 
Risk factors (including age, sex, ethnicity, BMI, family history of diabetes, etc.)                                
NB. These differ for different diseases but some factors overlap eg.BMI. 
 
     Blood glucose levels (BGL)¤ 
DIABETES PROJECT EXAMPLE 
 
 
  
                New links within the diagram 
 *Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
Normal       Time        IGR*      Time        Diabetes* 
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Step 3: Developing additional causal links 
A set of questions have been constructed which may be useful to help develop the diagram further, 
as shown in Box 1. The development of the understanding of the problem is iterative, and hence it 
may be useful to continually revisit these questions. 
 
Incorporating disease natural history 
Any relevant disease natural histories will not be causal in that having a ‘normal’ health state does 
not cause a disease to develop. For example, moving from having normal blood glucose levels to 
having diabetes is not causally related. However, the interventions being assessed within Public 
Health tend to be those which reduce morbidity and mortality by aiming to change behaviour. Thus 
where there is a disease natural history, it is likely to be affected by behaviour and as such the causal 
chain can show the relationship between the behaviour and the disease. For example, a decrease in 
physical activity might lead to an increase in blood glucose levels. Following the onset of disease, the 
disease natural history can be described by probabilistic causation. For instance, somebody with 
impaired glucose regulation has an increased probability of developing diabetes.  
 
Defining factors for inclusion  
The arrows between the factors within the diagram would ideally be definable by one relationship. 
For example, if the relationship between risk factors and stroke and risk factors and heart disease is 
known to be different, then it is preferable for these factors to be separated out within the diagram 
rather than being combined within the factor CVD. If this is not possible in order for the diagram to 
remain clear, then a note could be added to describe the different subsets within that factor.  
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Box 1: Questions about the decision problem to help with developing the diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A1. Questions relating to the disease and the determinants of health include: 
- Have any relevant disease natural histories been captured? 
Example: Disease natural history associated with diabetes 
- Are the following determinants of health (taken from Dahlgren and Whitehead) important in 
determining effects and in what way:   
o Age, sex and other inherent characteristics of the population of interest? 
o Individual lifestyle factors? (incl. diet, physical activity, smoking, alcohol/ drug misuse) 
o Social and community networks? (incl. friends, family including intergenerational 
impacts, wider social circles) 
o Living and working conditions and access to essential goods and services? (incl. 
unemployment, work environment, agriculture & food production, education, water & 
sanitation, health care services, housing) 
o General socioeconomic, cultural and environmental conditions? (incl. economic activity, 
government policies, climate, built environment including transportation, crime)  
Example: Relationship between age, ethnicity, BMI, smoking and blood glucose levels  
 
A2. Questions to help ensure the understanding of the problem is sufficiently broad include: 
- Are there any other (positive or negative) consequences of each concept? 
Example: Increases in BMI may also lead to increases in osteoarthritis incidence. 
 
A3. Questions to ensure that the dynamic complexity of the system has been captured are: 
- Could there be any other factors which explain two outcomes, for links which may not be 
causal, but correlated.  
Example: BMI may help explain both CVD incidence and increased blood glucose levels rather 
than CVD causing increased blood glucose levels directly. 
- Are there any other possible causal links between the factors? (with the aim of establishing 
whether there are any feedback loops) 
Example: increased BMI leads to increased diabetes incidence which leads to an increase in 
mental illness which may lead to increased BMI. 
- Are there interactions between people which affect outcomes? (see social networks above)  
Example: People interacting with friends and family with higher BMI are more likely to have 
a higher BMI. 
- Is timing/ ordering of events important? 
Example: Timing and type of CVD events may affect other disease outcomes. 
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Maximise health within a budget constraint 
                                                                                        
 
 
                         QALYs QALYs                Costs to NHS & PSS, the individual                                                                                                                         
                                                 & costs of productivity loss 
                             _                                                                                              
                                                                              + 
 
 
                                                                  
                                                                                                                                                                                             
          
                                                                                       
      Mental illness                         
                   +         + 
 
    
                                          Neuropathy   
                                                    +   
               Nephropathy 
                                        +        
            CVD                                                                                                                                      Retinopathy 
                          +                                                                                                                      +              
                       +                                                                                                                                    
 Cancers      +                                                                                                                                                                            
            +                                                                            
                                   
                                                                        +             
 
                                                                                                                             +                  
                 Risk factors of next generation 
                                                                                                                   + 
                                            Osteoarthritis 
                                                              +                            + 
 
 
Risk factors (including age, sex, ethnicity, BMI, family history of diabetes, etc.)                               
NB. These differ for different diseases but some factors overlap eg.BMI. 
 
 
 
 
 
                                                                                                    
 
 
 
                            
     Blood glucose levels (BGL)¤ 
DIABETES PROJECT EXAMPLE 
 
                New links within the diagram 
 *Different tests (OGTT, FPG, HbA1c) identify different individuals & diagnostic criteria have changed 
 
Normal       Time        IGR*      Time        Diabetes* 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
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Step 4: Incorporating types of intervention 
Within dynamically complex systems like Public Health systems, the possible types of interventions 
may not be easily definable at the start of the project prior to developing a sufficient understanding 
of the problem. Thus, the modeller can ask how to avoid or reduce the impact of the described 
problem. It is useful to firstly know what is considered to be current practice. Potential types of 
interventions can then be added based upon the project scope, any effectiveness studies identified, 
and by considering within the diagram where interventions may be beneficial. One way of doing this 
is to consider which of the potentially modifiable determinants of health (individual lifestyle factors; 
living and working conditions and access to essential goods; and general socioeconomic, cultural and 
environmental conditions) affect the decision problem. Combinations of individual, community and 
population interventions may be considered.23  It is not expected that the final interventions being 
assessed within the model will have been chosen at this stage. However, it is important to define the 
types of interventions which might be assessed within the model so that their impact upon model 
factors, including those not already incorporated into the diagram, may be considered.  
 
A set of questions have been constructed which may be useful for considering the impacts of the 
interventions, shown in Box 2. These should be considered in the context of each type of 
intervention potentially being assessed within the model.  
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Box 2: Questions about the interventions and their impacts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B1. Questions relating to the constraints of the decision making process are: 
- Are there constraints on the project scope? (eg. are we constrained by the types of 
interventions we are assessing? What about the population?)  
 
B2. Questions relating to the goals and mechanisms associated with the interventions are: 
- What is considered to be a good outcome? 
Example: Would it be a good outcome if the intervention led to people understanding the 
benefits of healthy behaviours but chose not to adopt them? 
- What would happen in the absence of the interventions versus as a result of the 
interventions – would negative outcomes be prevented or delayed? 
- Example: Would there be fewer diabetes and related-disease outcomes in total or would 
they simply be delayed by x years? What might x be? 
- What evidence exists to describe the outcomes of the intervention/ comparator over time? 
Are behavioural outcomes important? If so, do any relevant models of behaviour from 
psychology, sociology or behavioural economics exist to help describe the behaviour 
resulting from the intervention or the comparator? This will require additional targeted 
literature searches. 
- Are there any determinants of health reported by the effectiveness studies which are not 
included within the causal diagram? Can such a relationship be described? 
Example: Access to healthy foods may be reported rather than diet, physical activity or 
weight-related outcomes. 
 
B3. Questions relating to the dynamic complexity of the system are: 
- Might a third party act to reduce the impact of interventions? 
Example: Might fast food restaurants increase advertising if sales drop as a result of the 
intervention? 
- Are there any substantial impacts of social and/or community networks upon intervention 
effectiveness? Will these impacts be captured over the long term within the effectiveness 
evidence?  
Example: The intervention may be more effective if friends and family are also receiving it. 
- Are there any substantial impacts of the interventions upon other lifestyle factors? 
Example: Healthy eating could also be linked to reduction in binge drinking.  
- Might the interventions have other impacts not already considered? 
Example: Walking/ cycling interventions may be associated with environmental outcomes. 
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Maximise health within a budget constraint 
                      
                                                                                        
 
                         QALYs             QALYs                  Costs to NHS & PSS &                                                                                                                       
                                                                 Wider societal costs 
                                             _                                                                                              
                                                                                              + 
 
Environmental outcomes                                               Hypoglycaemia                                 
(congestion, CO2,                                                             & weight gain 
  pollutants)                                                                                                                                                                                            
          
                                                          Mental                            Pharmacological 
                             illness     +                           interventions 
                                    +        +          Lifestyle                Infectious 
                                                                              Interventions                 diseases 
                      Fatigue                                   
                                                                                 Neuropathy   
                                            +                              Erectile         +   
                        Non-alcoholic                dysfunction              Nephropathy 
                                      fatty liver                                                      +                      +                   +          Retinopathy 
                               CVD      +          +                                                                                                               + 
                            +            +                                                                                                                            +              
                                      +                                                                  _                                                                  
                  Cancers      +                                                                                                                                                                          
                  +                                                                                                
                               
          
   +     Lifestyle interventions for     
   Screening tests for                                                             high risk individuals 
                  high risk individuals                                                                                                                       +                                             
                                                                         Risk factors of next generation 
             Obstructive sleep apnoea                                                                   + 
                                                  +                             _       _                                 Osteoarthritis           
  Gestational diabetes/        +                               +         +                                                    +                                                  
  Pregnancy complications                                                                                                      +         
                                                                                                                                                                                                                                                                                                                                                   
Risk factors (including age, sex, ethnicity, a measure of physical activity & diet, family history of diabetes, etc.)** 
NB. These differ for different diseases but some factors overlap eg.BMI. 
                                                            _                          
Population-level lifestyle interventions                                                                       
       
 
         
 
          
DIABETES PROJECT EXAMPLE 
            Potential interventions 
             Affects usage of alternative intervention 
 
*Different tests (OGTT, FPG, HbA1c) identify different  
individuals & diagnostic criteria have changed 
 
 
~This leads to screening for CVD & microvascular complications which will affect these outcomes. If BGL are 
decreased, the risk of complications may decrease even if the individual is still termed ‘diabetic’. 
 
      +++  ++  
 
 
 
                                 Blood glucose levels (BGL)¤ 
 
                       +    Diagnosed IGR*    +   Diagnosed diabetes*~ 
 
Normal     Time    Undetected IGR  Time    Undetected diabetes 
 
¤ All included factors change  
over time, shown here in  
graphical form for BGL to 
highlight consideration of time 
 
**Risk factors may be worse in the future as lifestyles become more sedate 
CVD, retinopathy & hypoglycaemia may affect driving ability 
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Process suggestions which may be helpful to modellers 
Literature searching for developing the conceptual model of the problem: There is a dearth of defined 
methodology associated with searching for evidence to inform the understanding of the problem and model 
development. A doctoral thesis by Paisley investigates how evidence to inform clinical intervention model 
development might be identified.
24
  This thesis suggests that a range of methods are likely to be required, 
which may include using known sources of information such as a previous model (direct acquisition), a formal 
literature search to identify specific information (directed acquisition) and/or identifying information on one 
topic during a search for information on a different topic which allows new ideas and options to emerge, as 
well as evidence which may not be picked up by a standard search such as grey literature (indirect retrieval).
24
  
This process will be cyclical in that literature will increase the modeller’s understanding of the problem which 
will in turn direct where to search next for data. The modeller may begin this cyclical process by thinking about 
which sources of information may provide an initial high yield of information about the decision problem.
24
 For 
example, the modeller might begin by examining previous similar models and undertaking a broad search for 
reviews of the topic area. It is useful during this process to flag any literature which is identified which may be 
useful in specifying the structure of the model or model parameters.
24
   
 
Paisley suggests that literature search strategies should focus on maximising the retrieval of relevant 
information using an efficient, dynamic approach such as Berry Picking or Information Foraging.
24
  It is 
important to work closely with information specialists and reviewers and ensure that there is a shared 
understanding of what is required, particularly due to the dynamic nature of this type of search. The modeller 
has greater knowledge about the higher level goal, whilst the information specialist holds the searching 
expertise. Thus, a possible approach to information retrieval for understanding the problem and developing the 
model structure, based upon information theory, is described by Figure 5 below. Methods for reducing the 
iterations between the systematic reviewer and the modeller, such as the two working together in real time to 
identify appropriate search strategies, might be useful. 
 
Figure 5: Information retrieval for developing the understanding of the problem and model structure 
 
Iterative process between information specialist and 
modeller to identify relevant studies 
Developing initial understanding to be 
able to describe what would like to find 
to information specialist 
Initial 
systematic 
information 
gathering by 
modeller 
 
Informatio
n 
processing 
by 
modeller 
Systematic 
information 
gathering by 
information 
specialist 
 
Information 
processing by 
information 
specialist 
 
 
Informatio
n 
processing 
by 
modeller 
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Use of existing economic models: One of the sources of evidence for understanding the problem may be 
existing economic models since they can provide useful information about the problem in an efficient way. It is 
important to be mindful that these may have been developed for a slightly different problem/ context. 
Moreover, it is important to understand the current decision problem in its own right without being led by how 
others have modelled the topic. 
 
Mapping review for potential interventions: A useful approach which has been employed within the School of 
Health and Related Research at the University of Sheffield to facilitate the identification of potential types of 
interventions is to undertake a mapping review.
25
  This involves carrying out an initial broad search to 
understand what sort of evidence is available for interventions which fall into the project scope in order to 
define a more specific search. If there are too many possible types of interventions to assess within the 
constraints of the decision making process, decisions about which types of interventions to focus upon should 
be made through discussion with the stakeholders. If stakeholders broaden the potential types of interventions 
being assessed, the conceptual model of the problem may need to be expanded accordingly to capture any 
additional impacts of the interventions.  
 
Use of existing diagrams of the problem: The decision makers or other parts of the project team may have 
developed diagrams of their understanding of the problem.  For example, within the NICE process, logic models 
are developed by the decision makers to describe the relationships between actions and outcomes, 
incorporating relevant theory, in order to inform the project scope, including highlighting areas for potential 
interventions.
26
  The conceptual model of the problem may therefore build upon any other diagrams which 
have been developed by the rest of the project team or the decision makers, and importantly it should be 
consistent with them. If these diagrams were inconsistent, the reasons for these differences should be 
explained. Where such diagrams have not been developed, the conceptual model of the problem could be used 
for a similar purpose in terms of identifying potential interventions (according to potentially modifiable 
determinants of health) and informing the searches for intervention effectiveness evidence.  
 
Stakeholder involvement: The extent to which stakeholders can be involved in the development of the 
conceptual model of the problem will depend upon the specific project as discussed previously, but it could be 
developed or validated during a workshop with experts and decision makers (as in Strategic Options 
Development and Analysis
21
). Group judgements tend to be more accurate than individual judgements, 
particularly if a facilitator ensures that all people have chance to input.
17
  By each stakeholder sharing their 
beliefs and assumptions these can be questioned and discussed.
21
  However, practically it is likely that more 
than one way of communicating with stakeholders and a flexible approach will be necessary. For example, if 
holding stakeholder workshops, those that cannot attend the full workshop may be able to join for part of it by 
tele- or video-conference, and/or to provide comments upon circulated documents so that these can feed into 
the workshop. It may be appropriate to hold workshops/ meetings around relevant conferences or meetings to 
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increase attendance. One-to-one meetings, telephone conversations and/or email communication may be 
employed in addition to, or instead of, workshops.  
 
Stakeholder introductions: Drawing upon Checkland,
2
 understanding the worldviews of the stakeholders can 
help to:  
-Explore different views and the reasons for these between the stakeholders; 
-Identify concerns which may not otherwise have been identified; 
-Assess the stakeholders’ potential contribution towards the project rather than our expectation around  what 
they may be able to input; 
-Identify who it may be most appropriate to contact to ask specific questions or for clarifications; 
-Put what the stakeholders say into the context of their worldview so that any biases or assumptions about the 
world can be more easily identified; 
-Ensure that future workshops/ correspondence aims to address the aims and motivations of the stakeholders 
so that they remain engaged within the project. 
Thus, it may be valuable for each stakeholder to describe their perspective, what they think they can give to the 
project and what they would like out of their involvement either for 2-3 minutes at the start of the first 
workshop or within a paragraph of written text and for the modeller to refer back to these throughout the 
project. Within workshops, a 2-3 minute introduction also encourages each stakeholder to feel valued and gives 
each stakeholder chance to talk in order to promote later involvement in discussions.
2
  
 
Handling stakeholder disagreement: Throughout this process it is important to question the assumptions of the 
stakeholders involved. If discussion does not resolve any disagreements between stakeholders, and there is no 
evidence to suggest a preference, then it may be due to value judgements, in which case it would be most 
appropriate to incorporate all alternatives within the understanding of the problem. 
 
Suggested processes if running workshops - project team requirements: Providing some sort of description of 
the degree of consensus/ disagreement between stakeholders could help with model validity and credibility. A3 
diagrams (eg. of the conceptual model of the problem at various stages of development) are a useful tool for 
stakeholders to share ideas and record them within workshops. When choosing whether or not to run 
workshops, the project team should be aware that the resource requirements during the workshops are 
substantial in order to facilitate, maintain engagement with the stakeholders, record what is said and process 
and collate information developed during the workshop. If the conceptual model of the problem is developed 
during the workshop, it could be developed using specialist computer software such as Group Explorer (which 
allows each member of the group to anonymously add to the diagram) or using a pen, post-it notes and a white 
board.
21
   
 
Suggested processes if not running workshops: If resources, time requirements and/or availability of 
stakeholders do not allow for a workshop to take place, then it would be possible for the modeller to develop a 
451 
 
diagram of their perception of the problem based upon background reading and any previous diagrams 
developed for the project, and then circulate this initial version of the conceptual model of the problem for 
comment from the stakeholders.  
 
Causal assumptions: It is likely that several versions of the conceptual model of the problem will be developed 
due to the iterative process of building up the understanding of the project team and stakeholders. Some 
evidence may suggest, or stakeholders may perceive, factors as causal (where one factor directly causes 
another) when in fact they are correlated (there may be a third factor which causes both outcomes so that they 
appear to be causal but are not). Causality might be well established for some relationships, such as the 
relationship between CVD events and mortality. For other relationships, background knowledge and literature 
should be used to be able to justify the causal assumptions made (see Figure 4). Econometric studies (for 
example, least squares regression, instrumental variables, structural equation models, propensity score 
matching) can be used to establish the statistical association between these specified causal relationships. 
Causality could be graded according to the strength of evidence which might be done visually within the 
diagram, for example, by varying the width of arrows as was done within the Foresight map of obesity.
27
 In 
contrast to facilitation for problem structuring methods where the main benefits might be in terms of the 
learning that takes place whilst developing the diagram rather than the output of the diagram, the modeller 
needs to complete a diagram which will be useful for specifying and justifying the quantitative model structure. 
 
Depicting time: Time lags between discrete factors could be highlighted by adding the term ‘delay’ to the 
arrows if there are substantial time delays between cause and effect, as for causal loop diagrams within system 
dynamics.
8
  An illustrative graph depicting time could also be incorporated where time effects are unclear from 
the causal structure. 
 
Reporting the causal diagram: Different colours, dotted lines and/ or types of arrow can be used to depict 
different characteristics of the problem, accompanied by a key. More detailed notes can accompany the 
diagram. If the diagram becomes too unwieldy the ultimate aims could be removed and considered within a 
separate diagram or table since many of the factors are likely to link to these. The conceptual model of the 
problem can be input into the final report. The understanding of the problem may change; however, the 
diagram of the group’s initial understanding provides a foundation for comparison should the understanding of 
the problem change at a later stage within the project, and this can then be documented.  
 
Modelling objective 
The modelling objective should be clearly defined and regularly referred to during the design-
oriented conceptual modelling phase (see Phase D of the framework) so that the model is built for 
purpose. This can be developed based upon the conceptual model of the problem, and may 
comprise the ultimate goals, the types of interventions being assessed and the population(s) of 
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interest. As Roberts et al. suggest, the policy context of the modelling project needs to be clear, 
particularly in terms of the funder, the policy audience and whether the model is planned to be for 
single or multiple use.9 
 
DIABETES PROJECT EXAMPLE 
Modelling objective: To compare interventions for screening and prevention of type 2 diabetes 
within the general population and high-risk groups to maximise cost-effectiveness. 
 
ii) Describing current resource pathways 
The conceptual model of the problem can be used to inform what resources might need to be 
considered. This does not need to be a detailed description of resource use at this stage, since some 
factors within the conceptual model may be excluded from the quantitative model and hence it 
would be inefficient to collect detailed information. It also means that the general pathways can be 
validated with stakeholders prior to collecting detailed information. Flow diagrams, tables and/or a 
textual description of the resource pathways can be useful to inform consideration of the potential 
impact of the factors within the conceptual model of the problem upon the model results. This can 
be used to help choose which factors to include and exclude from the model as is discussed within 
the model boundary stage of the framework (see Section D(iii)).  
 
DIABETES PROJECT EXAMPLE 
For the diabetes case study, a number of flow diagrams were used from existing NICE guidance to 
describe the different elements of screening and treatment of disease. 
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D) Developing and justifying the model structure 
This section aims to outline an approach for specifying an appropriate model structure that is 
feasible, valid and credible to develop into a quantitative model. As described within Figure 3, this 
includes: (i) reviewing existing health economic models; (ii) choosing model interventions and 
comparators; (iii) determining the model boundary (deciding what factors are included within the 
model rather than being part of its external environment); (iv) determining the level of detail (the 
breakdown of what is included for each factor within the model boundary and how the relationships 
between factors are defined); (v) choosing the model type (the analytic modelling technique 
employed, for example a Markov model), and (vi) developing a qualitative description of the 
quantitative model. This may be described as the design-oriented conceptual modelling phase.7   
 
i) Reviewing existing health economic models 
It is standard practice within health economic evaluation to undertake a systematic review of 
existing health economic models in the same area. Some existing models may have been used to 
develop the understanding of the problem, but a systematic review of models at this stage can be 
used in a number of ways28: 
 To determine whether there is already a model which could be used, either in part or as a whole, 
based upon your understanding of the problem; 
 To consider the strengths and limitations of existing economic evaluations, which can be used to 
inform the model development, including considering the strengths and limitations of different 
model types in that area; 
 To compare and contrast how other modellers have chosen to structure the model and estimate 
key variables, and how the model results differ based upon these choices. This may involve 
considering the use of mathematical relationships such as risk equations or parameters which 
have been included within previous models if their source and justification has been 
appropriately explained; 
 To identify which variables are important in influencing model results (including any which have 
not been highlighted during the understanding of the problem phase) and which do not 
substantially affect the differences in outcomes between the interventions and comparators; 
 To provide an insight into the sort of data available which may inform the level of detail included 
within the model. 
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ii) Choosing model interventions and comparators 
Method for choosing model interventions to assess within the model 
The decision makers (with consideration of the clients’ needs if they are not the decision makers) 
should define which specific interventions to model grounded within the results of an evidence 
review and according to expertise from other stakeholders. Figure 7 shows how the specific 
interventions may be chosen based upon the project aims, the understanding of the problem and 
the intervention evidence review. Not all stages may be required depending upon the breadth of the 
study. If it was not possible to systematically review all potentially relevant interventions, then 
decision makers may have been asked to prioritise interventions to determine the inclusion and 
exclusion criteria for the systematic review at the understanding of the problem phase. The decision 
makers may use the systematic review of effectiveness evidence to further limit interventions by 
discussing trial populations, outcomes and other possible biases such as trial design associated with 
the effectiveness studies. It is possible that one good study or a number of studies can be used to 
estimate the short term effectiveness, depending upon the evidence available. As far as possible, the 
comparator can be based upon the same studies as the interventions if this is representative in 
practice. If practice is substantially different, then an adjustment on the effectiveness estimate 
would be required. Given that economic evaluation is a comparative analysis, the model results are 
only meaningful in relation to the comparators chosen.9 
 
Figure 7: Choosing model interventions 
 
Project aims/ specification/ scope 
Causal diagram of the problem 
Mapping review to identify 
breadth of intervention evidence 
Discussion with decision makers to prioritise 
interventions for systematic review 
Systematic review of effectiveness evidence 
Discussion with decision makers to inform which 
specific interventions to consider within the model 
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Extrapolation of study outcomes  
Which outcomes the effectiveness studies report will guide the development of the model structure. 
For example, within the diabetes project, if all of the studies reported disease outcomes rather than 
physical activity/ diet outcomes, it may be appropriate to exclude these behaviours as explicit 
factors from the model structure. If the intervention has an effect, the mechanism behind the 
effectiveness can be discussed to develop assumptions for extrapolating these effects beyond the 
trial data (see level of detail section).  
 
Use of the reviews to develop the model boundary, level of detail and model type 
The review of existing economic evaluations and the review of intervention effectiveness can be 
used to facilitate decisions around the model boundary, level of detail and model type as shown 
within Figure 8 below.  
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Figure 8: Defining the model boundary, level of detail and model type 
 
Develop understanding of the 
problem 
Assess whether there is 
an existing model which 
could be employed 
Identify strengths & 
limitations of different 
model structures 
Identify strengths & 
limitations of different 
model types 
Identify key variables which 
generally affect model results 
(incl. any not already 
identified) & key variables 
included within the causal 
diagram which do not 
Identify the sort 
of data available 
Identify factors with not many 
causal links & assess whether 
they would have a substantial 
impact upon the difference 
between outcomes of 
interventions & comparators 
Identify types of 
outcomes reported 
Identify long term 
evidence & mechanisms 
Describe effectiveness of 
interventions (to help 
choose which to model 
& for parameterisation) 
Model boundary Model detail Model type 
Discuss potential model perspectives, 
outcomes, interventions & 
populations with stakeholders 
Review existing health 
economic models 
Review effectiveness of 
relevant interventions 
Review evidence of 
relationships between 
factors 
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iii) Determining the model boundary 
Determining the model boundary is about deciding, based upon the understanding of the problem, 
what factors should be judged as relevant for inclusion within the model and which can be excluded 
given the time and resource constraints of the decision making process. The boundary of the model 
structure must differ from the boundary of the understanding of the problem in order to be able to 
make informed judgements about what it is important to include within the model structure (see 
Figure 1). It is important to define the boundary of the model such that all important interactions 
between the elements of the system identified within the understanding of the problem are 
captured.16   
 
Model population and subgroups 
The model populations can be discussed with the stakeholders, informed by the populations within 
the studies identified by the effectiveness review. The modelling team and the stakeholders could 
consider whether there is a bigger problem in a particular subgroup or whether the intervention is 
more effective in a particular subgroup and if there is sufficient data to undertake any subgroup 
analysis. These subgroups might be based upon the determinants of health outlined within Figure 2 
including age, sex and other inherent characteristics of the population of interest, individual lifestyle 
factors, living and working conditions and access to essential goods, and general socioeconomic, 
cultural and environmental conditions.  
 
DIABETES PROJECT EXAMPLE 
 
 
 
 
 
 
 
 
Model perspectives and outcomes 
Often within health economic evaluation, the NHS and PSS perspective is employed.29  However, 
within Public Health economic modelling, other perspectives are likely to be relevant because 
substantial costs and benefits may extend beyond these sectors. Alternative perspectives include 
(but are not limited to) a societal perspective, a Public Sector perspective or the perspective of the 
The populations and subgroups of interest were: 
- General population; 
- Local communities; 
- High-risk individuals including 
o Non-diabetic hyperglycaemic; 
o Women with gestatational diabetes;  
o South Asian individuals. 
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particular agencies involved within the system. The perspectives of the system owners identified 
within Section B of the framework are likely to be appropriate. For example, if employers are 
considered to be system owners, then it is likely to be useful to consider an employer perspective. 
The choice of perspectives will also depend upon the modelling objectives. It should be noted that 
there are currently unresolved issues around using these alternative perspectives in terms of (i) 
whether it is possible or desirable to make social value judgements associated with the value of 
health relative to the value of other costs and benefits and (ii) the practicality of transferring costs 
and benefits between sectors.30  Nonetheless, if substantial costs and benefits are expected to fall 
outside of the NHS and PSS, presenting these alternative perspectives is likely to be informative for 
decision makers.  
 
In order to be able to compare interventions across different populations in terms of health costs 
and outcomes, the incremental cost per QALY may be employed, based upon New Welfare 
Economics.31  Where the model boundary extends beyond health, it may be useful to understand the 
modelling requirements in other sectors so that relevant outcomes may be presented. One way of 
presenting multiple outcomes for different sectors is to present a cost-consequence analysis 
alongside the cost-effectiveness analysis.32-34  Decision makers can suggest which model outcomes it 
would be useful to report. For both model perspectives and outcomes, the modeller should follow 
any specific requirements of the decision makers such as the use of the NICE Public Health Methods 
Guide. A method for choosing model outcomes and perspectives has been outlined within Figure 8. 
 
Figure 8: Method for choosing appropriate modelling perspectives and outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) Consider what is theoretically appropriate and what is required under a reference case if 
applicable for (a) perspectives and (b) outcomes.  
When considering (b) model outcomes, how do the model perspectives affect this?  
 
2)    Consider by whom the results of the research will be used to consider whether additional 
(a) perspectives and (b) outcomes may be useful. 
3)    Discuss with stakeholders those perspectives and outcomes identified within (1) and (2) 
and ask if there are any additional (a) perspectives and (b) outcomes that it might  
be useful to consider. 
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DIABETES PROJECT EXAMPLE 
 NHS & Personal Social Services 
(PSS) perspective 
Employer perspective (given 
the number of workplace-
based interventions) 
Societal perspective 
Th
e 
co
st
 o
f.
..
 
The intervention and its delivery 
to the NHS and PSS 
The intervention and its 
delivery to the employer 
All costs of the intervention and 
its delivery (including to the 
patient) 
Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
 Diagnosis, treatment and follow 
up of the relevant diseases (for 
each disease) to the NHS and PSS 
and patients and carers 
(including travel costs) 
 Lost productivity Lost productivity 
  Lost leisure time 
O
u
tc
o
m
e
s 
Life years (LY) of the patient  Life years (LY) of the patient 
Quality-adjusted life years 
(QALYs) of the patient and carers 
 Quality-adjusted life years 
(QALYs) of the patient and carers 
Incremental cost per LY gained  Incremental cost per LY gained 
Incremental cost per QALY gained  Incremental cost per QALY 
gained 
  Environmental outcomes (if 
necessary) 
 
Other model boundary considerations 
An algorithm to help define the model boundary is shown within Figure 9 and can be considered for 
each factor within the conceptual model of the problem. Within Figure 9,  the question ‘does the 
factor have many causal links?’ aims to identify which factors are central and should be included 
within the model, even in the absence of data (lots of links), and which factors are less important 
(not many links to other factors). This can be done formally within computer software if preferred.21  
The question around whether the  impact of a factor is substantially captured by other factors 
attempts to exclude any double counting within the understanding of the problem phase (for 
example, including fatigue and diabetes) as far as possible from the quantitative model.  
 
It is valuable to predict very approximately the results of the model to facilitate model verification. 
These predictions can also help with defining the model boundary. Figure 9 encourages the modeller 
to think about whether it is worthwhile including non-central factors given the expected results of 
the model and the anticipated direction of effect of the factor upon those results, as well as the 
differential impacts of the interventions upon that factor. If different interventions impact the factor 
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by different mechanisms, then including or excluding the factor may lead to different conclusions 
based upon the incremental analysis. 
 
In terms of the question within Figure 9 around whether the factor is likely to have a substantial 
impact upon the difference between costs and effects of the interventions, this entails having an 
understanding of the magnitude of the cost and outcomes associated with the factor and the extent 
to which the interventions might change these. These subjective judgements will inevitably be 
considered in the context of the time available for modelling and the potential future uses of the 
model. Whether or not the factor will impact substantially upon the model results is a subjective 
judgement which, practically, may be influenced by the time available to develop the model. 
However, the model boundary stage should not be overly dependent upon the evidence or time 
available as this can be accommodated for by the level of detail incorporated. It is likely to be more 
appropriate to crudely include a factor which is expected to substantially affect the model results 
than to exclude it from the model completely.  
 
Finally, in order to maintain the credibility of the model, stakeholders can be asked whether they are 
happy, given the above justifications, with the exclusion of factors. One way of reporting this stage is 
to produce a table stating whether each factor is included or excluded and the justification for 
exclusion, as suggested by Robinson.35  An example of this is illustrated below Figure 9. A figure may 
also be useful to show which factors and relationships are planned to be included within the model. 
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Figure 9: Defining the model boundary 
 
Does the factor have many causal links? 
 
Yes No 
Is the factor likely to have a substantial 
impact upon the difference between costs & 
effects of the interventions? This may be 
based upon (though not limited to):  
(1) the review of economic evaluations; 
(2) the description of resource pathways; 
(3) clinical papers describing the causal links; 
(4) existing models in similar areas which 
describe the impact of the factor; 
(5) methodological choices eg. discounting; 
(6) expert advice. 
 
Yes No 
INCLUD
E 
Is the factor associated with the interventions, 
populations & outcomes being modelled? 
 
EXCLUD
E 
INCLUD
E 
EXCLUD
E 
Yes No 
Yes 
Is the impact of the factor predominantly 
captured by other included factors? 
Yes 
EXCLUD
E 
No 
Would stakeholders prefer to 
include the factor for model 
credibility AND is it relatively easy 
to incorporate in terms of 
modelling skill & data availability? 
INCLUD
E 
No 
Are all interventions likely to be cost saving/ have a low ICER 
AND does the factor further increase benefits/ decrease costs 
AND do all interventions affect the factor in the same way? 
Yes 
No 
To be considered in the context of the time available for modelling & potential model reuse 
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DIABETES PROJECT EXAMPLE 
Factor Include/ exclude Reason for inclusion/ exclusion 
Risk factors Include Key component. 
Blood glucose levels/Diabetes Include Key component. 
Gestational diabetes Include As a subgroup of the population who will be given intervention. 
Osteoarthritis Include From a random sample of 3664 members of the Dutch population aged >25 years, Tukker reports that ‘for each 
unit increase in BMI respondents were 8% more likely to report OA or chronic pain’ and the Foresight report 
highlights the high prevalence of osteoarthritis within the UK population. In addition, the report by Gillett et al. 
suggests that the cost of osteoarthritis is comparable to the cost of diabetes. 
Risk factors of next 
generation 
Exclude Within the high risk group, only a minority of people will parent a young child due to the age of the people 
affected. Within the general population, Whitaker et al. suggest that parental obesity more than doubles the risk 
of adult obesity among their children, but because these costs and outcomes would occur so far in the future, by 
applying a discount rate to both costs and effects, there would be minimal impact upon the model results.  
Hypoglycaemia & weight gain  Include (but not as a 
separate factor) 
The quality of life implications of hypoglycaemia and weight gain will be captured within the quality of life of 
people with diabetes. The costs of hypoglycaemia will be explicitly included within the cost of diabetes treatment. 
Non-alcoholic fatty liver Exclude as a seperate 
factor 
This is likely to be implicitly included within the costs and quality of life estimates associated with diabetes and 
obesity. 
Fatigue Exclude as a separate 
factor 
The quality of life implications of fatigue are likely to be captured within the quality of life of people with disease. 
There will be minimal additional costs associated with fatigue above those associated with treating disease.  
Nephropathy Include Key outcome associated with diabetes. 
Retinopathy Include Key outcome associated with diabetes 
Neuropathy Include Key outcome associated with diabetes. 
Erectile dysfunction Include (but not as a 
separate factor) 
This is likely to be included within the costs and quality of life impacts of neuropathy. 
Infectious diseases Exclude Relative to other model factors, this is likely to have a smaller impact upon the model outcomes. 
 
Cancers (post-menopausal 
breast cancer, colorectal 
cancer) 
Include The report by the World Cancer Research Fund (WCRF) Panel on Food, Nutrition, Physical Activity and the 
Prevention of Cancer suggests that BMI and physical activity is associated with colorectal cancer, postmenopausal 
breast cancer and endometrial cancer. Prevalence of colorectal cancer and post-menopausal breast cancer within 
the UK population is high and they are associated with substantial impacts upon costs and quality of life.  
CVD  Include Has a substantial impact upon both costs and effects.  
Mental illness (incl. 
dementia) 
Include The relationship between mental illness and diabetes is complex and currently not completely understood. 
Evidence suggests that approx. 18-28% of diabetics have depression (Egede 2005), which is substantially higher 
than within the general population and this has substantial impacts upon costs and QALYs. 
Obstructive sleep apnoea Exclude as a seperate 
factor 
The relationship between risk factors and CVD is expected to capture those events resulting from obstructive 
sleep apnoea.  
Environmental outcomes Exclude Majority of the interventions would not substantially affect this outcome; focus upon health-related outcomes. 
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iv) Determining the level of detail 
The level of detail is defined as the breakdown of what is included for each factor within the model 
boundary and how the relationships between factors are defined. A decision about which parts of the model 
are likely to benefit from a more detailed analysis can be made a priori in order to avoid situations in which 
the modeller focuses upon specific parts of the model because they are more easily dealt with and 
subsequently run out of time to develop other parts in detail. Essentially, determining the level of detail 
involves a mini cost-benefit analysis within which modellers can weigh up, based upon the documented 
understanding of the problem and the defined model boundary, whether the time required to do one 
analysis at a specific level of detail within the model is likely to have more of an impact upon the model 
results compared with the same time period spent upon other analysis, given the current evidence available 
and the overall time constraints. During model analysis, more detail can be incorporated if part of the model 
is shown to substantially affect the results. 
 
Box 3 summarises key questions for the modeller to help choose an appropriate level of detail. 
 
Searching for evidence 
Data for inclusion for specifying the model structure and for the parameters will need to be identified at this 
point if it has not been already. This could be based upon literature identified during the development of the 
conceptual model of the problem for which specific literature was noted as useful, although additional 
specific searches may also be required. Data collection and the development of a description of the level of 
detail for the model will be a highly iterative process. Sufficient evidence is required to be able to justify why 
the modelling choices have been made.24  It is important to note that elements for which there is a lack of 
empirical data which are considered to have key differential impacts upon the comparator(s) and the 
intervention(s) may be informed by expert elicitation. One consideration at this stage is likely to be the 
derivation of the disease natural history parameters which may be taken from existing studies or calibrated 
using statistical methods such as the Metropolis Hastings algorithm.36  
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Box 3: Questions to help in making judgements about the model level of detail 
 
General 
1) Is the time required to do the analysis at a specific level of detail likely to have more of an 
impact upon the model results than the same time period spent upon other analyses, 
given the evidence available and the overall time constraints? 
 
To describe the relationship between the included factors over time 
 What outcomes are reported within the review of intervention effectiveness?  
(to help choose which causal links to include) 
 What evidence is available to model the causal links and the outcomes of the factor? 
(to avoid relying on the first available evidence) 
 What do other economic evaluations suggest are the strengths and limitations of 
different mathematical relationships between model factors? 
 Which determinants of health are key drivers of the problem according to relevant 
theory? 
 
To extrapolate study outcomes 
 What outcomes are reported within the review of intervention effectiveness? 
 What evidence is available for long term follow up? 
 Is there sufficient evidence and time available to model social networks given the 
expected impact upon model results (based upon the understanding of the problem)? 
 
The level of detail used to describe each included factor  
 Which are the specific aspects of each factor that are likely to have a substantial impact 
upon the model results? 
o Is all costly resource use captured? 
o Are all substantial health benefits and disbenefits captured using measures 
acceptable to the decision maker given the available evidence? 
 Are impacts included within both costs and benefits where appropriate? 
 
How interventions will be implemented in practice 
1) What do the effectiveness studies describe? 
2) What do stakeholders suggest would happen in practice and is this likely to lead to 
different estimates of effectiveness to those within the study? 
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Distinction between model assumptions and simplifications 
Robinson highlights the distinction between model assumptions and simplifications; model assumptions ‘are 
made either when there are uncertainties or beliefs about the real world being modelled’ and model 
simplifications ‘are incorporated in the model to enable more rapid model development and use, and to 
improve transparency’.37  Thus, model assumptions are uncertain and alternative plausible assumptions can 
be tested within the model, whilst model simplifications are chosen because they are likely to have limited 
impact upon the model results. It is important to be explicit about both of these when describing the level of 
detail and highlight model assumptions which could be tested within sensitivity analyses. 
 
Reporting level of detail 
The simplifications and assumptions should be described and explained, initially for communication 
purposes with stakeholders and the project team to develop model validity and credibility, but also to 
facilitate future modelling projects in the same area. A document can be developed which specifies all of the 
key model simplifications and assumptions for discussion with stakeholders, ideally during a second 
workshop. This can help to identify the most appropriate evidence for the model and also improve model 
validity and credibility. Writing down all of the key simplifications and assumptions and their justification 
provides a mechanism for systematically questioning them within project team discussions and with the 
stakeholders; thus enhancing the appropriateness of the model simplifications and assumptions.   
 
Expressing structural uncertainty 
It may be that where there is more than one plausible assumption it is appropriate to develop model 
structures for each assumption in order to undertake posterior analysis of structural uncertainty, for 
example model averaging. This would be undertaken by creating a parameter to be included within the 
probabilistic sensitivity analysis to represent the probability of each structure being appropriate. This 
parameter and its distribution could then be estimated by elicitation with experts.38  
 
The level of detail will be affected by the model type chosen, and hence it will be an iterative process 
between identifying an appropriate level of detail and choosing the model type. 
 
  
466 
 
v) Choosing the model type 
Most appropriate method given the characteristics of the problem 
It is important to understand the most appropriate method given the characteristics of the problem, even if 
it is not practical to develop this model type, so that the modeller can understand the simplifications they 
are making. A number of existing papers outline taxonomies for deciding upon appropriate model types 
given the characteristics of the problem for health economic modelling.39-41  The taxonomy developed by 
Brennan et al. (2006) is used here,39  although others may be employed. It can be summarised by asking 
whether interaction, timing and stochasticity are important, and whether there is sufficient data for an 
individual level model rather than a cohort model, each of which leads to a preferred model type (see Table 
2 over page). Whilst decision trees and Markov models are most often employed within Health Technology 
Assessment,40 because of the complexity associated with Public Health systems it is likely that alternative 
model types may be more appropriate. 
  
Agent-based simulation (ABS) is not included within the taxonomy by Brennan et al. (or any other health 
economic modelling taxonomies identified); however it may be useful for modelling dynamically complex 
Public Health systems and so has been added to the taxonomy. ABS is an individual-level simulation 
modelling approach and is compared with the individual-level simulation approach DES which is included 
within the taxonomy.  
 
DES is a top-down approach where the behaviour of the centralised system is defined by the modeller and 
entities within the model are passively affected by the rules of the system. Conversely, ABS is a bottom-up 
approach where the behaviour of the system is a result of the defined behaviour (based upon a set of rules) 
of individual agents and their interactions within the system.42 These agents can learn over time. Therefore, 
DES may be preferable when the interaction between the agent and the environment is important (for 
example, a person has surgery which changes the probability of subsequent outcomes); whilst ABS may be 
preferable when the interactions between heterogeneous agents are important in addition to their 
interactions with the environment (for example, infectious disease modelling). Importantly, ABS more easily 
allows the analyst to capture spatial aspects in order to model appropriate interactions (for example, family 
and friend networks for transmission of a contagious disease).42  Studies have shown such social network 
impacts of Public Health behaviours such as physical activity and diet.43  Table 2 shows a revised version of 
Brennan’s taxonomy with an additional row incorporated for ABS. 
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Table 2: Revised version of Brennan’s taxonomy 
 A B C D 
Cohort/ aggregate level/ counts Individual level 
Expected value, 
continuous state, 
deterministic 
Markovian, discrete 
state, stochastic 
Markovian, discrete 
state 
Non-Markovian, 
discrete state 
1 No 
interaction  
Untimed Decision tree 
rollback 
Simulation decision 
tree 
Individual sampling model: Simulated 
patient-level decision tree 
2 Timed Markov model 
(deterministic) 
Simulation Markov 
model 
Individual sampling model: Simulated 
patient-level Markov model 
3 Interaction 
between 
entity and 
environment  
Discrete 
time 
System dynamics 
(finite difference 
equations) 
Discrete time 
Markov chain 
model 
Discrete-time 
individual event 
history model 
Discrete individual 
simulation 
4 Continuous 
time 
System dynamics 
(ordinary 
differential 
equations) 
Continuous time 
Markov chain 
model 
Continuous time 
individual event 
history model 
Discrete event 
simulation 
5 Interaction between 
heterogeneous entities/ 
Spatial aspects important  
X X X Agent-based 
simulation 
 
It is important to note that the choice of model type is not completely clear cut.39  For example, it would be 
possible to incorporate some timing into a decision tree or to develop a system dynamics model with some 
individual level behaviour; however many of these ‘work arounds’ often become more time consuming to 
program than employing the more complex model type. 
 
Most appropriate model type based upon broader considerations 
It may not always be practical to employ the model type which is most appropriate for the characteristics of 
the problem. Figure 10 provides an outline of how the modeller might decide on the most appropriate 
model type according to broader practical issues.  
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Figure 10: Choosing the model structure 
 
 
DIABETES PROJECT EXAMPLE 
Within the diabetes project, the most appropriate model type, based upon the understanding of the 
problem and the revised version of Brennan’s taxonomy was an agent-based simulation model. However, 
given the constraints of the project, a discrete event simulation was considered to be most appropriate and 
the provisos, uncertainties & implications of not modelling the social network effects of obesity were 
documented and highlighted as areas of further research. 
 
 
Determine the most appropriate model type for the characteristics of the problem using Table 4. 
Is this feasible within the time and resource constraints of the decision making process given: 
(i) the data available? 
 AND 
(ii) the accessibility of any existing relevant good quality economic evaluations for use as a 
starting point?  
AND 
(iii) the expertise of the modeller? 
 
Are you intending to use the 
model again for other projects? 
Can you answer the question with a few 
provisos with a simpler model type, given 
your understanding of the problem? 
Yes No 
Explore with the 
decision maker the 
most useful purpose of 
the modelling given 
the project constraints 
Develop the simpler 
model type, documenting 
the provisos, uncertainties 
& implications of the 
simplifications 
No Yes 
Do you think a simpler 
model type would lead to 
the same conclusions, 
given your understanding 
of the problem? 
Develop 
the 
model 
Yes No 
Develop the more 
complex model 
Develop the simpler model, 
documenting the provisos, 
uncertainties & implications 
of the simplifications 
Yes No 
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vi) Qualitative description of the quantitative model 
A qualitative diagram of the quantitative model alongside the development of the model structure can 
facilitate clear communication of the final model structure to stakeholders, other members of the team and 
people who may want to understand the model in the future. This will depend upon the model type 
developed but may take the forms outlined in Table 3. 
 
Table 3: Suggested diagrams to represent the implemented model  
Model type developed Suggested diagram 
Decision tree Decision tree diagram 
Markov model State transition diagram 
System dynamics Influence diagram / stock and flow diagram 
Individual event history model State transition diagram 
DES Activity cycle diagram 
Agent based model A flow diagram 
 
Whilst the design-oriented conceptual modelling can be described prior to the quantitative model 
development, it may be iteratively revised according to data availability and/or inconsistencies identified 
during the development of the quantitative model.7;11;12;35  These modifications should be documented 
throughout so that there is transparent justification for the final model developed. 
 
3. Further information 
For more information about how the conceptual modelling framework was developed and the evaluation of 
the framework please see the doctoral thesis by Squires (in preparation).44  
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A conceptual modelling framework for developing the structure of Public Health economic models 
 
Squires H, Chilcott J, Akehurst R, Burr J, Kelly M. 
Corresponding author: h.squires@sheffield.ac.uk 
 
Abstract 
Background: Public Health interventions tend to operate within dynamically complex systems and 
require consideration of a broader range of determinants of health than clinical interventions, including 
aspects of human behaviour and estimating impacts upon non-health costs and outcomes. The 
structural development of Public Health economic models is currently based upon ad hoc non-
transparent methods. A conceptual modelling framework is a set of steps which can help to guide 
modellers through the development of a model structure. Key advantages of a conceptual modelling 
framework are to: aid the development of modelling objectives; provide tools for communication with 
stakeholders; guide model development and experimentation; improve model validation and 
verification; and allow model reuse. This paper describes a conceptual modelling framework for Public 
Health economic models.  
 
Methods: The framework was informed by two literature reviews, qualitative research with modellers 
and a pilot study. The literature reviews aimed to: (1) describe the key challenges in Public Health 
economic modelling and (2) review existing conceptual modelling frameworks within the broader 
literature. The qualitative research aimed to understand the experiences of modellers when developing 
Public Health economic model structures and their views about the barriers and benefits of using a 
conceptual modelling framework. This involved; (i) following the development of a Public Health 
economic model including observing key meetings and undertaking in-depth interviews with the 
modellers involved; (ii) systematically analysing my own notes from a previous Public Health economic 
project; and (iii) holding a focus group meeting with modellers. A draft version of the conceptual 
modelling framework was piloted within a project assessing the cost-effectiveness of interventions for 
diabetes screening and prevention. 
 
Results: Four key principles of good practice were identified; (1) that a systems approach to Public 
Health modelling is appropriate (feedback loops & unintended consequences are important); (2) 
developing a thorough documented understanding of the problem is valuable prior to and alongside 
developing and justifying the model structure; (3) that a systematic consideration of the determinants of 
health is central to identifying all key impacts of the interventions within Public Health economic 
modelling; and (4) that strong communication with stakeholders and members of the team throughout 
model development is essential. The conceptual modelling framework is described within the paper. 
  
Discussion: A framework has been developed as a helpful tool for modellers of Public Health economic 
models. Initial evaluation will be via a focus group with modellers. It is offered for further testing within 
case studies.   
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1. Introduction 
This paper describes a conceptual modelling framework for Public Health economic evaluation. A conceptual 
modelling framework is defined as: ‘A methodology that helps to guide modellers through the development 
of a model structure, from developing and describing an understanding of the decision problem to the 
abstraction and non-software specific description of the quantitative model, using a transparent approach 
which enables each stage to be shared and questioned.’  
 
1.1 Aim of the conceptual modelling framework 
The aim of this framework is to provide a methodology, which can be moulded according to different 
situations by different users,1 to help modellers develop structures for Public Health economic models. It 
acts as a tool to help modellers make decisions about the model structure, but it does not provide 
automated solutions to these choices. It is intended to be used by any modellers undertaking Public Health 
economic evaluations; for inexperienced modellers it provides a transparent process to follow; for 
experienced modellers it provides Public Health-specific considerations such as the broader determinants of 
health and understanding and describing dynamically complex systems, as well as a standardised approach 
which will help decision makers/ clients to input into and use the model developed. Process suggestions and 
an example to illustrate the methods can be supplied upon request.  
 
1.2 Benefits of the conceptual modelling framework 
Conceptual modelling is the first part of a modelling project, which guides and impacts upon all other stages. 
This means that if this is done poorly, all subsequent analysis, no matter how mathematically sophisticated, 
is unlikely to be useful for decision makers.2  Key potential benefits of this conceptual modelling framework 
and what pitfalls these aim to avoid are shown within Table 1 below. 
 
Table 1: Potential benefits of the conceptual modelling framework 
Potential benefit What pitfalls can be avoided 
To aid the development 
of modelling objectives 
 Answering the wrong (or less useful) question with the model. 
To provide tools for 
communication with 
stakeholders 
 Representing a contextually naïve and uninformed basis for decision-making, 
including misunderstandings about the problem, producing unhelpful model 
outcomes, and incorporating inappropriate and/ or biased model assumptions. 
 Ignoring important variations between stakeholders’ views. 
 Producing model results which are not trusted by stakeholders. 
To guide model 
development and 
experimentation 
 Inefficient model implementation (i.e. repeatedly making structural changes to the 
implemented model) 
 Inadequate analyses 
To improve model 
validation 
 Answering the wrong (or less useful) question with the model. 
 Misunderstanding the key issues associated with the problem. 
 Using the first theories identified from the evidence to develop the model. 
 Not having a basis for justifying the model assumptions and simplifications.    
To improve model 
verification  
 Not having an intended model with which to compare the implemented model. 
To allow model reuse  Other experts not being able to identify or correctly interpret key model assumptions 
and simplifications and why these have been made. 
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2. Methods for developing the framework 
The conceptual modelling framework was informed by two literature reviews, qualitative research with 
modellers and a pilot study. The literature reviews aimed to: (1) describe the key challenges in Public Health 
economic modelling and (2) review existing conceptual modelling frameworks within the broader literature. 
The qualitative research aimed to understand the experiences of modellers when developing Public Health 
economic model structures and their views about the barriers and benefits of using a conceptual modelling 
framework. This involved; (i) following the development of a Public Health economic model including 
observing key meetings and undertaking in-depth interviews with the modellers involved; (ii) systematically 
analysing my own notes from a previous Public Health economic project; and (iii) holding a focus group 
meeting with modellers. A draft version of the conceptual modelling framework was piloted within a project 
assessing the cost-effectiveness of interventions for diabetes screening and prevention. A more detailed 
description of the methods of development is available within the PhD thesis by Squires (in preparation).3 
 
3. The conceptual modelling framework 
The conceptual modelling framework is made up of four key principles of good practice and a methodology 
consisting of four phases: (A) Aligning the framework with the decision making process; (B) Identifying 
relevant stakeholders; (C) Understanding the problem; and (D) Developing and justifying the model 
structure. Each of these will be described. 
 
3.1 Key principles of good practice 
The four key principles of good practice are that; (1) a systems approach to Public Health modelling is 
appropriate; (2) developing a thorough documented understanding of the problem is valuable prior to and 
alongside developing and justifying the model structure; (3) strong communication with stakeholders and 
members of the team throughout model development is essential; and (4) a systematic consideration of the 
determinants of health is central to identifying all key impacts of the interventions within Public Health 
economic modelling. 
 
(1) A systems approach to Public Health modelling is appropriate 
Public Health economic modelling generally involves understanding dynamically complex systems.4  This 
means that they are non-linear systems where the whole is not equal to the sum of the parts, they are 
history dependent, there is no clear boundary around the system being analysed, heterogeneity and self-
organisation impact upon the outcomes, and people affected by Public Health interventions may learn over 
time and change their behaviour accordingly.5  
 
Within complex systems there may be positive feedback loops, whereby if Factor A increases [decreases], 
the number of Factor B increases [decreases], which leads to Factor A increasing [decreasing] further, which 
would lead to exponential growth [decay] if no other factors were present.5  For example, an increase in 
population obesity might lead to an increase in population mental illness which in turn leads to an increase 
in obesity, and so on. There may also be negative feedback loops, where an increase [decrease] in Factor A 
leads to an increase [decrease] in Factor B which in turn leads to a decrease [increase] in Factor A.5  For 
example, an increase in eating will lead to an increase in weight gain (all other things being equal) which may 
lead to a decrease in eating. The dynamics of complex systems arise from the interaction between positive 
and negative feedback loops, and this may occur over a long period of time, often producing counter-
intuitive behaviour.5  The economy is an example of a complex system which displays such behaviour. Within 
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these dynamically complex systems, factors are constantly changing over time, and a sudden change in 
behaviour may arise as a result of a number of smaller heterogeneous changes, such as a stock market crash. 
Making assumptions of simple cause and effect may lead to inappropriate results. See the paper ‘Learning 
from Evidence in a Complex World’ by Sterman (2006) for a good discussion of dynamic complexity.5   
 
A systems approach, or systems thinking, is a holistic way of thinking about the interactions between parts 
within a system and with its environment.6;7  Within systems thinking there are multiple system levels, 
whereby the system of interest is subjectively defined and there is always a higher level system within which 
it belongs and a lower level system which describes detailed aspects. The challenge within health economic 
modelling is to determine which level will be that of the system of interest (the model), by having sufficient 
knowledge about the higher level system (the broader understanding of the problem), and subsequently to 
be able to define an appropriate level of detail for the system of interest. Within systems thinking, the 
importance of not considering one aspect of a system in isolation is emphasised to avoid ignoring 
unintended consequences. Soft systems thinking also recognises the impact of culture and politics upon a 
situation,1  which is interlocked with Public Health policy evaluation. Culture and politics affect the process 
by which decisions are made, what is modelled (eg. the identification of the problem, stakeholder 
involvement, the interventions assessed and the perspectives and outcomes of the analysis) and the 
effectiveness of the interventions (eg. service provision and the behaviour of individuals and society). Thus, a 
systems approach is suited to modelling these dynamically complex public health systems. Figure 1 has been 
developed to depict key elements of a systems approach. 
 
Figure 1: Systems thinking 
 
 
 
 
 
 
 
 
 
 
(2) The modeller should develop a thorough documented understanding of the problem prior to and 
alongside developing and justifying the model structure in order to develop a valid, credible and 
feasible model 
It is valuable to have an initial understanding of the problem and to document this understanding prior to 
making simplifications when developing the model structure because of both theoretical and practical 
reasons. Theoretically, it provides a basis for validation by facilitating the specification of an appropriate 
scope and structural assumptions, and for credibility by supporting stakeholder involvement and producing 
 
The defined system – 
adapts according to the 
higher level system 
Higher level system – 
constantly changing. 
Culture and politics 
important. 
Lower level  
systems 
Relationships between 
parts within the system 
are important 
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clear documentation when developing the model structure.8  We learn by building upon what we already 
know, and how we see the world or a problem is constrained by our previous ‘knowledge’.9  As such, if a 
model is data-led and/or based only upon the analyst’s interpretation of the data, it may lead to a narrow 
view of what should be included within the model. Documenting an understanding of the problem prior to 
analysing available datasets allows that understanding to be reflected upon and shared. This reduces the risk 
of ignoring something which may be important to the model outcomes, which is particularly important given 
the potential dynamic complexity of the system. In terms of systems thinking (see key principle of good 
practice 1), documenting an understanding of the problem (the higher level system) allows the modeller to 
be able to define the boundary of the system of interest for modelling (see Figure 1). This description of the 
understanding of the problem should also help the modeller to understand the impact of potential 
simplifying assumptions they are making within the model. 
 
Practically, if the problem is not sufficiently understood an inappropriate model structure may be developed 
which, if recognised at a later stage of model development, may take a long time to alter within the 
computer software. This is particularly true if an alternative model type needs to be developed (for example, 
a discrete event simulation rather than a Markov model). Thus taking the time at the beginning of the 
project to understand the problem could reduce overall time requirements. Documenting the understanding 
of the problem also enables communication with stakeholders and the project team (see key principle of 
good practice 3). An additional benefit is that the documentation of the understanding of the problem could 
be used (alongside any logic models developed) to help stakeholders understand all of the impacts of the 
interventions in order to inform the scoping and/or the interpretation of systematic reviews of intervention 
effectiveness. Finally, documenting the understanding of the project will enable researchers and policy 
makers who are not involved within the project to understand the problem and the basis for decisions about 
the model structure. 
 
Thus, as also proposed by Kaltenthaler et al. (2011) within the context of clinical economic modelling,8  it is 
recommended that the model structure be developed in two phases. The first is to develop an 
understanding of the decision problem which is sufficiently formed to tackle the above theoretical and 
practical issues and should not be limited by what empirical evidence is available (see Section C). The second 
is to specify a model structure for the decision problem that is feasible within the constraints of the decision 
making process (see Section D). The understanding of the problem will inevitably continue to form during 
model development; however this initial documented understanding provides a basis for comparison and 
any major changes to this understanding can subsequently be documented.  
 
(3) Strong communication with stakeholders and members of the team throughout model 
development is important for model transparency, validity and credibility 
Literature suggests that stakeholders can encourage learning about the problem (including geographical 
variation of healthcare provision and stakeholders’ values and preferences), help to develop appropriate 
model objectives and requirements, facilitate model verification and validation, help to develop credibility 
and confidence in the model and its results, guide model development and experimentation, encourage 
creativity in finding a solution and facilitate model re-use.8;10-15  Additionally, stakeholders can help to define 
the meaning of subject-specific terminology which has a different lay meaning. Pidd has used the metaphor 
of taking a photograph of a scene, whereby each person involved might see different aspects of the scene 
and frame the photo differently.16  The more frames provided by people with different interests, the better 
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our understanding of the scene, and differences between perspectives can be discussed explicitly. Section B 
of the framework describes the types of stakeholders which may be involved. 
 
The modeller is encouraged to question the assumptions of the stakeholders17 and the project team 
throughout the model development process in order to uncover inconsistent, biased and invalid 
assumptions. Within topics where the project team have existing ‘knowledge’, it is important for them to be 
aware of the tendency to anchor to initial beliefs and be open to accepting new theories in order to develop 
valid models.1;18  Effective ways of communicating information such as using clear diagrams should be used 
in order to share information and describe assumptions.  
 
(4) A systematic consideration of the determinants of health is central to identifying all key impacts of 
the interventions within Public Health economic modelling 
The determinants of health which include the social, economic and physical environment, as well as the 
person’s individual characteristics, are central in the consideration of Public Health interventions. The 
determinants of health as described by Dahlgren and Whitehead are shown within Figure 2.19  Individual 
behaviours (or lifestyle factors) impact upon the broader determinants of health, which in turn impact upon 
individual behaviours.20  Thus, it is important to consider these broader determinants of health in order to be 
able to predict the full impact of the interventions upon health outcomes. In addition, the determinants of 
health could be used to think through all of the non-health costs and outcomes associated with the 
interventions that it might be useful to report, such as those within transport or employment. Consideration 
of the broader determinants of health also facilitates identification of potential intervention types to assess 
within the model including those which might impact upon individual health through making community and 
population-level changes, such as food production, as well as those which might impact upon health through 
changing individual lifestyle factors. Similarly, subpopulations that might benefit from the intervention could 
be identified. Finally, the consideration of social network effects could affect the analytical model type 
chosen, and subsequently the predicted impact of the interventions.  
 
It would not be appropriate or feasible to include all of the determinants of health within the model; 
however, they should be systematically reflected upon during the understanding of the problem phase to 
consider which determinants it might be important to include within the model so that all important 
mechanisms and outcomes of the interventions can be captured. 
 
Figure 2: Determinants of health 
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3.2 Overview of the phases within the conceptual modelling framework 
Figure 3 describes an outline of the phases within the conceptual modelling framework.  
 
Figure 3: Overview of conceptual modelling framework for Public Health economic modelling 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An iterative approach 
Choosing stakeholders and aligning the framework with the decision making process will generally need to 
be undertaken in parallel because the choice of stakeholders and their ideal level of involvement will depend 
upon the decision making process, but the availability of the stakeholders may have a substantial impact 
upon the process which is followed. It may be necessary to iterate between choosing relevant stakeholders 
and developing the understanding of the problem since the understanding of the problem phase may 
highlight the need to include stakeholders with specific expertise. Similarly, whilst it is important to develop 
an understanding of the problem prior to developing and justifying the model structure (see principle of 
good practice 2), in practice the understanding of the problem is never complete and it may be necessary to 
transparently revise this understanding at a later stage. These iterations are described by double headed 
arrows within Figure 3. The steps within the developing and justifying the model structure phase are also 
iterative as shown within Figure 3. Evidence identification is not described as a separate stage within Figure 
3 (apart from reviewing existing models) since it is an activity required within the majority of the outlined 
stages. However, iterations are inevitable between appropriate conceptualisation and data collection 
because there is unlikely to be the exact evidence available that has been specified by the conceptual model. 
  
C) Identifying relevant 
stakeholders 
B) Aligning the framework with 
the decision making process 
 
E) Understanding the problem 
iii) Developing a conceptual model of the problem describing hypothesised causal 
relationships and modelling objectives 
 
iv) Describing current resource pathways 
F) Developing and justifying the model structure 
vii) Reviewing existing economic evaluations 
 
viii) Choosing specific model interventions 
 
ix) Determining the model boundary 
 
x) Determining the level of detail 
 
xi) Choosing the model type 
 
xii) Developing a qualitative description of the quantitative model 
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3.3 Detailed methods of the framework       
C) Aligning the framework with the decision making process  
The conceptual modelling framework is intended to be flexible for different decision making arenas which 
means that decisions about how to employ the framework within the process are required. For example, the 
project team may need to operate differently according to the nature of the engagement with decision 
makers and clients within the project. If the client is the decision maker, then the scope of the model in 
terms of the interventions, comparators, populations, outcomes and perspectives may be better defined at 
the start of the project than if the client is not the decision maker (eg. a research funding body). This may 
influence the approach to evidence searching (in particular the search for intervention effectiveness 
evidence) and the time and resources required for model scoping. If the client is not the decision maker, the 
project team will need to identify the relevant decision makers and include them within the stakeholder 
group (see Section B). 
 
A protocol document outlining the project plan can be produced using the framework, as a basis for 
discussion between the project team and stakeholders. This helps the clients to understand whether the 
project is planned to run appropriately and the project team with project planning. Key process decisions to 
be made during this phase relate to the relevant modes of stakeholder engagement, the approach to 
evidence searching, and the time and resources available for the modelling project and each step of the 
framework. 
 
D) Identifying relevant stakeholders 
There are a number of different types of stakeholder within any Public Health project including clinical 
experts, decision makers and lay members. The choice of stakeholders involved with the development of the 
model will inevitably affect the model developed and the interventions assessed because modelling is 
subjective. For instance, stakeholders help define the model scope, make value judgements, use their 
expertise to recommend structural assumptions such as extrapolating short term trial data over the long 
term, and choose which interventions to assess within the model. Within some projects, the experts who 
inform the model development are chosen by the modelling team, whilst within others a group of experts 
are chosen by a decision making body, such as within the NICE process (see Section A). There is, however, 
usually the opportunity to involve additional experts chosen by the project team. A group of experts who will 
provide different expertise over a range of perspectives can be identified (see below). Practically, the 
approach to stakeholder communication needs to be flexible and some stakeholders will provide more input 
than others. 
 
Customers, actors and system owners 
Based upon Soft Systems Methodology (SSM)1 and a conceptual modelling paper by Roberts et al.10, the 
types of stakeholders to involve are: 
4) Customers which might include patient representatives and lay members; 
5) Actors which might include clinical experts and epidemiologic experts for all relevant diseases and 
methods experts; 
6) System owners which might include policy experts (in addition to some of the people identified as 
actors).  
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E) Understanding the problem 
One of the four principles of this framework is that developing and documenting an understanding of the 
problem is at the core of developing an appropriate model structure. This is about understanding what is 
relevant to the problem, and should not be limited by what empirical evidence is available.8  The 
understanding of the problem phase within Figure 3 includes (i) developing a conceptual model of the 
problem describing hypothesised causal relationships and (ii) describing current resource pathways.  
 
iii) Developing a conceptual model of the problem describing hypothesised causal relationships 
This section outlines a methodology for developing a conceptual model of the problem by using the notation 
of causal diagrams, borrowing some of the methods from cognitive mapping,21 and ensuring that the 
worldview of each of the stakeholders is considered.1;21  This provides a systematic approach for developing 
an understanding of the problem at an appropriate and manageable level of relevance.  
 
A causal diagram depicts the relationships between factors by arrows, using a + or – sign to indicate a 
positive or negative causal relationship. Causal diagrams allow feedback loops to be described which depict 
the dynamic complexity of the system. Each factor is a quantity such that one factor leads to an increase or 
decrease in another factor. For example,  
 
mean an increase in CVD events leads to an increase in costs and a decrease in quality of life respectively. 
The hypothesised causal relationships associated with the problem can be depicted using this notation, 
bringing together the understanding of relevant diseases, human behaviour and societal influences. Drawing 
upon cognitive mapping, the ultimate aims can be stated at the top of the diagram (by asking ‘why is x a 
problem?’), with intermediate outcomes below and options for change underneath (by asking ‘how can the 
problem be avoided?’).21  Detailed steps to develop the diagram are described overleaf. 
 
Evidence for developing the conceptual model of the problem 
Causal assumptions for policy prediction will be based upon experience and judgement since observational 
data can only be used to assess the statistical association between the specified causal relationships.22  The 
proposed diagram can provide an explicit description of our hypotheses about causal relationships and the 
challenge is to be able to justify the causal assumptions made. The causal hypotheses can be developed 
based upon a range of sources including the project scope, literature, stakeholder input, the team’s previous 
work in the area and any other diagrams which have been developed by the rest of the current project team 
or the decision makers to depict their understanding of the problem, as described within Figure 4 below. By 
developing the diagram with input from stakeholders, it allows their assumptions and beliefs to be made 
explicit so that they can be agreed upon or questioned. The iterative process using all of the evidence 
sources outlined within Figure 4 provides multiple opportunities to question and adapt the causal 
assumptions. Ultimately, the diagram will depict the modeller’s assumptions and beliefs about the causal 
relationships based upon all of these sources of evidence. In doing so, some forms of information may 
dominate over others according to the modeller’s views of the validity of the information. 
 
  
+ CVD event Cost       and         CVD event                
_ 
Quality of life 
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Figure 4: Sources used for developing the conceptual model of the problem 
 
 
Step 1: What is the problem? 
The first step, based upon cognitive mapping,21 is to ask ‘what is the problem?’ This is the key problem from 
the decision makers’ perspective and could be based upon the project scope if available. The cause of the 
problem described should include a potentially modifiable component. The model objective is likely to be 
(although not necessarily) to assess the effectiveness and cost-effectiveness of interventions which might 
decrease this problem. Beginning the development of the diagram by identifying the key problem 
encourages a focused boundary around the understanding of the problem. 
 
Step 2: Why is this a problem? 
The modeller can then ask ‘why is this a problem?’, and continue to ask ‘why?’ or ‘what are the implications 
of this?’ until no more factors are identified, again based upon the methods of cognitive mapping.21  Within 
Public Health economic modelling the goal may be to maximise net benefit by maximising health and 
minimising costs, or equity may be considered of primary importance. 
 
Step 3: Developing additional causal links 
A set of questions have been constructed which may be useful to help develop the diagram further, as 
shown in Box 1. The development of the understanding of the problem is iterative, and hence it may be 
useful to continually revisit these questions. 
 
 
 
 
 
 
  
Starting with high 
yield sources 
Individual stakeholder 
assumptions & beliefs 
Stakeholder    
discussion 
Modeller assumptions 
& beliefs 
Project scope 
Literature 
sources 
Existing diagrams/ 
previous work       
Conceptual model of the problem 
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Box 1: Questions about the decision problem to help with developing the diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 4: Incorporating types of intervention 
Within dynamically complex systems like Public Health systems, the possible types of interventions may not 
be easily definable at the start of the project prior to developing a sufficient understanding of the problem. 
Thus, the modeller can ask how to avoid or reduce the impact of the described problem. It is useful to firstly 
know what is considered to be current practice. Potential types of interventions can then be added based 
upon the project scope, any effectiveness studies identified, and by considering within the diagram where 
interventions may be beneficial. One way of doing this is to consider which of the potentially modifiable 
determinants of health (individual lifestyle factors; living and working conditions and access to essential 
goods; and general socioeconomic, cultural and environmental conditions) affect the decision problem. 
Combinations of individual, community and population interventions may be considered.23 It is not expected 
that the final interventions being assessed within the model will have been chosen at this stage. However, it 
is important to define the types of interventions which might be assessed within the model so that their 
impact upon model factors, including those not already incorporated into the diagram, may be considered.  
 
A set of questions have been constructed which may be useful for considering the impacts of the 
interventions, shown in Box 2. These should be considered in the context of each type of intervention 
potentially being assessed within the model.  
A1. Questions relating to the disease and the determinants of health include: 
- Have any relevant disease natural histories been captured? 
- Are the following determinants of health (taken from Dahlgren and Whitehead) important in 
determining effects and in what way:   
o Age, sex and other inherent characteristics of the population of interest? 
o Individual lifestyle factors? (incl. diet, physical activity, smoking, alcohol/ drug misuse) 
o Social and community networks? (incl. friends, family including intergenerational impacts, wider 
social circles) 
o Living and working conditions and access to essential goods and services? (incl. unemployment, 
work environment, agriculture & food production, education, water & sanitation, health care 
services, housing) 
o General socioeconomic, cultural and environmental conditions? (incl. economic activity, 
government policies, climate, built environment including transportation, crime)  
 
A2. Questions to help ensure the understanding of the problem is sufficiently broad include: 
- Are there any other (positive or negative) consequences of each concept? 
 
A3. Questions to ensure that the dynamic complexity of the system has been captured are: 
- Could there be any other factors which explain two outcomes, for links which may not be causal, but 
correlated.  
- Are there any other possible causal links between the factors? (with the aim of establishing whether 
there are any feedback loops) 
- Are there interactions between people which affect outcomes? (see social networks above)  
- Is timing/ ordering of events important? 
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Box 2: Questions about the interventions and their impacts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modelling objectives 
The modelling objective should be clearly defined and regularly referred to during the design-oriented 
conceptual modelling phase (see Section D) so that the model is built for purpose. This can be developed 
based upon the conceptual model of the problem, and may comprise the ultimate goals, the types of 
interventions being assessed and the population(s) of interest. As Roberts et al. suggest, the policy context 
of the modelling project needs to be clear, particularly in terms of the funder, the policy audience and 
whether the model is planned to be for single or multiple use.10 
 
iv) Describing current resource pathways 
The conceptual model of the problem can be used to inform what resources might need to be considered. 
This does not need to be a detailed description of resource use at this stage, since some factors within the 
conceptual model may be excluded from the quantitative model and hence it would be inefficient to collect 
detailed information. It also means that the general pathways can be validated with stakeholders prior to 
collecting detailed information. Flow diagrams, tables and/or a textual description of the resource pathways 
can be useful to inform consideration of the potential impact of the factors within the conceptual model of 
the problem upon the model results. This can be used to help choose which factors to include and exclude 
from the model as is discussed within the model boundary stage of the framework (see Section D(iii)).  
  
  
B1. Questions relating to the constraints of the decision making process are: 
- Are there constraints on the project scope? (eg. are we constrained by the types of interventions we 
are assessing? What about the population?)  
 
B2. Questions relating to the goals and mechanisms associated with the interventions are: 
- What is considered to be a good outcome? 
- What would happen in the absence of the interventions versus as a result of the interventions – 
would negative outcomes be prevented or delayed? 
- What evidence exists to describe the outcomes of the intervention/ comparator over time? Are 
behavioural outcomes important? If so, do any relevant models of behaviour from psychology, 
sociology or behavioural economics exist to help describe the behaviour resulting from the 
intervention or the comparator? This will require additional targeted literature searches. 
- Are there any determinants of health reported by the effectiveness studies which are not included 
within the causal diagram? Can such a relationship be described? 
 
B3. Questions relating to the dynamic complexity of the system are: 
- Might a third party act to reduce the impact of interventions? 
- Are there any substantial impacts of social and/or community networks upon intervention 
effectiveness? Will these impacts be captured over the long term within the effectiveness evidence?  
- Are there any substantial impacts of the interventions upon other lifestyle factors? 
- Might the interventions have other impacts not already considered? 
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F) Developing and justifying the model structure 
This section aims to outline an approach for specifying an appropriate model structure that is feasible, valid 
and credible to develop into a quantitative model, which may be described as the design-oriented 
conceptual modelling phase.8  As outlined within Figure 3, this includes: (i) reviewing existing health 
economic models; (ii) choosing model interventions and comparators; (iii) determining the model boundary 
(deciding what factors are included within the model rather than being part of its external environment); (iv) 
determining the level of detail (the breakdown of what is included for each factor within the model 
boundary and how the relationships between factors are defined); (v) choosing the model type (the analytic 
modelling technique employed, for example a Markov model), and (vi) developing a qualitative description 
of the quantitative model.  
 
vii) Reviewing existing health economic models 
It is standard practice within health economic evaluation to undertake a systematic review of existing health 
economic models in the same area. Some existing models may have been used to develop the understanding 
of the problem, but a systematic review of models at this stage can be used in a number of ways24: 
 To determine whether there is already a model which could be used, either in part or as a whole; 
 To consider the strengths and limitations of existing economic evaluations, which can be used to inform 
the model development; 
 To compare and contrast how other modellers have chosen to structure the model and estimate key 
variables, and how the model results differ based upon these choices. This may involve considering the 
use of mathematical relationships such as risk equations or parameters which have been included within 
previous models if their source and justification has been appropriately explained; 
 To identify which variables are important in influencing model results (including any which have not been 
highlighted during the understanding of the problem phase) and which do not substantially affect the 
differences in outcomes between the interventions and comparators; 
 To provide an insight into the types of data available which may inform the model level of detail. 
 
viii) Choosing model interventions and comparators 
Method for choosing model interventions to assess within the model 
The decision makers (with consideration of the clients’ needs if they are not the decision makers) should 
define which specific interventions to model grounded within the results of an evidence review and 
according to expertise from other stakeholders. The decision makers may use the systematic review of 
effectiveness evidence to further limit interventions by discussing trial populations, outcomes and other 
potential biases. It is possible that one good study or a number of studies can be used to estimate the short 
term effectiveness. As far as possible, the comparator can be based upon the same studies as the 
interventions if this is representative in practice. If practice is substantially different, then an adjustment on 
the effectiveness estimate would be required. Given that economic evaluation is a comparative analysis, the 
model results are only meaningful in relation to the comparators chosen.10  Which outcomes the 
effectiveness studies report will guide the development of the model structure.  
 
Use of the reviews to develop the model boundary, level of detail and model type 
The review of existing economic evaluations and the review of intervention effectiveness can be used to 
facilitate decisions around the model boundary, level of detail and model type as shown within Figure 5 
below.  
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Figure 5: Defining the model boundary, level of detail and model type 
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ix) Determining the model boundary 
Determining the model boundary is about deciding, based upon the understanding of the problem, what 
factors should be judged as relevant for inclusion within the model and which can be excluded given the 
time and resource constraints of the decision making process. The boundary of the model structure must 
differ from the boundary of the understanding of the problem in order to be able to make informed 
judgements about what it is important to include within the model structure (see Figure 1). It is important to 
define the boundary of the model such that all important interactions between the elements of the system 
identified within the understanding of the problem are captured.17   
 
Model population and subgroups 
The model populations can be discussed with the stakeholders, informed by the populations within the 
effectiveness studies. The modelling team and the stakeholders could consider whether there is a bigger 
problem in a particular subgroup or whether the intervention is likely to be more effective in a particular 
subgroup and if there is sufficient data to undertake any subgroup analysis. These subgroups might be based 
upon the determinants of health outlined within Figure 2 including age, sex and other inherent 
characteristics of the population of interest, individual lifestyle factors, living and working conditions and 
access to essential goods, and general socioeconomic, cultural and environmental conditions.  
 
Model perspectives and outcomes 
Often within health economic evaluation, the NHS and PSS perspective is employed.25  However, within 
Public Health economic modelling, other perspectives are likely to be relevant because substantial costs and 
benefits may extend beyond these sectors. Alternative perspectives include (but are not limited to) a societal 
perspective, a Public Sector perspective or the perspective of the particular agencies involved within the 
system. The perspectives of the system owners identified within Section B of the framework are likely to be 
appropriate. For example, if employers are considered to be system owners, then it is likely to be useful to 
consider an employer perspective. The choice of perspectives will also depend upon the modelling 
objectives. It should be noted that there are currently unresolved issues around using these alternative 
perspectives in terms of (i) whether it is possible or desirable to make social value judgements associated 
with the value of health relative to the value of other costs and benefits and (ii) the practicality of 
transferring costs and benefits between sectors.26  Nonetheless, if substantial costs and benefits are 
expected to fall outside of the NHS and PSS, presenting these alternative perspectives is likely to be 
informative for decision makers.  
 
In order to be able to compare interventions across different populations in terms of health costs and 
outcomes, the incremental cost per QALY may be employed, based upon New Welfare Economics.27  Where 
the model boundary extends beyond health, it may be useful to understand the modelling requirements in 
other sectors so that relevant outcomes may be presented. One way of presenting multiple outcomes for 
different sectors is to present a cost-consequence analysis alongside the cost-effectiveness analysis.28-30  
Decision makers can suggest which model outcomes it would be useful to report. For both model 
perspectives and outcomes, the modeller should follow any specific requirements of the decision makers 
such as the use of the NICE Public Health Methods Guide. A method for choosing model outcomes and 
perspectives has been outlined within Figure 6. 
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Figure 6: Method for choosing appropriate modelling perspectives and outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
Other model boundary considerations 
An algorithm to help define the model boundary is shown within Figure 7 and can be considered for each 
factor within the conceptual model of the problem. Within Figure 7,  the question ‘does the factor have 
many causal links?’ aims to identify which factors are central and should be included within the model, even 
in the absence of data (lots of links), and which factors are less important (not many links to other factors). 
This can be done formally within computer software if preferred.21  The question around whether the  
impact of a factor is substantially captured by other factors attempts to exclude any double counting within 
the understanding of the problem phase (for example, including fatigue and diabetes) as far as possible from 
the quantitative model.  
 
It is valuable to predict very approximately the results of the model to facilitate model verification. These 
predictions can also help with defining the model boundary. Figure 7 encourages the modeller to think about 
whether it is worthwhile including non-central factors given the expected results of the model and the 
anticipated direction of effect of the factor upon those results, as well as the differential impacts of the 
interventions upon that factor. If different interventions impact the factor by different mechanisms, then 
including or excluding the factor may lead to different conclusions based upon the incremental analysis. 
 
In terms of the question within Figure 7 around whether the factor is likely to have a substantial impact upon 
the difference between costs and effects of the interventions, this entails having an understanding of the 
magnitude of the cost and outcomes associated with the factor and the extent to which the interventions 
might change these. These subjective judgements will inevitably be considered in the context of the time 
available for modelling and the potential future uses of the model. Whether or not the factor will impact 
substantially upon the model results is a subjective judgement which, practically, may be influenced by the 
time available to develop the model. However, the model boundary stage should not be overly dependent 
upon the evidence or time available as this can be accommodated for by the level of detail incorporated. It is 
likely to be more appropriate to crudely include a factor which is expected to substantially affect the model 
results than to exclude it from the model completely.  
 
Finally, to maintain model credibility, stakeholders can be asked whether they are happy, given the above 
justifications, with the exclusion of factors. One way of reporting this stage is to produce a table stating 
whether each factor is included or excluded and the justification for exclusion as suggested by Robinson.31   
2) Consider what is theoretically appropriate and what is required under a reference case if 
applicable for (a) perspectives and (b) outcomes.  
When considering (b) model outcomes, how do the model perspectives affect this?  
 
2)    Consider by whom the results of the research will be used to consider whether additional (a) 
perspectives and (b) outcomes may be useful. 
3)    Discuss with stakeholders those perspectives and outcomes identified within (1) and (2) and 
ask if there are any additional (a) perspectives and (b) outcomes that it might be useful to consider. 
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Figure 7: Defining the model boundary 
 
Does the factor have many causal links? 
 
Yes No 
Is the factor likely to have a substantial 
impact upon the difference between costs & 
effects of the interventions? This may be 
based upon (though not limited to):  
(7) the review of economic evaluations; 
(8) the description of resource pathways; 
(9) clinical papers describing the causal links; 
(10) existing models in similar areas which 
describe the impact of the factor; 
(11) methodological choices eg. 
discounting; 
(12) expert advice. 
Yes No 
INCLUD
E 
Is the factor associated with the interventions, 
populations & outcomes being modelled? 
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E 
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E 
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E 
Yes No 
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Is the impact of the factor predominantly 
captured by other included factors? 
Yes 
EXCLUD
E 
No 
Would stakeholders prefer to 
include the factor for model 
credibility AND is it relatively easy 
to incorporate in terms of 
modelling skill & data availability? 
INCLUD
E 
No 
Are all interventions likely to be cost saving/ have a low ICER 
AND does the factor further increase benefits/ decrease costs 
AND do all interventions affect the factor in the same way? 
Yes 
No 
To be considered in the context of the time available for modelling & potential model reuse 
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x) Determining the level of detail 
The level of detail is defined as the breakdown of what is included for each factor within the model 
boundary and how the relationships between factors are defined. A decision about which parts of 
the model are likely to benefit from a more detailed analysis can be made a priori in order to avoid 
situations in which the modeller focuses upon specific parts of the model because they are more 
easily dealt with and subsequently run out of time to develop other parts in detail. Essentially, 
determining the level of detail involves a mini cost-benefit analysis within which modellers can 
weigh up, based upon the documented understanding of the problem and the defined model 
boundary, whether the time required to do one analysis at a specific level of detail within the model 
is likely to have more of an impact upon the model results compared with the same time period 
spent upon other analysis, given the current evidence available and the overall time constraints. 
During model analysis, more detail can be incorporated if part of the model is shown to substantially 
affect the results. Box 3 summarises key questions for the modeller to help choose an appropriate 
level of detail. 
Box 3: Questions to help in making judgements about the model level of detail 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General 
 Is the time required to do the analysis at a specific level of detail likely to have more of an impact 
upon the model results than the same time period spent upon other analyses, given the 
evidence available and the overall time constraints? 
 
To describe the relationship between the included factors over time 
 What outcomes are reported within the review of intervention effectiveness?  
(to help choose which causal links to include) 
 What evidence is available to model the causal links and the outcomes of the factor? 
(to avoid relying on the first available evidence) 
 What do other economic evaluations suggest are the strengths and limitations of different 
mathematical relationships between model factors? 
 Which determinants of health are key drivers of the problem according to relevant theory? 
 
To extrapolate study outcomes 
 What outcomes are reported within the review of intervention effectiveness? 
 What evidence is available for long term follow up? 
 Is there sufficient evidence and time available to model social networks given the expected 
impact upon model results (based upon the understanding of the problem)? 
 
The level of detail used to describe each included factor  
 Which are the specific aspects of each factor that are likely to have a substantial impact upon the 
model results? 
o Is all costly resource use captured? 
o Are all substantial health benefits and disbenefits captured using measures acceptable 
to the decision maker given the available evidence? 
 Are impacts included within both costs and benefits where appropriate? 
 
How interventions will be implemented in practice 
 What do the effectiveness studies describe? 
 What do stakeholders suggest would happen in practice and is this likely to lead to different 
estimates of effectiveness to those within the study? 
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Searching for evidence 
Data for inclusion for specifying the model structure and for the parameters will need to be 
identified at this point if it has not been already. This could be based upon literature identified 
during the development of the conceptual model of the problem for which specific literature was 
noted as useful, although additional specific searches may also be required. Data collection and the 
development of a description of the level of detail for the model will be a highly iterative process. 
Sufficient evidence is required to be able to justify why the modelling choices have been made.32  It 
is important to note that elements for which there is a lack of empirical data which are considered to 
have key differential impacts upon the comparator(s) and the intervention(s) may be informed by 
expert elicitation. One consideration at this stage is likely to be the derivation of the disease natural 
history parameters which may be taken from existing studies or calibrated using statistical methods 
such as the Metropolis Hastings algorithm.33  
 
Distinction between model assumptions and simplifications 
Robinson highlights the distinction between model assumptions and simplifications; model 
assumptions ‘are made either when there are uncertainties or beliefs about the real world being 
modelled’ and model simplifications ‘are incorporated in the model to enable more rapid model 
development and use, and to improve transparency’.34  Thus, model assumptions are uncertain and 
alternative plausible assumptions can be tested within the model, whilst model simplifications are 
chosen because they are likely to have limited impact upon the model results. It is important to be 
explicit about both of these when describing the level of detail and highlight model assumptions 
which could be tested within sensitivity analyses. 
 
Reporting level of detail 
The simplifications and assumptions should be described and explained, initially for communication 
purposes with stakeholders and the project team to develop model validity and credibility, but also 
to facilitate future modelling projects in the same area. A document can be developed which 
specifies all of the key model simplifications and assumptions for discussion with stakeholders, 
ideally during a second workshop. This can help to identify the most appropriate evidence for the 
model and also improve model validity and credibility. Writing down all of the key simplifications 
and assumptions and their justification provides a mechanism for systematically questioning them 
within project team discussions and with the stakeholders; thus enhancing the appropriateness of 
the model simplifications and assumptions.   
 
Expressing structural uncertainty 
It may be that where there is more than one plausible assumption it is appropriate to develop model 
structures for each assumption in order to undertake posterior analysis of structural uncertainty, for 
example model averaging. This would be undertaken by creating a parameter to be included within 
the probabilistic sensitivity analysis to represent the probability of each structure being appropriate. 
This parameter and its distribution could then be estimated by elicitation with experts.35  
 
The level of detail will be affected by the model type chosen, and hence it will be an iterative process 
between identifying an appropriate level of detail and choosing the model type. 
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Determine the most appropriate model type for the characteristics of the problem (see above). 
Is this feasible within the time and resource constraints of the decision making process given: 
(iv) the data available? 
 AND 
(v) the accessibility of any existing relevant good quality economic evaluations for use as a starting point?  
AND 
(vi) the expertise of the modeller? 
 
Are you intending to use the model 
again for other projects? 
Can you answer the question with a few 
provisos with a simpler model type, given 
your understanding of the problem? 
Yes No 
Explore with the 
decision maker the 
most useful purpose of 
the modelling given 
the project constraints 
Develop the simpler 
model type, documenting 
the provisos, uncertainties 
& implications of the 
simplifications 
No Yes 
Do you think a simpler model 
type would lead to the same 
conclusions, given your 
understanding of the problem? 
Develop 
the 
model 
Yes No 
Develop the more 
complex model 
Develop the simpler model, 
documenting the provisos, 
uncertainties & implications 
of the simplifications 
Yes No 
xi) Choosing the model type 
Most appropriate model type given the characteristics of the problem 
It is important to understand the most appropriate method given the characteristics of the problem, 
even if it is not practical to develop this model type, so that the modeller can understand the 
simplifications they are making. A number of existing papers outline taxonomies for deciding upon 
appropriate model types given the characteristics of the problem for health economic modelling.36-38  
The taxonomy developed by Brennan et al. is used here.36 It can be summarised by asking whether 
interaction, timing and stochasticity are important, and whether there is sufficient data for an 
individual level model rather than a cohort model, each of which leads to a preferred model type. 
Whilst decision trees and Markov models are most often employed within Health Technology 
Assessment,37 because of the complexity associated with Public Health systems it is likely that 
alternative model types may be more appropriate. Agent-based simulation (ABS) is not included 
within the taxonomy by Brennan et al.; however it may be useful for modelling dynamically complex 
Public Health systems. ABS is a bottom-up approach where the behaviour of the system is a result of 
the defined behaviour (based upon a set of rules) of individual agents and their interactions within 
the system.39 Thus, ABS may be preferable when the interactions between heterogeneous agents 
and their environment are important. ABS more easily allows the analyst to capture spatial aspects 
in order to model appropriate interactions (eg. family and friend networks for transmission of a 
contagious disease).39 Studies have shown social network impacts of behaviours such as dietary 
habits.40   
 
Most appropriate model type based upon broader considerations 
It may not always be practical to employ the model type which is most appropriate for the 
characteristics of the problem. Figure 8 provides an outline of how the modeller might decide on the 
most appropriate model type according to broader practical issues. 
 
Figure 8: Choosing the model structure 
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xii) Qualitative description of the quantitative model 
A qualitative diagram of the quantitative model alongside the development of the model structure 
can facilitate clear communication of the final model structure to stakeholders, other members of 
the team and people who may want to understand the model in the future. This will depend upon 
the model type developed but may take the forms outlined in Table 2. Whilst the design-oriented 
conceptual modelling can be described prior to the quantitative model development, it may be 
iteratively revised according to data availability and/or inconsistencies identified during the 
development of the quantitative model.8;12;13;31  These modifications should be documented 
throughout so that there is transparent justification for the final model developed. 
 
Table 2: Suggested diagrams to represent the implemented model  
Model type developed Suggested diagram 
Decision tree Decision tree diagram 
Markov model State transition diagram 
System dynamics Influence diagram / stock and flow diagram 
Individual event history model State transition diagram 
Discrete event simulation Activity cycle diagram 
Agent based model A flow diagram 
 
4. Discussion 
A framework has been developed as a helpful tool for modellers of Public Health economic models. 
In 2011 Chilcott et al. highlighted the lack of formal methods for model development41 and when 
this research began, there were no publications associated with conceptual modelling within health 
economic modelling. Since then the International Society for Pharmacoeconomics and Outcomes 
Research and the Society for Medical Decision Making (ISPOR-SMDM) Joint Modeling Good Research 
Practices Task Force have developed guidance around conceptual modelling for health economic 
modelling and a Technical Support Document has been developed for the National Institute for 
Health and Care Excellence Decision Support Unit (NICE DSU) around identifying and reviewing 
evidence to inform the conceptualisation and population of cost-effectiveness models.8;10  The 
recent development of these two conceptual modelling frameworks highlights the importance and 
timely nature of this work. The conceptual modelling framework developed here complements and 
adds to these existing frameworks by focusing upon Public Health economic modelling. The main 
contribution of this research is that it provides a systematic approach to developing Public Health 
model structures, and in particular, systematic consideration of: 
a. Dynamic complexity (feedback loops, unintended consequences); 
b. The broader determinants of health; 
c. How to progress from an understanding of the problem to the model structure; 
d. Stakeholder involvement. 
 
Initial evaluation will be via a focus group with modellers. It is offered for further testing within case 
studies. The conceptual modelling framework that has been developed aims to provide a reference 
document which can be continually improved following its use within different Public Health 
economic modelling projects and according to developments within other related research areas 
(eg. modelling human behaviour, quantifying relevant outcomes). The framework has been 
developed within a UK context and would benefit from testing within an international arena. For 
more information about how the conceptual modelling framework was developed and the 
evaluation of the framework please see the doctoral thesis by Squires (in preparation).3  
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Appendix F: Critical assessment of the conceptual modelling framework 
Appendix F1: Topic guide for the evaluation focus group meeting 
Aim: to evaluate the potential of the conceptual modelling framework to improve the quality of 
Public Health economic model structures  
 
Preliminaries 
(7 mins) 
1) Introduce Paul and I (and explain that I won’t be staying in the room and why) 
2) Outline of the research topic, purpose (important for participation), funder 
3) Confidentiality (anonymous, but may be identifiable), audio recording, what will happen to 
the data, dissemination. Consent forms (get everyone to sign if not already). 
4) Please could everyone treat what is said as confidential and not repeat it outside of the 
session without permission from the relevant participant. 
I leave. 
(8 mins) 
5) Indication of expectations – want to have a discussion, participants should not wait to be 
invited before speaking (although don’t talk over each other), everyone’s views are of 
interest, want to hear as many different thoughts as possible, as such if agree or disagree 
with other participants say so. 
6) Ask everyone to introduce themselves – names & brief background focusing upon Public 
Health modelling. 
7) Could highlight the diversity/ similarity of the group as a whole. 
 
Topic guide 
Thinking of your previous experience (eg. think of previous projects), would a conceptual modelling 
framework have been helpful and why? (10 mins) 
Can give specific examples. 
Might it help with: 
- providing a tool for communication with stakeholders? 
- aiding the development of modelling objectives? 
- guiding model development and experimentation? 
- improving model credibility, verification, validation? 
-allowing model reuse? 
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What do you think would be the key benefits and issues with using the conceptual modelling 
framework presented? (30 mins – let this keep going longer if covering other topics) 
Why? 
Might it have helped structure your thinking? 
Are there aspects within the framework which you may not have considered? Eg. some of the 
broader determinants of health, the dynamic complexity with feedback loops etc. 
Would it have helped with stakeholder involvement decisions? 
Might there be feasibility issues with its use? 
Would you/ other modellers think that it does not add anything to what they currently do?    
Might it be less appropriate for some Public Health contexts? (relates to below question) 
Where there any parts of the framework that were more or less helpful than others and why? 
 
In what circumstances might you use or not use the outlined conceptual modelling framework?  
(15 mins) 
Would the decision to use the framework be affected by project timeframes, resources or the 
decision making context?  
To what extent is it relevant beyond the NICE process? 
To what extent do you think it might have international relevance? 
 
Who do you think might benefit from using the framework? (5-10 mins) 
 Experienced/ inexperienced modellers (in public health?) 
  
In what way do you think the outlined conceptual modelling framework has the potential to 
improve the quality of Public Health economic model structures? (30 mins) 
 Why? 
To what extent do you think it might: 
- provide a tool for communication with stakeholders? 
- aid the development of modelling objectives? 
- guide model development and experimentation? 
- improve model credibility, verification, validation? 
-allow model reuse? 
You have been very quiet; do you have concerns about whether the conceptual modelling 
framework would have the potential to improve the quality of Public Health economic model 
structures? 
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What do you think are the requirements for successful implementation of the conceptual modelling 
framework? (5-10 mins) 
 What further evaluation might be useful? 
What might encourage its use? Eg. Publication, conference presentations, recommendation 
by a decision-making body such as NICE. 
 
Is there anything else you’d like to say around what we’ve talked about today? (5 mins) 
 
Generic probes 
Why do you think that? 
What did you do after that?  
You talked about… Tell me more about… 
It would be useful to explore x further… 
What do you mean by…?  
 
Other notes about running the focus group 
Pressure on participants to conform: Ask whether anyone has any different views or ask a person 
who is likely to have a different view 
Dominant person: That’s really helpful; does anybody else have a view on this? 
Quiet person: What do you think? Or you said xxx previously, what… 
Recording non-verbal behaviour: ‘Everyone’s nodding  a lot – why is that?’ 
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Appendix F2: Verification of the conceptual modelling framework 
Framework aims  How this was incorporated into the conceptual modelling framework 
A conceptual modelling framework specifically for Public Health economic modelling has 
the potential to provide more guidance about the approach than a generic framework. 
The entire framework is based upon domain-specific procedures and 
considerations. 
To aid the model development process but not constrain it. It should allow for the 
variation in requirements of different Public Health economic modelling and be clear that 
there is scope for further methods development given the early phase of development of 
a framework within Public Health economic modelling. 
Phase A involves the modeller aligning how the framework is used with the 
decision making process. The general tone of the framework aims to be suggestive 
rather than restrictive. The HESG paper states within the discussion that there is 
scope for further methods development; however the document circulated to the 
focus group participants did not make this clear. 
To provide a general outline of the model development process in Public Health 
economic modelling. 
Figure 3 provides this. 
To provide a tool for communication with the project team and stakeholders. The diagrams and tables suggested aim to aid communication. 
To help modellers make decisions about what to include and exclude within a model. Figure 9 is a flow chart which aims to help modellers make judgements about 
what to include/ exclude from the model based upon the documented 
understanding of the problem. 
To help modellers determine appropriate and inappropriate simplifications of the 
problem. 
Box 3 outlines questions for modellers which aim to help them make judgements 
about the appropriate level of detail, based upon the understanding of the 
problem. This seems like the least well developed area of the conceptual 
modelling framework and this may because it is not possible to produce a simple 
algorithm to help modellers think about this.  
To provide a transparent approach for choosing model interventions. Section Dii outlines an approach with a flow diagram describing this.  
To encourage understanding of the implications of the structural choices that the 
modellers make. 
Documenting the understanding of the problem should help modellers consider 
the simplifications they are making when developing the model and the 
implications of these. Figure 10 encourages the modeller to consider the 
implications of choosing a specific model type. 
To help decision makers make decisions, as opposed to trying to represent reality. There is acknowledgment that time constraints are an important factor 
throughout, including when considering the most appropriate analytic model type. 
To facilitate clear reporting of the model structure and the process by which it was 
developed. 
(1) Documenting the understanding of the problem describing the hypothesised 
causal relationships; (2) Tabling the perspectives and outcomes and describing the 
interventions, comparators and populations to assess; (3) Tabling what is 
included/ excluded within the model and why compared with the understanding 
of the problem; (4) Recording the key model assumptions/ simplifications and 
their justification; (5) A diagram of the model structure. 
To encourage modellers to question the assumptions of the experts and decision makers. This is explicitly stated within Phase B of the framework. 
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Framework aims  How this was incorporated into the conceptual modelling framework 
To take into account that modellers have different skill sets and encourage modellers to 
recognise potential skill set biases and moderate impact. 
The general tone of the framework aims to be suggestive rather than restrictive. 
Figure 10 is a flow chart to help modellers make judgements about the most 
appropriate analytic model type and it considers the modellers expertise. 
To include an example to illustrate the methods. The methods are illustrated throughout using the diabetes project example. 
To be clear about what the framework can and cannot do. This is specified when describing the aim of the framework; however more detail 
could be added based upon the analysis of the focus group data and any future 
evaluation. 
To be culturally acceptable and simple to use in practice (use of flow diagrams, tables and 
boxes rather than large chunks of text). 
There is a mixture of text, diagrams, tables and boxes; however the qualitative 
research suggests that there is currently too much text (see Section 7.3.2). 
To clearly and concisely describe why a conceptual modelling framework is beneficial. A 
discussion about the preconceptions that modellers may have which might be 
inconsistent with the conceptual modelling framework could also be described. In 
addition, the key principles and methods within the framework need to be well justified 
and evidence-based where possible. 
Within the introduction Table 1 describes the benefits of a conceptual modelling 
framework. The key principles and methods are justified and relevant literature is 
referenced where appropriate. 
 
General principles: How the modeller should approach the problem How this was incorporated into the conceptual modelling framework 
A systems approach is expected to be an appropriate approach for modelling most Public 
Health systems, taking a holistic view of the system and focusing upon the relationships 
between components. This involves understanding the complex causal chains, including 
feedback loops, and the unintended consequences of the comparators and interventions 
upon other parts of the system. 
The method for documenting the understanding of the problem involves the 
modeller describing the hypothesised causal relationships between factors and 
the accompanying questions encourage consideration of feedback loops and 
unintended consequences. It is suggested that relevant stakeholders are identified 
using some features of soft systems methodology and that these are involved 
throughout model development. 
A systematic consideration of the determinants of health is central to identifying all key 
impacts of the interventions within Public Health economic modelling. 
The questions to help the modeller develop the understanding of the problem 
focus upon the broader determinants of health.  It is also suggested that they are 
considered when choosing the interventions and subpopulations of interest. 
To involve stakeholders within each stage of conceptual model development in order to 
encourage learning about the problem, develop appropriate model requirements, 
facilitate model verification and validation, help develop credibility and confidence in the 
model and its results, guide model development and experimentation, and encourage 
creativity in finding a solution. 
It is suggested that stakeholders are involved during all stages of model 
development and there is advice for doing this throughout the framework. 
To specify modelling objectives and develop a thorough documented understanding of 
the problem, and subsequently choose model options, determine the model scope and 
level of detail, and identify structural assumptions and model type, with a different 
representation for each. This model development process is iterative. 
The conceptual modelling framework follows this general approach, an overview 
of which is provided within Figure 3.  
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Methodological considerations: Things the modeller should do during conceptual 
modelling 
How this was incorporated into the conceptual modelling framework 
To consider the use of modelling methods to enable the broader determinants of health 
to be incorporated such as agent-based simulation and social network analysis. 
Different model types, including agent-based simulation, are considered within 
Phase D. 
To be practical within a decision making context by considering the needs of the decision 
makers, including the time requirements upon the stakeholders. 
Phase A involves the modeller aligning how the framework is used with the 
decision making process. The framework aims to be flexible throughout. 
Cognitive mapping, causal diagrams and SSM may be useful for objective setting and 
developing the understanding of the problem. 
An approach is suggested combining cognitive mapping and causal diagrams. 
Stakeholders are identified using features of SSM. 
At an early stage, to develop an understanding of the question and the interventions, the 
population and subgroups of interest. 
These are early stages of the framework as shown within Figure 3. 
To consider the most appropriate outcome measure and perspective to report to 
decision makers. 
Figure 8 is a flow diagram showing how these might be chosen. 
To consider the choice of experts and the implications of these choices. Phase B describes how stakeholders might be identified. 
To consider any diagrams, such as logic models, developed by decision makers or other 
parts of the team on the project. 
It is suggested that these are considered when developing the understanding of 
the problem. 
To recognise relevant methods guidance (eg. NICE methods guide). It is suggested that such guidance is considered when developing the 
understanding of the problem and when specifying the model scope. 
To consider the likely cost-effectiveness of the interventions in making decisions about 
model structure. 
This is incorporated into Figure 9 and Box 3 which aim to help the modellers make 
judgements about the model boundary and level of detail respectively. 
To consider the trade off between developing an appropriate structure for the problem 
versus ability to meet deadlines. 
Figure 9, Box 3 and Figure 10, which aim to help the modellers make judgements 
about the model boundary, level of detail and model type respectively, all include 
consideration of the time constraints of the project.  
To consider the trade-off between providing stakeholders with something to critique and 
limiting their thinking. 
This is considered within Phase C (understanding the problem). 
To explore the use of existing models in the same area. Section Di suggests exploring existing models and how this might be useful. 
To consider whether a more exploratory analysis would be useful given time constraints. This is included within the flow diagram for choosing model type (Figure 10). 
To suggest that the model perspectives, outcomes, potential interventions and 
populations are discussed at an early stage of the project, particularly if the project 
question and scope have been developed by researchers rather than decision maker. 
These are early stages of the framework as shown within Figure 3. It is suggested 
within the process suggestions that these are discussed within the first workshop 
with stakeholders if one is held. 
To undertake a first step to align the framework with the decision making process and 
develop a project plan. 
Phase A involves the modeller aligning how the framework is used with the 
decision making process. The framework aims to be flexible throughout. 
To describe resource use as a two-stage process in order to increase efficiency of model 
development; first establishing very generally what sort of resource processes there are 
for key components of the conceptual model of the problem; and second describing 
resource use in detail during the justifying and developing the model structure phase. 
This has been described within Phase Cii.  
For the project team to question each other’s assumptions throughout the conceptual 
modelling process. It is important for the modeller to be ready to acknowledge that the 
beliefs that they had about the system may not be the most appropriate. 
This is stated within Principle 3 of the framework. 
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Consideration of relevant issues for inclusion in the model How this was incorporated into the conceptual modelling framework 
To consider equity and the social gradient. Included within Step 2 of Phase Ci, although there is no discussion about why this 
is important within Public Health. 
To consider non-health costs and outcomes and what is a 'good' outcome. Included as questions in Box 1 to help develop the understanding of the problem. 
To consider stakeholders who might act to reduce/ increase the impact of intervention.  Included as a question in Box 1 to help develop the understanding of the problem.  
To incorporate outcomes dependent upon the determinants of health and consider step-
changes in societal behaviour due to sufficient people adopting a type of behaviour. 
Included as a question in Box 1 to help develop the understanding of the problem. 
To consider assessing population, community and individual-level interventions. A consideration when identifying potential intervention types in Phase Ci. 
To consider the culture and politics of the system. Included within the key principles of good practice. 
To consider heterogeneity and whether there are any appropriate subgroups, including 
socioeconomic status.  
Questions around the determinants of health (which highlights heterogeneity) are 
considered within Box 1 and Box 2. Subgroups are considered within Phase Diii. 
To highlight the difference between causation and association. Included within a process suggestions box and as a question within Box 1. 
To choose model type according to interactions and heterogeneity. Use of Brennan’s taxonomy within Phase Dv (choosing the model type). 
To consider intergenerational impacts. Included as a question in Box 1 to help develop the understanding of the problem. 
To explore the biases such as trial design associated with the effectiveness studies. Suggested within Phase Dii (choosing model interventions). 
To encourage understanding of the modelling requirements in other sectors when the 
scope of the model extends beyond health and wellbeing. 
Suggested within Phase Diii (determining the model boundary). 
To think about the constraints of the project scope. Included as a question in Box 2 to help incorporate interventions into the 
understanding of the problem. 
To encourage modellers to explore the exact meaning of topic specific terminology that 
also has a lay meaning. 
Considered within Principle 3 of the framework. 
To consider whether behaviour is being prevented or delayed. Included as a question in Box 1 to help develop the understanding of the problem. 
To encourage reflection upon whether there are other consequences (positive or 
negative) not considered by the effectiveness studies. 
Included as a question in Box 1 to help develop the understanding of the problem. 
To consider classifying and defining population subgroups of interest, defining harms and 
outcomes and modifiable components of risk, specifying the baseline position on policy 
variables, estimating the effects of changing the policy variables on the risk factors, risk 
functions relating to risk factors to harm, and monetary valuation. 
Included, although not in the same form, throughout the framework.  
To describe how to incorporate the disease natural history within the conceptual model 
of the problem. 
Described within Phase Ci (understanding the problem). 
To highlight the importance of depicting time in the conceptual model of the problem. Described within Phase Ci (understanding the problem). 
To consult relevant theory to choose which determinants of health to include. Considered within Phase Ci (understanding the problem) and described within 
Phase Diii for judging the model level of detail. 
To incorporate additional questions around the determinants of health to accompany 
the conceptual model of the problem. 
Included as questions in Box 1 to help develop the understanding of the problem. 
To expand the understanding of the problem if stakeholders broaden the potential 
interventions being assessed. 
Included as a question in Box 2 to help incorporate interventions into the 
understanding of the problem. 
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Process: Suggestions about the process the modeller might follow, although there may be alternative processes which 
would allow the general approach to be taken.  
How this was incorporated into the conceptual 
modelling framework 
If the term ‘conceptual model’ is employed within the framework it needs to be defined and which groups of people might be 
involved in the model development process should be clear.  
The stakeholders are clearly defined within Phase 
B. 
To encourage the use of the model for understanding the effectiveness of the interventions as well as the cost-effectiveness. Included within a process suggestions box. 
To align the stakeholders' expectations of the process and their requirements with the modellers’ expectations.  Included within a process suggestions box. 
To highlight that stakeholder recruitment is not a trivial task and that the project team should reflect upon potential 
stakeholder worldviews to understand their motivation for involvement in order to raise the efficiency of recruitment. 
Included within a process suggestions box. 
To choose lay members to represent different types of people within society where those differences are likely to be 
important to the topic area (eg. ethnic minorities, lower BMI, lower socioeconomic status) where feasible. If this is not 
possible, modellers could consider whether the assumed chains of behavioural causation developed within the conceptual 
model of the problem are likely to be violated by a particular subpopulation. 
Included within a process suggestions box. 
To describe a possible information retrieval approach for developing the understanding of the problem and model structure. Included within a process suggestions box. 
Decision makers should determine which interventions to consider within the model, based upon evidence reviews and input 
from other stakeholders. Discussions between the project team and the stakeholders may be required to limit the breadth of 
the search for the effectiveness review.   
Included within Phase Dii. 
  
The modeller should revisit the questions within the conceptual modelling framework to facilitate the development of the 
conceptual model of the problem throughout its development. 
Suggested within the understanding of the 
problem phase, above the questions. 
To highlight that within any workshops, stakeholders should be told that the aim is not necessarily to reach consensus; 
however after sharing divergent views, it is useful for the project team to limit these to a few key concepts and issues. During 
the understanding of the problem phase, it would be valuable to provide some sort of description of the degree of 
consensus/ disagreement between stakeholders. 
Included within a process suggestions box. 
To highlight that there is a need for flexibility with the approach for involving stakeholders within the model development 
process and several means of communication may be required. It may be appropriate to try and hold workshops or meetings 
with stakeholders around relevant conferences or meetings. Whilst workshops have the advantage of allowing issues to be 
discussed and debated, one-to-one meetings or telephone conversations may be employed in addition to, or instead of, 
workshops. 
Included within a process suggestions box. 
To highlight that the resource requirements during the workshops are substantial in order to maintain engagement with the 
stakeholders, record what is said and process and collate information developed during the workshop to share with the group 
later within the meeting.  
Included within a process suggestions box. 
Stakeholders could spend 2-3 minutes at the beginning of the first stakeholder workshop (or a paragraph of written text if not 
within a workshop) describing their perspective, what they think they can give to the project and what they would like out of 
their involvement.  
Included within a process suggestions box. 
The diagram developed within the understanding of the problem phase can be described as a ‘conceptual model of the 
problem depicting hypothesised causal relationships’. 
This is the terminology used throughout the 
framework. 
 
